
<html lang="en"     class="pb-page"  data-request-id="453b6f8f-4039-43d2-9b0a-24563af2cd78"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b00940;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions" /></meta><meta name="dc.Creator" content="Li  Li" /></meta><meta name="dc.Creator" content="Lei  Wang" /></meta><meta name="dc.Creator" content="Qi-Dong  You" /></meta><meta name="dc.Creator" content="Xiao-Li  Xu" /></meta><meta name="dc.Description" content="Hsp90 is one of the most important chaperones involved in regulating the maturation of more than 300 client proteins, many of which are closely associated with refractory diseases, including cancer..." /></meta><meta name="Description" content="Hsp90 is one of the most important chaperones involved in regulating the maturation of more than 300 client proteins, many of which are closely associated with refractory diseases, including cancer..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 30, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00940" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00940" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00940" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00940" /></link>
        
    
    

<title>Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00940" /></meta><meta property="og:title" content="Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0023.jpeg" /></meta><meta property="og:description" content="Hsp90 is one of the most important chaperones involved in regulating the maturation of more than 300 client proteins, many of which are closely associated with refractory diseases, including cancer, neurodegenerative diseases, and viral infections. Clinical Hsp90 inhibitors bind to the ATP pocket in the N-terminal domain of Hsp90 and subsequently suppress the ATPase activity of Hsp90. Recently, with the increased understanding of the discrepancies in the isoforms of Hsp90 and the modes of Hsp90-co-chaperone-client complex interactions, some new strategies for Hsp90 inhibition have emerged. Novel Hsp90 inhibitors that offer selective suppression of Hsp90 isoforms or specific disruption of Hsp90-co-chaperone protein–protein interactions are expected to show with satisfactory efficacy and safety profiles. This review summarizes the recent progress in Hsp90 inhibitors. Additionally, Hsp90 inhibitory strategies are emphasized in this review." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00940"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00940">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00940&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00940&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00940&amp;href=/doi/10.1021/acs.jmedchem.9b00940" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1798-1822</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01105" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00797" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Li Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li++Li">Li Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lei Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Wang">Lei Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8181-5644" title="Orcid link">http://orcid.org/0000-0002-8181-5644</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi-Dong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi-Dong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail, Q.-D.Y.: <a href="/cdn-cgi/l/email-protection#fe87918b8f9abecfc8cdd09d9193"><span class="__cf_email__" data-cfemail="e69f89939782a6d7d0d5c885898b">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi-Dong++You">Qi-Dong You</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiao-Li Xu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Li Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail, X.-L.X.: <a href="/cdn-cgi/l/email-protection#f38b868b9a929cac9f9ab3c2c1c5dd909c9e"><span class="__cf_email__" data-cfemail="a1d9d4d9c8c0cefecdc8e19093978fc2cecc">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Li++Xu">Xiao-Li Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1126-2538" title="Orcid link">http://orcid.org/0000-0002-1126-2538</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00940&amp;href=/doi/10.1021%2Facs.jmedchem.9b00940" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1798–1822</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 30, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 June 2019</li><li><span class="item_label"><b>Published</b> online</span>30 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00940</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1798%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi%2BLi%252C%2BLei%2BWang%252C%2BQi-Dong%2BYou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b00940%26title%3DHeat%2BShock%2BProtein%2B90%2BInhibitors%253A%2BAn%2BUpdate%2Bon%2BAchievements%252C%2BChallenges%252C%2Band%2BFuture%2BDirections%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1822%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00940"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2847</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00940" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Qi-Dong&quot;,&quot;last_name&quot;:&quot;You&quot;},{&quot;first_name&quot;:&quot;Xiao-Li&quot;,&quot;last_name&quot;:&quot;Xu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1798-1822&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00940&quot;},&quot;abstract&quot;:&quot;Hsp90 is one of the most important chaperones involved in regulating the maturation of more than 300 client proteins, many of which are closely associated with refractory diseases, including cancer, neurodegenerative diseases, and viral infections. Clinical Hsp90 inhibitors bind to the ATP pocket in the N-terminal domain of Hsp90 and subsequently suppress the ATPase activity of Hsp90. Recently, with the increased understanding of the discrepancies in the isoforms of Hsp90 and the modes of Hsp90-co-chaperone-client complex interactions, some new strategies for Hsp90 inhibition have emerged. Novel Hsp90 inhibitors that offer selective suppression of Hsp90 isoforms or specific disruption of Hsp90-co-chaperone protein–protein interactions are expected to show with satisfactory efficacy and safety profiles. This review summarizes the recent progress in Hsp90 inhibitors. Additionally, Hsp90 inhibitory strategies are emphasized in this review.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00940&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00940" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00940&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00940" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00940&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00940" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00940&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00940&amp;href=/doi/10.1021/acs.jmedchem.9b00940" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00940" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00940" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00940%26sid%3Dliteratum%253Aachs%26pmid%3D31663736%26genre%3Darticle%26aulast%3DLi%26date%3D2020%26atitle%3DHeat%2BShock%2BProtein%2B90%2BInhibitors%253A%2BAn%2BUpdate%2Bon%2BAchievements%252C%2BChallenges%252C%2Band%2BFuture%2BDirections%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D1798%26epage%3D1822%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Hsp90 is one of the most important chaperones involved in regulating the maturation of more than 300 client proteins, many of which are closely associated with refractory diseases, including cancer, neurodegenerative diseases, and viral infections. Clinical Hsp90 inhibitors bind to the ATP pocket in the N-terminal domain of Hsp90 and subsequently suppress the ATPase activity of Hsp90. Recently, with the increased understanding of the discrepancies in the isoforms of Hsp90 and the modes of Hsp90-co-chaperone-client complex interactions, some new strategies for Hsp90 inhibition have emerged. Novel Hsp90 inhibitors that offer selective suppression of Hsp90 isoforms or specific disruption of Hsp90-co-chaperone protein–protein interactions are expected to show with satisfactory efficacy and safety profiles. This review summarizes the recent progress in Hsp90 inhibitors. Additionally, Hsp90 inhibitory strategies are emphasized in this review.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many refractory diseases, such as malignancies and neurodegenerative disorders, pose a tremendous threat to human health due to their complicated pathogenesis, which includes the abnormal expression of many proteins and aberrant signal transduction. Thus, the simultaneous regulation of signaling pathways relevant to disease, especially in neoplasia, has emerged as a promising chemotherapeutic approach.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Hsp90, an essential and evolutionarily conserved molecular chaperone in eukaryotes, demonstrates increased expression during cellular stress to mitigate cell damage.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This biological process is termed the heat shock response (HSR). Hsp90 achieves its regulatory function by mediating the folding and maturation of more than 300 client proteins via the participation of co-chaperones.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Among these client proteins, numerous downstream substrates of Hsp90 are closely associated with hallmarks of cancer.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> More than 20 co-chaperones are required for the stabilization of a specific conformation of Hsp90 and/or recruitment of the corresponding client proteins.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In normal metabolism, Hsp90 is a primary master regulator of gene expression, proliferation, and the cell cycle. In contrast, dysregulation of Hsp90 causes dysregulation of cell homeostasis and overexpression of client proteins, which are inducible factors for the development of refractory diseases. In summary, Hsp90 is not only required for the maturation of downstream substrates, including tyrosine kinase receptors (such as EGFR and Her2), signal transduction proteins (such as Braf and Akt), cell cycle regulatory proteins (Cdk4/6), and antiapoptotic proteins (Bcl-2),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> but is also critical for the formation of a feedback loop with upstream transcriptional regulators.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Thus, Hsp90 plays a crucial role in cellular signal transduction networks, and its upregulation could lead to dysregulated expression of numerous proteins, especially in the development of cancer.</div><div class="NLM_p last">As Hsp90 is a significant target in cancer, Hsp90 inhibitors have attracted intense research attention. Many groups and companies have studied Hsp90 inhibitors, and a great deal of progress has been made over the past few decades. To date, several Hsp90 inhibitors have entered clinical trials for various refractory cancers and are summarized in <a class="ref internalNav" href="#sec5_1" aria-label="section 5.1">section 5.1</a>. However, most of these trials have been terminated in different clinical phases due to lack of efficacy and inevitable off-target effects, including hepatotoxicity and ocular toxicity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Consequently, numerous studies have been performed to explore novel Hsp90 inhibitors aimed at avoiding adverse effects and drug resistance. The inhibitory strategies of Hsp90 are worthy of intense study in the field of drug design. Therefore, analysis of the deficiencies of Hsp90 inhibitors and a discussion of the prospects of Hsp90-targeted therapies are necessary. Numerous compelling reviews have summarized the mechanistic development and performance of Hsp90 inhibitors in cancer therapy. Significant progress has been made regarding multiple aspects of this topic. Thus, it is necessary to review recent progress, summarizing different inhibition strategies and discussing future prospects and challenges. In this review, we briefly summarize the discovery of Hsp90 N-terminal inhibitors, focus on novel inhibitory strategies targeting Hsp90, and discuss future opportunities and challenges related to Hsp90 inhibition. Additionally, the causes of drug resistance and the toxicity of current inhibitors are highlighted to provide references for the development of Hsp90 inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Structure and Biological Functions of Hsp90</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hsp90 is thought to be the most abundant heat shock protein, and four isoforms can be categorized in mammalian cells: Hsp90α and Hsp90β in the cytosol, Grp94 in the endoplasmic reticulum, and Trap1 in mitochondria (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The N-terminal domain of Hsp90 (Hsp90N) is required for binding with ATP and co-chaperones.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> A mitochondrial signal sequence is located in the N-terminus of Trap1. Compared with the sequence of Hsp90α/β, the sequence of Grp94 includes five extra residues (QEDGQ) in the N-terminal ATP pocket. The charged linker in Hsp90α/β is responsible for nuclear localization but possesses calcium activity in Grp94. Unfolded client proteins are assembled on the middle domain of Hsp90 (Hsp90M). The C-terminal domain of Hsp90α/β ends with a highly conserved pentapeptide, MEEVD. This peptide is specialized to interact with co-chaperones containing tetratricopeptide repeats (TPRs).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Compared with Hsp90α/β, the sequence of KDEL in the C-terminal domain of Grp94 is responsible for endoplasmic reticulum localization.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition, another ATP binding pocket has been reported to be located in the C-terminal domain.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of the structural regions of Hsp90 isoforms: Hsp90α/β, Grp94, and Trap1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In general, Hsp90 acts as a clamp during the formation of homodimers. The clamp is anchored by dimerization of the C-terminus, and the jaw is composed of the N-terminal domains. ATP hydrolysis and co-chaperones binding in the N-terminus control the open or closed state of the clamp.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Co-chaperones are endowed with two main functions in the Hsp90 chaperone cycle, and these functions may overlap (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Co-chaperones are involved in regulating the conformational switch of the clamp through inhibition or promotion of ATP hydrolysis. The other primary function of co-chaperones is required for the recruitment of a subset of client proteins to assemble on Hsp90; importantly, some of these proteins specifically recognize certain clients. The selectivity mechanism may occur by the direct interaction of co-chaperones with specific clients. Co-chaperones interact with the different domains of Hsp90. TPR co-chaperones interact with the conserved MEEVD sequence in Hsp90C via their characteristic TPR domain. The functions and interaction domains of Hsp90-dependent co-chaperones are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Overview of the Functions and Interaction Domains of Hsp90-Dependent Co-chaperones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">co-chaperones</th><th class="colsep0 rowsep0" align="center">interaction domains in co-chaperone</th><th class="colsep0 rowsep0" align="center">interaction domains in Hsp90</th><th class="colsep0 rowsep0" align="center">client selectivity</th><th class="colsep0 rowsep0" align="center">effect on the conformation of Hsp90</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sti1/Hop</td><td class="colsep0 rowsep0" align="left">TPR</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">non-specific</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tah1</td><td class="colsep0 rowsep0" align="left">TPR</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">clients involved in assembling small nuclear ribonucleoprotein</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cdc37</td><td class="colsep0 rowsep0" align="left">M, C</td><td class="colsep0 rowsep0" align="left">N, M</td><td class="colsep0 rowsep0" align="left">kinase</td><td class="colsep0 rowsep0" align="left">stabilizes the open state</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sgt1</td><td class="colsep0 rowsep0" align="left">CS</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">nucleotide-binding leucine-rich repeat receptors</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aha1</td><td class="colsep0 rowsep0" align="left">N, C</td><td class="colsep0 rowsep0" align="left">N, M</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">promotes the closed state</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pp5/Ppt1</td><td class="colsep0 rowsep0" align="left">TPR</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">promotes the closed state</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FKBP51/FKBP52 Cyp40</td><td class="colsep0 rowsep0" align="left">TPR</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">steroid receptors kinases</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p23/Sba1</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">promotes the closed state</td></tr></tbody></table></div></div><div class="NLM_p last">In normal cells, Hsp90 is a vital regulator of the cell cycle, proliferation, signal transduction, and transcriptional regulation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, under stress conditions, Hsp90 induction is markedly upregulated to promote the misfolding and overexpression of client proteins.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Client proteins of Hsp90 are summarized on the Picard Lab Web site (<a href="https://www.picard.ch/downloads/Hsp90interactors.pdf" class="extLink">https://www.picard.ch/downloads/Hsp90interactors.pdf</a>). Hsp90α/β are extremely similar in regulating client proteins such as Tau,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Cdk4/6, Her2, EGFR, and Akt.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In contrast, Grp94 primarily modulates Toll-like receptors (TLRs), integrins, Her2, and LRP6.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The Wnt/β-catenin signaling pathway is crucial for immune regulation and oncogenesis. However, this signaling pathway was blocked in Grp94 knockout (Grp94-KO) multiple myeloma cell lines.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> These results suggest that Grp94 inhibition may be involved in immune disease<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and cancer. In addition, knockdown of Trap1 in esophageal cancer cell lines induced reactive oxygen species (ROS) accumulation and cell cycle arrest.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Furthermore, Trap1-KO esophageal cancer cell lines exhibited restored proliferation and cell apoptosis after re-expression of Trap1.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Briefly, Hsp90 upregulation results in (i) excessive aggregation of client proteins; (ii) promotion of cell proliferation and angiogenesis; (iii) acceleration of the cell cycle; and (iv) promotion of cell migration and invasion.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">3.  Regulatory Mechanism of Hsp90 Chaperones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Hsp90 chaperone cycle can be divided into the following steps (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Initially, Hsp70 is responsible for identifying unfolded substrates, which are delivered to Hsp90 via stress-inducible 1/Hsp70–Hsp90 organizing protein (Sti1/HOP).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> By this process, unfolded substrates are recognized by co-chaperones and loaded onto Hsp90M. Sequentially, Hsp90 ATPase activity is triggered by Hsp90 ATPase-1 (Aha1) along with the dissociation of Hsp70 and Hop, which promotes closure of the Hsp90 homodimer.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Unfolded substrates are assembled on Hsp90M. Subsequently, the procedure of ATP hydrolysis is catalyzed by PP5 on Hsp90N, leading to substrate folding and opening the N-terminal domain of the Hsp90 dimer to restore the initial conformation, which results in the release of mature client proteins.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> When Hsp90 is inhibited by modulators, the process of substrates folding is terminated, and these substrates are ubiquitinylated via CHIP for degradation. Hence, the progression of the ATPase cycle, the regulation of co-chaperones, and the biological function of client proteins are essential for studying Hsp90 inhibition strategies and exploring potential clinical applications.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hsp90 chaperone cycle. Hsp70 and Hop assist in loading client protein onto the middle domain of Hsp90. Aha1 increases Hsp90 ATPase activity, contributing to the closing of the N-terminal domain and the release of Hop and Hsp70. Client proteins are folded during the process of N-terminal domain closure. When the chaperone cycle is blocked by Hsp90 inhibitors, client proteins cannot be folded and degraded via CHIP modulation. <i>P</i>23 interacts with the N-terminal domain to stabilize the closed conformation. Finally, ATP hydrolysis causes the release of <i>P</i>23 and mature client proteins. The open conformation of the Hsp90 N-terminal domain is restored for the next chaperone cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">4.  Hsp90 and Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a key chaperone, the upregulation of Hsp90 plays an important role in the excessive accumulation of many client proteins, which are critical pathogenic factors in numerous diseases, including cancer, inflammation, neurodegeneration, and viral infection. Increased levels of Hsp90 exist in many aberrant cells. For example, upregulation of Hsp90 is regarded as a vital biomarker in cancer diagnosis. Thus, developing agents to inhibit the Hsp90 chaperone cycle is a valuable strategy to treat such intractable diseases.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.1.  Hsp90 and Cancer</h3><div class="NLM_p last">The ATPase activity of Hsp90 is a decisive factor in the Hsp90 chaperone cycle. ATP binding can trigger the folding of client proteins assembled on Hsp90. Many client proteins of Hsp90 are oncogenic proteins, including tyrosine kinase receptors (such as EGFR, Her2, and VEGFR), signal transduction proteins (such as Bcr-Abl, Alk, Braf, and Akt), transcription factors (such as androgen receptors and HIF1α), cell cycle regulatory proteins (such as Cdk4, Rb, and cyclin D), antiapoptotic proteins (such as Bcl2 and survivin).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The hallmarks of tumor cells can be divided into six categories: (i) overexpression of growth signals; (ii) insensitivity to antiproliferation signals; (iii) evasion of apoptosis; (iv) infinite division of aberrant cells; (v) activation of angiogenesis; and (vi) tissue invasion and metastasis. Oncogenic clients of Hsp90 are involved in these neoplastic hallmarks, leading to addiction to Hsp90 in the development of many cancer cases.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For example, Cdk4 is responsible for the G1 to S phase transition of cell cycle, which promotes the proliferation of tumor cells. Hsp90-Cdc37-Cdk4 complex is necessary for the maturation of Cdk4. Hsp90-Cdc37 interaction selectively stabilizes Cdk4 and Cdk6, which are rapidly degraded without binding to Hsp90. Steroid hormone receptors, including estrogen and androgen receptors, are also a class of clients of Hsp90. Overexpression of estrogen receptors is observed in most of breast cancer patients. Similarly, androgen receptors are critical factors in the development of prostate cancer. Both of these steroid receptors are Hsp90-dependent clients and activate their target genes after binding to Hsp90. In addition, angiogenesis is intensively required for the expending tumor volume. Angiogenesis is activated by vascular endothelial growth factor (VEGF). Receptors of VEGF (VEGFR) are also Hsp90-dependent clients. Inhibition of Hsp90 function reduces the level of VEGFR, resulting in the blocking of the transmission of angiogenesis signals.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Some excellent review articles have discussed the impartible relationship between the clients of Hsp90 and the development of cancer.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> In summary, inhibition of the activity of Hsp90 ATPase can induce the degradation of client proteins through the ubiquitin-proteasome pathway. Thus, tumors addicted to these client proteins are sensitive to Hsp90 inhibition. Currently, trials of monotherapy or combined therapy with Hsp90N ATP inhibitors<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> for the treatment of refractory solid tumors and hematological neoplasms have entered into different clinical phases (<a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=hsp90&amp;cntry=&amp;state=&amp;city=&amp;dist=" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=hsp90&cntry=&state=&city=&dist=</a>).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">4.2.  Hsp90 and Autoimmune/Inflammatory Diseases</h3><div class="NLM_p last">Autoimmune diseases are a series of immune disorders that are highly correlated with chronic inflammation. To date, specific immunosuppressive agents with hypotoxicity remain to be identified. An obvious symbol of Hsp90 inhibition is activation of the HSF1 pathway, which is a positive factor for cancer cell growth and survival but is an inducer of anti-inflammatory and immunosuppressive genes. Based on the effect of Hsp90 on the immune system, its potential application in autoimmune diseases has been increasingly researched.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Using a mouse model of encephalomyelitis, Bae et al. revealed that geldanamycin and its analog 17-AAG alleviated the development of encephalomyelitis in mice, which impaired the function of T cells, in turn contributing to the decreased IL-2 expression mediated by 17-AAG.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Another Hsp90N inhibitor, SNX-7081, was reported to suppress ankle and knee swelling in a rat model of collagen-induced arthritis and adjuvant-induced arthritis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Furthermore, EC144, a synthetic Hsp90 inhibitor, exerted the equivalent effect on collagen-induced arthritis mice model.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Systemic lupus erythematosus (SLE) is a typical autoimmune disease with overexpression of Hsp90, which entices researchers to explore the application of Hsp90 inhibition in SLE. 17-DMAG was demonstrated to decrease proteinuria, a universal phenomenon in patients with SLE, and to simulate the production of CD8-positive T cells.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Kasperkiewicz et al. revealed that treatment with 17-DMAG was effective in a mouse model of epidermolysis bullosa acquisita, hindering the expression of inflammatory factors, including IFN-γ, TNF-α, and IL-17.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In addition, the anti-inflammatory activity of 17-AAG was subsequently verified in rat and mouse models of lipopolysaccharide (LPS)-induced uveitis (EIU) and sepsis.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The Grp94 isoform is crucial for intestinal inflammation. Liu et al. reported that Grp94 could play an essential role in maintaining gut homeostasis through direct regulation of the canonical Wnt signaling pathway.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Grp94-KO mice and intestinal tissue-specific Grp94-KO mice developed serious intestinal lesions. Recently, our group demonstrated that a novel selective inhibitor of Grp94 had a positive effect in a DSS-induced ulcerative colitis (UC) mouse model.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This is the first evidence to confirm the potential therapeutic efficacy of Grp94 inhibitors in UC. In general, these results suggest that blockade of Hsp90 may provide a novel therapeutic method and a potential molecular target for autoimmune diseases.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">4.3.  Hsp90 and Neurodegenerative Diseases</h3><div class="NLM_p last">Alzheimer’s disease (AD) is an irreversible neurodegenerative disease in which integrated pathogenesis must be further examined. Excessive accumulation of amyloid-β (Aβ) in senile plaques and misfolding of the microtubule-associated protein Tau are considered to be two critical stimuli of AD. According to these findings, the relationship between Hsp90 chaperone function and AD pathogenesis has attracted extensive attention.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Hsp90 inhibition was reported to alleviate Aβ-induced toxicity and repair Aβ-induced cognitive impairment in mice.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Moreover, Hsp90 mediates the maturation of Tau, leading to the accumulation of pathological Tau.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In addition, substrates of Hsp90, including GSK3β and Akt, promote phosphorylation of Tau. Luo et al. demonstrated that blockade of Hsp90 inhibited the pathogenic activity of Tau and protected cells from aggregation, leading to tauopathies in cellular and mouse models.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Hence, inhibition of Hsp90 appears to reduce the levels of misfolded and hyperphosphorylated Tau protein and to suppress progressive neurodegeneration. The potential application of Hsp90 inhibitors in AD has been explored. 17-AAG reduced brain injury and improved cognitive processes in a mouse model.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Novobiocin and its derivatives, which are regarded to be Hsp90 C-terminal inhibitors, were demonstrated to protect cells from Aβ-induced cell death.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In addition, withaferin A (WA) interfered with the Hsp90/Cdc37 interaction, inducing instability in leucine-rich repeat kinase 2 (LRRK2), which has been found to be mutated in patients with familial and sporadic Parkinson’s disease and AD.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.4.  Hsp90 and Viral Infections</h3><div class="NLM_p last">Studies have shown that increased Hsp90 plays crucial roles in the viral life cycle and host stress response. First, exosome-mediated viral transmission is partially regulated by Hsp90. The replication competent complex Ago2-miR122-Hsp90 has been identified in exosomes from hepatitis C virus (HCV)-infected patients, in which Hsp90 stabilizes the RNA-replication complex by binding with Ago2.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Treatment with 17-DMAG was reported to markedly suppress exosome-mediated HCV transmission, suggesting the potential of Hsp90 inhibitors in viral diseases.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Second, host innate immune responses can be stimulated during viral infection. However, these responses can be neutralized by utilization of host Hsp90, which interacts with IκB kinase to regulate the immune response to DNA virus and retroviral infections through the NF-κB signaling pathway. Additionally, Hsp90 is an indispensable regulator of the proliferation or apoptosis of virus-infected cells. These results show that the maturation and proliferation of viruses are addicted to the functions of Hsp90. Notably, some Hsp90 inhibitors have been investigated in viral diseases. GDA was demonstrated to block the viral life cycle of hepatitis B virus (HBV), HCV, and herpes simplex virus type 1 (HSV-1).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In addition, 17-DMAG was shown to suppress the replication of HCV in a humanized mouse model with liver injury.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> A recent study demonstrated that inhibition of Hsp90 by 17-AAG and NVP-AUY922 disrupted the expression of HIV proteins, preventing rebound for 11 weeks in HIV-infected mice.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Vashist et al. reported that targeting Hsp90 <i>in vivo</i> could disrupt the replication of norovirus. Thus, Hsp90 can be regarded as a potential target for the treatment of viral infections.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">5.  Strategies for Hsp90 Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">5.1.  Inhibitors of Hsp90 ATPase Activity</h3><div class="NLM_p">Initial efforts to investigate Hsp90 inhibitors focused on suppression of the ATPase activity of Hsp90 via competitive bound to the ATP pocket in the N-terminus. These inhibitors block ATP hydrolysis of Hsp90 and subsequently impede the closure of the N-terminus of the Hsp90 dimer, which seriously impairs the Hsp90 chaperone cycle in the maturation of client proteins. Studies of the underlying biological mechanisms have allowed the classification of Hsp90 ATPase inhibitors into two types: (i) structures that bind to the Hsp90N ATP pocket and (ii) those that affect Hsp90 C-terminal ATPase activity. In this section, the development of these ATPase inhibitors is described.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">5.1.1.  Inhibitors Targeting the Hsp90 N-Terminus</h4><div class="NLM_p">Hsp90N ATP inhibitors can be divided into four classes according to the main scaffold: ansamycin-based, resorcinol-based, purine-based, and benzamide-based. Geldanamycin (GDA, <b>1</b>), is the first prominent Hsp90 inhibitor that exhibited potent antitumor activity via targeting the N-terminal ATP binding pocket of Hsp90. Preclinical trials of <b>1</b> were terminated due to its hepatotoxicity, <i>in vivo</i> instability, and poor solubility,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> which prompted research on structural modifications based on the skeleton of ansamycin (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Among these analogs, 17-AAG (<b>2</b>, IC<sub>50</sub> = 31 nM) was the first Hsp90 inhibitor in clinical studies. Following that study, 17-DMAG (<b>3</b>, IC<sub>50</sub> = 24 nM) was identified and shown to maintain biological activity and had improved solubility.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Additionally, two additional representative GDA derivatives, IPI-504 (<b>4</b>, EC<sub>50</sub> = 64 nM) and IPI-493 (<b>5</b>, EC<sub>50</sub> = 34 nM), were subsequently developed.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Both of these analogs have undergone clinical trials as an oral formulation with appropriate pharmacokinetics.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hsp90 N-terminal ATP inhibitors with an ansamycin scaffold. The IC<sub>50</sub> values of <b>2</b> and <b>3</b> were determined by competitive binding to Hsp90 in lysates of SKBR3 cells. The EC<sub>50</sub> values of <b>4</b> and <b>5</b> were determined by a fluorescence polarization assay of Hsp90α with BODIPYGDA as the probe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Radicicol (RDC, <b>6</b>, IC<sub>50</sub> = 30 nM) displayed high affinity for Hsp90 in an <i>in vitro</i> ATPase assay, with a <i>K</i><sub>d</sub> value of 19 nM. However, it lacks <i>in vivo</i> activity due to the rapid metabolism of allylic epoxide and α-, β-, γ-, and δ-unsaturated ketones. To improve stability, KF25706 (<b>7</b>, IC<sub>50</sub> = 39 nM) was found to exhibit potency comparable to that of radicicol against multiple human neoplastic cell lines. An X-ray crystallographic study of radicicol-Hsp90 revealed that the resorcinol moiety formed a hydrogen bonding network with residues (Asp93 and Thr184) in the ATP pocket, which primarily facilitated the high affinity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Based on the results presented in the crystal structural map, the resorcinol scaffold was maintained as a critical pharmacophore for the identification of several compounds under clinical investigation as anticancer agents via a fragment-based approach and high-throughput screening (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Fragment <b>8</b> was screened and found to bind to Hsp90N with an affinity of 790 μM.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The co-crystal structure presented obvious defects in the interaction model with the ATP pocket, and stretching of fragment <b>8</b> resulted in compound <b>9</b>, which had superior affinity (<i>K</i><sub>d</sub> = 0.54 nM).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Despite its potent antiproliferative activity, compound <b>9</b> displayed high plasma clearance in a mouse model, prompting optimization concentrated on the pharmacokinetic and physicochemical properties. Ultimately, compound AT-13387 (<b>10</b>, <i>K</i><sub>d</sub> = 0.71 nM) was selected to be advanced into clinical trials due to its high binding affinity for Hsp90 against various human tumor cell lines, as well as low plasma protein-binding activity and appropriate aqueous solubility.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Avila et al. reported an efficient assay to evaluate the ATPase activity of Hsp90;<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> compound <b>11</b> (IC<sub>50</sub> = 280 nM) was identified from a library containing ∼50 000 compounds through high-throughput screening.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The weak antiproliferative activity of <b>11</b> in HCT116 cells prompted structural modification focused on potency. Compound <b>12</b>, with a higher antiproliferative activity value of 260 nM, was identified and used as a template for further modification.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Accordingly, insight into the crystal structure of Hsp90 binding to <b>12</b> promoted the subsequent structure-based modification on the three rings with the aim of forming an appended hydrogen bond and improving solubility. Subsequently, NVP-AUY922 (<b>13</b>, IC<sub>50</sub> = 21 nM) was demonstrated to be a novel Hsp90 inhibitor with increased potency and was advanced into clinical trials for a series of cancer indications.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> In 2014, our group reported a novel series of tetrahydropyrido[4,3-<i>d</i>]pyrimidine compounds with inhibitory activity against Hsp90 through the construction of a rapid overlay of chemical structural (ROCS) model based on the conformation of AT-13387 in the co-crystal.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> A comprehensive structure–activity relationship (SAR) study was conducted to improve Hsp90 inhibitory activity and drug-like properties. Analog <b>14</b> exhibited an inhibitory value of 28 nM against Hsp90 and positive antitumor activity in an HCT116 xenograft model.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Additionally, <b>14</b> possessed good physicochemical properties and favorable ADME properties, suggesting its potential for further preclinical evaluation. Specifically, compared with NVP-AUY922 and TAS-116, <b>14</b> manifested no ocular toxicity in a rat retinal damage model. Liang et al. introduced unnatural amino acids (Tic) into a resorcinol fragment to mimic the isoindoline group of AT-13387 occupying the lipophilic pocket in the ATP binding site. As a result, compound <b>15</b> had a different chemical scaffold and was found to target Hsp90 in a cellular thermal shift (CETSA) assay and inhibit MDA-MB-231 cell viability with an IC<sub>50</sub> value of 980 nM.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hsp90 N-terminal ATP inhibitors containing the resorcinol scaffold. The IC<sub>50</sub> values of <b>6</b> and <b>7</b> represent the antiproliferative activity against MCF-7 and KNRK5.2 cells, respectively. The <i>K</i><sub>d</sub> values of <b>8</b>–<b>10</b> were measured using isothermal titration calorimetry (ITC). The IC<sub>50</sub> values of <b>11</b>–<b>13</b> were determined using a fluorescence polarization assay. The IC<sub>50</sub> values of <b>14</b> and <b>15</b> represent the antiproliferative activity against the MDA-MB-231 cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to ansamycin and resorcinol, Hsp90 inhibitors with purine-based structures were inspired by a focus on the endogenous ligand ATP. Eventually, five purine derivatives (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) (PU-H71, BIIB021, BIIB028, CUDC-305, and MPC-3100) were identified and advanced to clinical evaluation. PU-H71 (<b>16</b>, IC<sub>50</sub> = 90 nM) is an orally available inhibitor.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Another clinical purine-based inhibitor is BIIB028 (<b>18</b>), which is a prodrug of BIIB021 (<b>17</b>, IC<sub>50</sub> = 310 nM) that increased the therapeutic window for intravenous administration. Additionally, CUDC-305 (<b>19</b>, IC<sub>50</sub> = 100 nM) was shown to possess good oral bioavailability and tumor suppression activity.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> MPC-3100 (<b>20</b>, IC<sub>50</sub> = 540 nM) was selected as a clinical candidate with an impressive Hsp90 inhibition profile and superior pharmacokinetics (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Fragment <b>21</b> was screened by nuclear magnetic resonance (NMR), and compound <b>22</b> was identified from virtual screening (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). According to the crystal structures of both fragment <b>21</b> and compound <b>22</b>, compound <b>23</b> with 2-aminothieno[2,3-<i>d</i>]pyrimidine (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was synthesized and found to inhibit the activity of Hsp90 with an IC<sub>50</sub> value of 1250 μM via FP assay, and structural modification was performed according to the crystal structure.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Among the analogs, NVP-BEP800 (<b>24</b>), with an Hsp90 inhibition value of 58 nM via FP assay, was efficacious in preclinical trials in a BT474 human breast cancer xenograft mouse model (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hsp90 N-terminal ATP inhibitors with a purine scaffold. The IC<sub>50</sub> values of <b>16</b>–<b>20</b> represent the antiproliferative activity against MCF-7 (<b>16</b> and <b>17</b>), MV4–11 (<b>19</b>), and HCT116 (<b>20</b>) cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hsp90 N-terminal ATP inhibitors containing a purine scaffold. The IC<sub>50</sub> values of <b>21</b>–<b>24</b> were determined via fluorescence polarization assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another class of Hsp90N ATPase inhibitors is the benzamide-based class (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Two hits with Hsp90 inhibitory activity (<b>25</b>, IC<sub>50</sub> = 479 nM; <b>26</b>, IC<sub>50</sub> = 641 nM) were screened and displayed sub-micromolar inhibition rates in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Both of these compounds were selected as starting points for structural modification to enhance potency and maintain pharmacokinetic properties, leading to the discovery of XL888 (<b>27</b>, IC<sub>50</sub> = 24 nM), which is in the early stages of clinical trials.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In addition, Huang et al. performed a focused library screen targeting a series of ATPases. Compound <b>28</b> has a benzamide scaffold and exhibited moderate Hsp90 inhibitory activity and superior selectivity for the Hsp90N ATP binding site, with a <i>K</i><sub>d</sub> value of 3.7 μM in an 8-pt non-enzymatic ATPase assay. Computational chemistry and crystal structures guided the structural modification of benzamide derivatives, leading to SNX-2112 (<b>29</b>, IC<sub>50</sub> = 3 nM), which possessed a 230-fold higher affinity for Hsp90 than <b>28</b>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In HT-29 cell lines, SNX-2112 showed excellent antiproliferative activity, and its oral form SNX-5422 (<b>30</b>, IC<sub>50</sub> = 32 nM) showed <i>in vivo</i> potency, delaying growth by 67% in an HT-29 mouse model.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hsp90 N-terminal ATP inhibitors containing a benzamide scaffold. The IC<sub>50</sub> values of <b>25</b>–<b>27</b> were determined by Hsp90 enzymatic activity assays. The <i>K</i><sub>d</sub> value of <b>28</b> was determined by an 8-pt non-enzymatic ATPase assay. IC<sub>50</sub> values of <b>29</b> and <b>30</b> represent the antiproliferative activity against the HT-29 cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">5.1.2.  Inhibitors Targeting the Hsp90 C-Terminus</h4><div class="NLM_p">Another ATP binding pocket is found in the Hsp90 C-terminus. Some natural products and their derivatives (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) have been reported to target the Hsp90C-ATP pocket and exhibit antitumor activity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Novobiocin (<b>31</b>) was discovered as the first Hsp90C inhibitor with Hsp90 inhibitory activity and moderate antiproliferative effects on SKBR3 cells.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The levels of Hsp90-dependent clients (Raf-1, p185<sup>erbB2</sup>, mutant p53, and p60<sup>v-src</sup>) were observably reduced after treatment with novobiocin at 800 μM in SKBR3 cells. <i>In vivo</i> administration of <b>31</b> reduced the level of Raf-1 in murine splenocytes without altering the splenic content of gelsolin.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> To improve the antitumor activity of <b>31</b>, a comprehensive SAR study was performed. Among the identified analogs, <b>32</b> induced the degradation of Hsp90 clients (p-Akt and HIF-1α) via a different mechanism compared with 17-AAG.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Western blotting revealed that <b>32</b> did not induce the upregulation of Hsp90α/β and Hsp70, but 17-AAG did. Compound <b>33</b> exhibited potent antiproliferative activity, with IC<sub>50</sub> values of 0.14 and 0.64 μM against SKBR3 and MCF-7 cells, respectively.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The Hsp90 clients, including Her2, Raf-1, and Akt, were degraded in a concentration-dependent manner. In 2017, our group investigated the structural modification of novobiocin and identified compound <b>34</b> with potent activity against the MCF-7 and SKBR3 cell lines.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The levels of Hsp90 clients, including Akt, Erk, and CDK6, were reduced in MCF-7 cells without the upregulation of Hsp90 and Hsp70. In addition, <b>34</b> showed inhibitory activity against cell migration <i>in vitro</i> and an antitumor effect <i>in vivo</i> in a 4T1 breast xenograft mouse model. Notably, these analogs of novobiocin inhibited Hsp90 without triggering HSR.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Deguelin (<b>35</b>), a naturally occurring rotenoid, was suggested to downregulate clients of Hsp90 (Cdk4, Akt, eNOS, and MEK1/2).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Deguelin bound to ATP in an ATP-Sepharose assay without affecting the ATP pocket in Hsp90N.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> These results indicated that deguelin might bind to the ATP pocket in Hsp90C. Furthermore, <b>36</b> and <b>37</b>, which are derivatives of deguelin, both exhibited potent antiproliferative activity <i>in vitro</i> and showed lower cytotoxicity against normal cells compared to deguelin. Compound <b>37</b> exhibited potent antiangiogenic activity in a zebrafish model.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Epigallocatechin gallate (ECGC, <b>38</b>) was shown to exhibit antiproliferative activity against pancreatic cancer cells by reducing the levels of Hsp90 client proteins (Akt, Cdk4, Raf-1, Her-2, and pErk). Proteolytic footprinting and ATP-agarose pulldown assays demonstrated that <b>38</b> bound to Hsp90C without affecting the N-terminal ATP pocket.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Structural modification of <b>38</b> resulted in analog <b>39</b>, which had improved antitumor activity of greater than 18-fold against MCF-7 cells.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Additionally, derrubone (<b>40</b>) and silybin (<b>42</b>) were shown to possess antitumor activity related to targeting Hsp90C. Furthermore, their analogs (<b>41</b>, a derivative of derrubone, and <b>43</b>, a derivative of silybin) were designed and exhibited improved antiproliferative activity against MCF-7 cells, resulting in the downregulation of Her-2 and Raf.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a> Compared with inhibition of Hsp90N, targeting the C-terminal ATP pocket produces a negative effect on client proteins of Hsp90 and stabilizes Hsp70 without initiating the HSR. However, the efficacy of Hsp90C inhibitors against tumor cells and the molecular mechanism of the binding mode are remain unclear. In 2011, the potential binding site in Hsp90C was explored by protease fingerprinting and photoaffinity labeling utilizing LC-MS/MS.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The binding mode of Hsp90 and novobiocin was generated by a homology model of hHsp90α. Novobiocin binds to a pocket in the open conformation of the Hsp90C comprising the sequence of Glu537 to ASN686. Marcu and co-workers proposed that novobiocin bound to the Hsp90 C terminal site consisting of residues 538–728 through truncation studies.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> In addition, it was reported that novobiocin might bind to Hsp90 after the dimerization of its C terminus prevented ATP binding to the Hsp90 N terminal pocket (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80,81)</a> Mutational analysis showed that critical residues in the Hsp90N ATP binding pocket did not affect binding of novobiocin. In summary, inhibitors targeting Hsp90C ATPase activity are promising because most of them do not induce HSR. However, the structural information of the ATP pocket in Hsp90C and the binding mode with inhibitors remain obscure. Therefore, structural biological analysis of Hsp90C is needed, which is important for designing potent Hsp90 inhibitors without inducing HSR.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of Hsp90 C-terminal ATPase inhibitors <b>31</b>–<b>37</b>. IC<sub>50</sub> values represent the antiproliferative activity against various cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of Hsp90 C-terminal ATPase inhibitors <b>38</b>–<b>43</b>. IC<sub>50</sub> values represent the antiproliferative activity against various cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Two possible binding modes of novobiocin targeting Hsp90C. Novobiocin binding to Hsp90C may occur following dimerization of the Hsp90 C terminus, which has a negative effect on the Hsp90N-ATP interaction. In addition, novobiocin binding may occur when the domain is open, which disrupts the chaperone cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">5.2.  Inhibitors Directly Disrupting Hsp90 and Its Co-chaperones</h3><div class="NLM_p">Considering that the different functions of the Hsp90 chaperone machinery are dependent on the associated co-chaperones, selective Hsp90 inhibition with reduced toxicity and elevated selectivity may be achieved by disrupting certain protein–protein interactions (PPIs). N-terminal inhibitors will impair Hsp90 before the chaperone machinery is initiated. In contrast, inhibitors targeting Hsp90 and its co-chaperone interactions act via an entirely different mechanism and may provide an alternative pathway to avoid the toxicity induced by Hsp90 pan-inhibition. Targeting the interactions between Hsp90 and its co-chaperones may suppress the maturation of partial Hsp90 substrates without impacting the whole client protein (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Consequently, disrupting the interaction between Hsp90 and its co-chaperones has emerged as a different strategy for Hsp90 inhibition and has received the considerable attention of medicinal chemists, with some achievements being made in this area.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Strategies for inhibiting the Hsp90 chaperone machinery. Typical N-terminal ATPase inhibitors block the ATP binding pocket, leading to arrest of the Hsp90 ATP cycle, which non-selectively affects all of the client proteins. Compared with ATPase inhibitors, regulators that disrupt Hsp90 and its co-chaperones may selectively regulate some specific client proteins of Hsp90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">5.2.1.  Targeting the Hsp90-Cdc37 Protein–Protein Interaction</h4><div class="NLM_p">Human Cdc37 (50 kDa) consists of 378 amino residues and has been divided into three domains. The highly conserved N-terminus of Cdc37 (Cdc37N) is responsible for binding to kinases, and the middle domain and C-terminus are involved in the interaction with Hsp90. Oncogenic kinases, such as Akt, Cdk4, Erk, and B-Raf, depend on Cdc37 and the subsequent assembly of the Hsp90-Cdc37-kinase ternary complex.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82,83)</a> Increased Cdc37 is observed in various cancers, such as prostate carcinoma, anaplastic large-cell lymphoma, acute myelocytic leukemia, HCC, and multiple myeloma.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In addition, knockdown of Cdc37 induced growth arrest in prostate cancer cells.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Cdc37 can specifically recognize at least 90% of the unfolded kinase-ome before interacting with Hsp90.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The entire Cdc37-dependent kinase-ome has been summarized by the laboratory of Didier Picard on their Web site (<a href="https://www.picard.ch/downloads/Cdc37interactors.pdf" class="extLink">https://www.picard.ch/downloads/Cdc37interactors.pdf</a>). These kinases comprise a complex network of signaling cascades that regulate neoplastic cell cycle and proliferation.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Compared with the inferior specificity of Hsp90 for client proteins in cell lines, the oncogenic kinase-ome strongly depends on Cdc37 in tumors. Polier et al. found that ATP-competitive inhibitors, such as vemurafenib and lapatinib, impeded the interaction of Cdc37 with oncogenic kinases such as B-Raf and Her2 in cellular assays, blocking these kinases from accessing Hsp90-Cdc37 and leading to subsequent degradation.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> These results suggested that part of the efficacy of ATP-competitive kinase inhibitors is attributed to inhibition of the formation of the Hsp90-Cdc37-kinase complex. The crystal structure of yeast Hsp90-Cdc37 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1US7">1US7</a>) was first determined by Roe and co-workers,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and indicated that the M domain of Cdc37 binds to Hsp90N and partially overlaps the N-terminal nucleotide binding pocket (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The Hsp90-Cdc37 interaction pocket neighbors the ATP binding pocket in Hsp90N, with Arg167 on Cdc37 shallowly inserting into the mouth of the ATP pocket. Heteronuclear NMR spectroscopy was conducted to map the Hsp90-Cdc37 complex from human (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B">2K5B</a>), and the conclusion was drawn that Leu205 of Cdc37 is a critical residue in the binding to Hsp90.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Dynamic binding modes of Hsp90-Cdc37 PPI. (A) The crystal structure of the Hsp90N-CdcM interaction (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1US7">1US7</a>). (B) The crystal structure of the Hsp90M-CdcM/C interaction (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FWL">5FWL</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The affinity of the Hsp90-Cdc37 interaction was determined <i>in vitro</i> by ITC at the low micromole level (<i>K</i><sub>d</sub> = 1.46 μM). In 2017, the crystal structure of Hsp90-Cdc37-Cdk4 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FWL">5FWL</a>), reported by Agard, provided significant evidence for the chaperone-kinase interaction.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> In addition, the crystal structure suggests that the Hsp90-Cdc37-kinase interaction is highly dynamic (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The binding site of Cdc37 was transferred from Hsp90N to Hsp90M, indicating that the Hsp90-Cdc37 PPI is highly flexible and that Hsp90 contains two binding sites for the Cdc37 interaction. Currently, most of the reported regulators of the Hsp90-Cdc37 PPI are natural products (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). In 2008, Zhang et al. reported that celastrol (<b>44</b>, IC<sub>50</sub> = 3 μM) exhibited antitumor activity against the Panc-1 cell line and disrupted the Hsp90-Cdc37 interaction at a concentration of 10 μM in an immunoprecipitation assay.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In addition, an ATP-Sepharose pulldown assay provided evidence that <b>44</b> did not impact ATP binding at a concentration of 1 μM, suggesting a different mechanism of Hsp90 inhibition compared to that of traditional Hsp90 inhibitors. <b>44</b> markedly decreased the levels of client proteins, including Cdk4 and Akt. In a mouse model of pancreatic cancer, <b>44</b> exhibited excellent inhibitory activity against tumor growth (80%). Using proteolytic fingerprinting assay, Zhang et al. demonstrated that <b>44</b> modified Hsp90C to achieve allosteric regulation and disrupted the Hsp90-Cdc37 complex.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> A GST pulldown assay indicated that the quinone methide structure of <b>44</b> is an important pharmacophore, as dihydrocelastrol diacetate led to a 2-fold decrease in the inhibitory effect on the Hsp90-Cdc37 PPI. However, Sreeramulu et al. proposed another mechanism in which <b>44</b> covalently bound to cysteine residues in Cdc37N via the Michael reaction.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> This binding mode was determined by an <sup>1</sup>H–<sup>15</sup>N heteronuclear single-quantum correlation (HSQC) experiment in which most of the cross peaks disappeared after the addition of <b>44</b> to <sup>15</sup>N-labeled Cdc37. Based on these results, our group attempted to modify the C-29 carboxyl moiety of <b>44</b> to investigate the SAR and to improve the drug-like properties. Among the 23 derivatives, <b>45</b> exhibited a 2-fold increase in the antiproliferative activity against the MCF-7, Panc-1, and A549 cell lines and possessed superior permeability compared with <b>44</b>.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Treatment with 10 μM withaferin A (WA, <b>46</b>) dissociated the Hsp90-Cdc37 complex in a coimmunoprecipitation (CO-IP) assay in Panc-1 cells. Furthermore, the levels of client proteins dependent on the Hsp90-Cdc37 interaction, including Akt and Cdk4, were reduced in a Western blotting assay.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> In addition, <b>46</b> displayed antiproliferative activity against a series of pancreatic cancer cell lines (IC<sub>50</sub> = 1.24 μM, Panc-1; IC<sub>50</sub> = 2.93 μM, MiaPaCa2; and IC<sub>50</sub> = 2.78 μM, BxPc3) without an effect on the ATPase activity of Hsp90. Using a WA-biotin pulldown assay, Yu et al. illustrated that <b>46</b> covalently binds to the cysteine-containing C-terminus of human Hsp90 but not the N-terminus.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> These results suggested that <b>46</b> is an indirect inhibitor of the Hsp90-Cdc37 PPI via allosteric modulation of Hsp90C and is dependent on cysteine residues. Another Hsp90-Cdc37 PPI inhibitor is sulforaphane (<b>47</b>), which was proven to bind to Hsp90C via an immunoprecipitation assay. In addition, <b>47</b> was reported to impair Hsp90 chaperones via another mechanism that promoted hyperacetylation of Hsp90.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Another covalent inhibitor is kongensin A (<b>48</b>), which disrupts the Hsp90-Cdc37 PPI and thus blocks RIP3-dependent necroptosis in HT-29 cells by covalently binding Cys420 on Hsp90M.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Mutations of all cysteines (Cys366, Cys420, Cys521, Cys564, Cys589, and Cys590) in Hsp90 revealed that <b>48</b> specifically binds to Cys420 via a covalent mechanism; the selectivity was proven by mass spectrometry. Huang et al. used chemoproteomics to identify FW-04-804 (<b>49</b>) targeting Hsp90N in the Hsp90-Cdc37 binding pocket and inhibited the Hsp90-Cdc37 interaction by an immunoprecipitation assay in SKBR3 cell lysates with limited interference with ATPase activity.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Interestingly, this compound was more effective in a Her2-overexpressing SKBR3 tumor xenograft model than in a Her2-underexpressing MCF-7 model. In 2017, Li et al. showed that platycodin D (<b>50</b>) disrupted the Hsp90-Cdc37 complex in an immunoprecipitation assay of A549 cell lines without inhibiting the ATPase activity. Specifically, a Western blotting assay showed no change in the Hsp70 level and a reduction in the levels of EGFR, IGF1R, and Cdk6.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Natural products disrupting the Hsp90-Cdc37 interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the crystal structure of the Hsp90-Cdc37 complex (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B">2K5B</a>), our group focused on the <i>de novo</i> design of regulators targeting the Hsp90-Cdc37 PPI. In a previous work, an active peptide (<b>Pep-1</b>, Ac-KHFGMLRRWDD-NH<sub>2</sub>) component of 11 residues derived from Cdc37 was reported. <b>Pep-1</b> was identified by molecular dynamics simulation and molecular mechanics Poisson–Boltzmann surface area (MM-PBSA) analysis combined with <i>in vitro</i> verification. In a competitive biolayer interferometry (BLI) assay, <b>Pep-1</b> disrupted the Hsp90-Cdc37 interaction in a concentration-dependent manner and showed affinity for Hsp90N by ITC, with a <i>K</i><sub>d</sub> value of 6.90 μM.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a><b>Pep-1</b> possessed weak ATPase inhibitory activity at 3 μM. This peptide is a non-natural product inhibitor of the Hsp90-Cdc37 PPI and is a breakthrough. Next, to improve the physicochemical properties and binding affinity, a SAR study of <b>Pep-1</b> was conducted by mutation and shrinkage of residues, leading to the identification of an abbreviated <b>Pep-5</b> (Ac-HFGMLRR-NH<sub>2</sub>, <i>K</i><sub>d</sub> = 5.99 μM).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Our group studied the interaction hotspot between Hsp90 and Cdc37, resulting in the discovery of a heptapeptide that suppressed the activity of Hsp90-Cdc37 at low micromolar levels. Based on these results, a pharmacophore model was generated according to the critical interactions of Hsp90-<b>Pep1</b> (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>A), and a structure-based virtual screening workflow was conducted to identify a small molecule that disrupts the Hsp90-Cdc37 PPI. Subsequently, <b>51</b> was identified and showed moderate inhibition (100 μM, 59.33%) of Hsp90-Cdc37 binding in a homogeneous time-resolved fluorescence (HTRF) assay and weak ATPase inhibitory activity (100 μM, < 10%) in a GDA-FP assay.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> A SAR study of compound <b>52</b> (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>B) showed a maintained inhibition rate (100 μM, 79.4%) of Hsp90-Cdc37 in an HTRF assay and antiproliferative activity with an IC<sub>50</sub> of 14.67 μM, representing a 4-fold increase compared to that obtained with <b>51</b> in SKBR3 cells. Western blotting proved that compound <b>52</b> induced the degradation of Hsp90 clients in a concentration-dependent manner in SKBR3 cells, including Akt and Cdk4, and disrupted the Hsp90-Cdc37 PPI in a GST pulldown assay. The binding mode of compound <b>52</b> provides evidence that the identified interaction hotspot is an effective binding site for the Hsp90-Cdc37 PPI. According to molecular dynamics calculation and ITC determinations of mutant affinities, we confirmed the critical residues including R167 on Cdc37 and E47 and Q133 on Hsp90, which is one of the binding determinants in the interaction of Hsp90-Cdc37. Based on these results, we designed a hierarchical strategy that combines cascade docking, experimental assays, and chemical optimization, and an inhibitor termed DDO-5936 (<b>53</b>) was developed (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>C), which potently disrupted Hsp90-Cdc37 both <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> To identify the potential binding site between Hsp90 and <b>53</b>, we obtained a <sup>1</sup>H–<sup>15</sup>N transverse relaxation optimized spectroscopy (TROSY) heteronuclear single-quantum coherence (HSQC) spectrum, and the critical residues (E47 and Q133) of Hsp90 showed gradual shifts in NMR resonance positions upon titration with <b>53</b> in a dose-dependent manner. Compound <b>53</b> selectively downregulated Cdc37-dependent kinases including Cdk4/6 and p-Akt in HCT-116 cells, leading to cell cycle arrest and antiproliferative activity. Compound <b>53</b> showed efficiency in HCT116 tumor cell xenografts with a good safety profile in multiple organs including the lung, liver, and spleen.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Compound <b>53</b> could be regarded as the first small-molecule inhibitor targeting Hsp90-Cdc37 PPI with a clear binding mode and on-target specificity. Recently, Xu et al. found that KBU2046 (<b>54</b>) disrupted the Hsp90-Cdc37 PPI without cytotoxicity and selectively inhibited cell motility and invasion in tumor cell lines (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>C).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Interestingly, <b>54</b> individually binds to neither Hsp90 nor Cdc37 according to isothermal titration calorimetry, fluorescence-based thermal shift assays, and BLI assays, but it binds exclusively to the Hsp90-Cdc37 heterocomplex. In prostate and breast cancer mouse models, <b>54</b> markedly inhibited metastasis and prolonged survival. In addition, Chen et al. reported an inhibitor with a triazine scaffold, <b>DCZ3112</b> (<b>55</b>), that targeted Hsp90N and suppressed the Hsp90-Cdc37 PPI (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>C).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Compound <b>55</b> potently inhibited the viability of Her-2-positive breast cancer cell lines, including SKBR3 and BT-474, cells that are resistant to the Hsp90 ATPase inhibitor GDA. Moreover, <b>55</b> produced G1-phase arrest, downregulated the phosphorylation of Akt and Erk, and maintained antitumor activity in Her2-positive BT-474 xenografts.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Peptides and small-molecule inhibitors of the Hsp90-Cdc37 PPI. (A) The docking mode of <b>52</b> binding to the interaction hotspot of Hsp90-Cdc37. One imidazolyl group partially occupies the mouth of the ATP pocket, and the linker binds in a flat groove of the Hsp90-Cdc37 interaction site. (B) Structure–activity relationship (SAR) of a series of analogs of <b>51</b>. (C) Structures of peptides and small molecules (<b>53</b>–<b>55</b>) targeting the Hsp90-Cdc37 PPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">5.2.2.  Targeting the Hop-Hsp90 Protein–Protein Interaction</h4><div class="NLM_p">Sti1/HOP plays a key role in facilitating unfolded client transferred from Hsp70 to Hsp90 for maturation. The Hsp90-Hop-Hsp70 ternary complex depends on two TPR domains on Hop: TPR1 and TPR2A.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Although the binding affinity of TPR2A for Hsp90 is moderate, with a <i>K</i><sub>d</sub> value of 11 μM,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> this interaction is absolutely critical to initiate the Hsp90 chaperone cycle (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>A). Thus, the hypothesis of Hsp90-Hop PPI inhibition emerged as a potential alternative approach to inhibit Hsp90 activity (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<named-content content-type="anchor" rid="fig16" type="simple"></named-content> Surprisingly, Regan and co-workers demonstrated the feasibility of this strategy with a designed TPR domain that could competitively bind to Hsp90C and disrupt the Hsp90-Hop-Hsp70 complex. Six active compounds (<b>56</b>–<b>61</b>) with a pyrimido[5,4-<i>e</i>][1,2,4]triazine-5,7-dione structural core were identified from the NCGC compound library via an AlphaScreen assay (see <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). The isothermal titration calorimetry results showed that compound <b>56</b> bound to TPR2A at a 1:1 ratio with a <i>K</i><sub>d</sub> value of 16 μM.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Importantly, these compounds did not induce elevated Hsp70 expression, which is an undesired trait of Hsp90N inhibitors. Hsp70 induces HSR and inhibits apoptosis, which may contribute to drug resistance and toxicity. Thus, these compounds disrupted Hsp90-TPR2A (<i>K</i><sub>d</sub> < 1 μM in a competitive FP assay) <i>in vitro</i> and decreased the overexpression of the Hsp90-dependent client Her2 without Hsp70 upregulation in BT474 and SKBR3 cells. These compounds may represent a novel class of Hsp90 inhibitors with a distinct mechanism and superior safety profile. In subsequent studies, the TNBC cell line MDA-MB-231 was proven to be sensitive to compound <b>57</b> (IC<sub>50</sub> = 1.75 μM) due to disruption of the Hsp90-Hop PPI and a reduction in the Hsp70 level.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Moreover, <b>57</b> negatively affected the level of Cdc37, which may explain the decreased levels of Hsp90-dependent kinases, such as JNK1/2 and p38. Recently, Wang et al. reported <b>62</b> as a Hsp90 inhibitor with pyrimidine that acted by disrupting the Hsp90-Hop interaction<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).Compound <b>62</b> decreased the levels of Hsp90 client proteins, including Bcr-Abl, Raf-1, Akt, and Cdk6, but induced Hsp70 expression in SKBR3, A431, MCF-7, and SNU-5 cells. Disruption of the Hsp90-Hop interaction by <b>62</b> is reduced by thiol oxidation rather than by competitive binding to the Hsp90-Hop interaction pocket, triggering G0/G1 cell cycle arrest and apoptosis. An α,β-unsaturated bond with thiol-reactive scaffold provides the possibility of modifying cysteine residues on Hsp90 and further inhibiting its function. A Western blot with K562 cells showed that Hsp90 client proteins (Bcr-Abl, Raf-1, Akt, Cdk4, and Cdk6) were degraded and that Hsp70 induction was restored upon incubation with the thiol-containing antioxidant dithiothreitol (DTT) before treatment with <b>62</b>.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> These results suggested that <b>62</b> disrupted the Hsp90-Hop interaction via thiol oxidation. Additionally, <b>62</b> showed potential for the treatment of imatinib-resistant leukemia due to its efficacy in a Bcl-Abl point mutation model both <i>in vitro</i> and <i>in vivo</i>.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Hsp90-Hop PPI mediates Hsp90 clients folding. The disruption of the PPI induces protein degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Crystal structures of TPR-dependent co-chaperones interacting with the conserved sequence of MEEVD on Hsp90C. (A) The crystal structure of the TPR2A domain of Hop with MEEVD (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ELR">1ELR</a>). (B) The crystal structure of immunophilin (FKBP52) with MEEVD (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ2">1QZ2</a>). Carbons of MEEVD are shown in light yellow. The Hydron bonds are presented as red dash lines, and the receptor proteins are shown as surface mode.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">5.2.3.  Other Disruptors of Hsp90 and Its Co-chaperones</h4><div class="NLM_p">Co-chaperones with a TPR domain can identify the MEEVD sequence in Hsp90C.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> In addition to the aforementioned Hop, there are four other immunophilins that are TPR-dependent co-chaperones of Hsp90: FK506 binding protein 52 (FKBP52), FKBP51, cyclophilin 40 (Cyp40), and FKBP38 (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>B). Immunophilins selectively control the maturation of hormone receptors during Hsp90 chaperone machinery assembly, which can promote cell growth via a signaling cascade. Since complexes of Hsp90 and immunophilins regulate cell growth, blocking this interaction in tumor cells may induce cellular apoptosis, leading to a unique chemotherapy for cancer. In 2014, McAlpine and co-workers identified the first small molecule (<b>63</b>) that could disrupt the association between Hsp90 and immunophilins (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). In HeLa cells, this compound significantly decreased the level of immunophilins and moderately reduced the levels of the corresponding client protein, glucocorticoid receptor (GR). Notably, treatment with <b>63</b> did not affect the Hsp70 levels in HeLa cells, indicating that this compound did not trigger the HSR.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p">Aha1 is involved in the Hsp90 chaperone cycle by accelerating the N-terminal association of Hsp90 dimers (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a><named-content content-type="anchor" rid="fig18" type="simple"></named-content>Two binding modes of Hsp90 and Aha1 have been reported: one is the interaction of Hsp90M-Aha1N, and the other is the dynamic interaction between Hsp90N-Aha1C.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Additionally, this interaction is critical in the quality control of mutants of the cystic fibrosis transmembrane conductance regulator (CFTR), which is implicated in the development of cystic fibrosis.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Thus, the Hsp90-Aha1 interaction is believed to be involved in the selective binding of client proteins.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> However, the regulators of the Hsp90-Aha1 PPI require further research. Recently, a compound inhibiting the Hsp90-Aha1 complex was identified by Stiegler and colleagues through Förster resonance energy transfer (FRET). Compound <b>64</b> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) attenuated the Aha1-mediated ATPase activity of Hsp90 but was inefficient in the absence of Aha1.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> NMR was performed to demonstrate that the binding site of <b>64</b> was located in the <sup>15</sup>N-labeled Hsp90N rather than in Hsp90M, suggesting that <b>64</b> suppressed ATPase activity by partially disrupting the Hsp90-Aha1 interaction at the N-terminal binding site but did not affect the M-terminal binding site in Hsp90. In an <i>in vitro</i> yeast culture assay, <b>64</b> markedly inhibited the level of the mineralocorticoid receptor in a concentration-dependent manner, which is a client of Hsp90 associated with the Aha1 interaction. Moreover, <b>64</b> stabilized the level of a mutant of CFTR (with the deletion of F508 in the CFTR sequence), whose degradation plays a key role in cystic fibrosis.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Hsp90-Aha1 PPI accelerates the ATPase activity of Hsp90. Disruption of the PPI inhibits ATP hydrolysis and prevents closure of the Hsp90 dimer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Small molecules targeting Hsp90 and co-chaperone protein–protein interactions. Inhibitors (<b>56</b>–<b>62</b>) targeting Hsp90-Hop protein–protein interactions and their <i>K</i><sub>d</sub> values were determined by FP assays. Inhibitors targeting Hsp90-Aha1 (<b>63</b>) and Hsp90-immunophilins (<b>64</b>) protein–protein interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The Hsp90 chaperone cycle is driven not only by ATPase activation but also by the interaction with co-chaperones. Different co-chaperones with specific functions bind to Hsp90 in different stages in the chaperone cycle. For example, Cdc37 loads onto Hsp90 during the early stages of the cycle, introducing unfolded kinases to Hsp90 and inhibiting ATP binding by maintaining Hsp90N cleavage. In contrast, Aha1 accelerates the closed conformation of Hsp90N. Hence, these characteristics of the Hsp90-co-chaperone interaction provide a platform for different inhibition modes of the Hsp90 chaperone cycle. Progress in the field of Hsp90 PPI regulators suggests the feasibility of special inhibition of the Hsp90 chaperone cycle. Although some problems exist with these PPI inhibitors, such as low affinity and elusive mechanisms, some regulators exhibit positive effects on refractory cancer cells, such as TNBC and NSCLC cells. These results provide insights into the network of signaling pathways involved in Hsp90 functions and the application of these pathways to tumor treatment.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">5.3.  Selective Inhibition of Hsp90α/β, Grp94, and Trap1</h3><div class="NLM_p">The Hsp90 chaperone has four isoforms: Hsp90α, Hsp90β, Grp94, and Trap1. To date, the mechanisms of action for Hsp90α and Hsp90β are well known, but Trap1 and Grp94 are less understood. Grp94 is reported to be implicated in innate immunity.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Despite the high conservation of the isoforms in the structure map, selective inhibitors of Hsp90 isoforms have attracted much attention from medicinal chemists.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Furthermore, selective inhibitors are worthy of further investigation as this would provide deep insight about the biofunction of the individual isoforms. In this section, subtle differences in the structure of the isoforms as well as the selective inhibitors are summarized.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">5.3.1.  Selective inhibition of Hsp90α/β</h4><div class="NLM_p">Hsp90α/β are critical to reduce the levels of mutant huntingtin protein (mHtt), which constantly accumulates in the brain as Huntington’s disease (HD) progresses.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Based on the function of Hsp90α/β, the possibility of selectively targeting these cytosolic isoforms of Hsp90 has emerged. In 2013, Ernst and co-workers analyzed the relationship between chemotypes of clinical Hsp90 inhibitors and isoform selectivity.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The high degree of conservation in the binding sites of the four isoforms precludes designing isoform-specific inhibitors according to discrepancies between amino acid residues. Surprisingly, the X-ray crystal structure indicates that the conformation of residues 104–111 in the N-terminal ATP binding site is different in Hsp90α/β depending on chemical diversities in the bound ligand (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>A). Purine-based inhibitors, such as compound <b>17</b> (BIIB021), possess moderate selectivity due to the induction of an extended α-helix conformation in residues 104–111 in the Hsp90α/β binding site, which forms an incompact hinge in the co-crystal structure of other chemical skeletons, while the binding sites of Trap1 and Grp94 do not have this unique conformation of residues 104–111. These results provide a template for the structure-based design of Hsp90α/β-specific inhibitors (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) with low toxicity profiles to treat chronic neurodegenerative diseases.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structural basis of Hsp90 isoforms (Hsp90α/β, Grp94, and Trap1) bound to selective inhibitors. (A) Superimposition of the crystal structures of apo-N-terminal Hsp90α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YER">1YER</a>) and Hsp90N-BIIB021 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD">3QDD</a>). The different conformation of residues 104–111 is indicated in the black circle. (B) The co-crystal structure of Grp94-NECA (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H8M">2H8M</a>). Induced site 3 is indicated by the red curve. (C) The co-crystal structure of Grp94-PU-H54 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). The unique site 2 is indicated by the red curve. (D) The crystal structure of Trap1-<b>16</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1F">4Z1F</a>). The disordered sequence 171–202 in the binding site is indicated via red dash.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Hsp90α/β-selective inhibitors, Grp94-selective inhibitors and selective inhibitors of Trap1. The <i>K</i><sub>i</sub> and <i>K</i><sub>d</sub> values of <b>65</b>–<b>68</b> were determined by FP assay. The IC<sub>50</sub> and <i>K</i><sub>d</sub> values of <b>69</b>–<b>73</b> were determined by FP assays. The selectivity of <b>74</b> was achieved by the formation of a conjugate with the mitochondria-targeting moiety triphenylphosphonium. The IC<sub>50</sub> value of <b>75</b> was determined by an FP assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Based on the binding mode of the moderately selective Hsp90α/β inhibitor SNX-0723 (<b>65</b>, Hsp90α, <i>K</i><sub>i</sub> = 3 nM; Hsp90β, <i>K</i><sub>i</sub> = 4 nM; Grp94, <i>K</i><sub>i</sub> = 375 nM; Trap1, <i>K</i><sub>i</sub> = 1195 nM), a novel compound (<b>66</b>) bearing a benzolactam scaffold was designed by Ernst and co-workers.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The level of selectivity to Hsp90α/β was more than 2000-fold increased (Hsp90α, <i>K</i><sub>i</sub> = 5 nM; Hsp90β, <i>K</i><sub>i</sub> = 5 nM; Grp94, <i>K</i><sub>i</sub> > 10 μM; Trap1, <i>K</i><sub>i</sub> > 10 μM), and the physicochemical properties were improved, with oral availability. Compound <b>66</b> was shown to facilitate mHtt degradation <i>in vitro</i> and exert consistent effects in HEK cells (mHt, IC<sub>50</sub> = 24 nM) with a low toxicity profile. Furthermore, the levels of brain Htt were reduced in rats treated with compound <b>66</b>; thus, this compound is a potential chemotherapy for HD. An initial investigation of a series of 4-(1<i>H</i>-indol-1-yl)benzamide derivatives was conducted by Ohkubo and colleagues, resulting in the identification of TAS-116 (<b>67</b>) as a potent and orally available inhibitor of Hsp90α/β (Hsp90α, <i>K</i><sub>i</sub> = 34.7 nM; Hsp90β, <i>K</i><sub>i</sub> = 21.3 nM; Grp94 and Trap1, <i>K</i><sub>i</sub> > 50 μM).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Notably, <b>67</b> exhibited antitumor activity but did not impair the retina in rats, unlike clinical pan-inhibitors in a rat model of NSCLC. However, the selectivity between Hsp90α and Hsp90β was unsolved based on the conformational change in the binding site, due to the high identity (95%) of Hsp90α and Hsp90β. Recently, a Hsp90β-selective inhibitor, <b>68</b> (Hsp90α, <i>K</i><sub>d</sub> = 9.55 μM; Hsp90β, <i>K</i><sub>d</sub> = 0.18 μM; Grp94, <i>K</i><sub>d</sub> = 8.48 μM), was identified via the difference in steric hindrance in the Hsp90α/β binding sites.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Sequence alignment of Hsp90α/β revealed the subtly distinct composition of residues in the N-terminal ATP pockets: Ala52 and Leu91 in Hsp90β were replaced by Ser52 and Ile91 in Hsp90α.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> In the co-crystal structures of radicicol and Hsp90α/β, the subpocket in Hsp90β consisting of Ala52 and Leu91 tolerates the bulkier substituents at the 3-position of resorcinol, while the same site in Hsp90α exhibits an unfavorable steric effect. Hence, modification at the 3-position of resorcinol was performed, leading to a highly selective inhibitor of Hsp90β (<b>68</b>) bearing a benzoisoxazole scaffold. A Western blot assay with KUNB31 cells showed that <b>68</b> reduced the levels of Hsp90β-dependent client proteins (such as Cdk4/6, Akt, and CXCR4), while Hsp90α-dependent clients (Raf-1, ERK-5, and survivin) were unaffected.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">5.3.2.  Selective Inhibition of Grp94</h4><div class="NLM_p last">Many client proteins, such as TLRs, integrins, insulin-like growth factors (IGFs), and immunoglobulins,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> specifically depend on Grp94.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> These Grp94-dependent substrates are responsible for cell adhesion, communication, and motility, which are critical processes in tumor metastasis and immunoevasion. In particular, several Grp94-dependent clients play a key role in inflammatory diseases. Therefore, the development of Grp94-selective inhibitors is an attractive means to provide a therapy for cancer and inflammation. Currently, Grp94-selective inhibitors can be divided into three classes: purine-based, benzamide-based, and resorcinol-based (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>). The first class of Grp94-selective inhibitors, which feature a purine scaffold, was identified based on the co-crystal structure of PU-H54 in complex with Grp94 and was reported by Patel et al.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> This crystal structure contains a ligand-induced hydrophobic site 2 in Grp94 that is blocked in Hsp90α/β and Trap1(<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>C).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Consequently, Grp94 selectivity was achieved by designing purine-based analogs with a hydrophobic substitution available in the specific site 2 in Grp94.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Among this series of compounds, <b>69</b> exhibited a more than 100-fold increase in Grp94 selectivity, with an IC<sub>50</sub> value of 0.22 μM.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> In cell-based assays, the levels of several proteins downstream of Grp94 (such as TLR and IGF-II) were measured to provide evidence for the cellular selectivity of <b>69</b>. TRL9 expression decreased upon inhibition of Grp94 chaperone activity by <b>69</b>, which in turn suppressed TLR9-mediated TNF-α production. Specifically, accelerated localization in tumors was observed in a tumor-bearing mouse model upon treatment with <b>69</b>, providing potential opportunities to enhance the therapeutic index and alleviate side effects. This phenomenon should be further studied. On the basis of the unique hydrophobic cleavage in the Grp94 binding pocket, the tetrahydroindazolone moiety of SNX-2112 (<b>29</b>; Hsp90α, <i>K</i><sub>d</sub> = 4 nM; Grp94, <i>K</i><sub>d</sub> = 484 nM) was found to contribute to steric hindrance with site 2 in Grp94, leading to preference for binding with Hsp90α/β.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Hence, this fragment was substituted with a pyrrole attached to a phenyl in the 2-position, leading to compound <b>70</b>, which exhibits more favorable binding to site 2 in Grp94.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Compound <b>70</b> (Hsp90α, <i>K</i><sub>d</sub> > 100 μM; Grp94, <i>K</i><sub>d</sub> ∼ 440 nM) contains a benzamide scaffold and inhibited the migration of PC-3-MM-2 and MDA-MB-231 cell lines at a concentration of 10 μM. The levels of Grp94-specific clients, including integrin α2, integrin αL, Syne2, VAMP2, and Rab10, were markedly reduced in a Western blot assay with PC3-MM2 cells after treatment with <b>70</b>. Additionally, compound <b>70</b> remarkably induced a decrease in mutant I447N myocilin at 30 μM, which plays a key role in the development of glaucoma. Treatment with <b>70</b> at 30 μM did not influence the level of Hsp70 and Akt. These results indicated the potential of <b>70</b> for the treatment of metastatic cancer or glaucoma. To identify novel Grp94 inhibitors, our group performed an intensive study of the unique site 2 in Grp94. Analysis of the co-crystal structure of PU-H54 in complex with Hsp90α or Grp94 provided some hints. In the binding pocket of Hsp90α, residue Phe138 is parallel. However, the 8-aryl group of PU-H54 inserts into the induced site 2 in Grp94, and residue Phe199 is oblique (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>C). This “Phe199 shift” in the conformation of Grp94 occurs in the presence of a ligand. Consequently, we hypothesized that the Phe199 shift is the structural basis for Grp94 selectivity and that compounds with rigid groups may exhibit improved Grp94 selectivity by induction of this conformational change. According to these results, our group combined an aryl group with a benzamide scaffold, leading to a novel series of Grp94-selective inhibitors.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A comprehensive SAR study was conducted, resulting in analog <b>71</b>. This analog exhibited notably improved selectivity to Grp94, with an IC<sub>50</sub> value of 2 nM, and exhibited no Hsp90α inhibition at 100 μM in FP assay. Treatment of the Panc-1 cell line with <b>71</b> reduced the levels of Grp94-dependent clients, including integrin α2 and integrin αL, without influencing Hsp70 and Akt levels. Analog <b>71</b> exhibited potent anti-inflammatory activity in a mouse model of dextran sulfate sodium (DSS)-induced UC. In summary, our group provided evidence that the Phe199 shift and rigid moieties in ligands are important structural bases for the design of Grp94-selective inhibitors.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Moreover, this conclusion was corroborated by Gewirth et al. via a co-crystal approach.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Molecules with resorcinol scaffolds are another typical class of Hsp90 inhibitors. The co-crystal structure of radicicol with Hsp90 or Grp94 revealed a minor difference between the N-terminal ATP binding sites. The resorcinol ring adopted a similar binding mode in Hsp90 and Grp94, while the quinone moiety pointed to a specific site 3 in Grp94 consisting of Phe199, Tyr200, and Trp223 (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>B). Duerfeldt and colleagues exploited the hydrophobic surrogate of the quinone moiety combined with bioisosteres to accommodate the unique subpocket in the binding site of Grp94, contributing to a potent Grp94-selective inhibitor (<b>72</b>) that competitively bound to Grp94 with an IC<sub>50</sub> value of 1.15 μM in an FP competition assay.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Furthermore, compound <b>72</b> affected Grp94-dependent substrates by preventing the transfer of TLRs in HEK293 cells and inhibiting the secretion of IGF-II in C2C12 cells with little effect on cell viability. In contrast, client proteins of Hsp90α/β were not suppressed by compound <b>72</b>. The inhibitory activity on the growth of Drosophila larvae indicated that it may be a useful Grp94 inhibitor <i>in vivo</i>.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> To form additional interactions with the unique hydrophobic cleavage site in Grp94 and to thus increase the affinity and selectivity, extensive SAR of the aryl side chain was performed. SAR led to derivative <b>73</b> (<i>K</i><sub>d</sub> = 820 nM), which showed good affinity and selectivity for Grp94.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Integrins are Grp94-dependent clients responsible for cell adhesion and migration. Therefore, inhibition of Grp94 suppresses integrin maturation, resulting in reduced migration. As expected, <b>73</b> exhibited superior antimigratory activity (50% closure at 1 μM) compared to that of <b>72</b> (73% closure at 10 μM) in a wound healing scratch assay with MDA-MB-231 cells. According to a Western blot assay, <b>73</b> was shown to induce a decrease in integrin α2 expression without affecting Akt expression in a manner dependent on cytosolic isoforms of Hsp90. An <i>in vitro</i> assay on RPMI 8226 cells exhibited a moderate antiproliferative activity with an IC<sub>50</sub> value of 9.12 μM. Moreover, no increase in Hsp70 expression was observed, in contrast to the effect of pan-Hsp90 inhibitors.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">5.3.3.  Selective Inhibition of Trap1</h4><div class="NLM_p">Compared to Hsp90α/β and Grp94, scant information about the specific clients and crystal structure of mitochondrial Trap1 has been reported, which has hindered the development and application of Trap-1 selective inhibitors. In 2015, the crystal structure of human Trap1 in complex with PU-H71 (<b>16</b>) was initially determined by Jeong and co-workers for the first time.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> On the basis of the Trap1-PU-H71 co-crystal structure, the elaborate interaction mechanism was analyzed by researchers. The highly conserved sequence and the extremely subtle distinction of residues in the Trap1 binding site impeded the rational structure-based design of Trap1-selective inhibitors. However, the subcellular localization of Trap1 provided an opportunity to design a conjugate (<b>74</b>, SMTIN-P01) by combining PU-H71 (<b>16</b>) with a mitochondria-targeting triphenylphosphonium (TPP) moiety (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>); this conjugate accumulated in mitochondria to selectively impair the chaperone activity of Trap1.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Recently, Park and co-workers reported the design of Trap1 inhibitors without mitochondrial delivery vehicles. The co-crystal structures of PU-H71 (<b>16</b>) in complex with Hsp90 and Trap1 provided insight into the differences in the binding sites in Hsp90 and Trap1. The sequence of Leu172-Phe201 is disordered in the Trap1 binding site compared with that in Hsp90 (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>D), and two conserved residues (Asn171 and Gly202) have different configurations.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> A structure-based design was developed based on different configurations of the Trap1 active site, leading to the Trap1-selective inhibitor <b>75</b> (Trap1, IC<sub>50</sub> = 79 nM; Hsp90, IC<sub>50</sub> = 698 nM).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Compound <b>75</b> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) induced the loss of mitochondrial membrane potential and the overproduction of mitochondrial ROS, which is involved in Trap1 inhibition, in HeLa cells within 6 h. Furthermore, compound <b>75</b> reduced the levels of Hsp90 clients at a concentration of 20 μM, without inducing Hsp70.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><div class="NLM_p last">Targeting Hsp90 isoforms has emerged as an alternative strategy to reduce the adverse effects of pan-Hsp90 inhibitors. On the one hand, many co-crystal structures of Hsp90 and their inhibitors have been determined, and these results provide powerful guidance for the structure-based design of selective Hsp90 inhibitors. In addition, the discovery of Hsp90 isoform-selective inhibitors is beneficial for investigating the functions of the unique isoforms. On the other hand, all of the inhibitors occupy the same pocket, and despite the different conformations or residue configurations, these selective inhibitors inhibit the same process in the Hsp90 chaperone cycle by inhibiting ATPase activity. Hence, these selective inhibitors may cause adverse events via inherent defects in their mechanisms of action.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">5.4.  Inhibition of Hsp90 Post-translational Modifications</h3><div class="NLM_p">In addition to co-chaperones, different posttranslational modifications on various residues, including phosphorylation, acetylation, S-nitrosylation, oxidation, and ubiquitination, regulate the chaperone function of Hsp90. Hence, these posttranslational modifications may provide a platform to develop an alternate strategy for the inhibition of Hsp90. Phosphorylation plays a vital role in the posttranslational modification of Hsp90, whose phosphorylation level depends on the cellular environment. Various kinases are involved in Hsp90 phosphorylation and influence Hsp90 chaperone function (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). For instance, the phosphorylation of two threonine residues, which exist only in the N-terminal domain of human Hsp90α, is mediated by DNA-activated protein kinase (DNA-PK).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> This process is correlated with cellular DNA damage, but the mechanism and phenotypic effects are unknown. Protein kinase A (PKA) was found to phosphorylate Hsp90α on Thr90, which could stimulate the secretion of Hsp90α and thus tumor metastasis. CK2, a ubiquitous serine-threonine acidophilic kinase, phosphorylates Ser226 and Ser255 on Hsp90β, but phosphorylation was not observed in leukemic cells.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Moreover, inhibition of the phosphorylation of these two serine residues was reported to play a vital role in the interaction of Hsp90β with the apoptosome, which regulates apoptosis in leukemia.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Client proteins also regulate Hsp90 phosphorylation. Maturation of these kinases is mediated by the Hsp90 chaperone cycle and, in turn, can modulate Hsp90 chaperone function via phosphorylation. For example, B-Raf phosphorylates Ser263 on Hsp90α in melanoma cells.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Three isoforms of Hsp90, including Hsp90α/β and Grp94, can be phosphorylated by Akt in melanoma cells and are involved in processes underlying glomerular injury.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Kinase c-Src was reported to phosphorylate Tyr30 of Hsp90β, which is involved in vascular endothelial growth factor receptor-2 (VEGFR-2) activation.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> In addition, Tyr24/Tyr38 on Hsp90 are phosphorylated by <i>Saccharomyces</i> Wee1 (Swe1)/Wee1 tyrosine kinase when Hsp90 is in an open conformation, and phospho-mimetic mutation of these sites promoted kinase loading onto Hsp90.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Post-translational modification of Hsp90 plays an important role not only in various biological functions but also effects the sensitivity of the response to Hsp90 inhibitors.<a onclick="showRef(event, 'ref7 ref137'); return false;" href="javascript:void(0);" class="ref ref7 ref137">(7,137)</a> CK2-mediated phosphorylation of Thr22 on Hsp90 enhanced the affinity of Hsp90 inhibitors, including GDA, STA-9090, and SNX-2112.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Post-translational Sites in Hsp90 Isoforms</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">post-translational modification</th><th class="colsep0 rowsep0" align="center">isoform of Hsp90</th><th class="colsep0 rowsep0" align="center">residues</th><th class="colsep0 rowsep0" align="center">kinases</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Thr<sup>5</sup>, Thr<sup>7</sup></td><td class="colsep0 rowsep0" align="left">DNA-PK</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Thr<sup>36</sup>, Thr<sup>65</sup>, Thr<sup>72</sup>, Ser63, Ser68, Ser<sup>231</sup>, Ser<sup>263</sup></td><td class="colsep0 rowsep0" align="left">CK2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Tyr<sup>38</sup></td><td class="colsep0 rowsep0" align="left">Wee1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Thr<sup>90</sup>, Ser<sup>460</sup></td><td class="colsep0 rowsep0" align="left">PKA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Tyr<sup>309</sup></td><td class="colsep0 rowsep0" align="left">c-Src</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Thr<sup>31</sup>, Ser<sup>58</sup>, Thr<sup>60</sup>, Ser<sup>63</sup>, Thr<sup>67</sup>, Ser<sup>226</sup>, Ser<sup>255</sup></td><td class="colsep0 rowsep0" align="left">CK2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Thr<sup>85</sup>, Ser<sup>452</sup></td><td class="colsep0 rowsep0" align="left">PKA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Tyr<sup>33</sup></td><td class="colsep0 rowsep0" align="left">Wee1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphorylation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Tyr<sup>301</sup></td><td class="colsep0 rowsep0" align="left">c-Src</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acetylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Lys<sup>69</sup>, Lys<sup>100</sup>, Lys<sup>209</sup>, Lys<sup>224</sup>, Lys<sup>292</sup>, Lys<sup>294</sup>, Lys<sup>314</sup>, Lys<sup>356</sup>, Lys<sup>327</sup>, Lys<sup>407</sup>, Lys<sup>478</sup>, Lys<sup>485</sup>, Lys<sup>489</sup>, Lys<sup>546</sup>, Lys<sup>558</sup>, Lys<sup>631</sup>, Lys<sup>632</sup></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acetylation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Lys<sup>64</sup>, Lys<sup>95</sup>, Lys<sup>204</sup>, Lys<sup>219</sup>, Lys<sup>284</sup>, Lys<sup>286</sup>, Lys<sup>306</sup>, Lys<sup>319</sup>, Lys<sup>347</sup>, Lys<sup>399</sup>, Lys<sup>477</sup>, Lys<sup>481</sup>, Lys<sup>538</sup>, Lys<sup>550</sup>, Lys<sup>623</sup>, Lys<sup>624</sup></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S-nitrosylation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Cys<sup>597</sup></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S-nitrosylation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Cys<sup>589</sup></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oxidation</td><td class="colsep0 rowsep0" align="left">Hsp90α</td><td class="colsep0 rowsep0" align="left">Cys<sup>572</sup></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oxidation</td><td class="colsep0 rowsep0" align="left">Hsp90β</td><td class="colsep0 rowsep0" align="left">Cys<sup>564</sup></td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">Deacetylation of Hsp90 is promoted by histone deacetylases (HDACs). Different isoforms of HDACs affect the chaperone function of Hsp90. Inhibition of HDAC6 was reported to modulate VEGF receptor regulation and immune homeostasis.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> HDAC1 specifically deacetylates Hsp90 in the nucleus of human breast cancer cells.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Rao et al. demonstrated that hyperacetylation of Hsp90 caused by HDAC6 deficiency promoted the binding of 17-AAG to Hsp90,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> and Robbins et al. reported that acetylation of Lys290 enhanced the sensitivity of Hsp90α to 17-AAG.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> In addition, S-nitrosylation, which is dependent on nitric oxide (NO), can reversibly modify cysteines in Hsp90αC leading to the inhibition of ATPase activity.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> This phenomenon suggests crosstalk between the antitumor activity of NO and Hsp90 chaperone function. Tubocapsenolide A (<b>76</b>), a novel withanolide (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>), was shown to increase ROS accumulation and thus trigger thiol oxidation of Hsp90 with client protein degradation.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Mahanine (<b>77</b>), a carbazole alkaloid (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>), disrupts the Hsp90-Cdc37 interaction by inducing thiol oxidation of Hsp90.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Taken together, these results indicate that posttranslational modification of Hsp90 is a potential strategy for the development of novel Hsp90 inhibitors. Furthermore, the effect of these modifications on the sensitivity of current Hsp90 inhibitors may facilitate research on drug combination therapies. This strategy could allow a decrease in the dose of Hsp90 inhibitors by enhancing their sensitivity to Hsp90, which may reduce severe side effects.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Targeting Hsp90 posttranslational modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">6.  Challenges and Future Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">6.1.  Safety Concerns of Targeting Hsp90 ATPase</h3><div class="NLM_p">Despite the extensive study of Hsp90N ATP inhibitors, none have been approved by the FDA. The primary limitations of clinical Hsp90 inhibitors can be divided into two aspects: (i) the unacceptable adverse events such as hepatotoxicity and ocular toxicity; and (ii) the unsatisfactory efficiency caused by HSR and drug resistance. For example, a partial response was observed during treatment with SNX-5422 (<b>30</b>) in 1 of 25 patients with myeloma and lymphoma, but investigations were terminated due to ocular toxicity in preclinical and other phase I trials.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Consequently, identifying the causes of these unsolved problems related to Hsp90 ATPase inhibitors is necessary. On the one hand, Hsp90 is an abundant cellular protein that performs numerous critical biofunctions, and ATP binding is the basis of the Hsp90 chaperone cycle. Thus, inhibition of Hsp90 by ATPase inhibitors can impair the whole array of client proteins, which may cause unexpected effects on both normal cells and neoplastic cells. On the other hand, different tumor types are sensitive to specific Hsp90-dependent oncoproteins, for instance, Her2 upregulation in breast cancer and ALK accumulation in NSCLC. These examples suggest that not all client proteins of Hsp90 are equally necessary for inhibition. This observation may explain some of the severe side effects of clinical Hsp90 inhibitors. Additionally, a possible mechanism of resistance to Hsp90 ATPase inhibitors has been investigated (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>). First, mutation of the N-terminal nucleotide binding site would alter inhibitor affinity.<a onclick="showRef(event, 'ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref145 ref146">(145,146)</a> A single mutation, L34I, in <i>Humicola fuscoatra</i> Hsp90 decreased its affinity for radicicol.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> However, mutations in human cells treated with Hsp90 inhibitors remain unknown. Second, ATPase inhibitors hinder the progression of Hsp90 supercomplexes through the ATP cycle, leading to the free state of the Hsp90-bound transcription factor HSF-1.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Zou et al. showed that the Hsp90 multichaperone machinery is a significant repressor of HSF-1.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Activated HSF-1 is translocated into the nucleus after phosphorylation and trimerization, which initiates overexpression of Hsp’s, including Hsp27, Hsp40, and Hsp70, to mediate a prosurvival process called the HSR. One characteristic of the HSR is enhancement by Hsp70, which plays a key role in promoting antiapoptotic activity to protect tumor cells.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Furthermore, upregulation of Hsp70 was observed in a Western blot assay of tumor cell lysates after treatment with inhibitors of Hsp90 ATPase activity. These effects limit the activity of Hsp90 inhibitors. In contrast, silencing HSF1, Hsp70, or Hsp27 significantly enhanced sensitivity to Hsp90 inhibition. Moreover, SNX-2112 (<b>29</b>) was reported to promote the efflux function of P-glycoprotein (P-gp) pumps at a concentration of 320 nM, but P-gp inhibitors facilitated the intestinal absorption of SNX-2112 (<b>29</b>), with an increase of 3.1- to 14.1-fold.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Thus, drug accumulation may be blocked due to the action of ansamycin analogs as stimulators of P-gp, which may narrow the therapeutic window of these inhibitors.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Additionally, novel strategies for Hsp90 inhibition with client specificity or isoform selectivity aimed at certain oncogenic functions have been thoroughly researched.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Analysis of defects of clinical Hsp90 inhibitor. Drug resistance may be partially caused by increased levels of free HSF1. On one hand, HSF1 induces Hsp expression, which neutralizes Hsp90 inhibition by ATPase activity inhibitors, resulting in the lack of efficacy and HSR. Additionally, elevated Hsp stimulates the expression of P-gp, resulting in the efflux of drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hence, these tremendous challenges prevent Hsp90N inhibitors from entering the market. Researchers have attempted to solve these problems. The combination of clinical Hsp90 inhibitors with synergistic agents is a potential strategy to extend the therapeutic window with lower doses. HDACs play a key role in the regulation of oncogenes, and several HDAC inhibitors have been approved by the FDA for cancer treatment. Combinations of Hsp90 and HDAC inhibitors have been widely investigated in preclinical trials. For example, a combination of 17-AAG and HDAC inhibitors, including sodium butyrate (SB), suberoylanilide hydroxamic acid (SAHA), or LBH589, can synergistically induce apoptosis in leukemia cells.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Rao et al. demonstrated that silencing of the HDAC6 gene induced hyperacetylation of Hsp90 and enhanced the Hsp90 inhibitory activity of 17-AAG in leukemia cells.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> On the other hand, the combination of Hsp90 with tyrosine kinase inhibitors (TKIs) has been reported as a promising strategy to combat TKIs resistance.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Targeting the mutated or excessive receptor tyrosine kinase is a potent therapy in cancer treatment. However, patients usually suffer from TKI resistance after treatment. Studies have shown that Hsp90 inhibitors overcome drug resistance caused by TKIs and many receptor tyrosine kinases are clients of Hsp90, such as ALK, EGFR, Her2, and JAK. Wang et al. summarized the combination therapies of Hsp90 inhibitors and TKIs in detail.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> ALK and Hsp90 dual inhibitors bearing resorcinol and a 2,4-diaminopyrimidine scaffold have been designed leading to potent activity against H3122 cells.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Lee et al. showed that a Hsp90 inhibitor (NVP-AUY922) restored the sensitivity to a PI3K inhibitor (omipalisib) in human NSCLC cell lines and that these two inhibitors have a synergistic effect at a lower concentration.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><div class="NLM_p last">Compared with pan-inhibitors of Hsp90 ATPase activity, isoform-selective inhibitors of Hsp90 provide a means to understand the functional discrepancy between Hsp90 isoforms. The client proteins of Hsp90α/β and Grp94 are different from each other. Thus, investigation of potential indications of isoform-selective Hsp90 inhibitors is necessary. Several studies have revealed that Grp94 inhibitors have a positive treatment effect in open angle glaucoma without cytotoxicity to tumor cell lines.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">6.2.  Difficulty in Targeting the Highly Dynamic Interactions of Hsp90 and Its Co-chaperones</h3><div class="NLM_p last">Another Hsp90 inhibition strategy is targeting the binding sites of Hsp90 with its co-chaperones. In contrast to Hsp90 ATPase activity inhibitors, Hsp90 PPI inhibitors disrupt Hsp90 functions by selectively downregulating client proteins without affecting the ATPase activity of Hsp90. However, problems also exist in the development of PPI inhibitors targeting Hsp90 and its co-chaperones. For example, the highly dynamic state of the Hsp90-Cdc37 PPI has been proven via crystal structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1US7">1US7</a>, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FWL">5FWL</a>). The binding site of Cdc37 was reported to be transferred from Hsp90N to Hsp90 M by the formation of the Hsp90-Cdc37-Cdck4 ternary complex, which revealed that the Hsp90-Cdc37 interaction was highly dynamic.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Further, the interaction of Hsp90-Aha1 is also dynamic in the Hsp90 chaperone cycle. The binding sites are distinct from those involved in typical PPIs, which are flatter and more hydrophilic. Hence, this problem provides a big challenge for small molecular inhibitors that anchor the flat binding sites or improve the binding activity to Hsp90. More than 80% of cellular PPIs are non-classical PPIs with flat and dynamic interaction hotspots, rendering the development of small-molecule disruptors challenging. Therefore, the investigation of inhibitors targeting non-classical PPIs is helpful to understand these “difficult” tool molecules to explore the highly dynamic interactions between Hsp90 and co-chaperones.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">6.3.  Potential Development of Covalent Inhibitors as an Alternative and Specific Strategy</h3><div class="NLM_p last">The sequence of Hsp90 contains six cysteine residues. Some natural products, such as <b>46</b>, can disrupt the Hsp90-Cdc37 PPI via a covalent allosteric mechanism. In particular, the covalent bond between Hsp90 and <b>46</b> was verified by the mass spectra on Cys420. Some natural products shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, including celastrol and WA, target Hsp90 via a covalent mechanism. In addition, Antonio et al. reported that the modification of Cys598 on Hsp90 inhibited ATPase activity and eNOS activation in endothelial cells.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> These results suggested that the functions of Hsp90 can be disrupted by a covalent mechanism and that the cysteines on Hsp90 are feasible targets. The success of natural products may provide a potential strategy for the development of covalent Hsp90 inhibitors, but some problems must be addressed. First, the cysteine residues on Hsp90 are located in the C-terminal and M domains, far from the ATP binding pocket in the N-terminus. Therefore, further research should identify a druggable pocket around cysteine residues to anchor small molecules with a reactive warhead. Second, the properties of these cysteines, including the reactivity and solvent-exposed area, should be evaluated to determine whether the sulfhydryl group can be targeted. Furthermore, since Hsp90 interacts with more than 20 co-chaperones, selective disruption of Hsp90-co-chaperones after the formation of the Hsp90-inhibitor adduct on the cysteine residue needs to be further investigated. In general, a more in-depth investigation of the Hsp90 chaperone machinery will provide valuable information not only for the exploration of clinical applications of Hsp90 inhibitors but also for the identification of Hsp90 inhibitors with novel mechanisms.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">6.4.  Can New Technologies Aid Hsp90 Inhibitors?</h3><div class="NLM_p last">Hsp90 is highly expressed in tumor cells. Among the Hsp90 isoforms, induced expression of Hsp90α is particularly evident in tumor cells. Most Hsp90 inhibitors target the ATP pocket by inducing HSR with a compensatory increase in Hsp90. To date, all of the Hsp90 inhibitors can regulate the degradation of downstream clients of Hsp90 by suppressing Hsp90 functions; however, none of the inhibitors can regulate the level of Hsp90. This problem may provide prospects for the application of proteolysis targeting chimeras (PROTACs). Targeted protein degradation has emerged as a power new tool for drug discovery.<a onclick="showRef(event, 'ref157 ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref157 ref158 ref159">(157−159)</a> PROTACs are bifunctional molecules that can hijack cellular ubiquitin degradation systems to achieve targeted protein degradation.<a onclick="showRef(event, 'ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref160 ref161">(160,161)</a> PROTAC technology combines the advantages of siRNA and traditional small-molecule inhibitors, and can efficiently anchor the target and subsequently degrade it via cellular ubiquitin degradation systems.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> This PROTAC technology has successfully been employed and demonstrated by targeting a number of proteins, such as the BET (bromodomain and extra terminal domain) family protein BRD4,<a onclick="showRef(event, 'ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref163 ref164">(163,164)</a> the androgen receptor,<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Bcr-Abl,<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> and the estrogen-related receptor α (ERRα).<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Consequently, PROTACs may provide an opportunity for Hsp90 inhibition. This strategy may provide a highly efficient Hsp90 knockdown tool to achieve rapid knockdown of Hsp90 to decrease Hsp90 levels. In addition, studies have shown that non-selective small-molecule inhibitors designed to produce different types of PROTAC molecules may produce subtype-selective degradation (CDK family, BET family).<a onclick="showRef(event, 'ref162 ref163 ref167 ref168'); return false;" href="javascript:void(0);" class="ref ref162 ref163 ref167 ref168">(162,163,167,168)</a> These results have made it possible to find Hsp90 subtype-selective degradation agents. If the level of Hsp90 was reduced by the PROTAC strategy via transient interaction, the side effects of the Hsp90 inhibitor may be reduced or avoided all together. Therefore, a highly potent PROTAC Hsp90 degrader may prove to be a promising approach.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">7.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Hsp90 is considered a promising target due to its important effects on cellular signaling, especially on neoplastic cell growth controlled by its oncogenic clients. Therefore, inhibition of Hsp90 has attracted the interest of researchers as a notable target and a viable therapeutic approach for treating cancer and other diseases. Since the identification of the first natural inhibitor of Hsp90 (GDA) and the interaction site in the N-terminal ATP pocket, natural inhibitors and synthetic molecules have been sequentially identified. Subsequently, a golden age of Hsp90N inhibitor investigation has led to the identification of numerous inhibitors that have advanced into clinical trials over the last few decades. However, problems arose during those clinical trials, including ocular and hepatic toxicity and resistance, thus hindering the clinical development and market entry of these inhibitors and causing the termination of some trials. Based on these undesirable results, the exploration of new inhibition strategies has emerged. Structural biology indicates that co-chaperones of Hsp90 are client-selective. The disruption of certain Hsp90-co-chaperone interactions allows the degradation of specific clients involved in tumor growth. Another approach is the development of isoform-selective inhibitors based on subtle differences within the N-terminal ATP pockets of the four isoforms, which may offer a solution to the toxicity associated with the different isoforms. Currently, inhibitors based on these different strategies have been identified and tested in preclinical stages. In addition, posttranslational modifications of Hsp90 interfere with chaperone function, but further investigations are needed to verify the feasibility of these modifications for inhibiting Hsp90.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00940" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi-Dong You</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e59c8a909481a5d4d3d6cb868a88"><span class="__cf_email__" data-cfemail="0f76607a7e6b4f3e393c216c6062">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Li Xu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1126-2538" title="Orcid link">http://orcid.org/0000-0002-1126-2538</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#364e434e5f5759695a5f760704001855595b"><span class="__cf_email__" data-cfemail="dea6aba6b7bfb181b2b79eefece8f0bdb1b3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Wang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8181-5644" title="Orcid link">http://orcid.org/0000-0002-8181-5644</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Li Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=BIO-d7e2817-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Li Li</b> obtained her Bachelor of Science degree in medicinal chemistry from China Pharmaceutical University. Since 2017 she has been a Ph.D. student in medicinal chemistry at China Pharmaceutical University under the direction of Professor Qi-Dong You. Her research interest is mainly focused on the discovery and development of first-in-class small-molecule inhibitors targeting the Hsp90-Cdc37-kinase related system.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Lei Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=BIO-d7e2822-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lei Wang</b> received his Bachelor’s degree from China Pharmaceutical University, where he also obtained his Ph.D. in Medicinal Chemistry under the supervision of Professor Qi-Dong You. Currently, he is a member of the Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University. His main research topics focus on the following: (i) discovery and development of first-in-class small-molecule inhibitors targeting the Hsp90-Cdc37-kinase related system, and (ii) chemical biology study of molecule chaperone cycles.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Xiao-Li Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=BIO-d7e2827-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qi-Dong You</b> obtained his Bachelor’s degree from the Nanjing College of Pharmacy (the former China Pharmaceutical university), China, in 1982, and his Ph.D. in Medicinal Chemistry from Shanghai Institute of Pharmaceutical Industry in 1989. He did his research in medicinal chemistry as a visiting scholar at Department of Pharmaceutical Sciences, Strathclyde University, Glasgow, UK, between 1994 and 1995. Currently, he is a Professor of Medicinal Chemistry in the Department of Medicinal Chemistry, China Pharmaceutical University, and the director of Jiang Su Key Laboratory of Drug Design and Optimization. His research interests mainly focus on small-molecule inhibitors of protein–protein interactions, antitumor natural products, and targeted anticancer drugs.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Qi-Dong You</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=BIO-d7e2832-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiao-Li Xu</b> is an Associate Professor of Medicinal Chemistry in the Department of Pharmacy, China Pharmaceutical University. She obtained Ph.D. degree from China Pharmaceutical University at 2014, and then she continued her work as a postdoctoral researcher in Traditional Chinese Pharmacy of China Pharmaceutical University. Dr. Xu’s research is mainly focused on (i) the design and development of small drug-like molecules targeting heat shock proteins system, and (ii) chemical biology study of immuno-oncology.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the project 81872737, 81773639, and 81930100 of National Natural Science Foundation of China; National Science & Technology Major Project ‘Key New Drug Creation and Manufacturing Program’, China (Nos. 2017ZX09302003 and 2018ZX09711002); [CPU2018GY02] of Double First Class Innovation Team of China Pharmaceutical University; the Program for Outstanding Scientific and Technological Innovation Team of Jiangsu Higher Education; the Open Project of State Key Laboratory of Natural Medicines (SKLNMZZCX201803); the Priority Academic Program Development of Jiangsu Higher Education Institutions; and the Fundamental Research Funds (2632018ZD15) for the Central Universities of China Pharmaceutical University.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">Aha1</td><td class="NLM_def"><p class="first last">activator of Hsp90 ATPase-1</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">biolayer interferometry</p></td></tr><tr><td class="NLM_term">Cdc37N</td><td class="NLM_def"><p class="first last">N-terminus of Cdc37</p></td></tr><tr><td class="NLM_term">Cdk4/6</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases 4/6</p></td></tr><tr><td class="NLM_term">CETSA</td><td class="NLM_def"><p class="first last">cellular thermal shift</p></td></tr><tr><td class="NLM_term">CFTR</td><td class="NLM_def"><p class="first last">cystic fibrosis transmembrane conductance regulator</p></td></tr><tr><td class="NLM_term">CHIP</td><td class="NLM_def"><p class="first last">Hsp70-interacting protein</p></td></tr><tr><td class="NLM_term">CO-IP</td><td class="NLM_def"><p class="first last">coimmunoprecipitation</p></td></tr><tr><td class="NLM_term">CRPC</td><td class="NLM_def"><p class="first last">castration-resistant prostate cancer</p></td></tr><tr><td class="NLM_term">DNA-PK</td><td class="NLM_def"><p class="first last">DNA-activated protein kinase</p></td></tr><tr><td class="NLM_term">DSS</td><td class="NLM_def"><p class="first last">dextran sulfate sodium</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">Förster resonance energy transfer</p></td></tr><tr><td class="NLM_term">GDA</td><td class="NLM_def"><p class="first last">Geldanamycin</p></td></tr><tr><td class="NLM_term">GIST</td><td class="NLM_def"><p class="first last">gastrointestinal stromal tumors</p></td></tr><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">glucocorticoid receptor</p></td></tr><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntington’s disease</p></td></tr><tr><td class="NLM_term">HDACs</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">HOP</td><td class="NLM_def"><p class="first last">Hsp70-Hsp90 organizing protein</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">Hsp90M</td><td class="NLM_def"><p class="first last">middle domain of Hsp90</p></td></tr><tr><td class="NLM_term">Hsp90C</td><td class="NLM_def"><p class="first last">C-terminal domain of Hsp90</p></td></tr><tr><td class="NLM_term">Hsp90M</td><td class="NLM_def"><p class="first last">middle domain of Hsp90</p></td></tr><tr><td class="NLM_term">Hsp90C</td><td class="NLM_def"><p class="first last">C-terminal domain of Hsp90</p></td></tr><tr><td class="NLM_term">Hsp90N</td><td class="NLM_def"><p class="first last">N-terminal domain of Hsp90</p></td></tr><tr><td class="NLM_term">HSR</td><td class="NLM_def"><p class="first last">heat shock response</p></td></tr><tr><td class="NLM_term">Hsp90M</td><td class="NLM_def"><p class="first last">middle domain of Hsp90</p></td></tr><tr><td class="NLM_term">Hsp90C</td><td class="NLM_def"><p class="first last">C-terminal domain of Hsp90</p></td></tr><tr><td class="NLM_term">HSQC</td><td class="NLM_def"><p class="first last"><sup>1</sup>H–<sup>15</sup>N heteronuclear single-quantum correlation</p></td></tr><tr><td class="NLM_term">HSV-1</td><td class="NLM_def"><p class="first last">herpes simplex virus type 1</p></td></tr><tr><td class="NLM_term">IGFs</td><td class="NLM_def"><p class="first last">insulin-like growth factors</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">LD</td><td class="NLM_def"><p class="first last">longest dimension</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">Lipopolysaccharide</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">mHtt</td><td class="NLM_def"><p class="first last">mutant huntingtin protein</p></td></tr><tr><td class="NLM_term">MM-PBSA</td><td class="NLM_def"><p class="first last">molecular mechanics Poisson–Boltzmann surface area</p></td></tr><tr><td class="NLM_term">MPN</td><td class="NLM_def"><p class="first last">myeloproliferative neoplasms</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">PFS</td><td class="NLM_def"><p class="first last">progression-free survival</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">PPIs</td><td class="NLM_def"><p class="first last">protein–protein interactions</p></td></tr><tr><td class="NLM_term">RDC</td><td class="NLM_def"><p class="first last">Radicicol</p></td></tr><tr><td class="NLM_term">ROCS</td><td class="NLM_def"><p class="first last">rapid overlay of chemical structures</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAHA</td><td class="NLM_def"><p class="first last">suberoylanilide hydroxamic acid</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SB</td><td class="NLM_def"><p class="first last">sodium butyrate</p></td></tr><tr><td class="NLM_term">Sti1</td><td class="NLM_def"><p class="first last">stress-inducible 1</p></td></tr><tr><td class="NLM_term">Swe1</td><td class="NLM_def"><p class="first last"><i>Saccharomyces</i> Wee1</p></td></tr><tr><td class="NLM_term">TLRs</td><td class="NLM_def"><p class="first last">Toll-like receptors</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">TPP</td><td class="NLM_def"><p class="first last">triphenylphosphonium</p></td></tr><tr><td class="NLM_term">TPRs</td><td class="NLM_def"><p class="first last">tetratricopeptide repeats</p></td></tr><tr><td class="NLM_term">TROSY</td><td class="NLM_def"><p class="first last">transverse relaxation optimized spectroscopy</p></td></tr><tr><td class="NLM_term">UC</td><td class="NLM_def"><p class="first last">ulcerative colitis</p></td></tr><tr><td class="NLM_term">VEGFR-2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor-2</p></td></tr><tr><td class="NLM_term">WA</td><td class="NLM_def"><p class="first last">Withaferin A</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 168 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadi, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">A comprehensive map of molecular drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrd.2016.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27910877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=19-34&author=R.+Santosauthor=O.+Ursuauthor=A.+Gaultonauthor=A.+P.+Bentoauthor=R.+S.+Donadiauthor=C.+G.+Bologaauthor=A.+Karlssonauthor=B.+Al-Lazikaniauthor=A.+Herseyauthor=T.+I.+Opreaauthor=J.+P.+Overington&title=A+comprehensive+map+of+molecular+drug+targets&doi=10.1038%2Fnrd.2016.230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive map of molecular drug targets</span></div><div class="casAuthors">Santos, Rita; Ursu, Oleg; Gaulton, Anna; Bento, A. Patricia; Donadi, Ramesh S.; Bologa, Cristian G.; Karlsson, Anneli; Al-Lazikani, Bissan; Hersey, Anne; Oprea, Tudor I.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of mechanism-based drug discovery depends on the definition of the drug target.  This definition becomes even more important as we try to link drug response to genetic variation, understand stratified clin. efficacy and safety, rationalize the differences between drugs in the same therapeutic class and predict drug utility in patient subgroups.  However, drug targets are often poorly defined in the literature, both for launched drugs and for potential therapeutic agents in discovery and development.  Here, we present an updated comprehensive map of mol. targets of approved drugs.  We curate a total of 893 human and pathogen-derived biomols. through which 1,578 US FDA-approved drugs act.  These biomols. include 667 human-genome-derived proteins targeted by drugs for human disease.  Anal. of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncol.  We explore the relationships between bioactivity class and clin. success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes.  Through the collaboration of three independent teams, we highlight some of the ongoing challenges in accurately defining the targets of mol. therapeutics and present conventions for deconvoluting the complexities of mol. pharmacol. and drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTfWwWkoZnbrVg90H21EOLACvtfcHk0ljOqKPgsJN8ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK&md5=7437d4b678ac75dac0a5e3248df98761</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.230%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DDonadi%26aufirst%3DR.%2BS.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comprehensive%2520map%2520of%2520molecular%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D19%26epage%3D34%26doi%3D10.1038%2Fnrd.2016.230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhoff, G.</span></span> <span> </span><span class="NLM_article-title">Heat shock proteins in cancer</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1113</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1196/annals.1391.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1196%2Fannals.1391.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17978282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=192-201&author=M.+Shermanauthor=G.+Multhoff&title=Heat+shock+proteins+in+cancer&doi=10.1196%2Fannals.1391.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins in cancer</span></div><div class="casAuthors">Sherman, Michael; Multhoff, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">192-201</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Heat shock proteins (Hsps) are highly conserved and inhabit nearly all subcellular locations where they perform a variety of chaperoning functions including folding and unfolding of nascent polypeptides, proteins, transport of proteins, and support of antigen presentation processes.  Apart from their intracellular location Hsps with a mol. wt. of 70 kDa (Hsp70) also have been found on the plasma membrane of malignantly transformed cells, on virally/bacterial infected cells and in the extracellular space.  Depending on their intra- and extracellular location Hsps exert either protection against environmental stress or act as potent stimulators of the immune response.  In this review we address the dual function of intracellular and extracellular located small Hsps and members of the Hsp70 family and its immunol. consequences for cancer immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18rXmpHsdVLVg90H21EOLACvtfcHk0ljOqKPgsJN8ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfE&md5=1616c3ec4030e7c2f47b2e1799422565</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.030%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DM.%26aulast%3DMulthoff%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520proteins%2520in%2520cancer%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D192%26epage%3D201%26doi%3D10.1196%2Fannals.1391.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">Structure and functional relationships of hsp90</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.2174/1568009033481877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F1568009033481877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14529383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=301-323&author=C.+Prodromouauthor=L.+H.+Pearl&title=Structure+and+functional+relationships+of+hsp90&doi=10.2174%2F1568009033481877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and functional relationships of Hsp90</span></div><div class="casAuthors">Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">301-323</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Understanding the mode of action of heat-shock protein Hsp90 requires that mol. detail of its interactions with client proteins and co-chaperones are known.  The structure detn. of the N-terminal domain of Hsp90/Hsp90β, proof that it is an ATPase, that this activity is regulated, and the identification of co-chaperones that facilitate Hsp90 function have been landmarks toward understanding conformational changes in Hsp90 brought about by ATP, co-chaperones, and client proteins.  Proteins Sti1 and Cdc37/p50, which assoc. with early Hsp90 complexes, have been shown to be inhibitors of Hsp90 ATPase activity and therefore to promote its "open" state, whereas Sba1/p23, which assocs. with mature complexes, inhibits ATPase activity and stabilizes the "closed" state.  The isolation and characterization of Aha1, the only known strong activator of Hsp90 ATPase activity, which promotes the "closed" state of Hsp90, is also of major importance in understanding Hsp90 function.  The structure detn. of the middle region of Hsp90 has shed further light on the complex ATP-cycle of Hsp90, identifying a catalytic loop, with key residues that are essential for ATP hydrolysis.  These studies, together with biochem. ones, suggest that ATP hydrolysis, is dependent on a complex rate-limiting step, involving N-terminal dimerization and assocn. of the middle region, and therefore the catalytic loop, of Hsp90 with the N-terminal domains.  The structure of the middle region of Hsp90 also accelerates the understanding of client protein interactions since this region is implicated in their recognition and in particular their active site openings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnjqIzaFEY6LVg90H21EOLACvtfcHk0ljOqKPgsJN8ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrs%253D&md5=d6086db3e034c70b83b01d2c205798e5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568009033481877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481877%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructure%2520and%2520functional%2520relationships%2520of%2520hsp90%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D301%26epage%3D323%26doi%3D10.2174%2F1568009033481877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitesell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S. L.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and the chaperoning of cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1038/nrc1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=Hsp90+and+the+chaperoning+of+cancer&doi=10.1038%2Fnrc1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0ljmRCl35O_mgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHsp90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772%26doi%3D10.1038%2Fnrc1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">The chaperone hsp90: changing partners for demanding clients</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.tibs.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23507089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=253-262&author=A.+Rohlauthor=J.+Rohrbergauthor=J.+Buchner&title=The+chaperone+hsp90%3A+changing+partners+for+demanding+clients&doi=10.1016%2Fj.tibs.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone Hsp90: changing partners for demanding clients</span></div><div class="casAuthors">Rohl Alina; Rohrberg Julia; Buchner Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Trends in biochemical sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">253-62</span>
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">The heat shock protein (Hsp)90 chaperone machinery regulates the activity of hundreds of client proteins in the eukaryotic cytosol.  It undergoes large conformational changes between states that are similar in energy.  These transitions are rate-limiting for the ATPase cycle.  It has become evident that several of the many Hsp90 co-chaperones affect the conformational equilibrium by stabilizing specific intermediate states.  Consequently, there is an ordered progression of different co-chaperones during the conformational cycle.  Asymmetric complexes containing two different co-chaperones may be important for the processing of the client protein, although our understanding of this aspect, as well as the details of the interaction of Hsp90 with client proteins, is still in its infancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS2inA-utJHL5XHngOXiV_fW6udTcc2ebGCvcGoN56wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D&md5=3f0c5df5ba9088c3b41b3257b21b9d7a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DRohl%26aufirst%3DA.%26aulast%3DRohrberg%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520chaperone%2520hsp90%253A%2520changing%2520partners%2520for%2520demanding%2520clients%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D253%26epage%3D262%26doi%3D10.1016%2Fj.tibs.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, A.</span></span> <span> </span><span class="NLM_article-title">Hsp90: friends, clients and natural foes</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2016.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.biochi.2016.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27295069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2016&pages=227-240&author=S.+Vermaauthor=S.+Goyalauthor=S.+Jamalauthor=A.+Singhauthor=A.+Grover&title=Hsp90%3A+friends%2C+clients+and+natural+foes&doi=10.1016%2Fj.biochi.2016.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: Friends, clients and natural foes</span></div><div class="casAuthors">Verma, Sharad; Goyal, Sukriti; Jamal, Salma; Singh, Aditi; Grover, Abhinav</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">227-240</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Hsp90, a homodimeric ATPase, is responsible for the correct folding of a no. of newly synthesized polypeptides in addn. to the correct folding of denatured/misfolded client proteins.  It requires several co-chaperones and other partner proteins for chaperone activity.  Due to the involvement of Hsp90-dependent client proteins in a variety of oncogenic signaling pathways, Hsp90 inhibition has emerged as one of the leading strategies for anticancer chemotherapeutics.  Most of Hsp90 inhibitors blocks the N terminal ATP binding pocket and prevents the conformational changes which are essential for the loading of co-chaperones and client proteins.  Several other inhibitors have also been reported which disrupt chaperone cycle in ways other than binding to N terminal ATP binding pocket.  The Hsp90 inhibition is assocd. with heat shock response, mediated by HSF-1, to overcome the loss of Hsp90 and sustain cell survival.  This review is an attempt to give an over view of all the important players of chaperone cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaFj5PqGrTtLVg90H21EOLACvtfcHk0ljyZwa_LfFmcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWqsbw%253D&md5=f36f469da9a37bf71961434593440159</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2016.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DS.%26aulast%3DJamal%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DGrover%26aufirst%3DA.%26atitle%3DHsp90%253A%2520friends%252C%2520clients%2520and%2520natural%2520foes%26jtitle%3DBiochimie%26date%3D2016%26volume%3D127%26spage%3D227%26epage%3D240%26doi%3D10.1016%2Fj.biochi.2016.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Post-translational modifications of hsp90 and their contributions to chaperone regulation</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21856339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2rsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=648-655&author=M.+Mollapourauthor=L.+Neckers&title=Post-translational+modifications+of+hsp90+and+their+contributions+to+chaperone+regulation&doi=10.1016%2Fj.bbamcr.2011.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications of Hsp90 and their contributions to chaperone regulation</span></div><div class="casAuthors">Mollapour, Mehdi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mol. chaperones, as the name suggests, are involved in folding, maintenance, intracellular transport, and degrdn. of proteins as well as in facilitating cell signaling.  Heat shock protein 90 (Hsp90) is an essential eukaryotic mol. chaperone that carries out these processes in normal and cancer cells.  Hsp90 function in vivo is coupled to its ability to hydrolyze ATP and this can be regulated by co-chaperones and post-translational modifications.  In this review, we explore the varied roles of known post-translational modifications of cytosolic and nuclear Hsp90 (phosphorylation, acetylation, S-nitrosylation, oxidn. and ubiquitination) in fine-tuning chaperone function in eukaryotes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojxfJSzylBn7Vg90H21EOLACvtfcHk0li6soK8YVGliQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2rsL8%253D&md5=bd22c775cb17efa6e985705e42bcd473</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPost-translational%2520modifications%2520of%2520hsp90%2520and%2520their%2520contributions%2520to%2520chaperone%2520regulation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D648%26epage%3D655%26doi%3D10.1016%2Fj.bbamcr.2011.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jhaveri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (hsp90) inhibitors in cancers</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22062686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28hsp90%29+inhibitors+in+cancers&doi=10.1016%2Fj.bbamcr.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span></div><div class="casAuthors">Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an ATP dependent mol. chaperone protein which integrates multiple oncogenic pathways.  As such, Hsp90 inhibition is a promising anti-cancer strategy.  Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clin. evaluation.  Robust pre-clin. data suggested anti-tumor activity in multiple cancer types.  Clin., encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma.  In breast cancer, proof-of-concept was demonstrated by first generation Hsp90 inhibitors in combination with trastuzumab mainly in human epidermal growth factor receptor 2 (HER2) + metastatic breast cancer.  There are a multitude of second generation Hsp90 inhibitors currently under investigation.  To date, however, there is no FDA approved Hsp90 inhibitor nor standardized assay to ascertain Hsp90 inhibition.  This review summarizes the current status of both first and second generation Hsp90 inhibitors based on their chem. classification and stage of clin. development.  It also discusses the pharmacodynamic assays currently implemented in clinic as well as other novel strategies aimed at enhancing the effectiveness of Hsp90 inhibitors.  Ultimately, these efforts will aid in maximizing the full potential of this class of agents.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDrDTpRQxfYrVg90H21EOLACvtfcHk0lhQ6ejierrHKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D&md5=03cef7dc96667a4698324f635aacee7a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755%26doi%3D10.1016%2Fj.bbamcr.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydman, J.</span></span> <span> </span><span class="NLM_article-title">The hsp90 mosaic: a picture emerges</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1038/nsmb0109-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnsmb0109-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19125165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2-6&author=M.+P.+Mayerauthor=C.+Prodromouauthor=J.+Frydman&title=The+hsp90+mosaic%3A+a+picture+emerges&doi=10.1038%2Fnsmb0109-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Hsp90 mosaic: a picture emerges</span></div><div class="casAuthors">Mayer, Matthias P.; Prodromou, Chrisostomos; Frydman, Judith</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-6</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZS9gagh8ohLVg90H21EOLACvtfcHk0liyQEtokpRkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWitg%253D%253D&md5=a60cc5be2975750d370b0ca70d1f6152</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnsmb0109-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb0109-2%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DFrydman%26aufirst%3DJ.%26atitle%3DThe%2520hsp90%2520mosaic%253A%2520a%2520picture%2520emerges%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D2%26epage%3D6%26doi%3D10.1038%2Fnsmb0109-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheufler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourenkov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegoraro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartunik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarefi, I.</span></span> <span> </span><span class="NLM_article-title">Structure of tpr domain-peptide complexes: critical elements in the assembly of the hsp70-hsp90 multichaperone machine</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80830-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2800%2980830-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10786835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislKisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2000&pages=199-210&author=C.+Scheuflerauthor=A.+Brinkerauthor=G.+Bourenkovauthor=S.+Pegoraroauthor=L.+Moroderauthor=H.+Bartunikauthor=F.+U.+Hartlauthor=I.+Moarefi&title=Structure+of+tpr+domain-peptide+complexes%3A+critical+elements+in+the+assembly+of+the+hsp70-hsp90+multichaperone+machine&doi=10.1016%2FS0092-8674%2800%2980830-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine</span></div><div class="casAuthors">Scheufler, Clemens; Brinker, Achim; Bourenkov, Gleb; Pegoraro, Stefano; Moroder, Luis; Bartunik, Hans; Hartl, F. Ulrich; Moarefi, Ismail</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adaptor protein Hop mediates the assocn. of the mol. chaperones Hsp70 and Hsp90.  The TPR1 domain of Hop specifically recognizes the C-terminal heptapeptide of Hsp70 while the TPR2A domain binds the C-terminal pentapeptide of Hsp90.  Both sequences end with the motif EEVD.  The crystal structures of the TPR-peptide complexes show the peptides in an extended conformation, spanning a groove in the TPR domains.  Peptide binding is mediated by electrostatic interactions with the EEVD motif, with the C-terminal aspartate acting as a two-carboxylate anchor, and by hydrophobic interactions with residues upstream of EEVD.  The hydrophobic contacts with the peptide are crit. for specificity.  These results explain how TPR domains participate in the ordered assembly of Hsp70-Hsp90 multichaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph4AAcAeVIcLVg90H21EOLACvtfcHk0liyQEtokpRkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislKisrY%253D&md5=1d0c83e6a89ecc2165fcea6b977f3363</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980830-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980830-2%26sid%3Dliteratum%253Aachs%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DBourenkov%26aufirst%3DG.%26aulast%3DPegoraro%26aufirst%3DS.%26aulast%3DMoroder%26aufirst%3DL.%26aulast%3DBartunik%26aufirst%3DH.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DMoarefi%26aufirst%3DI.%26atitle%3DStructure%2520of%2520tpr%2520domain-peptide%2520complexes%253A%2520critical%2520elements%2520in%2520the%2520assembly%2520of%2520the%2520hsp70-hsp90%2520multichaperone%2520machine%26jtitle%3DCell%26date%3D2000%26volume%3D101%26spage%3D199%26epage%3D210%26doi%3D10.1016%2FS0092-8674%2800%2980830-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marzec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span> <span> </span><span class="NLM_article-title">Grp94: an hsp90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22079671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=774-787&author=M.+Marzecauthor=D.+Elettoauthor=Y.+Argon&title=Grp94%3A+an+hsp90-like+protein+specialized+for+protein+folding+and+quality+control+in+the+endoplasmic+reticulum&doi=10.1016%2Fj.bbamcr.2011.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span></div><div class="casAuthors">Marzec, Michal; Eletto, Davide; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">774-787</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glucose-regulated protein 94 is the HSP90-like protein in the lumen of the endoplasmic reticulum and therefore it chaperones secreted and membrane proteins.  It has essential functions in development and physiol. of multicellular organisms, at least in part because of this unique clientele.  GRP94 shares many biochem. features with other HSP90 proteins, in particular its domain structure and ATPase activity, but also displays distinct activities, such as calcium binding, necessitated by the conditions in the endoplasmic reticulum.  GRP94's mode of action varies from the general HSP90 theme in the conformational changes induced by nucleotide binding, and in its interactions with co-chaperones, which are very different from known cytosolic co-chaperones.  GRP94 is more selective than many of the ER chaperones and the basis for this selectivity remains obscure.  Recent development of mol. tools and functional assays has expanded the spectrum of clients that rely on GRP94 activity, but it is still not clear how the chaperone binds them, or what aspect of folding it impacts.  These mechanistic questions and the regulation of GRP94 activity by other proteins and by post-translational modification differences pose new questions and present future research avenues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnr8jU7cub5LVg90H21EOLACvtfcHk0liyQEtokpRkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D&md5=421b27e4a82e34398366793c11147b99</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DMarzec%26aufirst%3DM.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DGrp94%253A%2520an%2520hsp90-like%2520protein%2520specialized%2520for%2520protein%2520folding%2520and%2520quality%2520control%2520in%2520the%2520endoplasmic%2520reticulum%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D774%26epage%3D787%26doi%3D10.1016%2Fj.bbamcr.2011.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Novobiocin and additional inhibitors of the hsp90 c-terminal nucleotide-binding pocket</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2702</span>– <span class="NLM_lpage">2717</span>, <span class="refDoi"> DOI: 10.2174/092986708786242895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F092986708786242895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18991631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWiur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2702-2717&author=A.+Donnellyauthor=B.+S.+J.+Blagg&title=Novobiocin+and+additional+inhibitors+of+the+hsp90+c-terminal+nucleotide-binding+pocket&doi=10.2174%2F092986708786242895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide binding pocket</span></div><div class="casAuthors">Donnelly, Alison; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2702-2717</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 90 kDa heat shock proteins (Hsp90), which are integrally involved in cell signaling, proliferation, and survival, are ubiquitously expressed in cells.  Many proteins in tumor cells are dependent upon the Hsp90 protein folding machinery for their stability, refolding, and maturation.  Inhibition of Hsp90 uniquely targets client proteins assocd. with all six hallmarks of cancer.  Thus, Hsp90 has emerged as a promising target for the treatment of cancer.  Hsp90 exists as a homodimer, which contains three domains.  The N-terminal domain contains an ATP-binding site that binds the natural products geldanamycin and radicicol.  The middle domain is highly charged and has high affinity for cochaperones and client proteins.  Initial studies by Csermely and co-workers suggested a second ATP-binding site in the C-terminus of Hsp90.  This C-terminal nucleotide binding pocket has been shown to not only bind ATP, but cisplatin, novobiocin, epigallocatechin-3-gallate (EGCG) and taxol.  The coumarin antibiotics novobiocin, clorobiocin, and coumermycin A1 were isolated from several streptomyces strains and exhibit potent activity against Gram-pos. bacteria.  These compds. bind type II topoisomerases, including DNA gyrase, and inhibit the enzyme-catalyzed hydrolysis of ATP.  As a result, novobiocin analogs have garnered the attention of numerous researchers as an attractive agent for the treatment of bacterial infection.  Novobiocin was reported to bind weakly to the newly discovered Hsp90 C-terminal ATP binding site (∼700 M in SkBr3 cells) and induce degrdn. of Hsp90 client proteins.  Structural modification of this compds. has led to an increase of 1000-fold in activity in antiproliferative assays.  Recent studies of structure-activity relationship (SAR) by Renoir and co-workers highlighted the crucial role of the C-4 and/or C-7 positions of the coumarin and removal of the noviose moiety, which appeared to be essential for degrdn. of Hsp90 client proteins.  Unlike the N-terminal ATP binding site, there is no reported co-crystal structure of Hsp90 C-terminus bound to any inhibitor.  The Hsp90 C-terminal domain however, is known to contain a conserved pentapeptide sequence (MEEVD) which is recognized by co-chaperones.  Cisplatin is a platinum-contg. chemotherapeutic used to treat various types of cancers, including testicular, ovarian, bladder, and small cell lung cancer.  Most notably, cisplatin coordinates to DNA bases, resulting in cross-linked DNA, which prohibits rapidly dividing cells from duplicating DNA for mitosis.  Itoh and co-workers reported that cisplatin decreases the chaperone activity of Hsp90.  This group applied bovine brain cytosol to a cisplatin affinity column, eluted with cisplatin and detected Hsp90 in the eluent.  Subsequent expts. indicated that cisplatin exhibits high affinity for Hsp90.  Moreover Csermely and co-workers detd. that the cisplatin binding site is located proximal to the C-terminal ATP binding site.  EGCG is one of the active ingredients found in green tea.  EGCG is known to inhibit the activity of many Hsp90-dependent client proteins, including telomerase, several kinases, and the aryl hydrocarbon receptor (AhR).  Recently Gasiewicz and co-workers reported that EGCG manifests its antagonistic activity against AhR through binding Hsp90.  Similar to novobiocin, EGCG was shown to bind the C-terminus of Hsp90.  Unlike previously identified N-terminal Hsp90 inhibitors, EGCG does not appear to prevent Hsp90 from forming multiprotein complexes.  Studies are currently underway to det. whether EGCG competes with novobiocin or cisplatin binding.  Taxol, a well-known drug for the treatment of cancer, is responsible for the stabilization of microtubules and the inhibition of mitosis.  Previous studies have shown that taxol induces the activation of kinases and transcription factors, and mimics the effect of bacterial lipopolysaccharide (LPS), an attribute unrelated to its tubulin-binding properties.  Rosen and co-workers prepd. a biotinylated taxol deriv. and performed affinity chromatog. expts. with lysates from both mouse brain and macrophage cell lines.  These studies led to identification of two chaperones, Hsp70 and Hsp90, by mass spectrometry.  In contrast to typical Hsp90-binding drugs, taxol exhibits a stimulatory response.  Recently it was reported that the geldanamycin deriv. 17-AAG behaves synergistically with taxol-induced apoptosis.  This review describes the different C-terminal inhibitors of Hsp90, with specific emphasis on structure-activity relationship studies of novobiocin and their effects on anti-proliferative activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ1ZxUMTyXBrVg90H21EOLACvtfcHk0lh_6V-EE_mtgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWiur3M&md5=ee456e11ec9730f446bffd75d5d22c5e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986708786242895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708786242895%26sid%3Dliteratum%253Aachs%26aulast%3DDonnelly%26aufirst%3DA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DNovobiocin%2520and%2520additional%2520inhibitors%2520of%2520the%2520hsp90%2520c-terminal%2520nucleotide-binding%2520pocket%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2702%26epage%3D2717%26doi%3D10.2174%2F092986708786242895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span> <span> </span><span class="NLM_article-title">The ’active life’ of hsp90 complexes</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21840346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=614-623&author=C.+Prodromou&title=The+%E2%80%99active+life%E2%80%99+of+hsp90+complexes&doi=10.1016%2Fj.bbamcr.2011.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The active life' of Hsp90 complexes</span></div><div class="casAuthors">Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-623</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 forms a variety of complexes differing both in clientele and co-chaperones.  Central to the role of co-chaperones in the formation of Hsp90 complexes is the delivery of client proteins and the regulation of the ATPase activity of Hsp90.  Detg. the mechanisms by which co-chaperones regulate Hsp90 is essential in understanding the assembly of these complexes and the activation and maturation of Hsp90's clientele.  Mechanistically, co-chaperones alter the kinetics of the ATP-coupled conformational changes of Hsp90.  The structural changes leading to the formation of a catalytically active unit involve all regions of the Hsp90 dimer.  Their complexity has allowed different orthologues of Hsp90 to evolve kinetically in slightly different ways.  The interaction of the cytosolic Hsp90 with a variety of co-chaperones lends itself to a complex set of different regulatory mechanisms that modulate Hsp90's conformation and ATPase activity.  It also appears that the conformational switches of Hsp90 are not necessarily coupled under all circumstances.  Here, I described different co-chaperone complexes and then discuss in detail the mechanisms and role that specific co-chaperones play in this.  I will also discuss emerging evidence that post-translational modifications also affect the ATPase activity of Hsp90, and thus complex formation.  Finally, I will present evidence showing how Hsp90's active site, although being highly conserved, can be altered to show resistance to drug binding, but still maintain ATP binding and ATPase activity.  Such changes are therefore unlikely to significantly alter Hsp90's interactions with client proteins and co-chaperones.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEM4L7aY2HFrVg90H21EOLACvtfcHk0lh_6V-EE_mtgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7w%253D&md5=57d013f7cd3a06a663a598d29e0a193c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DThe%2520%25E2%2580%2599active%2520life%25E2%2580%2599%2520of%2520hsp90%2520complexes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D614%26epage%3D623%26doi%3D10.1016%2Fj.bbamcr.2011.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosz, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span> <span> </span><span class="NLM_article-title">Hsp90 at the hub of protein homeostasis: emerging mechanistic insights</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">528</span>, <span class="refDoi"> DOI: 10.1038/nrm2918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrm2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20531426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=515-528&author=M.+Taipaleauthor=D.+F.+Jaroszauthor=S.+Lindquist&title=Hsp90+at+the+hub+of+protein+homeostasis%3A+emerging+mechanistic+insights&doi=10.1038%2Fnrm2918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 at the hub of protein homeostasis: emerging mechanistic insights</span></div><div class="casAuthors">Taipale, Mikko; Jarosz, Daniel F.; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">515-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (HSP90) is a highly conserved mol. chaperone that facilitates the maturation of a wide range of proteins (known as clients).  Clients are enriched in signal transducers, including kinases and transcription factors.  Therefore, HSP90 regulates diverse cellular functions and exerts marked effects on normal biol., disease, and evolutionary processes.  Recent structural and functional analyses have provided new insights on the transcriptional and biochem. regulation of HSP90 and the structural dynamics it uses to act on a diverse client repertoire.  A comprehensive understanding of how HSP90 functions promises not only to provide new avenues for therapeutic intervention, but to shed light on fundamental biol. questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuMRSaY8uzGbVg90H21EOLACvtfcHk0lh_6V-EE_mtgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D&md5=492dca92cea32384d2ab4145230f53dd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrm2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2918%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DJarosz%26aufirst%3DD.%2BF.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DHsp90%2520at%2520the%2520hub%2520of%2520protein%2520homeostasis%253A%2520emerging%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D515%26epage%3D528%26doi%3D10.1038%2Fnrm2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic hsp90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+hsp90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0ljKkHZPX4kZ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520hsp90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaarniranta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltunen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span> <span> </span><span class="NLM_article-title">Hsp90 regulates tau pathology through co-chaperone complexes in alzheimer’s disease</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.pneurobio.2010.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21056617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=99-110&author=A.+Salminenauthor=J.+Ojalaauthor=K.+Kaarnirantaauthor=M.+Hiltunenauthor=H.+Soininen&title=Hsp90+regulates+tau+pathology+through+co-chaperone+complexes+in+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.pneurobio.2010.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease</span></div><div class="casAuthors">Salminen Antero; Ojala Johanna; Kaarniranta Kai; Hiltunen Mikko; Soininen Hilkka</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a tauopathy which involves the deposition of microtubule-associated tau proteins into neurofibrillary tangles.  Post-translational modifications, in particular site-specific phosphorylations, affect the conformation of tau protein which is an intrinsically disordered protein.  These structural changes significantly increase the affinity of tau protein for certain molecular chaperones.  Hsp90 is a major cellular chaperone which assembles large complexes with a variety of co-chaperones.  The main function of Hsp90 complexes is to maintain protein quality control and assist in protein degradation via proteasomal and autophagic-lysosomal pathways.  Tau protein is a client protein for these Hsp90 complexes.  If the tau protein is in an abnormal or modified form, then it can trigger the recruitment of CHIP protein, a co-chaperone with E3 activity, to the complex which induces the ubiquitination of tau protein and activates its downstream degradation processes.  Large immunophilins, FKBP51 and FKBP52 are also co-chaperones of Hsp90-tau complexes.  These proteins contain peptidylprolyl cis/trans isomerase activity which catalyzes phosphorylation-dependent rotation in pSer/Thr-Pro peptide bond.  The proline switch in the tau conformation triggers dephosphorylation of Ser/Thr residues phosphorylated, e.g. by two well-known tau kinases Cdk5 and GSK-3β.  Binding of PP5 protein phosphatase to Hsp90 complex, can also dephosphorylate tau protein.  Subsequently, dephosphorylated tau protein can be shuttled back to the microtubules.  It seems that high-affinity binding of abnormal tau to Hsp90 complexes may have some counteracting effects on the aggregation process, since Hsp90 inhibitors can ameliorate the aggregation process in several neurodegenerative diseases.  We will review the role of Hsp90 chaperone network in the regulation of tau biology and pathology in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIGys_IlOfaRe4jJGKT5N0fW6udTcc2eYQrWpBrD_Zdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D&md5=92c5535c5b5bc12c8c0807ea338310d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DOjala%26aufirst%3DJ.%26aulast%3DKaarniranta%26aufirst%3DK.%26aulast%3DHiltunen%26aufirst%3DM.%26aulast%3DSoininen%26aufirst%3DH.%26atitle%3DHsp90%2520regulates%2520tau%2520pathology%2520through%2520co-chaperone%2520complexes%2520in%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26volume%3D93%26spage%3D99%26epage%3D110%26doi%3D10.1016%2Fj.pneurobio.2010.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz-Ares, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hsp90 molecular chaperones: moving into the clinic</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e358</span>– <span class="NLM_lpage">e369</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS1470-2045%2813%2970169-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23896275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=e358-e369&author=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Inhibition+of+hsp90+molecular+chaperones%3A+moving+into+the+clinic&doi=10.1016%2FS1470-2045%2813%2970169-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HSP90 molecular chaperones: moving into the clinic</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Carnero, Amancio; Paz-Ares, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e358-e369</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (HSP90) is a mol. chaperone that is crucial for the stability and function of many proteins essential for cell survival.  Many oncogenes, including tyrosine kinases, transcription factors, and cell-cycle regulatory proteins, are client proteins of HSP90.  Inhibition of HSP90 causes client protein degrdn. via the ubiquitin-proteasome pathway, and is a mechanism that might simultaneously downregulate several redundant pathways crucial for cell viability and tumor development.  HSP90 inhibitors are currently being developed as anticancer agents, and have shown early promising results in molecularly defined subgroups of solid tumors (eg, ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer) and some haematol. malignancies (eg, multiple myeloma).  Here, we review the current status of HSP90 inhibitors in clin. development, including geldanamycin derivs., resorcinol derivs., purine analogs, and other synthetic inhibitors.  We also discuss novel strategies and future perspectives on how to optimize the therapeutic potential of this exciting new class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpulM7j4PFcx7Vg90H21EOLACvtfcHk0ljKkHZPX4kZ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI&md5=4821e86073624fb17d7343105d6e82cd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970169-4%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520hsp90%2520molecular%2520chaperones%253A%2520moving%2520into%2520the%2520clinic%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3De358%26epage%3De369%26doi%3D10.1016%2FS1470-2045%2813%2970169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Grp94/gp96 in cancer: biology, structure, immunology, and drug development</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fbs.acr.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26916005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=165-190&author=B.+X.+Wuauthor=F.+Hongauthor=Y.+Zhangauthor=E.+Ansa-Addoauthor=Z.+Li&title=Grp94%2Fgp96+in+cancer%3A+biology%2C+structure%2C+immunology%2C+and+drug+development&doi=10.1016%2Fbs.acr.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94/gp96 in cancer: biology, structure, immunology, and drug development</span></div><div class="casAuthors">Wu, Bill X.; Hong, Feng; Zhang, Yongliang; Ansa-Addo, Ephraim; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">165-190</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat-shock protein 90 (HSP90) paralog, GRP94 (glucose-regulated protein 94)/gp96 (hereafter referred to as GRP94) has been shown to be an essential master chaperone for multiple receptors including Toll-like receptors, Wnt coreceptors, and integrins.  Clin., expression of GRP94 correlates with advanced stage and poor survival in a variety of cancers.  Recent preclin. studies have also revealed that GRP94 expression is closely linked to cancer growth and metastasis in melanoma, ovarian cancer, multiple myeloma, lung cancer, and inflammation-assocd. colon cancer.  Thus, GRP94 is an attractive therapeutic target in a no. of malignancies.  The chaperone function of GRP94 depends on its ATPase domain, which is structurally distinct from HSP90, allowing design of highly selective GRP94-targeted inhibitors.  In this chapter, we discuss the biol. and structure-function relationship of GRP94.  We also summarize the immunol. roles of GRP94 based on the studies documented over the last two decades, as these pertain to tumorigenesis and cancer progression.  Finally, the structure-based rationale for the design of selective small-mol. inhibitors of GRP94 and their potential application in the treatment of cancer are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOidSXL_76bVg90H21EOLACvtfcHk0ljKkHZPX4kZ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D&md5=aa5f0de87db03540b0902ae305e658fc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAnsa-Addo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DGrp94%252Fgp96%2520in%2520cancer%253A%2520biology%252C%2520structure%252C%2520immunology%252C%2520and%2520drug%2520development%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2016%26volume%3D129%26spage%3D165%26epage%3D190%26doi%3D10.1016%2Fbs.acr.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White-Gilbertson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6242</span>– <span class="NLM_lpage">6251</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+P.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+DePinhoauthor=Z.+H.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-13-2083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0lgDSw4iYj87hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%2BP.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDePinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251%26doi%3D10.1158%2F1078-0432.CCR-13-2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">Identification of gp96 as a novel target for treatment of autoimmune disease in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e9792</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0009792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1371%2Fjournal.pone.0009792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20352117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3c3itFSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9792&author=J.+M.+Hanauthor=N.+H.+Kwonauthor=J.+Y.+Leeauthor=S.+J.+Jeongauthor=H.+J.+Jungauthor=H.+R.+Kimauthor=Z.+H.+Liauthor=S.+Kim&title=Identification+of+gp96+as+a+novel+target+for+treatment+of+autoimmune+disease+in+mice&doi=10.1371%2Fjournal.pone.0009792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of gp96 as a novel target for treatment of autoimmune disease in mice</span></div><div class="casAuthors">Han Jung Min; Kwon Nam Hoon; Lee Jin Young; Jeong Seung Jae; Jung Hee Jung; Kim Hyeong Rae; Li Zihai; Kim Sunghoon</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e9792</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock proteins have been implicated as endogenous activators for dendritic cells (DCs).  Chronic expression of heat shock protein gp96 on cell surfaces induces significant DC activations and systemic lupus erythematosus (SLE)-like phenotypes in mice.  However, its potential as a therapeutic target against SLE remains to be evaluated.  In this work, we conducted chemical approach to determine whether SLE-like phenotypes can be compromised by controlling surface translocation of gp96.  From screening of chemical library, we identified a compound that binds and suppresses surface presentation of gp96 by facilitating its oligomerization and retrograde transport to endoplasmic reticulum.  In vivo administration of this compound reduced maturation of DCs, populations of antigen presenting cells, and activated B and T cells.  The chemical treatment also alleviated the SLE-associated symptoms such as glomerulonephritis, proteinuria, and accumulation of anti-nuclear and -DNA antibodies in the SLE model mice resulting from chronic surface exposure of gp96.  These results suggest that surface translocation of gp96 can be chemically controlled and gp96 as a potential therapeutic target to treat autoimmune disease like SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAwZFYdxQArg5nADWVYHg1fW6udTcc2eY2ej_44HuhV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3itFSrtQ%253D%253D&md5=735e3a9d4cd07e38c5d804d432b74b7f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009792%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BM.%26aulast%3DKwon%26aufirst%3DN.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DJeong%26aufirst%3DS.%2BJ.%26aulast%3DJung%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520gp96%2520as%2520a%2520novel%2520target%2520for%2520treatment%2520of%2520autoimmune%2520disease%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9792%26doi%3D10.1371%2Fjournal.pone.0009792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. H.</span></span> <span> </span><span class="NLM_article-title">Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2819</span>, <span class="refDoi"> DOI: 10.1111/febs.12822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1111%2Ffebs.12822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24754231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=2805-2819&author=X.+Tianauthor=P.+Maauthor=C.+G.+Suiauthor=F.+D.+Mengauthor=Y.+Liauthor=L.+Y.+Fuauthor=T.+Jiangauthor=Y.+Wangauthor=Y.+H.+Jiang&title=Suppression+of+tumor+necrosis+factor+receptor-associated+protein+1+expression+induces+inhibition+of+cell+proliferation+and+tumor+growth+in+human+esophageal+cancer+cells&doi=10.1111%2Ffebs.12822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells</span></div><div class="casAuthors">Tian, Xin; Ma, Ping; Sui, Cheng-Guang; Meng, Fan-Dong; Li, Yan; Fu, Li-Ye; Jiang, Tao; Wang, Yang; Jiang, You-Hong</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2805-2819</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tumor necrosis factor receptor-assocd. protein 1 (TRAP1) is a mol. chaperone involved in multidrug resistance and antiapoptosis in some human tumors, but its regulatory mechanisms have not been revealed in esophageal squamous cell carcinoma (ESCC).  In this study, 138 specimens of ESCC were analyzed.  TRAP1 was overexpressed in ESCC, particularly in poorly differentiated tumors.  To further explore the mol. regulatory mechanism, we constructed specific small interfering RNA-expressing vectors targeting Trap1, and knocked down Trap1 expression in the esophageal cancer cell lines ECA109 and EC9706.  Knockdown of Trap1 induced increases in reactive oxygen species and mitochondrial depolarization, which have been proposed as crit. regulators of apoptosis.  The cell cycle was arrested in G2/M phase, and in vitro inhibition of cell proliferation was confirmed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide and bromodeoxyuridine assays.  Furthermore, re-expression of TRAP1 in Trap1 small interfering RNA-transfected ESCC cells restored cell proliferation and cell apoptosis.  Bioluminescence of s.c. xenografted ESCC tumor cells demonstrated significant inhibition of in vivo tumor growth by Trap1 knockdown.  This study shows that TRAP1 was overexpressed in most patients with ESCC, and caused an increase in antiapoptosis potency.  TRAP1 may be regarded as a target in ESCC biotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7H6sKjcHsrVg90H21EOLACvtfcHk0lgDSw4iYj87hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWlt7c%253D&md5=42f27193e87cf0b65d76e550921a07bf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12822%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DSui%26aufirst%3DC.%2BG.%26aulast%3DMeng%26aufirst%3DF.%2BD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%2BH.%26atitle%3DSuppression%2520of%2520tumor%2520necrosis%2520factor%2520receptor-associated%2520protein%25201%2520expression%2520induces%2520inhibition%2520of%2520cell%2520proliferation%2520and%2520tumor%2520growth%2520in%2520human%2520esophageal%2520cancer%2520cells%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26spage%3D2805%26epage%3D2819%26doi%3D10.1111%2Ffebs.12822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. E.</span></span> <span> </span><span class="NLM_article-title">The hsp70 family and cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgt111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1093%2Fcarcin%2Fbgt111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23563090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1181-1188&author=M.+E.+Murphy&title=The+hsp70+family+and+cancer&doi=10.1093%2Fcarcin%2Fbgt111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP70 family and cancer</span></div><div class="casAuthors">Murphy, Maureen E.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1181-1188</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The HSP70 family of heat shock proteins consists of mol. chaperones of approx. 70kDa in size that serve crit. roles in protein homeostasis.  These ATPases unfold misfolded or denatured proteins and can keep these proteins in an unfolded, folding-competent state.  They also protect nascently translating proteins, promote the cellular or organellar transport of proteins, reduce proteotoxic protein aggregates and serve general housekeeping roles in maintaining protein homeostasis.  The HSP70 family is the most conserved in evolution, and all eukaryotes contain multiple members.  Some members of this family serve specific organellar- or tissue-specific functions; however, in many cases, these members can function redundantly.  Overall, the HSP70 family of proteins can be thought of as a potent buffering system for cellular stress, either from extrinsic (physiol., viral and environmental) or intrinsic (replicative or oncogenic) stimuli.  As such, this family serves a crit. survival function in the cell.  Not surprisingly, cancer cells rely heavily on this buffering system for survival.  The overwhelming majority of human tumors overexpress HSP70 family members, and expression of these proteins is typically a marker for poor prognosis.  With the proof of principle that inhibitors of the HSP90 chaperone have emerged as important anticancer agents, intense focus has now been placed on the potential for HSP70 inhibitors to assume a role as a significant chemotherapeutic avenue.  In this review, the history, regulation, mechanism of action and role in cancer of the HSP70 family are reviewed.  Addnl., the promise of pharmacol. targeting this protein for cancer therapy is addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSLhAXHd5TMrVg90H21EOLACvtfcHk0li7XFyC5xv37A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFCnt7w%253D&md5=57d5da83aac342edb1dff2ba2bd0372b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt111%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26atitle%3DThe%2520hsp70%2520family%2520and%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D1181%26epage%3D1188%26doi%3D10.1093%2Fcarcin%2Fbgt111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">Integration of the accelerator aha1 in the hsp90 co-chaperone cycle</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnsmb.2502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23396352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1agtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=326-331&author=J.+Liauthor=K.+Richterauthor=J.+Reinsteinauthor=J.+Buchner&title=Integration+of+the+accelerator+aha1+in+the+hsp90+co-chaperone+cycle&doi=10.1038%2Fnsmb.2502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle</span></div><div class="casAuthors">Li, Jing; Richter, Klaus; Reinstein, Jochen; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">326-331</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat-shock protein 90 (Hsp90) is an ATP-dependent mol. chaperone that assocs. dynamically with various co-chaperones during its chaperone cycle.  Here we analyzed the role of the activating co-chaperone Aha1 in the progression of the yeast Hsp90 chaperone cycle and identified a crit. ternary Hsp90 complex contg. the co-chaperones Aha1 and Cpr6.  Aha1 accelerates the intrinsically slow conformational transitions of Hsp90 to an N-terminally assocd. state but does not fully close the nucleotide-binding pocket yet.  Cpr6 increases the affinity between Aha1 and Hsp90 and further stimulates the Hsp90 ATPase activity.  Synergistically, Aha1 and Cpr6 displace the inhibitory co-chaperone Sti1 from Hsp90.  To complete the cycle, Aha1 is released by the co-chaperone p23.  Thus, at distinct steps during the Hsp90 chaperone cycle, co-chaperones selectively trap statistically distributed Hsp90 conformers and thus turn Hsp90 into a deterministic machine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeeCJzW_WC07Vg90H21EOLACvtfcHk0li7XFyC5xv37A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1agtrs%253D&md5=5d9efe9ba6342ab18bd7567a70344956</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2502%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DIntegration%2520of%2520the%2520accelerator%2520aha1%2520in%2520the%2520hsp90%2520co-chaperone%2520cycle%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D326%26epage%3D331%26doi%3D10.1038%2Fnsmb.2502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiau, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southworth, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of e. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.cell.2006.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17055434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=329-340&author=A.+K.+Shiauauthor=S.+F.+Harrisauthor=D.+R.+Southworthauthor=D.+A.+Agard&title=Structural+analysis+of+e.+coli+hsp90+reveals+dramatic+nucleotide-dependent+conformational+rearrangements&doi=10.1016%2Fj.cell.2006.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span></div><div class="casAuthors">Shiau, Andrew K.; Harris, Seth F.; Southworth, Daniel R.; Agard, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-340</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In eukaryotes, the ubiquitous and abundant members of the 90 kDa heat-shock protein (hsp90) chaperone family facilitate the folding and conformational changes of a broad array of proteins important in cell signaling, proliferation, and survival.  Here we describe the effects of nucleotides on the structure of full-length HtpG, the Escherichia coli hsp90 ortholog.  By electron microscopy, the nucleotide-free, AMPPNP bound, and ADP bound states of HtpG adopt completely distinct conformations.  Structural characterization of nucleotide-free and ADP bound HtpG was extended to higher resoln. by x-ray crystallog.  In the absence of nucleotide, HtpG exhibits an "open" conformation in which the three domains of each monomer present hydrophobic elements into the large cleft formed by the dimer.  By contrast, ADP binding drives dramatic conformational changes that allow these hydrophobic elements to converge and shield each other from solvent, suggesting a mechanism by which nucleotides could control client protein binding and release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeAimQnRIXPbVg90H21EOLACvtfcHk0li7XFyC5xv37A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73J&md5=062feeb6f8ec5fde039ad55dbc093008</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DSouthworth%26aufirst%3DD.%2BR.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520e.%2520coli%2520hsp90%2520reveals%2520dramatic%2520nucleotide-dependent%2520conformational%2520rearrangements%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D329%26epage%3D340%26doi%3D10.1016%2Fj.cell.2006.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="ref25_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">The hallmarks of cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81683-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer&doi=10.1016%2FS0092-8674%2800%2981683-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref25_1R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0li7XFyC5xv37A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=ref25_1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70%26doi%3D10.1016%2FS0092-8674%2800%2981683-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">The therapeutic target hsp90 and cancer hallmarks</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.2174/138161213804143725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F138161213804143725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22920906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=347-365&author=Y.+Miyataauthor=H.+Nakamotoauthor=L.+Neckers&title=The+therapeutic+target+hsp90+and+cancer+hallmarks&doi=10.2174%2F138161213804143725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic target Hsp90 and cancer hallmarks</span></div><div class="casAuthors">Miyata, Yoshihiko; Nakamoto, Hitoshi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a major mol. chaperone that is expressed abundantly and plays a pivotal role in assisting correct folding and functionality of its client proteins in cells.  The Hsp90 client proteins include a wide variety of signal transducing mols. such as protein kinases and steroid hormone receptors.  Cancer is a complex disease, but most types of human cancer share common hallmarks, including self-sufficiency in growth signals, insensitivity to growth-inhibitory mechanism, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  A surprisingly large no. of Hsp90-client proteins play crucial roles in establishing cancer cell hallmarks.  We start the review by describing the structure and function of Hsp90 since conformational changes during the ATPase cycle of Hsp90 are closely related to its function.  Many co-chaperones, including Hop, p23, Cdc37, Aha1, and PP5, work together with Hsp90 by modulating the chaperone machinery.  Post-translational modifications of Hsp90 and its co-chaperones are vital for their function.  Many tumor-related Hsp90-client proteins, including signaling kinases, steroid hormone receptors, p53, and telomerase, are described.  Hsp90 and its co-chaperones are required for the function of these tumor-promoting client proteins; therefore, inhibition of Hsp90 by specific inhibitors such as geldanamycin and its derivs. attenuates the tumor progression.  Hsp90 inhibitors can be potential and effective cancer chemotherapeutic drugs with a unique profile and have been examd. in clin. trials.  We describe possible mechanisms why Hsp90 inhibitors show selectivity to cancer cells even though Hsp90 is essential also for normal cells.  Finally, we discuss the "Hsp90-addiction" of cancer cells, and suggest a role for Hsp90 in tumor evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCHug6Q3PILVg90H21EOLACvtfcHk0lgrIHXoFVl0_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D&md5=07f817fc5afc5ef0669aae0cd0dab15d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138161213804143725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143725%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DNakamoto%26aufirst%3DH.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DThe%2520therapeutic%2520target%2520hsp90%2520and%2520cancer%2520hallmarks%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D347%26epage%3D365%26doi%3D10.2174%2F138161213804143725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Hsp90 in cancer: transcriptional roles in the nucleus</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fbs.acr.2015.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26916002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=89-106&author=S.+K.+Calderwoodauthor=L.+Neckers&title=Hsp90+in+cancer%3A+transcriptional+roles+in+the+nucleus&doi=10.1016%2Fbs.acr.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 in cancer: transcriptional roles in the nucleus</span></div><div class="casAuthors">Calderwood, Stuart K.; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">89-106</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hsp90 plays a key role in fostering metabolic pathways essential in tumorigenesis through its functions as a mol. chaperone.  Multiple oncogenic factors in the membrane and cytoplasm are thus protected from degrdn. and destruction.  Here, we have considered Hsp90's role in transcription in the nucleus.  Hsp90 functions both in regulating the activity of sequence-specific transcription factors such as nuclear receptors and HSF1, as well as impacting more globally acting factors that act on chromatin and RNA polymerase II.  Hsp90 influences transcription by modulating histone modification mediated by its clients SMYD3 and trithorax/MLL, as well as by regulating the processivity of RNA polymerase II through neg. elongation factor.  It is not currently clear how the transcriptional role of Hsp90 may be influenced by the cancer milieu although recently discovered posttranslational modification of the chaperone may be involved.  Dysregulation of Hsp90 may thus influence malignant processes both by modulating the function of specific transcription factors and effects on more globally acting general components of the transcriptional machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxbKc0Wv-cbbVg90H21EOLACvtfcHk0lgrIHXoFVl0_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWru7c%253D&md5=8635e6f4b89e79d244c6b3cb3126a4c8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHsp90%2520in%2520cancer%253A%2520transcriptional%2520roles%2520in%2520the%2520nucleus%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2016%26volume%3D129%26spage%3D89%26epage%3D106%26doi%3D10.1016%2Fbs.acr.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span> <span> </span><span class="NLM_article-title">Drugging the cancer chaperone hsp90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1113</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1196/annals.1391.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckersauthor=N.+Rosen&title=Drugging+the+cancer+chaperone+hsp90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress&doi=10.1196%2Fannals.1391.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0lgrIHXoFVl0_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520hsp90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216%26doi%3D10.1196%2Fannals.1391.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Węgrzyn, G.</span></span> <span> </span><span class="NLM_article-title">Anti-hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/s12192-016-0670-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs12192-016-0670-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26786410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=213-218&author=S.+Tukajauthor=G.+W%C4%99grzyn&title=Anti-hsp90+therapy+in+autoimmune+and+inflammatory+diseases%3A+a+review+of+preclinical+studies&doi=10.1007%2Fs12192-016-0670-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span></div><div class="casAuthors">Tukaj, Stefan; Wegrzyn, Grzegorz</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90), a 90-kDa mol. chaperone, is responsible for biol. activities of key signaling mols. (clients) such as protein kinases, ubiquitin ligases, steroid receptors, cell cycle regulators, and transcription factors regulating various cellular processes, including growth, survival, differentiation, and apoptosis.  Because Hsp90 is also involved in stabilization of oncogenic 'client' proteins, its specific chaperone activity blockers are currently being tested as anticancer agents in advanced clin. trials.  Recent in vitro and in vivo studies have shown that Hsp90 is also involved in activation of innate and adaptive cells of the immune system.  For these reasons, pharmacol. inhibition of Hsp90 has been evaluated in murine models of autoimmune and inflammatory diseases.  This mini-review summarizes current knowledge of the effects of Hsp90 inhibitors on autoimmune and inflammatory diseases' features and is based solely on preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_LDdiZ_wJSrVg90H21EOLACvtfcHk0lhyy0ProilATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D&md5=e0b1d3ea522de06d60ab530e20b2b4d0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs12192-016-0670-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-016-0670-z%26sid%3Dliteratum%253Aachs%26aulast%3DTukaj%26aufirst%3DS.%26aulast%3DW%25C4%2599grzyn%26aufirst%3DG.%26atitle%3DAnti-hsp90%2520therapy%2520in%2520autoimmune%2520and%2520inflammatory%2520diseases%253A%2520a%2520review%2520of%2520preclinical%2520studies%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2016%26volume%3D21%26spage%3D213%26epage%3D218%26doi%3D10.1007%2Fs12192-016-0670-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90 is critical for regulation of phenotype and functional activity of human t lymphocytes and nk cells</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">1360</span>– <span class="NLM_lpage">1371</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1200593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.4049%2Fjimmunol.1200593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23293352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2013&pages=1360-1371&author=J.+Baeauthor=A.+Munshiauthor=C.+Liauthor=M.+Samurauthor=R.+Prabhalaauthor=C.+Mitsiadesauthor=K.+C.+Andersonauthor=N.+C.+Munshi&title=Heat+shock+protein+90+is+critical+for+regulation+of+phenotype+and+functional+activity+of+human+t+lymphocytes+and+nk+cells&doi=10.4049%2Fjimmunol.1200593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90 Is Critical for Regulation of Phenotype and Functional Activity of Human T Lymphocytes and NK Cells</span></div><div class="casAuthors">Bae, Jooeun; Munshi, Aditya; Li, Cheng; Samur, Mehmet; Prabhala, Rao; Mitsiades, Constantine; Anderson, Kenneth C.; Munshi, Nikhil C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1360-1371</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The 90-kDa heat shock protein (Hsp90) has become an important therapeutic target with ongoing evaluation in a no. of malignancies.  Although Hsp90 inhibitors have a high therapeutic index with limited effects on normal cells, they have been described to inhibit dendritic cell function.  However, its effect on human immune effector cells may have significant clin. implications, but remains unexplored.  In this study, we have evaluated the effects of Hsp90 inhibition on human T lymphocyte and NK cells, including their Ag expression, activation, proliferation, and functional activities.  These studies demonstrate that Hsp90 inhibition irreversibly downregulates cell surface expression of crit. Ags (CD3, CD4, CD8), the costimulatory mol. (CD28, CD40L), and αβ receptors on T lymphocytes, as well as activating receptors (CD2, CD11a, CD94, NKp30, NKp44, NKp46, KARp50.3) on NK cells.  Hsp90 inhibition significantly reduced CD4 protein expression on T lymphocytes at both the cell surface and intracellular level, which was shown to be assocd. with aberrant regulation of Src-kinase p56Lck.  Downregulation of the Ags triggered by Hsp90 inhibition on CD3+ T lymphocytes, both in CD4+ and CD8+ T cell subsets, was assocd. with a disruption in their cellular activation, proliferation, and/or IFN-γ prodn., when the inhibition occurred either in activated or inactivated cells.  In addn., downregulation of key activating receptors on NK cells following Hsp90 inhibition resulted in decreased cytotoxicity against tumor cells.  Therefore, these observations demonstrate the need to closely monitor immune function in patients being treated with a Hsp90 inhibitor and may provide a potential therapeutic application in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF-Ta4whAsmbVg90H21EOLACvtfcHk0lhyy0ProilATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWrt7k%253D&md5=e9606da26c71559ffbf1b1436f386637</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1200593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1200593%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%26aulast%3DMunshi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSamur%26aufirst%3DM.%26aulast%3DPrabhala%26aufirst%3DR.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%2520is%2520critical%2520for%2520regulation%2520of%2520phenotype%2520and%2520functional%2520activity%2520of%2520human%2520t%2520lymphocytes%2520and%2520nk%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D190%26spage%3D1360%26epage%3D1371%26doi%3D10.4049%2Fjimmunol.1200593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabbett, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3765</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1002/art.24047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fart.24047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19035474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3765-3775&author=J.+W.+Riceauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=A.+F.+Barabaszauthor=J.+M.+Partridgeauthor=T.+E.+Bartaauthor=L.+G.+Duboisauthor=K.+H.+Huangauthor=S.+R.+Mabbettauthor=M.+A.+Silinskiauthor=P.+M.+Steedauthor=S.+E.+Hall&title=Small+molecule+inhibitors+of+hsp90+potently+affect+inflammatory+disease+pathways+and+exhibit+activity+in+models+of+rheumatoid+arthritis&doi=10.1002%2Fart.24047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis</span></div><div class="casAuthors">Rice, John W.; Veal, James M.; Fadden, R. Patrick; Barabasz, Amy F.; Partridge, Jeffrey M.; Barta, Thomas E.; Dubois, Laura G.; Huang, Kenneth H.; Mabbett, Sarah R.; Silinski, Melanie A.; Steed, Paul M.; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3765-3775</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To evaluate the ability of SNX-7081, a novel small mol. inhibitor of Hsp90, to block components of inflammation, including cytokine prodn., protein kinase activity, and angiogenic signaling.  A close analog was evaluated in preclin. in vivo models of rheumatoid arthritis (RA).  SNX-7081 binding to Hsp90 was characterized in Jurkat cells and RA synovial fibroblasts (RASFs).  Inhibition of NF-κB nuclear translocation was evaluated in cellular systems, using lipopolysaccharide (LPS), tumor necrosis factor α, or interleukin-1β stimulation.  Suppression of cytokine prodn. in THP-1 cells, human umbilical vein endothelial cells, and RASFs was studied.  Disruption of MAPK signaling cascades by SNX-7081 following growth factor stimulation was assessed.  SNX-7081 was tested in 2 relevant angiogenesis assays: platelet-derived growth factor activation of fibroblasts and LPS-induced nitric oxide (NO) release in J774 macrophages.  A close analog, SNX-4414, was evaluated in rat collagen-induced arthritis and adjuvant-induced arthritis, following oral treatment.  SNX-7081 showed strong binding affinity to Hsp90 and expected induction of Hsp70.  NF-κB nuclear translocation was blocked by SNX-7081 at nanomolar concns., and cytokine prodn. was potently inhibited.  Growth factor activation of ERK and JNK signaling was significantly reduced by SNX-7081.  NO prodn. was also sharply inhibited.  In animal models, SNX-4414 fully inhibited paw swelling and improved body wt.  Scores for inflammation, pannus formation, cartilage damage, and bone resorption returned to normal.  The present results demonstrate that a small mol. Hsp90 inhibitor can impact inflammatory disease processes.  The strong in vivo efficacy obsd. with SNX-4414 provides preclin. validation for consideration of Hsp90 inhibitors in the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoT2siTMpu4rVg90H21EOLACvtfcHk0lhyy0ProilATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1ymtQ%253D%253D&md5=e3124416877b1c1d0de898eb2fd05da1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fart.24047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24047%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DMabbett%26aufirst%3DS.%2BR.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520hsp90%2520potently%2520affect%2520inflammatory%2520disease%2520pathways%2520and%2520exhibit%2520activity%2520in%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3765%26epage%3D3775%26doi%3D10.1002%2Fart.24047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yun, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harning, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giza, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabah, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehry, M. R.</span></span> <span> </span><span class="NLM_article-title">Ec144, a Synthetic Inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1000222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.4049%2Fjimmunol.1000222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21131419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FlsFOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=563-575&author=T.+J.+Yunauthor=E.+K.+Harningauthor=K.+Gizaauthor=D.+Rabahauthor=P.+Liauthor=J.+W.+Arndtauthor=D.+Luchettiauthor=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Lundgrenauthor=A.+Manningauthor=M.+R.+Kehry&title=Ec144%2C+a+Synthetic+Inhibitor+of+heat+shock+protein+90%2C+blocks+innate+and+adaptive+immune+responses+in+models+of+inflammation+and+autoimmunity&doi=10.4049%2Fjimmunol.1000222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity</span></div><div class="casAuthors">Yun Theodore J; Harning Erin K; Giza Keith; Rabah Dania; Li Ping; Arndt Joseph W; Luchetti David; Biamonte Marco A; Shi Jiandong; Lundgren Karen; Manning Anthony; Kehry Marilyn R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology (Baltimore, Md. : 1950)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">563-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a molecular chaperone involved in folding and stabilizing multiple intracellular proteins that have roles in cell activation and proliferation.  Many Hsp90 client proteins in tumor cells are mutated or overexpressed oncogenic proteins driving cancer cell growth, leading to the acceptance of Hsp90 as a potential therapeutic target for cancer.  Because several signal transduction molecules that are dependent on Hsp90 function are also involved in activation of innate and adaptive cells of the immune system, we investigated the mechanism by which inhibiting Hsp90 leads to therapeutic efficacy in rodent models of inflammation and autoimmunity.  EC144, a synthetic Hsp90 inhibitor, blocked LPS-induced TLR4 signaling in RAW 264.7 cells by inhibiting activation of ERK1/2, MEK1/2, JNK, and p38 MAPK but not NF-κB.  Ex vivo LPS-stimulated CD11b(+) peritoneal exudate cells from EC144-treated mice were blocked from phosphorylating tumor progression locus 2, MEK1/2, and ERK1/2.  Consequently, EC144-treated mice were resistant to LPS administration and had suppressed systemic TNF-α release.  Inhibiting Hsp90 also blocked in vitro CD4(+) T cell proliferation in mouse and human MLRs.  In vivo, semitherapeutic administration of EC144 blocked disease development in rat collagen-induced arthritis by suppressing the inflammatory response.  In a mouse collagen-induced arthritis model, EC144 also suppressed disease development, which correlated with a suppressed Ag-specific Ab response and a block in activation of Ag-specific CD4(+) T cells.  Our results describe mechanisms by which blocking Hsp90 function may be applicable to treatment of autoimmune diseases involving inflammation and activation of the adaptive immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTM1FYqPTUL0RFwe7cAcrfPfW6udTcc2ebinjRBGsHRyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FlsFOltw%253D%253D&md5=19230b0d2d8e5580313a3047dffc9ccc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1000222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1000222%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DT.%2BJ.%26aulast%3DHarning%26aufirst%3DE.%2BK.%26aulast%3DGiza%26aufirst%3DK.%26aulast%3DRabah%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DLuchetti%26aufirst%3DD.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DManning%26aufirst%3DA.%26aulast%3DKehry%26aufirst%3DM.%2BR.%26atitle%3DEc144%252C%2520a%2520Synthetic%2520Inhibitor%2520of%2520heat%2520shock%2520protein%252090%252C%2520blocks%2520innate%2520and%2520adaptive%2520immune%2520responses%2520in%2520models%2520of%2520inflammation%2520and%2520autoimmunity%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D563%26epage%3D575%26doi%3D10.4049%2Fjimmunol.1000222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimp, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafin, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regna, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caudell, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rylander, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, C. M.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90 inhibition by 17-dmag lessens disease in the mrl/lpr mouse model of systemic lupus erythematosus</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1038/cmi.2012.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fcmi.2012.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22543833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVehu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=255-266&author=S.+K.+Shimpauthor=C.+B.+Chafinauthor=N.+L.+Regnaauthor=S.+E.+Hammondauthor=M.+A.+Readauthor=D.+L.+Caudellauthor=M.+N.+Rylanderauthor=C.+M.+Reilly&title=Heat+shock+protein+90+inhibition+by+17-dmag+lessens+disease+in+the+mrl%2Flpr+mouse+model+of+systemic+lupus+erythematosus&doi=10.1038%2Fcmi.2012.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus</span></div><div class="casAuthors">Shimp, Samuel K, III; Chafin, Cristen B.; Regna, Nicole L.; Hammond, Sarah E.; Read, Molly A.; Caudell, David L.; Rylander, Marissa Nichole; Reilly, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Elevated expression of heat shock protein 90 (HSP90) has been found in kidneys and serum of systemic lupus erythematosus (SLE) patients and MRL/Mp-Faslpr/Faslpr (MRL/lpr) autoimmune mice.  We investigated if inhibition of HSP90 would reduce disease in MRL/lpr mice.  In vitro, pretreatment of mesangial cells with HSP90 inhibitor Geldanamycin prior to immune-stimulation showed reduced expression of IL-6, IL-12 and NO.  In vivo, we found HSP90 expression was elevated in MRL/lpr kidneys when compared to C57BL/6 mice and MRL/lpr mice treated with HSP90 inhibitor 17-DMAG.  MRL/lpr mice treated with 17-DMAG showed decreased proteinuria and reduced serum anti-dsDNA antibody prodn.  Glomerulonephritis and glomerular IgG and C3 were not significantly affected by administration of 17-DMAG in MRL/lpr. 17-DMAG increased CD8+ T cells, reduced double-neg. T cells, decreased the CD4/CD8 ratio and reduced follicular B cells.  These studies suggest that HSP90 may play a role in regulating T-cell differentiation and activation and that HSP90 inhibition may reduce inflammation in lupus.  Cellular & Mol. Immunol. (2012) 9, 255-266; doi:10.1038/cmi.2012.5; published online 30 Apr. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdlmMkrB3mD7Vg90H21EOLACvtfcHk0liqHQghRZOgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVehu78%253D&md5=e8bbe0724fc1fa9c2725845dfb716bc5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2012.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2012.5%26sid%3Dliteratum%253Aachs%26aulast%3DShimp%26aufirst%3DS.%2BK.%26aulast%3DChafin%26aufirst%3DC.%2BB.%26aulast%3DRegna%26aufirst%3DN.%2BL.%26aulast%3DHammond%26aufirst%3DS.%2BE.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DCaudell%26aufirst%3DD.%2BL.%26aulast%3DRylander%26aufirst%3DM.%2BN.%26aulast%3DReilly%26aufirst%3DC.%2BM.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibition%2520by%252017-dmag%2520lessens%2520disease%2520in%2520the%2520mrl%252Flpr%2520mouse%2520model%2520of%2520systemic%2520lupus%2520erythematosus%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2012%26volume%3D9%26spage%3D255%26epage%3D266%26doi%3D10.1038%2Fcmi.2012.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somlai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zillikens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orosz, A.</span></span> <span> </span><span class="NLM_article-title">Heat-shock protein 90 inhibition in autoimmunity to type vii collagen: evidence that nonmalignant plasma cells are not therapeutic targets</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">6135</span>– <span class="NLM_lpage">6142</span>, <span class="refDoi"> DOI: 10.1182/blood-2010-10-314609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1182%2Fblood-2010-10-314609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21490339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=6135-6142&author=M.+Kasperkiewiczauthor=R.+Mullerauthor=R.+Manzauthor=M.+Magensauthor=C.+M.+Hammersauthor=C.+Somlaiauthor=J.+Westermannauthor=E.+Schmidtauthor=D.+Zillikensauthor=R.+J.+Ludwigauthor=A.+Orosz&title=Heat-shock+protein+90+inhibition+in+autoimmunity+to+type+vii+collagen%3A+evidence+that+nonmalignant+plasma+cells+are+not+therapeutic+targets&doi=10.1182%2Fblood-2010-10-314609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets</span></div><div class="casAuthors">Kasperkiewicz, Michael; Mueller, Ralf; Manz, Rudolf; Magens, Moritz; Hammers, Christoph M.; Somlai, Csaba; Westermann, Juergen; Schmidt, Enno; Zillikens, Detlef; Ludwig, Ralf J.; Orosz, Antal</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6135-6142</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Blocking heat-shock protein 90 (Hsp90) induces death of malignant plasma cells by activation of the unfolded protein response, a signaling pathway activated by accumulation of misfolded proteins within the endoplasmic reticulum.  We hypothesized that nontransformed plasma cells are also hypersensitive to Hsp90 inhibition because of their high amt. of protein biosynthesis.  To investigate this hypothesis, 2 different Hsp90 inhibitors, the geldanamycin deriv. 17-DMAG and the nontoxic peptide deriv. TCBL-145, were applied to mice with exptl. epidermolysis bullosa acquisita, an autoimmune bullous disease characterized by autoantibodies against type VII collagen of the dermal-epidermal junction.  Both inhibitors ameliorated clin. disease of type VII collagen-immunized mice, suppressed auto-antibody prodn., and reduced dermal neutrophilic infiltrate.  Interestingly, total plasma cell nos., type VII collagen-specific plasma cells, and germinal center B cells were unaffected by anti-Hsp90 treatment in vivo.  However, T-cell proliferation was potently inhibited, as evidenced by the reduced response of isolated lymph node cells from immunized mice to in vitro restimulation with anti-CD3/CD28 antibody or autoantigen in the presence of Hsp90 inhibitors.  Our results suggest that Hsp90 blockade has no impact on normal or autoreactive plasma cells in vivo and identify T cells as targets of anti-Hsp90 treatment in autoimmunity to type VII collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTOT9rHH0PdbVg90H21EOLACvtfcHk0liqHQghRZOgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVyhsrg%253D&md5=b95d5427d0e23dbdcd72e67f448b9cea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-10-314609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-10-314609%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DR.%26aulast%3DManz%26aufirst%3DR.%26aulast%3DMagens%26aufirst%3DM.%26aulast%3DHammers%26aufirst%3DC.%2BM.%26aulast%3DSomlai%26aufirst%3DC.%26aulast%3DWestermann%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DZillikens%26aufirst%3DD.%26aulast%3DLudwig%26aufirst%3DR.%2BJ.%26aulast%3DOrosz%26aufirst%3DA.%26atitle%3DHeat-shock%2520protein%252090%2520inhibition%2520in%2520autoimmunity%2520to%2520type%2520vii%2520collagen%253A%2520evidence%2520that%2520nonmalignant%2520plasma%2520cells%2520are%2520not%2520therapeutic%2520targets%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D6135%26epage%3D6142%26doi%3D10.1182%2Fblood-2010-10-314609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Essential roles of grp94 in gut homeostasis via chaperoning canonical wnt pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6877</span>– <span class="NLM_lpage">6882</span>, <span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+grp94+in+gut+homeostasis+via+chaperoning+canonical+wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0lhIJZ2MhxGQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent grp94 selective inhibitor with anti-inflammatory efficacy in a mouse model of ulcerative colitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9513</span>– <span class="NLM_lpage">9533</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00800</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00800" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSrtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9513-9533&author=F.+Jiangauthor=A.+P.+Guoauthor=J.+C.+Xuauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Discovery+of+a+potent+grp94+selective+inhibitor+with+anti-inflammatory+efficacy+in+a+mouse+model+of+ulcerative+colitis&doi=10.1021%2Facs.jmedchem.8b00800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis</span></div><div class="casAuthors">Jiang, Fen; Guo, An-ping; Xu, Jia-chen; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9513-9533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As the endoplasmic reticulum paralog of Hsp90, Grp94 chaperones a small set of client proteins assocd. with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disorders.  Grp94-selective inhibition has been a potential therapeutic strategy for these diseases.  In this study, inspired by the conclusion that ligand-induced "Phe199 shift" effect is the structural basis of Grp94-selective inhibition, a series of novel Grp94 selective inhibitors incorporating "benzamide" moiety were developed, among which compd. I manifested the most potent Grp94 inhibitory activity with an IC50 value of 2 nM and over 1000-fold selectivity to Grp94 against Hsp90α.  In a DSS-induced mouse model of ulcerative colitis (UC), compd. I exhibited significant anti-inflammatory efficacy.  This work provides a potent Grp94 selective inhibitor as probe compd. for the biol. study of Grp94 and represents the first study that confirms the potential therapeutic efficacy of Grp94-selective inhibitors against UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSPk6ORrsg7bVg90H21EOLACvtfcHk0lhIJZ2MhxGQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSrtr7F&md5=65fa429395e1d57fc8bd6e5c51f52ccb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00800%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DA.%2BP.%26aulast%3DXu%26aufirst%3DJ.%2BC.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520grp94%2520selective%2520inhibitor%2520with%2520anti-inflammatory%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520ulcerative%2520colitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9513%26epage%3D9533%26doi%3D10.1021%2Facs.jmedchem.8b00800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobue, G.</span></span> <span> </span><span class="NLM_article-title">Modulation of hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1007/s00109-006-0066-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs00109-006-0066-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16741751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsVOku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=635-646&author=M.+Wazaauthor=H.+Adachiauthor=M.+Katsunoauthor=M.+Minamiyamaauthor=F.+Tanakaauthor=M.+Doyuauthor=G.+Sobue&title=Modulation+of+hsp90+function+in+neurodegenerative+disorders%3A+a+molecular-targeted+therapy+against+disease-causing+protein&doi=10.1007%2Fs00109-006-0066-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein</span></div><div class="casAuthors">Waza, Masahiro; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Tanaka, Fumiaki; Doyu, Manabu; Sobue, Gen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">635-646</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abnormal accumulation of disease-causing protein is a commonly obsd. characteristic in chronic neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and polyglutamine (polyQ) diseases.  A therapeutic approach that could selectively eliminate would be a promising remedy for neurodegenerative disorders.  Spinal and bulbar muscular atrophy (SBMA), one of the polyQ diseases, is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement.  The pathogenic gene product is polyQ-expanded androgen receptor (AR), which belongs to the heat shock protein (Hsp) 90 client protein family. 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a novel Hsp90 inhibitor, is a new deriv. of geldanamycin that shares its important biol. activities but shows less toxicity. 17-AAG is now in phase II clin. trials as a potential anti-cancer agent because of its ability to selectively degrade several oncoproteins.  We have recently demonstrated the efficacy and safety of 17-AAG in a mouse model of SBMA.  The administration of 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amt. of mutant AR. 17-AAG accomplished the preferential redn. of mutant AR mainly through Hsp90 chaperone complex formation and subsequent proteasome-dependent degrdn. 17-AAG induced Hsp70 and Hsp40 in vivo as previously reported; however, its ability to induce HSPs was limited, suggesting that the HSP induction might support the degrdn. of mutant protein.  The ability of 17-AAG to preferentially degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family.  Our proposed therapeutic approach, modulation of Hsp90 function by 17-AAG treatment, has emerged as a candidate for mol.-targeted therapies for neurodegenerative diseases.  This review will consider our research findings and discuss the possibility of a clin. application of 17-AAG to SBMA and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFRiB_ordSLVg90H21EOLACvtfcHk0lhIJZ2MhxGQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsVOku7k%253D&md5=c31a683263c9493c53aa448c8ea32682</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00109-006-0066-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-006-0066-0%26sid%3Dliteratum%253Aachs%26aulast%3DWaza%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DH.%26aulast%3DKatsuno%26aufirst%3DM.%26aulast%3DMinamiyama%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DF.%26aulast%3DDoyu%26aufirst%3DM.%26aulast%3DSobue%26aufirst%3DG.%26atitle%3DModulation%2520of%2520hsp90%2520function%2520in%2520neurodegenerative%2520disorders%253A%2520a%2520molecular-targeted%2520therapy%2520against%2520disease-causing%2520protein%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2006%26volume%3D84%26spage%3D635%26epage%3D646%26doi%3D10.1007%2Fs00109-006-0066-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F. F.</span></span> <span> </span><span class="NLM_article-title">Hsp90 chaperone inhibitor 17-aag attenuates abeta-induced synaptic toxicity and memory impairment</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2464</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0151-13.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1523%2FJNEUROSCI.0151-13.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24523537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlSgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=2464-2470&author=Y.+Chenauthor=B.+Wangauthor=D.+Liuauthor=J.+J.+Liauthor=Y.+Xueauthor=K.+Sakataauthor=L.+Q.+Zhuauthor=S.+A.+Heldtauthor=H.+Xuauthor=F.+F.+Liao&title=Hsp90+chaperone+inhibitor+17-aag+attenuates+abeta-induced+synaptic+toxicity+and+memory+impairment&doi=10.1523%2FJNEUROSCI.0151-13.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment</span></div><div class="casAuthors">Chen, Yaomin; Wang, Bin; Liu, Dan; Li, Jing Jing; Xue, Yueqiang; Sakata, Kazuko; Zhu, Ling-qiang; Heldt, Scott A.; Xu, Huaxi; Liao, Francesca-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2464-2470</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The excessive accumulation of sol. amyloid peptides (Aβ) plays a crucial role in the pathogenesis of Alzheimer's disease (AD), particularly in synaptic dysfunction.  The role of the two major chaperone proteins, Hsp70 and Hsp90, in clearing misfolded protein aggregates has been established.  Despite their abundant presence in synapses, the role of these chaperones in synapses remains elusive.  Here, we report that Hsp90 inhibition by 17-AAG elicited not only a heat shock-like response but also upregulated presynaptic and postsynaptic proteins, such as synapsin I, synaptophysin, and PSD95 in neurons.  17-AAG treatment enhanced high-frequency stimulation-evoked LTP and protected neurons from synaptic damage induced by sol. Aβ.  In AD transgenic mice, the daily administration of 17-AAG over 7 d resulted in a marked increase in PSD95 expression in hippocampi.  17-AAG treatments in wild-type C57BL/6 mice challenged by sol. Aβ significantly improved contextual fear memory.  Further, we demonstrate that 17-AAG activated synaptic protein expression via transcriptional mechanisms through the heat shock transcription factor HSF1.  Together, our findings identify a novel function of Hsp90 inhibition in regulating synaptic plasticity, in addn. to the known neuroprotective effects of the chaperones against Aβ and tau toxicity, thus further supporting the potential of Hsp90 inhibitors in treating neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXRaZEOCysLVg90H21EOLACvtfcHk0lhCBeet6cjLEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlSgsLc%253D&md5=44657c9c1d4f1c53484e010110e2597b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0151-13.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0151-13.2014%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DL.%2BQ.%26aulast%3DHeldt%26aufirst%3DS.%2BA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DF.%2BF.%26atitle%3DHsp90%2520chaperone%2520inhibitor%252017-aag%2520attenuates%2520abeta-induced%2520synaptic%2520toxicity%2520and%2520memory%2520impairment%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D2464%26epage%3D2470%26doi%3D10.1523%2FJNEUROSCI.0151-13.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span> <span> </span><span class="NLM_article-title">Tau in alzheimer disease and related tauopathies</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.2174/156720510793611592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F156720510793611592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20678074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1OgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=656-664&author=K.+Iqbalauthor=F.+Liuauthor=C.+X.+Gongauthor=I.+Grundke-Iqbal&title=Tau+in+alzheimer+disease+and+related+tauopathies&doi=10.2174%2F156720510793611592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tau in Alzheimer disease and related tauopathies</span></div><div class="casAuthors">Iqbal, K.; Liu, F.; Gong, C.-X.; Grundke-Iqbal, I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">656-664</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tau is the major microtubule assocd. protein (MAP) of a mature neuron.  The other two neuronal MAPs are MAP1 and MAP2.  An established function of MAPs is their interaction with tubulin and promotion of its assembly into microtubules and stabilization of the microtubule network.  The microtubule assembly promoting activity of tau, a phosphoprotein, is regulated by its degree of phosphorylation.  Normal adult human brain tau contains 2-3 mol phosphate/mol of tau protein.  Hyperphosphorylation of tau depresses this biol. activity of tau.  In Alzheimer disease (AD) brain tau is ∼three to four-fold more hyperphosphorylated than the normal adult brain tau and in this hyperphosphorylated state it is polymd. into paired helical filaments (PHF) admixed with straight filaments (SF) forming neurofibrillary tangles.  Tau is transiently hyperphosphorylated during development and during anesthesia and hypothermia but not to the same state as in AD brain.  The abnormally hyperphosphorylated tau in AD brain is distinguished from transiently hyperphosphorylated tau by its ability (1) to sequester normal tau, MAP1 and MAP2 and disrupt microtubules, and (2) to self-assemble into PHF/SF.  The cytosolic abnormally hyperphosphorylated tau, because of oligomerization, unlike normal tau, is sedimentable and on self-assembly into PHF/SF, loses its ability to sequester normal MAPs.  Some of the tau in AD brain is truncated which also promotes its self-assembly.  Tau mutations found in frontotemporal dementia apparently promote its abnormal hyperphosphorylation.  Thus, the AD abnormally hyperphosphorylated tau (1) is distinguishable from both normal and transiently hyperphosphorylated taus, and (2) is inhibitory when in a cytosolic/oligomeric state but not when it is self-assembled into PHF/SF.  Inhibition of abnormal hyperphosphorylation of tau offers a promising therapeutic target for AD and related tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzxgsQADKErbVg90H21EOLACvtfcHk0lhCBeet6cjLEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1OgtA%253D%253D&md5=0df16b447f8fc5894b84605262d2fcc1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F156720510793611592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720510793611592%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DTau%2520in%2520alzheimer%2520disease%2520and%2520related%2520tauopathies%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2010%26volume%3D7%26spage%3D656%26epage%3D664%26doi%3D10.2174%2F156720510793611592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chip, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulick, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">9511</span>– <span class="NLM_lpage">9516</span>, <span class="refDoi"> DOI: 10.1073/pnas.0701055104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.0701055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17517623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=9511-9516&author=W.+J.+Luoauthor=F.+Douauthor=A.+Rodinaauthor=S.+Chipauthor=J.+Kimauthor=Q.+Zhaoauthor=K.+Moulickauthor=J.+Aguirreauthor=N.+Wuauthor=P.+Greengardauthor=G.+Chiosis&title=Roles+of+heat-shock+protein+90+in+maintaining+and+facilitating+the+neurodegenerative+phenotype+in+tauopathies&doi=10.1073%2Fpnas.0701055104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span></div><div class="casAuthors">Luo, Wenjie; Dou, Fei; Rodina, Anna; Chip, Sophorn; Kim, Joungnam; Zhao, Qi; Moulick, Kamalika; Aguirre, Julia; Wu, Nian; Greengard, Paul; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9511-9516</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neurodegeneration, a result of multiple dysregulatory events, is a lengthy multistep process manifested by accrual of mutant variants and abnormal expression, posttranslational modification, and processing of certain proteins.  Accumulation of these dysregulated processes requires a mechanism that maintains their functional stability and allows the evolution of the neurodegenerative phenotype.  In malignant cells, the capacity to buffer transformation has been attributed to heat-shock protein 90 (Hsp90).  Although normal proteins seem to require limited assistance from the chaperone, their aberrant counterparts seem to be highly dependent on Hsp90.  Whereas enhanced Hsp90 affinity for mutated or functionally deregulated client proteins has been obsd. for several oncoproteins, it is unknown whether Hsp90 plays a similar role for neuronal proteins and thus maintains and facilitates the transformed phenotype in neurodegenerative diseases.  Tauopathies are neurodegenerative diseases characterized by aberrant phosphorylation and/or expression of Tau protein, leading to a time-dependent accumulation of Tau aggregates and subsequent neuronal death.  Here, we show that the stability of p35, a neuronal protein that activates cyclin-dependent protein kinase 5 through complex formation leading to aberrant Tau phosphorylation, and that of mutant but not WT Tau protein is maintained in tauopathies by Hsp90.  Inhibition of Hsp90 in cellular and mouse models of tauopathies leads to a redn. of the pathogenic activity of these proteins and results in elimination of aggregated Tau.  The results identify important roles played by Hsp90 in maintaining and facilitating the degenerative phenotype in these diseases and provide a common principle governing cancer and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCkJP_DiSK7Vg90H21EOLACvtfcHk0limew6dhLI2aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D&md5=232a72b98067db9340561258ebb6fcb8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701055104%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%2BJ.%26aulast%3DDou%26aufirst%3DF.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChip%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DRoles%2520of%2520heat-shock%2520protein%252090%2520in%2520maintaining%2520and%2520facilitating%2520the%2520neurodegenerative%2520phenotype%2520in%2520tauopathies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D9511%26epage%3D9516%26doi%3D10.1073%2Fpnas.0701055104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blair, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span> <span> </span><span class="NLM_article-title">Targeting hsp90 and its co-chaperones to treat alzheimer’s disease</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.943185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1517%2F14728222.2014.943185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25069659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=1219-1232&author=L.+J.+Blairauthor=J.+J.+Sabbaghauthor=C.+A.+Dickey&title=Targeting+hsp90+and+its+co-chaperones+to+treat+alzheimer%E2%80%99s+disease&doi=10.1517%2F14728222.2014.943185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease</span></div><div class="casAuthors">Blair, Laura J.; Sabbagh, Jonathan J.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1219-1232</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Alzheimer's disease, characterized by the accumulation of hyperphosphorylated tau and β amyloid (Aβ), currently lacks effective treatment.  Chaperone proteins, such as the heat shock protein (Hsp) 90, form macromol. complexes with co-chaperones, which can regulate tau metab. and Aβ processing.  Although small mol. inhibitors of Hsp90 have been successful at ameliorating tau and Aβ burden, their development into drugs to treat disease has been slow due to the off- and on-target effects of this approach as well as challenges with the pharmacol. of current scaffolds.  Thus, other approaches are being developed to improve these compds. and to target co-chaperones of Hsp90 in an effort to limit these liabilities.  This article discusses the most current developments in Hsp90 inhibitors including advances in blood-brain barrier permeability, decreased toxicity and homolog-specific small-mol. inhibitors.  In addn., we discuss current strategies targeting Hsp90 co-chaperones rather than Hsp90 itself to reduce off-target effects.  Although Hsp90 inhibitors have proven their efficacy at reducing tau pathol., they have yet to meet with success in the clinic.  The development of Hsp90/tau complex-specific inhibitors and further development of Hsp90 co-chaperone-specific drugs should yield more potent, less toxic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwfgbwFb4NDrVg90H21EOLACvtfcHk0lixqT_eyHUF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N&md5=e45b44478254d5872c355fec4e32c9d4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.943185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.943185%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DL.%2BJ.%26aulast%3DSabbagh%26aufirst%3DJ.%2BJ.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520hsp90%2520and%2520its%2520co-chaperones%2520to%2520treat%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D1219%26epage%3D1232%26doi%3D10.1517%2F14728222.2014.943185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bukong, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momen-Heravi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodys, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, G.</span></span> <span> </span><span class="NLM_article-title">Exosomes from hepatitis c infected patients transmit hcv infection and contain replication competent viral rna in complex with ago2-mir122-hsp90</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e1004424</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1004424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1371%2Fjournal.ppat.1004424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25275643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKjs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1004424&author=T.+N.+Bukongauthor=F.+Momen-Heraviauthor=K.+Kodysauthor=S.+Balaauthor=G.+Szabo&title=Exosomes+from+hepatitis+c+infected+patients+transmit+hcv+infection+and+contain+replication+competent+viral+rna+in+complex+with+ago2-mir122-hsp90&doi=10.1371%2Fjournal.ppat.1004424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90</span></div><div class="casAuthors">Bukong, Terence N.; Momen-Heravi, Fatemeh; Kodys, Karen; Bala, Shashi; Szabo, Gyongyi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1004424/1-e1004424/20, 20 pp.</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Antibodies targeting receptor-mediated entry of HCV into hepatocytes confer limited therapeutic benefits.  Evidence suggests that exosomes can transfer genetic materials between cells; however, their role in HCV infection remains obscure.  Here, we show that exosomes isolated from sera of chronic HCV infected patients or supernatants of J6/JFH1-HCV-infected Huh7.5 cells contained HCV RNA.  These exosomes could mediate viral receptor-independent transmission of HCV to hepatocytes.  Neg. sense HCV RNA, indicative of replication competent viral RNA, was present in exosomes of all HCV infected treatment non-responders and some treatment-naive individuals.  Remarkably, HCV RNA was assocd. with Ago2, HSP90 and miR-122 in exosomes isolated from HCV-infected individuals or HCV-infected Huh7.5 cell supernatants.  Exosome-loading with a miR-122 inhibitor, or inhibition of HSP90, vacuolar H+-ATPases and proton pumps, significantly suppressed exosome-mediated HCV transmission to naive cells.  Our findings provide mechanistic evidence for HCV transmission by blood-derived exosomes and highlight potential therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qlrNznUocrVg90H21EOLACvtfcHk0lgplMP517sM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKjs7jP&md5=bc46fff89c6227d7e794082819389c3e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004424%26sid%3Dliteratum%253Aachs%26aulast%3DBukong%26aufirst%3DT.%2BN.%26aulast%3DMomen-Heravi%26aufirst%3DF.%26aulast%3DKodys%26aufirst%3DK.%26aulast%3DBala%26aufirst%3DS.%26aulast%3DSzabo%26aufirst%3DG.%26atitle%3DExosomes%2520from%2520hepatitis%2520c%2520infected%2520patients%2520transmit%2520hcv%2520infection%2520and%2520contain%2520replication%2520competent%2520viral%2520rna%2520in%2520complex%2520with%2520ago2-mir122-hsp90%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26spage%3De1004424%26doi%3D10.1371%2Fjournal.ppat.1004424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braga, A. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinaga, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahal, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hepatitis c virus using sirna targeted to the virus and hsp90</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1007/s12192-016-0747-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs12192-016-0747-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27858224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2nsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=113-122&author=A.+C.+S.+Bragaauthor=B.+M.+Carneiroauthor=M.+N.+Batistaauthor=M.+M.+Akinagaauthor=P.+Rahal&title=Inhibition+of+hepatitis+c+virus+using+sirna+targeted+to+the+virus+and+hsp90&doi=10.1007%2Fs12192-016-0747-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90</span></div><div class="casAuthors">Braga, Ana Claudia Silva; Carneiro, Bruno Moreira; Batista, Mariana Nogueira; Akinaga, Monica Mayumi; Rahal, Paula</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-122</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Hepatitis C (HCV) is a viral disease affecting millions of people worldwide, and persistent HCV infection can lead to progressive liver disease with the development of liver cirrhosis and hepatocellular carcinoma.  During treatment for hepatitis C, the occurrence of viral resistance is common.  To reduce the occurrence of resistance, new viral treatments should target both viral and cellular factors.  Many interactions occur between viral and host proteins during the HCV replication cycle and might be used for the development of new therapies against hepatitis C.  Heat shock protein 90 (Hsp90) plays a role in the folding of cellular and viral proteins and also interacts with HCV proteins.  In the present study, we knocked down the expression of the Hsp90 gene and inhibited viral replication using siRNA mols.  Reducing the expression of Hsp90 successfully decreased HCV replication.  All siRNA mols. specific to the viral genome showed the efficient inhibition of viral replication, particularly siRNA targeted to the 5'UTR region.  The combination of siRNAs targeting the viral genome and Hsp90 mRNA also successfully reduced HCV replication and reduced the occurrence of viral resistance.  Moreover, these results suggest that an approach based on the combination of cellular and viral siRNAs can be used as an effective alternative for hepatitis C viral suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8TD9X35InEbVg90H21EOLACvtfcHk0liNDG0c0RD6nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2nsbnO&md5=7960f2169c1fbb19ed8560bebfc6d47e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs12192-016-0747-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-016-0747-8%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DA.%2BC.%2BS.%26aulast%3DCarneiro%26aufirst%3DB.%2BM.%26aulast%3DBatista%26aufirst%3DM.%2BN.%26aulast%3DAkinaga%26aufirst%3DM.%2BM.%26aulast%3DRahal%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520hepatitis%2520c%2520virus%2520using%2520sirna%2520targeted%2520to%2520the%2520virus%2520and%2520hsp90%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2017%26volume%3D22%26spage%3D113%26epage%3D122%26doi%3D10.1007%2Fs12192-016-0747-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, M.</span></span> <span> </span><span class="NLM_article-title">Hsp90 inhibitors suppress hcv replication in replicon cells and humanized liver mice</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.12.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbrc.2006.12.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17196931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVarsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2007&pages=882-888&author=S.+Nakagawaauthor=T.+Umeharaauthor=C.+Matsudaauthor=S.+Kugeauthor=M.+Sudohauthor=M.+Kohara&title=Hsp90+inhibitors+suppress+hcv+replication+in+replicon+cells+and+humanized+liver+mice&doi=10.1016%2Fj.bbrc.2006.12.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice</span></div><div class="casAuthors">Nakagawa, Shin-ichiro; Umehara, Takuya; Matsuda, Chiho; Kuge, Shusuke; Sudoh, Masayuki; Kohara, Michinori</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">882-888</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Persistent infection with hepatitis C virus (HCV) is a major cause of liver diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.  Here we report that inhibition of heat shock protein 90 (Hsp90) is highly effective in suppressing HCV genome replication.  In HCV replicon cells, HCV replication was reduced by Hsp90 inhibitors and by knockdown of endogenous Hsp90 expression mediated by small-interfering RNA (siRNA).  The suppression of HCV replication by an Hsp90 inhibitor was prevented by transfection with Hsp90 expression vector.  We also tested the anti-HCV effect of Hsp90 inhibition in HCV-infected chimeric mice with humanized liver.  Combined administration of an Hsp90 inhibitor and polyethylene glycol-conjugated interferon (PEG-IFN) was more effective in reducing HCV genome RNA levels in serum than was PEG-IFN monotherapy.  These results suggest that inhibition of Hsp90 could provide a new therapeutic approach to HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5RCgsdWI0bVg90H21EOLACvtfcHk0lju860z6Fwosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVarsg%253D%253D&md5=2b854778960c3929cd42117446e6f44b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.12.117%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DC.%26aulast%3DKuge%26aufirst%3DS.%26aulast%3DSudoh%26aufirst%3DM.%26aulast%3DKohara%26aufirst%3DM.%26atitle%3DHsp90%2520inhibitors%2520suppress%2520hcv%2520replication%2520in%2520replicon%2520cells%2520and%2520humanized%2520liver%2520mice%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D353%26spage%3D882%26epage%3D888%26doi%3D10.1016%2Fj.bbrc.2006.12.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maidji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, C. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of heat shock protein 90 prevents hiv rebound</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">10332</span>– <span class="NLM_lpage">10346</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.717538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M116.717538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26957545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xntlylt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=10332-10346&author=P.+Joshiauthor=E.+Maidjiauthor=C.+A.+Stoddart&title=Inhibition+of+heat+shock+protein+90+prevents+hiv+rebound&doi=10.1074%2Fjbc.M116.717538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Heat Shock Protein 90 Prevents HIV Rebound</span></div><div class="casAuthors">Joshi, Pheroze; Maidji, Ekaterina; Stoddart, Cheryl A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10332-10346</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">HIV evades eradication because transcriptionally dormant proviral genomes persist in long-lived reservoirs of resting CD4+ T cells and myeloid cells, which are the source of viral rebound after cessation of antiretroviral therapy.  Dormant HIV genomes readily produce infectious virus upon cellular activation because host transcription factors activated specifically by cell stress and heat shock mediate full-length HIV transcription.  The mol. chaperone heat shock protein 90 (Hsp90) is overexpressed during heat shock and activates inducible cellular transcription factors.  Heat shock accelerates HIV transcription through induction of Hsp90 activity, which activates essential HIV-specific cellular transcription factors (NF-κB, NFAT, and STAT5), and that inhibition of Hsp90 greatly reduces gene expression mediated by these factors.  More importantly, the authors show that Hsp90 controls virus transcription in vivo by specific Hsp90 inhibitors in clin. development, tanespimycin (17-(allylamino)-17-demethoxygeldanamycin) and AUY922, which durably prevented viral rebound in HIV-infected humanized NOD scid IL-2Rγ-/- bone marrow-liver-thymus mice up to 11 wk after treatment cessation.  Despite the absence of rebound viremia, the authors were able to recover infectious HIV from PBMC with heat shock.  Replication-competent virus was detected in spleen cells from these nonviremic Hsp90 inhibitor-treated mice, indicating the presence of a tissue reservoir of persistent infection.  The authors' novel findings provide in vivo evidence that inhibition of Hsp90 activity prevents HIV gene expression in replication-competent cellular reservoirs that would typically cause rebound in plasma viremia after antiretroviral therapy cessation.  Alternating or supplementing Hsp90 inhibitors with current antiretroviral therapy regimens could conceivably suppress rebound viremia from persistent HIV reservoirs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Yqtp1bZiQ7Vg90H21EOLACvtfcHk0lh7TFiUH8Jo6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xntlylt7Y%253D&md5=e7f7bdd1595bdca45ea85a795df8a91a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.717538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.717538%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DMaidji%26aufirst%3DE.%26aulast%3DStoddart%26aufirst%3DC.%2BA.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%252090%2520prevents%2520hiv%2520rebound%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D10332%26epage%3D10346%26doi%3D10.1074%2Fjbc.M116.717538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vashist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Hernandez, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Rougemont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha-Pereira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wobus, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, I.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperone hsp90 is a therapeutic target for noroviruses</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">6352</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1128/JVI.00315-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1128%2FJVI.00315-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25855731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFCrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=6352-6363&author=S.+Vashistauthor=L.+Urenaauthor=M.+B.+Gonzalez-Hernandezauthor=J.+Choiauthor=A.+de+Rougemontauthor=J.+Rocha-Pereiraauthor=J.+Neytsauthor=S.+Hwangauthor=C.+E.+Wobusauthor=I.+Goodfellow&title=Molecular+chaperone+hsp90+is+a+therapeutic+target+for+noroviruses&doi=10.1128%2FJVI.00315-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular chaperone Hsp90 is a therapeutic target for noroviruses</span></div><div class="casAuthors">Vashist, Surender; Urena, Luis; Gonzalez-Hernandez, Mariam B.; Choi, Jayoung; de Rougemont, Alexis; Rocha-Pereira, Joana; Neyts, Johan; Hwang, Seungmin; Wobus, Christiane E.; Goodfellow, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6352-6363</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human noroviruses (HuNoV) are a significant cause of acute gastroenteritis in the developed world, and yet our understanding of the mol. pathways involved in norovirus replication and pathogenesis has been limited by the inability to efficiently culture these viruses in the lab.  Using the murine norovirus (MNV) model, we have recently identified a network of host factors that interact with the 5' and 3' extremities of the norovirus RNA genome.  In addn. to a no. of well-known cellular RNA binding proteins, the mol. chaperone Hsp90 was identified as a component of the ribonucleoprotein complex.  Here, we show that the inhibition of Hsp90 activity neg. impacts norovirus replication in cell culture.  Small-mol.-mediated inhibition of Hsp90 activity using 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin) revealed that Hsp90 plays a pleiotropic role in the norovirus life cycle but that the stability of the viral capsid protein is integrally linked to Hsp90 activity.  Furthermore, we demonstrate that both the MNV-1 and the HuNoV capsid proteins require Hsp90 activity for their stability and that targeting Hsp90 in vivo can significantly reduce virus replication.  In summary, we demonstrate that targeting cellular proteostasis can inhibit norovirus replication, identifying a potential novel therapeutic target for the treatment of norovirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoei6xbhjVH5LVg90H21EOLACvtfcHk0lh7TFiUH8Jo6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFCrtb0%253D&md5=982eebcef72127609a4bbf9f0693fde2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FJVI.00315-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00315-15%26sid%3Dliteratum%253Aachs%26aulast%3DVashist%26aufirst%3DS.%26aulast%3DUrena%26aufirst%3DL.%26aulast%3DGonzalez-Hernandez%26aufirst%3DM.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3Dde%2BRougemont%26aufirst%3DA.%26aulast%3DRocha-Pereira%26aufirst%3DJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DWobus%26aufirst%3DC.%2BE.%26aulast%3DGoodfellow%26aufirst%3DI.%26atitle%3DMolecular%2520chaperone%2520hsp90%2520is%2520a%2520therapeutic%2520target%2520for%2520noroviruses%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D6352%26epage%3D6363%26doi%3D10.1128%2FJVI.00315-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lh7TFiUH8Jo6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembski, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georges, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbitts, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of hsp90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4606</span>– <span class="NLM_lpage">4615</span>, <span class="refDoi"> DOI: 10.1021/jm0603116</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVelurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbittsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+hsp90&doi=10.1021%2Fjm0603116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Hydroquinone Derivatives of 17-Amino-17-demethoxygeldanamycin as Potent, Water-Soluble Inhibitors of Hsp90</span></div><div class="casAuthors">Ge, Jie; Normant, Emmanuel; Porter, James R.; Ali, Janid A.; Dembski, Marlene S.; Gao, Yun; Georges, Asimina T.; Grenier, Louis; Pak, Roger H.; Patterson, Jon; Sydor, Jens R.; Tibbitts, Thomas T.; Tong, Jeffrey K.; Adams, Julian; Palombella, Vito J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4606-4615</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">17-Allylamino-17-demethoxygeldanamycin (17-AAG) is a semisynthetic inhibitor of the 90 kDa heat shock protein (Hsp90) currently in clin. trials for the treatment of cancer.  However, 17-AAG faces challenging formulation issues due to its poor soly.  Here we report the synthesis and evaluation of a highly sol. hydroquinone hydrochloride deriv. of 17-AAG, I (IPI-504), and several of the physiol. metabolites.  These compds. show comparable binding affinity to human Hsp90 and its endoplasmic reticulum (ER) homolog, the 94 kDa glucose regulated protein (Grp94).  Furthermore, the compds. inhibit the growth of the human cancer cell lines SKBR3 and SKOV3, which overexpress Hsp90 client protein Her2, and cause down-regulation of Her2 as well as induction of Hsp70 consistent with Hsp90 inhibition.  There is a clear correlation between the measured binding affinity of the compds. and their cellular activities.  Upon the basis of its potent activity against Hsp90 and a significant improvement in soly., I is currently under evaluation in Phase I clin. trials for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9IjX75MjbULVg90H21EOLACvtfcHk0lhlzFCJ-_-ZEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVelurw%253D&md5=892e372e121f75465edc6f1251e55dc6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbitts%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520hsp90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615%26doi%3D10.1021%2Fjm0603116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreras, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myles, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of novel 17-aminogeldanamycin derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5317</span>– <span class="NLM_lpage">5329</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2004.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15388159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFWlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5317-5329&author=Z.+Q.+Tianauthor=Y.+Q.+Liuauthor=D.+Zhangauthor=Z.+Wangauthor=S.+D.+Dongauthor=C.+W.+Carrerasauthor=Y.+Q.+Zhouauthor=G.+Rastelliauthor=D.+V.+Santiauthor=D.+C.+Myles&title=Synthesis+and+biological+activities+of+novel+17-aminogeldanamycin+derivatives&doi=10.1016%2Fj.bmc.2004.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of novel 17-aminogeldanamycin derivatives</span></div><div class="casAuthors">Tian, Zong-Qiang; Liu, Yaoquan; Zhang, Dan; Wang, Zhan; Dong, Steven D.; Carreras, Christopher W.; Zhou, Yiqing; Rastelli, Giulio; Santi, Daniel V.; Myles, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5317-5329</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Geldanamycin interferes with the action of heat shock protein 90 (Hsp90) by binding to the N-terminal ATP binding site and inhibiting an essential ATPase activity.  In a program directed toward finding potent, water sol. inhibitors of Hsp90, we prepd. a library of over sixty 17-alkylamino-17-demethoxygeldanamycin analogs, and compared their affinity for Hsp90, ability to inhibit growth of SKBr3 mammalian cells, and in selected cases, water soly.  Over 20 analogs showed cell growth inhibition potencies similar to that of 17-allylamino-17-demethoxygeldanamycin (17-AAG), the front-runner geldanamycin analog that is currently in multiple clin. trials.  Many of these analogs showed water soly. properties that were desirable for formulation.  One of the most potent and water-sol. analogs in the series was 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin (17-DMAG), which was independently prepd. by the NCI and will soon enter clin. trials.  Importantly, the binding affinity of these analogs to the mol. target Hsp90 does not correlate well with their cytotoxicity in SKBr3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohR8AjynvPbbVg90H21EOLACvtfcHk0lhlzFCJ-_-ZEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFWlu78%253D&md5=e550ea4739d30c069e0c14aa1b019318</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DZ.%2BQ.%26aulast%3DLiu%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DS.%2BD.%26aulast%3DCarreras%26aufirst%3DC.%2BW.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DMyles%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520novel%252017-aminogeldanamycin%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5317%26epage%3D5329%26doi%3D10.1016%2Fj.bmc.2004.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnolo, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pengelly, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D. E.</span></span> <span> </span><span class="NLM_article-title">Fragment screening using capillary electrophoresis (cefrag) for hit identification of heat shock protein 90 atpase inhibitors</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">876</span>, <span class="refDoi"> DOI: 10.1177/1087057112445785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1177%2F1087057112445785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22573733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC38nhvFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=868-876&author=C.+Austinauthor=S.+N.+Pettitauthor=S.+K.+Magnoloauthor=J.+Sanvoisinauthor=W.+J.+Chenauthor=S.+P.+Woodauthor=L.+D.+Freemanauthor=R.+J.+Pengellyauthor=D.+E.+Hughes&title=Fragment+screening+using+capillary+electrophoresis+%28cefrag%29+for+hit+identification+of+heat+shock+protein+90+atpase+inhibitors&doi=10.1177%2F1087057112445785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors</span></div><div class="casAuthors">Austin Carol; Pettit Simon N; Magnolo Sharon K; Sanvoisin Jonathan; Chen Wenjie; Wood Stephen P; Freeman Lauren D; Pengelly Reuben J; Hughes Dallas E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CEfrag is a new fragment screening technology based on affinity capillary electrophoresis (ACE).  Here we report on the development of a mobility shift competition assay using full-length human heat shock protein 90α (Hsp90α), radicicol as the competitor probe ligand, and successful screening of the Selcia fragment library.  The CEfrag assay was able to detect weaker affinity (IC(50) >500 μM) fragments than were detected by a fluorescence polarization competition assay using FITC-labeled geldanamycin.  The binding site of selected fragments was determined by co-crystallization with recombinant Hsp90α N-terminal domain and X-ray analysis.  The results of this study confirm that CEfrag is a sensitive microscale technique enabling detection of fragments binding to the biological target in near-physiological solution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQN-AvJAV98sXwOGIfWJ7-GfW6udTcc2ebBLEdwd_KPB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nhvFymsw%253D%253D&md5=1bb948cd9eccb18f828f45d9f6a3e56d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1177%2F1087057112445785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112445785%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DPettit%26aufirst%3DS.%2BN.%26aulast%3DMagnolo%26aufirst%3DS.%2BK.%26aulast%3DSanvoisin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%2BJ.%26aulast%3DWood%26aufirst%3DS.%2BP.%26aulast%3DFreeman%26aufirst%3DL.%2BD.%26aulast%3DPengelly%26aufirst%3DR.%2BJ.%26aulast%3DHughes%26aufirst%3DD.%2BE.%26atitle%3DFragment%2520screening%2520using%2520capillary%2520electrophoresis%2520%2528cefrag%2529%2520for%2520hit%2520identification%2520of%2520heat%2520shock%2520protein%252090%2520atpase%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D868%26epage%3D876%26doi%3D10.1177%2F1087057112445785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug discovery applied to hsp90. discovery of two lead series with high ligand efficiency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5942</span>– <span class="NLM_lpage">5955</span>, <span class="refDoi"> DOI: 10.1021/jm100059d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100059d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVChsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5942-5955&author=C.+W.+Murrayauthor=M.+G.+Carrauthor=O.+Callaghanauthor=G.+Chessariauthor=M.+Congreveauthor=S.+Cowanauthor=J.+E.+Coyleauthor=R.+Downhamauthor=E.+Figueroaauthor=M.+Fredericksonauthor=B.+Grahamauthor=R.+McMenaminauthor=M.+A.+O%E2%80%99Brienauthor=S.+Patelauthor=T.+R.+Phillipsauthor=G.+Williamsauthor=A.+J.+Woodheadauthor=A.+J.+Woolford&title=Fragment-based+drug+discovery+applied+to+hsp90.+discovery+of+two+lead+series+with+high+ligand+efficiency&doi=10.1021%2Fjm100059d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency</span></div><div class="casAuthors">Murray, Christopher W.; Carr, Maria G.; Callaghan, Owen; Chessari, Gianni; Congreve, Miles; Cowan, Suzanna; Coyle, Joseph E.; Downham, Robert; Figueroa, Eva; Frederickson, Martyn; Graham, Brent; McMenamin, Rachel; O'Brien, M. Alistair; Patel, Sahil; Phillips, Theresa R.; Williams, Glyn; Woodhead, Andrew J.; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5942-5955</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the chaperone Hsp90 are potentially useful as chemotherapeutic agents in cancer.  This paper describes an application of fragment screening to Hsp90 using a combination of NMR and high throughput x-ray crystallog.  The screening identified an aminopyrimidine with affinity in the high micromolar range and subsequent structure-based design allowed its optimization into a low nanomolar series with good ligand efficiency.  A phenolic chemotype was also identified in fragment screening and was found to bind with affinity close to 1 mM.  This fragment was optimized using structure based design into a resorcinol lead which has subnanomolar affinity for Hsp90, excellent cell potency, and good ligand efficiency.  This fragment to lead campaign improved affinity for Hsp90 by over 1,000,000 fold with the addn. of only 6 heavy atoms.  The companion paper (DOI: 10.1021/jm100060b) describes how the resorcinol lead was optimized into a compd. that is now in clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqISC3cw2labbVg90H21EOLACvtfcHk0ligztMxrZeT_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVChsb0%253D&md5=d1ad900aa5a45ba6ba3a5e9ccdcd96b3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm100059d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100059d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DT.%2BR.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520applied%2520to%2520hsp90.%2520discovery%2520of%2520two%2520lead%2520series%2520with%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5942%26epage%3D5955%26doi%3D10.1021%2Fjm100059d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angove, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (at13387), a novel inhibitor of the molecular chaperone hsp90 by fragment based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5969</span>, <span class="refDoi"> DOI: 10.1021/jm100060b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5956-5969&author=A.+J.+Woodheadauthor=H.+Angoveauthor=M.+G.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=J.+E.+Coyleauthor=J.+Cosmeauthor=B.+Grahamauthor=P.+J.+Dayauthor=R.+Downham&title=Discovery+of+%282%2C4-dihydroxy-5-isopropylphenyl%29-%5B5-%284-methylpiperazin-1-ylmethyl%29-1%2C3-dihydroisoindol-2-yl%5Dmethanone+%28at13387%29%2C+a+novel+inhibitor+of+the+molecular+chaperone+hsp90+by+fragment+based+drug+design&doi=10.1021%2Fjm100060b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design</span></div><div class="casAuthors">Woodhead, Andrew J.; Angove, Hayley; Carr, Maria G.; Chessari, Gianni; Congreve, Miles; Coyle, Joseph E.; Cosme, Jose; Graham, Brent; Day, Philip J.; Downham, Robert; Fazal, Lynsey; Feltell, Ruth; Figueroa, Eva; Frederickson, Martyn; Lewis, Jonathan; McMenamin, Rachel; Murray, Christopher W.; O'Brien, M. Alistair; Parra, Lina; Patel, Sahil; Phillips, Theresa; Rees, David C.; Rich, Sharna; Smith, Donna-Michelle; Trewartha, Gary; Vinkovic, Mladen; Williams, Brian; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5956-5969</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the mol. chaperone heat shock protein 90 (Hsp90) are currently generating significant interest in clin. development as potential treatments for cancer.  In a preceding publication (DOI: 10.1021/jm100059d) we describe Astex's approach to screening fragments against Hsp90 and the subsequent optimization of two hits into leads with inhibitory activities in the low nanomolar range.  This paper describes the structure guided optimization of the 2,4-dihydroxybenzamide lead mol. 1 and details some of the drug discovery strategies employed in the identification of AT13387 (35), which has progressed through preclin. development and is currently being tested in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEtcgAmkVk7Vg90H21EOLACvtfcHk0li5ZxYcnKvP6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D&md5=a2d2ac6dd9e9ba4cb89f83c32727a1d8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100060b%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DAngove%26aufirst%3DH.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDownham%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520%25282%252C4-dihydroxy-5-isopropylphenyl%2529-%255B5-%25284-methylpiperazin-1-ylmethyl%2529-1%252C3-dihydroisoindol-2-yl%255Dmethanone%2520%2528at13387%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520molecular%2520chaperone%2520hsp90%2520by%2520fragment%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5956%26epage%3D5969%26doi%3D10.1021%2Fjm100060b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornilayev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development and optimization of a useful assay for determining hsp90’s inherent atpase activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1134</span>– <span class="NLM_lpage">1142</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2005.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16213144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1134-1142&author=C.+Avilaauthor=B.+A.+Kornilayevauthor=B.+S.+J.+Blagg&title=Development+and+optimization+of+a+useful+assay+for+determining+hsp90%E2%80%99s+inherent+atpase+activity&doi=10.1016%2Fj.bmc.2005.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity</span></div><div class="casAuthors">Avila, Christopher; Kornilayev, Boris A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1134-1142</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Hsp90 mol. chaperone is responsible for the conformational maturation of nascent polypeptides and the rematuration of denatured proteins.  Inhibition of Hsp90 represents a promising approach towards the treatment of cancer because numerous signaling cascades can be simultaneously targeted by disruption of the Hsp90-mediated process.  Hsp90's ATPase activity is essential to the Hsp90-mediated protein folding process, consequently, a coupled assay was developed and optimized for detn. of Hsp90's inherent ATPase activity.  Using maltose phosphorylase, glucose oxidase, and horseradish peroxidase as components of this assay, a highly reproducible assay with a Z-factor of 0.87 has been produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88K6sLLHnXLVg90H21EOLACvtfcHk0liVRNQaAtbmGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFKqsA%253D%253D&md5=6232dbd8f0ca74406d452f750e699b33</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DC.%26aulast%3DKornilayev%26aufirst%3DB.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520and%2520optimization%2520of%2520a%2520useful%2520assay%2520for%2520determining%2520hsp90%25E2%2580%2599s%2520inherent%2520atpase%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1134%26epage%3D1142%26doi%3D10.1016%2Fj.bmc.2005.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornilayev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening for hsp90 atpase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3005</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2006.02.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16530412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFygtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3005-3008&author=C.+Avilaauthor=M.+K.+Haddenauthor=Z.+Maauthor=B.+A.+Kornilayevauthor=Q.+Z.+Yeauthor=B.+S.+J.+Blagg&title=High-throughput+screening+for+hsp90+atpase+inhibitors&doi=10.1016%2Fj.bmcl.2006.02.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening for Hsp90 ATPase inhibitors</span></div><div class="casAuthors">Avila, Christopher; Hadden, M. Kyle; Ma, Zeqiang; Kornilayev, Boris A.; Ye, Qi-Zhuang; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3005-3008</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently, we reported a useful assay for the detn. of yeast Hsp90 ATPase activity.  Using this assay, high-throughput screening of ∼10,000 compds. was performed to det. the feasibility of this assay on large scale.  Results from high-throughput screening indicated that the assay was reproducible (av Z-factor = 0.80) and identified 0.57% of the compds. as Hsp90 inhibitors that exhibited IC50s less than 20 μM.  The structures of several of these inhibitory scaffolds are reported along with their IC50 values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8dqs3sRASxLVg90H21EOLACvtfcHk0liVRNQaAtbmGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFygtLk%253D&md5=37fa7d6df613df74e75c85098fd84ec5</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.063%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DC.%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DKornilayev%26aufirst%3DB.%2BA.%26aulast%3DYe%26aufirst%3DQ.%2BZ.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DHigh-throughput%2520screening%2520for%2520hsp90%2520atpase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3005%26epage%3D3008%26doi%3D10.1016%2Fj.bmcl.2006.02.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcdonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Novel, potent small-molecule inhibitors of the molecular chaperone hsp90 discovered through structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4212</span>– <span class="NLM_lpage">4215</span>, <span class="refDoi"> DOI: 10.1021/jm050355z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050355z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4212-4215&author=B.+W.+Dymockauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=A.+Masseyauthor=E.+Mcdonaldauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=S.+D.+Roughleyauthor=P.+Webb&title=Novel%2C+potent+small-molecule+inhibitors+of+the+molecular+chaperone+hsp90+discovered+through+structure-based+design&doi=10.1021%2Fjm050355z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design</span></div><div class="casAuthors">Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, Andrew; McDonald, Edward; Hubbard, Roderick E.; Surgenor, Allan; Roughley, Stephen D.; Webb, Paul; Workman, Paul; Wright, Lisa; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4212-4215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of a previously reported screening hit 1 (CCT018159) bound to the N terminal domain of mol. chaperone Hsp90 has been used to design 5-amide analogs.  These exhibit enhanced potency against the target in binding and functional assays with accompanying appropriate cellular pharmacodynamic changes.  Compd. 11 (VER-49009) compares favorably with the clin. evaluated 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR4ICeTnHxbVg90H21EOLACvtfcHk0liVRNQaAtbmGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D&md5=3a854d5f6fd1eb0e292292b2a8d22401</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm050355z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050355z%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMcdonald%26aufirst%3DE.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DWebb%26aufirst%3DP.%26atitle%3DNovel%252C%2520potent%2520small-molecule%2520inhibitors%2520of%2520the%2520molecular%2520chaperone%2520hsp90%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4212%26epage%3D4215%26doi%3D10.1021%2Fjm050355z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgognoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">4,5-Diarylisoxazole hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1021/jm701018h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+Daviesauthor=M.+J.+Drysdale&title=4%2C5-Diarylisoxazole+hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1021%2Fjm701018h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></div><div class="casAuthors">Brough, Paul A.; Aherne, Wynne; Barril, Xavier; Borgognoni, Jennifer; Boxall, Kathy; Cansfield, Julie E.; Cheung, Kwai-Ming J.; Collins, Ian; Davies, Nicholas G. M.; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Finch, Harry; Fink, Alexandra; Hayes, Angela; Howes, Robert; Hubbard, Roderick E.; James, Karen; Jordan, Allan M.; Lockie, Andrea; Martins, Vanessa; Massey, Andrew; Matthews, Thomas P.; McDonald, Edward; Northfield, Christopher J.; Pearl, Laurence H.; Prodromou, Chrisostomos; Ray, Stuart; Raynaud, Florence I.; Roughley, Stephen D.; Sharp, Swee Y.; Surgenor, Allan; Walmsley, D. Lee; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 [heat shock protein 90] mol. chaperone show considerable promise as potential chemotherapeutic agents for cancer.  The structure-based design, synthesis, structure-activity relationships, and pharmacokinetics of potent small-mol. inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold were studied.  Analogs from this series have high affinity for Hsp90, as measured in a fluorescence polarization competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  The [(morpholinomethyl)phenyl]isoxazolecarboxamide I (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM.  I is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice.  In a human colon cancer xenograft model, I inhibits tumor growth by ∼50%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNA9AoWb8gLVg90H21EOLACvtfcHk0lgXUN25Bra6iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK&md5=fdb98dec600987e862b9b05555427948</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3D4%252C5-Diarylisoxazole%2520hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218%26doi%3D10.1021%2Fjm701018h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherfaoui, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of novel hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2014.03.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24763261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=399-412&author=H.+P.+Sunauthor=J.+M.+Jiaauthor=F.+Jiangauthor=X.+L.+Xuauthor=F.+Liuauthor=X.+K.+Guoauthor=B.+Cherfaouiauthor=H.+Z.+Huangauthor=Y.+Panauthor=Q.+D.+You&title=Identification+and+optimization+of+novel+hsp90+inhibitors+with+tetrahydropyrido%5B4%2C3-d%5Dpyrimidines+core+through+shape-based+screening&doi=10.1016%2Fj.ejmech.2014.03.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening</span></div><div class="casAuthors">Sun, Hao-Peng; Jia, Jian-Min; Jiang, Fen; Xu, Xiao-Li; Liu, Fang; Guo, Xiao-Ke; Cherfaoui, Bahidja; Huang, Hao-Ze; Pan, Yang; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">399-412</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Rapid Overlay of Chem. Structures (ROCS), which can rapidly identify potentially active compds. by shape comparison, is recognized as a powerful virtual screening tool.  By ROCS, a class of novel Hsp90 inhibitors was identified.  The authors report prepn. of a series of tetrahydropyrido[4,3-d]pyrimidines.  Over 100-fold improvement was achieved in the target-based assay.  The most potent compd. 57h(I) inhibited Hsp90 with IC50 0.10 ± 0.01 μM.  It also showed much improved cell potency and ligand efficiency.  The authors' study showed that ROCS is efficient in the identification of novel cores of Hsp90 inhibitors. I can be ideal leads for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsUgCLHRAhcbVg90H21EOLACvtfcHk0lgXUN25Bra6iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWntrc%253D&md5=f446bf48db3534f77dbdb8cbeec894c7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%2BP.%26aulast%3DJia%26aufirst%3DJ.%2BM.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DCherfaoui%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DH.%2BZ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%2520hsp90%2520inhibitors%2520with%2520tetrahydropyrido%255B4%252C3-d%255Dpyrimidines%2520core%2520through%2520shape-based%2520screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D399%26epage%3D412%26doi%3D10.1016%2Fj.ejmech.2014.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Novel tetrahydropyrido[4,3-d]pyrimidines as potent inhibitors of chaperone heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10498</span>– <span class="NLM_lpage">10519</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00912</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00912" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVehs7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10498-10519&author=F.+Jiangauthor=H.+J.+Wangauthor=Y.+H.+Jinauthor=Q.+Zhangauthor=Z.+H.+Wangauthor=J.+M.+Jiaauthor=F.+Liuauthor=L.+Wangauthor=Q.+C.+Baoauthor=D.+D.+Liauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Novel+tetrahydropyrido%5B4%2C3-d%5Dpyrimidines+as+potent+inhibitors+of+chaperone+heat+shock+protein+90&doi=10.1021%2Facs.jmedchem.6b00912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90</span></div><div class="casAuthors">Jiang, Fen; Wang, Hui-Jie; Jin, Yu-Hui; Zhang, Qiong; Wang, Zhi-Hui; Jia, Jian-Min; Liu, Fang; Wang, Lei; Bao, Qi-Chao; Li, Dong-Dong; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10498-10519</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat-shock protein 90 (Hsp90) is a potential target for oncol. therapeutics.  Some inhibitors have shown anti-tumor effects in clin. trials, spurring the discovery of small-mol. Hsp90 inhibitors.  Here, the authors describe the structural optimization studies of a hit compd., tetrahydropyrido[4,3-d]pyrimidine-based Hsp90 inhibitor, which exhibits inhibitory activity against Hsp90.  A series of analogs were synthesized, and their structure-activity relationships and structure-property relationships were analyzed.  These explorations led to the discovery of compd. 73 ((2,4-dihydroxy-5-isopropylphenyl)(4-(ethylamino)-2-(2-methoxyethoxy)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)methanone), which exhibited potent in vitro activities, good physicochem. properties, favorable ADME properties and potent anti-tumor effect in an HCT116 xenograft model.  Furthermore, 73 exhibited no ocular toxicity in a rat retinal damage model, suggesting it is a relatively safe Hsp90 inhibitor.  As a promising anti-tumor agent, 73 was progressed for further pre-clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhftxgoZ3blLVg90H21EOLACvtfcHk0lgXUN25Bra6iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVehs7nF&md5=d3ab4651aa7d68854edf7c0b6e712ee2</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DJia%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DLi%26aufirst%3DD.%2BD.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DNovel%2520tetrahydropyrido%255B4%252C3-d%255Dpyrimidines%2520as%2520potent%2520inhibitors%2520of%2520chaperone%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10498%26epage%3D10519%26doi%3D10.1021%2Facs.jmedchem.6b00912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of n-(5-chloro-2,4-dihydroxybenzoyl)-(r)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel hsp90 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2016.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27266997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWnsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=272-282&author=C.+Liangauthor=H.+Haoauthor=X.+Wuauthor=Z.+Liauthor=J.+Zhuauthor=C.+Luauthor=Y.+Shen&title=Design+and+synthesis+of+n-%285-chloro-2%2C4-dihydroxybenzoyl%29-%28r%29-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxamides+as+novel+hsp90+inhibitors&doi=10.1016%2Fj.ejmech.2016.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors</span></div><div class="casAuthors">Liang, Chuanpeng; Hao, Huilin; Wu, Xingkang; Li, Zhenyu; Zhu, Jing; Lu, Chunhua; Shen, Yuemao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">272-282</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein, the design and synthesis of two series of novel compd. I and II [ R= NHMe, NHEt, NH-i-pr etc. ] as Hsp90 inhibitors using (S)-Tic (1,2,3,4-tetrahydroisoquinoline-3- carboxylic acid) (A1-13) and (R)-Tic (B1-13) as scaffold, resp. was reported.  Cellular thermal shift assay (CETSA) screening showed that compds. II with (R)-Tic scaffold exhibited potent ability to stabilize Hsp90α.  Compd. II [ R = NHBn ] showed not only the most potent ability to induce thermal stabilization of Hsp90α but also the strongest cytotoxicity.  The IC50 values of compd. II [ R = NHBn ] were 0.98 μM and 1.74 μM against the proliferation of human breast cancer MDA-MB-231 and human cervical cancer HeLa cell lines, resp.  Moreover, CETSA melt and ITDRFCETSA (isothermal dose-response fingerprint) curves confirmed that Compd. II [ R = NHBn ] bound to Hsp90α in 293T cells.  Western blotting results indicated that compd. II [ R = NHBn ] induced the degrdn. of Hsp90 clients CDK4, Her2, Cdc-2 and C-raf.  In addn., docking and Mol. dynamics (MD) refinement of the B7-Hsp90 complex showed that the binding model of compd. II [ R = NHBn ] to Hsp90 was similar with that of 8-benzyladenines.  The overall properties warrant compd. II [ R = NHBn ] a promising lead for the development of Hsp90 inhibitor antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRchNM19rw7Vg90H21EOLACvtfcHk0lgHmDNwDcZCAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWnsrfE&md5=d93ac271d1cd78c83a44d093b0d8347f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520n-%25285-chloro-2%252C4-dihydroxybenzoyl%2529-%2528r%2529-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxamides%2520as%2520novel%2520hsp90%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D272%26epage%3D282%26doi%3D10.1016%2Fj.ejmech.2016.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatorska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llauger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1021/jm0508078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Z.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+H.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90&doi=10.1021%2Fjm0508078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0lgHmDNwDcZCAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%2BZ.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390%26doi%3D10.1021%2Fjm0508078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zifcak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atoyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DellaRocca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span> <span> </span><span class="NLM_article-title">Cudc-305, a novel synthetic hsp90 inhibitor with unique pharmacologic properties for cancer therapy</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4046</span>– <span class="NLM_lpage">4057</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-0152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-09-0152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19509149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=4046-4057&author=R.+Baoauthor=C.+J.+Laiauthor=H.+Quauthor=D.+Wangauthor=L.+Yinauthor=B.+Zifcakauthor=R.+Atoyanauthor=J.+Wangauthor=M.+Samsonauthor=J.+Forresterauthor=S.+DellaRoccaauthor=G.+X.+Xuauthor=X.+Taoauthor=H.+X.+Zhaiauthor=X.+Caiauthor=C.+Qian&title=Cudc-305%2C+a+novel+synthetic+hsp90+inhibitor+with+unique+pharmacologic+properties+for+cancer+therapy&doi=10.1158%2F1078-0432.CCR-09-0152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy</span></div><div class="casAuthors">Bao, Rudi; Lai, Cheng-Jung; Qu, Hui; Wang, Dagong; Yin, Ling; Zifcak, Brian; Atoyan, Ruzanna; Wang, Jing; Samson, Maria; Forrester, Jeffrey; Della Rocca, Steven; Xu, Guang-Xin; Tao, Xu; Zhai, Hai-Xiao; Cai, Xiong; Qian, Changgeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4046-4057</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We designed and synthesized CUDC-305, an HSP90 inhibitor of the novel imidazopyridine class.  Here, we report its unique pharmacol. properties and antitumor activities in a variety of tumor types.  The potency of the compd. was analyzed by fluorescence polarization competition binding assay.  Its antiproliferative activities were assessed in 40 human cancer cell lines.  Its pharmacol. properties and antitumor activities were evaluated in a variety of tumor xenograft models.  CUDC-305 shows high affinity for HSP90α/β (IC50, ∼100 nmol/L) and HSP90 complex derived from cancer cells (IC50, 48.8 nmol/L).  It displays potent antiproliferative activity against a broad range of cancer cell lines (mean IC50, 220 nmol/L).  CUDC-305 exhibits high oral bioavailability (96.0%) and selective retention in tumor (half-life, 20.4 h) compared with normal tissues.  Furthermore, CUDC-305 can cross blood-brain barrier and reach therapeutic levels in brain tissue.  CUDC-305 exhibits dose-dependent antitumor activity in an s.c. xenograft model of U87MG glioblastoma and significantly prolongs animal survival in U87MG orthotopic model.  CUDC-305 also displays potent antitumor activity in animal models of erlotinib-resistant non-small cell lung cancer and induces tumor regression in animal models of MDA-MB-468 breast cancer and MV4-11 acute myelogenous leukemia.  Correlating with its efficacy in these various tumor models, CUDC-305 robustly inhibits multiple signaling pathways, including PI3K/AKT and RAF/MEK/ERK, and induces apoptosis.  In combination studies, CUDC-305 enhances the antitumor activity of std.-of-care agents in breast and colorectal tumor models.  CUDC-305 is a promising drug candidate for the treatment of a variety of cancers, including brain malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxsZpWkM4MrVg90H21EOLACvtfcHk0lge1y1rWCtypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D&md5=b872c7658a2fc98f263f7e6a23cb58f6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-0152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-0152%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DC.%2BJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DZifcak%26aufirst%3DB.%26aulast%3DAtoyan%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSamson%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DDellaRocca%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%2BX.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.%2BX.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DCudc-305%252C%2520a%2520novel%2520synthetic%2520hsp90%2520inhibitor%2520with%2520unique%2520pharmacologic%2520properties%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D4046%26epage%3D4057%26doi%3D10.1158%2F1078-0432.CCR-09-0152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tangallapally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovitz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenderovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimbora, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yager, K. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of (2s)-1-[4-(2-{6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9h-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (mpc-3100), a purine-based hsp90 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7480</span>– <span class="NLM_lpage">7501</span>, <span class="refDoi"> DOI: 10.1021/jm3004619</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3004619" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1CisrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7480-7501&author=S.+H.+Kimauthor=A.+Bajjiauthor=R.+Tangallapallyauthor=B.+Markovitzauthor=R.+Trovatoauthor=M.+Shenderovichauthor=V.+Baichwalauthor=P.+Bartelauthor=D.+Cimboraauthor=R.+McKinnonauthor=R.+Robinsonauthor=D.+Papacauthor=D.+Wettsteinauthor=R.+Carlsonauthor=K.+M.+Yager&title=Discovery+of+%282s%29-1-%5B4-%282-%7B6-amino-8-%5B%286-bromo-1%2C3-benzodioxol-5-yl%29sulfanyl%5D-9h-purin-9-yl%7Dethyl%29piperidin-1-yl%5D-2-hydroxypropan-1-one+%28mpc-3100%29%2C+a+purine-based+hsp90+inhibitor&doi=10.1021%2Fjm3004619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor</span></div><div class="casAuthors">Kim, Se-Ho; Bajji, Ashok; Tangallapally, Rajendra; Markovitz, Benjamin; Trovato, Richard; Shenderovich, Mark; Baichwal, Vijay; Bartel, Paul; Cimbora, Daniel; McKinnon, Rena; Robinson, Rosann; Papac, Damon; Wettstein, Daniel; Carlson, Robert; Yager, Kraig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7480-7501</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis.  This has spurred the search for small-mol. Hsp90 inhibitors.  Here we describe our lead optimization studies centered on the purine-based Hsp90 inhibitor 28a (I; R = CHO) contg. a piperidine moiety at the purine N9 position.  In this study, key SAR was established for the piperidine N-substituent and for the congeners of the 1,3-benzodioxole at C8.  These efforts led to the identification of orally bioavailable 28g [I; R = (S)-2-hydroxypropanoyl] that exhibits good in vitro profiles and a characteristic mol. biomarker signature of Hsp90 inhibition both in vitro and in vivo.  Favorable pharmacokinetic properties along with significant antitumor effects in multiple human cancer xenograft models led to the selection of 28g (MPC-3100) as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0VPSOwHXnrVg90H21EOLACvtfcHk0lge1y1rWCtypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1CisrbO&md5=ea005d78eb1be66625d8b237fed14be1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm3004619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3004619%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBajji%26aufirst%3DA.%26aulast%3DTangallapally%26aufirst%3DR.%26aulast%3DMarkovitz%26aufirst%3DB.%26aulast%3DTrovato%26aufirst%3DR.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DBartel%26aufirst%3DP.%26aulast%3DCimbora%26aufirst%3DD.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DPapac%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DD.%26aulast%3DCarlson%26aufirst%3DR.%26aulast%3DYager%26aufirst%3DK.%2BM.%26atitle%3DDiscovery%2520of%2520%25282s%2529-1-%255B4-%25282-%257B6-amino-8-%255B%25286-bromo-1%252C3-benzodioxol-5-yl%2529sulfanyl%255D-9h-purin-9-yl%257Dethyl%2529piperidin-1-yl%255D-2-hydroxypropan-1-one%2520%2528mpc-3100%2529%252C%2520a%2520purine-based%2520hsp90%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7480%26epage%3D7501%26doi%3D10.1021%2Fjm3004619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgognoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chene, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padfield, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radimerski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmonite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walls, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span> <span> </span><span class="NLM_article-title">Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the hsp90 molecular chaperone</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4794</span>– <span class="NLM_lpage">4809</span>, <span class="refDoi"> DOI: 10.1021/jm900357y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900357y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4794-4809&author=P.+A.+Broughauthor=X.+Barrilauthor=J.+Borgognoniauthor=P.+Cheneauthor=N.+G.+Daviesauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=C.+Garcia-Echeverriaauthor=C.+Fromontauthor=A.+Hayesauthor=R.+E.+Hubbardauthor=A.+M.+Jordanauthor=M.+R.+Jensenauthor=A.+Masseyauthor=A.+Merrettauthor=A.+Padfieldauthor=R.+Parsonsauthor=T.+Radimerskiauthor=F.+I.+Raynaudauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=H.+Simmoniteauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=M.+Valentiauthor=S.+Wallsauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=Combining+hit+identification+strategies%3A+fragment-based+and+in+silico+approaches+to+orally+active+2-aminothieno%5B2%2C3-d%5Dpyrimidine+inhibitors+of+the+hsp90+molecular+chaperone&doi=10.1021%2Fjm900357y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Brough, Paul A.; Barril, Xavier; Borgognoni, Jenifer; Chene, Patrick; Davies, Nicholas G. M.; Davis, Ben; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Garcia-Echeverria, Carlos; Fromont, Christophe; Hayes, Angela; Hubbard, Roderick E.; Jordan, Allan M.; Jensen, Michael Rugaard; Massey, Andrew; Merrett, Angela; Padfield, Antony; Parsons, Rachel; Radimerski, Thomas; Raynaud, Florence I.; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Simmonite, Heather; Sharp, Swee Y.; Surgenor, Allan; Valenti, Melanie; Walls, Steven; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4794-4809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing considerable promise as potential mol. therapeutic agents for the treatment of cancer.  Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallog.  Examples from this series have high affinity (IC50 = 50-100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  Several compds. caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofpAier7tW7Vg90H21EOLACvtfcHk0lifwhVg90QomA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D&md5=4d1988060b0f87dc776e1972ea14808e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWalls%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DCombining%2520hit%2520identification%2520strategies%253A%2520fragment-based%2520and%2520in%2520silico%2520approaches%2520to%2520orally%2520active%25202-aminothieno%255B2%252C3-d%255Dpyrimidine%2520inhibitors%2520of%2520the%2520hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4794%26epage%3D4809%26doi%3D10.1021%2Fjm900357y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X. J.</span></span> <span> </span><span class="NLM_article-title">A time-resolved fluorescence resonance energy transfer-based hts assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ab.2004.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15265741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2004&pages=349-357&author=V.+Zhouauthor=S.+L.+Hanauthor=A.+Brinkerauthor=H.+Klockauthor=J.+Caldwellauthor=X.+J.+Gu&title=A+time-resolved+fluorescence+resonance+energy+transfer-based+hts+assay+and+a+surface+plasmon+resonance-based+binding+assay+for+heat+shock+protein+90+inhibitors&doi=10.1016%2Fj.ab.2004.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors</span></div><div class="casAuthors">Zhou, Vicki; Han, Shulin; Brinker, Achim; Klock, Heath; Caldwell, Jeremy; Gu, Xiang-ju</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-357</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an ATP-dependent mol. chaperone required for the stability and function of a no. of client proteins, many of which are involved in cancer development.  The natural products geldanamycin (GM) and radicicol (RD) are known inhibitors of Hsp90, and their derivs. are being developed for the treatment of various cancers.  To identify novel Hsp90 inhibitors, a highly robust time-resolved fluorescence resonance energy transfer (TR-FRET)-based HTS assay that measures the binding of biotinylated geldanamycin (biotin-GM) to the His-tagged human Hsp90 N-terminal ATP-binding domain (Hsp90N) was developed.  This assay was optimized in 1536-well plates and was used as the primary assay to screen 106 compds.  Identified "hits" were then confirmed in a scintillation proximity assay (SPA) and a DEAE membrane-based assay for [3H]AAG binding to Hsp90.  In addn., a surface plasmon resonance (SPR) assay that measures the direct interaction of Hsp90 with its inhibitors was developed and used to further characterize the identified inhibitors.  Several potent and reversible inhibitors of human Hsp90 with Kd values measured in the high nanomolar range were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB9HPTahQVyrVg90H21EOLACvtfcHk0lifwhVg90QomA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVWjurk%253D&md5=93bbfc42bc8e7bd1a08a07706b9a687b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DS.%2BL.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DKlock%26aufirst%3DH.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.%2BJ.%26atitle%3DA%2520time-resolved%2520fluorescence%2520resonance%2520energy%2520transfer-based%2520hts%2520assay%2520and%2520a%2520surface%2520plasmon%2520resonance-based%2520binding%2520assay%2520for%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D331%26spage%3D349%26epage%3D357%26doi%3D10.1016%2Fj.ab.2004.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bussenius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcalas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowles, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhr, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFina, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lougheed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manalo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womble, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of xl888: a novel tropane-derived small molecule inhibitor of hsp90</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5396</span>– <span class="NLM_lpage">5404</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2012.07.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22877636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5396-5404&author=J.+Busseniusauthor=C.+M.+Blazeyauthor=N.+Aayauthor=N.+K.+Anandauthor=A.+Arcalasauthor=T.+Baikauthor=O.+J.+Bowlesauthor=C.+A.+Buhrauthor=S.+Costanzoauthor=J.+K.+Curtisauthor=S.+C.+DeFinaauthor=L.+Dubenkoauthor=T.+S.+Heuerauthor=P.+Huangauthor=C.+Jaegerauthor=A.+Joshiauthor=A.+R.+Kennedyauthor=A.+I.+Kimauthor=K.+Laraauthor=J.+Leeauthor=J.+Liauthor=J.+C.+Lougheedauthor=S.+Maauthor=S.+Malekauthor=J.+C.+Manaloauthor=J.+F.+Martiniauthor=G.+McGrathauthor=M.+Nicollauthor=J.+M.+Nussauthor=M.+Packauthor=C.+J.+Petoauthor=T.+H.+Tsangauthor=L.+Wangauthor=S.+W.+Wombleauthor=M.+Yakesauthor=W.+Zhangauthor=K.+D.+Rice&title=Discovery+of+xl888%3A+a+novel+tropane-derived+small+molecule+inhibitor+of+hsp90&doi=10.1016%2Fj.bmcl.2012.07.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90</span></div><div class="casAuthors">Bussenius, Joerg; Blazey, Charles M.; Aay, Naing; Anand, Neel K.; Arcalas, Arlyn; Baik, TaeGon; Bowles, Owen J.; Buhr, Chris A.; Costanzo, Simona; Curtis, Jeffrey K.; DeFina, Steven C.; Dubenko, Larisa; Heuer, Timothy S.; Huang, Ping; Jaeger, Christopher; Joshi, Anagha; Kennedy, Abigail R.; Kim, Angie I.; Lara, Katherine; Lee, Jae; Li, Jonathan; Lougheed, Julie C.; Ma, Sunghoon; Malek, Shiva; Manalo, Jean-Claire L.; Martini, Jean-Francois; McGrath, Garth; Nicoll, Monique; Nuss, John M.; Pack, Michael; Peto, Csaba J.; Tsang, Tsze H.; Wang, Longcheng; Womble, Scott W.; Yakes, Michael; Zhang, Wentao; Rice, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5396-5404</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With structural guidance, tropane-derived HTS hits were modified to optimize for HSP90 inhibition and a desirable in vivo profile.  Through an iterative SAR development process 12i [I; X = cyclopropyl, R1 = Me, R2 = (R)-sec-Bu, XL888] was discovered and shown to reduce HSP90 client protein content in PD studies.  Furthermore, efficacy expts. performed in a NCI-N87 mouse xenograft model demonstrated tumor regression in some dosing regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYT__qJeDg0rVg90H21EOLACvtfcHk0lifwhVg90QomA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL&md5=d62d69690c1f80ae0489a6a1350f2abe</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DBussenius%26aufirst%3DJ.%26aulast%3DBlazey%26aufirst%3DC.%2BM.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DAnand%26aufirst%3DN.%2BK.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DBowles%26aufirst%3DO.%2BJ.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DCostanzo%26aufirst%3DS.%26aulast%3DCurtis%26aufirst%3DJ.%2BK.%26aulast%3DDeFina%26aufirst%3DS.%2BC.%26aulast%3DDubenko%26aufirst%3DL.%26aulast%3DHeuer%26aufirst%3DT.%2BS.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DA.%2BI.%26aulast%3DLara%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLougheed%26aufirst%3DJ.%2BC.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DManalo%26aufirst%3DJ.%2BC.%26aulast%3DMartini%26aufirst%3DJ.%2BF.%26aulast%3DMcGrath%26aufirst%3DG.%26aulast%3DNicoll%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DPack%26aufirst%3DM.%26aulast%3DPeto%26aufirst%3DC.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWomble%26aufirst%3DS.%2BW.%26aulast%3DYakes%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRice%26aufirst%3DK.%2BD.%26atitle%3DDiscovery%2520of%2520xl888%253A%2520a%2520novel%2520tropane-derived%2520small%2520molecule%2520inhibitor%2520of%2520hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5396%26epage%3D5404%26doi%3D10.1016%2Fj.bmcl.2012.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzamide tetrahydro-4h-carbazol-4-ones as novel small molecule inhibitors of hsp90</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3517</span>– <span class="NLM_lpage">3521</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2008.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18511277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3517-3521&author=T.+E.+Bartaauthor=J.+M.+Vealauthor=J.+W.+Riceauthor=J.+M.+Partridgeauthor=R.+P.+Faddenauthor=W.+Maauthor=M.+Jenksauthor=L.+Gengauthor=G.+J.+Hansonauthor=K.+H.+Huangauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=J.+Ottoauthor=S.+E.+Hall&title=Discovery+of+benzamide+tetrahydro-4h-carbazol-4-ones+as+novel+small+molecule+inhibitors+of+hsp90&doi=10.1016%2Fj.bmcl.2008.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90</span></div><div class="casAuthors">Barta, Thomas E.; Veal, James M.; Rice, John W.; Partridge, Jeffrey M.; Fadden, R. Patrick; Ma, Wei; Jenks, Matthew; Geng, Lifeng; Hanson, Gunnar J.; Huang, Kenneth H.; Barabasz, Amy F.; Foley, Briana E.; Otto, James; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3517-3521</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp90 maintains the conformational stability of multiple proteins implicated in oncogenesis and has emerged as a target for chemotherapy.  We report here the discovery of a novel small mol. scaffold that inhibits Hsp90.  X-ray data show that the scaffold binds competitively at the ATP site on Hsp90.  Cellular proliferation and client assays demonstrate that members of the series are able to inhibit Hsp90 at nanomolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC-Wjx_IUjKbVg90H21EOLACvtfcHk0lhuUpkXJXpfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D&md5=f965e9a2cfd0d44a57bb1949cd87de63</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520benzamide%2520tetrahydro-4h-carbazol-4-ones%2520as%2520novel%2520small%2520molecule%2520inhibitors%2520of%2520hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3517%26epage%3D3521%26doi%3D10.1016%2Fj.bmcl.2008.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4288</span>– <span class="NLM_lpage">4305</span>, <span class="refDoi"> DOI: 10.1021/jm900230j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective+and+orally+active+antitumor+agents&doi=10.1021%2Fjm900230j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0lhuUpkXJXpfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305%26doi%3D10.1021%2Fjm900230j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins</span>. <i>J. Natl. Cancer. Inst.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1093/jnci/92.3.242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1093%2Fjnci%2F92.3.242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10655441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFShsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=242-248&author=M.+G.+Marcuauthor=T.+W.+Schulteauthor=L.+Neckers&title=Novobiocin+and+related+coumarins+and+depletion+of+heat+shock+protein+90-dependent+signaling+proteins&doi=10.1093%2Fjnci%2F92.3.242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins</span></div><div class="casAuthors">Marcu, Monica G.; Schulte, Theodore W.; Neckers, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">242-248</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) interacts with and stabilizes several oncogenic protein kinases (e.g., p185erbB2, p60v-src, and Raf-1) and is required for the stability and dominant-neg. function of mutated p53 protein.  Two unrelated antibiotics, geldanamycin and radicicol, bind specifically to an atypical nucleotide-binding pocket of Hsp90, a site that shares homol. with the ATP-binding domain of bacterial DNA gyrase B.  This interaction leads to destabilization of proteins that interact with Hsp90.  Since the nucleotide-binding site of gyrase B is targeted by coumarin antibiotics (e.g., novobiocin), we investigated whether these drugs can also interact with Hsp90 and affect its activity.  We used immobilized novobiocin, geldanamycin, or radicicol to isolate either endogenous Hsp90 from cell lysates or Hsp90 deletion fragments translated in vitro.  Effects of the coumarin antibiotics novobiocin, chlorobiocin, and coumermycin A1 on several proteins interacting with Hsp90 were assessed in vitro and in vivo.  Hsp90 binding to immobilized novobiocin was competed by sol. coumarins and ATP but not by geldanamycin or radicicol.  A carboxy-terminal Hsp90 fragment bound immobilized novobiocin but not immobilized geldanamycin, while a geldanamycin-binding amino-terminal fragment did not bind novobiocin.  All three coumarins markedly reduced cellular levels of p185erbB2, p60v-src, Raf-1, and mutated p53.  Furthermore, novobiocin reduced Raf-1 levels in the spleens of mice treated with the drug.  These coumarin antibiotics, particularly novobiocin, represent a first-generation alternative to other Hsp90-targeting drugs that are not as well tolerated.  Novobiocin's unique interaction with Hsp90 identifies an addnl. site on this protein amenable to pharmacol. interference with small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSMDAYykmhSbVg90H21EOLACvtfcHk0lhuUpkXJXpfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFShsbk%253D&md5=05873d976f0d6a3e721576732e580ff2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.3.242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.3.242%26sid%3Dliteratum%253Aachs%26aulast%3DMarcu%26aufirst%3DM.%2BG.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DNovobiocin%2520and%2520related%2520coumarins%2520and%2520depletion%2520of%2520heat%2520shock%2520protein%252090-dependent%2520signaling%2520proteins%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D242%26epage%3D248%26doi%3D10.1093%2Fjnci%2F92.3.242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhouche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L. M.</span></span> <span> </span><span class="NLM_article-title">The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized atp-binding domain in the carboxyl terminus of the chaperone</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">37181</span>– <span class="NLM_lpage">37186</span>, <span class="refDoi"> DOI: 10.1074/jbc.M003701200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M003701200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10945979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslWlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=37181-37186&author=M.+G.+Marcuauthor=A.+Chadliauthor=I.+Bouhoucheauthor=M.+Catelliauthor=L.+M.+Neckers&title=The+heat+shock+protein+90+antagonist+novobiocin+interacts+with+a+previously+unrecognized+atp-binding+domain+in+the+carboxyl+terminus+of+the+chaperone&doi=10.1074%2Fjbc.M003701200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone</span></div><div class="casAuthors">Marcu, Monica G.; Chadli, Ahmed; Bouhouche, Ilham; Catelli, Maria; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">37181-37186</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90), one of the most abundant chaperones in eukaryotes, participates in folding and stabilization of signal-transducing mols. including steroid hormone receptors and protein kinases.  The amino terminus of Hsp90 contains a non-conventional nucleotide-binding site, related to the ATP-binding motif of bacterial DNA gyrase.  The anti-tumor agents geldanamycin and radicicol bind specifically at this site and induce destabilization of Hsp90-dependent client proteins.  We recently demonstrated that the gyrase inhibitor novobiocin also interacts with Hsp90, altering the affinity of the chaperone for geldanamycin and radicicol and causing in vitro and in vivo depletion of key regulatory Hsp90-dependent kinases including v-Src, Raf-1, and p185ErbB2.  In the present study we used deletion/mutation anal. to identify the site of interaction of novobiocin with Hsp90, and we demonstrate that the novobiocin-binding site resides in the carboxyl terminus of the chaperone.  Surprisingly, this motif also recognizes ATP, and ATP and novobiocin efficiently compete with each other for binding to this region of Hsp90.  Novobiocin interferes with assocn. of the co-chaperones Hsc70 and p23 with Hsp90.  These results identify a second site on Hsp90 where the binding of small mol. inhibitors can significantly impact the function of this chaperone, and they support the hypothesis that both amino- and carboxyl-terminal domains of Hsp90 interact to modulate chaperone activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYmW6Q8h7j4LVg90H21EOLACvtfcHk0lijHUvIzTjjjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslWlt7s%253D&md5=837ade0878a635b98abd82a0bcf83cee</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003701200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003701200%26sid%3Dliteratum%253Aachs%26aulast%3DMarcu%26aufirst%3DM.%2BG.%26aulast%3DChadli%26aufirst%3DA.%26aulast%3DBouhouche%26aufirst%3DI.%26aulast%3DCatelli%26aufirst%3DM.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520heat%2520shock%2520protein%252090%2520antagonist%2520novobiocin%2520interacts%2520with%2520a%2520previously%2520unrecognized%2520atp-binding%2520domain%2520in%2520the%2520carboxyl%2520terminus%2520of%2520the%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D37181%26epage%3D37186%26doi%3D10.1074%2Fjbc.M003701200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawgo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vielhauer, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajewski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. D.</span></span> <span> </span><span class="NLM_article-title">Ku135, a novel novobiocin-derived c-terminal inhibitor of the 90-kda heat shock protein, exerts potent antiproliferative effects in human leukemic cells</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1314</span>– <span class="NLM_lpage">1322</span>, <span class="refDoi"> DOI: 10.1124/mol.109.058545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1124%2Fmol.109.058545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19741006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFajtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=1314-1322&author=S.+N.+Sheltonauthor=M.+E.+Shawgoauthor=S.+B.+Matthewsauthor=Y.+M.+Luauthor=A.+C.+Donnellyauthor=K.+Szablaauthor=M.+Tanolauthor=G.+A.+Vielhauerauthor=R.+A.+Rajewskiauthor=R.+L.+Mattsauthor=B.+S.+J.+Blaggauthor=J.+D.+Robertson&title=Ku135%2C+a+novel+novobiocin-derived+c-terminal+inhibitor+of+the+90-kda+heat+shock+protein%2C+exerts+potent+antiproliferative+effects+in+human+leukemic+cells&doi=10.1124%2Fmol.109.058545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells</span></div><div class="casAuthors">Shelton, Shary N.; Shawgo, Mary E.; Matthews, Shawna B.; Lu, Yuanming; Donnelly, Alison C.; Szabla, Kristen; Tanol, Mehmet; Vielhauer, George A.; Rajewski, Roger A.; Matts, Robert L.; Blagg, Brian S. J.; Robertson, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1314-1322</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The 90-kDa heat shock protein (Hsp90) assists in the proper folding of numerous mutated or overexpressed signal transduction proteins that are involved in cancer.  Consequently, there is considerable interest in developing chemotherapeutic drugs that specifically disrupt the function of Hsp90.  Here, we investigated the extent to which a novel novobiocin-derived C-terminal Hsp90 inhibitor, designated KU135, induced antiproliferative effects in Jurkat T-lymphocytes.  The results indicated that KU135 bound directly to Hsp90, caused the degrdn. of known Hsp90 client proteins, and induced more potent antiproliferative effects than the established N-terminal Hsp90 inhibitor 17-allylamino-demethoxygeldanamycin (17-AAG).  Closer examn. of the cellular response to KU135 and 17-AAG revealed that only 17-AAG induced a strong up-regulation of Hsp70 and Hsp90.  In addn., KU135 caused wild-type cells to undergo G2/M arrest, whereas cells treated with 17-AAG accumulated in G1.  Furthermore, KU135 but not 17-AAG was found to be a potent inducer of mitochondria-mediated apoptosis as evidenced, in part, by the fact that cell death was inhibited to a similar extent by Bcl-2/Bcl-xL overexpression or the depletion of apoptotic protease-activating factor-1 (Apaf-1).  Together, these data suggest that KU135 inhibits cell proliferation by regulating signaling pathways that are mechanistically different from those targeted by 17-AAG and as such represents a novel opportunity for Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnRfCmPO43irVg90H21EOLACvtfcHk0lijHUvIzTjjjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFajtbzK&md5=03fe82110c457194b6a58a9222ffaeac</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.058545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.058545%26sid%3Dliteratum%253Aachs%26aulast%3DShelton%26aufirst%3DS.%2BN.%26aulast%3DShawgo%26aufirst%3DM.%2BE.%26aulast%3DMatthews%26aufirst%3DS.%2BB.%26aulast%3DLu%26aufirst%3DY.%2BM.%26aulast%3DDonnelly%26aufirst%3DA.%2BC.%26aulast%3DSzabla%26aufirst%3DK.%26aulast%3DTanol%26aufirst%3DM.%26aulast%3DVielhauer%26aufirst%3DG.%2BA.%26aulast%3DRajewski%26aufirst%3DR.%2BA.%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BD.%26atitle%3DKu135%252C%2520a%2520novel%2520novobiocin-derived%2520c-terminal%2520inhibitor%2520of%2520the%252090-kda%2520heat%2520shock%2520protein%252C%2520exerts%2520potent%2520antiproliferative%2520effects%2520in%2520human%2520leukemic%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D76%26spage%3D1314%26epage%3D1322%26doi%3D10.1124%2Fmol.109.058545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girgis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of biphenylamide derivatives as hsp90 c-terminal inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2014.10.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25462258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOjtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=442-466&author=H.+P.+Zhaoauthor=G.+Gargauthor=J.+B.+Zhaoauthor=E.+Moroniauthor=A.+Girgisauthor=L.+S.+Francoauthor=S.+Singhauthor=G.+Colomboauthor=B.+S.+J.+Blagg&title=Design%2C+synthesis+and+biological+evaluation+of+biphenylamide+derivatives+as+hsp90+c-terminal+inhibitors&doi=10.1016%2Fj.ejmech.2014.10.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors</span></div><div class="casAuthors">Zhao, Huiping; Garg, Gaurav; Zhao, Jinbo; Moroni, Elisabetta; Girgis, Antwan; Franco, Lucas S.; Singh, Swapnil; Colombo, Giorgio; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">442-466</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Modulation of Hsp90 C-terminal function represents a promising therapeutic approach for the treatment of cancer and neurodegenerative diseases.  Current drug discovery efforts toward Hsp90 C-terminal inhibition focus on novobiocin, an antibiotic that was transformed into an Hsp90 inhibitor.  Based on structural information obtained during the development of novobiocin derivs. and mol. docking studies, scaffolds contg. a biphenyl moiety in lieu of the coumarin ring present in novobiocin were identified as new Hsp90 C-terminal inhibitors.  Structure-activity relationship studies produced new derivs. that inhibit the proliferation of breast cancer cell lines at nanomolar concns., which corresponded directly with Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriNBiJ3-nN5bVg90H21EOLACvtfcHk0lhzNkQm9ZmfXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOjtr7P&md5=db84a45153f85cfce09c8c2a7487f93d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.034%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%2BP.%26aulast%3DGarg%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DJ.%2BB.%26aulast%3DMoroni%26aufirst%3DE.%26aulast%3DGirgis%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DL.%2BS.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DG.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520biphenylamide%2520derivatives%2520as%2520hsp90%2520c-terminal%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D442%26epage%3D466%26doi%3D10.1016%2Fj.ejmech.2014.10.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent hsp90 c-terminal inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2017.07.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29028527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=1-14&author=F.+Jiangauthor=A.+P.+Guoauthor=J.+C.+Xuauthor=H.+J.+Wangauthor=X.+F.+Moauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Identification+and+optimization+of+novel+6-acylamino-2-aminoquinolines+as+potent+hsp90+c-terminal+inhibitors&doi=10.1016%2Fj.ejmech.2017.07.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent Hsp90 C-terminal inhibitors</span></div><div class="casAuthors">Jiang, Fen; Guo, An-ping; Xu, Jia-cheng; Wang, Hui-Jie; Mo, Xiao-fei; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In order to discover novel Hsp90 inhibitors targeting the C-terminal ATP binding pocket, a novobiocin deriv. based ROCS model was constructed for virtual screening.  Compd. I was identified as the lead compd. and then a systematical structure activity relationship (SAR) study was conducted.  These efforts led to compd. II, which exhibited potent anti-proliferative activities against MCF7 and SKBr3 breast cancer cell lines.  In 4T1 mice breast cancer models, II exhibited potent tumor growth inhibition and anti-metastasis effect.  Compd. II as a potent antitumor agent targeting the Hsp90 C-terminal is worthy of further pre-clin. study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqd_QoafcBbVg90H21EOLACvtfcHk0lhzNkQm9ZmfXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvJ&md5=01389c6f8957dc81c124051127410ecb</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.080%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DA.%2BP.%26aulast%3DXu%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DMo%26aufirst%3DX.%2BF.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%25206-acylamino-2-aminoquinolines%2520as%2520potent%2520hsp90%2520c-terminal%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D1%26epage%3D14%26doi%3D10.1016%2Fj.ejmech.2017.07.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazici, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for depletion of heat shock protein 90 client proteins by deguelin</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1093/jnci/djm007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1093%2Fjnci%2Fdjm007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17565155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVaqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2007&pages=949-961&author=S.+H.+Ohauthor=J.+K.+Wooauthor=Y.+D.+Yaziciauthor=J.+N.+Myersauthor=W.+Y.+Kimauthor=Q.+Jinauthor=S.+S.+Hongauthor=H.+J.+Parkauthor=Y.+G.+Suhauthor=K.+W.+Kimauthor=W.+K.+Hongauthor=H.+Y.+Lee&title=Structural+basis+for+depletion+of+heat+shock+protein+90+client+proteins+by+deguelin&doi=10.1093%2Fjnci%2Fdjm007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for depletion of heat shock protein 90 client proteins by deguelin</span></div><div class="casAuthors">Oh, Seung Hyun; Woo, Jong Kyu; Yazici, Yasemin Dakak; Myers, Jeffrey N.; Kim, Woo-Young; Jin, Quanri; Hong, Soon Sun; Park, Hyun-Ju; Suh, Young-Ger; Kim, Kyu-Won; Hong, Waun Ki; Lee, Ho-Young</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">949-961</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background The mol. chaperone heat shock protein 90 (Hsp90) participates in preserving the expression and activity of various oncoproteins, including hypoxia-inducible factor 1α (HIF-1α) and Akt.  Deguelin is a rotenoid with antitumor activities.  We investigated whether the antitumor activities of deguelin involve the functional inhibition of Hsp90.  Method Human xenograft tumors were generated in mice from H1299 (n = 6 per group) and A549 (n = 4 per group) non-small-cell lung cancer cells, UMSCC38 (n = 5 per group) head and neck cancer cells, MKN45 (n = 5 per group) stomach cancer cells, and PC-3 (n = 3 per group) prostate cancer cells.  Tumor-bearing mice were treated with deguelin at 4 or 8 mg/kg or with vehicle (as a control) twice a day by oral gavage for 15-28 days.  Protein expression was assessed by western blot anal.  Akt and Hsp90 were assessed by use of adenoviral vectors expressing constitutively active Akt or Hsp90.  Binding of deguelin to Hsp90 was examd. by docking anal. and by competition binding expts. with ATP-Sepharose beads.  The proteasome inhibitor MG132 was used to investigate deguelin's effect on the induction of ubiquitin-mediated proteasomal degrdn. of HIF-1α.  All statistical tests were two-sided.  Results Deguelin bound to the ATP-binding pocket of Hsp90 and disrupted Hsp90 function, leading to ubiquitin-mediated degrdn. of HIF-1α.  Administration of deguelin to xenograft-bearing mice statistically significantly decreased tumor growth by inducing apoptosis and decreasing the expression of Hsp90 client proteins, without detectable toxic effects.  For example, at 15 days after the start of deguelin treatment, the vol. of untreated control H1299 xenograft tumors was 798 mm3 and that of xenograft tumors treated with deguelin at 4 mg/kg was 115.9 mm3 (difference = 682.1 mm3, 95% confidence interval = 480.4 to 883.9 mm3; P<.001).  Conclusions The antitumor activities of deguelin appear to involve its binding to the ATP-binding pocket of Hsp90, which suppresses Hsp90 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq0Ge16pQ-y7Vg90H21EOLACvtfcHk0lhzNkQm9ZmfXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVaqtrY%253D&md5=4bd7e522dc30d92a136556d171a7dbf3</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjm007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjm007%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%2BH.%26aulast%3DWoo%26aufirst%3DJ.%2BK.%26aulast%3DYazici%26aufirst%3DY.%2BD.%26aulast%3DMyers%26aufirst%3DJ.%2BN.%26aulast%3DKim%26aufirst%3DW.%2BY.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DSuh%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DHong%26aufirst%3DW.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BY.%26atitle%3DStructural%2520basis%2520for%2520depletion%2520of%2520heat%2520shock%2520protein%252090%2520client%2520proteins%2520by%2520deguelin%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2007%26volume%3D99%26spage%3D949%26epage%3D961%26doi%3D10.1093%2Fjnci%2Fdjm007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (hsp90) inhibitors targeting proliferation and angiogenesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10863</span>– <span class="NLM_lpage">10884</span>, <span class="refDoi"> DOI: 10.1021/jm301488q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301488q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10863-10884&author=D.+J.+Changauthor=H.+Anauthor=K.+S.+Kimauthor=H.+H.+Kimauthor=J.+Jungauthor=J.+M.+Leeauthor=N.+J.+Kimauthor=Y.+T.+Hanauthor=H.+Yunauthor=S.+Leeauthor=G.+Leeauthor=S.+Leeauthor=J.+S.+Leeauthor=J.+H.+Chaauthor=J.+H.+Parkauthor=J.+W.+Parkauthor=S.+C.+Leeauthor=S.+G.+Kimauthor=J.+H.+Kimauthor=H.+Y.+Leeauthor=K.+W.+Kimauthor=Y.+G.+Suh&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+deguelin-based+heat+shock+protein+90+%28hsp90%29+inhibitors+targeting+proliferation+and+angiogenesis&doi=10.1021%2Fjm301488q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis</span></div><div class="casAuthors">Chang, Dong-Jo; An, Hongchan; Kim, Kyoung-suk; Kim, Hyun Ho; Jung, Jinkyung; Lee, Jung Min; Kim, Nam-Jung; Han, Young Taek; Yun, Hwayoung; Lee, Sujin; Lee, Geumwoo; Lee, Seungbeom; Lee, Ju Sung; Cha, Jong-Ho; Park, Ji-Hyeon; Park, Ji Won; Lee, Su-Chan; Kim, Sang Geon; Kim, Jeong Hun; Lee, Ho-Young; Kim, Kyu-Won; Suh, Young-Ger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10863-10884</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deguelin exhibits potent apoptotic and antiangiogenic activities in a variety of transformed cells and cancer cells.  Deguelin also exhibits potent tumor suppressive effects in xenograft tumor models for many human cancers.  Our initial studies confirmed that deguelin disrupts ATP binding to HSP90 and consequently induces destabilization of its client proteins such as HIF-1α.  Interestingly, a fluorescence probe assay revealed that deguelin and its analogs do not compete with ATP binding to the N-terminus of HSP90, unlike most HSP90 inhibitors.  To det. the key parts of deguelin that contribute to its potent HSP90 inhibition, as well as its antiproliferative and antiangiogenic activities, we have established a structure-activity relationship (SAR) of deguelin.  In the course of these studies, we identified a series of novel and potent HSP90 inhibitors.  In particular, analogs 54 and 69, the B- and C-ring-truncated compds., exhibited excellent antiproliferative activities with IC50 of 140 and 490 nM in the H1299 cell line, resp., and antiangiogenic activities in zebrafish embryos in a dose dependent manner (0.25-1.25 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonMGujwNaDpLVg90H21EOLACvtfcHk0lhErxzF0l15yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgsbvF&md5=d997eea48c1301b19830f6f7c41f3747</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm301488q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301488q%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DD.%2BJ.%26aulast%3DAn%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BH.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DN.%2BJ.%26aulast%3DHan%26aufirst%3DY.%2BT.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DSuh%26aufirst%3DY.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520deguelin-based%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520inhibitors%2520targeting%2520proliferation%2520and%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10863%26epage%3D10884%26doi%3D10.1021%2Fjm301488q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seong, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of a novel deguelin derivative, l80, which disrupts atp binding to the c-terminal domain of heat shock protein 90</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1124/mol.114.096883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1124%2Fmol.114.096883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25976766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaqsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=245-255&author=S.+C.+Leeauthor=H.+Y.+Minauthor=H.+Choiauthor=H.+S.+Kimauthor=K.+C.+Kimauthor=S.+J.+Parkauthor=M.+A.+Seongauthor=J.+H.+Seoauthor=H.+J.+Parkauthor=Y.+G.+Suhauthor=K.+W.+Kimauthor=H.+S.+Hongauthor=H.+Kimauthor=M.+Y.+Leeauthor=J.+Leeauthor=H.+Y.+Lee&title=Synthesis+and+evaluation+of+a+novel+deguelin+derivative%2C+l80%2C+which+disrupts+atp+binding+to+the+c-terminal+domain+of+heat+shock+protein+90&doi=10.1124%2Fmol.114.096883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a novel deguelin derivative, L80, which disrupts ATP binding to the C-terminal domain of heat shock protein 90</span></div><div class="casAuthors">Lee, Su-Chan; Min, Hye-Young; Choi, Hoon; Kim, Ho Shin; Kim, Kyong-Cheol; Park, So-Jung; Seong, Myeong A.; Seo, Ji Hae; Park, Hyun-Ju; Suh, Young-Ger; Kim, Kyu-Won; Hong, Hyun-Seok; Kim, Hee; Lee, Min-Young; Lee, Jeewoo; Lee, Ho-Young</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The clin. benefit of current anticancer regimens for lung cancer therapy is still limited due to moderate efficacy, drug resistance, and recurrence.  Therefore, the development of effective anticancer drugs for first-line therapy and for optimal second-line treatment is necessary.  Because the 90-kDa mol. chaperone heat shock protein (Hsp90) contributes to the maturation of numerous mutated or overexpressed oncogenic proteins, targeting Hsp90 may offer an effective anticancer therapy.  Here, we investigated antitumor activities and toxicity of a novel deguelin-derived C-terminal Hsp90 inhibitor, designated L80.  L80 displayed significant inhibitory effects on the viability, colony formation, angiogenesis-stimulating activity, migration, and invasion of a panel of non-small cell lung cancer cell lines and their sublines with acquired resistance to paclitaxel with minimal toxicity to normal lung epithelial cells, hippocampal cells, vascular endothelial cells, and ocular cells.  Biochem. analyses and mol. docking simulation revealed that L80 disrupted Hsp90 function by binding to the C-terminal ATP-binding pocket of Hsp90, leading to the disruption of the interaction between hypoxia-inducible factor (HIF)-1α and Hsp90, downregulation of HIF-1α and its target genes, including vascular endothelial growth factor (VEGF) and insulin-like growth factor 2 (IGF2), and decreased the expression of various Hsp90 client proteins.  Consistent with these in vitro findings, L80 exhibited significant antitumor and antiangiogenic activities in H1299 xenograft tumors.  These results suggest that L80 represents a novel C-terminal Hsp90 inhibitor with effective anticancer activities with minimal toxicities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxzKLGllhTD7Vg90H21EOLACvtfcHk0lhErxzF0l15yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaqsbnO&md5=e7a2f4f64cce715e19ffd9393f88cd1a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.096883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.096883%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DMin%26aufirst%3DH.%2BY.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DSeong%26aufirst%3DM.%2BA.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DSuh%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DM.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DH.%2BY.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520deguelin%2520derivative%252C%2520l80%252C%2520which%2520disrupts%2520atp%2520binding%2520to%2520the%2520c-terminal%2520domain%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D245%26epage%3D255%26doi%3D10.1124%2Fmol.114.096883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasiewicz, T. A.</span></span> <span> </span><span class="NLM_article-title">(−)-Epigallocatechin-3-gallate is a novel hsp90 inhibitor</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/bi801637q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801637q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVA%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=336-345&author=Z.+Y.+Yinauthor=E.+C.+Henryauthor=T.+A.+Gasiewicz&title=%28%E2%88%92%29-Epigallocatechin-3-gallate+is+a+novel+hsp90+inhibitor&doi=10.1021%2Fbi801637q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">(-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor</span></div><div class="casAuthors">Yin, Zhengyu; Henry, Ellen C.; Gasiewicz, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">336-345</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea, protects against certain types of cancers, although the mechanism has not yet been detd.  It was previously demonstrated that EGCG blocks aryl hydrocarbon receptor (AhR)-mediated transcription induced by the potent carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).  Unlike other AhR antagonists that directly bind to the AhR, EGCG inhibits AhR-mediated transcription by binding to hsp90.  We hypothesize that EGCG exerts anti-AhR and anticancer effects by acting as an hsp90 inhibitor.  Using proteolytic footprinting, immunopptn., and an ATP-agarose pull-down assay, EGCG was found to directly modulate the conformation of hsp90 and bind at or near to a C-terminal ATP binding site.  Hsp90 chaperone function, as assessed by its ability to mediate refolding of denatured luciferase, was inhibited by EGCG treatment.  Hsp90 dimerization, which occurs at the C-terminal end, was also inhibited by EGCG treatment.  Coimmunopptn. studies showed that EGCG stabilizes an AhR complex that includes hsp90 and XAP2 (hepatitis B virus X-assocd. protein 2), and decreases the assocn. of aryl hydrocarbon nuclear translocator (Arnt) with ligand-activated AhR.  Thus, EGCG, through its ability to bind to hsp90, blocks AhR response element (AhRE) recognition.  These studies indicate a novel mechanism whereby EGCG inhibits ligand-induced AhRE binding and AhR-mediated transcriptional activity.  In EGCG-treated human ovarian carcinoma SKOV3 cells, decreased levels of several cancer-related hsp90 client proteins, such as ErbB2, Raf-1 and phospho-AKT, were obsd.  EGCG also modified the assocn. of hsp90 with several cochaperones.  Overall, these data indicate that EGCG is a novel hsp90 inhibitor.  Further studies are needed to det. if this has a role in the antitumor actions of EGCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJtTASUyiNZLVg90H21EOLACvtfcHk0lhErxzF0l15yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVA%253D&md5=f68a174c84abfa0c7513e1d1125721dd</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fbi801637q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801637q%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DZ.%2BY.%26aulast%3DHenry%26aufirst%3DE.%2BC.%26aulast%3DGasiewicz%26aufirst%3DT.%2BA.%26atitle%3D%2528%25E2%2588%2592%2529-Epigallocatechin-3-gallate%2520is%2520a%2520novel%2520hsp90%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D336%26epage%3D345%26doi%3D10.1021%2Fbi801637q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasiewicz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotella, D. P.</span></span> <span> </span><span class="NLM_article-title">Towards the discovery of drug-like epigallocatechin gallate analogs as hsp90 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2263</span>– <span class="NLM_lpage">2266</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2014.03.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24745965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVWgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2263-2266&author=R.+Bhatauthor=A.+T.+Adamauthor=J.+J.+Leeauthor=T.+A.+Gasiewiczauthor=E.+C.+Henryauthor=D.+P.+Rotella&title=Towards+the+discovery+of+drug-like+epigallocatechin+gallate+analogs+as+hsp90+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Adam, Amna T.; Lee, Jungeun Jasmine; Gasiewicz, Thomas A.; Henry, Ellen C.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2263-2266</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">(-)-Epigallocatechin gallate (EGCG) is the major flavonoid of green tea and has been widely explored for a range of biol. activities including anti-infective, anti-inflammatory, anticancer, and neuroprotection.  Existing structure-activity data for EGCG has been largely limited to exploration of simple ethers and hydroxyl deletion.  EGCG has poor drug-like properties because of multiple phenolic hydroxyl moieties and a metabolically labile ester.  This work reports a substantial expansion of structure-activity understanding by exploring a range of semi-synthetic and synthetic derivs. with ester replacements and variously substituted arom. and alicyclic groups contg. more drug-like substituents.  Structure-activity relationships for these mols. were obtained for Hsp90 inhibition.  The results indicate that amide and sulfonamide linkers are suitable ester replacements.  Hydroxylated arom. rings and the cis-stereochem. in EGCG are not essential for Hsp90 inhibition.  Selected analogs in this series are more potent than EGCG in a luciferase refolding assay for Hsp90 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOuaPPZjVk-7Vg90H21EOLACvtfcHk0liOpIsGOOYvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVWgs7s%253D&md5=4398fa70ba76afc9c19e155259cf2cd6</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.088%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DAdam%26aufirst%3DA.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DGasiewicz%26aufirst%3DT.%2BA.%26aulast%3DHenry%26aufirst%3DE.%2BC.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DTowards%2520the%2520discovery%2520of%2520drug-like%2520epigallocatechin%2520gallate%2520analogs%2520as%2520hsp90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2263%26epage%3D2266%26doi%3D10.1016%2Fj.bmcl.2014.03.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of derrubone and select analogues</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1021/jo702366g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo702366g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOntb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=369-373&author=J.+M.+Hastingsauthor=M.+K.+Haddenauthor=B.+S.+J.+Blagg&title=Synthesis+and+evaluation+of+derrubone+and+select+analogues&doi=10.1021%2Fjo702366g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Derrubone and Select Analogues</span></div><div class="casAuthors">Hastings, Jedidiah M.; Hadden, M. Kyle; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-373</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, we reported that the natural product derrubone (I) exhibits Hsp90 inhibitory activity.  Due to its unique architectural scaffold and proposed rapid assembly, the synthesis of this natural product was pursued with the aim of identifying structure-activity relationships.  Synthesis of the natural product was accomplished in eight highly convergent steps, which led to a facile method for the construction of related compds.  Biol. evaluation of derrubone and its analogs identified several compds. that exhibit low micromolar inhibitory activity against breast and colon cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy5GrygGbgkbVg90H21EOLACvtfcHk0liOpIsGOOYvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOntb3P&md5=5a121ce4c7369c2e7091373745ef4916</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjo702366g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo702366g%26sid%3Dliteratum%253Aachs%26aulast%3DHastings%26aufirst%3DJ.%2BM.%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520derrubone%2520and%2520select%2520analogues%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D369%26epage%3D373%26doi%3D10.1021%2Fjo702366g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Identification and initial sar of silybin: an hsp90 inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2659</span>– <span class="NLM_lpage">2664</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2010.12.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21273068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFKitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2659-2664&author=H.+Zhaoauthor=G.+E.+Brandtauthor=L.+Galamauthor=R.+L.+Mattsauthor=B.+S.+J.+Blagg&title=Identification+and+initial+sar+of+silybin%3A+an+hsp90+inhibitor&doi=10.1016%2Fj.bmcl.2010.12.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and initial SAR of silybin: An Hsp90 inhibitor</span></div><div class="casAuthors">Zhao, Huiping; Brandt, Gary E.; Galam, Lakshmi; Matts, Robert L.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2659-2664</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Through Hsp90-dependent firefly luciferase refolding and Hsp90-dependent heme-regulated eIF2α kinase (HRI) activation assays, silybin was identified as a novel Hsp90 inhibitor.  Subsequently, a library of silybin analogs was designed, synthesized and evaluated.  Initial SAR studies identified the essential, non-essential and detrimental functionalities on silybin that contribute to Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt94Ogk4uDwLVg90H21EOLACvtfcHk0liOpIsGOOYvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFKitro%253D&md5=e4b5fe0694f91b55cb3d017a1c475d0f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.088%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DBrandt%26aufirst%3DG.%2BE.%26aulast%3DGalam%26aufirst%3DL.%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DIdentification%2520and%2520initial%2520sar%2520of%2520silybin%253A%2520an%2520hsp90%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2659%26epage%3D2664%26doi%3D10.1016%2Fj.bmcl.2010.12.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voruganti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhivker, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Elucidation of the hsp90 c-terminal inhibitor binding site</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.1021/cb200052x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200052x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=800-807&author=R.+L.+Mattsauthor=A.+Dixitauthor=L.+B.+Petersonauthor=L.+Sunauthor=S.+Vorugantiauthor=P.+Kalyanaramanauthor=S.+D.+Hartsonauthor=G.+M.+Verkhivkerauthor=B.+S.+J.+Blagg&title=Elucidation+of+the+hsp90+c-terminal+inhibitor+binding+site&doi=10.1021%2Fcb200052x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site</span></div><div class="casAuthors">Matts, Robert L.; Dixit, Anshuman; Peterson, Laura B.; Sun, Liang; Voruganti, Sudhakar; Kalyanaraman, Palgunan; Hartson, Steve D.; Verkhivker, Gennady M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">800-807</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Hsp90 chaperone machine is required for the folding, activation, and/or stabilization of more than 50 proteins directly related to malignant progression.  Hsp90 contains small mol. binding sites at both its N- and C-terminal domains; however, limited structural and biochem. data regarding the C-terminal binding site is available.  In this report, the small mol. binding site in the Hsp90 C-terminal domain was revealed by protease fingerprinting and photoaffinity labeling utilizing LC-MS/MS.  The identified site was characterized by generation of a homol. model for hHsp90α using the SAXS open structure of HtpG and docking the bioactive conformation of NB into the generated model.  The resulting model for the bioactive conformation of NB bound to Hsp90α is presented herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlggNNK43lbVg90H21EOLACvtfcHk0liOpIsGOOYvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSgurc%253D&md5=04d10587dc95be898ec7e225cd0a7d4b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fcb200052x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200052x%26sid%3Dliteratum%253Aachs%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DVoruganti%26aufirst%3DS.%26aulast%3DKalyanaraman%26aufirst%3DP.%26aulast%3DHartson%26aufirst%3DS.%2BD.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DElucidation%2520of%2520the%2520hsp90%2520c-terminal%2520inhibitor%2520binding%2520site%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D800%26epage%3D807%26doi%3D10.1021%2Fcb200052x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratajczak, T.</span></span> <span> </span><span class="NLM_article-title">Modulation of chaperone function and cochaperone interaction by novobiocin in the C-Terminal domain of hsp90 - evidence that coumarin antibiotics disrupt hsp90 dimerization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">7161</span>– <span class="NLM_lpage">7171</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512406200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M512406200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16421106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ygsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7161-7171&author=R.+K.+Allanauthor=D.+Mokauthor=B.+K.+Wardauthor=T.+Ratajczak&title=Modulation+of+chaperone+function+and+cochaperone+interaction+by+novobiocin+in+the+C-Terminal+domain+of+hsp90+-+evidence+that+coumarin+antibiotics+disrupt+hsp90+dimerization&doi=10.1074%2Fjbc.M512406200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90. Evidence that Coumarin Antibiotics Disrupt Hsp90 Dimerization</span></div><div class="casAuthors">Allan, Rudi K.; Mok, Danny; Ward, Bryan K.; Ratajczak, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7161-7171</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The C-terminal domain of Hsp90 displays independent chaperone activity, mediates dimerization, and contains the MEEVD motif essential for interaction with tetratricopeptide repeat-contg. immunophilin cochaperones assembled in mature steroid receptor complexes.  An α-helical region, upstream of the MEEVD peptide, helps form the dimerization interface and includes a hydrophobic microdomain that contributes to the Hsp90 interaction with the immunophilin cochaperones and corresponds to the binding site for novobiocin, a coumarin-related Hsp90 inhibitor.  Mutation of selected residues within the hydrophobic microdomain significantly impacted the chaperone function of a recombinant C-terminal Hsp90 fragment and novobiocin inhibited wild-type chaperone activity.  Prior incubation of the Hsp90 fragment with novobiocin led to a direct blockade of immunophilin cochaperone binding.  However, the drug had little influence on the pre-formed Hsp90-immunophilin complex, suggesting that bound cochaperones mask the novobiocin-binding site.  We obsd. a differential effect of the drug on Hsp90-immunophilin interaction, suggesting that the immunophilins make distinct contacts within the C-terminal domain to specifically modulate Hsp90 function.  Novobiocin also precluded the interaction of full-length Hsp90 with the p50cdc37 cochaperone, which targets the N-terminal nucleotide-binding domain, and is prevalent in Hsp90 complexes with protein kinase substrates.  Novobiocin therefore acts locally and allosterically to induce conformational changes within multiple regions of the Hsp90 protein.  We provide evidence that coumermycin A1, a coumarin structurally related to novobiocin, interferes with dimerization of the Hsp90 C-terminal domain.  Coumarin-based inhibitors then may antagonize Hsp90 function by inducing a conformation favoring sepn. of the C-terminal domains and release of substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqafkJcVZJK97Vg90H21EOLACvtfcHk0lhmRx-drvYgOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ygsLo%253D&md5=17eb0a30eb1e2cce9c803d8f52e3dccc</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512406200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512406200%26sid%3Dliteratum%253Aachs%26aulast%3DAllan%26aufirst%3DR.%2BK.%26aulast%3DMok%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DB.%2BK.%26aulast%3DRatajczak%26aufirst%3DT.%26atitle%3DModulation%2520of%2520chaperone%2520function%2520and%2520cochaperone%2520interaction%2520by%2520novobiocin%2520in%2520the%2520C-Terminal%2520domain%2520of%2520hsp90%2520-%2520evidence%2520that%2520coumarin%2520antibiotics%2520disrupt%2520hsp90%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7161%26epage%3D7171%26doi%3D10.1074%2Fjbc.M512406200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gray, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, S. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the oncogene and kinome chaperone cdc37</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1038/nrc2420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrc2420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18511936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFOkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=491-495&author=P.+J.+Grayauthor=T.+Princeauthor=J.+Chengauthor=M.+A.+Stevensonauthor=S.+K.+Calderwood&title=Targeting+the+oncogene+and+kinome+chaperone+cdc37&doi=10.1038%2Fnrc2420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the oncogene and kinome chaperone CDC37</span></div><div class="casAuthors">Gray, Phillip J., Jr.; Prince, Thomas; Cheng, Jinrong; Stevenson, Mary Ann; Calderwood, Stuart K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">491-495</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  CDC37 is oncogenic because it stabilizes the structures of mutated or overexpressed oncogenic kinases.  Targeting this chaperone activity, on which many tumors depend, is therefore an attractive option for broad-based therapy.  CDC37 is a mol. chaperone that phys. stabilizes the catalytic domains found in protein kinases and is therefore a wide-spectrum regulator of protein phosphorylation.  It is also an overexpressed oncoprotein that mediates carcinogenesis by stabilizing the compromised structures of mutant and/or overexpressed oncogenic kinases.  Recent work shows that such dependency of malignant cells on increased CDC37 expression is a vulnerability that can be targeted in cancer by agents that deplete or inhibit CDC37.  CDC37 is thus a candidate for broad-spectrum mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWFC_lNqASUbVg90H21EOLACvtfcHk0lhmRx-drvYgOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFOkt7Y%253D&md5=4d58abe1731c3b24702e96c38b359a0f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnrc2420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2420%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DP.%2BJ.%26aulast%3DPrince%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DStevenson%26aufirst%3DM.%2BA.%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26atitle%3DTargeting%2520the%2520oncogene%2520and%2520kinome%2520chaperone%2520cdc37%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D491%26epage%3D495%26doi%3D10.1038%2Fnrc2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, D.</span></span> <span> </span><span class="NLM_article-title">Cdc37 goes beyond hsp90 and kinases</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14627196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=114-119&author=M.+MacLeanauthor=D.+Picard&title=Cdc37+goes+beyond+hsp90+and+kinases&doi=10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc37 goes beyond Hsp90 and kinases</span></div><div class="casAuthors">MacLean, Morag; Picard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">114-119</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Cell Stress Society International</span>)
        </div><div class="casAbstract">A review.  Cdc37 is a relatively poorly conserved and yet essential mol. chaperone.  It has long been thought to function primarily as an accessory factor for Hsp90, notably directing Hsp90 to kinases as substrates.  More recent discoveries challenge this simplistic view.  Cdc37 client proteins other than kinases have now been found, and Cdc37 displays a variety of Hsp90-independent activities both in vitro and in vivo.  It can function as a mol. chaperone by itself, interact with other Hsp90 cochaperones in the absence of Hsp90, and even support yeast growth and protein folding without its Hsp90-binding domain.  Thus, for many substrates, there may be many alternative chaperone pathways involving Cdc37, Hsp90, or both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMWmosbT89-rVg90H21EOLACvtfcHk0liQuotW1vJJZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlWkt7w%253D&md5=d411091b8924d2f909889c5d72ef7e5e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1379%252F1466-1268%25282003%2529008%253C0114%253ACGBHAK%253E2.0.CO%253B2%26sid%3Dliteratum%253Aachs%26aulast%3DMacLean%26aufirst%3DM.%26aulast%3DPicard%26aufirst%3DD.%26atitle%3DCdc37%2520goes%2520beyond%2520hsp90%2520and%2520kinases%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2003%26volume%3D8%26spage%3D114%26epage%3D119%26doi%3D10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMayo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finegold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span> <span> </span><span class="NLM_article-title">Induction of human cdc37 in prostate cancer correlates with the ability of targeted cdc37 expression to promote prostatic hyperplasia</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2186</span>– <span class="NLM_lpage">2193</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1203561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fsj.onc.1203561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10822368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslelsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2186-2193&author=L.+Stepanovaauthor=G.+Yangauthor=F.+DeMayoauthor=T.+M.+Wheelerauthor=M.+Finegoldauthor=T.+C.+Thompsonauthor=J.+W.+Harper&title=Induction+of+human+cdc37+in+prostate+cancer+correlates+with+the+ability+of+targeted+cdc37+expression+to+promote+prostatic+hyperplasia&doi=10.1038%2Fsj.onc.1203561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia</span></div><div class="casAuthors">Stepanova, Lilia; Yang, Guang; DeMayo, Franco; Wheeler, Thomas M.; Finegold, Milton; Thompson, Timothy C.; Harper, J. Wade</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2186-2193</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Cdc37 gene encodes a 50 kDa protein which targets intrinsically unstable oncoprotein kinases such as Cdk4, Raf-1, and src to the mol. chaperone Hsp90.  This activity is thought to play an important role in the establishment of signaling pathways controlling cell proliferation.  The budding yeast Cdc37 homolog is required for cell division and mammalian Cdc37 is expressed in proliferative zones during embryonic development and in adult tissues, consistent with a pos. role in proliferation.  Here the authors report that human prostatic tumors, neoplasias and certain pre-malignant lesions display increased Cdc37 expression, suggesting an important and early role for Cdc37 in prostatic transformation.  To test the consequences of increased Cdc37 levels, transgenic mice expressing Cdc37 in the prostate were generated.  These mice displayed a wide range of growth-related abnormalities including prostatic epithelial cell hyperplasia and dysplasia.  These data suggest that the expression of Cdc37 may promote inappropriate proliferation and may be an important early step in the development of human prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDstJD51g2NrVg90H21EOLACvtfcHk0li5OFAjkBNhvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslelsbs%253D&md5=c513eda410627ed0fa71330f074d0202</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203561%26sid%3Dliteratum%253Aachs%26aulast%3DStepanova%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDeMayo%26aufirst%3DF.%26aulast%3DWheeler%26aufirst%3DT.%2BM.%26aulast%3DFinegold%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DT.%2BC.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26atitle%3DInduction%2520of%2520human%2520cdc37%2520in%2520prostate%2520cancer%2520correlates%2520with%2520the%2520ability%2520of%2520targeted%2520cdc37%2520expression%2520to%2520promote%2520prostatic%2520hyperplasia%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2186%26epage%3D2193%26doi%3D10.1038%2Fsj.onc.1203561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">The mechanism of hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37)</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)01027-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2803%2901027-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14718169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotF2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=87-98&author=S.+M.+Roeauthor=M.+M.+Aliauthor=P.+Meyerauthor=C.+K.+Vaughanauthor=B.+Panaretouauthor=P.+W.+Piperauthor=C.+Prodromouauthor=L.+H.+Pearl&title=The+mechanism+of+hsp90+regulation+by+the+protein+kinase-specific+cochaperone+p50%28cdc37%29&doi=10.1016%2FS0092-8674%2803%2901027-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50cdc37</span></div><div class="casAuthors">Roe, S. Mark; Ali, Maruf M. U.; Meyer, Philippe; Vaughan, Cara K.; Panaretou, Barry; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recruitment of protein kinase clients to the Hsp90 chaperone involves the cochaperone p50cdc37 acting as a scaffold, binding protein kinases via its N-terminal domain and Hsp90 via its C-terminal region.  P50cdc37 also has a regulatory activity, arresting Hsp90's ATP-ase cycle during client-protein loading.  We have localized the binding site for p50cdc37 to the N-terminal nucleotide binding domain of Hsp90 and detd. the crystal structure of the Hsp90-p50cdc37 core complex.  Dimeric p50cdc37 binds to surfaces of the Hsp90 N-domain implicated in ATP-dependent N-terminal dimerization and assocn. with the middle segment of the chaperone.  This interaction fixes the lid segment in an open conformation, inserts an arginine side chain into the ATP binding pocket to disable catalysis, and prevents trans-activating interaction of the N domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_fX2JWo9hA7Vg90H21EOLACvtfcHk0ljT1WdeZaxA5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotF2gsQ%253D%253D&md5=88bc0830eec565bac998b0c2e2e40c01</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2901027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252901027-4%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DAli%26aufirst%3DM.%2BM.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DThe%2520mechanism%2520of%2520hsp90%2520regulation%2520by%2520the%2520protein%2520kinase-specific%2520cochaperone%2520p50%2528cdc37%2529%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D87%26epage%3D98%26doi%3D10.1016%2FS0092-8674%2803%2901027-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and cdc37 - a chaperone cancer conspiracy</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.gde.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15661534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=55-61&author=L.+H.+Pearl&title=Hsp90+and+cdc37+-+a+chaperone+cancer+conspiracy&doi=10.1016%2Fj.gde.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 and Cdc37 - a chaperone cancer conspiracy</span></div><div class="casAuthors">Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol. chaperone system is involved in the activation of an important set of cell regulatory proteins, including many whose dysregulation drives cancer.  Recruitment of protein kinases to the Hsp90 system is mediated by the co-chaperone adaptor Cdc37 - an essential protein whose overexpression is itself, oncogenic.  Current structural, biochem. and biol. studies of Cdc37 are beginning to unravel the nature of its interactions with Hsp90 and protein kinase clients, and implicate it as a key permissive factor in cell transformation by dysregulated protein kinases.  The central role of the Hsp90-Cdc37 chaperone complex makes it an important target for future anti-cancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaofLA0wLnrVg90H21EOLACvtfcHk0lhDy8BuPkrlmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D&md5=2795e3e44b6b0bbbe12dda55cb335769</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DHsp90%2520and%2520cdc37%2520-%2520a%2520chaperone%2520cancer%2520conspiracy%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2005%26volume%3D15%26spage%3D55%26epage%3D61%26doi%3D10.1016%2Fj.gde.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samant, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">ATP-competitive inhibitors block protein kinase recruitment to the hsp90-cdc37 system</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">406</span>, <span class="refDoi"> DOI: 10.1038/nchembio0613-406d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnchembio0613-406d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2rsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=406&author=S.+Polierauthor=R.+S.+Samantauthor=P.+A.+Clarkeauthor=P.+Workmanauthor=C.+Prodromouauthor=L.+H.+Pearl&title=ATP-competitive+inhibitors+block+protein+kinase+recruitment+to+the+hsp90-cdc37+system&doi=10.1038%2Fnchembio0613-406d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system [Erratum to document cited in CA158:493078]</span></div><div class="casAuthors">Polier, Sigrun; Samant, Rahul S.; Clarke, Paul A.; Workman, Paul; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">406</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clarification is provided for ambiguous text on the displacement of Cdc37 and Hsp90 from ErbB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4sMwGErB_LVg90H21EOLACvtfcHk0lgfC7y8Cd9Zaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2rsL4%253D&md5=1248426a4117c05b42b19aadde98ead8</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnchembio0613-406d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio0613-406d%26sid%3Dliteratum%253Aachs%26aulast%3DPolier%26aufirst%3DS.%26aulast%3DSamant%26aufirst%3DR.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP-competitive%2520inhibitors%2520block%2520protein%2520kinase%2520recruitment%2520to%2520the%2520hsp90-cdc37%2520system%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D406%26doi%3D10.1038%2Fnchembio0613-406d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">The human cdc37/hsp90 complex studied by heteronuclear nmr spectroscopy</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">3885</span>– <span class="NLM_lpage">3896</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806715200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M806715200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19073599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=3885-3896&author=S.+Sreeramuluauthor=H.+R.+Jonkerauthor=T.+Langerauthor=C.+Richterauthor=C.+R.+Lancasterauthor=H.+Schwalbe&title=The+human+cdc37%2Fhsp90+complex+studied+by+heteronuclear+nmr+spectroscopy&doi=10.1074%2Fjbc.M806715200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Cdc37·Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy</span></div><div class="casAuthors">Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Lancaster, C. Roy D.; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3885-3896</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are mol. chaperones, which are crucial elements in the protein signaling pathway.  The largest class of client proteins for Cdc37 and Hsp90 are protein kinases.  The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90.  Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 Å resoln. and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear soln. state NMR data and docking.  Our results demonstrate that the middle domain of Cdc37 exists as a monomer.  NMR and mutagenesis expts. reveal Leu-205 in Cdc37 as a key residue enabling complex formation.  These findings can be very useful in the development of small mol. inhibitors against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0h2OpThcpv7Vg90H21EOLACvtfcHk0lhrhFBxeGKUKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D&md5=aa7c4ab0d6585cd00dedca91c37372ea</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806715200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806715200%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DJonker%26aufirst%3DH.%2BR.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DRichter%26aufirst%3DC.%26aulast%3DLancaster%26aufirst%3DC.%2BR.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DThe%2520human%2520cdc37%252Fhsp90%2520complex%2520studied%2520by%2520heteronuclear%2520nmr%2520spectroscopy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D3885%26epage%3D3896%26doi%3D10.1074%2Fjbc.M806715200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verba, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span> <span> </span><span class="NLM_article-title">Atomic structure of hsp90-cdc37-cdk4 reveals that hsp90 traps and stabilizes an unfolded kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1542</span>– <span class="NLM_lpage">1547</span>, <span class="refDoi"> DOI: 10.1126/science.aaf5023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1126%2Fscience.aaf5023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27339980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaitL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2016&pages=1542-1547&author=K.+A.+Verbaauthor=R.+Y.+R.+Wangauthor=A.+Arakawaauthor=Y.+X.+Liuauthor=M.+Shirouzuauthor=S.+Yokoyamaauthor=D.+A.+Agard&title=Atomic+structure+of+hsp90-cdc37-cdk4+reveals+that+hsp90+traps+and+stabilizes+an+unfolded+kinase&doi=10.1126%2Fscience.aaf5023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase</span></div><div class="casAuthors">Verba, Kliment A.; Wang, Ray Yu-Ruei; Arakawa, Akihiko; Liu, Yanxin; Shirouzu, Mikako; Yokoyama, Shigeyuki; Agard, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">6293</span>),
    <span class="NLM_cas:pages">1542-1547</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The Hsp90 mol. chaperone and its Cdc37 cochaperone help stabilize and activate more than half of the human kinome.  However, both the mechanism by which these chaperones assist their "client" kinases and the reason why some kinases are addicted to Hsp90 while closely related family members are independent are unknown.  A structural understanding of these interactions is lacking, as no full-length structures of human Hsp90, Cdc37, or either of these proteins with a kinase have been elucidated.  Here, the authors report a 3.9-Å cryo-electron microscopy structure of the Hsp90-Cdc37-Cdk4 kinase complex.  Surprisingly, the 2 lobes of Cdk4 were completely sepd. with the β4-β5 sheet unfolded.  Cdc37 mimicked part of the kinase N-lobe, stabilizing an open kinase conformation by wedging itself between the 2 lobes.  Finally, Hsp90 clamped around the unfolded kinase β5 strand and interacted with exposed N- and C-lobe interfaces, protecting the kinase in a trapped unfolded state.  On the basis of this structure and an extensive amt. of previously collected data, the authors propose unifying conceptual and mechanistic models of chaperone-kinase interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUbM1uvGsXbVg90H21EOLACvtfcHk0lh8rYf-11VP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaitL3O&md5=677703f45a5021d6f64b1811116816c4</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf5023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf5023%26sid%3Dliteratum%253Aachs%26aulast%3DVerba%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DR.%2BY.%2BR.%26aulast%3DArakawa%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%2BX.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DAtomic%2520structure%2520of%2520hsp90-cdc37-cdk4%2520reveals%2520that%2520hsp90%2520traps%2520and%2520stabilizes%2520an%2520unfolded%2520kinase%26jtitle%3DScience%26date%3D2016%26volume%3D352%26spage%3D1542%26epage%3D1547%26doi%3D10.1126%2Fscience.aaf5023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. A.</span></span> <span> </span><span class="NLM_article-title">Novel hsp90 inhibitor to disrupt hsp90/cdc37 complex against pancreatic cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-0484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1535-7163.MCT-07-0484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18202019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=162-170&author=T.+Zhangauthor=A.+Hamzaauthor=X.+Caoauthor=B.+Wangauthor=S.+Yuauthor=C.+G.+Zhanauthor=D.+A.+Sun&title=Novel+hsp90+inhibitor+to+disrupt+hsp90%2Fcdc37+complex+against+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.MCT-07-0484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span></div><div class="casAuthors">Zhang, Tao; Hamza, Adel; Cao, Xianhua; Wang, Bing; Yu, Shuwen; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive disease with multiple biochem. and genetic alterations.  Thus, a single agent to hit one mol. target may not be sufficient to treat this disease.  The purpose of this study is to identify a novel Hsp90 inhibitor to disrupt protein-protein interactions of Hsp90 and its cochaperones for down-regulating many oncogenes simultaneously against pancreatic cancer cells.  Here, we reported that celastrol disrupted Hsp90-Cdc37 interaction in the superchaperone complex to exhibit antitumor activity in vitro and in vivo.  Mol. docking and mol. dynamic simulations showed that celastrol blocked the crit. interaction of Glu33 (Hsp90) and Arg167 (Cdc37).  Immunopptn. confirmed that celastrol (10 μmol/L) disrupted the Hsp90-Cdc37 interaction in the pancreatic cancer cell line Panc-1.  In contrast to classic Hsp90 inhibitor (geldanamycin), celastrol (0.1-100 μmol/L) did not interfere with ATP binding to Hsp90.  However, celastrol (1-5 μmol/L) induced Hsp90 client protein degrdn. (Cdk4 and Akt) by 70% to 80% and increased Hsp70 expression by 12-fold.  Celastrol induced apoptosis in vitro and significantly inhibited tumor growth in Panc-1 xenografts.  Moreover, celastrol (3 mg/kg) effectively suppressed tumor metastasis by more than 80% in RIP1-Tag2 transgenic mouse model with pancreatic islet cell carcinogenesis.  The data suggest that celastrol is a novel Hsp90 inhibitor to disrupt Hsp90-Cdc37 interaction against pancreatic cancer cells. [Mol Cancer Ther 2008;7(1):162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaUNr9Bi1cbVg90H21EOLACvtfcHk0lh8rYf-11VP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D&md5=2af27701d6ccd4397c7a7486d1335730</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0484%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26aulast%3DSun%26aufirst%3DD.%2BA.%26atitle%3DNovel%2520hsp90%2520inhibitor%2520to%2520disrupt%2520hsp90%252Fcdc37%2520complex%2520against%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D162%26epage%3D170%26doi%3D10.1158%2F1535-7163.MCT-07-0484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">Characterization of celastrol to inhibit hsp90 and cdc37 interaction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">35381</span>– <span class="NLM_lpage">35389</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.051532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M109.051532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19858214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35381-35389&author=T.+Zhangauthor=Y.+Y.+Liauthor=Y.+K.+Yuauthor=P.+Zouauthor=Y.+Q.+Jiangauthor=D.+X.+Sun&title=Characterization+of+celastrol+to+inhibit+hsp90+and+cdc37+interaction&doi=10.1074%2Fjbc.M109.051532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction</span></div><div class="casAuthors">Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35381-35389</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer.  The loading of protein kinases to Hsp90 is actively mediated by the co-chaperone Cdc37.  The crucial role of the Hsp90-Cdc37 complex has made it an exciting target for cancer treatment.  In this study, the authors characterize Hsp90 and Cdc37 interaction and drug disruption using a reconstituted protein system.  The GST pull-down assay and ELISA assay show that Cdc37 binds to ADP-bound/nucleotide-free Hsp90 but not ATP-bound Hsp90.  Celastrol disrupts Hsp90-Cdc37 complex formation, whereas the classical Hsp90 inhibitors (e.g., geldanamycin) have no effect.  Celastrol inhibits Hsp90 ATPase activity without blocking ATP binding.  Proteolytic fingerprinting indicates celastrol binds to Hsp90 C-terminal domain to protect it from trypsin digestion.  These data suggest that celastrol may represent a new class of Hsp90 inhibitor by modifying Hsp90 C terminus to allosterically regulate its chaperone activity and disrupt Hsp90-Cdc37 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPbfNGpAapIrVg90H21EOLACvtfcHk0lh8rYf-11VP-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN&md5=f8d15de4ecac58de8bb5274d9cf9cdcd</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.051532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.051532%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DYu%26aufirst%3DY.%2BK.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%2BQ.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DCharacterization%2520of%2520celastrol%2520to%2520inhibit%2520hsp90%2520and%2520cdc37%2520interaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D35381%26epage%3D35389%26doi%3D10.1074%2Fjbc.M109.051532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gande, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of inhibition of the human protein complex hsp90-cdc37, a kinome chaperone-cochaperone, by triterpene celastrol</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5853</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1002/anie.200900929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fanie.200900929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19585625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5853-5855&author=S.+Sreeramuluauthor=S.+L.+Gandeauthor=M.+G%C3%B6belauthor=H.+Schwalbe&title=Molecular+mechanism+of+inhibition+of+the+human+protein+complex+hsp90-cdc37%2C+a+kinome+chaperone-cochaperone%2C+by+triterpene+celastrol&doi=10.1002%2Fanie.200900929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol</span></div><div class="casAuthors">Sreeramulu, Sridhar; Gande, Santosh Lakshmi; Goebel, Michael; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5853-5855, S5853/1-S5853/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the kinome chaperone Hsp90 (kinome = set of all protein kinases in an organism) has long been known as mol. target for anticancer therapy.  Cdc37, a cochaperone of Hsp90 in mammalian cells, targets protein kinases and is upregulated in various cancers.  Gene-based expression studies have identified the triterpene celastrol, which represents a new class of non ATP-competitive inhibitors of Hsp90.  Herein, we describe in detail how celastrol disrupts the human Hsp90-Cdc37 complex.  We report that celastrol binds to Cdc37 but not to HSP90N as previously described.  This study is important as it will shift efforts in medicinal chem. towards the correct target within the protein-protein complex.  Our results indicates that the N-terminal kinase- binding and middle Hsp90N-binding domain of Cdc37 are the mol. target for the triterpene celastrol.  In light of the considerable potential of Cdc37 as a drug target and the binding of celastrol to it, these results can now be used to further understand the mol. basis for inhibiting this key Cdc37-Hsp90 complex in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWgmOS-yFB6rVg90H21EOLACvtfcHk0ljl28G5rXl7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D&md5=d5264a2213c19a8b33ca56305ac2a29c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fanie.200900929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200900929%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DGande%26aufirst%3DS.%2BL.%26aulast%3DG%25C3%25B6bel%26aufirst%3DM.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DMolecular%2520mechanism%2520of%2520inhibition%2520of%2520the%2520human%2520protein%2520complex%2520hsp90-cdc37%252C%2520a%2520kinome%2520chaperone-cochaperone%252C%2520by%2520triterpene%2520celastrol%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D5853%26epage%3D5855%26doi%3D10.1002%2Fanie.200900929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Optimization and biological evaluation of celastrol derivatives as hsp90-cdc37 interaction disruptors with improved druglike properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5431</span>– <span class="NLM_lpage">5439</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2016.08.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27647369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5431-5439&author=F.+Jiangauthor=H.+J.+Wangauthor=Q.+C.+Baoauthor=L.+Wangauthor=Y.+H.+Jinauthor=Q.+Zhangauthor=D.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Optimization+and+biological+evaluation+of+celastrol+derivatives+as+hsp90-cdc37+interaction+disruptors+with+improved+druglike+properties&doi=10.1016%2Fj.bmc.2016.08.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties</span></div><div class="casAuthors">Jiang, Fen; Wang, Hui-Jie; Bao, Qi-Chao; Wang, Lei; Jin, Yu-Hui; Zhang, Qiong; Jiang, Di; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5431-5439</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) as a mol. target for oncol. therapeutics has attracted much attention in the last decade.  The Hsp90 multichaperone complex has important roles in the growth and/or survival of cancer cells.  Cdc37, as a cochaperone, assocs. kinase clients to Hsp90 and promotes the development of malignant tumors.  Disrupting the Hsp90-Cdc37 interaction provides an alternative strategy to inhibit the function of Hsp90 for cancer therapy.  Celastrol, as a natural product, can disrupt the Hsp90-Cdc37 interaction and induce degrdn. of kinase clients.  The study conducted here attempted to elucidate the structure-activity relationship of celastrol derivs. as Hsp90-Cdc37 disruptors and to improve the druglike properties.  23 Celastrol derivs. were designed, synthesized, and the biol. activities and physicochem. properties were detd.  The deriv. CEL20 showed improved Hsp90-Cdc37 disruption activity, anti-proliferative activities as well as druglike properties.  Addnl., CEL20 induced clients degrdn., cell cycle arrest and apoptosis in Panc-1 cells.  This study can provide ref. for the discovery of novel Hsp90-Cdc37 disruptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzu8IFI5qzR7Vg90H21EOLACvtfcHk0ljl28G5rXl7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL&md5=94fadc51317b113c4e79fdb1e338c6ab</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.070%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DOptimization%2520and%2520biological%2520evaluation%2520of%2520celastrol%2520derivatives%2520as%2520hsp90-cdc37%2520interaction%2520disruptors%2520with%2520improved%2520druglike%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5431%26epage%3D5439%26doi%3D10.1016%2Fj.bmc.2016.08.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilaka, A. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">Withaferin a targets heat shock protein 90 in pancreatic. Cancer Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bcp.2009.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19769945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGgtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=542-551&author=Y.+K.+Yuauthor=A.+Hamzaauthor=T.+Zhangauthor=M.+C.+Guauthor=P.+Zouauthor=B.+Newmanauthor=Y.+Y.+Liauthor=A.+A.+L.+Gunatilakaauthor=C.+G.+Zhanauthor=D.+X.+Sun&title=Withaferin+a+targets+heat+shock+protein+90+in+pancreatic.+Cancer+Cells&doi=10.1016%2Fj.bcp.2009.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Withaferin A targets heat shock protein 90 in pancreatic cancer cells</span></div><div class="casAuthors">Yu, Yanke; Hamza, Adel; Zhang, Tao; Gu, Mancang; Zou, Peng; Newman, Bryan; Li, Yanyan; Gunatilaka, A. A. Leslie; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-551</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of this study is to investigate the efficacy and the mechanism of Hsp90 inhibition of Withaferin A (WA), a steroidal lactone occurring in Withania somnifera, in pancreatic cancer in vitro and in vivo.  Withaferin A exhibited potent antiproliferative activity against pancreatic cancer cells in vitro (with IC50s of 1.24, 2.93 and 2.78 μM) in pancreatic cancer cell lines Panc-1, MiaPaCa2 and BxPc3, resp.  Annexin V staining showed that WA induced significant apoptosis in Panc-1 cells in a dose-dependent manner.  Western blotting demonstrated that WA inhibited Hsp90 chaperone activity to induce degrdn. of Hsp90 client proteins (Akt, Cdk4 and glucocorticoid receptor), which was reversed by the proteasomal inhibitor, MG132.  WA-biotin pull down assay of Hsp90 using Panc-1 cancer cell lyzates and purified Hsp90 showed that WA-biotin binds to C-terminus of Hsp90 which was competitively blocked by unlabeled WA.  Co-immunopptn. exhibited that WA (10 μM) disrupted Hsp90-Cdc37 complexes from 1 to 24 h post-treatment, while it neither blocked ATP binding to Hsp90, nor changed Hsp90-P23 assocn.  WA (3, 6 mg/kg) inhibited tumor growth in pancreatic Panc-1 xenografts by 30% and 58%, resp.  These data demonstrate that Withaferin A binds Hsp90, inhibits Hsp90 chaperone activity through an ATP-independent mechanism, results in Hsp90 client protein degrdn., and exhibits in vivo anticancer activity against pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriFWBOwGN6_rVg90H21EOLACvtfcHk0ljl28G5rXl7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGgtLzK&md5=98f0361915cd78d07965763f30afc392</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%2BK.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DGu%26aufirst%3DM.%2BC.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DGunatilaka%26aufirst%3DA.%2BA.%2BL.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DWithaferin%2520a%2520targets%2520heat%2520shock%2520protein%252090%2520in%2520pancreatic.%2520Cancer%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D542%26epage%3D551%26doi%3D10.1016%2Fj.bcp.2009.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagoz, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, A. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudiger, S. G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">Sulforaphane inhibits pancreatic cancer through disrupting hsp90-p50(cdc37) complex and direct interactions with amino acids residues of hsp90</span>. <i>J. Nutr. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1617</span>– <span class="NLM_lpage">1626</span>, <span class="refDoi"> DOI: 10.1016/j.jnutbio.2011.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.jnutbio.2011.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22444872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XksFejtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=1617-1626&author=Y.+Y.+Liauthor=G.+E.+Karagozauthor=Y.+H.+Seoauthor=T.+Zhangauthor=Y.+Q.+Jiangauthor=Y.+K.+Yuauthor=A.+M.+S.+Duarteauthor=S.+J.+Schwartzauthor=R.+Boelensauthor=K.+Carrollauthor=S.+G.+D.+Rudigerauthor=D.+X.+Sun&title=Sulforaphane+inhibits+pancreatic+cancer+through+disrupting+hsp90-p50%28cdc37%29+complex+and+direct+interactions+with+amino+acids+residues+of+hsp90&doi=10.1016%2Fj.jnutbio.2011.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50Cdc37 complex and direct interactions with amino acids residues of Hsp90</span></div><div class="casAuthors">Li, Yanyan; Karagoz, G. Elif; Seo, Young Ho; Zhang, Tao; Jiang, Yiqun; Yu, Yanke; Duarte, Afonso M. S.; Schwartz, Steven J.; Boelens, Rolf; Carroll, Kate; Rudiger, Stefan G. D.; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1617-1626</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sulforaphane [1-isothiocyanato-4-((methyl-sulfinyl) butane)], an isothiocyanate derived from cruciferous vegetables, was shown to possess potent chemopreventive activity.  We analyzed the effect of sulforaphane on the proliferation of pancreatic cancer cells.  Sulforaphane inhibited pancreatic cancer cell growth in vitro with IC50s of around 10-15 μM and induced apoptosis.  In pancreatic cancer xenograft mouse model, administration of sulforaphane showed remarkable inhibition of tumor growth without apparent toxicity noticed.  We found that sulforaphane induced the degrdn. of heat shock protein 90 (Hsp90) client proteins and blocked the interaction of Hsp90 with its cochaperone p50Cdc37 in pancreatic cancer cells.  Using NMR spectroscopy (NMR) with an isoleucine-specific labeling strategy, we overcame the protein size limit of conventional NMR and studied the interaction of sulforaphane with full-length Hsp90 dimer (170 kDa) in soln.  NMR revealed multiple chem. shifts in sheet 2 and the adjacent loop in Hsp90 N-terminal domain after incubation of Hsp90 with sulforaphane.  Liq. chromatog. coupled to mass spectrometry further mapped a short peptide in this region that was tagged with sulforaphane.  These data suggest a new mechanism of sulforaphane that disrupts protein-protein interaction in Hsp90 complex for its chemopreventive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow4f3hTm6sKbVg90H21EOLACvtfcHk0liZ2rPGne6rlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksFejtLg%253D&md5=56aa422e918b432dc6748f4a6009e547</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.jnutbio.2011.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jnutbio.2011.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DKaragoz%26aufirst%3DG.%2BE.%26aulast%3DSeo%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DY.%2BQ.%26aulast%3DYu%26aufirst%3DY.%2BK.%26aulast%3DDuarte%26aufirst%3DA.%2BM.%2BS.%26aulast%3DSchwartz%26aufirst%3DS.%2BJ.%26aulast%3DBoelens%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DRudiger%26aufirst%3DS.%2BG.%2BD.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DSulforaphane%2520inhibits%2520pancreatic%2520cancer%2520through%2520disrupting%2520hsp90-p50%2528cdc37%2529%2520complex%2520and%2520direct%2520interactions%2520with%2520amino%2520acids%2520residues%2520of%2520hsp90%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2012%26volume%3D23%26spage%3D1617%26epage%3D1626%26doi%3D10.1016%2Fj.jnutbio.2011.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z. R.</span></span> <span> </span><span class="NLM_article-title">Natural product kongensin a is a non-canonical hsp90 inhibitor that blocks rip3-dependent necroptosis</span>. <i>Cell. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.chembiol.2015.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27028885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=257-266&author=D.+R.+Liauthor=C.+Liauthor=L.+Liauthor=S.+Chenauthor=L.+Wangauthor=Q.+Liauthor=X.+D.+Wangauthor=X.+G.+Leiauthor=Z.+R.+Shen&title=Natural+product+kongensin+a+is+a+non-canonical+hsp90+inhibitor+that+blocks+rip3-dependent+necroptosis&doi=10.1016%2Fj.chembiol.2015.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis</span></div><div class="casAuthors">Li, Dianrong; Li, Chao; Li, Lin; Chen, She; Wang, Lei; Li, Qiang; Wang, Xiaodong; Lei, Xiaoguang; Shen, Zhirong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3-dependent necroptosis has recently garnered significant interest because of the unique signaling mechanisms and pathol. functions involved in this process.  Accordingly, a no. of chem. screens have identified several effective small-mol. inhibitors that specifically block necroptosis.  Here, we report the discovery that kongensin A (KA), a natural product isolated from Croton kongensis, is a potent inhibitor of necroptosis and an inducer of apoptosis.  Using a new bioorthogonal ligation method (TQ ligation), we reveal that the direct cellular target of KA is heat shock protein 90 (HSP90).  Further studies demonstrate that KA covalently binds to a previously uncharacterized cysteine 420 in the middle domain of HSP90 and dissocs. HSP90 from its cochaperone CDC37, which leads to inhibition of RIP3-dependent necroptosis and promotion of apoptosis in multiple cancer cell lines.  Collectively, our findings demonstrate that KA is an effective HSP90 inhibitor that has potential anti-necroptosis and anti-inflammation applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCEeQjx4di8rVg90H21EOLACvtfcHk0liZ2rPGne6rlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D&md5=0750612b811f8bd7379feca734ab6014</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%2BD.%26aulast%3DLei%26aufirst%3DX.%2BG.%26aulast%3DShen%26aufirst%3DZ.%2BR.%26atitle%3DNatural%2520product%2520kongensin%2520a%2520is%2520a%2520non-canonical%2520hsp90%2520inhibitor%2520that%2520blocks%2520rip3-dependent%2520necroptosis%26jtitle%3DCell.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D257%26epage%3D266%26doi%3D10.1016%2Fj.chembiol.2015.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span> <span> </span><span class="NLM_article-title">Fw-04–806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to n-terminus of hsp90 and disrupting hsp90-cdc37 complex formation</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">150</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-13-150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1186%2F1476-4598-13-150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24927996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=150&author=W.+Huangauthor=M.+Yeauthor=L.+R.+Zhangauthor=Q.+D.+Wuauthor=M.+Zhangauthor=J.+H.+Xuauthor=W.+Zheng&title=Fw-04%E2%80%93806+inhibits+proliferation+and+induces+apoptosis+in+human+breast+cancer+cells+by+binding+to+n-terminus+of+hsp90+and+disrupting+hsp90-cdc37+complex+formation&doi=10.1186%2F1476-4598-13-150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation</span></div><div class="casAuthors">Huang, Wei; Ye, Min; Zhang, Lian-Ru; Wu, Qun-Dan; Zhang, Min; Xu, Jian-Hua; Zheng, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">150/1-150/23, 23 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Heat shock protein 90 (Hsp90) is a promising therapeutic target and inhibition of Hsp90 will presumably result in suppression of multiple signaling pathways.  FW-04-806, a bis-oxazolyl macrolide compd. extd. from China-native Streptomyces FIM-04-806, was reported to be identical in structure to the polyketide Conglobatin.  Methods: We adopted the methods of chemproteomics, computational docking, immunopptn., siRNA gene knock down, Quant. Real-time PCR and xenograft models on the research of FW-04-806 antitumor mechanism, through the HER2-overexpressing breast cancer SKBR3 and HER2-underexpressing breast cancer MCF-7 cell line.  Results: We have verified the direct binding of FW-04-806 to the N-terminal domain of Hsp90 and found that FW-04-806 inhibits Hsp90/cell division cycle protein 37 (Cdc37) chaperone/co-chaperone interactions, but does not affect ATP-binding capability of Hsp90, thereby leading to the degrdn. of multiple Hsp90 client proteins via the proteasome pathway.  In breast cancer cell lines, FW-04-806 inhibits cell proliferation, caused G2/M cell cycle arrest, induced apoptosis, and downregulated Hsp90 client proteins HER2, Akt, Raf-1 and their phosphorylated forms (p-HER2, p-Akt) in a dose and time-dependent manner.  Importantly, FW-04-806 displays a better anti-tumor effect in HER2-overexpressed SKBR3 tumor xenograft model than in HER2-underexpressed MCF-7 model.  The result is consistent with cell proliferation assay and in vitro apoptosis assay applied for SKBR-3 and MCF-7.  Furthermore, FW-04-806 has a favorable toxicity profile.  Conclusions: As a novel Hsp90 inhibitor, FW-04-806 binds to the N-terminal of Hsp90 and inhibits Hsp90/Cdc37 interaction, resulting in the disassocn. of Hsp90/Cdc37/client complexes and the degrdn. of Hsp90 client proteins.  FW-04-806 displays promising antitumor activity against breast cancer cells both in vitro and in vivo, esp. for HER2-overexpressed breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI4HO_8pKpELVg90H21EOLACvtfcHk0lh4OV6IA1oFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWns7o%253D&md5=bfa6127b46be0281667d296f020fde1b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-13-150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-13-150%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DQ.%2BD.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%2BH.%26aulast%3DZheng%26aufirst%3DW.%26atitle%3DFw-04%25E2%2580%2593806%2520inhibits%2520proliferation%2520and%2520induces%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520binding%2520to%2520n-terminus%2520of%2520hsp90%2520and%2520disrupting%2520hsp90-cdc37%2520complex%2520formation%26jtitle%3DMol.%2520Cancer%26date%3D2014%26volume%3D13%26spage%3D150%26doi%3D10.1186%2F1476-4598-13-150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. J.</span></span> <span> </span><span class="NLM_article-title">Novel hsp90 inhibitor platycodin d disrupts hsp90/cdc37 complex and enhances the anticancer effect of mtor inhibitor</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2017.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.taap.2017.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28711525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Sjs77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2017&pages=65-73&author=T.+Liauthor=X.+Chenauthor=X.+Y.+Daiauthor=B.+Weiauthor=Q.+J.+Wengauthor=X.+P.+Chenauthor=D.+F.+Ouyangauthor=R.+Yanauthor=Z.+J.+Huangauthor=H.+L.+Jiangauthor=H.+Zhuauthor=J.+J.+Lu&title=Novel+hsp90+inhibitor+platycodin+d+disrupts+hsp90%2Fcdc37+complex+and+enhances+the+anticancer+effect+of+mtor+inhibitor&doi=10.1016%2Fj.taap.2017.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor</span></div><div class="casAuthors">Li, Ting; Chen, Xin; Dai, Xiao-Yang; Wei, Bin; Weng, Qin-Jie; Chen, Xiuping; Ouyang, De-Fang; Yan, Ru; Huang, Zhang-Jian; Jiang, Hu-Lin; Zhu, Hong; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-73</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a critically conserved mol. chaperone protein and promising therapeutic target for cancer treatment.  In this study, platycodin D (PD), a saponin isolated from traditional Chinese herb Platycodonis Radix, was identified as a novel Hsp90 inhibitor.  We verified that PD did not affect the ATPase activity of Hsp90.  However, PD disrupted the co-chaperone interaction of Hsp90/cell division cycle protein 37 (Cdc37) and subsequently degraded multiple Hsp90 client proteins without the feedback increase of Hsp70.  In different genotypes of non-small cell lung cancer cells, co-treatment with the mTOR inhibitor Everolimus and PD enhanced antiproliferation activity and apoptotic effect.  The feedback survival signal upon mTOR inhibition was fully terminated by the co-administration with PD through reduced epidermal growth factor receptor (EGFR) and insulin growth factor 1 receptor (IGF1R) expression, suppressed AKT activity, and reinforced 4E-BP1 inhibition.  Our results not only identified PD as a novel Hsp90 inhibitor by disrupting the protein-protein interaction of Hsp90/Cdc37 complex, but also provided mechanistic insights into the ineffectiveness of mTOR inhibitors and identified therapeutic strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqej7RTT1O-r7Vg90H21EOLACvtfcHk0ljuCY7NA9fnrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sjs77P&md5=a75f51f4c0cf6bebe7cae977ee538848</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2017.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2017.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DX.%2BY.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DWeng%26aufirst%3DQ.%2BJ.%26aulast%3DChen%26aufirst%3DX.%2BP.%26aulast%3DOuyang%26aufirst%3DD.%2BF.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26atitle%3DNovel%2520hsp90%2520inhibitor%2520platycodin%2520d%2520disrupts%2520hsp90%252Fcdc37%2520complex%2520and%2520enhances%2520the%2520anticancer%2520effect%2520of%2520mtor%2520inhibitor%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2017%26volume%3D330%26spage%3D65%26epage%3D73%26doi%3D10.1016%2Fj.taap.2017.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and identification of cdc37-derived peptides targeting the hsp90-cdc37 protein-protein interaction</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">96138</span>– <span class="NLM_lpage">96145</span>, <span class="refDoi"> DOI: 10.1039/C5RA20408A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1039%2FC5RA20408A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=96138-96145&author=L.+Wangauthor=Q.+C.+Baoauthor=X.+L.+Xuauthor=F.+Jiangauthor=K.+Guauthor=Z.+Y.+Jiangauthor=X.+J.+Zhangauthor=X.+K.+Guoauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+and+identification+of+cdc37-derived+peptides+targeting+the+hsp90-cdc37+protein-protein+interaction&doi=10.1039%2FC5RA20408A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and identification of Cdc37-derived peptides targeting the Hsp90-Cdc37 protein-protein interaction</span></div><div class="casAuthors">Wang, Lei; Bao, Qi-Chao; Xu, Xiao-Li; Jiang, Fen; Gu, Kai; Jiang, Zheng-Yu; Zhang, Xiao-Jin; Guo, Xiao-Ke; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">116</span>),
    <span class="NLM_cas:pages">96138-96145</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As an attractive anticancer target, the Hsp90 chaperone machine regulates a wide range of oncoproteins.  Most of the Hsp90 inhibitors in clin. trials employ the same ATP blockage mechanism while little progress has been achieved with Hsp90-cochaperone complexes.  Numerous protein kinases assoc. with the Hsp90-Cdc37 PPI, a potential target for the treatment of cancers, to implement folding and maturation.  In order to explore the key residues of the Hsp90-Cdc37 binding interface for further design of peptide inhibitors, a combined strategy of mol. dynamics simulation and MM-PBSA anal. was performed.  Subsequent design and identification of an eleven-residue peptide (Pep-1) directly derived from the Cdc37 binding interface was achieved to exhibit a 6.9 μM binding capacity and 3.0 μM ATPase inhibitory rate.  This is the first evidence that a peptide inhibitor not only interferes with Hsp90 ATPase ability but also disrupts the Cdc37-Hsp90 PPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprJuH5_AXE6bVg90H21EOLACvtfcHk0ljuCY7NA9fnrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7jI&md5=b7b3c57b5aa96ac8236adf5121c5aab8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1039%2FC5RA20408A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA20408A%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DGu%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520and%2520identification%2520of%2520cdc37-derived%2520peptides%2520targeting%2520the%2520hsp90-cdc37%2520protein-protein%2520interaction%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D96138%26epage%3D96145%26doi%3D10.1039%2FC5RA20408A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Optimization and bioevaluation of cdc37-derived peptides: an insight into hsp90-cdc37 protein-protein interaction modulators</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2016.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27818030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2iu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=233-240&author=L.+Wangauthor=L.+Liauthor=W.+T.+Fuauthor=Z.+Y.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Optimization+and+bioevaluation+of+cdc37-derived+peptides%3A+an+insight+into+hsp90-cdc37+protein-protein+interaction+modulators&doi=10.1016%2Fj.bmc.2016.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and bioevaluation of Cdc37-derived peptides: An insight into Hsp90-Cdc37 protein-protein interaction modulators</span></div><div class="casAuthors">Wang, Lei; Li, Li; Fu, Wei-Tao; Jiang, Zheng-Yu; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting Hsp90-Cdc37 protein-protein interaction (PPI) is becoming an alternative approach for future anti-cancer drug development.  We previously reported the discovery of an eleven-residue peptide (Pep-1) with micromolar activity for the disruption of Hsp90-Cdc37 PPI.  Efforts to improve upon the Pep-1 led to the discovery of more potent modulators for Hsp90-Cdc37 PPI.  Through the anal. of peptides binding patterns, more peptides were designed for further verification which resulted in Pep-5, the shortest peptide targeting Hsp90-Cdc37, exerting the optimal structure and the most efficient binding mode.  Subsequent MD simulation anal. also confirmed that Pep-5 could perform more stable binding ability and better ligand properties than Pep-1.  Under the premise of retentive binding capacity, Pep-5 exhibited lower mol. wt. and higher ligand efficiency with a Kd value of 5.99 μM (Pep-1 Kd = 6.90 μM) in both direct binding detn. and biol. evaluation.  The optimal and shortest Pep-5 might provide a breakthrough and a better model for the future design of small mol. inhibitors targeting Hsp90-Cdc37 PPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozt_piL7_yrbVg90H21EOLACvtfcHk0ljHow-kIRkJSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2iu73M&md5=a5e693af05109ebb1413198e4154ab53</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DW.%2BT.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DOptimization%2520and%2520bioevaluation%2520of%2520cdc37-derived%2520peptides%253A%2520an%2520insight%2520into%2520hsp90-cdc37%2520protein-protein%2520interaction%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D233%26epage%3D240%26doi%3D10.1016%2Fj.bmc.2016.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Structure-based virtual screening and optimization of modulators targeting hsp90-cdc37 interaction</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2017.04.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28482218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvFGjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=63-73&author=L.+Wangauthor=L.+Liauthor=Z.+H.+Zhouauthor=Z.+Y.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Structure-based+virtual+screening+and+optimization+of+modulators+targeting+hsp90-cdc37+interaction&doi=10.1016%2Fj.ejmech.2017.04.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction</span></div><div class="casAuthors">Wang, Lei; Li, Li; Zhou, Zi-Han; Jiang, Zheng-Yu; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Identification of novel Hsp90 inhibitors to disrupt Hsp90-Cdc37 protein-protein interaction (PPI) could be an alternative strategy to achieve Hsp90 inhibition.  In this paper, a series of small mols. targeting Hsp90-Cdc37 complex are addressed and characterized.  The mols.' key characters are detd. by utilizing a structure-based virtual screening workflow, derivs. synthesis, and biol. evaluation.  Structural optimization and structure-activity relationship (SAR) anal. were then carried out on the virtual hit of VS-8 with potent activity, which resulted in the discovery of compd. I as a more potent regulator of Hsp90-Cdc37 interaction with a promising inhibitory effect (IC50 = 27 μM), a moderate binding capacity (KD = 40 μM) and a preferable antiproliferative activity against several cancer lines including MCF-7, SKBR3 and A549 cell lines (IC50 = 26 μM, 15 μM and 38 μM resp.).  All the data suggest that compd. I exhibits moderate inhibitory effect on Hsp90-Cdc37 and could be regard as a first evidence of a nonnatural compd. targeting Hsp90-Cdc37 PPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4dkE1WfkLwLVg90H21EOLACvtfcHk0lgXjIHRkyYCOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvFGjt7c%253D&md5=4c4e51f6ccfc194f30d64b6310d2ac54</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.074%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DZ.%2BH.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DStructure-based%2520virtual%2520screening%2520and%2520optimization%2520of%2520modulators%2520targeting%2520hsp90-cdc37%2520interaction%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D63%26epage%3D73%26doi%3D10.1016%2Fj.ejmech.2017.04.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitor targeting the hsp90-cdc37 protein-protein interaction in colorectal cancer</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">eaax2277</span> <span class="refDoi"> DOI: 10.1126/sciadv.aax2277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1126%2Fsciadv.aax2277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=31555737" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&author=L.+Wangauthor=L.+X.+Zhangauthor=L.+Liauthor=J.+Jiangauthor=Z.+Zhengauthor=J.+Shangauthor=C.+Wangauthor=W.+L.+Chenauthor=Q.+C.+Baoauthor=X.+L.+Xuauthor=Z.+Y.+Jiangauthor=J.+Zhangauthor=Q.+D.+You&title=Small-molecule+inhibitor+targeting+the+hsp90-cdc37+protein-protein+interaction+in+colorectal+cancer&doi=10.1126%2Fsciadv.aax2277"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.aax2277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.aax2277%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%2BX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%2BL.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DSmall-molecule%2520inhibitor%2520targeting%2520the%2520hsp90-cdc37%2520protein-protein%2520interaction%2520in%2520colorectal%2520cancer%26jtitle%3DSci.%2520Adv.%26date%3D2019%26volume%3D5%26doi%3D10.1126%2Fsciadv.aax2277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattanayak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nibbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valsecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergan, R.</span></span> <span> </span><span class="NLM_article-title">Precision therapeutic targeting of human cancer cell motility</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2454</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-04465-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs41467-018-04465-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29934502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FhtVSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2454&author=L.+Xuauthor=R.+Gordonauthor=R.+Farmerauthor=A.+Pattanayakauthor=A.+Binkowskiauthor=X.+K.+Huangauthor=M.+Avramauthor=S.+Krishnaauthor=E.+Vollauthor=J.+Paveseauthor=J.+Chavezauthor=J.+Bruceauthor=A.+Mazarauthor=A.+Nibbsauthor=W.+Andersonauthor=L.+Liauthor=B.+Jovanovicauthor=S.+Pruellauthor=M.+Valsecchiauthor=G.+Franciaauthor=R.+Betoriauthor=K.+Scheidtauthor=R.+Bergan&title=Precision+therapeutic+targeting+of+human+cancer+cell+motility&doi=10.1038%2Fs41467-018-04465-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Precision therapeutic targeting of human cancer cell motility</span></div><div class="casAuthors">Xu Li; Huang Xiaoke; Krishna Sankar; Voll Eric; Pavese Janet; Pruell Sean; Valsecchi Matias; Xu Li; Gordon Ryan; Pattanayak Abhinandan; Bergan Raymond; Farmer Rebecca; Mazar Andrew; Nibbs Antoinette; Betori Rick; Scheidt Karl; Binkowski Andrew; Avram Michael; Chavez Juan; Bruce James; Anderson Wayne; Li Lin; Jovanovic Borko; Francia Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2454</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increased cancer cell motility constitutes a root cause of end organ destruction and mortality, but its complex regulation represents a barrier to precision targeting.  We use the unique characteristics of small molecules to probe and selectively modulate cell motility.  By coupling efficient chemical synthesis routes to multiple upfront in parallel phenotypic screens, we identify that KBU2046 inhibits cell motility and cell invasion in vitro.  Across three different murine models of human prostate and breast cancer, KBU2046 inhibits metastasis, decreases bone destruction, and prolongs survival at nanomolar blood concentrations after oral administration.  Comprehensive molecular, cellular and systemic-level assays all support a high level of selectivity.  KBU2046 binds chaperone heterocomplexes, selectively alters binding of client proteins that regulate motility, and lacks all the hallmarks of classical chaperone inhibitors, including toxicity.  We identify a unique cell motility regulatory mechanism and synthesize a targeted therapeutic, providing a platform to pursue studies in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTEhMxiVKBI9ysZ1x6zOs0vfW6udTcc2ebMU1vo6rUYz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FhtVSqsQ%253D%253D&md5=ddd8197485a52f20bc8bc406480f1c87</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-04465-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-04465-5%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DFarmer%26aufirst%3DR.%26aulast%3DPattanayak%26aufirst%3DA.%26aulast%3DBinkowski%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DX.%2BK.%26aulast%3DAvram%26aufirst%3DM.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DVoll%26aufirst%3DE.%26aulast%3DPavese%26aufirst%3DJ.%26aulast%3DChavez%26aufirst%3DJ.%26aulast%3DBruce%26aufirst%3DJ.%26aulast%3DMazar%26aufirst%3DA.%26aulast%3DNibbs%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DJovanovic%26aufirst%3DB.%26aulast%3DPruell%26aufirst%3DS.%26aulast%3DValsecchi%26aufirst%3DM.%26aulast%3DFrancia%26aufirst%3DG.%26aulast%3DBetori%26aufirst%3DR.%26aulast%3DScheidt%26aufirst%3DK.%26aulast%3DBergan%26aufirst%3DR.%26atitle%3DPrecision%2520therapeutic%2520targeting%2520of%2520human%2520cancer%2520cell%2520motility%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D2454%26doi%3D10.1038%2Fs41467-018-04465-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L. G.</span></span> <span> </span><span class="NLM_article-title">Dcz3112, a novel hsp90 inhibitor, exerts potent antitumor activity against her2-positive breast cancer through disruption of hsp90-cdc37 interaction</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.canlet.2018.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=30017966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKmur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2018&pages=70-80&author=X.+L.+Chenauthor=P.+Liuauthor=Q.+R.+Wangauthor=Y.+Liauthor=L.+Fuauthor=H.+Y.+Fuauthor=J.+M.+Zhuauthor=Z.+Q.+Chenauthor=W.+L.+Zhuauthor=C.+Y.+Xieauthor=L.+G.+Lou&title=Dcz3112%2C+a+novel+hsp90+inhibitor%2C+exerts+potent+antitumor+activity+against+her2-positive+breast+cancer+through+disruption+of+hsp90-cdc37+interaction&doi=10.1016%2Fj.canlet.2018.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction</span></div><div class="casAuthors">Chen, Xiangling; Liu, Peng; Wang, Quanren; Li, Yun; Fu, Li; Fu, Haoyu; Zhu, Jianming; Chen, Zhaoqiang; Zhu, Weiliang; Xie, Chengying; Lou, Liguang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-80</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hsp90 regulates the stability of oncoproteins important in tumor development and progression, and represents a potential therapeutic target.  However, all Hsp90 inhibitors currently in clin. trials target Hsp90 ATPase activity and exhibit low selectivity and high toxicity.  In this study, we discovered a new Hsp90 inhibitor, DCZ3112, with a novel mechanism of action.  DCZ3112 directly bound to the N-terminal domain of Hsp90 and inhibited Hsp90-Cdc37 interaction without inhibiting ATPase activity.  DCZ3112 inhibited the proliferation predominantly in HER2-pos. breast cancer cells, including those resistant to the classical Hsp90 inhibitor geldanamycin, which mainly targets ATPase.  DCZ3112 produced synergistic in vitro activity in inhibiting cell proliferation, inducing G1-phase arrest and apoptosis, and reducing AKT and ERK phosphorylation.  Consistent with this, DCZ3112 alone inhibited the growth of HER2-pos. BT-474 xenografts, and exhibited enhanced antitumor activity when combined with the anti-HER2 antibody trastuzumab.  Importantly, DCZ3112 also significantly inhibited the growth of trastuzumab-resistant BT-474 cells, and combined treatment retained synergistic antitumor activity.  Thus, our findings show that disrupting Hsp90-Cdc37 interaction may represent a promising strategy against HER2-pos. breast cancer, esp. those with acquired resistance to trastuzumab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq61vGUgD2y7LVg90H21EOLACvtfcHk0lhtuBgUiVHFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKmur%252FP&md5=b1b995c35747c963804982f0e0700379</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DQ.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DH.%2BY.%26aulast%3DZhu%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DZ.%2BQ.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DXie%26aufirst%3DC.%2BY.%26aulast%3DLou%26aufirst%3DL.%2BG.%26atitle%3DDcz3112%252C%2520a%2520novel%2520hsp90%2520inhibitor%252C%2520exerts%2520potent%2520antitumor%2520activity%2520against%2520her2-positive%2520breast%2520cancer%2520through%2520disruption%2520of%2520hsp90-cdc37%2520interaction%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D434%26spage%3D70%26epage%3D80%26doi%3D10.1016%2Fj.canlet.2018.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, L.</span></span> <span> </span><span class="NLM_article-title">A novel class of small molecule inhibitors of hsp90</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1021/cb800162x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb800162x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=645-654&author=F.+Yiauthor=L.+Regan&title=A+novel+class+of+small+molecule+inhibitors+of+hsp90&doi=10.1021%2Fcb800162x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Class of Small Molecule Inhibitors of Hsp90</span></div><div class="casAuthors">Yi, Fang; Regan, Lynne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">645-654</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Unregulated cellular proliferation, caused by mutation or dysregulation of growth-promoting proteins, is an underlying cause of cancer.  Many such growth-promoting proteins exhibit an increased dependence on the activity of the chaperone heat-shock protein 90 (Hsp90) for correct folding and maturation in the cell.  One can therefore envision that inhibition of Hsp90 would be an effective and broadly applicable strategy for the development of anticancer agents.  Hsp90 functions in multichaperone complexes driven by the binding and hydrolysis of ATP.  Encouraging results have been obtained by inhibiting Hsp90 with 17-AAG, an active-site binding ATP analog.  Here we present the results of a different approach to inhibiting Hsp90 by disrupting its interaction with a cochaperone named Hsp organizing protein (HOP).  We have used an AlphaScreen technol. based high-throughput in vitro screen to identify compds. that inhibit this interaction.  In addn., we demonstrate that these compds. are active in vivo.  Treatment of human breast cancer cell lines BT474 and SKBR3 with these compds. decreases the levels of the Hsp90-dependent client protein HER2, with assocd. cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovstWzsi2PILVg90H21EOLACvtfcHk0lhtuBgUiVHFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrsrjE&md5=ff2403160252e80306cca52c1e12db64</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fcb800162x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb800162x%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DF.%26aulast%3DRegan%26aufirst%3DL.%26atitle%3DA%2520novel%2520class%2520of%2520small%2520molecule%2520inhibitors%2520of%2520hsp90%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D645%26epage%3D654%26doi%3D10.1021%2Fcb800162x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L. G.</span></span> <span> </span><span class="NLM_article-title">Y-632 inhibits heat shock protein 90 (hsp90) function by disrupting the interaction between hsp90 and hsp70/hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo</span>. <i>Cancer. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1111/cas.12934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1111%2Fcas.12934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27002306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslOjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=782-790&author=W.+Q.+Wangauthor=Y.+Liuauthor=Z.+X.+Zhaoauthor=C.+Y.+Xieauthor=Y.+P.+Xuauthor=Y.+H.+Huauthor=H.+T.+Quanauthor=L.+G.+Lou&title=Y-632+inhibits+heat+shock+protein+90+%28hsp90%29+function+by+disrupting+the+interaction+between+hsp90+and+hsp70%2Fhsp90+organizing+protein%2C+and+exerts+antitumor+activity+in+vitro+and+in+vivo&doi=10.1111%2Fcas.12934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo</span></div><div class="casAuthors">Wang, Wenqian; Liu, Yang; Zhao, Zhixin; Xie, Chengying; Xu, Yongping; Hu, Youhong; Quan, Haitian; Lou, Liguang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">782-790</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) stabilizes a variety of proteins required for cancer cell survival and has been identified as a promising drug target for cancer treatment.  To date, several Hsp90 inhibitors have entered into clin. trials, but none has been approved for cancer therapy yet.  Thus, exploring new Hsp90 inhibitors with novel mechanisms of action is urgent.  In the present study, we show that Y-632, a novel pyrimidine deriv., inhibited Hsp90 in a different way from the conventional Hsp90 inhibitor geldanamycin.  Y-632 induced degrdn. of diverse Hsp90 client proteins through the ubiquitin-proteasome pathway, as geldanamycin did; however, it neither directly bound to Hsp90 nor inhibited Hsp90 ATPase activity.  Y-632 inhibited Hsp90 function mainly through inducing intracellular thiol oxidn., which led to disruption of the Hsp90-Hsp70/Hsp90 organizing protein complex and further induced cell adhesion inhibition, G0/G1 cell cycle arrest, and apoptosis.  Moreover, Y-632 efficiently overcame imatinib resistance mediated by Bcr-Abl point mutations both in vitro and in vivo.  We believe that Y-632, acting as a novel small-mol. inhibitor of the Hsp90-Hsp70/Hsp90 organizing protein complex, has great potential to be a promising Hsp90 inhibitor for cancer therapy, such as for imatinib-resistant leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb3SWb5XmEcrVg90H21EOLACvtfcHk0lj90edMfigXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslOjtL0%253D&md5=30bfc6b358cfb2e140434ff5b730b6c3</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1111%2Fcas.12934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12934%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%2BX.%26aulast%3DXie%26aufirst%3DC.%2BY.%26aulast%3DXu%26aufirst%3DY.%2BP.%26aulast%3DHu%26aufirst%3DY.%2BH.%26aulast%3DQuan%26aufirst%3DH.%2BT.%26aulast%3DLou%26aufirst%3DL.%2BG.%26atitle%3DY-632%2520inhibits%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520function%2520by%2520disrupting%2520the%2520interaction%2520between%2520hsp90%2520and%2520hsp70%252Fhsp90%2520organizing%2520protein%252C%2520and%2520exerts%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer.%2520Sci.%26date%3D2016%26volume%3D107%26spage%3D782%26epage%3D790%26doi%3D10.1111%2Fcas.12934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitt, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinkers, M.</span></span> <span> </span><span class="NLM_article-title">Overlapping sites of tetratricopeptide repeat protein binding and chaperone activity in heat shock protein 90</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">17857</span>– <span class="NLM_lpage">17862</span>, <span class="refDoi"> DOI: 10.1074/jbc.M001625200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M001625200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10751404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFakur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=17857-17862&author=A.+J.+Ramseyauthor=L.+C.+Russellauthor=S.+R.+Whittauthor=M.+Chinkers&title=Overlapping+sites+of+tetratricopeptide+repeat+protein+binding+and+chaperone+activity+in+heat+shock+protein+90&doi=10.1074%2Fjbc.M001625200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Overlapping sites of tetratricopeptide repeat protein binding and chaperone activity in heat shock protein 90</span></div><div class="casAuthors">Ramsey, Andrew J.; Russell, Lance C.; Whitt, Sherry R.; Chinkers, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">17857-17862</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The sequential binding of different tetratricopeptide repeat (TPR) proteins to heat shock protein 90 (hsp90) is essential to its chaperone function in vivo.  We have previously shown that three basic residues in the TPR domain of PP5 are required for binding to the acidic C-terminal domain of hsp90.  We have now tested which acidic residues in this C-terminal domain are required for binding to three different TPR proteins as follows: PP5, FKBP52, and Hop.  Mutation of Glu-279, Glu-730, and Asp-732 at the C terminus of hsp90 interfered with binding of all three TPR proteins.  Mutation of Glu-720, Asp-722, Asp-723, and Asp-724 inhibited binding of FKBP52 and PP5 but not of Hop.  Mutation of Glu-651 and Asp-653 did not affect binding of FKBP52 or PP5 but inhibited both Hop binding and hsp90 chaperone activity.  We also found that a conserved Lys residue required for PP5 binding to hsp90 was crit. for the binding of FKBP52 but not for the binding of Hop to hsp90.  These results suggest distinct but overlapping binding sites on hsp90 for different TPR proteins and indicate that the binding site for Hop, which is assocd. with hsp90 in intermediate stages of protein folding, overlaps with a site of chaperone activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjEclxxKhPLVg90H21EOLACvtfcHk0lj90edMfigXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFakur8%253D&md5=5bf7f5a12cd22debdb4104eb1beac0da</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001625200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001625200%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DA.%2BJ.%26aulast%3DRussell%26aufirst%3DL.%2BC.%26aulast%3DWhitt%26aufirst%3DS.%2BR.%26aulast%3DChinkers%26aufirst%3DM.%26atitle%3DOverlapping%2520sites%2520of%2520tetratricopeptide%2520repeat%2520protein%2520binding%2520and%2520chaperone%2520activity%2520in%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D17857%26epage%3D17862%26doi%3D10.1074%2Fjbc.M001625200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, S. R.</span></span> <span> </span><span class="NLM_article-title">A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2013.11.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24360559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOku73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=661-666&author=J.+R.+McConnellauthor=L.+A.+Alexanderauthor=S.+R.+McAlpine&title=A+heat+shock+protein+90+inhibitor+that+modulates+the+immunophilins+and+regulates+hormone+receptors+without+inducing+the+heat+shock+response&doi=10.1016%2Fj.bmcl.2013.11.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response</span></div><div class="casAuthors">McConnell, Jeanette R.; Alexander, Leslie A.; McAlpine, Shelli R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-666</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">When a cell encounters external stressors, such as lack of nutrients, elevated temps., changes in pH or other stressful environments, a key set of evolutionarily conserved proteins, the heat shock proteins (hsps), become overexpressed.  Hsps are classified into six major families with the hsp90 family being the best understood; an increase in cell stress leads to increased levels of hsp90, which leads to cellular protection.  A hallmark of hsp90 inhibitors is that they induce a cell rescue mechanism, the heat shock response.  The authors define the unique mol. profile of a compd. (SM145) that regulates hormone receptor protein levels through hsp90 inhibition without inducing the heat shock response.  Modulation of the binding event between heat shock protein 90 and the immunophilins/homologs using SM145, leads to a decrease in hormone receptor protein levels.  Unlike N-terminal hsp90 inhibitors, this hsp90 inhibitor does not induce a heat shock response.  This work is proof of principle that controlling hormone receptor expression can occur by inhibiting hsp90 without inducing pro-survival protein heat shock protein 70 (hsp70) or other proteins assocd. with the heat shock response.  Innovatively, the authors show that blocking the heat shock response, in addn. to hsp90, is key to regulating hsp90-assocd. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-Jpd-Yb7brVg90H21EOLACvtfcHk0lj90edMfigXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOku73E&md5=a28c42be8b45e6e9525cf47096f3c2e8</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DMcConnell%26aufirst%3DJ.%2BR.%26aulast%3DAlexander%26aufirst%3DL.%2BA.%26aulast%3DMcAlpine%26aufirst%3DS.%2BR.%26atitle%3DA%2520heat%2520shock%2520protein%252090%2520inhibitor%2520that%2520modulates%2520the%2520immunophilins%2520and%2520regulates%2520hormone%2520receptors%2520without%2520inducing%2520the%2520heat%2520shock%2520response%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D661%26epage%3D666%26doi%3D10.1016%2Fj.bmcl.2013.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Retzlaff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitschke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">Asymmetric activation of the hsp90 dimer by its cochaperone aha1</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.molcel.2010.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20159554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=344-354&author=M.+Retzlaffauthor=F.+Hagnauthor=L.+Mitschkeauthor=M.+Hesslingauthor=F.+Gugelauthor=H.+Kesslerauthor=K.+Richterauthor=J.+Buchner&title=Asymmetric+activation+of+the+hsp90+dimer+by+its+cochaperone+aha1&doi=10.1016%2Fj.molcel.2010.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric activation of the Hsp90 dimer by its cochaperone Aha1</span></div><div class="casAuthors">Retzlaff, Marco; Hagn, Franz; Mitschke, Lars; Hessling, Martin; Gugel, Frederik; Kessler, Horst; Richter, Klaus; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-354</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The chaperone Hsp90 is an ATP-dependent, dimeric mol. machine regulated by several cochaperones, including inhibitors and the unique ATPase activator Aha1.  Here, we analyzed the mechanism of the Aha1-mediated acceleration of Hsp90 ATPase activity and identified the interaction surfaces of both proteins using multidimensional NMR techniques.  For max. activation of Hsp90, the two domains of Aha1 bind to sites in the middle and N-terminal domains of Hsp90 in a sequential manner.  This binding induces the kinetically unfavored N terminally dimerized state of Hsp90, which primes for the hydrolysis-competent conformation.  Surprisingly, this activation mechanism is asym.  The presence of one Aha1 mol. per Hsp90 dimer is sufficient to bridge the two subunits and to fully stimulate Hsp90 ATPase activity.  This seems to functionalize the two subunits of the Hsp90 dimer in different ways, in that one subunit can be used for conformational ATPase regulation and the other for substrate protein processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6haR106PYbVg90H21EOLACvtfcHk0lj90edMfigXJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktbo%253D&md5=a57a2df1a7d29f1388d1e426fd3b8772</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DRetzlaff%26aufirst%3DM.%26aulast%3DHagn%26aufirst%3DF.%26aulast%3DMitschke%26aufirst%3DL.%26aulast%3DHessling%26aufirst%3DM.%26aulast%3DGugel%26aufirst%3DF.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DAsymmetric%2520activation%2520of%2520the%2520hsp90%2520dimer%2520by%2520its%2520cochaperone%2520aha1%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D37%26spage%3D344%26epage%3D354%26doi%3D10.1016%2Fj.molcel.2010.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koulov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPointe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razvi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, W. E.</span></span> <span> </span><span class="NLM_article-title">Biological and structural basis for aha1 regulation of hsp90 atpase activity in maintaining proteostasis in the human disease cystic fibrosis</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1091/mbc.e09-12-1017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1091%2Fmbc.e09-12-1017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20089831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1eqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=871-884&author=A.+V.+Koulovauthor=P.+LaPointeauthor=B.+W.+Luauthor=A.+Razviauthor=J.+Coppingerauthor=M.+Q.+Dongauthor=J.+Mattesonauthor=R.+Laisterauthor=C.+Arrowsmithauthor=J.+R.+Yatesauthor=W.+E.+Balch&title=Biological+and+structural+basis+for+aha1+regulation+of+hsp90+atpase+activity+in+maintaining+proteostasis+in+the+human+disease+cystic+fibrosis&doi=10.1091%2Fmbc.e09-12-1017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis</span></div><div class="casAuthors">Koulov, Atanas V.; La Pointe, Paul; Lu, Bingwen; Razvi, Abbas; Coppinger, Judith; Dong, Meng-Qiu; Matteson, Jeanne; Laister, Rob; Arrowsmith, Cheryl; Yates, John R., III; Balch, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">871-884</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The activator of Hsp90 ATPase 1, Aha1, has been shown to participate in the Hsp90 chaperone cycle by stimulating the low intrinsic ATPase activity of Hsp90.  To elucidate the structural basis for ATPase stimulation of human Hsp90 by human Aha1, the authors have developed novel mass spectrometry approaches that demonstrate that the N- and C-terminal domains of Aha1 cooperatively bind across the dimer interface of Hsp90 to modulate the ATP hydrolysis cycle and client activity in vivo.  Mutations in both the N- and C-terminal domains of Aha1 impair its ability to bind Hsp90 and stimulate its ATPase activity in vitro and impair in vivo the ability of the Hsp90 system to modulate the folding and trafficking of wild-type and variant (ΔF508) cystic fibrosis transmembrane conductance regulator (CFTR) responsible for the inherited disease cystic fibrosis (CF).  The authors now propose a general model for the role of Aha1 in the Hsp90 ATPase cycle in proteostasis whereby Aha1 regulates the dwell time of Hsp90 with client.  The authors suggest that Aha1 activity integrates chaperone function with client folding energetics by modulating ATPase sensitive N-terminal dimer structural transitions, thereby protecting transient folding intermediates in vivo that could contribute to protein misfolding systems disorders such as CF when destabilized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXgOZEiYJ7ELVg90H21EOLACvtfcHk0lhJxIc_leVTtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1eqs7w%253D&md5=c4e6b806b8571f42253d9cece24d8011</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e09-12-1017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e09-12-1017%26sid%3Dliteratum%253Aachs%26aulast%3DKoulov%26aufirst%3DA.%2BV.%26aulast%3DLaPointe%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DB.%2BW.%26aulast%3DRazvi%26aufirst%3DA.%26aulast%3DCoppinger%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DM.%2BQ.%26aulast%3DMatteson%26aufirst%3DJ.%26aulast%3DLaister%26aufirst%3DR.%26aulast%3DArrowsmith%26aufirst%3DC.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DBalch%26aufirst%3DW.%2BE.%26atitle%3DBiological%2520and%2520structural%2520basis%2520for%2520aha1%2520regulation%2520of%2520hsp90%2520atpase%2520activity%2520in%2520maintaining%2520proteostasis%2520in%2520the%2520human%2520disease%2520cystic%2520fibrosis%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2010%26volume%3D21%26spage%3D871%26epage%3D884%26doi%3D10.1091%2Fmbc.e09-12-1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, C. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlasic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H</span></span> <span> </span><span class="NLM_article-title">Structural basis for recruitment of the atpase activator aha1 to the hsp90 chaperone machinery</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7600060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fsj.emboj.7600060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14739935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtV2ru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=511-519&author=P.+Meyerauthor=C.+Prodromouauthor=C.+Liaoauthor=B.+Huauthor=S.+M.+Roeauthor=C.+K+Vaughanauthor=I.+Vlasicauthor=B.+Panaretouauthor=P.+W+Piperauthor=L.+H+Pearl&title=Structural+basis+for+recruitment+of+the+atpase+activator+aha1+to+the+hsp90+chaperone+machinery&doi=10.1038%2Fsj.emboj.7600060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery</span></div><div class="casAuthors">Meyer, Philippe; Prodromou, Chrisostomos; Liao, Chunyan; Hu, Bin; Roe, S. Mark; Vaughan, Cara K.; Vlasic, Ignacija; Panaretou, Barry; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-519</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hsp90 is a mol. chaperone essential for the activation and assembly of many key eukaryotic signaling and regulatory proteins.  Hsp90 is assisted and regulated by co-chaperones that participate in an ordered series of dynamic multiprotein complexes, linked to Hsp90s conformationally coupled ATPase cycle.  The co-chaperones Aha1 and Hch1 bind to Hsp90 and stimulate its ATPase activity.  Biochem. anal. shows that this activity is dependent on the N-terminal domain of Aha1, which interacts with the central segment of Hsp90.  The structural basis for this interaction is revealed by the crystal structure of the N-terminal domain (1-153) of Aha1 (equiv. to the whole of Hch1) in complex with the middle segment of Hsp90 (273-530).  Structural anal. and mutagenesis show that binding of N-Aha1 promotes a conformational switch in the middle-segment catalytic loop (370-390) of Hsp90 that releases the catalytic Arg-380 and enables its interaction with ATP in the N-terminal nucleotide-binding domain of the chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpiG2JApXabrVg90H21EOLACvtfcHk0lhJxIc_leVTtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtV2ru7c%253D&md5=8e1699ec0804e3649a613710ba6e9001</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600060%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DVaughan%26aufirst%3DC.%2BK%26aulast%3DVlasic%26aufirst%3DI.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW%26aulast%3DPearl%26aufirst%3DL.%2BH%26atitle%3DStructural%2520basis%2520for%2520recruitment%2520of%2520the%2520atpase%2520activator%2520aha1%2520to%2520the%2520hsp90%2520chaperone%2520machinery%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D511%26epage%3D519%26doi%3D10.1038%2Fsj.emboj.7600060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiegler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbelke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korotkov, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">A chemical compound inhibiting the aha1-hsp90 chaperone complex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">17073</span>– <span class="NLM_lpage">17083</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.797829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M117.797829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28851842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Cqu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=17073-17083&author=S.+C.+Stieglerauthor=M.+Rubbelkeauthor=V.+S.+Korotkovauthor=M.+Weiwadauthor=C.+Johnauthor=G.+Fischerauthor=S.+A.+Sieberauthor=M.+Sattlerauthor=J.+Buchner&title=A+chemical+compound+inhibiting+the+aha1-hsp90+chaperone+complex&doi=10.1074%2Fjbc.M117.797829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical compound inhibiting the Aha1-Hsp90 chaperone complex</span></div><div class="casAuthors">Stiegler, Sandrine C.; Ruebbelke, Martin; Korotkov, Vadim S.; Weiwad, Matthias; John, Christine; Fischer, Gunter; Sieber, Stephan A.; Sattler, Michael; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">17073-17083</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The eukaryotic Hsp90 chaperone machinery comprises many co-chaperones and regulates the conformation of hundreds of cytosolic client proteins.  Therefore, it is not surprising that the Hsp90 machinery has become an attractive therapeutic target for diseases such as cancer.  The compds. used so far to target this machinery affect the entire Hsp90 system.  However, it would be desirable to achieve a more selective targeting of Hsp90-co-chaperone complexes.  To test this concept, in this-proof-of-principle study, the authors screened for modulators of the interaction between Hsp90 and its co-chaperone Aha1, which accelerates the ATPase activity of Hsp90.  A FRET-based assay that monitored Aha1 binding to Hsp90 enabled identification of several chem. compds. modulating the effect of Aha1 on Hsp90 activity.  The authors found that one of these inhibitors can abrogate the Aha1-induced ATPase stimulation of Hsp90 without significantly affecting Hsp90 ATPase activity in the absence of Aha1.  NMR spectroscopy revealed that this inhibitory compd. binds the N-terminal domain of Hsp90 close to its ATP-binding site and overlapping with a transient Aha1-interaction site.  The authors also noted that this inhibitor does not dissoc. the Aha1-Hsp90 complex but prevents the specific interaction with the N-terminal domain of Hsp90 required for catalysis.  In consequence, the inhibitor affected the activation and processing of Hsp90-Aha1-dependent client proteins in vivo.  The authors conclude that it is possible to abrogate a specific co-chaperone function of Hsp90 without inhibiting the entire Hsp90 machinery.  This concept may also hold true for other co-chaperones of Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWjWH-WJgm7Vg90H21EOLACvtfcHk0liJgxYE25RSvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Cqu7fF&md5=f1ea46c7c36e9b146f0efd3c91832d9c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.797829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.797829%26sid%3Dliteratum%253Aachs%26aulast%3DStiegler%26aufirst%3DS.%2BC.%26aulast%3DRubbelke%26aufirst%3DM.%26aulast%3DKorotkov%26aufirst%3DV.%2BS.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DJohn%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DA%2520chemical%2520compound%2520inhibiting%2520the%2520aha1-hsp90%2520chaperone%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D17073%26epage%3D17083%26doi%3D10.1074%2Fjbc.M117.797829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuniga-Pflucker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguila, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldschneider, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span> <span> </span><span class="NLM_article-title">Gp96, an endoplasmic reticulum master chaperone for integrins and toll-like receptors, selectively regulates early t and b lymphopoiesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2380</span>– <span class="NLM_lpage">2390</span>, <span class="refDoi"> DOI: 10.1182/blood-2009-07-233031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1182%2Fblood-2009-07-233031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19965672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2380-2390&author=M.+Staronauthor=Y.+Yangauthor=B.+Liuauthor=J.+Liauthor=Y.+K.+Shenauthor=J.+C.+Zuniga-Pfluckerauthor=H.+L.+Aguilaauthor=I.+Goldschneiderauthor=Z.+H.+Li&title=Gp96%2C+an+endoplasmic+reticulum+master+chaperone+for+integrins+and+toll-like+receptors%2C+selectively+regulates+early+t+and+b+lymphopoiesis&doi=10.1182%2Fblood-2009-07-233031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis</span></div><div class="casAuthors">Staron, Matthew; Yang, Yi; Liu, Bei; Li, Janet; Shen, Yuankai; Zuniga-Pflucker, Juan Carlos; Aguila, Hector L.; Goldschneider, Irving; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2380-2390</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Integrins contribute to lymphopoiesis, whereas Toll-like receptors (TLRs) facilitate the myeloid replenishment during inflammation.  The combined role of TLRs and integrin on hematopoiesis remains unclear.  Gp96 (grp94, HSP90b1) is an endoplasmic reticulum master chaperone for multiple TLRs.  We report herein that gp96 is also essential for expression of 14 hematopoietic system-specific integrins.  Genetic deletion of gp96 thus enables us to det. the collective roles of gp96, Integrins, and TLRs in hematopoiesis.  We found that gp96-null hematopoietic stem cells could support long-term myelopoiesis.  B- and T-cell development, however, was severely compromised with transitional block from pro-B to pre-B cells and the inability of thymocytes to develop beyond the CD4-CD8- stage.  These defects were cell-intrinsic and could be recapitulated on bone marrow stromal cell culture.  Furthermore, defective lymphopoiesis correlated strongly with failure of hematopoietic progenitors to form close contact with stromal cell niche and was not the result of the defect in the assembly of antigen receptor or interleukin-7 signaling.  These findings define gp96 as the only known mol. chaperone to specifically regulate T- and B-cell development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNk-bPWPJeWLVg90H21EOLACvtfcHk0lhvHQyqXJHeaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlOkurc%253D&md5=eef1c142b09de6d0856b121d25eaed54</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-233031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-233031%26sid%3Dliteratum%253Aachs%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%2BK.%26aulast%3DZuniga-Pflucker%26aufirst%3DJ.%2BC.%26aulast%3DAguila%26aufirst%3DH.%2BL.%26aulast%3DGoldschneider%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26atitle%3DGp96%252C%2520an%2520endoplasmic%2520reticulum%2520master%2520chaperone%2520for%2520integrins%2520and%2520toll-like%2520receptors%252C%2520selectively%2520regulates%2520early%2520t%2520and%2520b%2520lymphopoiesis%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2380%26epage%3D2390%26doi%3D10.1182%2Fblood-2009-07-233031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Paralog specific hsp90 inhibitors - a brief history and a bright future</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F1568026616666160413141154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27072700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2779-2791&author=D.+T.+Gewirth&title=Paralog+specific+hsp90+inhibitors+-+a+brief+history+and+a+bright+future&doi=10.2174%2F1568026616666160413141154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future</span></div><div class="casAuthors">Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2779-2791</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background. The high sequence and structural homol. among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition.  Objective. This review surveys the state of developments in structural anal., compd. screening, and structure-based design that have been brought to bear on this problem.  Results. First generation compds. that selectively bind to Hsp90, Grp94, or Trap-1 have been identified.  Conclusion. With the proof of principle firmly established, the prospects for further progress are bright.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdyZyrXOyou7Vg90H21EOLACvtfcHk0lhvHQyqXJHeaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN&md5=208025ff36aa6e2d92d3ee107b20ab5f</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141154%26sid%3Dliteratum%253Aachs%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DParalog%2520specific%2520hsp90%2520inhibitors%2520-%2520a%2520brief%2520history%2520and%2520a%2520bright%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2779%26epage%3D2791%26doi%3D10.2174%2F1568026616666160413141154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baldo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paganetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span> <span> </span><span class="NLM_article-title">A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (hsp90) client protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">1406</span>– <span class="NLM_lpage">1414</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.294801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M111.294801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22123826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjslyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=1406-1414&author=B.+Baldoauthor=A.+Weissauthor=C.+N.+Parkerauthor=M.+Bibelauthor=P.+Paganettiauthor=K.+Kaupmann&title=A+screen+for+enhancers+of+clearance+identifies+huntingtin+as+a+heat+shock+protein+90+%28hsp90%29+client+protein&doi=10.1074%2Fjbc.M111.294801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein</span></div><div class="casAuthors">Baldo, Barbara; Weiss, Andreas; Parker, Christian N.; Bibel, Miriam; Paganetti, Paolo; Kaupmann, Klemens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1406-1414</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mechanisms to reduce the cellular levels of mutant huntingtin (mHtt) provide promising strategies for treating Huntington disease (HD).  To identify compds. enhancing the degrdn. of mHtt, we performed a high throughput screen using a hippocampal HN10 cell line expressing a 573-amino acid mHtt fragment.  Several hit structures were identified as heat shock protein 90 (Hsp90) inhibitors.  Cell treatment with these compds. reduced levels of mHtt without overt toxic effects as measured by time-resolved Foerster resonance energy transfer assays and Western blots.  To characterize the mechanism of mHtt degrdn., we used the potent and selective Hsp90 inhibitor NVP-AUY922.  In HdhQ150 embryonic stem (ES) cells and in ES cell-derived neurons, NVP-AUY922 treatment substantially reduced sol. full-length mHtt levels.  In HN10 cells, Hsp90 inhibition by NVP-AUY922 enhanced mHtt clearance in the absence of any detectable Hsp70 induction.  Furthermore, inhibition of protein synthesis with cycloheximide or overexpression of dominant neg. heat shock factor 1 (Hsf1) in HdhQ150 ES cells attenuated Hsp70 induction but did not affect NVP-AUY922-mediated mHtt clearance.  Together, these data provided evidence that direct inhibition of Hsp90 chaperone function was crucial for mHtt degrdn. rather than heat shock response induction and Hsp70 up-regulation.  Co-immunopptn. expts. revealed a phys. interaction of mutant and wild-type Htt with the Hsp90 chaperone.  Hsp90 inhibition disrupted the interaction and induced clearance of Htt through the ubiquitin-proteasome system.  These data suggest that Htt is an Hsp90 client protein and that Hsp90 inhibition may provide a means to reduce mHtt in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBzgxmFERTErVg90H21EOLACvtfcHk0lg1iWcj_gGjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjslyksw%253D%253D&md5=b0cde124dc9c309851719560d6e44f28</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.294801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.294801%26sid%3Dliteratum%253Aachs%26aulast%3DBaldo%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DC.%2BN.%26aulast%3DBibel%26aufirst%3DM.%26aulast%3DPaganetti%26aufirst%3DP.%26aulast%3DKaupmann%26aufirst%3DK.%26atitle%3DA%2520screen%2520for%2520enhancers%2520of%2520clearance%2520identifies%2520huntingtin%2520as%2520a%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520client%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D1406%26epage%3D1414%26doi%3D10.1074%2Fjbc.M111.294801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vought, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Correlation between chemotype-dependent binding conformations of hsp90α/β and isoform selectivity—implications for the structure-based design of hsp90α/β selective inhibitors for treating neurodegenerative diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2013.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24332488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=204-208&author=J.+T.+Ernstauthor=M.+Liuauthor=H.+Zuccolaauthor=T.+Neubertauthor=K.+Beaumontauthor=A.+Turnbullauthor=A.+Kallelauthor=B.+Voughtauthor=D.+Stamos&title=Correlation+between+chemotype-dependent+binding+conformations+of+hsp90%CE%B1%2F%CE%B2+and+isoform+selectivity%E2%80%94implications+for+the+structure-based+design+of+hsp90%CE%B1%2F%CE%B2+selective+inhibitors+for+treating+neurodegenerative+diseases&doi=10.1016%2Fj.bmcl.2013.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span></div><div class="casAuthors">Ernst, Justin T.; Liu, Michael; Zuccola, Harmon; Neubert, Timothy; Beaumont, Kevin; Turnbull, Amy; Kallel, Adam; Vought, Bryan; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-208</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HSP90 continues to be a target of interest for neurodegeneration indications.  Selective knockdown of the HSP90 cytosolic isoforms α and β is sufficient to reduce mutant huntingtin protein levels in vitro.  Chemotype-dependent binding conformations of HSP90α/β appear to strongly influence isoform selectivity.  The rational design of HSP90α/β inhibitors selective vs. the mitochondrial (TRAP1) and endoplasmic reticulum (GRP94) isoforms offers a potential mitigating strategy for mechanism-based toxicities.  Better tolerated HSP90 inhibitors would be attractive for targeting chronic neurodegenerative diseases such as Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64ZOr5JsRerVg90H21EOLACvtfcHk0lg1iWcj_gGjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO&md5=6799a46090ee297d70700f7c42b79f80</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DKallel%26aufirst%3DA.%26aulast%3DVought%26aufirst%3DB.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DCorrelation%2520between%2520chemotype-dependent%2520binding%2520conformations%2520of%2520hsp90%25CE%25B1%252F%25CE%25B2%2520and%2520isoform%2520selectivity%25E2%2580%2594implications%2520for%2520the%2520structure-based%2520design%2520of%2520hsp90%25CE%25B1%252F%25CE%25B2%2520selective%2520inhibitors%2520for%2520treating%2520neurodegenerative%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D204%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2013.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woody, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcacio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Identification of novel hsp90 alpha/beta isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3400</span>, <span class="refDoi"> DOI: 10.1021/jm500042s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500042s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3382-3400&author=J.+T.+Ernstauthor=T.+Neubertauthor=M.+Liuauthor=S.+Sperryauthor=H.+Zuccolaauthor=A.+Turnbullauthor=B.+Fleckauthor=W.+Kargoauthor=L.+Woodyauthor=P.+Chiangauthor=D.+Tranauthor=W.+C.+Chenauthor=P.+Snyderauthor=T.+Alcacioauthor=A.+Nezamiauthor=J.+Reynoldsauthor=K.+Alviauthor=L.+Gouletauthor=D.+Stamos&title=Identification+of+novel+hsp90+alpha%2Fbeta+isoform+selective+inhibitors+using+structure-based+drug+design.+demonstration+of+potential+utility+in+treating+cns+disorders+such+as+huntington%E2%80%99s+disease&doi=10.1021%2Fjm500042s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease</span></div><div class="casAuthors">Ernst, Justin T.; Neubert, Timothy; Liu, Michael; Sperry, Samuel; Zuccola, Harmon; Turnbull, Amy; Fleck, Beth; Kargo, William; Woody, Lisa; Chiang, Peggy; Tran, Dao; Chen, Weichao; Snyder, Phillip; Alcacio, Timothy; Nezami, Azin; Reynolds, James; Alvi, Khisal; Goulet, Lance; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-based drug design strategy was used to optimize a novel benzolactam series of HSP90α/β inhibitors to achieve >1000-fold selectivity vs. the HSP90 endoplasmic reticulum and mitochondrial isoforms (GRP94 and TRAP1, resp.).  Selective HSP90α/β inhibitors were found to be equipotent to pan-HSP90 inhibitors in promoting the clearance of mutant huntington protein (mHtt) in vitro, however with less cellular toxicity.  Improved tolerability profiles may enable the use of HSP90α/β selective inhibitors in treating chronic neurodegenerative indications such as Huntington's disease (HD).  A potent, selective, orally available HSP90α/β inhibitor, 8-Cyclopentyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one, was identified that crosses the blood-brain barrier and demonstrated proof of concept by successfully reducing brain Htt levels following oral dosing in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKpHcuphxPXbVg90H21EOLACvtfcHk0lg1iWcj_gGjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D&md5=0d55fb738fc0f0615b5336b8dc17056a</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500042s%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DFleck%26aufirst%3DB.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DWoody%26aufirst%3DL.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DSnyder%26aufirst%3DP.%26aulast%3DAlcacio%26aufirst%3DT.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DAlvi%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520novel%2520hsp90%2520alpha%252Fbeta%2520isoform%2520selective%2520inhibitors%2520using%2520structure-based%2520drug%2520design.%2520demonstration%2520of%2520potential%2520utility%2520in%2520treating%2520cns%2520disorders%2520such%2520as%2520huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3382%26epage%3D3400%26doi%3D10.1021%2Fjm500042s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsumachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Tas-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1535-7163.MCT-14-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25416789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=14-22&author=S.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=H.+Hitotsumachiauthor=C.+Yoshimuraauthor=M.+Kitadeauthor=A.+Hashimotoauthor=K.+Itoauthor=A.+Gomoriauthor=K.+Takahashi&title=Tas-116%2C+a+highly+selective+inhibitor+of+heat+shock+protein+90%CE%B1+and+%CE%B2%2C+demonstrates+potent+antitumor+activity+and+minimal+ocular+toxicity+in+preclinical+models&doi=10.1158%2F1535-7163.MCT-14-0219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models</span></div><div class="casAuthors">Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins.  A no. of HSP90 inhibitors have been developed clin. for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic.  The 4-(1H-pyrazolo[3,4-b]pyridine-1-yl)benzamide TAS-116 is a selective inhibitor of cytosolic HSP90α and β that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1.  Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90α and β alone was sufficient to exert antitumor activity in certain tumor models.  One of the most notable HSP90-related adverse events universally obsd. to differing degrees in the clin. setting is visual disturbance.  A two-week administration of the isoxazole resorcinol NVP-AUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats.  In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue.  Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compd. in s.c. xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina.  Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors.  Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are obsd. with other compds. of this class.  Mol Cancer Ther; 14(1); 14-22. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB25Txc_IcKbVg90H21EOLACvtfcHk0ljMHhBF7NnzCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D&md5=3ffdc26a7f0178d4e44413e22c003f77</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0219%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DHitotsumachi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DKitade%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DGomori%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26atitle%3DTas-116%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%25CE%25B1%2520and%2520%25CE%25B2%252C%2520demonstrates%2520potent%2520antitumor%2520activity%2520and%2520minimal%2520ocular%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D14%26epage%3D22%26doi%3D10.1158%2F1535-7163.MCT-14-0219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Structure-guided design of an hsp90β n-terminal isoform-selective inhibitor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">425</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs41467-017-02013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29382832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=425&author=A.+Khandelwalauthor=C.+N.+Kentauthor=M.+Balchauthor=S.+Pengauthor=S.+J.+Mishraauthor=J.+Dengauthor=V.+W.+Dayauthor=W.+Liuauthor=C.+Subramanianauthor=M.+Cohen&title=Structure-guided+design+of+an+hsp90%CE%B2+n-terminal+isoform-selective+inhibitor&doi=10.1038%2Fs41467-017-02013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span></div><div class="casAuthors">Khandelwal Anuj; Mishra Sanket J; Kent Caitlin N; Blagg Brian S J; Balch Maurie; Peng Shuxia; Deng Junpeng; Matts Robert; Day Victor W; Liu Weiya; Holzbeierlein Jeffery M; Subramanian Chitra; Cohen Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">425</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression.  Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways.  Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response.  The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments.  Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels.  Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmyRre9-yoQBpyrDyM_m9cfW6udTcc2eYitiwZffcrmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D&md5=cfa47e314c9bdbc1c38802108330cba7</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBalch%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DV.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26atitle%3DStructure-guided%2520design%2520of%2520an%2520hsp90%25CE%25B2%2520n-terminal%2520isoform-selective%2520inhibitor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D425%26doi%3D10.1038%2Fs41467-017-02013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span> <span> </span><span class="NLM_article-title">The chaperone activity of grp94 toward insulin-like growth factor ii is necessary for the stress response to serum deprivation</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1855</span>– <span class="NLM_lpage">1864</span>, <span class="refDoi"> DOI: 10.1091/mbc.e08-04-0346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1091%2Fmbc.e08-04-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19158397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1855-1864&author=O.+Ostrovskyauthor=N.+T.+Ahmedauthor=Y.+Argon&title=The+chaperone+activity+of+grp94+toward+insulin-like+growth+factor+ii+is+necessary+for+the+stress+response+to+serum+deprivation&doi=10.1091%2Fmbc.e08-04-0346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone activity of GRP94 toward insulin-like growth factor II is necessary for the stress response to serum deprivation</span></div><div class="casAuthors">Ostrovsky, Olga; Ahmed, Noreen T.; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1855-1864</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Insulin-like growth factor (IGF)-II is a hormone with mitogenic activity for many cell types and tissues.  We demonstrate that its intracellular processing and secretion strictly depend on the endoplasmic reticulum chaperone glucose-regulated protein (GRP) 94.  GRP94 interacts phys. and transiently with pro-IGF-II intermediates, and its activity is essential for secretion of active IGF-II, thus establishing IGF-II as a client of GRP94.  Embryonic stem (ES) cells that lack GRP94 are hypersensitive to stress conditions such as serum deprivation and die by apoptosis because they cannot respond to the stress by producing active IGF-II.  This chaperone-client interaction may explain the previously documented antiapoptotic activity of GRP94 in a no. of stress responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknJ115ssE_rVg90H21EOLACvtfcHk0liuwlx0jCW13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D&md5=a38b8f235e33dd0e6c01fe3a04d3587e</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e08-04-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e08-04-0346%26sid%3Dliteratum%253Aachs%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DAhmed%26aufirst%3DN.%2BT.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DThe%2520chaperone%2520activity%2520of%2520grp94%2520toward%2520insulin-like%2520growth%2520factor%2520ii%2520is%2520necessary%2520for%2520the%2520stress%2520response%2520to%2520serum%2520deprivation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2009%26volume%3D20%26spage%3D1855%26epage%3D1864%26doi%3D10.1091%2Fmbc.e08-04-0346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, P. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. S</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Paralog-selective hsp90 inhibitors define tumor-specific regulation of her2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D+Patelauthor=P.+Yanauthor=P.+M+Seidlerauthor=H.+J+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+hsp90+inhibitors+define+tumor-specific+regulation+of+her2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lgXhGfTEpc_FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM%26aulast%3DPatel%26aufirst%3DH.%2BJ%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520her2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/jm9004708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.+C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials&doi=10.1021%2Fjm9004708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0ljyvU1-wZW_1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17%26doi%3D10.1021%2Fjm9004708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Que, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Structure based design of a grp94-selective inhibitor: exploiting a key residue in grp94 to optimize paralog-selective binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2793</span>– <span class="NLM_lpage">2805</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2793-2805&author=N.+Queauthor=V.+M.+Crowleyauthor=A.+S.+Duerfeldtauthor=J.+Zhaoauthor=C.+N.+Kentauthor=B.+S.+J.+Blaggauthor=D.+T.+Gewirth&title=Structure+based+design+of+a+grp94-selective+inhibitor%3A+exploiting+a+key+residue+in+grp94+to+optimize+paralog-selective+binding&doi=10.1021%2Facs.jmedchem.7b01608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding</span></div><div class="casAuthors">Que, Nanette L. S.; Crowley, Vincent M.; Duerfeldt, Adam S.; Zhao, Jinbo; Kent, Caitlin N.; Blagg, Brian S. J.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2793-2805</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 and Hsp90, the ER and cytoplasmic hsp90 paralogs, share a conserved ATP-binding pocket that has been targeted for therapeutics.  Paralog-selective inhibitors may lead to drugs with fewer side effects.  Here, the authors analyzed 1 (BnIm), a benzyl imidazole resorcinylic inhibitor, for its mode of binding.  The structures of 1 bound to Hsp90 and Grp94 reveal large conformational changes in Grp94 but not Hsp90 that expose site 2, a binding pocket adjacent to the central ATP cavity that is ordinarily blocked.  The Grp94:1 structure reveals a flipped pose of the resorcinylic scaffold that inserts into the exposed site 2.  The authors exploited this flipped binding pose to develop a Grp94-selective deriv. of 1.  The authors' structural anal. shows that the ability of the ligand to insert its benzyl imidazole substituent into site 1, a different side pocket off the ATP binding cavity, is the key to exposing site 2 in Grp94.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhACqcGHClIrVg90H21EOLACvtfcHk0lhhjW5pFJmH7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D&md5=a44f6bf0bd3df65cf20ca570a1ef37b8</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01608%26sid%3Dliteratum%253Aachs%26aulast%3DQue%26aufirst%3DN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520based%2520design%2520of%2520a%2520grp94-selective%2520inhibitor%253A%2520exploiting%2520a%2520key%2520residue%2520in%2520grp94%2520to%2520optimize%2520paralog-selective%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2793%26epage%3D2805%26doi%3D10.1021%2Facs.jmedchem.7b01608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Transformation of the non-selective aminocyclohexanol-based hsp90 inhibitor into a grp94-seletive scaffold</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=244-253&author=S.+J.+Mishraauthor=S.+Ghoshauthor=A.+R.+Stothertauthor=C.+A.+Dickeyauthor=B.+S.+J.+Blagg&title=Transformation+of+the+non-selective+aminocyclohexanol-based+hsp90+inhibitor+into+a+grp94-seletive+scaffold&doi=10.1021%2Facschembio.6b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold</span></div><div class="casAuthors">Mishra, Sanket J.; Ghosh, Suman; Stothert, Andrew R.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">244-253</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 kDa, Grp94, is the endoplasmic reticulum (ER) localized isoform of heat shock protein 90 (Hsp90) that is responsible for the trafficking and maturation of toll-like receptors, Igs, and integrins.  As a result, Grp94 has emerged as a therapeutic target to disrupt cellular communication, adhesion, and tumor proliferation, potentially with fewer side effects compared to pan-inhibitors of all Hsp90 isoforms.  Although, the N-terminal ATP binding site is highly conserved among all four Hsp90 isoforms, recent cocrystal structures of Grp94 have revealed subtle differences between Grp94 and other Hsp90 isoforms that has been exploited for the development of Grp94-selective inhibitors.  In the current study, a structure-based approach has been applied to a Grp94 nonselective compd., SNX 2112, which led to the development of 8j (ACO1), a Grp94-selective inhibitor that manifests ∼440 nM affinity and >200-fold selectivity against cytosolic Hsp90 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVr4w6ywqwLVg90H21EOLACvtfcHk0lhhjW5pFJmH7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF&md5=5e9924483ab0c13f9a819a2d4bda55ee</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DTransformation%2520of%2520the%2520non-selective%2520aminocyclohexanol-based%2520hsp90%2520inhibitor%2520into%2520a%2520grp94-seletive%2520scaffold%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D244%26epage%3D253%26doi%3D10.1021%2Facschembio.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of a grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+J.+Blagg&title=Development+of+a+grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhcBYER45Yglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of radamide analogs as grp94 inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4083</span>– <span class="NLM_lpage">4098</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2014.05.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25027801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4083-4098&author=A.+Muthauthor=V.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=J.+B.+Zhaoauthor=J.+Hallauthor=B.+S.+J.+Blagg&title=Development+of+radamide+analogs+as+grp94+inhibitors&doi=10.1016%2Fj.bmc.2014.05.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radamide analogs as Grp94 inhibitors</span></div><div class="casAuthors">Muth, Aaron; Crowley, Vincent; Khandelwal, Anuj; Mishra, Sanket; Zhao, Jinbo; Hall, Jessica; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4083-4098</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hsp90 isoform-selective inhibition is highly desired as it can potentially avoid the toxic side-effects of pan-inhibition.  The current study developed selective inhibitors of one such isoform, Grp94, predicated on the chimeric and pan-Hsp90 inhibitor, radamide (RDA).  Replacement of the quinone moiety of RDA with a Ph ring (2) was found to be better suited for Grp94 inhibition as it can fully interact with a unique hydrophobic pocket present in Grp94.  An extensive SAR for this scaffold showed that substitutions at the 2- and 4-positions (8 and 27, resp.) manifested excellent Grp94 affinity and selectivity.  Introduction of heteroatoms into the ring also proved beneficial, with a 2-pyridine deriv. (38) exhibiting the highest Grp94 affinity (Kd = 820 nM).  Subsequent cell-based assays showed that these Grp94 inhibitors inhibit migration of the metastatic breast cancer cell line, MDA-MB-231, as well as exhibit an anti-proliferative affect against the multiple myeloma cell line, RPMI 8226.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdbHibsHh3rVg90H21EOLACvtfcHk0lhcBYER45Yglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK&md5=6025c533f1c107eb5c54a559c679c8d2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.075%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%2BB.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520radamide%2520analogs%2520as%2520grp94%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4083%26epage%3D4098%26doi%3D10.1016%2Fj.bmc.2014.05.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span> <span> </span><span class="NLM_article-title">Crystallization and preliminary x-ray diffraction analysis of trap1 complexed with hsp90 inhibitors</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1683</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1107/S2053230X14024959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1107%2FS2053230X14024959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25484226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=1683-1687&author=H.+Jeongauthor=B.+H.+Kangauthor=C.+Lee&title=Crystallization+and+preliminary+x-ray+diffraction+analysis+of+trap1+complexed+with+hsp90+inhibitors&doi=10.1107%2FS2053230X14024959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallization and preliminary X-ray diffraction analysis of Trap1 complexed with Hsp90 inhibitors</span></div><div class="casAuthors">Jeong, Hanbin; Kang, Byoung Heon; Lee, Changwook</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1683-1687</span>CODEN:
                <span class="NLM_cas:coden">ACSFEN</span>;
        ISSN:<span class="NLM_cas:issn">2053-230X</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Hsp90 is a mol. chaperone responsible for the assembly and regulation of many cellular client proteins.  In particular, Trap1, a mitochondrial Hsp90 homolog, plays a pivotal role in maintaining mitochondrial integrity, protecting against apoptosis in cancer cells.  The N (N-terminal)-M (middle) domain of human Trap1 was crystd. in complex with Hsp90 inhibitors (PU-H71 and BIIB-021) by the hanging-drop vapor-diffusion method at pH 6.5 and 293 K using 15% PEG 8K as a precipitant.  Diffraction data were collected from crystals of the Trap1-PU-H71 (2.7 Å) and Trap1-BIIB-021 (3.1 Å) complexes to high resoln. at a synchrotron-radiation source.  Preliminary X-ray diffraction anal. revealed that both crystals belonged to space group P41212 or P43212, with unit-cell parameters a = b = 69.2, c = 252.5 Å, and contained one mol. per asym. unit according to Matthews coeff. calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGparb6NUaz8eLVg90H21EOLACvtfcHk0lhcBYER45Yglw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCls7bJ&md5=24ac12c18ae7c77a5f881f80959191b0</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1107%2FS2053230X14024959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053230X14024959%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DC.%26atitle%3DCrystallization%2520and%2520preliminary%2520x-ray%2520diffraction%2520analysis%2520of%2520trap1%2520complexed%2520with%2520hsp90%2520inhibitors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Commun.%26date%3D2014%26volume%3D70%26spage%3D1683%26epage%3D1687%26doi%3D10.1107%2FS2053230X14024959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheon, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Development of a mitochondria-targeted hsp90 inhibitor based on the crystal structures of human trap1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">4358</span>– <span class="NLM_lpage">4367</span>, <span class="refDoi"> DOI: 10.1021/ja511893n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja511893n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=4358-4367&author=C.+Leeauthor=H.+K.+Parkauthor=H.+Jeongauthor=J.+Limauthor=A.+J.+Leeauthor=K.+Y.+Cheonauthor=C.+S.+Kimauthor=A.+P.+Thomasauthor=B.+Baeauthor=N.+D.+Kim&title=Development+of+a+mitochondria-targeted+hsp90+inhibitor+based+on+the+crystal+structures+of+human+trap1&doi=10.1021%2Fja511893n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1</span></div><div class="casAuthors">Lee, Changwook; Park, Hye-Kyung; Jeong, Hanbin; Lim, Jaehwa; Lee, An-Jung; Cheon, Keun Young; Kim, Chul-Su; Thomas, Ajesh P.; Bae, Boram; Kim, Nam Doo; Kim, Seong Heon; Suh, Pann-Ghill; Ryu, Ja-Hyoung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4358-4367</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mitochondrial pool of Hsp90 and its mitochondrial paralog, TRAP1, suppresses cell death and reprograms energy metab. in cancer cells; therefore, Hsp90 and TRAP1 have been suggested as target proteins for anticancer drug development.  Here, the authors report that the actual target protein in cancer cell mitochondria is TRAP1, and current Hsp90 inhibitors cannot effectively inactivate TRAP1 because of their insufficient accumulation in the mitochondria.  To develop mitochondrial TRAP1 inhibitors, the authors detd. the crystal structures of human TRAP1 complexed with Hsp90 inhibitors.  The iso-Pr amine of the Hsp90 inhibitor PU-H71 was replaced with the mitochondria-targeting moiety triphenylphosphonium to produce SMTIN-P01.  SMTIN-P01 showed a different mode of action from the nontargeted PU-H71, as well as much improved cytotoxicity to cancer cells.  In addn., the authors detd. the structure of a TRAP1-adenylyl-imidodiphosphate (AMP-PNP) complex.  On the basis of comparative anal. of TRAP1 structures, the authors propose a mol. mechanism of ATP hydrolysis that is crucial for chaperone function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-VB5CkPi2LVg90H21EOLACvtfcHk0lg_ZgfC_hJV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D&md5=c1142149eaa5f4157377ce64662fcfc1</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fja511893n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja511893n%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DCheon%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DC.%2BS.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DBae%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520mitochondria-targeted%2520hsp90%2520inhibitor%2520based%2520on%2520the%2520crystal%2520structures%2520of%2520human%2520trap1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D4358%26epage%3D4367%26doi%3D10.1021%2Fja511893n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Paralog specificity determines subcellular distribution, action mechanism, and anticancer activity of trap1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7569</span>– <span class="NLM_lpage">7578</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7569-7578&author=H.+K.+Parkauthor=H.+Jeongauthor=E.+Koauthor=G.+Leeauthor=J.+E.+Leeauthor=S.+K.+Leeauthor=A.+J.+Leeauthor=J.+Y.+Imauthor=S.+Huauthor=S.+H.+Kim&title=Paralog+specificity+determines+subcellular+distribution%2C+action+mechanism%2C+and+anticancer+activity+of+trap1+inhibitors&doi=10.1021%2Facs.jmedchem.7b00978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors</span></div><div class="casAuthors">Park, Hye-Kyung; Jeong, Hanbin; Ko, Eunhwa; Lee, Geumwoo; Lee, Ji-Eun; Lee, Sang Kwang; Lee, An-Jung; Im, Jin Young; Hu, Sung; Kim, Seong Heon; Lee, Ji Hoon; Lee, Changwook; Kang, Soosung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7569-7578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although Hsp90 inhibitors can inhibit multiple tumorigenic pathways in cancer cells, their anticancer activity has been disappointingly modest.  However, by forcing Hsp90 inhibitors into the mitochondria with mitochondrial delivery vehicles, they were converted into potent drugs targeting the mitochondrial Hsp90 paralog TRAP1.  Here, to improve mitochondrial drug accumulation without using the mitochondrial delivery vehicle, we increased freely available drug concns. in the cytoplasm by reducing the binding of the drugs to the abundant cytoplasmic Hsp90.  After analyzing X-ray cocrystal structures, the purine ring of the Hsp90 inhibitor 2 (BIIB021) was modified to pyrazolopyrimidine scaffolds.  One pyrazolopyrimidine, 12b (DN401), bound better to TRAP1 than to Hsp90, inactivated the mitochondrial TRAP1 in vivo, and it exhibited potent anticancer activity.  Therefore, the rationale and feasible guidelines for developing 12b can potentially be exploited to design a potent TRAP1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfck9jHWGc7Vg90H21EOLACvtfcHk0lg_ZgfC_hJV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM&md5=7cfcb60a5a2691eb7be6950ef7ede0ed</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00978%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DIm%26aufirst%3DJ.%2BY.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DParalog%2520specificity%2520determines%2520subcellular%2520distribution%252C%2520action%2520mechanism%252C%2520and%2520anticancer%2520activity%2520of%2520trap1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7569%26epage%3D7578%26doi%3D10.1021%2Facs.jmedchem.7b00978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lees-Miller, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C. W.</span></span> <span> </span><span class="NLM_article-title">The human double-stranded dna-activated protein kinase phosphorylates the 90-kda heat-shock protein, hsp90 alpha at two nh2-terminal threonine residues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">17275</span>– <span class="NLM_lpage">17280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=2507541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADyaK3cXjtlCn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=17275-17280&author=S.+P.+Lees-Millerauthor=C.+W.+Anderson&title=The+human+double-stranded+dna-activated+protein+kinase+phosphorylates+the+90-kda+heat-shock+protein%2C+hsp90+alpha+at+two+nh2-terminal+threonine+residues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90α at two amino-terminal threonine residues</span></div><div class="casAuthors">Lees-Miller, Susan P.; Anderson, Carl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">17275-80</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The 90-kDa heat-shock protein, hsp90, is an abundant cytoplasmic protein that can be phosphorylated in vitro by a double-stranded (ds) DNA-activated protein kinase found in cells from several species.  The dsDNA-activated protein kinase from human HeLa cells phosphorylates 2 threonine residues in the sequence PEETQTQDQPME at the N-terminus of human hsp90α.  Hsp90β, which is 97% identical to hsp90α but lacks both N-terminal threonines, is not phosphorylated by the dsDNA-activated protein kinase.  Mouse hsp86 and rabbit hsp90α are homologous to human hsp90α; both heterologous proteins are phosphorylated at the same N-terminal threonines by the human dsDNA-activated protein kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNjFNhZV0j5rVg90H21EOLACvtfcHk0lg_ZgfC_hJV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjtlCn&md5=a00d1ed87ade6d7a1f8d824d4f4b8d28</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees-Miller%26aufirst%3DS.%2BP.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26atitle%3DThe%2520human%2520double-stranded%2520dna-activated%2520protein%2520kinase%2520phosphorylates%2520the%252090-kda%2520heat-shock%2520protein%252C%2520hsp90%2520alpha%2520at%2520two%2520nh2-terminal%2520threonine%2520residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D17275%26epage%3D17280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, Y.</span></span> <span> </span><span class="NLM_article-title">Protein kinase ck2 in health and disease: ck2: the kinase controlling the hsp90 chaperone machinery</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1840</span>– <span class="NLM_lpage">1849</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-9152-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs00018-009-9152-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19387550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1840-1849&author=Y.+Miyata&title=Protein+kinase+ck2+in+health+and+disease%3A+ck2%3A+the+kinase+controlling+the+hsp90+chaperone+machinery&doi=10.1007%2Fs00018-009-9152-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">CK2: the kinase controlling the Hsp90 chaperone machinery</span></div><div class="casAuthors">Miyata, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1840-1849</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is a ubiquitous and essential protein kinase with pleiotropic substrates and function, but it remains unclear how, when, and where CK2 activity is regulated in cells.  Hsp90 is a major mol. chaperone that is required for the folding and function of its client proteins.  A complex contg. Hsp90 and its client protein includes co-chaperones such as steroid hormone receptor-specific FKBP52 and signaling kinase-specific Cdc37.  Co-chaperones work cooperatively with Hsp90 to stabilize client proteins and to keep them in a conformation amenable to activation under appropriate conditions.  Here, crit. roles of CK2 in the regulation of the Hsp90-mediated chaperone system are described.  CK2 phosphorylates and modulates Hsp90 and its co-chaperones, FKBP52 and Cdc37.  CK2-dependent phosphorylation of Cdc37 is essential for the chaperoning function of Hsp90-Cdc37 for multiple signaling protein kinases.  The tumor kinome appears to become addicted to the Hsp90-Cdc37 chaperone system, thus, targeting Hsp90, Cdc37, and CK2 is a promising strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW2ZhBoll7aLVg90H21EOLACvtfcHk0lg_ZgfC_hJV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D&md5=b4447a54564fde9c88ba6ab0b5b22e90</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9152-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9152-0%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26atitle%3DProtein%2520kinase%2520ck2%2520in%2520health%2520and%2520disease%253A%2520ck2%253A%2520the%2520kinase%2520controlling%2520the%2520hsp90%2520chaperone%2520machinery%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D1840%26epage%3D1849%26doi%3D10.1007%2Fs00018-009-9152-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornbluth, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of apoptosome formation by suppression of hsp90beta phosphorylation in tyrosine kinase-induced leukemias</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">5494</span>– <span class="NLM_lpage">5506</span>, <span class="refDoi"> DOI: 10.1128/MCB.00265-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1128%2FMCB.00265-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18591256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVersLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=5494-5506&author=M.+Kurokawaauthor=C.+Zhaoauthor=T.+Reyaauthor=S.+Kornbluth&title=Inhibition+of+apoptosome+formation+by+suppression+of+hsp90beta+phosphorylation+in+tyrosine+kinase-induced+leukemias&doi=10.1128%2FMCB.00265-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of apoptosome formation by suppression of Hsp90β phosphorylation in tyrosine kinase-induced leukemias</span></div><div class="casAuthors">Kurokawa, Manabu; Zhao, Chen; Reya, Tannishtha; Kornbluth, Sally</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5494-5506</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Constitutively active tyrosine kinases promote leukemogenesis by increasing cell proliferation and inhibiting apoptosis.  However, mechanisms underlying apoptotic inhibition have not been fully elucidated.  In many settings, apoptosis occurs by mitochondrial cytochrome c release, which nucleates the Apaf-1/caspase-9 apoptosome.  Here the authors report that the leukemogenic kinases, Bcr-Abl, FLT3/D835Y, and Tel-PDGFRβ, all can inhibit apoptosome function.  In cells expressing these kinases, the previously reported apoptosome inhibitor, Hsp90β, bound strongly to Apaf-1, preventing cytochrome c-induced Apaf-1 oligomerization and caspase-9 recruitment.  Hsp90β interacted weakly with the apoptosome in untransformed cells.  While Hsp90β was phosphorylated at Ser 226/Ser 255 in untransformed cells, phosphorylation was absent in leukemic cells.  Expression of mutant Hsp90β (S226A/S255A), which mimics the hypophosphorylated form in leukemic cells, conferred resistance to cytochrome c-induced apoptosome activation in normal cells, reflecting enhanced binding of nonphosphorylatable Hsp90β to Apaf-1.  In Bcr-Abl-pos. mouse bone marrow cells, nonphosphorylatable Hsp90β expression conferred imatinib (Gleevec) resistance.  These data provide an explanation for apoptosome inhibition by activated leukemogenic tyrosine kinases and suggest that alterations in Hsp90β-apoptosome interactions may contribute to chemoresistance in leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVlqJSEyA3-rVg90H21EOLACvtfcHk0ljLs3gXZRoWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVersLvF&md5=c55df706baaa7a54dc98a4289ce5ebf4</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1128%2FMCB.00265-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00265-08%26sid%3Dliteratum%253Aachs%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DReya%26aufirst%3DT.%26aulast%3DKornbluth%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520apoptosome%2520formation%2520by%2520suppression%2520of%2520hsp90beta%2520phosphorylation%2520in%2520tyrosine%2520kinase-induced%2520leukemias%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D5494%26epage%3D5506%26doi%3D10.1128%2FMCB.00265-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Old, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabb, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couts, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litman, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croy, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Arendt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witze, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweppe, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resing, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, N. G.</span></span> <span> </span><span class="NLM_article-title">Functional proteomics identifies targets of phosphorylation by b-raf signaling in melanoma</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.molcel.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19362540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1SrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=115-131&author=W.+M.+Oldauthor=J.+B.+Shabbauthor=S.+Houelauthor=H.+Wangauthor=K.+L.+Coutsauthor=C.+Y.+Yenauthor=E.+S.+Litmanauthor=C.+H.+Croyauthor=K.+Meyer-Arendtauthor=J.+G.+Mirandaauthor=R.+A.+Brownauthor=E.+S.+Witzeauthor=R.+E.+Schweppeauthor=K.+A.+Resingauthor=N.+G.+Ahn&title=Functional+proteomics+identifies+targets+of+phosphorylation+by+b-raf+signaling+in+melanoma&doi=10.1016%2Fj.molcel.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma</span></div><div class="casAuthors">Old, William M.; Shabb, John B.; Houel, Stephane; Wang, Hong; Couts, Kasey L.; Yen, Chia-yu; Litman, Elizabeth S.; Croy, Carrie H.; Meyer-Arendt, Karen; Miranda, Jose G.; Brown, Robert A.; Witze, Eric S.; Schweppe, Rebecca E.; Resing, Katheryn A.; Ahn, Natalie G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-131</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Melanoma and other cancers harbor oncogenic mutations in the protein kinase B-Raf, which leads to constitutive activation and dysregulation of MAP kinase signaling.  To elucidate mol. determinants responsible for B-Raf control of cancer phenotypes, the authors present a method for phosphoprotein profiling, using neg. ionization mass spectrometry to detect phosphopeptides based on their fragment ion signature caused by release of PO3-.  The method provides an alternative strategy for phosphoproteomics, circumventing affinity enrichment of phosphopeptides and isotopic labeling of samples.  Ninety phosphorylation events were regulated by oncogenic B-Raf signaling, based on their responses to treating melanoma cells with MKK1/2 inhibitor.  Regulated phosphoproteins included known signaling effectors and cytoskeletal regulators.  The authors investigated MINERVA/FAM129B, a target belonging to a protein family with unknown category and function, and established the importance of this protein and its MAP kinase-dependent phosphorylation in controlling melanoma cell invasion into three-dimensional collagen matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5p9Eyn9VIbbVg90H21EOLACvtfcHk0ljLs3gXZRoWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1SrsLk%253D&md5=4e5e895c9a0f78097ad4fb418f4846d3</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DOld%26aufirst%3DW.%2BM.%26aulast%3DShabb%26aufirst%3DJ.%2BB.%26aulast%3DHouel%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCouts%26aufirst%3DK.%2BL.%26aulast%3DYen%26aufirst%3DC.%2BY.%26aulast%3DLitman%26aufirst%3DE.%2BS.%26aulast%3DCroy%26aufirst%3DC.%2BH.%26aulast%3DMeyer-Arendt%26aufirst%3DK.%26aulast%3DMiranda%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DR.%2BA.%26aulast%3DWitze%26aufirst%3DE.%2BS.%26aulast%3DSchweppe%26aufirst%3DR.%2BE.%26aulast%3DResing%26aufirst%3DK.%2BA.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26atitle%3DFunctional%2520proteomics%2520identifies%2520targets%2520of%2520phosphorylation%2520by%2520b-raf%2520signaling%2520in%2520melanoma%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D34%26spage%3D115%26epage%3D131%26doi%3D10.1016%2Fj.molcel.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barati, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rane, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeish, K. R.</span></span> <span> </span><span class="NLM_article-title">A proteomic screen identified stress-induced chaperone proteins as targets of akt phosphorylation in mesangial cells</span>. <i>J. Proteome. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1646</span>, <span class="refDoi"> DOI: 10.1021/pr0502469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr0502469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFShtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1636-1646&author=M.+T.+Baratiauthor=M.+J.+Raneauthor=J.+B.+Kleinauthor=K.+R.+McLeish&title=A+proteomic+screen+identified+stress-induced+chaperone+proteins+as+targets+of+akt+phosphorylation+in+mesangial+cells&doi=10.1021%2Fpr0502469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A Proteomic Screen Identified Stress-Induced Chaperone Proteins as Targets of Akt Phosphorylation in Mesangial Cells</span></div><div class="casAuthors">Barati, Michelle T.; Rane, Madhavi J.; Klein, Jon B.; McLeish, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1636-1646</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The serine-threonine kinase Akt regulates mesangial cell apoptosis, proliferation, and hypertrophy.  To define Akt signaling pathways in mesangial cells, we performed a functional proteomic screen for rat mesangial cell proteins phosphorylated by Akt.  A group of chaperone proteins, heat shock protein (Hsp) 70, Hsp90α, Hsp90β, Glucose-regulated protein (Grp) Grp78, Grp94, and protein disulfide isomerase (PDI) were identified as potential Akt substrates by two techniques: (a) in vitro phosphorylation of mesangial cell lysate by recombinant active Akt followed by protein sepn. by SDS-PAGE or 2-DE and phosphoprotein identification by peptide mass fingerprinting using MALDI-MS, or (b) immunoblot anal. of proteins from PDGF-stimulated mesangial cells using an anti-Akt phospho-motif antibody.  In vitro kinase reactions using recombinant proteins confirmed that Akt phosphorylates Hsp70, Hsp90α and β, Grp94, and PDI.  Immunopptn. of Akt from mesangial cell lysate copptd. Grp78 and Hsp70.  PDGF stimulation of mesangial cells caused an acidic shift in the isoelec. point of Hsp70, Hsp90, and PDI that was dependent on PI-3K activity for Hsp70 and Hsp90.  The data suggest that Akt-mediated phosphorylation of stress-induced chaperones represents a mechanism for regulation of chaperone function during mesangial cell responses to physiol. and pathol. stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG6MaU5uvP87Vg90H21EOLACvtfcHk0lgBYwLtEZc7ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFShtrs%253D&md5=4fcf7b7be5e8dae9b1b8bb135085f0b3</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fpr0502469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr0502469%26sid%3Dliteratum%253Aachs%26aulast%3DBarati%26aufirst%3DM.%2BT.%26aulast%3DRane%26aufirst%3DM.%2BJ.%26aulast%3DKlein%26aufirst%3DJ.%2BB.%26aulast%3DMcLeish%26aufirst%3DK.%2BR.%26atitle%3DA%2520proteomic%2520screen%2520identified%2520stress-induced%2520chaperone%2520proteins%2520as%2520targets%2520of%2520akt%2520phosphorylation%2520in%2520mesangial%2520cells%26jtitle%3DJ.%2520Proteome.%2520Res.%26date%3D2006%26volume%3D5%26spage%3D1636%26epage%3D1646%26doi%3D10.1021%2Fpr0502469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Boeuf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratton, J. P.</span></span> <span> </span><span class="NLM_article-title">Src-mediated phosphorylation of hsp90 in response to vascular endothelial growth factor (vegf) is required for vegf receptor-2 signaling to endothelial no synthase</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4659</span>– <span class="NLM_lpage">4668</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-05-0467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1091%2Fmbc.e07-05-0467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17855507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12js7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=4659-4668&author=M.+Duvalauthor=F.+Le+Boeufauthor=J.+Huotauthor=J.+P.+Gratton&title=Src-mediated+phosphorylation+of+hsp90+in+response+to+vascular+endothelial+growth+factor+%28vegf%29+is+required+for+vegf+receptor-2+signaling+to+endothelial+no+synthase&doi=10.1091%2Fmbc.e07-05-0467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase</span></div><div class="casAuthors">Duval, Martine; Le Boeuf, Fabrice; Huot, Jacques; Gratton, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4659-4668</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Nitric oxide (NO) release from endothelial cells, via endothelial NO synthase (eNOS) activation, is central to the proangiogenic actions of vascular endothelial growth factor (VEGF).  VEGF signaling to eNOS is principally mediated by an Akt-dependent phosphorylation of eNOS and by increased assocn. of eNOS to the mol. chaperone, heat-shock protein 90 kDa (HSP 90).  Herein, the authors report that VEGFR-2 activation induces tyrosine phosphorylation of VEGF receptor 2 (VEGFR-2)-assocd. HSP 90β.  Tyrosine phosphorylation of HSP 90β in response to VEGF is dependent on internalization of the VEGFR-2 and on Src kinase activation.  Furthermore, the authors demonstrate that c-Src directly phosphorylates HSP 90 on tyrosine 300 residue and that this event is essential for VEGF-stimulated eNOS assocn. to HSP 90 and thus NO release from endothelial cells.  The authors' work identifies Y300 phosphorylation of HSP 90 as a novel regulated posttranslational modification of the chaperone and demonstrates its importance in the proangiogenic actions of VEGF, namely by regulating NO release from endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8mNvqIDcvcLVg90H21EOLACvtfcHk0liydszeDDcmRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12js7nJ&md5=d769bb43d5186e3bc567b878d06b8d22</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-05-0467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-05-0467%26sid%3Dliteratum%253Aachs%26aulast%3DDuval%26aufirst%3DM.%26aulast%3DLe%2BBoeuf%26aufirst%3DF.%26aulast%3DHuot%26aufirst%3DJ.%26aulast%3DGratton%26aufirst%3DJ.%2BP.%26atitle%3DSrc-mediated%2520phosphorylation%2520of%2520hsp90%2520in%2520response%2520to%2520vascular%2520endothelial%2520growth%2520factor%2520%2528vegf%2529%2520is%2520required%2520for%2520vegf%2520receptor-2%2520signaling%2520to%2520endothelial%2520no%2520synthase%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2007%26volume%3D18%26spage%3D4659%26epage%3D4668%26doi%3D10.1091%2Fmbc.e07-05-0467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokita, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourboulia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B. T.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Swe1wee1-dependent tyrosine phosphorylation of hsp90 regulates distinct facets of chaperone function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.molcel.2010.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20159553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=333-343&author=M.+Mollapourauthor=S.+Tsutsumiauthor=A.+C.+Donnellyauthor=K.+Beebeauthor=M.+J.+Tokitaauthor=M.+J.+Leeauthor=S.+Leeauthor=G.+Morraauthor=D.+Bourbouliaauthor=B.+T.+Scroggins&title=Swe1wee1-dependent+tyrosine+phosphorylation+of+hsp90+regulates+distinct+facets+of+chaperone+function&doi=10.1016%2Fj.molcel.2010.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function</span></div><div class="casAuthors">Mollapour, Mehdi; Tsutsumi, Shinji; Donnelly, Alison C.; Beebe, Kristin; Tokita, Mari J.; Lee, Min-Jung; Lee, Sunmin; Morra, Giulia; Bourboulia, Dimitra; Scroggins, Bradley T.; Colombo, Giorgio; Blagg, Brian S.; Panaretou, Barry; Stetler-Stevenson, William G.; Trepel, Jane B.; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-343</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Saccharomyces WEE1 (Swe1), the only "true" tyrosine kinase in budding yeast, is an Hsp90 client protein.  Here we show that Swe1Wee1 phosphorylates a conserved tyrosine residue (Y24 in yeast Hsp90 and Y38 in human Hsp90α) in the N domain of Hsp90.  Phosphorylation is cell-cycle assocd. and modulates the ability of Hsp90 to chaperone a selected clientele, including v-Src and several other kinases.  Nonphosphorylatable mutants have normal ATPase activity, support yeast viability, and productively chaperone the Hsp90 client glucocorticoid receptor.  Deletion of SWE1 in yeast increases Hsp90 binding to its inhibitor geldanamycin, and pharmacol. inhibition/silencing of Wee1 sensitizes cancer cells to Hsp90 inhibitor-induced apoptosis.  These findings demonstrate that Hsp90 chaperoning of distinct client proteins is differentially regulated by specific posttranslational modification of a unique subcellular pool of the chaperone, and they provide a strategy to increase the cellular potency of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7UKPV6M9pnbVg90H21EOLACvtfcHk0ljjXQ6t00gX5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktb0%253D&md5=0c604b88a699ed15813e983cbf27bc29</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DA.%2BC.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DTokita%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DMorra%26aufirst%3DG.%26aulast%3DBourboulia%26aufirst%3DD.%26aulast%3DScroggins%26aufirst%3DB.%2BT.%26atitle%3DSwe1wee1-dependent%2520tyrosine%2520phosphorylation%2520of%2520hsp90%2520regulates%2520distinct%2520facets%2520of%2520chaperone%2520function%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D37%26spage%3D333%26epage%3D343%26doi%3D10.1016%2Fj.molcel.2010.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zierer, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.18632%2Foncotarget.1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23867252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1065-1074&author=K.+Beebeauthor=M.+Mollapourauthor=B.+Scrogginsauthor=C.+Prodromouauthor=W.+Xuauthor=M.+Tokitaauthor=T.+Taldoneauthor=L.+Pullenauthor=B.+K.+Ziererauthor=M.+J.+Leeauthor=J.+Trepelauthor=J.+Buchnerauthor=D.+Bolonauthor=G.+Chiosisauthor=L.+Neckers&title=Posttranslational+modification+and+conformational+state+of+heat+shock+protein+90+differentially+affect+binding+of+chemically+diverse+small+molecule+inhibitors&doi=10.18632%2Foncotarget.1099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span></div><div class="casAuthors">Beebe Kristin; Mollapour Mehdi; Scroggins Bradley; Prodromou Chrisostomos; Xu Wanping; Tokita Mari; Taldone Tony; Pullen Lester; Zierer Bettina K; Lee Min-Jung; Trepel Jane; Buchner Johannes; Bolon Daniel; Chiosis Gabriela; Neckers Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1065-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an essential molecular chaperone in eukaryotes that facilitates the conformational maturation and function of a diverse protein clientele, including aberrant and/or over-expressed proteins that are involved in cancer growth and survival.  A role for Hsp90 in supporting the protein homeostasis of cancer cells has buoyed interest in the utility of Hsp90 inhibitors as anti-cancer drugs.  Despite the fact that all clinically evaluated Hsp90 inhibitors target an identical nucleotide-binding pocket in the N domain of the chaperone, the precise determinants that affect drug binding in the cellular environment remain unclear, and it is possible that chemically distinct inhibitors may not share similar binding preferences.  Here we demonstrate that two chemically unrelated Hsp90 inhibitors, the benzoquinone ansamycin geldanamycin and the purine analog PU-H71, select for overlapping but not identical subpopulations of total cellular Hsp90, even though both inhibitors bind to an amino terminal nucleotide pocket and prevent N domain dimerization.  Our data also suggest that PU-H71 is able to access a broader range of N domain undimerized Hsp90 conformations than is geldanamycin and is less affected by Hsp90 phosphorylation, consistent with its broader and more potent anti-tumor activity.  A more complete understanding of the impact of the cellular milieu on small molecule inhibitor binding to Hsp90 should facilitate their more effective use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZ-jT50Ygfa91pGlMMoT5fW6udTcc2eYS6inTaNoQ4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D&md5=1db8c9dca9517cd39a1b911107869582</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1099%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DScroggins%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DTokita%26aufirst%3DM.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPullen%26aufirst%3DL.%26aulast%3DZierer%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DBolon%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPosttranslational%2520modification%2520and%2520conformational%2520state%2520of%2520heat%2520shock%2520protein%252090%2520differentially%2520affect%2520binding%2520of%2520chemically%2520diverse%2520small%2520molecule%2520inhibitors%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D1065%26epage%3D1074%26doi%3D10.18632%2Foncotarget.1099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandawat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span> <span> </span><span class="NLM_article-title">Hdac6 inhibition enhances 17-aag-mediated abrogation of hsp90 chaperone function in human leukemia cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1893</span>, <span class="refDoi"> DOI: 10.1182/blood-2008-03-143644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1182%2Fblood-2008-03-143644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18591380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVylu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1886-1893&author=R.+Raoauthor=W.+Fiskusauthor=Y.+H.+Yangauthor=P.+Leeauthor=R.+Joshiauthor=P.+Fernandezauthor=A.+Mandawatauthor=P.+Atadjaauthor=J.+E.+Bradnerauthor=K.+Bhalla&title=Hdac6+inhibition+enhances+17-aag-mediated+abrogation+of+hsp90+chaperone+function+in+human+leukemia+cells&doi=10.1182%2Fblood-2008-03-143644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells</span></div><div class="casAuthors">Rao, Rekha; Fiskus, Warren; Yang, Yonghua; Lee, Pearl; Joshi, Rajeshree; Fernandez, Pravina; Mandawat, Aditya; Atadja, Peter; Bradner, James E.; Bhalla, Kapil</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1886-1893</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a heat shock protein 90 (hsp90) deacetylase.  Treatment with pan-HDAC inhibitors or depletion of HDAC6 by siRNA induces hyperacetylation and inhibits ATP binding and chaperone function of hsp90.  Treatment with 17-allylamino-demothoxy geldanamycin (17-AAG) also inhibits ATP binding and chaperone function of hsp90, resulting in polyubiquitylation and proteasomal degrdn. of hsp90 client proteins.  In this study, we detd. the effect of hsp90 hyperacetylation on the anti-hsp90 and antileukemia activity of 17-AAG.  Hyperacetylation of hsp90 increased its binding to 17-AAG, as well as enhanced 17-AAG-mediated attenuation of ATP and the cochaperone p23 binding to hsp90.  Notably, treatment with 17-AAG alone also reduced HDAC6 binding to hsp90 and induced hyperacetylation of hsp90.  This promoted the proteasomal degrdn. of HDAC6.  Cotreatment with 17-AAG and siRNA to HDAC6 induced more inhibition of hsp90 chaperone function and depletion of BCR-ABL and c-Raf than treatment with either agent alone.  In addn., cotreatment with 17-AAG and tubacin augmented the loss of survival of K562 cells and viability of primary acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) samples.  These findings demonstrate that HDAC6 is an hsp90 client protein and hyperacetylation of hsp90 augments the anti-hsp90 and anti-leukemia effects of 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRs9whnsH5-rVg90H21EOLACvtfcHk0li3Q4FgJOr29w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVylu7jI&md5=146c22ba5b2fb605748f7afebe58878c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-03-143644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-03-143644%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DP.%26aulast%3DMandawat%26aufirst%3DA.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DHdac6%2520inhibition%2520enhances%252017-aag-mediated%2520abrogation%2520of%2520hsp90%2520chaperone%2520function%2520in%2520human%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1886%26epage%3D1893%26doi%3D10.1182%2Fblood-2008-03-143644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoston, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, N. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of dna methyltransferase 1 in human breast cancer cells</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-0330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1541-7786.MCR-07-0330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18505931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=873-883&author=Q.+Zhouauthor=A.+T.+Agostonauthor=P.+Atadjaauthor=W.+G.+Nelsonauthor=N.+E.+Davidson&title=Inhibition+of+histone+deacetylases+promotes+ubiquitin-dependent+proteasomal+degradation+of+dna+methyltransferase+1+in+human+breast+cancer+cells&doi=10.1158%2F1541-7786.MCR-07-0330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells</span></div><div class="casAuthors">Zhou, Qun; Agoston, Agoston T.; Atadja, Peter; Nelson, William G.; Davidson, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">873-883</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Histone deacetylases (HDAC) play a crit. role in chromatin modification and gene expression.  Recent evidence indicates that HDACs can also regulate functions of nonhistone proteins by catalyzing the removal of acetylated lysine residues.  Here, we show that the HDAC inhibitor LBH589 down-regulates DNA methyltransferase 1 (DNMT1) protein expression in the nucleus of human breast cancer cells.  Cotreatment with the proteasomal inhibitor MG-132 abolishes the ability of LBH589 to reduce DNMT1, suggesting that the proteasomal pathway mediates DNMT1 degrdn. on HDAC inhibition.  Deletion of the N-terminal 120 amino acids of DNMT1 diminishes LBH589-induced ubiquitination, indicating that this domain is essential for its proteasomal degrdn.  DNMT1 recruits the mol. chaperone heat shock protein 90 (Hsp90) to form a chaperone complex.  Treatment with LBH589 induces hyperacetylation of Hsp90, thereby inhibiting the assocn. of DNMT1 with Hsp90 and promoting ubiquitination of DNMT1.  In addn., inactivation of HDAC1 activity by small interfering RNA and MS-275 is assocd. with Hsp90 acetylation in conjunction with redn. of DNMT1 protein expression.  We conclude that the stability of DNMT1 is maintained in part through its assocn. with Hsp90.  Disruption of Hsp90 function by HDAC inhibition is a unique mechanism that mediates the ubiquitin-proteasome pathway for DNMT1 degrdn.  Our studies suggest a new role for HDAC1 and identify a novel mechanism of action for the HDAC inhibitors as down-regulators of DNMT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiWptPKR1-KLVg90H21EOLACvtfcHk0ljsNP7dGq-OYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsbo%253D&md5=3f4d1413990ed13ae6c54de161824191</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-0330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-0330%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DAgoston%26aufirst%3DA.%2BT.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DW.%2BG.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26atitle%3DInhibition%2520of%2520histone%2520deacetylases%2520promotes%2520ubiquitin-dependent%2520proteasomal%2520degradation%2520of%2520dna%2520methyltransferase%25201%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D873%26epage%3D883%26doi%3D10.1158%2F1541-7786.MCR-07-0330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nechtman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span> <span> </span><span class="NLM_article-title">Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">4833</span>– <span class="NLM_lpage">4842</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F0008-5472.CAN-08-0644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18559531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=4833-4842&author=Y.+Yangauthor=R.+Raoauthor=J.+Shenauthor=Y.+Tangauthor=W.+Fiskusauthor=J.+Nechtmanauthor=P.+Atadjaauthor=K.+Bhalla&title=Role+of+acetylation+and+extracellular+location+of+heat+shock+protein+90alpha+in+tumor+cell+invasion&doi=10.1158%2F0008-5472.CAN-08-0644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Role of acetylation and extracellular location of heat shock protein 90α in tumor cell invasion</span></div><div class="casAuthors">Yang, Yonghua; Rao, Rehka; Shen, Jie; Tang, Yun; Fiskus, Warren; Nechtman, John; Atadja, Peter; Bhalla, Kapil</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4833-4842</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Heat shock protein (hsp) 90 is an ATP-dependent mol. chaperone that maintains the active conformation of client oncoproteins in cancer cells.  An isoform, hsp90α, promotes extracellular maturation of matrix metalloproteinase (MMP)-2, involved in tumor invasion and metastasis.  Knockdown of histone deacetylase (HDAC) 6, which deacetylates lysine residues in hsp90, induces reversible hyperacetylation and attenuates ATP binding and chaperone function of hsp90.  Here, using mass spectrometry, we identified seven lysine residues in hsp90α that are hyperacetylated after treatment of eukaryotic cells with a pan-HDAC inhibitor that also inhibits HDAC6.  Depending on the specific lysine residue in the middle domain involved, although acetylation affects ATP, cochaperone, and client protein binding to hsp90α, acetylation of all seven lysines increased the binding of hsp90α to 17-allyl-amino-demethoxy geldanamycin.  Notably, after treatment with the pan-HDAC inhibitor panobinostat (LBH589), the extracellular hsp90α was hyperacetylated and it bound to MMP-2, which was assocd. with increased in vitro tumor cell invasiveness.  Treatment with antiacetylated hsp90α antibody inhibited in vitro invasion by tumor cells.  Thus, reversible hyperacetylation modulates the intracellular and extracellular chaperone function of hsp90, and targeting extracellular hyperacetylated hsp90α may undermine tumor invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKmXVX2VVP5rVg90H21EOLACvtfcHk0ljsNP7dGq-OYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ejsLc%253D&md5=8bb95a83c6be8a48fe25a7c0ef64fc49</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0644%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DNechtman%26aufirst%3DJ.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DRole%2520of%2520acetylation%2520and%2520extracellular%2520location%2520of%2520heat%2520shock%2520protein%252090alpha%2520in%2520tumor%2520cell%2520invasion%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D4833%26epage%3D4842%26doi%3D10.1158%2F0008-5472.CAN-08-0644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Retzlaff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagleder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">Hsp90 is regulated by a switch point in the c-terminal domain</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1153</span>, <span class="refDoi"> DOI: 10.1038/embor.2009.153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fembor.2009.153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19696785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1147-1153&author=M.+Retzlaffauthor=M.+Stahlauthor=H.+C.+Eberlauthor=S.+Laglederauthor=J.+Beckauthor=H.+Kesslerauthor=J.+Buchner&title=Hsp90+is+regulated+by+a+switch+point+in+the+c-terminal+domain&doi=10.1038%2Fembor.2009.153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 is regulated by a switch point in the C-terminal domain</span></div><div class="casAuthors">Retzlaff, Marco; Stahl, Michael; Eberl, H. Christian; Lagleder, Stephan; Beck, Juergen; Kessler, Horst; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1147-1153</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an abundant, dimeric ATP-dependent mol. chaperone, and ATPase activity is essential for its in vivo functions.  S-nitrosylation of a residue located in the carboxy-terminal domain has been shown to affect Hsp90 activity in vivo.  To understand how variation of a specific amino acid far away from the amino-terminal ATP-binding site regulates Hsp90 functions, we mutated the corresponding residue and analyzed yeast and human Hsp90 variants both in vivo and in vitro.  Here, we show that this residue is a conserved, strong regulator of Hsp90 functions, including ATP hydrolysis and chaperone activity.  Unexpectedly, the variants alter both the C-terminal and N-terminal assocn. properties of Hsp90, and shift its conformational equil. within the ATPase cycle.  Thus, S-nitrosylation of this residue allows the fast and efficient fine regulation of Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsCS-4WbYkCbVg90H21EOLACvtfcHk0ljuHJ7zzr6pqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrK&md5=bb8a17c9eac352e8aebaeff863f432e8</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fembor.2009.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2009.153%26sid%3Dliteratum%253Aachs%26aulast%3DRetzlaff%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DEberl%26aufirst%3DH.%2BC.%26aulast%3DLagleder%26aufirst%3DS.%26aulast%3DBeck%26aufirst%3DJ.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DHsp90%2520is%2520regulated%2520by%2520a%2520switch%2520point%2520in%2520the%2520c-terminal%2520domain%26jtitle%3DEMBO%2520Rep.%26date%3D2009%26volume%3D10%26spage%3D1147%26epage%3D1153%26doi%3D10.1038%2Fembor.2009.153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span> <span> </span><span class="NLM_article-title">Tubocapsenolide a, a novel withanolide, inhibits proliferation and induces apoptosis in mda-mb-231 cells by thiol oxidation of heat shock proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">17184</span>– <span class="NLM_lpage">17193</span>, <span class="refDoi"> DOI: 10.1074/jbc.M709447200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M709447200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18442981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFSnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=17184-17193&author=W.+Y.+Chenauthor=F.+R.+Changauthor=Z.+Y.+Huangauthor=J.+H.+Chenauthor=Y.+C.+Wuauthor=C.+C.+Wu&title=Tubocapsenolide+a%2C+a+novel+withanolide%2C+inhibits+proliferation+and+induces+apoptosis+in+mda-mb-231+cells+by+thiol+oxidation+of+heat+shock+proteins&doi=10.1074%2Fjbc.M709447200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Tubocapsenolide A, a Novel Withanolide, Inhibits Proliferation and Induces Apoptosis in MDA-MB-231 Cells by Thiol Oxidation of Heat Shock Proteins</span></div><div class="casAuthors">Chen, Wen-Ying; Chang, Fang-Rong; Huang, Zih-You; Chen, Jyun-Hong; Wu, Yang-Chang; Wu, Chin-Chung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">17184-17193</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tubocapsenolide A (TA), a novel withanolide-type steroid, exhibits potent cytotoxicity against several human cancer cell lines.  In the present study, we obsd. that treatment of human breast cancer MDA-MB-231 cells with TA led to cell cycle arrest at G1 phase and apoptosis.  The actions of TA were correlated with proteasome-dependent degrdn. of Cdk4, cyclin D1, Raf-1, Akt, and mutant p53, which are heat shock protein 90 (Hsp90) client proteins.  TA treatment induced a transient increase in reactive oxygen species and a decrease in the intracellular glutathione contents.  Nonreducing SDS-PAGE revealed that TA rapidly and selectively induced thiol oxidn. and aggregation of Hsp90 and Hsp70, both in intact cells and in cell-free systems using purified recombinant proteins.  Furthermore, TA inhibited the chaperone activity of Hsp90-Hsp70 complex in the luciferase refolding assay.  N-Acetylcysteine, a thiol antioxidant, prevented all of the TA-induced effects, including oxidn. of heat shock proteins, degrdn. of Hsp90 client proteins, and apoptosis.  In contrast, non-thiol antioxidants (trolox and vitamin C) were ineffective to prevent Hsp90 inhibition and cell death.  Taken together, our results demonstrate that the TA inhibits the activity of Hsp90-Hsp70 chaperone complex, at least in part, by a direct thiol oxidn., which in turn leads to the destabilization and depletion of Hsp90 client proteins and thus causes cell cycle arrest and apoptosis in MDA-MB-231 cells.  Therefore, TA can be considered as a new type of inhibitor of Hsp90-Hsp70 chaperone complex, which has the potential to be developed as a novel strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6jKcM90BvAbVg90H21EOLACvtfcHk0ljuHJ7zzr6pqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFSnt7c%253D&md5=1ea1deed86bc1ad05dc39b44313dda3e</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M709447200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M709447200%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BY.%26aulast%3DChang%26aufirst%3DF.%2BR.%26aulast%3DHuang%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DTubocapsenolide%2520a%252C%2520a%2520novel%2520withanolide%252C%2520inhibits%2520proliferation%2520and%2520induces%2520apoptosis%2520in%2520mda-mb-231%2520cells%2520by%2520thiol%2520oxidation%2520of%2520heat%2520shock%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D17184%26epage%3D17193%26doi%3D10.1074%2Fjbc.M709447200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative inhibition of hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1002/ijc.27687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fijc.27687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22729780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVOmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=695-706&author=S.+Sarkarauthor=D.+Duttaauthor=S.+K.+Samantaauthor=K.+Bhattacharyaauthor=B.+C.+Palauthor=J.+P.+Liauthor=K.+Dattaauthor=C.+Mandalauthor=C.+Mandal&title=Oxidative+inhibition+of+hsp90+disrupts+the+super-chaperone+complex+and+attenuates+pancreatic+adenocarcinoma+in+vitro+and+in+vivo&doi=10.1002%2Fijc.27687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo</span></div><div class="casAuthors">Sarkar, Sayantani; Dutta, Devawati; Samanta, Suman Kumar; Bhattacharya, Kaushik; Pal, Bikas Chandra; Li, Jinping; Datta, Kaustubh; Mandal, Chhabinath; Mandal, Chitra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">695-706</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Pancreatic cancer is almost always fatal, in part because of its delayed diagnosis, poor prognosis, rapid progression and chemoresistance.  Oncogenic proteins are stabilized by the Hsp90, making it a potential therapeutic target.  We investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer.  Mahanine exhibited antiproliferative activity against several pancreatic cancer cell lines through apoptosis.  It induced early accumulation of reactive oxygen species (ROS) leading to thiol oxidn., aggregation and dysfunction of Hsp90 in MIAPaCa-2.  N-acetyl-L-cysteine prevented mahanine-induced ROS accumulation, aggregation of Hsp90, degrdn. of client proteins and cell death.  Mahanine disrupted Hsp90-Cdc37 complex in MIAPaCa-2 as a consequence of ROS generation.  Client proteins were restored by MG132, suggesting a possible role of ubiquitinylated protein degrdn. pathway.  Surface plasmon resonance study demonstrated that the rate of interaction of mahanine with recombinant Hsp90 is in the range of seconds.  Mol. dynamics simulation showed its weak interactions with Hsp90.  However, no disruption of the Hsp90-Cdc37 complex was obsd. at an early time point, thus ruling out that mahanine directly disrupts the complex.  It did not impede the ATP binding pocket of Hsp90.  Mahanine also reduced in vitro migration and tube formation in cancer cells.  Further, it inhibited orthotopic pancreatic tumor growth in nude mice.  Taken together, these results provide evidence for mahanine-induced ROS-mediated destabilization of Hsp90 chaperone activity resulting in Hsp90-Cdc37 disruption leading to apoptosis, suggesting its potential as a specific target in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2wjaaP-3orVg90H21EOLACvtfcHk0ljuHJ7zzr6pqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVOmsrk%253D&md5=d78916f699b062c5d06f56338bf3526b</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1002%2Fijc.27687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27687%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DDutta%26aufirst%3DD.%26aulast%3DSamanta%26aufirst%3DS.%2BK.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DPal%26aufirst%3DB.%2BC.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DDatta%26aufirst%3DK.%26aulast%3DMandal%26aufirst%3DC.%26aulast%3DMandal%26aufirst%3DC.%26atitle%3DOxidative%2520inhibition%2520of%2520hsp90%2520disrupts%2520the%2520super-chaperone%2520complex%2520and%2520attenuates%2520pancreatic%2520adenocarcinoma%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D695%26epage%3D706%26doi%3D10.1002%2Fijc.27687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcon, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crandon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zein, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannargudi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shnaidman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brega, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span> <span> </span><span class="NLM_article-title">A phase I study of pf-04929113 (snx-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6831</span>– <span class="NLM_lpage">6839</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-0821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-11-0821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21908572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWlsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6831-6839&author=A.+Rajanauthor=R.+J.+Kellyauthor=J.+B.+Trepelauthor=Y.+S.+Kimauthor=S.+V.+Alarconauthor=S.+Kummarauthor=M.+Gutierrezauthor=S.+Crandonauthor=W.+M.+Zeinauthor=L.+Jainauthor=B.+Mannargudiauthor=W.+D.+Figgauthor=B.+E.+Houkauthor=M.+Shnaidmanauthor=N.+Bregaauthor=G.+Giaccone&title=A+phase+I+study+of+pf-04929113+%28snx-5422%29%2C+an+orally+bioavailable+heat+shock+protein+90+inhibitor%2C+in+patients+with+refractory+solid+tumor+malignancies+and+lymphomas&doi=10.1158%2F1078-0432.CCR-11-0821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas</span></div><div class="casAuthors">Rajan, Arun; Kelly, Ronan J.; Trepel, Jane B.; Kim, Yeong Sang; Alarcon, Sylvia V.; Kummar, Shivaani; Gutierrez, Martin; Crandon, Sonja; Zein, Wadih M.; Jain, Lokesh; Mannargudi, Baskar; Figg, William D.; Houk, Brett E.; Shnaidman, Michael; Brega, Nicoletta; Giaccone, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6831-6839</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To det. the max. tolerated dose (MTD), toxicities, and pharmacokinetic/pharmacodynamic profile of the Hsp90 inhibitor PF-04929113 (SNX-5422) in patients with advanced solid tumors and lymphomas.  METHODS: This was a single-institution, phase I, dose-escalation study of PF-04929113 administered twice weekly.  Endpoints included detn. of dose-limiting toxicities (DLT), MTD, the safety profile of PF-04929113, pharmacodynamic assessment of PF-04929113 on Hsp70 induction, pharmacokinetic anal. of PF-04928473 (SNX-2112) and its prodrug PF-04929113, and assessment of response.  RESULTS: Thirty-three patients with advanced malignancies were treated.  Dose escalation was continued up to 177 mg/m2 administered orally twice a week.  One DLT (nonseptic arthritis) was noted.  No grade 4 drug-related adverse events were seen; grade 3 adverse events included diarrhea (9%), nonseptic arthritis (3%), aspartate aminotransferase elevation (3%), and thrombocytopenia (3%).  No objective responses were seen in 32 evaluable patients.  Fifteen patients (47%) had stable disease; 17 patients (53%) had progressive disease.  Pharmacokinetic data revealed rapid absorption, hepatic, and extrahepatic clearance, extensive tissue binding, and almost linear pharmacokinetics of the active drug PF-04928473.  Pharmacodynamic studies confirmed inhibition of Hsp90 and a linear correlation between pharmacokinetic parameters and Hsp70 induction.  CONCLUSIONS: PF-04929113 administered orally twice a week is well tolerated and inhibits its intended target Hsp90.  No objective responses were seen, but long-lasting stabilizations were obtained.  Although no clin. significant drug-related ocular toxicity was seen in this study, the development of PF-04929113 has been discontinued because of ocular toxicity seen in animal models and in a sep. phase I study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQzbnkoUJnibVg90H21EOLACvtfcHk0lhoZLV4e1YBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWlsrzM&md5=2b10fada0eb9d1dc7e06826724edf21f</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0821%26sid%3Dliteratum%253Aachs%26aulast%3DRajan%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DR.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DAlarcon%26aufirst%3DS.%2BV.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DCrandon%26aufirst%3DS.%26aulast%3DZein%26aufirst%3DW.%2BM.%26aulast%3DJain%26aufirst%3DL.%26aulast%3DMannargudi%26aufirst%3DB.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DHouk%26aufirst%3DB.%2BE.%26aulast%3DShnaidman%26aufirst%3DM.%26aulast%3DBrega%26aufirst%3DN.%26aulast%3DGiaccone%26aufirst%3DG.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520pf-04929113%2520%2528snx-5422%2529%252C%2520an%2520orally%2520bioavailable%2520heat%2520shock%2520protein%252090%2520inhibitor%252C%2520in%2520patients%2520with%2520refractory%2520solid%2520tumor%2520malignancies%2520and%2520lymphomas%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D6831%26epage%3D6839%26doi%3D10.1158%2F1078-0432.CCR-11-0821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Hsp90 inhibition: elimination of shock and stress</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4983</span>– <span class="NLM_lpage">4987</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2010.06.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20656483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4983-4987&author=A.+S.+Duerfeldtauthor=B.+S.+J.+Blagg&title=Hsp90+inhibition%3A+elimination+of+shock+and+stress&doi=10.1016%2Fj.bmcl.2010.06.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 inhibition: Elimination of shock and stress</span></div><div class="casAuthors">Duerfeldt, Adam S.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4983-4987</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The 90 kDa heat shock proteins (Hsp90) represent a class of mol. chaperones responsible for the maturation and stabilization of many oncogenic proteins.  Disrupting the ability of ATP to bind and facilitate the operation of Hsp90 has emerged as a promising approach toward cancer chemotherapeutic development.  While numerous Hsp90 inhibitory scaffolds have been identified, progress through the clinic has revealed many obstacles that should be addressed in future analog development.  Recent reports of the complications, pitfalls, and downstream effects assocd. with Hsp90 inhibition are discussed herein, in hopes of providing a ref. that can be used to guide the future design of Hsp90 inhibitory scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXsn3PYU8oqLVg90H21EOLACvtfcHk0lhoZLV4e1YBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbjE&md5=d6f1ad3e632e69eb8d0df2ade911db69</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.108%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DHsp90%2520inhibition%253A%2520elimination%2520of%2520shock%2520and%2520stress%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4983%26epage%3D4987%26doi%3D10.1016%2Fj.bmcl.2010.06.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuttall, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the radicicol resistance displayed by a fungal hsp90</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1021/cb9000316</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb9000316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtl2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=289-297&author=C.+Prodromouauthor=J.+M.+Nuttallauthor=S.+H.+Millsonauthor=S.+M.+Roeauthor=T.+S.+Simauthor=D.+Tanauthor=P.+Workmanauthor=L.+H.+Pearlauthor=P.+W.+Piper&title=Structural+basis+of+the+radicicol+resistance+displayed+by+a+fungal+hsp90&doi=10.1021%2Fcb9000316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90</span></div><div class="casAuthors">Prodromou, Chrisostomos; Nuttall, James M.; Millson, Stefan H.; Roe, S. Mark; Sim, Tiow-Suan; Tan, Doreen; Workman, Paul; Pearl, Laurence H.; Piper, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-297</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a promising cancer drug target, as multiple oncogenic proteins are destabilized simultaneously when it loses its activity in tumor cells.  Highly selective Hsp90 inhibitors, including the natural antibiotics geldanamycin (GdA) and radicicol (RAD), inactivate this essential mol. chaperone by occupying its nucleotide binding site.  Often cancer drug therapy is compromised by the development of resistance, but a resistance to these Hsp90 inhibitors should not arise readily by mutation of those amino acids within Hsp90 that facilitate inhibitor binding, as these are required for the essential ATP binding/ATPase steps of the chaperone cycle and are tightly conserved.  Despite this, the Hsp90 of a RAD-producing fungus is shown to possess an unusually low binding affinity for RAD but not GdA.  Within its nucleotide binding site a normally conserved leucine is replaced by isoleucine, though the chaperone ATPase activity is not severely affected.  Inserted into the Hsp90 of yeast, this conservative leucine to isoleucine substitution recreated this lowered affinity for RAD in vitro.  It also generated a substantially enhanced resistance to RAD in vivo.  Co-crystal structures reveal that the change to isoleucine is assocd. with a localized increase in the hydration of an Hsp90-bound RAD but not GdA.  To the best of our knowledge, this is the first demonstration that it is possible for Hsp90 inhibitor resistance to arise by subtle alteration to the structure of Hsp90 itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqBiwlzDNYbVg90H21EOLACvtfcHk0lhoZLV4e1YBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtl2qtbk%253D&md5=2498a51c8240132da8bfa3e88cbbc67e</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fcb9000316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9000316%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DNuttall%26aufirst%3DJ.%2BM.%26aulast%3DMillson%26aufirst%3DS.%2BH.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DSim%26aufirst%3DT.%2BS.%26aulast%3DTan%26aufirst%3DD.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26atitle%3DStructural%2520basis%2520of%2520the%2520radicicol%2520resistance%2520displayed%2520by%2520a%2520fungal%2520hsp90%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26spage%3D289%26epage%3D297%26doi%3D10.1021%2Fcb9000316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettouche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voellmy, R.</span></span> <span> </span><span class="NLM_article-title">Repression of heat shock transcription factor hsf1 activation by hsp90 (hsp90 complex) that forms a stress-sensitive complex with hsf1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81588-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2800%2981588-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=9727490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADyaK1cXlslOrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=471-480&author=J.+Zouauthor=Y.+Guoauthor=T.+Guettoucheauthor=D.+F.+Smithauthor=R.+Voellmy&title=Repression+of+heat+shock+transcription+factor+hsf1+activation+by+hsp90+%28hsp90+complex%29+that+forms+a+stress-sensitive+complex+with+hsf1&doi=10.1016%2FS0092-8674%2800%2981588-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1</span></div><div class="casAuthors">Zou, Jiangying; Guo, Yongle; Guettouche, Toumy; Smith, David F.; Voellmy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">471-480</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heat shock and other proteotoxic stresses cause accumulation of nonnative proteins that trigger activation of heat shock protein (Hsp) genes.  A chaperone/Hsp functioning as repressor of heat shock transcription factor (HSF) could make activation of hsp genes dependent on protein unfolding.  In a novel in vitro system, in which human HSF1 can be activated by nonnative protein, heat, and geldanamycin, addn. of Hsp90 inhibits activation.  Redn. of the level of Hsp90 but not of Hsp/c70, Hop, Hip, p23, CyP40, or Hsp40 dramatically activates HSF1.  In vivo, geldanamycin activates HSF1 under conditions in which it is an Hsp90-specific reagent.  Hsp90-contg. HSF1 complex is present in the unstressed cell and dissocs. during stress.  We conclude that Hsp90, by itself and/or assocd. with multichaperone complexes, is a major repressor of HSF1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW_ZsrrM8VFrVg90H21EOLACvtfcHk0lgqm-pdXZyIIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslOrsrY%253D&md5=26024c9d4e94c7f46986320fc667fd6f</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981588-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981588-3%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGuettouche%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DVoellmy%26aufirst%3DR.%26atitle%3DRepression%2520of%2520heat%2520shock%2520transcription%2520factor%2520hsf1%2520activation%2520by%2520hsp90%2520%2528hsp90%2520complex%2529%2520that%2520forms%2520a%2520stress-sensitive%2520complex%2520with%2520hsf1%26jtitle%3DCell%26date%3D1998%26volume%3D94%26spage%3D471%26epage%3D480%26doi%3D10.1016%2FS0092-8674%2800%2981588-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">New developments in hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.drup.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19179103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=17-27&author=Y.+Y.+Liauthor=T.+Zhangauthor=S.+J.+Schwartzauthor=D.+X.+Sun&title=New+developments+in+hsp90+inhibitors+as+anti-cancer+therapeutics%3A+mechanisms%2C+clinical+perspective+and+more+potential&doi=10.1016%2Fj.drup.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span></div><div class="casAuthors">Li Yanyan; Zhang Tao; Schwartz Steven J; Sun Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The molecular chaperone Hsp90 (heat shock protein 90) is a promising target in cancer therapy.  Preclinical and clinical evaluations of a variety of Hsp90 inhibitors have shown anti-tumor effect as a single agent and in combination with chemotherapy.  Current Hsp90 inhibitors are categorized into several classes based on distinct modes of inhibition, including (i) blockade of ATP binding, (ii) disruption of co-chaperone/Hsp90 interactions, (iii) antagonism of client/Hsp90 associations and (iv) interference with post-translational modifications of Hsp90.  The different functions of Hsp90 isoforms and the isoform selectivity of drugs need further investigation.  The correlation of cell surface Hsp90 with cancer metastasis and the emerging involvement of Hsp90 inhibition in cancer stem cells have become exciting areas that could be exploited.  Therefore, the aim of this review is (1) to summarize the up-to-date knowledge of mechanistic studies and clinical prospect of currently available Hsp90 inhibitors, (2) to enhance our perspectives for designing and discovering novel Hsp90 inhibitors, and (3) to provide an insight into less-understood potential of Hsp90 inhibition in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5kNKTb14uEhcr74wzj5o5fW6udTcc2earJaehaeQD-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D&md5=4d848faff412f714fb669add9d0cc4c7</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DS.%2BJ.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DNew%2520developments%2520in%2520hsp90%2520inhibitors%2520as%2520anti-cancer%2520therapeutics%253A%2520mechanisms%252C%2520clinical%2520perspective%2520and%2520more%2520potential%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2009%26volume%3D12%26spage%3D17%26epage%3D27%26doi%3D10.1016%2Fj.drup.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein (p-gp)-mediated efflux limits intestinal absorption of the hsp90 inhibitor snx-2112 in rats</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.3109/00498254.2014.891781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.3109%2F00498254.2014.891781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24555822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=763-768&author=H.+Liuauthor=H.+Sunauthor=Z.+Wuauthor=X.+Zhangauthor=B.+Wu&title=P-glycoprotein+%28p-gp%29-mediated+efflux+limits+intestinal+absorption+of+the+hsp90+inhibitor+snx-2112+in+rats&doi=10.3109%2F00498254.2014.891781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in rats</span></div><div class="casAuthors">Liu, Hongming; Sun, Hua; Wu, Zhufeng; Zhang, Xingwang; Wu, Baojian</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">763-768</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. The promising anticancer agent SNX-2112 (a novel Hsp90 inhibitor) is poorly bioavailable after oral administration.  Here, we aim to det. the role of P-glycoprotein (P-gp) in the intestinal absorption of SNX-2112.  2. We found that SNX-2112 significantly stimulated P-gp ATPase activity in in vitro ATPase assay with a small EC50 (the half-maximal effective concn.) value of 0.32 μM.  3. In the single-pass perfused rat intestine model, absorption of SNX-2112 was not favored in the small intestine with a (the wall permeability) value of 0.38-0.64.  By contrast, the compd. was well absorbed in the colon with a value of 1.19.  The P-gp inhibitors cyclosporine and elacridar (i.e. GF120918A) markedly enhanced SNX-2112 absorption in all four intestinal segments (i.e. duodenum, jejunum, ileum and colon) and the fold change ranged from 3.1 to 14.1.  Pharmacokinetic study revealed that cyclosporine increased the systemic exposure of SNX-2112 by a 2.5-fold after oral administration.  4. This is the first report that P-gp-mediated efflux is a limiting factor for intestinal absorption of SNX-2112 in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpkim7OEVzjbVg90H21EOLACvtfcHk0lii245me0B-Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtLvJ&md5=8f1c1d5c849ab665be1bc94677cace42</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.891781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.891781%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DP-glycoprotein%2520%2528p-gp%2529-mediated%2520efflux%2520limits%2520intestinal%2520absorption%2520of%2520the%2520hsp90%2520inhibitor%2520snx-2112%2520in%2520rats%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26spage%3D763%26epage%3D768%26doi%3D10.3109%2F00498254.2014.891781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilaboa, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aller, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of multidrug resistance 1 (mdr1)/p-glycoprotein gene expression and activity by heat-shock transcription factor 1 (hsf1)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">24970</span>, <span class="refDoi"> DOI: 10.1074/jbc.M909136199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M909136199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10816597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsl2jtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=24970&author=N.+E.+Vilaboaauthor=A.+Galanauthor=A.+Troyanoauthor=E.+de+Blasauthor=P.+Aller&title=Regulation+of+multidrug+resistance+1+%28mdr1%29%2Fp-glycoprotein+gene+expression+and+activity+by+heat-shock+transcription+factor+1+%28hsf1%29&doi=10.1074%2Fjbc.M909136199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1)</span></div><div class="casAuthors">Vilaboa, Nuria E.; Galan, Alba; Troyano, Alfonso; De Blas, Elena; Aller, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">24970-24976</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Infection of HeLa cells with adenovirus-carrying HSF1+ cDNA, which encodes a mutated form of HSF1 with constitutive transactivation capacity, increased multidrug resistance 1 (MDR1) mRNA level and P-glycoprotein (P-gp) cell surface content and stimulated rhodamine 123 accumulation and vinblastine efflux activity.  On the other hand, infection with adenovirus-carrying HSP70 and HSP27 cDNAs did not increase MDR1/P-gp expression.  HSF1 regulates MDR1/P-gp expression at the transcriptional level, since HSF1+ bound the heat-shock consensus elements (HSEs) in the MDR1 gene promoter and also activated the expression of an MDR1 promoter-driven reporter plasmid (pMDR1(-1202)).  In addn., heat-shock increased pMDR1(-1202) promoter activity but not the activity of a similar reporter plasmid with point mutations at specific HSEs, and the heat-induced increase was totally inhibited by co-transfection with an expression plasmid carrying HSF1-, a dominant neg. mutant of HSF1.  The stress inducers arsenite, butyrate, and etoposide also increased pMDR1(-1202) promoter activity, but the increase was not inhibited (in the case of butyrate) or was only partially inhibited (in the case of arsenite and etoposide) by HSF1-.  These results demonstrate that HSF1 regulates MDR1 expression, and that the HSEs present in the -315 to -285 region mediate the heat-induced activation of the MDR1 promoter.  However, other factors may also participate in MDR1 induction by stressing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFTNvDebI3JLVg90H21EOLACvtfcHk0lhQnksmUTZ31g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsl2jtb8%253D&md5=99fcd79dc175de14e75a9163e0a61e14</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M909136199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M909136199%26sid%3Dliteratum%253Aachs%26aulast%3DVilaboa%26aufirst%3DN.%2BE.%26aulast%3DGalan%26aufirst%3DA.%26aulast%3DTroyano%26aufirst%3DA.%26aulast%3Dde%2BBlas%26aufirst%3DE.%26aulast%3DAller%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520multidrug%2520resistance%25201%2520%2528mdr1%2529%252Fp-glycoprotein%2520gene%2520expression%2520and%2520activity%2520by%2520heat-shock%2520transcription%2520factor%25201%2520%2528hsf1%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D24970%26doi%3D10.1074%2Fjbc.M909136199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ojha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HuangFu, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J. P.</span></span> <span> </span><span class="NLM_article-title">1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of hsp90 and hdac</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2018.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29567459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlt1OhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=667-677&author=R.+Ojhaauthor=H.+L.+Huangauthor=W.+C.+HuangFuauthor=Y.+W.+Wuauthor=K.+Nepaliauthor=M.+J.+Laiauthor=C.+J.+Suauthor=T.+Y.+Sungauthor=Y.+L.+Chenauthor=S.+L.+Panauthor=J.+P.+Liou&title=1-Aroylindoline-hydroxamic+acids+as+anticancer+agents%2C+inhibitors+of+hsp90+and+hdac&doi=10.1016%2Fj.ejmech.2018.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC</span></div><div class="casAuthors">Ojha, Ritu; Huang, Han-Li; Huang Fu, Wei-Chun; Wu, Yi-Wen; Nepali, Kunal; Lai, Mei-Jung; Su, Chih-Jou; Sung, Ting-Yi; Chen, Yi-Lin; Pan, Shiow-Lin; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">667-677</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 1-aroylindoline-hydroxamic acids I [n = 2 - 8] and II were synthesized.  The results of the biol. evaluation led to the identification of compd. I [n = 6] as dual HDAC6/HSP90 inhibitor.  Compd. I [n = 6] displayed striking inhibitory effects towards the HDAC6 isoform and HSP90 protein with IC50 values of 1.15 nM (HDAC6) and 46.3 nM (HSP90).  Compd. I [n = 6] also exhibited 113, 139 and 246 fold higher selectivity for HDAC6 over HDAC 1, HDAC 3 and HDAC 8 isoforms and was endowed with significant cytotoxic effects with GI50 values ranging 1.04-1.61 μM against lung A549, colorectal HCT116, leukemia HL60 and EGFR T790M mutant lung H1975 cell lines.  Another interesting finding of the study was substantial cytotoxic effects of compd. I particularly against lung H1975 (NSCLC) cell lines with IC50 = 0.26 μM which was mediated through HSP90 inhibition.  Compd. I [n = 2] as such was devoid of HDAC inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgF2Cb1sTQY7Vg90H21EOLACvtfcHk0ljeO6TiJ5-dOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlt1OhtLk%253D&md5=7c6b877c774d207150bf49c45f9a9303</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DOjha%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DH.%2BL.%26aulast%3DHuangFu%26aufirst%3DW.%2BC.%26aulast%3DWu%26aufirst%3DY.%2BW.%26aulast%3DNepali%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.%2BJ.%26aulast%3DSu%26aufirst%3DC.%2BJ.%26aulast%3DSung%26aufirst%3DT.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DPan%26aufirst%3DS.%2BL.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26atitle%3D1-Aroylindoline-hydroxamic%2520acids%2520as%2520anticancer%2520agents%252C%2520inhibitors%2520of%2520hsp90%2520and%2520hdac%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D667%26epage%3D677%26doi%3D10.1016%2Fj.ejmech.2018.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Development of heat shock protein (hsp90) inhibitors to combat resistance to tyrosine kinase inhibitors through hsp90-kinase interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5563</span>– <span class="NLM_lpage">5586</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01106</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01106" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5563-5586&author=M.+Wangauthor=A.+Shenauthor=C.+Zhangauthor=Z.+Songauthor=J.+Aiauthor=H.+Liuauthor=L.+Sunauthor=J.+Dingauthor=M.+Gengauthor=A.+Zhang&title=Development+of+heat+shock+protein+%28hsp90%29+inhibitors+to+combat+resistance+to+tyrosine+kinase+inhibitors+through+hsp90-kinase+interactions&doi=10.1021%2Facs.jmedchem.5b01106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions</span></div><div class="casAuthors">Wang, Meining; Shen, Aijun; Zhang, Chi; Song, Zilan; Ai, Jing; Liu, Hongchun; Sun, Liping; Ding, Jian; Geng, Meiyu; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5563-5586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a ubiquitous chaperone of all of the oncogenic tyrosine kinases.  Many Hsp90 inhibitors, alone or in combination, have shown significant antitumor efficacy against the kinase-pos. na.ovrddot.ive and mutant models.  However, clin. trials of these inhibitors are unsuccessful due to insufficient clin. benefits and nonoptimal safety profiles.  Recently, much progress has been reported on the Hsp90-cochaperone-client complex, which will undoubtedly assist in the understanding of the interactions between Hsp90 and its clients.  Meanwhile, Hsp90 inhibitors have shown promise against patients' resistance caused by early generation tyrosine kinase inhibitors (TKIs), and at least 13 Hsp90 inhibitors are being reevaluated in the clinic.  In this regard, the objectives of the current perspective are to summarize the structure and function of the Hsp90-cochaperone-client complex, to analyze the structural and functional insights into the Hsp90-client interactions to address several existing unresolved problems with Hsp90 inhibitors, and to highlight the preclin. and clin. studies of Hsp90 inhibitors as an effective treatment against resistance to tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrgsVY9MSMrVg90H21EOLACvtfcHk0lhEoXdnNHdQkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D&md5=2408b273b2a00136223ff21709c7ae2d</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520heat%2520shock%2520protein%2520%2528hsp90%2529%2520inhibitors%2520to%2520combat%2520resistance%2520to%2520tyrosine%2520kinase%2520inhibitors%2520through%2520hsp90-kinase%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5563%26epage%3D5586%26doi%3D10.1021%2Facs.jmedchem.5b01106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and pharmacological evaluation of alk and hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2018.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29698859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVWmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=76-86&author=K.+Gengauthor=H.+Liuauthor=Z.+Songauthor=C.+Zhangauthor=M.+Zhangauthor=H.+Yangauthor=J.+Caoauthor=M.+Gengauthor=A.+Shenauthor=A.+Zhang&title=Design%2C+synthesis+and+pharmacological+evaluation+of+alk+and+hsp90+dual+inhibitors+bearing+resorcinol+and+2%2C4-diaminopyrimidine+motifs&doi=10.1016%2Fj.ejmech.2018.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs</span></div><div class="casAuthors">Geng, Kaijun; Liu, Hongchun; Song, Zilan; Zhang, Chi; Zhang, Minmin; Yang, Hong; Cao, Jingchen; Geng, Meiyu; Shen, Aijun; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-86</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Rather than by directly focusing on the ever-changing ALK mutants, here we report an alternative strategy to overcome the drug resistance caused by treatment of ALK inhibitors by developing ALK and Hsp90 dual targeting inhibitors.  Since Hsp90 is a mol. chaperone that regulates the maturation, activation and stability of numerous "client proteins" including ALK, dual targeting ALK and Hsp90 may bring more benefits and efficacy against drug resistance of ALK inhibitors.  By using our previously developed ALK inhibitor 6 and the clin. Hsp90 inhibitors AUY922 or AT13387 as the templates, we developed several series of resorcinol tethered 2,4-diaminopyrimidines as ALK/Hsp90 dual inhibitors bearing various linkers at different linking sites.  Compd. 10h and 10j showed high potency against ALK (17.3 vs 9.8 nM) and Hsp90α (100 vs 40 nM).  They also have high potency against ALK resistant mutants, esp. the gatekeeper mutation ALKL1196M.  Both compds. showed strong antiproliferative activity against the ALK-addictive H3122 cells (11 vs 13 nM).  The dual functioning mechanism is further confirmed by their down-regulation of the Hsp90 clients ALK and AKT, and up-regulation of the chaperone protein Hsp70 in H3122 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmqigxUQsz8bVg90H21EOLACvtfcHk0ljr87ZrO_V7yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVWmsLY%253D&md5=a64e43ba5d725642af62313c1dbc8111</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%2520alk%2520and%2520hsp90%2520dual%2520inhibitors%2520bearing%2520resorcinol%2520and%25202%252C4-diaminopyrimidine%2520motifs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D152%26spage%3D76%26epage%3D86%26doi%3D10.1016%2Fj.ejmech.2018.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span> <span> </span><span class="NLM_article-title">The hsp90 inhibitor, nvp-auy922, attenuates intrinsic pi3k inhibitor resistance in kras-mutant non-small cell lung cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.canlet.2017.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28797845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2017&pages=47-53&author=K.+S.+Parkauthor=H.+Yangauthor=J.+Choiauthor=S.+Seoauthor=D.+Kimauthor=C.+H.+Leeauthor=H.+Jeonauthor=S.+W.+Kimauthor=D.+H.+Lee&title=The+hsp90+inhibitor%2C+nvp-auy922%2C+attenuates+intrinsic+pi3k+inhibitor+resistance+in+kras-mutant+non-small+cell+lung+cancer&doi=10.1016%2Fj.canlet.2017.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer</span></div><div class="casAuthors">Park, Kang-Seo; Yang, Hannah; Choi, Junyoung; Seo, Seyoung; Kim, Deokhoon; Lee, Chang Hoon; Jeon, Hanwool; Kim, Sang-We; Lee, Dae Ho</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">More than 25% of non-small cell lung cancers (NSCLCs) carry mutations in KRAS, one of the most common oncogenic drivers in this disease.  KRAS-mutant NSCLC responds poorly to currently available therapies; therefore, novel treatment strategies are needed.  Here, we describe a particularly promising targeted therapeutic strategy against KRAS mutation-harboring NSCLC intrinsically resistant to treatment by PI3K inhibition.  We found that intrinsic resistance to PI3K inhibition derived from RAF/MEK/ERK and RSK activation, bypassing blockage of the PI3K/AKT/mTOR pathway.  The HSP90 inhibitor AUY922 suppressed both PI3K/AKT/mTOR and RAF/MEK/ERK signaling, rendering cells sensitive to a PI3K inhibitor (omipalisib, GSK458).  Combining these two drugs achieved a synergistic effect, even using only sub-therapeutic concns.  Dual inhibition of the HSP90 and PI3K signaling pathways with sub-therapeutic doses of these combined anticancer drugs may represent a potent treatment strategy for KRAS-mutant NSCLC with intrinsic resistance to PI3K inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFsmXfZcBd8bVg90H21EOLACvtfcHk0ljr87ZrO_V7yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWks7%252FL&md5=751a305c9837aa4eb04b5a041aefdeba</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DD.%2BH.%26atitle%3DThe%2520hsp90%2520inhibitor%252C%2520nvp-auy922%252C%2520attenuates%2520intrinsic%2520pi3k%2520inhibitor%2520resistance%2520in%2520kras-mutant%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D406%26spage%3D47%26epage%3D53%26doi%3D10.1016%2Fj.canlet.2017.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaxton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugle, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riesenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span> <span> </span><span class="NLM_article-title">Clients and oncogenic roles of molecular chaperone gp96/grp94</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2765</span>– <span class="NLM_lpage">2778</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F1568026616666160413141613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27072698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2765-2778&author=E.+A.+Ansa-Addoauthor=J.+Thaxtonauthor=F.+Hongauthor=B.+X.+Wuauthor=Y.+L.+Zhangauthor=C.+W.+Fugleauthor=A.+Metelliauthor=B.+Riesenbergauthor=K.+Williamsauthor=D.+T.+Gewirthauthor=G.+Chiosisauthor=B.+Liuauthor=Z.+H.+Li&title=Clients+and+oncogenic+roles+of+molecular+chaperone+gp96%2Fgrp94&doi=10.2174%2F1568026616666160413141613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94</span></div><div class="casAuthors">Ansa-Addo, Ephraim A.; Thaxton, Jessica; Hong, Feng; Wu, Bill X.; Zhang, Yongliang; Fugle, Caroline W.; Metelli, Alessandra; Riesenberg, Brian; Williams, Katelyn; Gewirth, Daniel T.; Chiosis, Gabriela; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2765-2778</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat shock protein (HSP) 90 paralogue, glycoprotein (gp) 96 possesses immunol. properties by chaperoning antigenic peptides for activation of T cells.  Genetic studies in the last decade have unveiled that gp96 is also an essential master chaperone for multiple receptors and secreting proteins including Toll-like receptors (TLRs), integrins, the Wnt coreceptor, Low D. Lipoprotein Receptor-Related Protein 6 (LRP6), the latent TGF docking receptor, Glycoprotein A Repetitions Predominant (GARP), Glycoprotein (GP) Ib and insulin-like growth factors (IGF).  Clin., elevated expression of gp96 in a variety of cancers correlates with the advanced stage and poor survival of cancer patients.  Recent preclin. studies have also uncovered that gp96 expression is closely linked to cancer progression in multiple myeloma, hepatocellular carcinoma, breast cancer and inflammation-assocd. colon cancer.  Thus, gp96 is an attractive therapeutic target for cancer treatment.  The chaperone function of gp96 depends on its ATPase domain, which is structurally distinct from other HSP90 members, and thus favors the design of highly selective gp96-targeted inhibitors against cancer.  We herein discuss the strategically important oncogenic clients of gp96 and their underlying biol.  The roles of cell-intrinsic gp96 in T cell biol. are also discussed, in part because it offers another opportunity of cancer therapy by manipulating levels of gp96 in T cells to enhance host immune defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTKDihIb-tPrVg90H21EOLACvtfcHk0ljr87ZrO_V7yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK&md5=52930fd6506186a93a1a8decad51388c</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141613%26sid%3Dliteratum%253Aachs%26aulast%3DAnsa-Addo%26aufirst%3DE.%2BA.%26aulast%3DThaxton%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DFugle%26aufirst%3DC.%2BW.%26aulast%3DMetelli%26aufirst%3DA.%26aulast%3DRiesenberg%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26atitle%3DClients%2520and%2520oncogenic%2520roles%2520of%2520molecular%2520chaperone%2520gp96%252Fgrp94%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2765%26epage%3D2778%26doi%3D10.2174%2F1568026616666160413141613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Orduna, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ferrer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higueras, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Crespo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamas, S.</span></span> <span> </span><span class="NLM_article-title">S-nitrosylation of hsp90 promotes the inhibition of its atpase and endothelial nitric oxide synthase regulatory activities</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">8525</span>– <span class="NLM_lpage">8530</span>, <span class="refDoi"> DOI: 10.1073/pnas.0407294102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.0407294102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15937123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFCgsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8525-8530&author=A.+Martinez-Ruizauthor=L.+Villanuevaauthor=C.+G.+de+Ordunaauthor=D.+Lopez-Ferrerauthor=M.+A.+Higuerasauthor=C.+Tarinauthor=I.+Rodriguez-Crespoauthor=J.+Vazquezauthor=S.+Lamas&title=S-nitrosylation+of+hsp90+promotes+the+inhibition+of+its+atpase+and+endothelial+nitric+oxide+synthase+regulatory+activities&doi=10.1073%2Fpnas.0407294102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities</span></div><div class="casAuthors">Martinez-Ruiz, Antonio; Villanueva, Laura; Gonzalez de Orduna, Cecilia; Lopez-Ferrer, Daniel; Higueras, Maria Angeles; Tarin, Carlos; Rodriguez-Crespo, Ignacio; Vazquez, Jesus; Lamas, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8525-8530</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Nitric oxide is implicated in a variety of signaling pathways in different systems, notably in endothelial cells.  Some of its effects can be exerted through covalent modifications of proteins and, among these modifications, increasing attention is being paid to S-nitrosylation as a signaling mechanism.  In this work, we show by a variety of methods (ozone chemiluminescence, biotin switch, and mass spectrometry) that the mol. chaperone Hsp90 is a target of S-nitrosylation and identify a susceptible cysteine residue in the region of the C-terminal domain that interacts with endothelial nitric oxide synthase (eNOS).  We also show that the modification occurs in endothelial cells when they are treated with S-nitroso-L-cysteine and when they are exposed to eNOS activators.  Hsp90 ATPase activity and its pos. effect on eNOS activity are both inhibited by S-nitrosylation.  Together, these data suggest that S-nitrosylation may functionally regulate the general activities of Hsp90 and provide a feedback mechanism for limiting eNOS activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndOSKWMybg7Vg90H21EOLACvtfcHk0lg5Io488qdaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFCgsbk%253D&md5=fd2103a67a370d38a64789148eeb7f58</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407294102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407294102%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Ruiz%26aufirst%3DA.%26aulast%3DVillanueva%26aufirst%3DL.%26aulast%3Dde%2BOrduna%26aufirst%3DC.%2BG.%26aulast%3DLopez-Ferrer%26aufirst%3DD.%26aulast%3DHigueras%26aufirst%3DM.%2BA.%26aulast%3DTarin%26aufirst%3DC.%26aulast%3DRodriguez-Crespo%26aufirst%3DI.%26aulast%3DVazquez%26aufirst%3DJ.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DS-nitrosylation%2520of%2520hsp90%2520promotes%2520the%2520inhibition%2520of%2520its%2520atpase%2520and%2520endothelial%2520nitric%2520oxide%2520synthase%2520regulatory%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D8525%26epage%3D8530%26doi%3D10.1073%2Fpnas.0407294102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burslem, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule modulation of protein homeostasis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">11269</span>– <span class="NLM_lpage">11301</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ohur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=11269-11301&author=G.+M.+Burslemauthor=C.+M.+Crews&title=Small-molecule+modulation+of+protein+homeostasis&doi=10.1021%2Facs.chemrev.7b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Modulation of Protein Homeostasis</span></div><div class="casAuthors">Burslem, George M.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11269-11301</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Control of protein levels by nucleic-acid-based technologies has proven to be a useful research tool but lacks the advantages of small mols. with respect to cell permeability, temporal control, and the potential generation of therapeutics.  In this Review, we discuss the technologies available for the control of intracellular protein levels with small mols. and compare the various systems available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcARydbgPK9bVg90H21EOLACvtfcHk0lg5Io488qdaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ohur3K&md5=f9f8dd98e2c71c7166d2d500b514d578</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00077%26sid%3Dliteratum%253Aachs%26aulast%3DBurslem%26aufirst%3DG.%2BM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520modulation%2520of%2520protein%2520homeostasis%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D11269%26epage%3D11301%26doi%3D10.1021%2Facs.chemrev.7b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Waste disposal-an attractive strategy for cancer therapy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1163</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1126/science.aam7340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1126%2Fscience.aam7340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28302825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1163-1167&author=J.+Salamiauthor=C.+M.+Crews&title=Waste+disposal-an+attractive+strategy+for+cancer+therapy&doi=10.1126%2Fscience.aam7340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Waste disposal-An attractive strategy for cancer therapy</span></div><div class="casAuthors">Salami, Jemilat; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6330</span>),
    <span class="NLM_cas:pages">1163-1167</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Targeted therapies for cancer are typically small mols. or monoclonal antibodies that act by inhibiting the activity of specific proteins that drive tumor growth.  Although many of these drugs are effective in cancer patients, the response is often not durable because tumor cells develop resistance to the drugs.  Another limitation of this strategy is that not all oncogenic driver proteins are "druggable" enzymes or receptors with activities that can be inhibited.  Here the authors describe an alternative approach to targeted therapy that is based on co-opting the cellular quality-control machinery-the ubiquitin-proteasome system-to remove specific cancer-causing proteins from the cell.  The authors first discuss examples of existing cancer drugs that work by degrading specific proteins and then review recent progress in the rational design and preclin. testing of small mols. that induce selective degrdn. of specific target proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVoZn-YpfXmbVg90H21EOLACvtfcHk0lg5Io488qdaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmt74%253D&md5=918621d50a82b7797aa0300537a4486e</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1126%2Fscience.aam7340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aam7340%26sid%3Dliteratum%253Aachs%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DWaste%2520disposal-an%2520attractive%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1163%26epage%3D1167%26doi%3D10.1126%2Fscience.aam7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Proteolysis-targeting chimeras: harnessing the ubiquitin-proteasome system to induce degradation of specific target proteins</span>. <i>Annu. Rev. Canc Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1146/annurev-cancerbio-030617-050430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1146%2Fannurev-cancerbio-030617-050430" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=41-58&author=K.+G.+Colemanauthor=C.+M.+Crews&title=Proteolysis-targeting+chimeras%3A+harnessing+the+ubiquitin-proteasome+system+to+induce+degradation+of+specific+target+proteins&doi=10.1146%2Fannurev-cancerbio-030617-050430"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cancerbio-030617-050430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cancerbio-030617-050430%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DK.%2BG.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DProteolysis-targeting%2520chimeras%253A%2520harnessing%2520the%2520ubiquitin-proteasome%2520system%2520to%2520induce%2520degradation%2520of%2520specific%2520target%2520proteins%26jtitle%3DAnnu.%2520Rev.%2520Canc%2520Biol.%26date%3D2018%26volume%3D2%26spage%3D41%26epage%3D58%26doi%3D10.1146%2Fannurev-cancerbio-030617-050430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paiva, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Targeted protein degradation: elements of protac design</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2019.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.cbpa.2019.02.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=31004963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2019&pages=111-119&author=S.+L.+Paivaauthor=C.+M.+Crews&title=Targeted+protein+degradation%3A+elements+of+protac+design&doi=10.1016%2Fj.cbpa.2019.02.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted protein degradation: elements of PROTAC design</span></div><div class="casAuthors">Paiva, Stacey-Lynn; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111-119</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Targeted protein degrdn. using Proteolysis Targeting Chimeras (PROTACs) has emerged as a novel therapeutic modality in drug discovery.  PROTACs mediate the degrdn. of select proteins of interest (POIs) by hijacking the activity of E3 ubiquitin ligases for POI ubiquitination and subsequent degrdn. by the 26S proteasome.  This hijacking mechanism has been used to degrade various types of disease-relevant POIs.  In this review, we aim to highlight the recent advances in targeted protein degrdn. and describe the challenges that need to be addressed in order to efficiently develop potent PROTACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol6Nk0VkUdzLVg90H21EOLACvtfcHk0lgDX0FqNtK9sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7s%253D&md5=5783311db47da378180c14d67526a398</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DPaiva%26aufirst%3DS.%2BL.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeted%2520protein%2520degradation%253A%2520elements%2520of%2520protac%2520design%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D50%26spage%3D111%26epage%3D119%26doi%3D10.1016%2Fj.cbpa.2019.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondeson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mares, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, I. E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miah, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulholland, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelth-Savitski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casillas, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Besten, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Famm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruidenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Catalytic in vivo protein knockdown by small-molecule protacs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnchembio.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26075522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=611-617&author=D.+P.+Bondesonauthor=A.+Maresauthor=I.+E.+D.+Smithauthor=E.+Koauthor=S.+Camposauthor=A.+H.+Miahauthor=K.+E.+Mulhollandauthor=N.+Routlyauthor=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=N.+Zinnauthor=P.+Grandiauthor=S.+Shimamuraauthor=G.+Bergaminiauthor=M.+Faelth-Savitskiauthor=M.+Bantscheffauthor=C.+Coxauthor=D.+A.+Gordonauthor=R.+R.+Willardauthor=J.+J.+Flanaganauthor=L.+N.+Casillasauthor=B.+J.+Vottaauthor=W.+den+Bestenauthor=K.+Fammauthor=L.+Kruidenierauthor=P.+S.+Carterauthor=J.+D.+Harlingauthor=I.+Churcherauthor=C.+M.+Crews&title=Catalytic+in+vivo+protein+knockdown+by+small-molecule+protacs&doi=10.1038%2Fnchembio.1858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic in vivo protein knockdown by small-molecule PROTACs</span></div><div class="casAuthors">Bondeson, Daniel P.; Mares, Alina; Smith, Ian E. D.; Ko, Eunhwa; Campos, Sebastien; Miah, Afjal H.; Mulholland, Katie E.; Routly, Natasha; Buckley, Dennis L.; Gustafson, Jeffrey L.; Zinn, Nico; Grandi, Paola; Shimamura, Satoko; Bergamini, Giovanna; Faelth-Savitski, Maria; Bantscheff, Marcus; Cox, Carly; Gordon, Deborah A.; Willard, Ryan R.; Flanagan, John J.; Casillas, Linda N.; Votta, Bartholomew J.; den Besten, Willem; Famm, Kristoffer; Kruidenier, Laurens; Carter, Paul S.; Harling, John D.; Churcher, Ian; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The current predominant therapeutic paradigm is based on maximizing drug-receptor occupancy to achieve clin. benefit.  This strategy, however, generally requires excessive drug concns. to ensure sufficient occupancy, often leading to adverse side effects.  Here, we describe major improvements to the proteolysis targeting chimeras (PROTACs) method, a chem. knockdown strategy in which a heterobifunctional mol. recruits a specific protein target to an E3 ubiquitin ligase, resulting in the target's ubiquitination and degrdn.  These compds. behave catalytically in their ability to induce the ubiquitination of super-stoichiometric quantities of proteins, providing efficacy that is not limited by equil. occupancy.  We present two PROTACs that are capable of specifically reducing protein levels by >90% at nanomolar concns.  In addn., mouse studies indicate that they provide broad tissue distribution and knockdown of the targeted protein in tumor xenografts.  Together, these data demonstrate a protein knockdown system combining many of the favorable properties of small-mol. agents with the potent protein knockdown of RNAi and CRISPR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhnajD3CxS7Vg90H21EOLACvtfcHk0lgDX0FqNtK9sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP&md5=31eb8756c5661f78ab4527a50dc1e251</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1858%26sid%3Dliteratum%253Aachs%26aulast%3DBondeson%26aufirst%3DD.%2BP.%26aulast%3DMares%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DI.%2BE.%2BD.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DMulholland%26aufirst%3DK.%2BE.%26aulast%3DRoutly%26aufirst%3DN.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DFaelth-Savitski%26aufirst%3DM.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DWillard%26aufirst%3DR.%2BR.%26aulast%3DFlanagan%26aufirst%3DJ.%2BJ.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3Dden%2BBesten%26aufirst%3DW.%26aulast%3DFamm%26aufirst%3DK.%26aulast%3DKruidenier%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCatalytic%2520in%2520vivo%2520protein%2520knockdown%2520by%2520small-molecule%2520protacs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D611%26epage%3D617%26doi%3D10.1038%2Fnchembio.1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamman, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Differential protac substrate specificity dictated by orientation of recruited e3 ligase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">131</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-08027-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs41467-018-08027-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=30631068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BB3cjgt1Sksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=131&author=B.+E.+Smithauthor=S.+L.+Wangauthor=S.+Jaime-Figueroaauthor=A.+Harbinauthor=J.+Wangauthor=B.+D.+Hammanauthor=C.+M.+Crews&title=Differential+protac+substrate+specificity+dictated+by+orientation+of+recruited+e3+ligase&doi=10.1038%2Fs41467-018-08027-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase</span></div><div class="casAuthors">Smith Blake E; Wang Stephen L; Jaime-Figueroa Saul; Crews Craig M; Harbin Alicia; Wang Jing; Hamman Brian D; Crews Craig M; Crews Craig M</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PROteolysis-TArgeting Chimeras (PROTACs) are hetero-bifunctional molecules that recruit an E3 ubiquitin ligase to a given substrate protein resulting in its targeted degradation.  Many potent PROTACs with specificity for dissimilar targets have been developed; however, the factors governing degradation selectivity within closely-related protein families remain elusive.  Here, we generate isoform-selective PROTACs for the p38 MAPK family using a single warhead (foretinib) and recruited E3 ligase (von Hippel-Lindau).  Based on their distinct linker attachments and lengths, these two PROTACs differentially recruit VHL, resulting in degradation of p38α or p38δ.  We characterize the role of ternary complex formation in driving selectivity, showing that it is necessary, but insufficient, for PROTAC-induced substrate ubiquitination.  Lastly, we explore the p38δ:PROTAC:VHL complex to explain the different selectivity profiles of these PROTACs.  Our work attributes the selective degradation of two closely-related proteins using the same warhead and E3 ligase to heretofore underappreciated aspects of the ternary complex model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYPr3dBOGbeuR_TJajKxJDfW6udTcc2eY0gGWORt4fTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjgt1Sksg%253D%253D&md5=bd56c51f5966709ca5d1ff3dadb7cc79</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-08027-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-08027-7%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BE.%26aulast%3DWang%26aufirst%3DS.%2BL.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DHarbin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHamman%26aufirst%3DB.%2BD.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DDifferential%2520protac%2520substrate%2520specificity%2520dictated%2520by%2520orientation%2520of%2520recruited%2520e3%2520ligase%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D131%26doi%3D10.1038%2Fs41467-018-08027-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Hijacking the e3 ubiquitin ligase cereblon to efficiently target brd4</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+e3+ubiquitin+ligase+cereblon+to+efficiently+target+brd4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0ljyyeRTZ7f7mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520e3%2520ubiquitin%2520ligase%2520cereblon%2520to%2520efficiently%2520target%2520brd4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span> <span> </span><span class="NLM_article-title">Protac-induced bet protein degradation as a therapy for castration-resistant prostate cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">7124</span>– <span class="NLM_lpage">7129</span>, <span class="refDoi"> DOI: 10.1073/pnas.1521738113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.1521738113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27274052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xptlyqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=7124-7129&author=K.+Rainaauthor=J.+Luauthor=Y.+M.+Qianauthor=M.+Altieriauthor=D.+Gordonauthor=A.+M.+K.+Rossiauthor=J.+Wangauthor=X.+Chenauthor=H.+Q.+Dongauthor=K.+Siuauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=C.+M.+Crewsauthor=K.+G.+Coleman&title=Protac-induced+bet+protein+degradation+as+a+therapy+for+castration-resistant+prostate+cancer&doi=10.1073%2Fpnas.1521738113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer</span></div><div class="casAuthors">Raina, Kanak; Lu, Jing; Qian, Yimin; Altieri, Martha; Gordon, Deborah; Rossi, Ann Marie K.; Wang, Jing; Chen, Xin; Dong, Hanqing; Siu, Kam; Winkler, James D.; Crew, Andrew P.; Crews, Craig M.; Coleman, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7124-7129</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostate cancer has the second highest incidence among cancers in men worldwide and is the second leading cause of cancer deaths of men in the United States.  Although androgen deprivation can initially lead to remission, the disease often progresses to castration-resistant prostate cancer (CRPC), which is still reliant on androgen receptor (AR) signaling and is assocd. with a poor prognosis.  Some success against CRPC has been achieved by drugs that target AR signaling, but secondary resistance invariably emerges, and new therapies are urgently needed.  Recently, inhibitors of bromodomain and extra-terminal (BET) family proteins have shown growth-inhibitory activity in preclin. models of CRPC.  Here, we demonstrate that ARV-771, a small-mol. pan-BET degrader based on proteolysis-targeting chimera (PROTAC) technol., demonstrates dramatically improved efficacy in cellular models of CRPC as compared with BET inhibition.  Unlike BET inhibitors, ARV-771 results in suppression of both AR signaling and AR levels and leads to tumor regression in a CRPC mouse xenograft model.  This study is, to our knowledge, the first to demonstrate efficacy with a small-mol. BET degrader in a solid-tumor malignancy and potentially represents an important therapeutic advance in the treatment of CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD7QtYgZVig7Vg90H21EOLACvtfcHk0lj9gN7Nxa2fVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xptlyqs7s%253D&md5=34218e685ad72950f3eb85586110c43d</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1521738113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1521738113%26sid%3Dliteratum%253Aachs%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%2BM.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DA.%2BM.%2BK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DH.%2BQ.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DColeman%26aufirst%3DK.%2BG.%26atitle%3DProtac-induced%2520bet%2520protein%2520degradation%2520as%2520a%2520therapy%2520for%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D7124%26epage%3D7129%26doi%3D10.1073%2Fpnas.1521738113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alabi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neklesa, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Androgen receptor degradation by the proteolysis-targeting chimera arcc-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">100</span>, <span class="refDoi"> DOI: 10.1038/s42003-018-0105-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs42003-018-0105-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=30271980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BB3czksVCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&pages=100&author=J.+Salamiauthor=S.+Alabiauthor=R.+R.+Willardauthor=N.+J.+Vitaleauthor=J.+Wangauthor=H.+Dongauthor=M.+Jinauthor=D.+P.+McDonnellauthor=A.+P.+Crewauthor=T.+K.+Neklesaauthor=C.+M.+Crews&title=Androgen+receptor+degradation+by+the+proteolysis-targeting+chimera+arcc-4+outperforms+enzalutamide+in+cellular+models+of+prostate+cancer+drug+resistance&doi=10.1038%2Fs42003-018-0105-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance</span></div><div class="casAuthors">Salami Jemilat; Crews Craig M; Alabi Shanique; Crews Craig M; Willard Ryan R; Vitale Nick J; Wang Jing; Dong Hanqing; Jin Meizhong; Crew Andrew P; Neklesa Taavi K; McDonnell Donald P; Crews Craig M</div><div class="citationInfo"><span class="NLM_cas:title">Communications biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The androgen receptor is a major driver of prostate cancer and inhibition of its transcriptional activity using competitive antagonists, such as enzalutamide remains a frontline therapy for prostate cancer management.  However, the majority of patients eventually develop drug resistance.  We propose that targeting the androgen receptor for degradation via Proteolysis Targeting Chimeras (PROTACs) will be a better therapeutic strategy for targeting androgen receptor signaling in prostate cancer cells.  Here we perform a head-to-head comparison between a currently approved androgen receptor antagonist enzalutamide, and its PROTAC derivative, ARCC-4, across different cellular models of prostate cancer drug resistance.  ARCC-4 is a low-nanomolar androgen receptor degrader able to degrade about 95% of cellular androgen receptors.  ARCC-4 inhibits prostate tumor cell proliferation, degrades clinically relevant androgen receptor point mutants and unlike enzalutamide, retains antiproliferative effect in a high androgen environment.  Thus, ARCC-4 exemplifies how protein degradation can address the drug resistance hurdles of enzalutamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQilKiHIro9_JI8NvIb08rbfW6udTcc2eZCBe1vkvQwr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czksVCksA%253D%253D&md5=b8b7a81226dcf37d9ff430244b21f952</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1038%2Fs42003-018-0105-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-018-0105-8%26sid%3Dliteratum%253Aachs%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DAlabi%26aufirst%3DS.%26aulast%3DWillard%26aufirst%3DR.%2BR.%26aulast%3DVitale%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DNeklesa%26aufirst%3DT.%2BK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DAndrogen%2520receptor%2520degradation%2520by%2520the%2520proteolysis-targeting%2520chimera%2520arcc-4%2520outperforms%2520enzalutamide%2520in%2520cellular%2520models%2520of%2520prostate%2520cancer%2520drug%2520resistance%26jtitle%3DCommun.%2520Biol.%26date%3D2018%26volume%3D1%26spage%3D100%26doi%3D10.1038%2Fs42003-018-0105-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerschmied, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Modular protac design for the degradation of oncogenic bcr-abl</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1002/anie.201507634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fanie.201507634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=807-810&author=A.+C.+Laiauthor=M.+Toureauthor=D.+Hellerschmiedauthor=J.+Salamiauthor=S.+Jaime-Figueroaauthor=E.+Koauthor=J.+Hinesauthor=C.+M.+Crews&title=Modular+protac+design+for+the+degradation+of+oncogenic+bcr-abl&doi=10.1002%2Fanie.201507634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL</span></div><div class="casAuthors">Lai, Ashton C.; Toure, Momar; Hellerschmied, Doris; Salami, Jemilat; Jaime-Figueroa, Saul; Ko, Eunhwa; Hines, John; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">807-810</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteolysis Targeting Chimera (PROTAC) technol. is a rapidly emerging alternative therapeutic strategy with the potential to address many of the challenges currently faced in modern drug development programs.  PROTAC technol. employs small mols. that recruit target proteins for ubiquitination and removal by the proteasome.  The synthesis of PROTAC compds. that mediate the degrdn. of c-ABL and BCR-ABL by recruiting either Cereblon or Von Hippel Lindau E3 ligases is reported.  During the course of their development, the authors discovered that the capacity of a PROTAC to induce degrdn. involves more than just target binding: the identity of the inhibitor warhead and the recruited E3 ligase largely det. the degrdn. profiles of the compds.; thus, as a starting point for PROTAC development, both the target ligand and the recruited E3 ligase should be varied to rapidly generate a PROTAC with the desired degrdn. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdcSTHt5WfILVg90H21EOLACvtfcHk0liGUxDFAMUhVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN&md5=58a5d78f32bc8a21fd1a6e0c38b8979c</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507634%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DToure%26aufirst%3DM.%26aulast%3DHellerschmied%26aufirst%3DD.%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DModular%2520protac%2520design%2520for%2520the%2520degradation%2520of%2520oncogenic%2520bcr-abl%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D807%26epage%3D810%26doi%3D10.1002%2Fanie.201507634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajapakshe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mill, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coarfa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K. N.</span></span> <span> </span><span class="NLM_article-title">Bet protein proteolysis targeting chimera (protac) exerts potent lethal activity against mantle cell lymphoma cells</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1038/leu.2017.207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fleu.2017.207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28663582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eqt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=343-352&author=B.+Sunauthor=W.+Fiskusauthor=Y.+Qianauthor=K.+Rajapaksheauthor=K.+Rainaauthor=K.+G.+Colemanauthor=A.+P.+Crewauthor=A.+Shenauthor=D.+T.+Saenzauthor=C.+P.+Millauthor=A.+J.+Nowakauthor=N.+Jainauthor=L.+Zhangauthor=M.+Wangauthor=J.+D.+Khouryauthor=C.+Coarfaauthor=C.+M.+Crewsauthor=K.+N.+Bhalla&title=Bet+protein+proteolysis+targeting+chimera+%28protac%29+exerts+potent+lethal+activity+against+mantle+cell+lymphoma+cells&doi=10.1038%2Fleu.2017.207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Bet protein proteolysis targeting chimera (protac) exerts potent lethal activity against mantle cell lymphoma cells</span></div><div class="casAuthors">Sun, B.; Fiskus, W.; Qian, Y.; Rajapakshe, K.; Raina, K.; Coleman, K. G.; Crew, A. P.; Shen, A.; Saenz, D. T.; Mill, C. P.; Nowak, A. J.; Jain, N.; Zhang, L.; Wang, M.; Khoury, J. D.; Coarfa, C.; Crews, C. M.; Bhalla, K. N.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">343-352</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Bromodomain extraterminal protein (BETP) inhibitors transcriptionally repress oncoproteins and nuclear factor-κB (NF-κB) target genes that undermines the growth and survival of mantle cell lymphoma (MCL) cells.  However, BET bromodomain inhibitor (BETi) treatment causes accumulation of BETPs, assocd. with reversible binding and incomplete inhibition of BRD4 that potentially compromises the activity of BETi in MCL cells.  Unlike BETi, BET-PROTACs (proteolysis-targeting chimera) ARV-825 and ARV-771 (Arvinas, Inc.) recruit and utilize an E3-ubiquitin ligase to effectively degrade BETPs in MCL cells.  BET-PROTACs induce more apoptosis than BETi of MCL cells, including those resistant to ibrutinib.  BET-PROTAC treatment induced more perturbations in the mRNA and protein expressions than BETi, with depletion of c-Myc, CDK4, cyclin D1 and the NF-κB transcriptional targets Bcl-xL, XIAP and BTK, while inducing the levels of HEXIM1, NOXA and CDKN1A/p21.  Treatment with ARV-771, which possesses superior pharmacol. properties compared with ARV-825, inhibited the in vivo growth and induced greater survival improvement than the BETi OTX015 of immune-depleted mice engrafted with MCL cells.  Cotreatment of ARV-771 with ibrutinib or the BCL2 antagonist venetoclax or CDK4/6 inhibitor palbociclib synergistically induced apoptosis of MCL cells.  These studies highlight promising and superior preclin. activity of BET-PROTAC than BETi, requiring further in vivo evaluation of BET-PROTAC as a therapy for ibrutinib-sensitive or -resistant MCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAZxihoDZILrVg90H21EOLACvtfcHk0liGUxDFAMUhVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eqt77J&md5=f771eee574daf11546b93866ea314381</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fleu.2017.207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2017.207%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DRajapakshe%26aufirst%3DK.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DColeman%26aufirst%3DK.%2BG.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DSaenz%26aufirst%3DD.%2BT.%26aulast%3DMill%26aufirst%3DC.%2BP.%26aulast%3DNowak%26aufirst%3DA.%2BJ.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DKhoury%26aufirst%3DJ.%2BD.%26aulast%3DCoarfa%26aufirst%3DC.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DBet%2520protein%2520proteolysis%2520targeting%2520chimera%2520%2528protac%2529%2520exerts%2520potent%2520lethal%2520activity%2520against%2520mantle%2520cell%2520lymphoma%2520cells%26jtitle%3DLeukemia%26date%3D2018%26volume%3D32%26spage%3D343%26epage%3D352%26doi%3D10.1038%2Fleu.2017.207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Salas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziazadeh, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of qca570 as an exceptionally potent and efficacious proteolysis targeting chimera (protac) degrader of the bromodomain and extra-terminal (bet) proteins capable of inducing complete and durable tumor regression</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6685</span>– <span class="NLM_lpage">6704</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00506</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00506" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlaqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6685-6704&author=C.+Qinauthor=Y.+Huauthor=B.+Zhouauthor=E.+Fernandez-Salasauthor=C.+Y.+Yangauthor=L.+Liuauthor=D.+McEachernauthor=S.+Przybranowskiauthor=M.+Wangauthor=J.+Stuckeyauthor=J.+Meagherauthor=L.+C.+Baiauthor=Z.+Chenauthor=M.+Linauthor=J.+L.+Yangauthor=D.+N.+Ziazadehauthor=F.+M.+Xuauthor=J.+T.+Huauthor=W.+G.+Xiangauthor=L.+Y.+Huangauthor=S.+W.+Liauthor=B.+Wenauthor=D.+X.+Sunauthor=S.+M.+Wang&title=Discovery+of+qca570+as+an+exceptionally+potent+and+efficacious+proteolysis+targeting+chimera+%28protac%29+degrader+of+the+bromodomain+and+extra-terminal+%28bet%29+proteins+capable+of+inducing+complete+and+durable+tumor+regression&doi=10.1021%2Facs.jmedchem.8b00506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression</span></div><div class="casAuthors">Qin, Chong; Hu, Yang; Zhou, Bing; Fernandez-Salas, Ester; Yang, Chao-Yie; Liu, Liu; McEachern, Donna; Przybranowski, Sally; Wang, Mi; Stuckey, Jeanne; Meagher, Jennifer; Bai, Longchuan; Chen, Zhuo; Lin, Mei; Yang, Jiuling; Ziazadeh, Danya N.; Xu, Fuming; Hu, Jiantao; Xing, Weiguo; Huang, Liyue; Li, Siwei; Wen, Bo; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6685-6704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteins of the bromodomain and extra-terminal (BET) family are epigenetics "readers" and promising therapeutic targets for cancer and other human diseases.  We describe herein a structure-guided design of [1,4]oxazepines as a new class of BET inhibitors and our subsequent design, synthesis, and evaluation of proteolysis-targeting chimeric (PROTAC) small-mol. BET degraders.  Our efforts have led to the discovery of extremely potent BET degraders, exemplified by QCA570, which effectively induces degrdn. of BET proteins and inhibits cell growth in human acute leukemia cell lines even at low picomolar concns.  QCA570 achieves complete and durable tumor regression in leukemia xenograft models in mice at well-tolerated dose-schedules.  QCA570 is the most potent and efficacious BET degrader reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ZUIsfX3p6LVg90H21EOLACvtfcHk0lhqh7l-PM7Tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlaqsLrE&md5=2a731730641372f4526543e03d9ac76f</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00506%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DFernandez-Salas%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%2BC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%2BL.%26aulast%3DZiazadeh%26aufirst%3DD.%2BN.%26aulast%3DXu%26aufirst%3DF.%2BM.%26aulast%3DHu%26aufirst%3DJ.%2BT.%26aulast%3DXiang%26aufirst%3DW.%2BG.%26aulast%3DHuang%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DWen%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DD.%2BX.%26aulast%3DWang%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520qca570%2520as%2520an%2520exceptionally%2520potent%2520and%2520efficacious%2520proteolysis%2520targeting%2520chimera%2520%2528protac%2529%2520degrader%2520of%2520the%2520bromodomain%2520and%2520extra-terminal%2520%2528bet%2529%2520proteins%2520capable%2520of%2520inducing%2520complete%2520and%2520durable%2520tumor%2520regression%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6685%26epage%3D6704%26doi%3D10.1021%2Facs.jmedchem.8b00506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['ref25_1'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xin-Hui Zhang, Qin-Ma, Hui-Pan Wu, Mussa Yussuf Khamis, Yi-Han Li, Li-Ying Ma, <span class="NLM_string-name hlFld-ContribAuthor">Hong-Min Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1362-1391. <a href="https://doi.org/10.1021/acs.jmedchem.0c01782" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01782%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BReview%252Bof%252BProgress%252Bin%252BHistone%252BDeacetylase%252B6%252BInhibitors%252BResearch%25253A%252BStructural%252BSpecificity%252Band%252BFunctional%252BDiversity%26aulast%3DZhang%26aufirst%3DXin-Hui%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D01022021%26volume%3D64%26issue%3D3%26spage%3D1362%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul T. Marcyk, Emmanuelle V. LeBlanc, Douglas A. Kuntz, Alice Xue, Francisco Ortiz, Richard Trilles, Stephen Bengtson, Tristan M. G. Kenney, David S. Huang, Nicole Robbins, Noelle S. Williams, Damian J. Krysan, Gilbert G. Privé, Luke Whitesell, Leah E. Cowen, <span class="NLM_string-name hlFld-ContribAuthor">Lauren E. Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1139-1169. <a href="https://doi.org/10.1021/acs.jmedchem.0c01777" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01777%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFungal-Selective%252BResorcylate%252BAminopyrazole%252BHsp90%252BInhibitors%25253A%252BOptimization%252Bof%252BWhole-Cell%252BAnticryptococcal%252BActivity%252Band%252BInsights%252Binto%252Bthe%252BStructural%252BOrigins%252Bof%252BCryptococcal%252BSelectivity%26aulast%3DMarcyk%26aufirst%3DPaul%2BT.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20102020%26date%3D14012021%26volume%3D64%26issue%3D2%26spage%3D1139%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Margaret J. Hilton, Christopher M. Brackett, Brandon Q. Mercado, Brian S. J. Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Scott J. Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Catalysis-Enabled Access to Cryptic Geldanamycin Oxides. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (3)
                                     , 426-435. <a href="https://doi.org/10.1021/acscentsci.0c00024" title="DOI URL">https://doi.org/10.1021/acscentsci.0c00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.0c00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.0c00024%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DCatalysis-Enabled%252BAccess%252Bto%252BCryptic%252BGeldanamycin%252BOxides%26aulast%3DHilton%26aufirst%3DMargaret%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08012020%26date%3D24022020%26volume%3D6%26issue%3D3%26spage%3D426%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian-Wen  Ni</span>, <span class="hlFld-ContribAuthor ">Xiao-Chuan  Duan</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Mei-Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Nan  Qin</span>, <span class="hlFld-ContribAuthor ">Hong-Quan  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Alkaloid derivative ION-31a inhibits breast cancer metastasis and angiogenesis by targeting HSP90α. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>115 </em>, 105201. <a href="https://doi.org/10.1016/j.bioorg.2021.105201" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105201%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAlkaloid%252Bderivative%252BION-31a%252Binhibits%252Bbreast%252Bcancer%252Bmetastasis%252Band%252Bangiogenesis%252Bby%252Btargeting%252BHSP90%2525CE%2525B1%26aulast%3DNi%26aufirst%3DTian-Wen%26date%3D2021%26volume%3D115%26spage%3D105201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-Truong  Nguyen</span>, <span class="hlFld-ContribAuthor ">Minh  Thanh La</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Gibeom  Nam</span>, <span class="hlFld-ContribAuthor ">Hyun-Ju  Park</span>, <span class="hlFld-ContribAuthor ">Jung  Min Park</span>, <span class="hlFld-ContribAuthor ">Yoon-Jae  Kim</span>, <span class="hlFld-ContribAuthor ">Ji  Young Kim</span>, <span class="hlFld-ContribAuthor ">Jae  Hong Seo</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a simplified deguelin analog as an HSP90 C-terminal inhibitor for HER2-positive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>45 </em>, 128134. <a href="https://doi.org/10.1016/j.bmcl.2021.128134" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128134%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bsimplified%252Bdeguelin%252Banalog%252Bas%252Ban%252BHSP90%252BC-terminal%252Binhibitor%252Bfor%252BHER2-positive%252Bbreast%252Bcancer%26aulast%3DNguyen%26aufirst%3DCong-Truong%26date%3D2021%26volume%3D45%26spage%3D128134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hana  Štorkánová</span>, <span class="hlFld-ContribAuthor ">Lenka  Štorkánová</span>, <span class="hlFld-ContribAuthor ">Adéla  Navrátilová</span>, <span class="hlFld-ContribAuthor ">Viktor  Bečvář</span>, <span class="hlFld-ContribAuthor ">Hana  Hulejová</span>, <span class="hlFld-ContribAuthor ">Sabína  Oreská</span>, <span class="hlFld-ContribAuthor ">Barbora  Heřmánková</span>, <span class="hlFld-ContribAuthor ">Maja  Špiritović</span>, <span class="hlFld-ContribAuthor ">Radim  Bečvář</span>, <span class="hlFld-ContribAuthor ">Karel  Pavelka</span>, <span class="hlFld-ContribAuthor ">Jiří  Vencovský</span>, <span class="hlFld-ContribAuthor ">Jörg H. W.  Distler</span>, <span class="hlFld-ContribAuthor ">Ladislav  Šenolt</span>, <span class="hlFld-ContribAuthor ">Michal  Tomčík</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (6)
                                     , 650. <a href="https://doi.org/10.3390/biomedicines9060650" title="DOI URL">https://doi.org/10.3390/biomedicines9060650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9060650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9060650%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DInhibition%252Bof%252BHsp90%252BCounteracts%252Bthe%252BEstablished%252BExperimental%252BDermal%252BFibrosis%252BInduced%252Bby%252BBleomycin%26aulast%3D%25C5%25A0tork%25C3%25A1nov%25C3%25A1%26aufirst%3DHana%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D6%26spage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qiuyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the HSP90–CDC37–kinase chaperone cycle: A promising therapeutic strategy for cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>95 </em><a href="https://doi.org/10.1002/med.21807" title="DOI URL">https://doi.org/10.1002/med.21807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21807%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bthe%252BHSP90%2525E2%252580%252593CDC37%2525E2%252580%252593kinase%252Bchaperone%252Bcycle%25253A%252BA%252Bpromising%252Btherapeutic%252Bstrategy%252Bfor%252Bcancer%26aulast%3DWang%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oi Wei  Mak</span>, <span class="hlFld-ContribAuthor ">Nabangshu  Sharma</span>, <span class="hlFld-ContribAuthor ">Jóhannes  Reynisson</span>, <span class="hlFld-ContribAuthor ">Ivanhoe K.H.  Leung</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel Hsp90 C-terminal domain inhibitors that disrupt co-chaperone binding. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127857. <a href="https://doi.org/10.1016/j.bmcl.2021.127857" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127857%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252BHsp90%252BC-terminal%252Bdomain%252Binhibitors%252Bthat%252Bdisrupt%252Bco-chaperone%252Bbinding%26aulast%3DMak%26aufirst%3DOi%2BWei%26date%3D2021%26volume%3D38%26spage%3D127857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Nannan  Chen</span>, <span class="hlFld-ContribAuthor ">Dandan  Xia</span>, <span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Tong</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>104 </em><a href="https://doi.org/10.1016/j.chembiol.2021.03.016" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252Bcovalent%252Binhibitor%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252Bwith%252Bantitumor%252Bactivity%252Bthat%252Bblocks%252Bthe%252Bco-chaperone%252Bbinding%252Bvia%252BC-terminal%252Bmodification%26aulast%3DLi%26aufirst%3DLi%26date%3D2021%26volume%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aykut  Özgür</span>, <span class="hlFld-ContribAuthor ">Altan  Kara</span>, <span class="hlFld-ContribAuthor ">Nazan  Gökşen Tosun</span>, <span class="hlFld-ContribAuthor ">Şaban  Tekin</span>, <span class="hlFld-ContribAuthor ">İsa  Gökçe</span>. </span><span class="cited-content_cbyCitation_article-title">Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology Reports</span><span> <strong>2021,</strong> <em>48 </em>
                                    (4)
                                     , 3439-3449. <a href="https://doi.org/10.1007/s11033-021-06392-z" title="DOI URL">https://doi.org/10.1007/s11033-021-06392-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11033-021-06392-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11033-021-06392-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520Reports%26atitle%3DDebio-0932%25252C%252Ba%252Bsecond%252Bgeneration%252Boral%252BHsp90%252Binhibitor%25252C%252Binduces%252Bapoptosis%252Bin%252BMCF-7%252Band%252BMDA-MB-231%252Bcell%252Blines%26aulast%3D%25C3%2596zg%25C3%25BCr%26aufirst%3DAykut%26date%3D2021%26date%3D2021%26volume%3D48%26issue%3D4%26spage%3D3439%26epage%3D3449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhijnya  Kanugovi Vijayavittal</span>, <span class="hlFld-ContribAuthor ">Sreedhar  Amere Subbarao</span>. </span><span class="cited-content_cbyCitation_article-title">The conformation-specific Hsp90 inhibition interferes with the oncogenic RAF kinase adaptation and triggers premature cellular senescence, hence, acts as a tumor suppressor mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2021,</strong> <em>1868 </em>
                                    (3)
                                     , 118943. <a href="https://doi.org/10.1016/j.bbamcr.2020.118943" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2020.118943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2020.118943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2020.118943%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DThe%252Bconformation-specific%252BHsp90%252Binhibition%252Binterferes%252Bwith%252Bthe%252Boncogenic%252BRAF%252Bkinase%252Badaptation%252Band%252Btriggers%252Bpremature%252Bcellular%252Bsenescence%25252C%252Bhence%25252C%252Bacts%252Bas%252Ba%252Btumor%252Bsuppressor%252Bmechanism%26aulast%3DKanugovi%2BVijayavittal%26aufirst%3DAbhijnya%26date%3D2021%26volume%3D1868%26issue%3D3%26spage%3D118943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikalet  Everson</span>, <span class="hlFld-ContribAuthor ">Jordan  Bach</span>, <span class="hlFld-ContribAuthor ">Jared T.  Hammill</span>, <span class="hlFld-ContribAuthor ">Mofolusho O.  Falade</span>, <span class="hlFld-ContribAuthor ">Amy L.  Rice</span>, <span class="hlFld-ContribAuthor ">R. Kiplin  Guy</span>, <span class="hlFld-ContribAuthor ">Scott  Eagon</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Plasmodium falciparum heat shock 90 inhibitors via molecular docking. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>35 </em>, 127818. <a href="https://doi.org/10.1016/j.bmcl.2021.127818" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127818%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BPlasmodium%252Bfalciparum%252Bheat%252Bshock%252B90%252Binhibitors%252Bvia%252Bmolecular%252Bdocking%26aulast%3DEverson%26aufirst%3DNikalet%26date%3D2021%26volume%3D35%26spage%3D127818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander E.  Kabakov</span>, <span class="hlFld-ContribAuthor ">Anna O.  Yakimova</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 1102. <a href="https://doi.org/10.3390/cancers13051102" title="DOI URL">https://doi.org/10.3390/cancers13051102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13051102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13051102%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DHypoxia-Induced%252BCancer%252BCell%252BResponses%252BDriving%252BRadioresistance%252Bof%252BHypoxic%252BTumors%25253A%252BApproaches%252Bto%252BTargeting%252Band%252BRadiosensitizing%26aulast%3DKabakov%26aufirst%3DAlexander%2BE.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Huiting  zhu</span>, <span class="hlFld-ContribAuthor ">Zhixian  Shi</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel celastrol-triazole derivatives with Hsp90-Cdc37 disruption to induce tumor cell apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em> </em>, 104867. <a href="https://doi.org/10.1016/j.bioorg.2021.104867" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104867%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bcelastrol-triazole%252Bderivatives%252Bwith%252BHsp90-Cdc37%252Bdisruption%252Bto%252Binduce%252Btumor%252Bcell%252Bapoptosis%26aulast%3DLi%26aufirst%3DNa%26date%3D2021%26spage%3D104867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell R.A.  Kitson</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel geldanamycin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>82 </em>, 131927. <a href="https://doi.org/10.1016/j.tet.2021.131927" title="DOI URL">https://doi.org/10.1016/j.tet.2021.131927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.131927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.131927%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bnovel%252Bgeldanamycin%252Bderivatives%26aulast%3DKitson%26aufirst%3DRussell%2BR.A.%26date%3D2021%26volume%3D82%26spage%3D131927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farid Ahmad  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Hanna  Parkkola</span>, <span class="hlFld-ContribAuthor ">Vladimir  Vukic</span>, <span class="hlFld-ContribAuthor ">Christina  Oetken-Lindholm</span>, <span class="hlFld-ContribAuthor ">Alok  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Alexandros  Kiriazis</span>, <span class="hlFld-ContribAuthor ">Karolina  Pavic</span>, <span class="hlFld-ContribAuthor ">Tero  Aittokallio</span>, <span class="hlFld-ContribAuthor ">Tiina A.  Salminen</span>, <span class="hlFld-ContribAuthor ">Daniel  Abankwa</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 927. <a href="https://doi.org/10.3390/cancers13040927" title="DOI URL">https://doi.org/10.3390/cancers13040927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040927%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNovel%252BSmall%252BMolecule%252BHsp90%25252FCdc37%252BInterface%252BInhibitors%252BIndirectly%252BTarget%252BK-Ras-Signaling%26aulast%3DSiddiqui%26aufirst%3DFarid%2BAhmad%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuto  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Lisa  Matsukura</span>, <span class="hlFld-ContribAuthor ">Yuji  Ito</span>, <span class="hlFld-ContribAuthor ">Naoyuki  Miyashita</span>, <span class="hlFld-ContribAuthor ">Masumi  Taki</span>. </span><span class="cited-content_cbyCitation_article-title">A medium-firm drug-candidate library of cryptand-like structures on T7 phage: design and selection of a strong binder for Hsp90. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (1)
                                     , 146-150. <a href="https://doi.org/10.1039/D0OB01855D" title="DOI URL">https://doi.org/10.1039/D0OB01855D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01855D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01855D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bmedium-firm%252Bdrug-candidate%252Blibrary%252Bof%252Bcryptand-like%252Bstructures%252Bon%252BT7%252Bphage%25253A%252Bdesign%252Band%252Bselection%252Bof%252Ba%252Bstrong%252Bbinder%252Bfor%252BHsp90%26aulast%3DMochizuki%26aufirst%3DKazuto%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D1%26spage%3D146%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Nan-Nan  Chen</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">An updated patent review of anticancer Hsp90 inhibitors (2013-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 67-80. <a href="https://doi.org/10.1080/13543776.2021.1829595" title="DOI URL">https://doi.org/10.1080/13543776.2021.1829595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1829595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1829595%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAn%252Bupdated%252Bpatent%252Breview%252Bof%252Banticancer%252BHsp90%252Binhibitors%252B%2525282013-present%252529%26aulast%3DLi%26aufirst%3DLi%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D67%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuexuan  Wu</span>, <span class="hlFld-ContribAuthor ">Jianrui  Zhou</span>, <span class="hlFld-ContribAuthor ">Lixiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>, <span class="hlFld-ContribAuthor ">Lianshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioevaluation of inhibitors targeting HSP90-CDC37 protein-protein interaction based on a hydrophobic core. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112959. <a href="https://doi.org/10.1016/j.ejmech.2020.112959" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112959%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioevaluation%252Bof%252Binhibitors%252Btargeting%252BHSP90-CDC37%252Bprotein-protein%252Binteraction%252Bbased%252Bon%252Ba%252Bhydrophobic%252Bcore%26aulast%3DZhang%26aufirst%3DQiuyue%26date%3D2021%26volume%3D210%26spage%3D112959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang-ling  Chen</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Wei-liang  Zhu</span>, <span class="hlFld-ContribAuthor ">Li-guang  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>42 </em>
                                    (1)
                                     , 132-141. <a href="https://doi.org/10.1038/s41401-020-0398-2" title="DOI URL">https://doi.org/10.1038/s41401-020-0398-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-0398-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-0398-2%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDCZ5248%25252C%252Ba%252Bnovel%252Bdual%252Binhibitor%252Bof%252BHsp90%252Band%252Bautophagy%25252C%252Bexerts%252Bantitumor%252Bactivity%252Bagainst%252Bcolon%252Bcancer%26aulast%3DChen%26aufirst%3DXiang-ling%26date%3D2021%26date%3D2020%26volume%3D42%26issue%3D1%26spage%3D132%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhabrata  Chaudhury</span>, <span class="hlFld-ContribAuthor ">Bradley M.  Keegan</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (1)
                                     , 202-222. <a href="https://doi.org/10.1002/med.21729" title="DOI URL">https://doi.org/10.1002/med.21729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21729%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252Brole%252Band%252Btherapeutic%252Bpotential%252Bof%252BHsp90%25252C%252BHsp70%25252C%252Band%252Bsmaller%252Bheat%252Bshock%252Bproteins%252Bin%252Bperipheral%252Band%252Bcentral%252Bneuropathies%26aulast%3DChaudhury%26aufirst%3DSubhabrata%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D1%26spage%3D202%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqing  Hu</span>, <span class="hlFld-ContribAuthor ">Rui  Zhao</span>, <span class="hlFld-ContribAuthor ">Qinglian  Liu</span>, <span class="hlFld-ContribAuthor ">Qianbin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphys.2020.01081" title="DOI URL">https://doi.org/10.3389/fphys.2020.01081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2020.01081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2020.01081%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DNew%252BInsights%252BInto%252BHeat%252BShock%252BProtein%252B90%252Bin%252Bthe%252BPathogenesis%252Bof%252BPulmonary%252BArterial%252BHypertension%26aulast%3DHu%26aufirst%3DLiqing%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-Truong  Nguyen</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Raghaba  Sahu</span>, <span class="hlFld-ContribAuthor ">Woong Sub  Byun</span>, <span class="hlFld-ContribAuthor ">Sangkook  Lee</span>, <span class="hlFld-ContribAuthor ">Gibeom  Nam</span>, <span class="hlFld-ContribAuthor ">Hyun-Ju  Park</span>, <span class="hlFld-ContribAuthor ">Soeun  Park</span>, <span class="hlFld-ContribAuthor ">Yoon-Jae  Kim</span>, <span class="hlFld-ContribAuthor ">Ji Young  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Hong  Seo</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (17)
                                     , 127374. <a href="https://doi.org/10.1016/j.bmcl.2020.127374" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127374%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Banti-breast%252Bcancer%252Bagents%252Bderived%252Bfrom%252Bdeguelin%252Bas%252Binhibitors%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252B%252528HSP90%252529%26aulast%3DNguyen%26aufirst%3DCong-Truong%26date%3D2020%26volume%3D30%26issue%3D17%26spage%3D127374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Skrzypczak</span>, <span class="hlFld-ContribAuthor ">Krystian  Pyta</span>, <span class="hlFld-ContribAuthor ">Piotr  Ruszkowski</span>, <span class="hlFld-ContribAuthor ">Maria  Gdaniec</span>, <span class="hlFld-ContribAuthor ">Franz  Bartl</span>, <span class="hlFld-ContribAuthor ">Piotr  Przybylski</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112624. <a href="https://doi.org/10.1016/j.ejmech.2020.112624" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112624%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bstructure%252Band%252Banticancer%252Bactivity%252Bof%252Bnew%252Bgeldanamycin%252Bamine%252Banalogs%252Bcontaining%252BC%25252817%252529-%252Bor%252BC%25252820%252529-%252Bflexible%252Band%252Brigid%252Barms%252Bas%252Bwell%252Bas%252Bclosed%252Bor%252Bopen%252Bansa-bridges%26aulast%3DSkrzypczak%26aufirst%3DNatalia%26date%3D2020%26volume%3D202%26spage%3D112624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tihomir  Tomašič</span>, <span class="hlFld-ContribAuthor ">Martina  Durcik</span>, <span class="hlFld-ContribAuthor ">Bradley M.  Keegan</span>, <span class="hlFld-ContribAuthor ">Darja Gramec  Skledar</span>, <span class="hlFld-ContribAuthor ">Živa  Zajec</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>, <span class="hlFld-ContribAuthor ">Sharon D.  Bryant</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (18)
                                     , 6898. <a href="https://doi.org/10.3390/ijms21186898" title="DOI URL">https://doi.org/10.3390/ijms21186898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21186898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21186898%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252BNovel%252BHsp90%252BC-Terminal%252BInhibitors%252BUsing%252B3D-Pharmacophores%252BDerived%252Bfrom%252BMolecular%252BDynamics%252BSimulations%26aulast%3DToma%25C5%25A1i%25C4%258D%26aufirst%3DTihomir%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D18%26spage%3D6898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishal C.  Birar</span>, <span class="hlFld-ContribAuthor ">Ioannis  Gelis</span>, <span class="hlFld-ContribAuthor ">Ang  Zuo</span>, <span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of paramagnetic ligands that target the C-terminal binding site of Hsp90. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (16)
                                     , 127303. <a href="https://doi.org/10.1016/j.bmcl.2020.127303" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127303%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bparamagnetic%252Bligands%252Bthat%252Btarget%252Bthe%252BC-terminal%252Bbinding%252Bsite%252Bof%252BHsp90%26aulast%3DBirar%26aufirst%3DVishal%2BC.%26date%3D2020%26volume%3D30%26issue%3D16%26spage%3D127303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Sanchez-Martin</span>, <span class="hlFld-ContribAuthor ">Stefano A.  Serapian</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>, <span class="hlFld-ContribAuthor ">Andrea  Rasola</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamically Shaping Chaperones. Allosteric Modulators of HSP90 Family as Regulatory Tools of Cell Metabolism in Neoplastic Progression. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.01177" title="DOI URL">https://doi.org/10.3389/fonc.2020.01177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.01177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.01177%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DDynamically%252BShaping%252BChaperones.%252BAllosteric%252BModulators%252Bof%252BHSP90%252BFamily%252Bas%252BRegulatory%252BTools%252Bof%252BCell%252BMetabolism%252Bin%252BNeoplastic%252BProgression%26aulast%3DSanchez-Martin%26aufirst%3DCarlos%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ameneh  Jafari</span>, <span class="hlFld-ContribAuthor ">Mostafa  Rezaei-Tavirani</span>, <span class="hlFld-ContribAuthor ">Behrouz  Farhadihosseinabadi</span>, <span class="hlFld-ContribAuthor ">Shahrouz  Taranejoo</span>, <span class="hlFld-ContribAuthor ">Hakimeh  Zali</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 and Co-chaperones: Impact on Tumor Progression and Prospects for Molecular-Targeted Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancer Investigation</span><span> <strong>2020,</strong> <em>38 </em>
                                    (5)
                                     , 310-328. <a href="https://doi.org/10.1080/07357907.2020.1752227" title="DOI URL">https://doi.org/10.1080/07357907.2020.1752227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07357907.2020.1752227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07357907.2020.1752227%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Investigation%26atitle%3DHSP90%252Band%252BCo-chaperones%25253A%252BImpact%252Bon%252BTumor%252BProgression%252Band%252BProspects%252Bfor%252BMolecular-Targeted%252BCancer%252BTherapy%26aulast%3DJafari%26aufirst%3DAmeneh%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D5%26spage%3D310%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rabdan M.  Tikhov</span>, <span class="hlFld-ContribAuthor ">Nikolai Yu.  Kuznetsov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of piperidine-2,4-dione-type azaheterocycles and their application in modern drug development and natural product synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (15)
                                     , 2793-2812. <a href="https://doi.org/10.1039/D0OB00287A" title="DOI URL">https://doi.org/10.1039/D0OB00287A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00287A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00287A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConstruction%252Bof%252Bpiperidine-2%25252C4-dione-type%252Bazaheterocycles%252Band%252Btheir%252Bapplication%252Bin%252Bmodern%252Bdrug%252Bdevelopment%252Band%252Bnatural%252Bproduct%252Bsynthesis%26aulast%3DTikhov%26aufirst%3DRabdan%2BM.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D15%26spage%3D2793%26epage%3D2812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Kabakov</span>, <span class="hlFld-ContribAuthor ">Anna  Yakimova</span>, <span class="hlFld-ContribAuthor ">Olga  Matchuk</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (4)
                                     , 892. <a href="https://doi.org/10.3390/cells9040892" title="DOI URL">https://doi.org/10.3390/cells9040892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9040892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9040892%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DMolecular%252BChaperones%252Bin%252BCancer%252BStem%252BCells%25253A%252BDeterminants%252Bof%252BStemness%252Band%252BPotential%252BTargets%252Bfor%252BAntitumor%252BTherapy%26aulast%3DKabakov%26aufirst%3DAlexander%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Xian-Hua  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Duan</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Complex structure of human Hsp90N and a novel small inhibitor FS5. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Science and Techniques</span><span> <strong>2020,</strong> <em>31 </em>
                                    (3)
                                     <a href="https://doi.org/10.1007/s41365-020-0739-3" title="DOI URL">https://doi.org/10.1007/s41365-020-0739-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41365-020-0739-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41365-020-0739-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Science%2520and%2520Techniques%26atitle%3DComplex%252Bstructure%252Bof%252Bhuman%252BHsp90N%252Band%252Ba%252Bnovel%252Bsmall%252Binhibitor%252BFS5%26aulast%3DLiu%26aufirst%3DRui%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anusha  Kishore</span>, <span class="hlFld-ContribAuthor ">Carsten  Zeilinger</span>. </span><span class="cited-content_cbyCitation_article-title">Threading Microarrays into Novel Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 151-165. <a href="https://doi.org/10.1007/7515_2020_7" title="DOI URL">https://doi.org/10.1007/7515_2020_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7515_2020_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7515_2020_7%26sid%3Dliteratum%253Aachs%26atitle%3DThreading%252BMicroarrays%252Binto%252BNovel%252BApplications%26aulast%3DKishore%26aufirst%3DAnusha%26date%3D2020%26date%3D2020%26spage%3D151%26epage%3D165%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProteins%252Bin%252BHuman%252BDiseases%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2021%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of the structural regions of Hsp90 isoforms: Hsp90α/β, Grp94, and Trap1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hsp90 chaperone cycle. Hsp70 and Hop assist in loading client protein onto the middle domain of Hsp90. Aha1 increases Hsp90 ATPase activity, contributing to the closing of the N-terminal domain and the release of Hop and Hsp70. Client proteins are folded during the process of N-terminal domain closure. When the chaperone cycle is blocked by Hsp90 inhibitors, client proteins cannot be folded and degraded via CHIP modulation. <i>P</i>23 interacts with the N-terminal domain to stabilize the closed conformation. Finally, ATP hydrolysis causes the release of <i>P</i>23 and mature client proteins. The open conformation of the Hsp90 N-terminal domain is restored for the next chaperone cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hsp90 N-terminal ATP inhibitors with an ansamycin scaffold. The IC<sub>50</sub> values of <b>2</b> and <b>3</b> were determined by competitive binding to Hsp90 in lysates of SKBR3 cells. The EC<sub>50</sub> values of <b>4</b> and <b>5</b> were determined by a fluorescence polarization assay of Hsp90α with BODIPYGDA as the probe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hsp90 N-terminal ATP inhibitors containing the resorcinol scaffold. The IC<sub>50</sub> values of <b>6</b> and <b>7</b> represent the antiproliferative activity against MCF-7 and KNRK5.2 cells, respectively. The <i>K</i><sub>d</sub> values of <b>8</b>–<b>10</b> were measured using isothermal titration calorimetry (ITC). The IC<sub>50</sub> values of <b>11</b>–<b>13</b> were determined using a fluorescence polarization assay. The IC<sub>50</sub> values of <b>14</b> and <b>15</b> represent the antiproliferative activity against the MDA-MB-231 cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hsp90 N-terminal ATP inhibitors with a purine scaffold. The IC<sub>50</sub> values of <b>16</b>–<b>20</b> represent the antiproliferative activity against MCF-7 (<b>16</b> and <b>17</b>), MV4–11 (<b>19</b>), and HCT116 (<b>20</b>) cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Hsp90 N-terminal ATP inhibitors containing a purine scaffold. The IC<sub>50</sub> values of <b>21</b>–<b>24</b> were determined via fluorescence polarization assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hsp90 N-terminal ATP inhibitors containing a benzamide scaffold. The IC<sub>50</sub> values of <b>25</b>–<b>27</b> were determined by Hsp90 enzymatic activity assays. The <i>K</i><sub>d</sub> value of <b>28</b> was determined by an 8-pt non-enzymatic ATPase assay. IC<sub>50</sub> values of <b>29</b> and <b>30</b> represent the antiproliferative activity against the HT-29 cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of Hsp90 C-terminal ATPase inhibitors <b>31</b>–<b>37</b>. IC<sub>50</sub> values represent the antiproliferative activity against various cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of Hsp90 C-terminal ATPase inhibitors <b>38</b>–<b>43</b>. IC<sub>50</sub> values represent the antiproliferative activity against various cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Two possible binding modes of novobiocin targeting Hsp90C. Novobiocin binding to Hsp90C may occur following dimerization of the Hsp90 C terminus, which has a negative effect on the Hsp90N-ATP interaction. In addition, novobiocin binding may occur when the domain is open, which disrupts the chaperone cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Strategies for inhibiting the Hsp90 chaperone machinery. Typical N-terminal ATPase inhibitors block the ATP binding pocket, leading to arrest of the Hsp90 ATP cycle, which non-selectively affects all of the client proteins. Compared with ATPase inhibitors, regulators that disrupt Hsp90 and its co-chaperones may selectively regulate some specific client proteins of Hsp90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Dynamic binding modes of Hsp90-Cdc37 PPI. (A) The crystal structure of the Hsp90N-CdcM interaction (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1US7">1US7</a>). (B) The crystal structure of the Hsp90M-CdcM/C interaction (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FWL">5FWL</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Natural products disrupting the Hsp90-Cdc37 interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Peptides and small-molecule inhibitors of the Hsp90-Cdc37 PPI. (A) The docking mode of <b>52</b> binding to the interaction hotspot of Hsp90-Cdc37. One imidazolyl group partially occupies the mouth of the ATP pocket, and the linker binds in a flat groove of the Hsp90-Cdc37 interaction site. (B) Structure–activity relationship (SAR) of a series of analogs of <b>51</b>. (C) Structures of peptides and small molecules (<b>53</b>–<b>55</b>) targeting the Hsp90-Cdc37 PPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Hsp90-Hop PPI mediates Hsp90 clients folding. The disruption of the PPI induces protein degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Crystal structures of TPR-dependent co-chaperones interacting with the conserved sequence of MEEVD on Hsp90C. (A) The crystal structure of the TPR2A domain of Hop with MEEVD (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ELR">1ELR</a>). (B) The crystal structure of immunophilin (FKBP52) with MEEVD (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ2">1QZ2</a>). Carbons of MEEVD are shown in light yellow. The Hydron bonds are presented as red dash lines, and the receptor proteins are shown as surface mode.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Hsp90-Aha1 PPI accelerates the ATPase activity of Hsp90. Disruption of the PPI inhibits ATP hydrolysis and prevents closure of the Hsp90 dimer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Small molecules targeting Hsp90 and co-chaperone protein–protein interactions. Inhibitors (<b>56</b>–<b>62</b>) targeting Hsp90-Hop protein–protein interactions and their <i>K</i><sub>d</sub> values were determined by FP assays. Inhibitors targeting Hsp90-Aha1 (<b>63</b>) and Hsp90-immunophilins (<b>64</b>) protein–protein interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structural basis of Hsp90 isoforms (Hsp90α/β, Grp94, and Trap1) bound to selective inhibitors. (A) Superimposition of the crystal structures of apo-N-terminal Hsp90α (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YER">1YER</a>) and Hsp90N-BIIB021 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD">3QDD</a>). The different conformation of residues 104–111 is indicated in the black circle. (B) The co-crystal structure of Grp94-NECA (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H8M">2H8M</a>). Induced site 3 is indicated by the red curve. (C) The co-crystal structure of Grp94-PU-H54 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). The unique site 2 is indicated by the red curve. (D) The crystal structure of Trap1-<b>16</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1F">4Z1F</a>). The disordered sequence 171–202 in the binding site is indicated via red dash.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Hsp90α/β-selective inhibitors, Grp94-selective inhibitors and selective inhibitors of Trap1. The <i>K</i><sub>i</sub> and <i>K</i><sub>d</sub> values of <b>65</b>–<b>68</b> were determined by FP assay. The IC<sub>50</sub> and <i>K</i><sub>d</sub> values of <b>69</b>–<b>73</b> were determined by FP assays. The selectivity of <b>74</b> was achieved by the formation of a conjugate with the mitochondria-targeting moiety triphenylphosphonium. The IC<sub>50</sub> value of <b>75</b> was determined by an FP assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Targeting Hsp90 posttranslational modifications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/medium/jm9b00940_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Analysis of defects of clinical Hsp90 inhibitor. Drug resistance may be partially caused by increased levels of free HSF1. On one hand, HSF1 induces Hsp expression, which neutralizes Hsp90 inhibition by ATPase activity inhibitors, resulting in the lack of efficacy and HSR. Additionally, elevated Hsp stimulates the expression of P-gp, resulting in the efflux of drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b00940/20200306/images/large/jm9b00940_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00940&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 168 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadi, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">A comprehensive map of molecular drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrd.2016.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27910877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=19-34&author=R.+Santosauthor=O.+Ursuauthor=A.+Gaultonauthor=A.+P.+Bentoauthor=R.+S.+Donadiauthor=C.+G.+Bologaauthor=A.+Karlssonauthor=B.+Al-Lazikaniauthor=A.+Herseyauthor=T.+I.+Opreaauthor=J.+P.+Overington&title=A+comprehensive+map+of+molecular+drug+targets&doi=10.1038%2Fnrd.2016.230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive map of molecular drug targets</span></div><div class="casAuthors">Santos, Rita; Ursu, Oleg; Gaulton, Anna; Bento, A. Patricia; Donadi, Ramesh S.; Bologa, Cristian G.; Karlsson, Anneli; Al-Lazikani, Bissan; Hersey, Anne; Oprea, Tudor I.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of mechanism-based drug discovery depends on the definition of the drug target.  This definition becomes even more important as we try to link drug response to genetic variation, understand stratified clin. efficacy and safety, rationalize the differences between drugs in the same therapeutic class and predict drug utility in patient subgroups.  However, drug targets are often poorly defined in the literature, both for launched drugs and for potential therapeutic agents in discovery and development.  Here, we present an updated comprehensive map of mol. targets of approved drugs.  We curate a total of 893 human and pathogen-derived biomols. through which 1,578 US FDA-approved drugs act.  These biomols. include 667 human-genome-derived proteins targeted by drugs for human disease.  Anal. of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncol.  We explore the relationships between bioactivity class and clin. success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes.  Through the collaboration of three independent teams, we highlight some of the ongoing challenges in accurately defining the targets of mol. therapeutics and present conventions for deconvoluting the complexities of mol. pharmacol. and drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTfWwWkoZnbrVg90H21EOLACvtfcHk0lhMWhUPamiPmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK&md5=7437d4b678ac75dac0a5e3248df98761</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.230%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DDonadi%26aufirst%3DR.%2BS.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comprehensive%2520map%2520of%2520molecular%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D19%26epage%3D34%26doi%3D10.1038%2Fnrd.2016.230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhoff, G.</span></span> <span> </span><span class="NLM_article-title">Heat shock proteins in cancer</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1113</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1196/annals.1391.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1196%2Fannals.1391.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17978282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=192-201&author=M.+Shermanauthor=G.+Multhoff&title=Heat+shock+proteins+in+cancer&doi=10.1196%2Fannals.1391.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins in cancer</span></div><div class="casAuthors">Sherman, Michael; Multhoff, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">192-201</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Heat shock proteins (Hsps) are highly conserved and inhabit nearly all subcellular locations where they perform a variety of chaperoning functions including folding and unfolding of nascent polypeptides, proteins, transport of proteins, and support of antigen presentation processes.  Apart from their intracellular location Hsps with a mol. wt. of 70 kDa (Hsp70) also have been found on the plasma membrane of malignantly transformed cells, on virally/bacterial infected cells and in the extracellular space.  Depending on their intra- and extracellular location Hsps exert either protection against environmental stress or act as potent stimulators of the immune response.  In this review we address the dual function of intracellular and extracellular located small Hsps and members of the Hsp70 family and its immunol. consequences for cancer immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18rXmpHsdVLVg90H21EOLACvtfcHk0lhMWhUPamiPmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfE&md5=1616c3ec4030e7c2f47b2e1799422565</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.030%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DM.%26aulast%3DMulthoff%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520proteins%2520in%2520cancer%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D192%26epage%3D201%26doi%3D10.1196%2Fannals.1391.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">Structure and functional relationships of hsp90</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.2174/1568009033481877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F1568009033481877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14529383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=301-323&author=C.+Prodromouauthor=L.+H.+Pearl&title=Structure+and+functional+relationships+of+hsp90&doi=10.2174%2F1568009033481877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and functional relationships of Hsp90</span></div><div class="casAuthors">Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">301-323</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Understanding the mode of action of heat-shock protein Hsp90 requires that mol. detail of its interactions with client proteins and co-chaperones are known.  The structure detn. of the N-terminal domain of Hsp90/Hsp90β, proof that it is an ATPase, that this activity is regulated, and the identification of co-chaperones that facilitate Hsp90 function have been landmarks toward understanding conformational changes in Hsp90 brought about by ATP, co-chaperones, and client proteins.  Proteins Sti1 and Cdc37/p50, which assoc. with early Hsp90 complexes, have been shown to be inhibitors of Hsp90 ATPase activity and therefore to promote its "open" state, whereas Sba1/p23, which assocs. with mature complexes, inhibits ATPase activity and stabilizes the "closed" state.  The isolation and characterization of Aha1, the only known strong activator of Hsp90 ATPase activity, which promotes the "closed" state of Hsp90, is also of major importance in understanding Hsp90 function.  The structure detn. of the middle region of Hsp90 has shed further light on the complex ATP-cycle of Hsp90, identifying a catalytic loop, with key residues that are essential for ATP hydrolysis.  These studies, together with biochem. ones, suggest that ATP hydrolysis, is dependent on a complex rate-limiting step, involving N-terminal dimerization and assocn. of the middle region, and therefore the catalytic loop, of Hsp90 with the N-terminal domains.  The structure of the middle region of Hsp90 also accelerates the understanding of client protein interactions since this region is implicated in their recognition and in particular their active site openings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnjqIzaFEY6LVg90H21EOLACvtfcHk0lhxysgQeWZXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrs%253D&md5=d6086db3e034c70b83b01d2c205798e5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568009033481877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481877%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DStructure%2520and%2520functional%2520relationships%2520of%2520hsp90%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D301%26epage%3D323%26doi%3D10.2174%2F1568009033481877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitesell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S. L.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and the chaperoning of cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1038/nrc1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=Hsp90+and+the+chaperoning+of+cancer&doi=10.1038%2Fnrc1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0lhxysgQeWZXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHsp90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772%26doi%3D10.1038%2Fnrc1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">The chaperone hsp90: changing partners for demanding clients</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2013.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.tibs.2013.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23507089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=253-262&author=A.+Rohlauthor=J.+Rohrbergauthor=J.+Buchner&title=The+chaperone+hsp90%3A+changing+partners+for+demanding+clients&doi=10.1016%2Fj.tibs.2013.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone Hsp90: changing partners for demanding clients</span></div><div class="casAuthors">Rohl Alina; Rohrberg Julia; Buchner Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Trends in biochemical sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">253-62</span>
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    </div><div class="casAbstract">The heat shock protein (Hsp)90 chaperone machinery regulates the activity of hundreds of client proteins in the eukaryotic cytosol.  It undergoes large conformational changes between states that are similar in energy.  These transitions are rate-limiting for the ATPase cycle.  It has become evident that several of the many Hsp90 co-chaperones affect the conformational equilibrium by stabilizing specific intermediate states.  Consequently, there is an ordered progression of different co-chaperones during the conformational cycle.  Asymmetric complexes containing two different co-chaperones may be important for the processing of the client protein, although our understanding of this aspect, as well as the details of the interaction of Hsp90 with client proteins, is still in its infancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS2inA-utJHL5XHngOXiV_fW6udTcc2eaTk32mOZ3Y1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svnsVartQ%253D%253D&md5=3f0c5df5ba9088c3b41b3257b21b9d7a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2013.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2013.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DRohl%26aufirst%3DA.%26aulast%3DRohrberg%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520chaperone%2520hsp90%253A%2520changing%2520partners%2520for%2520demanding%2520clients%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D253%26epage%3D262%26doi%3D10.1016%2Fj.tibs.2013.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, A.</span></span> <span> </span><span class="NLM_article-title">Hsp90: friends, clients and natural foes</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2016.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.biochi.2016.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27295069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2016&pages=227-240&author=S.+Vermaauthor=S.+Goyalauthor=S.+Jamalauthor=A.+Singhauthor=A.+Grover&title=Hsp90%3A+friends%2C+clients+and+natural+foes&doi=10.1016%2Fj.biochi.2016.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: Friends, clients and natural foes</span></div><div class="casAuthors">Verma, Sharad; Goyal, Sukriti; Jamal, Salma; Singh, Aditi; Grover, Abhinav</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">227-240</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Hsp90, a homodimeric ATPase, is responsible for the correct folding of a no. of newly synthesized polypeptides in addn. to the correct folding of denatured/misfolded client proteins.  It requires several co-chaperones and other partner proteins for chaperone activity.  Due to the involvement of Hsp90-dependent client proteins in a variety of oncogenic signaling pathways, Hsp90 inhibition has emerged as one of the leading strategies for anticancer chemotherapeutics.  Most of Hsp90 inhibitors blocks the N terminal ATP binding pocket and prevents the conformational changes which are essential for the loading of co-chaperones and client proteins.  Several other inhibitors have also been reported which disrupt chaperone cycle in ways other than binding to N terminal ATP binding pocket.  The Hsp90 inhibition is assocd. with heat shock response, mediated by HSF-1, to overcome the loss of Hsp90 and sustain cell survival.  This review is an attempt to give an over view of all the important players of chaperone cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaFj5PqGrTtLVg90H21EOLACvtfcHk0lhxysgQeWZXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWqsbw%253D&md5=f36f469da9a37bf71961434593440159</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2016.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DS.%26aulast%3DJamal%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DGrover%26aufirst%3DA.%26atitle%3DHsp90%253A%2520friends%252C%2520clients%2520and%2520natural%2520foes%26jtitle%3DBiochimie%26date%3D2016%26volume%3D127%26spage%3D227%26epage%3D240%26doi%3D10.1016%2Fj.biochi.2016.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Post-translational modifications of hsp90 and their contributions to chaperone regulation</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21856339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2rsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=648-655&author=M.+Mollapourauthor=L.+Neckers&title=Post-translational+modifications+of+hsp90+and+their+contributions+to+chaperone+regulation&doi=10.1016%2Fj.bbamcr.2011.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications of Hsp90 and their contributions to chaperone regulation</span></div><div class="casAuthors">Mollapour, Mehdi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mol. chaperones, as the name suggests, are involved in folding, maintenance, intracellular transport, and degrdn. of proteins as well as in facilitating cell signaling.  Heat shock protein 90 (Hsp90) is an essential eukaryotic mol. chaperone that carries out these processes in normal and cancer cells.  Hsp90 function in vivo is coupled to its ability to hydrolyze ATP and this can be regulated by co-chaperones and post-translational modifications.  In this review, we explore the varied roles of known post-translational modifications of cytosolic and nuclear Hsp90 (phosphorylation, acetylation, S-nitrosylation, oxidn. and ubiquitination) in fine-tuning chaperone function in eukaryotes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojxfJSzylBn7Vg90H21EOLACvtfcHk0li9YtR4lLt5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2rsL8%253D&md5=bd22c775cb17efa6e985705e42bcd473</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPost-translational%2520modifications%2520of%2520hsp90%2520and%2520their%2520contributions%2520to%2520chaperone%2520regulation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D648%26epage%3D655%26doi%3D10.1016%2Fj.bbamcr.2011.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jhaveri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (hsp90) inhibitors in cancers</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22062686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28hsp90%29+inhibitors+in+cancers&doi=10.1016%2Fj.bbamcr.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span></div><div class="casAuthors">Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an ATP dependent mol. chaperone protein which integrates multiple oncogenic pathways.  As such, Hsp90 inhibition is a promising anti-cancer strategy.  Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clin. evaluation.  Robust pre-clin. data suggested anti-tumor activity in multiple cancer types.  Clin., encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma.  In breast cancer, proof-of-concept was demonstrated by first generation Hsp90 inhibitors in combination with trastuzumab mainly in human epidermal growth factor receptor 2 (HER2) + metastatic breast cancer.  There are a multitude of second generation Hsp90 inhibitors currently under investigation.  To date, however, there is no FDA approved Hsp90 inhibitor nor standardized assay to ascertain Hsp90 inhibition.  This review summarizes the current status of both first and second generation Hsp90 inhibitors based on their chem. classification and stage of clin. development.  It also discusses the pharmacodynamic assays currently implemented in clinic as well as other novel strategies aimed at enhancing the effectiveness of Hsp90 inhibitors.  Ultimately, these efforts will aid in maximizing the full potential of this class of agents.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDrDTpRQxfYrVg90H21EOLACvtfcHk0li9YtR4lLt5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D&md5=03cef7dc96667a4698324f635aacee7a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755%26doi%3D10.1016%2Fj.bbamcr.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydman, J.</span></span> <span> </span><span class="NLM_article-title">The hsp90 mosaic: a picture emerges</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1038/nsmb0109-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnsmb0109-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19125165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2-6&author=M.+P.+Mayerauthor=C.+Prodromouauthor=J.+Frydman&title=The+hsp90+mosaic%3A+a+picture+emerges&doi=10.1038%2Fnsmb0109-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Hsp90 mosaic: a picture emerges</span></div><div class="casAuthors">Mayer, Matthias P.; Prodromou, Chrisostomos; Frydman, Judith</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-6</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZS9gagh8ohLVg90H21EOLACvtfcHk0li9YtR4lLt5dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWitg%253D%253D&md5=a60cc5be2975750d370b0ca70d1f6152</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnsmb0109-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb0109-2%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DFrydman%26aufirst%3DJ.%26atitle%3DThe%2520hsp90%2520mosaic%253A%2520a%2520picture%2520emerges%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D2%26epage%3D6%26doi%3D10.1038%2Fnsmb0109-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheufler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourenkov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegoraro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartunik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarefi, I.</span></span> <span> </span><span class="NLM_article-title">Structure of tpr domain-peptide complexes: critical elements in the assembly of the hsp70-hsp90 multichaperone machine</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80830-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2800%2980830-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10786835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislKisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2000&pages=199-210&author=C.+Scheuflerauthor=A.+Brinkerauthor=G.+Bourenkovauthor=S.+Pegoraroauthor=L.+Moroderauthor=H.+Bartunikauthor=F.+U.+Hartlauthor=I.+Moarefi&title=Structure+of+tpr+domain-peptide+complexes%3A+critical+elements+in+the+assembly+of+the+hsp70-hsp90+multichaperone+machine&doi=10.1016%2FS0092-8674%2800%2980830-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine</span></div><div class="casAuthors">Scheufler, Clemens; Brinker, Achim; Bourenkov, Gleb; Pegoraro, Stefano; Moroder, Luis; Bartunik, Hans; Hartl, F. Ulrich; Moarefi, Ismail</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adaptor protein Hop mediates the assocn. of the mol. chaperones Hsp70 and Hsp90.  The TPR1 domain of Hop specifically recognizes the C-terminal heptapeptide of Hsp70 while the TPR2A domain binds the C-terminal pentapeptide of Hsp90.  Both sequences end with the motif EEVD.  The crystal structures of the TPR-peptide complexes show the peptides in an extended conformation, spanning a groove in the TPR domains.  Peptide binding is mediated by electrostatic interactions with the EEVD motif, with the C-terminal aspartate acting as a two-carboxylate anchor, and by hydrophobic interactions with residues upstream of EEVD.  The hydrophobic contacts with the peptide are crit. for specificity.  These results explain how TPR domains participate in the ordered assembly of Hsp70-Hsp90 multichaperone complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph4AAcAeVIcLVg90H21EOLACvtfcHk0lgv43B3fXW17A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislKisrY%253D&md5=1d0c83e6a89ecc2165fcea6b977f3363</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980830-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980830-2%26sid%3Dliteratum%253Aachs%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DBourenkov%26aufirst%3DG.%26aulast%3DPegoraro%26aufirst%3DS.%26aulast%3DMoroder%26aufirst%3DL.%26aulast%3DBartunik%26aufirst%3DH.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DMoarefi%26aufirst%3DI.%26atitle%3DStructure%2520of%2520tpr%2520domain-peptide%2520complexes%253A%2520critical%2520elements%2520in%2520the%2520assembly%2520of%2520the%2520hsp70-hsp90%2520multichaperone%2520machine%26jtitle%3DCell%26date%3D2000%26volume%3D101%26spage%3D199%26epage%3D210%26doi%3D10.1016%2FS0092-8674%2800%2980830-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marzec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span> <span> </span><span class="NLM_article-title">Grp94: an hsp90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22079671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=774-787&author=M.+Marzecauthor=D.+Elettoauthor=Y.+Argon&title=Grp94%3A+an+hsp90-like+protein+specialized+for+protein+folding+and+quality+control+in+the+endoplasmic+reticulum&doi=10.1016%2Fj.bbamcr.2011.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span></div><div class="casAuthors">Marzec, Michal; Eletto, Davide; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">774-787</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glucose-regulated protein 94 is the HSP90-like protein in the lumen of the endoplasmic reticulum and therefore it chaperones secreted and membrane proteins.  It has essential functions in development and physiol. of multicellular organisms, at least in part because of this unique clientele.  GRP94 shares many biochem. features with other HSP90 proteins, in particular its domain structure and ATPase activity, but also displays distinct activities, such as calcium binding, necessitated by the conditions in the endoplasmic reticulum.  GRP94's mode of action varies from the general HSP90 theme in the conformational changes induced by nucleotide binding, and in its interactions with co-chaperones, which are very different from known cytosolic co-chaperones.  GRP94 is more selective than many of the ER chaperones and the basis for this selectivity remains obscure.  Recent development of mol. tools and functional assays has expanded the spectrum of clients that rely on GRP94 activity, but it is still not clear how the chaperone binds them, or what aspect of folding it impacts.  These mechanistic questions and the regulation of GRP94 activity by other proteins and by post-translational modification differences pose new questions and present future research avenues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnr8jU7cub5LVg90H21EOLACvtfcHk0lgv43B3fXW17A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D&md5=421b27e4a82e34398366793c11147b99</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DMarzec%26aufirst%3DM.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DGrp94%253A%2520an%2520hsp90-like%2520protein%2520specialized%2520for%2520protein%2520folding%2520and%2520quality%2520control%2520in%2520the%2520endoplasmic%2520reticulum%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D774%26epage%3D787%26doi%3D10.1016%2Fj.bbamcr.2011.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Novobiocin and additional inhibitors of the hsp90 c-terminal nucleotide-binding pocket</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2702</span>– <span class="NLM_lpage">2717</span>, <span class="refDoi"> DOI: 10.2174/092986708786242895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F092986708786242895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18991631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWiur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2702-2717&author=A.+Donnellyauthor=B.+S.+J.+Blagg&title=Novobiocin+and+additional+inhibitors+of+the+hsp90+c-terminal+nucleotide-binding+pocket&doi=10.2174%2F092986708786242895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide binding pocket</span></div><div class="casAuthors">Donnelly, Alison; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2702-2717</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 90 kDa heat shock proteins (Hsp90), which are integrally involved in cell signaling, proliferation, and survival, are ubiquitously expressed in cells.  Many proteins in tumor cells are dependent upon the Hsp90 protein folding machinery for their stability, refolding, and maturation.  Inhibition of Hsp90 uniquely targets client proteins assocd. with all six hallmarks of cancer.  Thus, Hsp90 has emerged as a promising target for the treatment of cancer.  Hsp90 exists as a homodimer, which contains three domains.  The N-terminal domain contains an ATP-binding site that binds the natural products geldanamycin and radicicol.  The middle domain is highly charged and has high affinity for cochaperones and client proteins.  Initial studies by Csermely and co-workers suggested a second ATP-binding site in the C-terminus of Hsp90.  This C-terminal nucleotide binding pocket has been shown to not only bind ATP, but cisplatin, novobiocin, epigallocatechin-3-gallate (EGCG) and taxol.  The coumarin antibiotics novobiocin, clorobiocin, and coumermycin A1 were isolated from several streptomyces strains and exhibit potent activity against Gram-pos. bacteria.  These compds. bind type II topoisomerases, including DNA gyrase, and inhibit the enzyme-catalyzed hydrolysis of ATP.  As a result, novobiocin analogs have garnered the attention of numerous researchers as an attractive agent for the treatment of bacterial infection.  Novobiocin was reported to bind weakly to the newly discovered Hsp90 C-terminal ATP binding site (∼700 M in SkBr3 cells) and induce degrdn. of Hsp90 client proteins.  Structural modification of this compds. has led to an increase of 1000-fold in activity in antiproliferative assays.  Recent studies of structure-activity relationship (SAR) by Renoir and co-workers highlighted the crucial role of the C-4 and/or C-7 positions of the coumarin and removal of the noviose moiety, which appeared to be essential for degrdn. of Hsp90 client proteins.  Unlike the N-terminal ATP binding site, there is no reported co-crystal structure of Hsp90 C-terminus bound to any inhibitor.  The Hsp90 C-terminal domain however, is known to contain a conserved pentapeptide sequence (MEEVD) which is recognized by co-chaperones.  Cisplatin is a platinum-contg. chemotherapeutic used to treat various types of cancers, including testicular, ovarian, bladder, and small cell lung cancer.  Most notably, cisplatin coordinates to DNA bases, resulting in cross-linked DNA, which prohibits rapidly dividing cells from duplicating DNA for mitosis.  Itoh and co-workers reported that cisplatin decreases the chaperone activity of Hsp90.  This group applied bovine brain cytosol to a cisplatin affinity column, eluted with cisplatin and detected Hsp90 in the eluent.  Subsequent expts. indicated that cisplatin exhibits high affinity for Hsp90.  Moreover Csermely and co-workers detd. that the cisplatin binding site is located proximal to the C-terminal ATP binding site.  EGCG is one of the active ingredients found in green tea.  EGCG is known to inhibit the activity of many Hsp90-dependent client proteins, including telomerase, several kinases, and the aryl hydrocarbon receptor (AhR).  Recently Gasiewicz and co-workers reported that EGCG manifests its antagonistic activity against AhR through binding Hsp90.  Similar to novobiocin, EGCG was shown to bind the C-terminus of Hsp90.  Unlike previously identified N-terminal Hsp90 inhibitors, EGCG does not appear to prevent Hsp90 from forming multiprotein complexes.  Studies are currently underway to det. whether EGCG competes with novobiocin or cisplatin binding.  Taxol, a well-known drug for the treatment of cancer, is responsible for the stabilization of microtubules and the inhibition of mitosis.  Previous studies have shown that taxol induces the activation of kinases and transcription factors, and mimics the effect of bacterial lipopolysaccharide (LPS), an attribute unrelated to its tubulin-binding properties.  Rosen and co-workers prepd. a biotinylated taxol deriv. and performed affinity chromatog. expts. with lysates from both mouse brain and macrophage cell lines.  These studies led to identification of two chaperones, Hsp70 and Hsp90, by mass spectrometry.  In contrast to typical Hsp90-binding drugs, taxol exhibits a stimulatory response.  Recently it was reported that the geldanamycin deriv. 17-AAG behaves synergistically with taxol-induced apoptosis.  This review describes the different C-terminal inhibitors of Hsp90, with specific emphasis on structure-activity relationship studies of novobiocin and their effects on anti-proliferative activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ1ZxUMTyXBrVg90H21EOLACvtfcHk0lgv43B3fXW17A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWiur3M&md5=ee456e11ec9730f446bffd75d5d22c5e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986708786242895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708786242895%26sid%3Dliteratum%253Aachs%26aulast%3DDonnelly%26aufirst%3DA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DNovobiocin%2520and%2520additional%2520inhibitors%2520of%2520the%2520hsp90%2520c-terminal%2520nucleotide-binding%2520pocket%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2702%26epage%3D2717%26doi%3D10.2174%2F092986708786242895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span> <span> </span><span class="NLM_article-title">The ’active life’ of hsp90 complexes</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbamcr.2011.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21840346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=614-623&author=C.+Prodromou&title=The+%E2%80%99active+life%E2%80%99+of+hsp90+complexes&doi=10.1016%2Fj.bbamcr.2011.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The active life' of Hsp90 complexes</span></div><div class="casAuthors">Prodromou, Chrisostomos</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-623</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 forms a variety of complexes differing both in clientele and co-chaperones.  Central to the role of co-chaperones in the formation of Hsp90 complexes is the delivery of client proteins and the regulation of the ATPase activity of Hsp90.  Detg. the mechanisms by which co-chaperones regulate Hsp90 is essential in understanding the assembly of these complexes and the activation and maturation of Hsp90's clientele.  Mechanistically, co-chaperones alter the kinetics of the ATP-coupled conformational changes of Hsp90.  The structural changes leading to the formation of a catalytically active unit involve all regions of the Hsp90 dimer.  Their complexity has allowed different orthologues of Hsp90 to evolve kinetically in slightly different ways.  The interaction of the cytosolic Hsp90 with a variety of co-chaperones lends itself to a complex set of different regulatory mechanisms that modulate Hsp90's conformation and ATPase activity.  It also appears that the conformational switches of Hsp90 are not necessarily coupled under all circumstances.  Here, I described different co-chaperone complexes and then discuss in detail the mechanisms and role that specific co-chaperones play in this.  I will also discuss emerging evidence that post-translational modifications also affect the ATPase activity of Hsp90, and thus complex formation.  Finally, I will present evidence showing how Hsp90's active site, although being highly conserved, can be altered to show resistance to drug binding, but still maintain ATP binding and ATPase activity.  Such changes are therefore unlikely to significantly alter Hsp90's interactions with client proteins and co-chaperones.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEM4L7aY2HFrVg90H21EOLACvtfcHk0lgv43B3fXW17A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7w%253D&md5=57d013f7cd3a06a663a598d29e0a193c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26atitle%3DThe%2520%25E2%2580%2599active%2520life%25E2%2580%2599%2520of%2520hsp90%2520complexes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D614%26epage%3D623%26doi%3D10.1016%2Fj.bbamcr.2011.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosz, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span> <span> </span><span class="NLM_article-title">Hsp90 at the hub of protein homeostasis: emerging mechanistic insights</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">528</span>, <span class="refDoi"> DOI: 10.1038/nrm2918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrm2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20531426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=515-528&author=M.+Taipaleauthor=D.+F.+Jaroszauthor=S.+Lindquist&title=Hsp90+at+the+hub+of+protein+homeostasis%3A+emerging+mechanistic+insights&doi=10.1038%2Fnrm2918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 at the hub of protein homeostasis: emerging mechanistic insights</span></div><div class="casAuthors">Taipale, Mikko; Jarosz, Daniel F.; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">515-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (HSP90) is a highly conserved mol. chaperone that facilitates the maturation of a wide range of proteins (known as clients).  Clients are enriched in signal transducers, including kinases and transcription factors.  Therefore, HSP90 regulates diverse cellular functions and exerts marked effects on normal biol., disease, and evolutionary processes.  Recent structural and functional analyses have provided new insights on the transcriptional and biochem. regulation of HSP90 and the structural dynamics it uses to act on a diverse client repertoire.  A comprehensive understanding of how HSP90 functions promises not only to provide new avenues for therapeutic intervention, but to shed light on fundamental biol. questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuMRSaY8uzGbVg90H21EOLACvtfcHk0lhPJPKkiOh8jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D&md5=492dca92cea32384d2ab4145230f53dd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrm2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2918%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DJarosz%26aufirst%3DD.%2BF.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DHsp90%2520at%2520the%2520hub%2520of%2520protein%2520homeostasis%253A%2520emerging%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D515%26epage%3D528%26doi%3D10.1038%2Fnrm2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic hsp90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+hsp90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lhPJPKkiOh8jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520hsp90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaarniranta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltunen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, H.</span></span> <span> </span><span class="NLM_article-title">Hsp90 regulates tau pathology through co-chaperone complexes in alzheimer’s disease</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.pneurobio.2010.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21056617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=99-110&author=A.+Salminenauthor=J.+Ojalaauthor=K.+Kaarnirantaauthor=M.+Hiltunenauthor=H.+Soininen&title=Hsp90+regulates+tau+pathology+through+co-chaperone+complexes+in+alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.pneurobio.2010.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease</span></div><div class="casAuthors">Salminen Antero; Ojala Johanna; Kaarniranta Kai; Hiltunen Mikko; Soininen Hilkka</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease is a tauopathy which involves the deposition of microtubule-associated tau proteins into neurofibrillary tangles.  Post-translational modifications, in particular site-specific phosphorylations, affect the conformation of tau protein which is an intrinsically disordered protein.  These structural changes significantly increase the affinity of tau protein for certain molecular chaperones.  Hsp90 is a major cellular chaperone which assembles large complexes with a variety of co-chaperones.  The main function of Hsp90 complexes is to maintain protein quality control and assist in protein degradation via proteasomal and autophagic-lysosomal pathways.  Tau protein is a client protein for these Hsp90 complexes.  If the tau protein is in an abnormal or modified form, then it can trigger the recruitment of CHIP protein, a co-chaperone with E3 activity, to the complex which induces the ubiquitination of tau protein and activates its downstream degradation processes.  Large immunophilins, FKBP51 and FKBP52 are also co-chaperones of Hsp90-tau complexes.  These proteins contain peptidylprolyl cis/trans isomerase activity which catalyzes phosphorylation-dependent rotation in pSer/Thr-Pro peptide bond.  The proline switch in the tau conformation triggers dephosphorylation of Ser/Thr residues phosphorylated, e.g. by two well-known tau kinases Cdk5 and GSK-3β.  Binding of PP5 protein phosphatase to Hsp90 complex, can also dephosphorylate tau protein.  Subsequently, dephosphorylated tau protein can be shuttled back to the microtubules.  It seems that high-affinity binding of abnormal tau to Hsp90 complexes may have some counteracting effects on the aggregation process, since Hsp90 inhibitors can ameliorate the aggregation process in several neurodegenerative diseases.  We will review the role of Hsp90 chaperone network in the regulation of tau biology and pathology in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIGys_IlOfaRe4jJGKT5N0fW6udTcc2ebl3kZGFhMcbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvFSitw%253D%253D&md5=92c5535c5b5bc12c8c0807ea338310d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DSalminen%26aufirst%3DA.%26aulast%3DOjala%26aufirst%3DJ.%26aulast%3DKaarniranta%26aufirst%3DK.%26aulast%3DHiltunen%26aufirst%3DM.%26aulast%3DSoininen%26aufirst%3DH.%26atitle%3DHsp90%2520regulates%2520tau%2520pathology%2520through%2520co-chaperone%2520complexes%2520in%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26volume%3D93%26spage%3D99%26epage%3D110%26doi%3D10.1016%2Fj.pneurobio.2010.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz-Ares, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hsp90 molecular chaperones: moving into the clinic</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e358</span>– <span class="NLM_lpage">e369</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS1470-2045%2813%2970169-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23896275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=e358-e369&author=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Inhibition+of+hsp90+molecular+chaperones%3A+moving+into+the+clinic&doi=10.1016%2FS1470-2045%2813%2970169-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HSP90 molecular chaperones: moving into the clinic</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Carnero, Amancio; Paz-Ares, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e358-e369</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (HSP90) is a mol. chaperone that is crucial for the stability and function of many proteins essential for cell survival.  Many oncogenes, including tyrosine kinases, transcription factors, and cell-cycle regulatory proteins, are client proteins of HSP90.  Inhibition of HSP90 causes client protein degrdn. via the ubiquitin-proteasome pathway, and is a mechanism that might simultaneously downregulate several redundant pathways crucial for cell viability and tumor development.  HSP90 inhibitors are currently being developed as anticancer agents, and have shown early promising results in molecularly defined subgroups of solid tumors (eg, ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer) and some haematol. malignancies (eg, multiple myeloma).  Here, we review the current status of HSP90 inhibitors in clin. development, including geldanamycin derivs., resorcinol derivs., purine analogs, and other synthetic inhibitors.  We also discuss novel strategies and future perspectives on how to optimize the therapeutic potential of this exciting new class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpulM7j4PFcx7Vg90H21EOLACvtfcHk0lhwE_DASnVEPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI&md5=4821e86073624fb17d7343105d6e82cd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970169-4%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520hsp90%2520molecular%2520chaperones%253A%2520moving%2520into%2520the%2520clinic%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3De358%26epage%3De369%26doi%3D10.1016%2FS1470-2045%2813%2970169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Grp94/gp96 in cancer: biology, structure, immunology, and drug development</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fbs.acr.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26916005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=165-190&author=B.+X.+Wuauthor=F.+Hongauthor=Y.+Zhangauthor=E.+Ansa-Addoauthor=Z.+Li&title=Grp94%2Fgp96+in+cancer%3A+biology%2C+structure%2C+immunology%2C+and+drug+development&doi=10.1016%2Fbs.acr.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94/gp96 in cancer: biology, structure, immunology, and drug development</span></div><div class="casAuthors">Wu, Bill X.; Hong, Feng; Zhang, Yongliang; Ansa-Addo, Ephraim; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">165-190</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat-shock protein 90 (HSP90) paralog, GRP94 (glucose-regulated protein 94)/gp96 (hereafter referred to as GRP94) has been shown to be an essential master chaperone for multiple receptors including Toll-like receptors, Wnt coreceptors, and integrins.  Clin., expression of GRP94 correlates with advanced stage and poor survival in a variety of cancers.  Recent preclin. studies have also revealed that GRP94 expression is closely linked to cancer growth and metastasis in melanoma, ovarian cancer, multiple myeloma, lung cancer, and inflammation-assocd. colon cancer.  Thus, GRP94 is an attractive therapeutic target in a no. of malignancies.  The chaperone function of GRP94 depends on its ATPase domain, which is structurally distinct from HSP90, allowing design of highly selective GRP94-targeted inhibitors.  In this chapter, we discuss the biol. and structure-function relationship of GRP94.  We also summarize the immunol. roles of GRP94 based on the studies documented over the last two decades, as these pertain to tumorigenesis and cancer progression.  Finally, the structure-based rationale for the design of selective small-mol. inhibitors of GRP94 and their potential application in the treatment of cancer are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOidSXL_76bVg90H21EOLACvtfcHk0lhwE_DASnVEPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D&md5=aa5f0de87db03540b0902ae305e658fc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAnsa-Addo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DGrp94%252Fgp96%2520in%2520cancer%253A%2520biology%252C%2520structure%252C%2520immunology%252C%2520and%2520drug%2520development%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2016%26volume%3D129%26spage%3D165%26epage%3D190%26doi%3D10.1016%2Fbs.acr.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White-Gilbertson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6242</span>– <span class="NLM_lpage">6251</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+P.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+DePinhoauthor=Z.+H.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-13-2083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0lhwE_DASnVEPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%2BP.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDePinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251%26doi%3D10.1158%2F1078-0432.CCR-13-2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">Identification of gp96 as a novel target for treatment of autoimmune disease in mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e9792</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0009792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1371%2Fjournal.pone.0009792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20352117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3c3itFSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9792&author=J.+M.+Hanauthor=N.+H.+Kwonauthor=J.+Y.+Leeauthor=S.+J.+Jeongauthor=H.+J.+Jungauthor=H.+R.+Kimauthor=Z.+H.+Liauthor=S.+Kim&title=Identification+of+gp96+as+a+novel+target+for+treatment+of+autoimmune+disease+in+mice&doi=10.1371%2Fjournal.pone.0009792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of gp96 as a novel target for treatment of autoimmune disease in mice</span></div><div class="casAuthors">Han Jung Min; Kwon Nam Hoon; Lee Jin Young; Jeong Seung Jae; Jung Hee Jung; Kim Hyeong Rae; Li Zihai; Kim Sunghoon</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e9792</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock proteins have been implicated as endogenous activators for dendritic cells (DCs).  Chronic expression of heat shock protein gp96 on cell surfaces induces significant DC activations and systemic lupus erythematosus (SLE)-like phenotypes in mice.  However, its potential as a therapeutic target against SLE remains to be evaluated.  In this work, we conducted chemical approach to determine whether SLE-like phenotypes can be compromised by controlling surface translocation of gp96.  From screening of chemical library, we identified a compound that binds and suppresses surface presentation of gp96 by facilitating its oligomerization and retrograde transport to endoplasmic reticulum.  In vivo administration of this compound reduced maturation of DCs, populations of antigen presenting cells, and activated B and T cells.  The chemical treatment also alleviated the SLE-associated symptoms such as glomerulonephritis, proteinuria, and accumulation of anti-nuclear and -DNA antibodies in the SLE model mice resulting from chronic surface exposure of gp96.  These results suggest that surface translocation of gp96 can be chemically controlled and gp96 as a potential therapeutic target to treat autoimmune disease like SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAwZFYdxQArg5nADWVYHg1fW6udTcc2eal8meYW8FPx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3itFSrtQ%253D%253D&md5=735e3a9d4cd07e38c5d804d432b74b7f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009792%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BM.%26aulast%3DKwon%26aufirst%3DN.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DJeong%26aufirst%3DS.%2BJ.%26aulast%3DJung%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520gp96%2520as%2520a%2520novel%2520target%2520for%2520treatment%2520of%2520autoimmune%2520disease%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9792%26doi%3D10.1371%2Fjournal.pone.0009792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. H.</span></span> <span> </span><span class="NLM_article-title">Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2819</span>, <span class="refDoi"> DOI: 10.1111/febs.12822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1111%2Ffebs.12822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24754231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=2805-2819&author=X.+Tianauthor=P.+Maauthor=C.+G.+Suiauthor=F.+D.+Mengauthor=Y.+Liauthor=L.+Y.+Fuauthor=T.+Jiangauthor=Y.+Wangauthor=Y.+H.+Jiang&title=Suppression+of+tumor+necrosis+factor+receptor-associated+protein+1+expression+induces+inhibition+of+cell+proliferation+and+tumor+growth+in+human+esophageal+cancer+cells&doi=10.1111%2Ffebs.12822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells</span></div><div class="casAuthors">Tian, Xin; Ma, Ping; Sui, Cheng-Guang; Meng, Fan-Dong; Li, Yan; Fu, Li-Ye; Jiang, Tao; Wang, Yang; Jiang, You-Hong</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2805-2819</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tumor necrosis factor receptor-assocd. protein 1 (TRAP1) is a mol. chaperone involved in multidrug resistance and antiapoptosis in some human tumors, but its regulatory mechanisms have not been revealed in esophageal squamous cell carcinoma (ESCC).  In this study, 138 specimens of ESCC were analyzed.  TRAP1 was overexpressed in ESCC, particularly in poorly differentiated tumors.  To further explore the mol. regulatory mechanism, we constructed specific small interfering RNA-expressing vectors targeting Trap1, and knocked down Trap1 expression in the esophageal cancer cell lines ECA109 and EC9706.  Knockdown of Trap1 induced increases in reactive oxygen species and mitochondrial depolarization, which have been proposed as crit. regulators of apoptosis.  The cell cycle was arrested in G2/M phase, and in vitro inhibition of cell proliferation was confirmed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide and bromodeoxyuridine assays.  Furthermore, re-expression of TRAP1 in Trap1 small interfering RNA-transfected ESCC cells restored cell proliferation and cell apoptosis.  Bioluminescence of s.c. xenografted ESCC tumor cells demonstrated significant inhibition of in vivo tumor growth by Trap1 knockdown.  This study shows that TRAP1 was overexpressed in most patients with ESCC, and caused an increase in antiapoptosis potency.  TRAP1 may be regarded as a target in ESCC biotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7H6sKjcHsrVg90H21EOLACvtfcHk0liJK9d_Q9kf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWlt7c%253D&md5=42f27193e87cf0b65d76e550921a07bf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12822%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DSui%26aufirst%3DC.%2BG.%26aulast%3DMeng%26aufirst%3DF.%2BD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%2BH.%26atitle%3DSuppression%2520of%2520tumor%2520necrosis%2520factor%2520receptor-associated%2520protein%25201%2520expression%2520induces%2520inhibition%2520of%2520cell%2520proliferation%2520and%2520tumor%2520growth%2520in%2520human%2520esophageal%2520cancer%2520cells%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26spage%3D2805%26epage%3D2819%26doi%3D10.1111%2Ffebs.12822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. E.</span></span> <span> </span><span class="NLM_article-title">The hsp70 family and cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgt111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1093%2Fcarcin%2Fbgt111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23563090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1181-1188&author=M.+E.+Murphy&title=The+hsp70+family+and+cancer&doi=10.1093%2Fcarcin%2Fbgt111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP70 family and cancer</span></div><div class="casAuthors">Murphy, Maureen E.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1181-1188</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The HSP70 family of heat shock proteins consists of mol. chaperones of approx. 70kDa in size that serve crit. roles in protein homeostasis.  These ATPases unfold misfolded or denatured proteins and can keep these proteins in an unfolded, folding-competent state.  They also protect nascently translating proteins, promote the cellular or organellar transport of proteins, reduce proteotoxic protein aggregates and serve general housekeeping roles in maintaining protein homeostasis.  The HSP70 family is the most conserved in evolution, and all eukaryotes contain multiple members.  Some members of this family serve specific organellar- or tissue-specific functions; however, in many cases, these members can function redundantly.  Overall, the HSP70 family of proteins can be thought of as a potent buffering system for cellular stress, either from extrinsic (physiol., viral and environmental) or intrinsic (replicative or oncogenic) stimuli.  As such, this family serves a crit. survival function in the cell.  Not surprisingly, cancer cells rely heavily on this buffering system for survival.  The overwhelming majority of human tumors overexpress HSP70 family members, and expression of these proteins is typically a marker for poor prognosis.  With the proof of principle that inhibitors of the HSP90 chaperone have emerged as important anticancer agents, intense focus has now been placed on the potential for HSP70 inhibitors to assume a role as a significant chemotherapeutic avenue.  In this review, the history, regulation, mechanism of action and role in cancer of the HSP70 family are reviewed.  Addnl., the promise of pharmacol. targeting this protein for cancer therapy is addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSLhAXHd5TMrVg90H21EOLACvtfcHk0liJK9d_Q9kf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFCnt7w%253D&md5=57d5da83aac342edb1dff2ba2bd0372b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgt111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgt111%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BE.%26atitle%3DThe%2520hsp70%2520family%2520and%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2013%26volume%3D34%26spage%3D1181%26epage%3D1188%26doi%3D10.1093%2Fcarcin%2Fbgt111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">Integration of the accelerator aha1 in the hsp90 co-chaperone cycle</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnsmb.2502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23396352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1agtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=326-331&author=J.+Liauthor=K.+Richterauthor=J.+Reinsteinauthor=J.+Buchner&title=Integration+of+the+accelerator+aha1+in+the+hsp90+co-chaperone+cycle&doi=10.1038%2Fnsmb.2502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle</span></div><div class="casAuthors">Li, Jing; Richter, Klaus; Reinstein, Jochen; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">326-331</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat-shock protein 90 (Hsp90) is an ATP-dependent mol. chaperone that assocs. dynamically with various co-chaperones during its chaperone cycle.  Here we analyzed the role of the activating co-chaperone Aha1 in the progression of the yeast Hsp90 chaperone cycle and identified a crit. ternary Hsp90 complex contg. the co-chaperones Aha1 and Cpr6.  Aha1 accelerates the intrinsically slow conformational transitions of Hsp90 to an N-terminally assocd. state but does not fully close the nucleotide-binding pocket yet.  Cpr6 increases the affinity between Aha1 and Hsp90 and further stimulates the Hsp90 ATPase activity.  Synergistically, Aha1 and Cpr6 displace the inhibitory co-chaperone Sti1 from Hsp90.  To complete the cycle, Aha1 is released by the co-chaperone p23.  Thus, at distinct steps during the Hsp90 chaperone cycle, co-chaperones selectively trap statistically distributed Hsp90 conformers and thus turn Hsp90 into a deterministic machine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeeCJzW_WC07Vg90H21EOLACvtfcHk0liJK9d_Q9kf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1agtrs%253D&md5=5d9efe9ba6342ab18bd7567a70344956</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2502%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DIntegration%2520of%2520the%2520accelerator%2520aha1%2520in%2520the%2520hsp90%2520co-chaperone%2520cycle%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D326%26epage%3D331%26doi%3D10.1038%2Fnsmb.2502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiau, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southworth, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of e. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.cell.2006.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17055434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=329-340&author=A.+K.+Shiauauthor=S.+F.+Harrisauthor=D.+R.+Southworthauthor=D.+A.+Agard&title=Structural+analysis+of+e.+coli+hsp90+reveals+dramatic+nucleotide-dependent+conformational+rearrangements&doi=10.1016%2Fj.cell.2006.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span></div><div class="casAuthors">Shiau, Andrew K.; Harris, Seth F.; Southworth, Daniel R.; Agard, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-340</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In eukaryotes, the ubiquitous and abundant members of the 90 kDa heat-shock protein (hsp90) chaperone family facilitate the folding and conformational changes of a broad array of proteins important in cell signaling, proliferation, and survival.  Here we describe the effects of nucleotides on the structure of full-length HtpG, the Escherichia coli hsp90 ortholog.  By electron microscopy, the nucleotide-free, AMPPNP bound, and ADP bound states of HtpG adopt completely distinct conformations.  Structural characterization of nucleotide-free and ADP bound HtpG was extended to higher resoln. by x-ray crystallog.  In the absence of nucleotide, HtpG exhibits an "open" conformation in which the three domains of each monomer present hydrophobic elements into the large cleft formed by the dimer.  By contrast, ADP binding drives dramatic conformational changes that allow these hydrophobic elements to converge and shield each other from solvent, suggesting a mechanism by which nucleotides could control client protein binding and release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeAimQnRIXPbVg90H21EOLACvtfcHk0liiwGQRR4iroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73J&md5=062feeb6f8ec5fde039ad55dbc093008</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DSouthworth%26aufirst%3DD.%2BR.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520e.%2520coli%2520hsp90%2520reveals%2520dramatic%2520nucleotide-dependent%2520conformational%2520rearrangements%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D329%26epage%3D340%26doi%3D10.1016%2Fj.cell.2006.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-ref25_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">The hallmarks of cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81683-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer&doi=10.1016%2FS0092-8674%2800%2981683-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref25_1R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0liiwGQRR4iroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=ref25_1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70%26doi%3D10.1016%2FS0092-8674%2800%2981683-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">The therapeutic target hsp90 and cancer hallmarks</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.2174/138161213804143725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F138161213804143725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22920906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=347-365&author=Y.+Miyataauthor=H.+Nakamotoauthor=L.+Neckers&title=The+therapeutic+target+hsp90+and+cancer+hallmarks&doi=10.2174%2F138161213804143725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic target Hsp90 and cancer hallmarks</span></div><div class="casAuthors">Miyata, Yoshihiko; Nakamoto, Hitoshi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a major mol. chaperone that is expressed abundantly and plays a pivotal role in assisting correct folding and functionality of its client proteins in cells.  The Hsp90 client proteins include a wide variety of signal transducing mols. such as protein kinases and steroid hormone receptors.  Cancer is a complex disease, but most types of human cancer share common hallmarks, including self-sufficiency in growth signals, insensitivity to growth-inhibitory mechanism, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  A surprisingly large no. of Hsp90-client proteins play crucial roles in establishing cancer cell hallmarks.  We start the review by describing the structure and function of Hsp90 since conformational changes during the ATPase cycle of Hsp90 are closely related to its function.  Many co-chaperones, including Hop, p23, Cdc37, Aha1, and PP5, work together with Hsp90 by modulating the chaperone machinery.  Post-translational modifications of Hsp90 and its co-chaperones are vital for their function.  Many tumor-related Hsp90-client proteins, including signaling kinases, steroid hormone receptors, p53, and telomerase, are described.  Hsp90 and its co-chaperones are required for the function of these tumor-promoting client proteins; therefore, inhibition of Hsp90 by specific inhibitors such as geldanamycin and its derivs. attenuates the tumor progression.  Hsp90 inhibitors can be potential and effective cancer chemotherapeutic drugs with a unique profile and have been examd. in clin. trials.  We describe possible mechanisms why Hsp90 inhibitors show selectivity to cancer cells even though Hsp90 is essential also for normal cells.  Finally, we discuss the "Hsp90-addiction" of cancer cells, and suggest a role for Hsp90 in tumor evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCHug6Q3PILVg90H21EOLACvtfcHk0liiwGQRR4iroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D&md5=07f817fc5afc5ef0669aae0cd0dab15d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138161213804143725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143725%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DNakamoto%26aufirst%3DH.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DThe%2520therapeutic%2520target%2520hsp90%2520and%2520cancer%2520hallmarks%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D347%26epage%3D365%26doi%3D10.2174%2F138161213804143725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Hsp90 in cancer: transcriptional roles in the nucleus</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fbs.acr.2015.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26916002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=89-106&author=S.+K.+Calderwoodauthor=L.+Neckers&title=Hsp90+in+cancer%3A+transcriptional+roles+in+the+nucleus&doi=10.1016%2Fbs.acr.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 in cancer: transcriptional roles in the nucleus</span></div><div class="casAuthors">Calderwood, Stuart K.; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">89-106</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hsp90 plays a key role in fostering metabolic pathways essential in tumorigenesis through its functions as a mol. chaperone.  Multiple oncogenic factors in the membrane and cytoplasm are thus protected from degrdn. and destruction.  Here, we have considered Hsp90's role in transcription in the nucleus.  Hsp90 functions both in regulating the activity of sequence-specific transcription factors such as nuclear receptors and HSF1, as well as impacting more globally acting factors that act on chromatin and RNA polymerase II.  Hsp90 influences transcription by modulating histone modification mediated by its clients SMYD3 and trithorax/MLL, as well as by regulating the processivity of RNA polymerase II through neg. elongation factor.  It is not currently clear how the transcriptional role of Hsp90 may be influenced by the cancer milieu although recently discovered posttranslational modification of the chaperone may be involved.  Dysregulation of Hsp90 may thus influence malignant processes both by modulating the function of specific transcription factors and effects on more globally acting general components of the transcriptional machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxbKc0Wv-cbbVg90H21EOLACvtfcHk0liiwGQRR4iroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWru7c%253D&md5=8635e6f4b89e79d244c6b3cb3126a4c8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHsp90%2520in%2520cancer%253A%2520transcriptional%2520roles%2520in%2520the%2520nucleus%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2016%26volume%3D129%26spage%3D89%26epage%3D106%26doi%3D10.1016%2Fbs.acr.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span> <span> </span><span class="NLM_article-title">Drugging the cancer chaperone hsp90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1113</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1196/annals.1391.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1196%2Fannals.1391.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17513464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1113&publication_year=2007&pages=202-216&author=P.+Workmanauthor=F.+Burrowsauthor=L.+Neckersauthor=N.+Rosen&title=Drugging+the+cancer+chaperone+hsp90%3A+combinatorial+therapeutic+exploitation+of+oncogene+addiction+and+tumor+stress&doi=10.1196%2Fannals.1391.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging the cancer chaperone HSP90: combinatorial therapeutic expolitation on oncogene addiction and tumor stress</span></div><div class="casAuthors">Workman, Paul; Burrows, Francis; Neckers, Len; Rosen, Neal</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1113</span>
        (<span class="NLM_cas:issue">Stress Responses in Biology and Medicine</span>),
    <span class="NLM_cas:pages">202-216</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone HSP90 has emerged as an exciting target for cancer treatment.  We review the potential advantages of HSP90 inhibitors, particularly the simultaneous combinatorial depletion of multiple oncogenic "client" proteins, leading to blockade of many cancer-causing pathways and the antagonism of all of the hallmark pathol. traits of malignancy.  Cancer selectivity is achieved by exploiting cancer "dependencies," including oncogene addiction and the stressed state of malignant cells.  The multiple downstream effects of HSP90 inhibitors should make the development of resistance more difficult than with agents having more restricted effects.  We review the various classes of HSP90 inhibitor that have been developed, including the natural products geldanamycin and radicicol and also the purine scaffold and pyrazole/isoxazole class of synthetic small mol. inhibitors.  A first-in-class HSP90 drug, the geldanamycin analog 17-AAG, has provided proof of concept for HSP90 inhibition in patients at well tolerated doses and therapeutic activity has been seen.  Other inhibitors show promise in preclin. and clin. development.  Opportunities and challenges for HSP90 inhibitors are discussed, including use in combination with other agents.  Most of the current HSP90 inhibitors act by blocking the essential nucleotide binding and ATPase activity required for chaperone function.  Potential new approaches are discussed, for example, interference with cochaperone binding and function in the superchaperone complex.  Biomarkers for use with HSP90 inhibitors are described.  We stress how basic and translational research has been mutually beneficial and indicate future directions to enhance our understanding of mol. chaperones and their exploitation in cancer and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi_I-DGevqj7Vg90H21EOLACvtfcHk0ljtO1Yb_SM1Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVanurfF&md5=a537c5d947847c6b3cdf613968214623</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1196%2Fannals.1391.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1391.012%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBurrows%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDrugging%2520the%2520cancer%2520chaperone%2520hsp90%253A%2520combinatorial%2520therapeutic%2520exploitation%2520of%2520oncogene%2520addiction%2520and%2520tumor%2520stress%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2007%26volume%3D1113%26spage%3D202%26epage%3D216%26doi%3D10.1196%2Fannals.1391.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Węgrzyn, G.</span></span> <span> </span><span class="NLM_article-title">Anti-hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/s12192-016-0670-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs12192-016-0670-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26786410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=213-218&author=S.+Tukajauthor=G.+W%C4%99grzyn&title=Anti-hsp90+therapy+in+autoimmune+and+inflammatory+diseases%3A+a+review+of+preclinical+studies&doi=10.1007%2Fs12192-016-0670-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span></div><div class="casAuthors">Tukaj, Stefan; Wegrzyn, Grzegorz</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90), a 90-kDa mol. chaperone, is responsible for biol. activities of key signaling mols. (clients) such as protein kinases, ubiquitin ligases, steroid receptors, cell cycle regulators, and transcription factors regulating various cellular processes, including growth, survival, differentiation, and apoptosis.  Because Hsp90 is also involved in stabilization of oncogenic 'client' proteins, its specific chaperone activity blockers are currently being tested as anticancer agents in advanced clin. trials.  Recent in vitro and in vivo studies have shown that Hsp90 is also involved in activation of innate and adaptive cells of the immune system.  For these reasons, pharmacol. inhibition of Hsp90 has been evaluated in murine models of autoimmune and inflammatory diseases.  This mini-review summarizes current knowledge of the effects of Hsp90 inhibitors on autoimmune and inflammatory diseases' features and is based solely on preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_LDdiZ_wJSrVg90H21EOLACvtfcHk0ljtO1Yb_SM1Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D&md5=e0b1d3ea522de06d60ab530e20b2b4d0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs12192-016-0670-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-016-0670-z%26sid%3Dliteratum%253Aachs%26aulast%3DTukaj%26aufirst%3DS.%26aulast%3DW%25C4%2599grzyn%26aufirst%3DG.%26atitle%3DAnti-hsp90%2520therapy%2520in%2520autoimmune%2520and%2520inflammatory%2520diseases%253A%2520a%2520review%2520of%2520preclinical%2520studies%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2016%26volume%3D21%26spage%3D213%26epage%3D218%26doi%3D10.1007%2Fs12192-016-0670-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90 is critical for regulation of phenotype and functional activity of human t lymphocytes and nk cells</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">1360</span>– <span class="NLM_lpage">1371</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1200593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.4049%2Fjimmunol.1200593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23293352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2013&pages=1360-1371&author=J.+Baeauthor=A.+Munshiauthor=C.+Liauthor=M.+Samurauthor=R.+Prabhalaauthor=C.+Mitsiadesauthor=K.+C.+Andersonauthor=N.+C.+Munshi&title=Heat+shock+protein+90+is+critical+for+regulation+of+phenotype+and+functional+activity+of+human+t+lymphocytes+and+nk+cells&doi=10.4049%2Fjimmunol.1200593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90 Is Critical for Regulation of Phenotype and Functional Activity of Human T Lymphocytes and NK Cells</span></div><div class="casAuthors">Bae, Jooeun; Munshi, Aditya; Li, Cheng; Samur, Mehmet; Prabhala, Rao; Mitsiades, Constantine; Anderson, Kenneth C.; Munshi, Nikhil C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1360-1371</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The 90-kDa heat shock protein (Hsp90) has become an important therapeutic target with ongoing evaluation in a no. of malignancies.  Although Hsp90 inhibitors have a high therapeutic index with limited effects on normal cells, they have been described to inhibit dendritic cell function.  However, its effect on human immune effector cells may have significant clin. implications, but remains unexplored.  In this study, we have evaluated the effects of Hsp90 inhibition on human T lymphocyte and NK cells, including their Ag expression, activation, proliferation, and functional activities.  These studies demonstrate that Hsp90 inhibition irreversibly downregulates cell surface expression of crit. Ags (CD3, CD4, CD8), the costimulatory mol. (CD28, CD40L), and αβ receptors on T lymphocytes, as well as activating receptors (CD2, CD11a, CD94, NKp30, NKp44, NKp46, KARp50.3) on NK cells.  Hsp90 inhibition significantly reduced CD4 protein expression on T lymphocytes at both the cell surface and intracellular level, which was shown to be assocd. with aberrant regulation of Src-kinase p56Lck.  Downregulation of the Ags triggered by Hsp90 inhibition on CD3+ T lymphocytes, both in CD4+ and CD8+ T cell subsets, was assocd. with a disruption in their cellular activation, proliferation, and/or IFN-γ prodn., when the inhibition occurred either in activated or inactivated cells.  In addn., downregulation of key activating receptors on NK cells following Hsp90 inhibition resulted in decreased cytotoxicity against tumor cells.  Therefore, these observations demonstrate the need to closely monitor immune function in patients being treated with a Hsp90 inhibitor and may provide a potential therapeutic application in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF-Ta4whAsmbVg90H21EOLACvtfcHk0ljtO1Yb_SM1Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWrt7k%253D&md5=e9606da26c71559ffbf1b1436f386637</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1200593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1200593%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.%26aulast%3DMunshi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSamur%26aufirst%3DM.%26aulast%3DPrabhala%26aufirst%3DR.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%2520is%2520critical%2520for%2520regulation%2520of%2520phenotype%2520and%2520functional%2520activity%2520of%2520human%2520t%2520lymphocytes%2520and%2520nk%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2013%26volume%3D190%26spage%3D1360%26epage%3D1371%26doi%3D10.4049%2Fjimmunol.1200593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabbett, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3765</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1002/art.24047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fart.24047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19035474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3765-3775&author=J.+W.+Riceauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=A.+F.+Barabaszauthor=J.+M.+Partridgeauthor=T.+E.+Bartaauthor=L.+G.+Duboisauthor=K.+H.+Huangauthor=S.+R.+Mabbettauthor=M.+A.+Silinskiauthor=P.+M.+Steedauthor=S.+E.+Hall&title=Small+molecule+inhibitors+of+hsp90+potently+affect+inflammatory+disease+pathways+and+exhibit+activity+in+models+of+rheumatoid+arthritis&doi=10.1002%2Fart.24047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis</span></div><div class="casAuthors">Rice, John W.; Veal, James M.; Fadden, R. Patrick; Barabasz, Amy F.; Partridge, Jeffrey M.; Barta, Thomas E.; Dubois, Laura G.; Huang, Kenneth H.; Mabbett, Sarah R.; Silinski, Melanie A.; Steed, Paul M.; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3765-3775</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To evaluate the ability of SNX-7081, a novel small mol. inhibitor of Hsp90, to block components of inflammation, including cytokine prodn., protein kinase activity, and angiogenic signaling.  A close analog was evaluated in preclin. in vivo models of rheumatoid arthritis (RA).  SNX-7081 binding to Hsp90 was characterized in Jurkat cells and RA synovial fibroblasts (RASFs).  Inhibition of NF-κB nuclear translocation was evaluated in cellular systems, using lipopolysaccharide (LPS), tumor necrosis factor α, or interleukin-1β stimulation.  Suppression of cytokine prodn. in THP-1 cells, human umbilical vein endothelial cells, and RASFs was studied.  Disruption of MAPK signaling cascades by SNX-7081 following growth factor stimulation was assessed.  SNX-7081 was tested in 2 relevant angiogenesis assays: platelet-derived growth factor activation of fibroblasts and LPS-induced nitric oxide (NO) release in J774 macrophages.  A close analog, SNX-4414, was evaluated in rat collagen-induced arthritis and adjuvant-induced arthritis, following oral treatment.  SNX-7081 showed strong binding affinity to Hsp90 and expected induction of Hsp70.  NF-κB nuclear translocation was blocked by SNX-7081 at nanomolar concns., and cytokine prodn. was potently inhibited.  Growth factor activation of ERK and JNK signaling was significantly reduced by SNX-7081.  NO prodn. was also sharply inhibited.  In animal models, SNX-4414 fully inhibited paw swelling and improved body wt.  Scores for inflammation, pannus formation, cartilage damage, and bone resorption returned to normal.  The present results demonstrate that a small mol. Hsp90 inhibitor can impact inflammatory disease processes.  The strong in vivo efficacy obsd. with SNX-4414 provides preclin. validation for consideration of Hsp90 inhibitors in the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoT2siTMpu4rVg90H21EOLACvtfcHk0lhQscrcxXjJIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1ymtQ%253D%253D&md5=e3124416877b1c1d0de898eb2fd05da1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fart.24047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24047%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DMabbett%26aufirst%3DS.%2BR.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520hsp90%2520potently%2520affect%2520inflammatory%2520disease%2520pathways%2520and%2520exhibit%2520activity%2520in%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3765%26epage%3D3775%26doi%3D10.1002%2Fart.24047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yun, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harning, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giza, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabah, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehry, M. R.</span></span> <span> </span><span class="NLM_article-title">Ec144, a Synthetic Inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1000222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.4049%2Fjimmunol.1000222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21131419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FlsFOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=563-575&author=T.+J.+Yunauthor=E.+K.+Harningauthor=K.+Gizaauthor=D.+Rabahauthor=P.+Liauthor=J.+W.+Arndtauthor=D.+Luchettiauthor=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Lundgrenauthor=A.+Manningauthor=M.+R.+Kehry&title=Ec144%2C+a+Synthetic+Inhibitor+of+heat+shock+protein+90%2C+blocks+innate+and+adaptive+immune+responses+in+models+of+inflammation+and+autoimmunity&doi=10.4049%2Fjimmunol.1000222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity</span></div><div class="casAuthors">Yun Theodore J; Harning Erin K; Giza Keith; Rabah Dania; Li Ping; Arndt Joseph W; Luchetti David; Biamonte Marco A; Shi Jiandong; Lundgren Karen; Manning Anthony; Kehry Marilyn R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology (Baltimore, Md. : 1950)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">563-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a molecular chaperone involved in folding and stabilizing multiple intracellular proteins that have roles in cell activation and proliferation.  Many Hsp90 client proteins in tumor cells are mutated or overexpressed oncogenic proteins driving cancer cell growth, leading to the acceptance of Hsp90 as a potential therapeutic target for cancer.  Because several signal transduction molecules that are dependent on Hsp90 function are also involved in activation of innate and adaptive cells of the immune system, we investigated the mechanism by which inhibiting Hsp90 leads to therapeutic efficacy in rodent models of inflammation and autoimmunity.  EC144, a synthetic Hsp90 inhibitor, blocked LPS-induced TLR4 signaling in RAW 264.7 cells by inhibiting activation of ERK1/2, MEK1/2, JNK, and p38 MAPK but not NF-κB.  Ex vivo LPS-stimulated CD11b(+) peritoneal exudate cells from EC144-treated mice were blocked from phosphorylating tumor progression locus 2, MEK1/2, and ERK1/2.  Consequently, EC144-treated mice were resistant to LPS administration and had suppressed systemic TNF-α release.  Inhibiting Hsp90 also blocked in vitro CD4(+) T cell proliferation in mouse and human MLRs.  In vivo, semitherapeutic administration of EC144 blocked disease development in rat collagen-induced arthritis by suppressing the inflammatory response.  In a mouse collagen-induced arthritis model, EC144 also suppressed disease development, which correlated with a suppressed Ag-specific Ab response and a block in activation of Ag-specific CD4(+) T cells.  Our results describe mechanisms by which blocking Hsp90 function may be applicable to treatment of autoimmune diseases involving inflammation and activation of the adaptive immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTM1FYqPTUL0RFwe7cAcrfPfW6udTcc2eawC_U_RXYAhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FlsFOltw%253D%253D&md5=19230b0d2d8e5580313a3047dffc9ccc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1000222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1000222%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DT.%2BJ.%26aulast%3DHarning%26aufirst%3DE.%2BK.%26aulast%3DGiza%26aufirst%3DK.%26aulast%3DRabah%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DLuchetti%26aufirst%3DD.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DManning%26aufirst%3DA.%26aulast%3DKehry%26aufirst%3DM.%2BR.%26atitle%3DEc144%252C%2520a%2520Synthetic%2520Inhibitor%2520of%2520heat%2520shock%2520protein%252090%252C%2520blocks%2520innate%2520and%2520adaptive%2520immune%2520responses%2520in%2520models%2520of%2520inflammation%2520and%2520autoimmunity%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D563%26epage%3D575%26doi%3D10.4049%2Fjimmunol.1000222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimp, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafin, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regna, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caudell, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rylander, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, C. M.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90 inhibition by 17-dmag lessens disease in the mrl/lpr mouse model of systemic lupus erythematosus</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1038/cmi.2012.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fcmi.2012.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22543833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVehu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=255-266&author=S.+K.+Shimpauthor=C.+B.+Chafinauthor=N.+L.+Regnaauthor=S.+E.+Hammondauthor=M.+A.+Readauthor=D.+L.+Caudellauthor=M.+N.+Rylanderauthor=C.+M.+Reilly&title=Heat+shock+protein+90+inhibition+by+17-dmag+lessens+disease+in+the+mrl%2Flpr+mouse+model+of+systemic+lupus+erythematosus&doi=10.1038%2Fcmi.2012.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus</span></div><div class="casAuthors">Shimp, Samuel K, III; Chafin, Cristen B.; Regna, Nicole L.; Hammond, Sarah E.; Read, Molly A.; Caudell, David L.; Rylander, Marissa Nichole; Reilly, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Elevated expression of heat shock protein 90 (HSP90) has been found in kidneys and serum of systemic lupus erythematosus (SLE) patients and MRL/Mp-Faslpr/Faslpr (MRL/lpr) autoimmune mice.  We investigated if inhibition of HSP90 would reduce disease in MRL/lpr mice.  In vitro, pretreatment of mesangial cells with HSP90 inhibitor Geldanamycin prior to immune-stimulation showed reduced expression of IL-6, IL-12 and NO.  In vivo, we found HSP90 expression was elevated in MRL/lpr kidneys when compared to C57BL/6 mice and MRL/lpr mice treated with HSP90 inhibitor 17-DMAG.  MRL/lpr mice treated with 17-DMAG showed decreased proteinuria and reduced serum anti-dsDNA antibody prodn.  Glomerulonephritis and glomerular IgG and C3 were not significantly affected by administration of 17-DMAG in MRL/lpr. 17-DMAG increased CD8+ T cells, reduced double-neg. T cells, decreased the CD4/CD8 ratio and reduced follicular B cells.  These studies suggest that HSP90 may play a role in regulating T-cell differentiation and activation and that HSP90 inhibition may reduce inflammation in lupus.  Cellular & Mol. Immunol. (2012) 9, 255-266; doi:10.1038/cmi.2012.5; published online 30 Apr. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdlmMkrB3mD7Vg90H21EOLACvtfcHk0lhQscrcxXjJIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVehu78%253D&md5=e8bbe0724fc1fa9c2725845dfb716bc5</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2012.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2012.5%26sid%3Dliteratum%253Aachs%26aulast%3DShimp%26aufirst%3DS.%2BK.%26aulast%3DChafin%26aufirst%3DC.%2BB.%26aulast%3DRegna%26aufirst%3DN.%2BL.%26aulast%3DHammond%26aufirst%3DS.%2BE.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DCaudell%26aufirst%3DD.%2BL.%26aulast%3DRylander%26aufirst%3DM.%2BN.%26aulast%3DReilly%26aufirst%3DC.%2BM.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibition%2520by%252017-dmag%2520lessens%2520disease%2520in%2520the%2520mrl%252Flpr%2520mouse%2520model%2520of%2520systemic%2520lupus%2520erythematosus%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2012%26volume%3D9%26spage%3D255%26epage%3D266%26doi%3D10.1038%2Fcmi.2012.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasperkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somlai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zillikens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orosz, A.</span></span> <span> </span><span class="NLM_article-title">Heat-shock protein 90 inhibition in autoimmunity to type vii collagen: evidence that nonmalignant plasma cells are not therapeutic targets</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">6135</span>– <span class="NLM_lpage">6142</span>, <span class="refDoi"> DOI: 10.1182/blood-2010-10-314609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1182%2Fblood-2010-10-314609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21490339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=6135-6142&author=M.+Kasperkiewiczauthor=R.+Mullerauthor=R.+Manzauthor=M.+Magensauthor=C.+M.+Hammersauthor=C.+Somlaiauthor=J.+Westermannauthor=E.+Schmidtauthor=D.+Zillikensauthor=R.+J.+Ludwigauthor=A.+Orosz&title=Heat-shock+protein+90+inhibition+in+autoimmunity+to+type+vii+collagen%3A+evidence+that+nonmalignant+plasma+cells+are+not+therapeutic+targets&doi=10.1182%2Fblood-2010-10-314609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets</span></div><div class="casAuthors">Kasperkiewicz, Michael; Mueller, Ralf; Manz, Rudolf; Magens, Moritz; Hammers, Christoph M.; Somlai, Csaba; Westermann, Juergen; Schmidt, Enno; Zillikens, Detlef; Ludwig, Ralf J.; Orosz, Antal</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6135-6142</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Blocking heat-shock protein 90 (Hsp90) induces death of malignant plasma cells by activation of the unfolded protein response, a signaling pathway activated by accumulation of misfolded proteins within the endoplasmic reticulum.  We hypothesized that nontransformed plasma cells are also hypersensitive to Hsp90 inhibition because of their high amt. of protein biosynthesis.  To investigate this hypothesis, 2 different Hsp90 inhibitors, the geldanamycin deriv. 17-DMAG and the nontoxic peptide deriv. TCBL-145, were applied to mice with exptl. epidermolysis bullosa acquisita, an autoimmune bullous disease characterized by autoantibodies against type VII collagen of the dermal-epidermal junction.  Both inhibitors ameliorated clin. disease of type VII collagen-immunized mice, suppressed auto-antibody prodn., and reduced dermal neutrophilic infiltrate.  Interestingly, total plasma cell nos., type VII collagen-specific plasma cells, and germinal center B cells were unaffected by anti-Hsp90 treatment in vivo.  However, T-cell proliferation was potently inhibited, as evidenced by the reduced response of isolated lymph node cells from immunized mice to in vitro restimulation with anti-CD3/CD28 antibody or autoantigen in the presence of Hsp90 inhibitors.  Our results suggest that Hsp90 blockade has no impact on normal or autoreactive plasma cells in vivo and identify T cells as targets of anti-Hsp90 treatment in autoimmunity to type VII collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTOT9rHH0PdbVg90H21EOLACvtfcHk0lhMv2W9XAD-1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVyhsrg%253D&md5=b95d5427d0e23dbdcd72e67f448b9cea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-10-314609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-10-314609%26sid%3Dliteratum%253Aachs%26aulast%3DKasperkiewicz%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DR.%26aulast%3DManz%26aufirst%3DR.%26aulast%3DMagens%26aufirst%3DM.%26aulast%3DHammers%26aufirst%3DC.%2BM.%26aulast%3DSomlai%26aufirst%3DC.%26aulast%3DWestermann%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DZillikens%26aufirst%3DD.%26aulast%3DLudwig%26aufirst%3DR.%2BJ.%26aulast%3DOrosz%26aufirst%3DA.%26atitle%3DHeat-shock%2520protein%252090%2520inhibition%2520in%2520autoimmunity%2520to%2520type%2520vii%2520collagen%253A%2520evidence%2520that%2520nonmalignant%2520plasma%2520cells%2520are%2520not%2520therapeutic%2520targets%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D6135%26epage%3D6142%26doi%3D10.1182%2Fblood-2010-10-314609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Essential roles of grp94 in gut homeostasis via chaperoning canonical wnt pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6877</span>– <span class="NLM_lpage">6882</span>, <span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+grp94+in+gut+homeostasis+via+chaperoning+canonical+wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0lhMv2W9XAD-1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent grp94 selective inhibitor with anti-inflammatory efficacy in a mouse model of ulcerative colitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9513</span>– <span class="NLM_lpage">9533</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00800</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00800" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSrtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9513-9533&author=F.+Jiangauthor=A.+P.+Guoauthor=J.+C.+Xuauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Discovery+of+a+potent+grp94+selective+inhibitor+with+anti-inflammatory+efficacy+in+a+mouse+model+of+ulcerative+colitis&doi=10.1021%2Facs.jmedchem.8b00800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis</span></div><div class="casAuthors">Jiang, Fen; Guo, An-ping; Xu, Jia-chen; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9513-9533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As the endoplasmic reticulum paralog of Hsp90, Grp94 chaperones a small set of client proteins assocd. with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disorders.  Grp94-selective inhibition has been a potential therapeutic strategy for these diseases.  In this study, inspired by the conclusion that ligand-induced "Phe199 shift" effect is the structural basis of Grp94-selective inhibition, a series of novel Grp94 selective inhibitors incorporating "benzamide" moiety were developed, among which compd. I manifested the most potent Grp94 inhibitory activity with an IC50 value of 2 nM and over 1000-fold selectivity to Grp94 against Hsp90α.  In a DSS-induced mouse model of ulcerative colitis (UC), compd. I exhibited significant anti-inflammatory efficacy.  This work provides a potent Grp94 selective inhibitor as probe compd. for the biol. study of Grp94 and represents the first study that confirms the potential therapeutic efficacy of Grp94-selective inhibitors against UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSPk6ORrsg7bVg90H21EOLACvtfcHk0lhMv2W9XAD-1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSrtr7F&md5=65fa429395e1d57fc8bd6e5c51f52ccb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00800%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DA.%2BP.%26aulast%3DXu%26aufirst%3DJ.%2BC.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520grp94%2520selective%2520inhibitor%2520with%2520anti-inflammatory%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520ulcerative%2520colitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9513%26epage%3D9533%26doi%3D10.1021%2Facs.jmedchem.8b00800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobue, G.</span></span> <span> </span><span class="NLM_article-title">Modulation of hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1007/s00109-006-0066-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs00109-006-0066-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16741751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsVOku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=635-646&author=M.+Wazaauthor=H.+Adachiauthor=M.+Katsunoauthor=M.+Minamiyamaauthor=F.+Tanakaauthor=M.+Doyuauthor=G.+Sobue&title=Modulation+of+hsp90+function+in+neurodegenerative+disorders%3A+a+molecular-targeted+therapy+against+disease-causing+protein&doi=10.1007%2Fs00109-006-0066-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein</span></div><div class="casAuthors">Waza, Masahiro; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Tanaka, Fumiaki; Doyu, Manabu; Sobue, Gen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">635-646</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abnormal accumulation of disease-causing protein is a commonly obsd. characteristic in chronic neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and polyglutamine (polyQ) diseases.  A therapeutic approach that could selectively eliminate would be a promising remedy for neurodegenerative disorders.  Spinal and bulbar muscular atrophy (SBMA), one of the polyQ diseases, is a late-onset motor neuron disease characterized by proximal muscle atrophy, weakness, contraction fasciculations, and bulbar involvement.  The pathogenic gene product is polyQ-expanded androgen receptor (AR), which belongs to the heat shock protein (Hsp) 90 client protein family. 17-Allylamino-17-demethoxygeldanamycin (17-AAG), a novel Hsp90 inhibitor, is a new deriv. of geldanamycin that shares its important biol. activities but shows less toxicity. 17-AAG is now in phase II clin. trials as a potential anti-cancer agent because of its ability to selectively degrade several oncoproteins.  We have recently demonstrated the efficacy and safety of 17-AAG in a mouse model of SBMA.  The administration of 17-AAG significantly ameliorated polyQ-mediated motor neuron degeneration by reducing the total amt. of mutant AR. 17-AAG accomplished the preferential redn. of mutant AR mainly through Hsp90 chaperone complex formation and subsequent proteasome-dependent degrdn. 17-AAG induced Hsp70 and Hsp40 in vivo as previously reported; however, its ability to induce HSPs was limited, suggesting that the HSP induction might support the degrdn. of mutant protein.  The ability of 17-AAG to preferentially degrade mutant protein would be directly applicable to SBMA and other neurodegenerative diseases in which the disease-causing proteins also belong to the Hsp90 client protein family.  Our proposed therapeutic approach, modulation of Hsp90 function by 17-AAG treatment, has emerged as a candidate for mol.-targeted therapies for neurodegenerative diseases.  This review will consider our research findings and discuss the possibility of a clin. application of 17-AAG to SBMA and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFRiB_ordSLVg90H21EOLACvtfcHk0lh8Eg5GXIQzyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsVOku7k%253D&md5=c31a683263c9493c53aa448c8ea32682</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00109-006-0066-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-006-0066-0%26sid%3Dliteratum%253Aachs%26aulast%3DWaza%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DH.%26aulast%3DKatsuno%26aufirst%3DM.%26aulast%3DMinamiyama%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DF.%26aulast%3DDoyu%26aufirst%3DM.%26aulast%3DSobue%26aufirst%3DG.%26atitle%3DModulation%2520of%2520hsp90%2520function%2520in%2520neurodegenerative%2520disorders%253A%2520a%2520molecular-targeted%2520therapy%2520against%2520disease-causing%2520protein%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2006%26volume%3D84%26spage%3D635%26epage%3D646%26doi%3D10.1007%2Fs00109-006-0066-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, F. F.</span></span> <span> </span><span class="NLM_article-title">Hsp90 chaperone inhibitor 17-aag attenuates abeta-induced synaptic toxicity and memory impairment</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2464</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0151-13.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1523%2FJNEUROSCI.0151-13.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24523537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlSgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=2464-2470&author=Y.+Chenauthor=B.+Wangauthor=D.+Liuauthor=J.+J.+Liauthor=Y.+Xueauthor=K.+Sakataauthor=L.+Q.+Zhuauthor=S.+A.+Heldtauthor=H.+Xuauthor=F.+F.+Liao&title=Hsp90+chaperone+inhibitor+17-aag+attenuates+abeta-induced+synaptic+toxicity+and+memory+impairment&doi=10.1523%2FJNEUROSCI.0151-13.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment</span></div><div class="casAuthors">Chen, Yaomin; Wang, Bin; Liu, Dan; Li, Jing Jing; Xue, Yueqiang; Sakata, Kazuko; Zhu, Ling-qiang; Heldt, Scott A.; Xu, Huaxi; Liao, Francesca-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2464-2470</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The excessive accumulation of sol. amyloid peptides (Aβ) plays a crucial role in the pathogenesis of Alzheimer's disease (AD), particularly in synaptic dysfunction.  The role of the two major chaperone proteins, Hsp70 and Hsp90, in clearing misfolded protein aggregates has been established.  Despite their abundant presence in synapses, the role of these chaperones in synapses remains elusive.  Here, we report that Hsp90 inhibition by 17-AAG elicited not only a heat shock-like response but also upregulated presynaptic and postsynaptic proteins, such as synapsin I, synaptophysin, and PSD95 in neurons.  17-AAG treatment enhanced high-frequency stimulation-evoked LTP and protected neurons from synaptic damage induced by sol. Aβ.  In AD transgenic mice, the daily administration of 17-AAG over 7 d resulted in a marked increase in PSD95 expression in hippocampi.  17-AAG treatments in wild-type C57BL/6 mice challenged by sol. Aβ significantly improved contextual fear memory.  Further, we demonstrate that 17-AAG activated synaptic protein expression via transcriptional mechanisms through the heat shock transcription factor HSF1.  Together, our findings identify a novel function of Hsp90 inhibition in regulating synaptic plasticity, in addn. to the known neuroprotective effects of the chaperones against Aβ and tau toxicity, thus further supporting the potential of Hsp90 inhibitors in treating neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXRaZEOCysLVg90H21EOLACvtfcHk0lh8Eg5GXIQzyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlSgsLc%253D&md5=44657c9c1d4f1c53484e010110e2597b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0151-13.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0151-13.2014%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DL.%2BQ.%26aulast%3DHeldt%26aufirst%3DS.%2BA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DF.%2BF.%26atitle%3DHsp90%2520chaperone%2520inhibitor%252017-aag%2520attenuates%2520abeta-induced%2520synaptic%2520toxicity%2520and%2520memory%2520impairment%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D2464%26epage%3D2470%26doi%3D10.1523%2FJNEUROSCI.0151-13.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span> <span> </span><span class="NLM_article-title">Tau in alzheimer disease and related tauopathies</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.2174/156720510793611592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F156720510793611592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20678074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1OgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=656-664&author=K.+Iqbalauthor=F.+Liuauthor=C.+X.+Gongauthor=I.+Grundke-Iqbal&title=Tau+in+alzheimer+disease+and+related+tauopathies&doi=10.2174%2F156720510793611592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tau in Alzheimer disease and related tauopathies</span></div><div class="casAuthors">Iqbal, K.; Liu, F.; Gong, C.-X.; Grundke-Iqbal, I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">656-664</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tau is the major microtubule assocd. protein (MAP) of a mature neuron.  The other two neuronal MAPs are MAP1 and MAP2.  An established function of MAPs is their interaction with tubulin and promotion of its assembly into microtubules and stabilization of the microtubule network.  The microtubule assembly promoting activity of tau, a phosphoprotein, is regulated by its degree of phosphorylation.  Normal adult human brain tau contains 2-3 mol phosphate/mol of tau protein.  Hyperphosphorylation of tau depresses this biol. activity of tau.  In Alzheimer disease (AD) brain tau is ∼three to four-fold more hyperphosphorylated than the normal adult brain tau and in this hyperphosphorylated state it is polymd. into paired helical filaments (PHF) admixed with straight filaments (SF) forming neurofibrillary tangles.  Tau is transiently hyperphosphorylated during development and during anesthesia and hypothermia but not to the same state as in AD brain.  The abnormally hyperphosphorylated tau in AD brain is distinguished from transiently hyperphosphorylated tau by its ability (1) to sequester normal tau, MAP1 and MAP2 and disrupt microtubules, and (2) to self-assemble into PHF/SF.  The cytosolic abnormally hyperphosphorylated tau, because of oligomerization, unlike normal tau, is sedimentable and on self-assembly into PHF/SF, loses its ability to sequester normal MAPs.  Some of the tau in AD brain is truncated which also promotes its self-assembly.  Tau mutations found in frontotemporal dementia apparently promote its abnormal hyperphosphorylation.  Thus, the AD abnormally hyperphosphorylated tau (1) is distinguishable from both normal and transiently hyperphosphorylated taus, and (2) is inhibitory when in a cytosolic/oligomeric state but not when it is self-assembled into PHF/SF.  Inhibition of abnormal hyperphosphorylation of tau offers a promising therapeutic target for AD and related tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzxgsQADKErbVg90H21EOLACvtfcHk0lh8Eg5GXIQzyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1OgtA%253D%253D&md5=0df16b447f8fc5894b84605262d2fcc1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F156720510793611592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720510793611592%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26atitle%3DTau%2520in%2520alzheimer%2520disease%2520and%2520related%2520tauopathies%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2010%26volume%3D7%26spage%3D656%26epage%3D664%26doi%3D10.2174%2F156720510793611592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chip, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulick, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">9511</span>– <span class="NLM_lpage">9516</span>, <span class="refDoi"> DOI: 10.1073/pnas.0701055104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.0701055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17517623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=9511-9516&author=W.+J.+Luoauthor=F.+Douauthor=A.+Rodinaauthor=S.+Chipauthor=J.+Kimauthor=Q.+Zhaoauthor=K.+Moulickauthor=J.+Aguirreauthor=N.+Wuauthor=P.+Greengardauthor=G.+Chiosis&title=Roles+of+heat-shock+protein+90+in+maintaining+and+facilitating+the+neurodegenerative+phenotype+in+tauopathies&doi=10.1073%2Fpnas.0701055104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies</span></div><div class="casAuthors">Luo, Wenjie; Dou, Fei; Rodina, Anna; Chip, Sophorn; Kim, Joungnam; Zhao, Qi; Moulick, Kamalika; Aguirre, Julia; Wu, Nian; Greengard, Paul; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9511-9516</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neurodegeneration, a result of multiple dysregulatory events, is a lengthy multistep process manifested by accrual of mutant variants and abnormal expression, posttranslational modification, and processing of certain proteins.  Accumulation of these dysregulated processes requires a mechanism that maintains their functional stability and allows the evolution of the neurodegenerative phenotype.  In malignant cells, the capacity to buffer transformation has been attributed to heat-shock protein 90 (Hsp90).  Although normal proteins seem to require limited assistance from the chaperone, their aberrant counterparts seem to be highly dependent on Hsp90.  Whereas enhanced Hsp90 affinity for mutated or functionally deregulated client proteins has been obsd. for several oncoproteins, it is unknown whether Hsp90 plays a similar role for neuronal proteins and thus maintains and facilitates the transformed phenotype in neurodegenerative diseases.  Tauopathies are neurodegenerative diseases characterized by aberrant phosphorylation and/or expression of Tau protein, leading to a time-dependent accumulation of Tau aggregates and subsequent neuronal death.  Here, we show that the stability of p35, a neuronal protein that activates cyclin-dependent protein kinase 5 through complex formation leading to aberrant Tau phosphorylation, and that of mutant but not WT Tau protein is maintained in tauopathies by Hsp90.  Inhibition of Hsp90 in cellular and mouse models of tauopathies leads to a redn. of the pathogenic activity of these proteins and results in elimination of aggregated Tau.  The results identify important roles played by Hsp90 in maintaining and facilitating the degenerative phenotype in these diseases and provide a common principle governing cancer and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCkJP_DiSK7Vg90H21EOLACvtfcHk0lgYJNWRZnnStQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlGqsr4%253D&md5=232a72b98067db9340561258ebb6fcb8</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701055104%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%2BJ.%26aulast%3DDou%26aufirst%3DF.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChip%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DRoles%2520of%2520heat-shock%2520protein%252090%2520in%2520maintaining%2520and%2520facilitating%2520the%2520neurodegenerative%2520phenotype%2520in%2520tauopathies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D9511%26epage%3D9516%26doi%3D10.1073%2Fpnas.0701055104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blair, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span> <span> </span><span class="NLM_article-title">Targeting hsp90 and its co-chaperones to treat alzheimer’s disease</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.943185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1517%2F14728222.2014.943185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25069659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=1219-1232&author=L.+J.+Blairauthor=J.+J.+Sabbaghauthor=C.+A.+Dickey&title=Targeting+hsp90+and+its+co-chaperones+to+treat+alzheimer%E2%80%99s+disease&doi=10.1517%2F14728222.2014.943185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease</span></div><div class="casAuthors">Blair, Laura J.; Sabbagh, Jonathan J.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1219-1232</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Alzheimer's disease, characterized by the accumulation of hyperphosphorylated tau and β amyloid (Aβ), currently lacks effective treatment.  Chaperone proteins, such as the heat shock protein (Hsp) 90, form macromol. complexes with co-chaperones, which can regulate tau metab. and Aβ processing.  Although small mol. inhibitors of Hsp90 have been successful at ameliorating tau and Aβ burden, their development into drugs to treat disease has been slow due to the off- and on-target effects of this approach as well as challenges with the pharmacol. of current scaffolds.  Thus, other approaches are being developed to improve these compds. and to target co-chaperones of Hsp90 in an effort to limit these liabilities.  This article discusses the most current developments in Hsp90 inhibitors including advances in blood-brain barrier permeability, decreased toxicity and homolog-specific small-mol. inhibitors.  In addn., we discuss current strategies targeting Hsp90 co-chaperones rather than Hsp90 itself to reduce off-target effects.  Although Hsp90 inhibitors have proven their efficacy at reducing tau pathol., they have yet to meet with success in the clinic.  The development of Hsp90/tau complex-specific inhibitors and further development of Hsp90 co-chaperone-specific drugs should yield more potent, less toxic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwfgbwFb4NDrVg90H21EOLACvtfcHk0lgYJNWRZnnStQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N&md5=e45b44478254d5872c355fec4e32c9d4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.943185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.943185%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DL.%2BJ.%26aulast%3DSabbagh%26aufirst%3DJ.%2BJ.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520hsp90%2520and%2520its%2520co-chaperones%2520to%2520treat%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D1219%26epage%3D1232%26doi%3D10.1517%2F14728222.2014.943185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bukong, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momen-Heravi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodys, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, G.</span></span> <span> </span><span class="NLM_article-title">Exosomes from hepatitis c infected patients transmit hcv infection and contain replication competent viral rna in complex with ago2-mir122-hsp90</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e1004424</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1004424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1371%2Fjournal.ppat.1004424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25275643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKjs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1004424&author=T.+N.+Bukongauthor=F.+Momen-Heraviauthor=K.+Kodysauthor=S.+Balaauthor=G.+Szabo&title=Exosomes+from+hepatitis+c+infected+patients+transmit+hcv+infection+and+contain+replication+competent+viral+rna+in+complex+with+ago2-mir122-hsp90&doi=10.1371%2Fjournal.ppat.1004424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90</span></div><div class="casAuthors">Bukong, Terence N.; Momen-Heravi, Fatemeh; Kodys, Karen; Bala, Shashi; Szabo, Gyongyi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1004424/1-e1004424/20, 20 pp.</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Antibodies targeting receptor-mediated entry of HCV into hepatocytes confer limited therapeutic benefits.  Evidence suggests that exosomes can transfer genetic materials between cells; however, their role in HCV infection remains obscure.  Here, we show that exosomes isolated from sera of chronic HCV infected patients or supernatants of J6/JFH1-HCV-infected Huh7.5 cells contained HCV RNA.  These exosomes could mediate viral receptor-independent transmission of HCV to hepatocytes.  Neg. sense HCV RNA, indicative of replication competent viral RNA, was present in exosomes of all HCV infected treatment non-responders and some treatment-naive individuals.  Remarkably, HCV RNA was assocd. with Ago2, HSP90 and miR-122 in exosomes isolated from HCV-infected individuals or HCV-infected Huh7.5 cell supernatants.  Exosome-loading with a miR-122 inhibitor, or inhibition of HSP90, vacuolar H+-ATPases and proton pumps, significantly suppressed exosome-mediated HCV transmission to naive cells.  Our findings provide mechanistic evidence for HCV transmission by blood-derived exosomes and highlight potential therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9qlrNznUocrVg90H21EOLACvtfcHk0lgYJNWRZnnStQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKjs7jP&md5=bc46fff89c6227d7e794082819389c3e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004424%26sid%3Dliteratum%253Aachs%26aulast%3DBukong%26aufirst%3DT.%2BN.%26aulast%3DMomen-Heravi%26aufirst%3DF.%26aulast%3DKodys%26aufirst%3DK.%26aulast%3DBala%26aufirst%3DS.%26aulast%3DSzabo%26aufirst%3DG.%26atitle%3DExosomes%2520from%2520hepatitis%2520c%2520infected%2520patients%2520transmit%2520hcv%2520infection%2520and%2520contain%2520replication%2520competent%2520viral%2520rna%2520in%2520complex%2520with%2520ago2-mir122-hsp90%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26spage%3De1004424%26doi%3D10.1371%2Fjournal.ppat.1004424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braga, A. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinaga, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahal, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hepatitis c virus using sirna targeted to the virus and hsp90</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1007/s12192-016-0747-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs12192-016-0747-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27858224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2nsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=113-122&author=A.+C.+S.+Bragaauthor=B.+M.+Carneiroauthor=M.+N.+Batistaauthor=M.+M.+Akinagaauthor=P.+Rahal&title=Inhibition+of+hepatitis+c+virus+using+sirna+targeted+to+the+virus+and+hsp90&doi=10.1007%2Fs12192-016-0747-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90</span></div><div class="casAuthors">Braga, Ana Claudia Silva; Carneiro, Bruno Moreira; Batista, Mariana Nogueira; Akinaga, Monica Mayumi; Rahal, Paula</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-122</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Hepatitis C (HCV) is a viral disease affecting millions of people worldwide, and persistent HCV infection can lead to progressive liver disease with the development of liver cirrhosis and hepatocellular carcinoma.  During treatment for hepatitis C, the occurrence of viral resistance is common.  To reduce the occurrence of resistance, new viral treatments should target both viral and cellular factors.  Many interactions occur between viral and host proteins during the HCV replication cycle and might be used for the development of new therapies against hepatitis C.  Heat shock protein 90 (Hsp90) plays a role in the folding of cellular and viral proteins and also interacts with HCV proteins.  In the present study, we knocked down the expression of the Hsp90 gene and inhibited viral replication using siRNA mols.  Reducing the expression of Hsp90 successfully decreased HCV replication.  All siRNA mols. specific to the viral genome showed the efficient inhibition of viral replication, particularly siRNA targeted to the 5'UTR region.  The combination of siRNAs targeting the viral genome and Hsp90 mRNA also successfully reduced HCV replication and reduced the occurrence of viral resistance.  Moreover, these results suggest that an approach based on the combination of cellular and viral siRNAs can be used as an effective alternative for hepatitis C viral suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8TD9X35InEbVg90H21EOLACvtfcHk0ljRuu6ZsOwZeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2nsbnO&md5=7960f2169c1fbb19ed8560bebfc6d47e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs12192-016-0747-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-016-0747-8%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DA.%2BC.%2BS.%26aulast%3DCarneiro%26aufirst%3DB.%2BM.%26aulast%3DBatista%26aufirst%3DM.%2BN.%26aulast%3DAkinaga%26aufirst%3DM.%2BM.%26aulast%3DRahal%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520hepatitis%2520c%2520virus%2520using%2520sirna%2520targeted%2520to%2520the%2520virus%2520and%2520hsp90%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2017%26volume%3D22%26spage%3D113%26epage%3D122%26doi%3D10.1007%2Fs12192-016-0747-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umehara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, M.</span></span> <span> </span><span class="NLM_article-title">Hsp90 inhibitors suppress hcv replication in replicon cells and humanized liver mice</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.12.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bbrc.2006.12.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17196931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVarsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2007&pages=882-888&author=S.+Nakagawaauthor=T.+Umeharaauthor=C.+Matsudaauthor=S.+Kugeauthor=M.+Sudohauthor=M.+Kohara&title=Hsp90+inhibitors+suppress+hcv+replication+in+replicon+cells+and+humanized+liver+mice&doi=10.1016%2Fj.bbrc.2006.12.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice</span></div><div class="casAuthors">Nakagawa, Shin-ichiro; Umehara, Takuya; Matsuda, Chiho; Kuge, Shusuke; Sudoh, Masayuki; Kohara, Michinori</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">882-888</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Persistent infection with hepatitis C virus (HCV) is a major cause of liver diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.  Here we report that inhibition of heat shock protein 90 (Hsp90) is highly effective in suppressing HCV genome replication.  In HCV replicon cells, HCV replication was reduced by Hsp90 inhibitors and by knockdown of endogenous Hsp90 expression mediated by small-interfering RNA (siRNA).  The suppression of HCV replication by an Hsp90 inhibitor was prevented by transfection with Hsp90 expression vector.  We also tested the anti-HCV effect of Hsp90 inhibition in HCV-infected chimeric mice with humanized liver.  Combined administration of an Hsp90 inhibitor and polyethylene glycol-conjugated interferon (PEG-IFN) was more effective in reducing HCV genome RNA levels in serum than was PEG-IFN monotherapy.  These results suggest that inhibition of Hsp90 could provide a new therapeutic approach to HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5RCgsdWI0bVg90H21EOLACvtfcHk0ljRuu6ZsOwZeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVarsg%253D%253D&md5=2b854778960c3929cd42117446e6f44b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.12.117%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DC.%26aulast%3DKuge%26aufirst%3DS.%26aulast%3DSudoh%26aufirst%3DM.%26aulast%3DKohara%26aufirst%3DM.%26atitle%3DHsp90%2520inhibitors%2520suppress%2520hcv%2520replication%2520in%2520replicon%2520cells%2520and%2520humanized%2520liver%2520mice%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D353%26spage%3D882%26epage%3D888%26doi%3D10.1016%2Fj.bbrc.2006.12.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maidji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, C. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of heat shock protein 90 prevents hiv rebound</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">10332</span>– <span class="NLM_lpage">10346</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.717538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M116.717538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26957545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xntlylt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=10332-10346&author=P.+Joshiauthor=E.+Maidjiauthor=C.+A.+Stoddart&title=Inhibition+of+heat+shock+protein+90+prevents+hiv+rebound&doi=10.1074%2Fjbc.M116.717538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Heat Shock Protein 90 Prevents HIV Rebound</span></div><div class="casAuthors">Joshi, Pheroze; Maidji, Ekaterina; Stoddart, Cheryl A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10332-10346</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">HIV evades eradication because transcriptionally dormant proviral genomes persist in long-lived reservoirs of resting CD4+ T cells and myeloid cells, which are the source of viral rebound after cessation of antiretroviral therapy.  Dormant HIV genomes readily produce infectious virus upon cellular activation because host transcription factors activated specifically by cell stress and heat shock mediate full-length HIV transcription.  The mol. chaperone heat shock protein 90 (Hsp90) is overexpressed during heat shock and activates inducible cellular transcription factors.  Heat shock accelerates HIV transcription through induction of Hsp90 activity, which activates essential HIV-specific cellular transcription factors (NF-κB, NFAT, and STAT5), and that inhibition of Hsp90 greatly reduces gene expression mediated by these factors.  More importantly, the authors show that Hsp90 controls virus transcription in vivo by specific Hsp90 inhibitors in clin. development, tanespimycin (17-(allylamino)-17-demethoxygeldanamycin) and AUY922, which durably prevented viral rebound in HIV-infected humanized NOD scid IL-2Rγ-/- bone marrow-liver-thymus mice up to 11 wk after treatment cessation.  Despite the absence of rebound viremia, the authors were able to recover infectious HIV from PBMC with heat shock.  Replication-competent virus was detected in spleen cells from these nonviremic Hsp90 inhibitor-treated mice, indicating the presence of a tissue reservoir of persistent infection.  The authors' novel findings provide in vivo evidence that inhibition of Hsp90 activity prevents HIV gene expression in replication-competent cellular reservoirs that would typically cause rebound in plasma viremia after antiretroviral therapy cessation.  Alternating or supplementing Hsp90 inhibitors with current antiretroviral therapy regimens could conceivably suppress rebound viremia from persistent HIV reservoirs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Yqtp1bZiQ7Vg90H21EOLACvtfcHk0ljRuu6ZsOwZeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xntlylt7Y%253D&md5=e7f7bdd1595bdca45ea85a795df8a91a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.717538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.717538%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DMaidji%26aufirst%3DE.%26aulast%3DStoddart%26aufirst%3DC.%2BA.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%252090%2520prevents%2520hiv%2520rebound%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D10332%26epage%3D10346%26doi%3D10.1074%2Fjbc.M116.717538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vashist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Hernandez, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Rougemont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha-Pereira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wobus, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, I.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperone hsp90 is a therapeutic target for noroviruses</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">6352</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1128/JVI.00315-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1128%2FJVI.00315-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25855731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFCrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=6352-6363&author=S.+Vashistauthor=L.+Urenaauthor=M.+B.+Gonzalez-Hernandezauthor=J.+Choiauthor=A.+de+Rougemontauthor=J.+Rocha-Pereiraauthor=J.+Neytsauthor=S.+Hwangauthor=C.+E.+Wobusauthor=I.+Goodfellow&title=Molecular+chaperone+hsp90+is+a+therapeutic+target+for+noroviruses&doi=10.1128%2FJVI.00315-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular chaperone Hsp90 is a therapeutic target for noroviruses</span></div><div class="casAuthors">Vashist, Surender; Urena, Luis; Gonzalez-Hernandez, Mariam B.; Choi, Jayoung; de Rougemont, Alexis; Rocha-Pereira, Joana; Neyts, Johan; Hwang, Seungmin; Wobus, Christiane E.; Goodfellow, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6352-6363</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human noroviruses (HuNoV) are a significant cause of acute gastroenteritis in the developed world, and yet our understanding of the mol. pathways involved in norovirus replication and pathogenesis has been limited by the inability to efficiently culture these viruses in the lab.  Using the murine norovirus (MNV) model, we have recently identified a network of host factors that interact with the 5' and 3' extremities of the norovirus RNA genome.  In addn. to a no. of well-known cellular RNA binding proteins, the mol. chaperone Hsp90 was identified as a component of the ribonucleoprotein complex.  Here, we show that the inhibition of Hsp90 activity neg. impacts norovirus replication in cell culture.  Small-mol.-mediated inhibition of Hsp90 activity using 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin) revealed that Hsp90 plays a pleiotropic role in the norovirus life cycle but that the stability of the viral capsid protein is integrally linked to Hsp90 activity.  Furthermore, we demonstrate that both the MNV-1 and the HuNoV capsid proteins require Hsp90 activity for their stability and that targeting Hsp90 in vivo can significantly reduce virus replication.  In summary, we demonstrate that targeting cellular proteostasis can inhibit norovirus replication, identifying a potential novel therapeutic target for the treatment of norovirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoei6xbhjVH5LVg90H21EOLACvtfcHk0ljRuu6ZsOwZeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFCrtb0%253D&md5=982eebcef72127609a4bbf9f0693fde2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FJVI.00315-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00315-15%26sid%3Dliteratum%253Aachs%26aulast%3DVashist%26aufirst%3DS.%26aulast%3DUrena%26aufirst%3DL.%26aulast%3DGonzalez-Hernandez%26aufirst%3DM.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3Dde%2BRougemont%26aufirst%3DA.%26aulast%3DRocha-Pereira%26aufirst%3DJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DWobus%26aufirst%3DC.%2BE.%26aulast%3DGoodfellow%26aufirst%3DI.%26atitle%3DMolecular%2520chaperone%2520hsp90%2520is%2520a%2520therapeutic%2520target%2520for%2520noroviruses%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D6352%26epage%3D6363%26doi%3D10.1128%2FJVI.00315-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lg1k9c6m3Qd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembski, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georges, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbitts, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of hsp90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4606</span>– <span class="NLM_lpage">4615</span>, <span class="refDoi"> DOI: 10.1021/jm0603116</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVelurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4606-4615&author=J.+Geauthor=E.+Normantauthor=J.+R.+Porterauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=Y.+Gaoauthor=A.+T.+Georgesauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+Pattersonauthor=J.+R.+Sydorauthor=T.+T.+Tibbittsauthor=J.+K.+Tongauthor=J.+Adamsauthor=V.+J.+Palombella&title=Design%2C+synthesis%2C+and+biological+evaluation+of+hydroquinone+derivatives+of+17-amino-17-demethoxygeldanamycin+as+potent%2C+water-soluble+inhibitors+of+hsp90&doi=10.1021%2Fjm0603116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Hydroquinone Derivatives of 17-Amino-17-demethoxygeldanamycin as Potent, Water-Soluble Inhibitors of Hsp90</span></div><div class="casAuthors">Ge, Jie; Normant, Emmanuel; Porter, James R.; Ali, Janid A.; Dembski, Marlene S.; Gao, Yun; Georges, Asimina T.; Grenier, Louis; Pak, Roger H.; Patterson, Jon; Sydor, Jens R.; Tibbitts, Thomas T.; Tong, Jeffrey K.; Adams, Julian; Palombella, Vito J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4606-4615</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">17-Allylamino-17-demethoxygeldanamycin (17-AAG) is a semisynthetic inhibitor of the 90 kDa heat shock protein (Hsp90) currently in clin. trials for the treatment of cancer.  However, 17-AAG faces challenging formulation issues due to its poor soly.  Here we report the synthesis and evaluation of a highly sol. hydroquinone hydrochloride deriv. of 17-AAG, I (IPI-504), and several of the physiol. metabolites.  These compds. show comparable binding affinity to human Hsp90 and its endoplasmic reticulum (ER) homolog, the 94 kDa glucose regulated protein (Grp94).  Furthermore, the compds. inhibit the growth of the human cancer cell lines SKBR3 and SKOV3, which overexpress Hsp90 client protein Her2, and cause down-regulation of Her2 as well as induction of Hsp70 consistent with Hsp90 inhibition.  There is a clear correlation between the measured binding affinity of the compds. and their cellular activities.  Upon the basis of its potent activity against Hsp90 and a significant improvement in soly., I is currently under evaluation in Phase I clin. trials for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9IjX75MjbULVg90H21EOLACvtfcHk0lg1k9c6m3Qd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVelurw%253D&md5=892e372e121f75465edc6f1251e55dc6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm0603116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603116%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGeorges%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTibbitts%26aufirst%3DT.%2BT.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520hydroquinone%2520derivatives%2520of%252017-amino-17-demethoxygeldanamycin%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520hsp90%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4606%26epage%3D4615%26doi%3D10.1021%2Fjm0603116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreras, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myles, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of novel 17-aminogeldanamycin derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5317</span>– <span class="NLM_lpage">5329</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2004.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15388159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFWlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5317-5329&author=Z.+Q.+Tianauthor=Y.+Q.+Liuauthor=D.+Zhangauthor=Z.+Wangauthor=S.+D.+Dongauthor=C.+W.+Carrerasauthor=Y.+Q.+Zhouauthor=G.+Rastelliauthor=D.+V.+Santiauthor=D.+C.+Myles&title=Synthesis+and+biological+activities+of+novel+17-aminogeldanamycin+derivatives&doi=10.1016%2Fj.bmc.2004.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of novel 17-aminogeldanamycin derivatives</span></div><div class="casAuthors">Tian, Zong-Qiang; Liu, Yaoquan; Zhang, Dan; Wang, Zhan; Dong, Steven D.; Carreras, Christopher W.; Zhou, Yiqing; Rastelli, Giulio; Santi, Daniel V.; Myles, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5317-5329</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Geldanamycin interferes with the action of heat shock protein 90 (Hsp90) by binding to the N-terminal ATP binding site and inhibiting an essential ATPase activity.  In a program directed toward finding potent, water sol. inhibitors of Hsp90, we prepd. a library of over sixty 17-alkylamino-17-demethoxygeldanamycin analogs, and compared their affinity for Hsp90, ability to inhibit growth of SKBr3 mammalian cells, and in selected cases, water soly.  Over 20 analogs showed cell growth inhibition potencies similar to that of 17-allylamino-17-demethoxygeldanamycin (17-AAG), the front-runner geldanamycin analog that is currently in multiple clin. trials.  Many of these analogs showed water soly. properties that were desirable for formulation.  One of the most potent and water-sol. analogs in the series was 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin (17-DMAG), which was independently prepd. by the NCI and will soon enter clin. trials.  Importantly, the binding affinity of these analogs to the mol. target Hsp90 does not correlate well with their cytotoxicity in SKBr3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohR8AjynvPbbVg90H21EOLACvtfcHk0lg1k9c6m3Qd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFWlu78%253D&md5=e550ea4739d30c069e0c14aa1b019318</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DZ.%2BQ.%26aulast%3DLiu%26aufirst%3DY.%2BQ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DS.%2BD.%26aulast%3DCarreras%26aufirst%3DC.%2BW.%26aulast%3DZhou%26aufirst%3DY.%2BQ.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DMyles%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520novel%252017-aminogeldanamycin%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5317%26epage%3D5329%26doi%3D10.1016%2Fj.bmc.2004.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnolo, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pengelly, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D. E.</span></span> <span> </span><span class="NLM_article-title">Fragment screening using capillary electrophoresis (cefrag) for hit identification of heat shock protein 90 atpase inhibitors</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">876</span>, <span class="refDoi"> DOI: 10.1177/1087057112445785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1177%2F1087057112445785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22573733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC38nhvFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=868-876&author=C.+Austinauthor=S.+N.+Pettitauthor=S.+K.+Magnoloauthor=J.+Sanvoisinauthor=W.+J.+Chenauthor=S.+P.+Woodauthor=L.+D.+Freemanauthor=R.+J.+Pengellyauthor=D.+E.+Hughes&title=Fragment+screening+using+capillary+electrophoresis+%28cefrag%29+for+hit+identification+of+heat+shock+protein+90+atpase+inhibitors&doi=10.1177%2F1087057112445785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors</span></div><div class="casAuthors">Austin Carol; Pettit Simon N; Magnolo Sharon K; Sanvoisin Jonathan; Chen Wenjie; Wood Stephen P; Freeman Lauren D; Pengelly Reuben J; Hughes Dallas E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CEfrag is a new fragment screening technology based on affinity capillary electrophoresis (ACE).  Here we report on the development of a mobility shift competition assay using full-length human heat shock protein 90α (Hsp90α), radicicol as the competitor probe ligand, and successful screening of the Selcia fragment library.  The CEfrag assay was able to detect weaker affinity (IC(50) >500 μM) fragments than were detected by a fluorescence polarization competition assay using FITC-labeled geldanamycin.  The binding site of selected fragments was determined by co-crystallization with recombinant Hsp90α N-terminal domain and X-ray analysis.  The results of this study confirm that CEfrag is a sensitive microscale technique enabling detection of fragments binding to the biological target in near-physiological solution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQN-AvJAV98sXwOGIfWJ7-GfW6udTcc2ebetB7X4vgvf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nhvFymsw%253D%253D&md5=1bb948cd9eccb18f828f45d9f6a3e56d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1177%2F1087057112445785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112445785%26sid%3Dliteratum%253Aachs%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DPettit%26aufirst%3DS.%2BN.%26aulast%3DMagnolo%26aufirst%3DS.%2BK.%26aulast%3DSanvoisin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%2BJ.%26aulast%3DWood%26aufirst%3DS.%2BP.%26aulast%3DFreeman%26aufirst%3DL.%2BD.%26aulast%3DPengelly%26aufirst%3DR.%2BJ.%26aulast%3DHughes%26aufirst%3DD.%2BE.%26atitle%3DFragment%2520screening%2520using%2520capillary%2520electrophoresis%2520%2528cefrag%2529%2520for%2520hit%2520identification%2520of%2520heat%2520shock%2520protein%252090%2520atpase%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D868%26epage%3D876%26doi%3D10.1177%2F1087057112445785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug discovery applied to hsp90. discovery of two lead series with high ligand efficiency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5942</span>– <span class="NLM_lpage">5955</span>, <span class="refDoi"> DOI: 10.1021/jm100059d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100059d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVChsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5942-5955&author=C.+W.+Murrayauthor=M.+G.+Carrauthor=O.+Callaghanauthor=G.+Chessariauthor=M.+Congreveauthor=S.+Cowanauthor=J.+E.+Coyleauthor=R.+Downhamauthor=E.+Figueroaauthor=M.+Fredericksonauthor=B.+Grahamauthor=R.+McMenaminauthor=M.+A.+O%E2%80%99Brienauthor=S.+Patelauthor=T.+R.+Phillipsauthor=G.+Williamsauthor=A.+J.+Woodheadauthor=A.+J.+Woolford&title=Fragment-based+drug+discovery+applied+to+hsp90.+discovery+of+two+lead+series+with+high+ligand+efficiency&doi=10.1021%2Fjm100059d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency</span></div><div class="casAuthors">Murray, Christopher W.; Carr, Maria G.; Callaghan, Owen; Chessari, Gianni; Congreve, Miles; Cowan, Suzanna; Coyle, Joseph E.; Downham, Robert; Figueroa, Eva; Frederickson, Martyn; Graham, Brent; McMenamin, Rachel; O'Brien, M. Alistair; Patel, Sahil; Phillips, Theresa R.; Williams, Glyn; Woodhead, Andrew J.; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5942-5955</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the chaperone Hsp90 are potentially useful as chemotherapeutic agents in cancer.  This paper describes an application of fragment screening to Hsp90 using a combination of NMR and high throughput x-ray crystallog.  The screening identified an aminopyrimidine with affinity in the high micromolar range and subsequent structure-based design allowed its optimization into a low nanomolar series with good ligand efficiency.  A phenolic chemotype was also identified in fragment screening and was found to bind with affinity close to 1 mM.  This fragment was optimized using structure based design into a resorcinol lead which has subnanomolar affinity for Hsp90, excellent cell potency, and good ligand efficiency.  This fragment to lead campaign improved affinity for Hsp90 by over 1,000,000 fold with the addn. of only 6 heavy atoms.  The companion paper (DOI: 10.1021/jm100060b) describes how the resorcinol lead was optimized into a compd. that is now in clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqISC3cw2labbVg90H21EOLACvtfcHk0ljtpoQB-0SSaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVChsb0%253D&md5=d1ad900aa5a45ba6ba3a5e9ccdcd96b3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm100059d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100059d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DT.%2BR.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520applied%2520to%2520hsp90.%2520discovery%2520of%2520two%2520lead%2520series%2520with%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5942%26epage%3D5955%26doi%3D10.1021%2Fjm100059d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angove, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (at13387), a novel inhibitor of the molecular chaperone hsp90 by fragment based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5969</span>, <span class="refDoi"> DOI: 10.1021/jm100060b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5956-5969&author=A.+J.+Woodheadauthor=H.+Angoveauthor=M.+G.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=J.+E.+Coyleauthor=J.+Cosmeauthor=B.+Grahamauthor=P.+J.+Dayauthor=R.+Downham&title=Discovery+of+%282%2C4-dihydroxy-5-isopropylphenyl%29-%5B5-%284-methylpiperazin-1-ylmethyl%29-1%2C3-dihydroisoindol-2-yl%5Dmethanone+%28at13387%29%2C+a+novel+inhibitor+of+the+molecular+chaperone+hsp90+by+fragment+based+drug+design&doi=10.1021%2Fjm100060b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design</span></div><div class="casAuthors">Woodhead, Andrew J.; Angove, Hayley; Carr, Maria G.; Chessari, Gianni; Congreve, Miles; Coyle, Joseph E.; Cosme, Jose; Graham, Brent; Day, Philip J.; Downham, Robert; Fazal, Lynsey; Feltell, Ruth; Figueroa, Eva; Frederickson, Martyn; Lewis, Jonathan; McMenamin, Rachel; Murray, Christopher W.; O'Brien, M. Alistair; Parra, Lina; Patel, Sahil; Phillips, Theresa; Rees, David C.; Rich, Sharna; Smith, Donna-Michelle; Trewartha, Gary; Vinkovic, Mladen; Williams, Brian; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5956-5969</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the mol. chaperone heat shock protein 90 (Hsp90) are currently generating significant interest in clin. development as potential treatments for cancer.  In a preceding publication (DOI: 10.1021/jm100059d) we describe Astex's approach to screening fragments against Hsp90 and the subsequent optimization of two hits into leads with inhibitory activities in the low nanomolar range.  This paper describes the structure guided optimization of the 2,4-dihydroxybenzamide lead mol. 1 and details some of the drug discovery strategies employed in the identification of AT13387 (35), which has progressed through preclin. development and is currently being tested in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEtcgAmkVk7Vg90H21EOLACvtfcHk0liIxHKnMP2Xeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D&md5=a2d2ac6dd9e9ba4cb89f83c32727a1d8</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100060b%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DAngove%26aufirst%3DH.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDownham%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520%25282%252C4-dihydroxy-5-isopropylphenyl%2529-%255B5-%25284-methylpiperazin-1-ylmethyl%2529-1%252C3-dihydroisoindol-2-yl%255Dmethanone%2520%2528at13387%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520molecular%2520chaperone%2520hsp90%2520by%2520fragment%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5956%26epage%3D5969%26doi%3D10.1021%2Fjm100060b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornilayev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development and optimization of a useful assay for determining hsp90’s inherent atpase activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1134</span>– <span class="NLM_lpage">1142</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2005.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16213144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1134-1142&author=C.+Avilaauthor=B.+A.+Kornilayevauthor=B.+S.+J.+Blagg&title=Development+and+optimization+of+a+useful+assay+for+determining+hsp90%E2%80%99s+inherent+atpase+activity&doi=10.1016%2Fj.bmc.2005.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity</span></div><div class="casAuthors">Avila, Christopher; Kornilayev, Boris A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1134-1142</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Hsp90 mol. chaperone is responsible for the conformational maturation of nascent polypeptides and the rematuration of denatured proteins.  Inhibition of Hsp90 represents a promising approach towards the treatment of cancer because numerous signaling cascades can be simultaneously targeted by disruption of the Hsp90-mediated process.  Hsp90's ATPase activity is essential to the Hsp90-mediated protein folding process, consequently, a coupled assay was developed and optimized for detn. of Hsp90's inherent ATPase activity.  Using maltose phosphorylase, glucose oxidase, and horseradish peroxidase as components of this assay, a highly reproducible assay with a Z-factor of 0.87 has been produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88K6sLLHnXLVg90H21EOLACvtfcHk0liIxHKnMP2Xeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFKqsA%253D%253D&md5=6232dbd8f0ca74406d452f750e699b33</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DC.%26aulast%3DKornilayev%26aufirst%3DB.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520and%2520optimization%2520of%2520a%2520useful%2520assay%2520for%2520determining%2520hsp90%25E2%2580%2599s%2520inherent%2520atpase%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1134%26epage%3D1142%26doi%3D10.1016%2Fj.bmc.2005.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornilayev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening for hsp90 atpase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3005</span>– <span class="NLM_lpage">3008</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.02.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2006.02.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16530412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFygtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3005-3008&author=C.+Avilaauthor=M.+K.+Haddenauthor=Z.+Maauthor=B.+A.+Kornilayevauthor=Q.+Z.+Yeauthor=B.+S.+J.+Blagg&title=High-throughput+screening+for+hsp90+atpase+inhibitors&doi=10.1016%2Fj.bmcl.2006.02.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening for Hsp90 ATPase inhibitors</span></div><div class="casAuthors">Avila, Christopher; Hadden, M. Kyle; Ma, Zeqiang; Kornilayev, Boris A.; Ye, Qi-Zhuang; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3005-3008</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently, we reported a useful assay for the detn. of yeast Hsp90 ATPase activity.  Using this assay, high-throughput screening of ∼10,000 compds. was performed to det. the feasibility of this assay on large scale.  Results from high-throughput screening indicated that the assay was reproducible (av Z-factor = 0.80) and identified 0.57% of the compds. as Hsp90 inhibitors that exhibited IC50s less than 20 μM.  The structures of several of these inhibitory scaffolds are reported along with their IC50 values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8dqs3sRASxLVg90H21EOLACvtfcHk0liIxHKnMP2Xeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFygtLk%253D&md5=37fa7d6df613df74e75c85098fd84ec5</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.02.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.02.063%26sid%3Dliteratum%253Aachs%26aulast%3DAvila%26aufirst%3DC.%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DKornilayev%26aufirst%3DB.%2BA.%26aulast%3DYe%26aufirst%3DQ.%2BZ.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DHigh-throughput%2520screening%2520for%2520hsp90%2520atpase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3005%26epage%3D3008%26doi%3D10.1016%2Fj.bmcl.2006.02.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcdonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Novel, potent small-molecule inhibitors of the molecular chaperone hsp90 discovered through structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4212</span>– <span class="NLM_lpage">4215</span>, <span class="refDoi"> DOI: 10.1021/jm050355z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050355z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4212-4215&author=B.+W.+Dymockauthor=X.+Barrilauthor=P.+A.+Broughauthor=J.+E.+Cansfieldauthor=A.+Masseyauthor=E.+Mcdonaldauthor=R.+E.+Hubbardauthor=A.+Surgenorauthor=S.+D.+Roughleyauthor=P.+Webb&title=Novel%2C+potent+small-molecule+inhibitors+of+the+molecular+chaperone+hsp90+discovered+through+structure-based+design&doi=10.1021%2Fjm050355z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Potent Small-Molecule Inhibitors of the Molecular Chaperone Hsp90 Discovered through Structure-Based Design</span></div><div class="casAuthors">Dymock, Brian W.; Barril, Xavier; Brough, Paul A.; Cansfield, Julie E.; Massey, Andrew; McDonald, Edward; Hubbard, Roderick E.; Surgenor, Allan; Roughley, Stephen D.; Webb, Paul; Workman, Paul; Wright, Lisa; Drysdale, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4212-4215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The crystal structure of a previously reported screening hit 1 (CCT018159) bound to the N terminal domain of mol. chaperone Hsp90 has been used to design 5-amide analogs.  These exhibit enhanced potency against the target in binding and functional assays with accompanying appropriate cellular pharmacodynamic changes.  Compd. 11 (VER-49009) compares favorably with the clin. evaluated 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR4ICeTnHxbVg90H21EOLACvtfcHk0liIxHKnMP2Xeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslSnsbg%253D&md5=3a854d5f6fd1eb0e292292b2a8d22401</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm050355z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050355z%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMcdonald%26aufirst%3DE.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DWebb%26aufirst%3DP.%26atitle%3DNovel%252C%2520potent%2520small-molecule%2520inhibitors%2520of%2520the%2520molecular%2520chaperone%2520hsp90%2520discovered%2520through%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4212%26epage%3D4215%26doi%3D10.1021%2Fjm050355z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgognoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">4,5-Diarylisoxazole hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1021/jm701018h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+Daviesauthor=M.+J.+Drysdale&title=4%2C5-Diarylisoxazole+hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1021%2Fjm701018h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></div><div class="casAuthors">Brough, Paul A.; Aherne, Wynne; Barril, Xavier; Borgognoni, Jennifer; Boxall, Kathy; Cansfield, Julie E.; Cheung, Kwai-Ming J.; Collins, Ian; Davies, Nicholas G. M.; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Finch, Harry; Fink, Alexandra; Hayes, Angela; Howes, Robert; Hubbard, Roderick E.; James, Karen; Jordan, Allan M.; Lockie, Andrea; Martins, Vanessa; Massey, Andrew; Matthews, Thomas P.; McDonald, Edward; Northfield, Christopher J.; Pearl, Laurence H.; Prodromou, Chrisostomos; Ray, Stuart; Raynaud, Florence I.; Roughley, Stephen D.; Sharp, Swee Y.; Surgenor, Allan; Walmsley, D. Lee; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 [heat shock protein 90] mol. chaperone show considerable promise as potential chemotherapeutic agents for cancer.  The structure-based design, synthesis, structure-activity relationships, and pharmacokinetics of potent small-mol. inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold were studied.  Analogs from this series have high affinity for Hsp90, as measured in a fluorescence polarization competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  The [(morpholinomethyl)phenyl]isoxazolecarboxamide I (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM.  I is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice.  In a human colon cancer xenograft model, I inhibits tumor growth by ∼50%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNA9AoWb8gLVg90H21EOLACvtfcHk0lhptqfM4nu5HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK&md5=fdb98dec600987e862b9b05555427948</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3D4%252C5-Diarylisoxazole%2520hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218%26doi%3D10.1021%2Fjm701018h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherfaoui, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of novel hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2014.03.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24763261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=399-412&author=H.+P.+Sunauthor=J.+M.+Jiaauthor=F.+Jiangauthor=X.+L.+Xuauthor=F.+Liuauthor=X.+K.+Guoauthor=B.+Cherfaouiauthor=H.+Z.+Huangauthor=Y.+Panauthor=Q.+D.+You&title=Identification+and+optimization+of+novel+hsp90+inhibitors+with+tetrahydropyrido%5B4%2C3-d%5Dpyrimidines+core+through+shape-based+screening&doi=10.1016%2Fj.ejmech.2014.03.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening</span></div><div class="casAuthors">Sun, Hao-Peng; Jia, Jian-Min; Jiang, Fen; Xu, Xiao-Li; Liu, Fang; Guo, Xiao-Ke; Cherfaoui, Bahidja; Huang, Hao-Ze; Pan, Yang; You, Qi-Dong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">399-412</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Rapid Overlay of Chem. Structures (ROCS), which can rapidly identify potentially active compds. by shape comparison, is recognized as a powerful virtual screening tool.  By ROCS, a class of novel Hsp90 inhibitors was identified.  The authors report prepn. of a series of tetrahydropyrido[4,3-d]pyrimidines.  Over 100-fold improvement was achieved in the target-based assay.  The most potent compd. 57h(I) inhibited Hsp90 with IC50 0.10 ± 0.01 μM.  It also showed much improved cell potency and ligand efficiency.  The authors' study showed that ROCS is efficient in the identification of novel cores of Hsp90 inhibitors. I can be ideal leads for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsUgCLHRAhcbVg90H21EOLACvtfcHk0lhptqfM4nu5HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWntrc%253D&md5=f446bf48db3534f77dbdb8cbeec894c7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%2BP.%26aulast%3DJia%26aufirst%3DJ.%2BM.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DCherfaoui%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DH.%2BZ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%2520hsp90%2520inhibitors%2520with%2520tetrahydropyrido%255B4%252C3-d%255Dpyrimidines%2520core%2520through%2520shape-based%2520screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D399%26epage%3D412%26doi%3D10.1016%2Fj.ejmech.2014.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Novel tetrahydropyrido[4,3-d]pyrimidines as potent inhibitors of chaperone heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10498</span>– <span class="NLM_lpage">10519</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00912</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00912" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVehs7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10498-10519&author=F.+Jiangauthor=H.+J.+Wangauthor=Y.+H.+Jinauthor=Q.+Zhangauthor=Z.+H.+Wangauthor=J.+M.+Jiaauthor=F.+Liuauthor=L.+Wangauthor=Q.+C.+Baoauthor=D.+D.+Liauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Novel+tetrahydropyrido%5B4%2C3-d%5Dpyrimidines+as+potent+inhibitors+of+chaperone+heat+shock+protein+90&doi=10.1021%2Facs.jmedchem.6b00912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90</span></div><div class="casAuthors">Jiang, Fen; Wang, Hui-Jie; Jin, Yu-Hui; Zhang, Qiong; Wang, Zhi-Hui; Jia, Jian-Min; Liu, Fang; Wang, Lei; Bao, Qi-Chao; Li, Dong-Dong; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10498-10519</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat-shock protein 90 (Hsp90) is a potential target for oncol. therapeutics.  Some inhibitors have shown anti-tumor effects in clin. trials, spurring the discovery of small-mol. Hsp90 inhibitors.  Here, the authors describe the structural optimization studies of a hit compd., tetrahydropyrido[4,3-d]pyrimidine-based Hsp90 inhibitor, which exhibits inhibitory activity against Hsp90.  A series of analogs were synthesized, and their structure-activity relationships and structure-property relationships were analyzed.  These explorations led to the discovery of compd. 73 ((2,4-dihydroxy-5-isopropylphenyl)(4-(ethylamino)-2-(2-methoxyethoxy)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)methanone), which exhibited potent in vitro activities, good physicochem. properties, favorable ADME properties and potent anti-tumor effect in an HCT116 xenograft model.  Furthermore, 73 exhibited no ocular toxicity in a rat retinal damage model, suggesting it is a relatively safe Hsp90 inhibitor.  As a promising anti-tumor agent, 73 was progressed for further pre-clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhftxgoZ3blLVg90H21EOLACvtfcHk0lhptqfM4nu5HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVehs7nF&md5=d3ab4651aa7d68854edf7c0b6e712ee2</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DJia%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DLi%26aufirst%3DD.%2BD.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DNovel%2520tetrahydropyrido%255B4%252C3-d%255Dpyrimidines%2520as%2520potent%2520inhibitors%2520of%2520chaperone%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10498%26epage%3D10519%26doi%3D10.1021%2Facs.jmedchem.6b00912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of n-(5-chloro-2,4-dihydroxybenzoyl)-(r)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel hsp90 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2016.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27266997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWnsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=272-282&author=C.+Liangauthor=H.+Haoauthor=X.+Wuauthor=Z.+Liauthor=J.+Zhuauthor=C.+Luauthor=Y.+Shen&title=Design+and+synthesis+of+n-%285-chloro-2%2C4-dihydroxybenzoyl%29-%28r%29-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxamides+as+novel+hsp90+inhibitors&doi=10.1016%2Fj.ejmech.2016.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors</span></div><div class="casAuthors">Liang, Chuanpeng; Hao, Huilin; Wu, Xingkang; Li, Zhenyu; Zhu, Jing; Lu, Chunhua; Shen, Yuemao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">272-282</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein, the design and synthesis of two series of novel compd. I and II [ R= NHMe, NHEt, NH-i-pr etc. ] as Hsp90 inhibitors using (S)-Tic (1,2,3,4-tetrahydroisoquinoline-3- carboxylic acid) (A1-13) and (R)-Tic (B1-13) as scaffold, resp. was reported.  Cellular thermal shift assay (CETSA) screening showed that compds. II with (R)-Tic scaffold exhibited potent ability to stabilize Hsp90α.  Compd. II [ R = NHBn ] showed not only the most potent ability to induce thermal stabilization of Hsp90α but also the strongest cytotoxicity.  The IC50 values of compd. II [ R = NHBn ] were 0.98 μM and 1.74 μM against the proliferation of human breast cancer MDA-MB-231 and human cervical cancer HeLa cell lines, resp.  Moreover, CETSA melt and ITDRFCETSA (isothermal dose-response fingerprint) curves confirmed that Compd. II [ R = NHBn ] bound to Hsp90α in 293T cells.  Western blotting results indicated that compd. II [ R = NHBn ] induced the degrdn. of Hsp90 clients CDK4, Her2, Cdc-2 and C-raf.  In addn., docking and Mol. dynamics (MD) refinement of the B7-Hsp90 complex showed that the binding model of compd. II [ R = NHBn ] to Hsp90 was similar with that of 8-benzyladenines.  The overall properties warrant compd. II [ R = NHBn ] a promising lead for the development of Hsp90 inhibitor antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRchNM19rw7Vg90H21EOLACvtfcHk0litDqV9ABu97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWnsrfE&md5=d93ac271d1cd78c83a44d093b0d8347f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520n-%25285-chloro-2%252C4-dihydroxybenzoyl%2529-%2528r%2529-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxamides%2520as%2520novel%2520hsp90%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D272%26epage%3D282%26doi%3D10.1016%2Fj.ejmech.2016.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatorska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llauger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1021/jm0508078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Z.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+H.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90&doi=10.1021%2Fjm0508078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0litDqV9ABu97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%2BZ.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390%26doi%3D10.1021%2Fjm0508078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zifcak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atoyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DellaRocca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span> <span> </span><span class="NLM_article-title">Cudc-305, a novel synthetic hsp90 inhibitor with unique pharmacologic properties for cancer therapy</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4046</span>– <span class="NLM_lpage">4057</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-0152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-09-0152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19509149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=4046-4057&author=R.+Baoauthor=C.+J.+Laiauthor=H.+Quauthor=D.+Wangauthor=L.+Yinauthor=B.+Zifcakauthor=R.+Atoyanauthor=J.+Wangauthor=M.+Samsonauthor=J.+Forresterauthor=S.+DellaRoccaauthor=G.+X.+Xuauthor=X.+Taoauthor=H.+X.+Zhaiauthor=X.+Caiauthor=C.+Qian&title=Cudc-305%2C+a+novel+synthetic+hsp90+inhibitor+with+unique+pharmacologic+properties+for+cancer+therapy&doi=10.1158%2F1078-0432.CCR-09-0152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy</span></div><div class="casAuthors">Bao, Rudi; Lai, Cheng-Jung; Qu, Hui; Wang, Dagong; Yin, Ling; Zifcak, Brian; Atoyan, Ruzanna; Wang, Jing; Samson, Maria; Forrester, Jeffrey; Della Rocca, Steven; Xu, Guang-Xin; Tao, Xu; Zhai, Hai-Xiao; Cai, Xiong; Qian, Changgeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4046-4057</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We designed and synthesized CUDC-305, an HSP90 inhibitor of the novel imidazopyridine class.  Here, we report its unique pharmacol. properties and antitumor activities in a variety of tumor types.  The potency of the compd. was analyzed by fluorescence polarization competition binding assay.  Its antiproliferative activities were assessed in 40 human cancer cell lines.  Its pharmacol. properties and antitumor activities were evaluated in a variety of tumor xenograft models.  CUDC-305 shows high affinity for HSP90α/β (IC50, ∼100 nmol/L) and HSP90 complex derived from cancer cells (IC50, 48.8 nmol/L).  It displays potent antiproliferative activity against a broad range of cancer cell lines (mean IC50, 220 nmol/L).  CUDC-305 exhibits high oral bioavailability (96.0%) and selective retention in tumor (half-life, 20.4 h) compared with normal tissues.  Furthermore, CUDC-305 can cross blood-brain barrier and reach therapeutic levels in brain tissue.  CUDC-305 exhibits dose-dependent antitumor activity in an s.c. xenograft model of U87MG glioblastoma and significantly prolongs animal survival in U87MG orthotopic model.  CUDC-305 also displays potent antitumor activity in animal models of erlotinib-resistant non-small cell lung cancer and induces tumor regression in animal models of MDA-MB-468 breast cancer and MV4-11 acute myelogenous leukemia.  Correlating with its efficacy in these various tumor models, CUDC-305 robustly inhibits multiple signaling pathways, including PI3K/AKT and RAF/MEK/ERK, and induces apoptosis.  In combination studies, CUDC-305 enhances the antitumor activity of std.-of-care agents in breast and colorectal tumor models.  CUDC-305 is a promising drug candidate for the treatment of a variety of cancers, including brain malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxsZpWkM4MrVg90H21EOLACvtfcHk0litDqV9ABu97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D&md5=b872c7658a2fc98f263f7e6a23cb58f6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-0152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-0152%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DC.%2BJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DZifcak%26aufirst%3DB.%26aulast%3DAtoyan%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSamson%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DDellaRocca%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%2BX.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.%2BX.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DCudc-305%252C%2520a%2520novel%2520synthetic%2520hsp90%2520inhibitor%2520with%2520unique%2520pharmacologic%2520properties%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D4046%26epage%3D4057%26doi%3D10.1158%2F1078-0432.CCR-09-0152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tangallapally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovitz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenderovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimbora, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yager, K. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of (2s)-1-[4-(2-{6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9h-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (mpc-3100), a purine-based hsp90 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7480</span>– <span class="NLM_lpage">7501</span>, <span class="refDoi"> DOI: 10.1021/jm3004619</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3004619" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1CisrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7480-7501&author=S.+H.+Kimauthor=A.+Bajjiauthor=R.+Tangallapallyauthor=B.+Markovitzauthor=R.+Trovatoauthor=M.+Shenderovichauthor=V.+Baichwalauthor=P.+Bartelauthor=D.+Cimboraauthor=R.+McKinnonauthor=R.+Robinsonauthor=D.+Papacauthor=D.+Wettsteinauthor=R.+Carlsonauthor=K.+M.+Yager&title=Discovery+of+%282s%29-1-%5B4-%282-%7B6-amino-8-%5B%286-bromo-1%2C3-benzodioxol-5-yl%29sulfanyl%5D-9h-purin-9-yl%7Dethyl%29piperidin-1-yl%5D-2-hydroxypropan-1-one+%28mpc-3100%29%2C+a+purine-based+hsp90+inhibitor&doi=10.1021%2Fjm3004619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor</span></div><div class="casAuthors">Kim, Se-Ho; Bajji, Ashok; Tangallapally, Rajendra; Markovitz, Benjamin; Trovato, Richard; Shenderovich, Mark; Baichwal, Vijay; Bartel, Paul; Cimbora, Daniel; McKinnon, Rena; Robinson, Rosann; Papac, Damon; Wettstein, Daniel; Carlson, Robert; Yager, Kraig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7480-7501</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis.  This has spurred the search for small-mol. Hsp90 inhibitors.  Here we describe our lead optimization studies centered on the purine-based Hsp90 inhibitor 28a (I; R = CHO) contg. a piperidine moiety at the purine N9 position.  In this study, key SAR was established for the piperidine N-substituent and for the congeners of the 1,3-benzodioxole at C8.  These efforts led to the identification of orally bioavailable 28g [I; R = (S)-2-hydroxypropanoyl] that exhibits good in vitro profiles and a characteristic mol. biomarker signature of Hsp90 inhibition both in vitro and in vivo.  Favorable pharmacokinetic properties along with significant antitumor effects in multiple human cancer xenograft models led to the selection of 28g (MPC-3100) as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0VPSOwHXnrVg90H21EOLACvtfcHk0lhrPZ_gL5osYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1CisrbO&md5=ea005d78eb1be66625d8b237fed14be1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm3004619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3004619%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBajji%26aufirst%3DA.%26aulast%3DTangallapally%26aufirst%3DR.%26aulast%3DMarkovitz%26aufirst%3DB.%26aulast%3DTrovato%26aufirst%3DR.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DBartel%26aufirst%3DP.%26aulast%3DCimbora%26aufirst%3DD.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DPapac%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DD.%26aulast%3DCarlson%26aufirst%3DR.%26aulast%3DYager%26aufirst%3DK.%2BM.%26atitle%3DDiscovery%2520of%2520%25282s%2529-1-%255B4-%25282-%257B6-amino-8-%255B%25286-bromo-1%252C3-benzodioxol-5-yl%2529sulfanyl%255D-9h-purin-9-yl%257Dethyl%2529piperidin-1-yl%255D-2-hydroxypropan-1-one%2520%2528mpc-3100%2529%252C%2520a%2520purine-based%2520hsp90%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7480%26epage%3D7501%26doi%3D10.1021%2Fjm3004619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgognoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chene, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrett, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padfield, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radimerski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmonite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walls, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span> <span> </span><span class="NLM_article-title">Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the hsp90 molecular chaperone</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4794</span>– <span class="NLM_lpage">4809</span>, <span class="refDoi"> DOI: 10.1021/jm900357y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900357y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4794-4809&author=P.+A.+Broughauthor=X.+Barrilauthor=J.+Borgognoniauthor=P.+Cheneauthor=N.+G.+Daviesauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=C.+Garcia-Echeverriaauthor=C.+Fromontauthor=A.+Hayesauthor=R.+E.+Hubbardauthor=A.+M.+Jordanauthor=M.+R.+Jensenauthor=A.+Masseyauthor=A.+Merrettauthor=A.+Padfieldauthor=R.+Parsonsauthor=T.+Radimerskiauthor=F.+I.+Raynaudauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=H.+Simmoniteauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=M.+Valentiauthor=S.+Wallsauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=Combining+hit+identification+strategies%3A+fragment-based+and+in+silico+approaches+to+orally+active+2-aminothieno%5B2%2C3-d%5Dpyrimidine+inhibitors+of+the+hsp90+molecular+chaperone&doi=10.1021%2Fjm900357y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Brough, Paul A.; Barril, Xavier; Borgognoni, Jenifer; Chene, Patrick; Davies, Nicholas G. M.; Davis, Ben; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Garcia-Echeverria, Carlos; Fromont, Christophe; Hayes, Angela; Hubbard, Roderick E.; Jordan, Allan M.; Jensen, Michael Rugaard; Massey, Andrew; Merrett, Angela; Padfield, Antony; Parsons, Rachel; Radimerski, Thomas; Raynaud, Florence I.; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Simmonite, Heather; Sharp, Swee Y.; Surgenor, Allan; Valenti, Melanie; Walls, Steven; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4794-4809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing considerable promise as potential mol. therapeutic agents for the treatment of cancer.  Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallog.  Examples from this series have high affinity (IC50 = 50-100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  Several compds. caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofpAier7tW7Vg90H21EOLACvtfcHk0lhrPZ_gL5osYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D&md5=4d1988060b0f87dc776e1972ea14808e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWalls%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DCombining%2520hit%2520identification%2520strategies%253A%2520fragment-based%2520and%2520in%2520silico%2520approaches%2520to%2520orally%2520active%25202-aminothieno%255B2%252C3-d%255Dpyrimidine%2520inhibitors%2520of%2520the%2520hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4794%26epage%3D4809%26doi%3D10.1021%2Fjm900357y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X. J.</span></span> <span> </span><span class="NLM_article-title">A time-resolved fluorescence resonance energy transfer-based hts assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ab.2004.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15265741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2004&pages=349-357&author=V.+Zhouauthor=S.+L.+Hanauthor=A.+Brinkerauthor=H.+Klockauthor=J.+Caldwellauthor=X.+J.+Gu&title=A+time-resolved+fluorescence+resonance+energy+transfer-based+hts+assay+and+a+surface+plasmon+resonance-based+binding+assay+for+heat+shock+protein+90+inhibitors&doi=10.1016%2Fj.ab.2004.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors</span></div><div class="casAuthors">Zhou, Vicki; Han, Shulin; Brinker, Achim; Klock, Heath; Caldwell, Jeremy; Gu, Xiang-ju</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-357</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an ATP-dependent mol. chaperone required for the stability and function of a no. of client proteins, many of which are involved in cancer development.  The natural products geldanamycin (GM) and radicicol (RD) are known inhibitors of Hsp90, and their derivs. are being developed for the treatment of various cancers.  To identify novel Hsp90 inhibitors, a highly robust time-resolved fluorescence resonance energy transfer (TR-FRET)-based HTS assay that measures the binding of biotinylated geldanamycin (biotin-GM) to the His-tagged human Hsp90 N-terminal ATP-binding domain (Hsp90N) was developed.  This assay was optimized in 1536-well plates and was used as the primary assay to screen 106 compds.  Identified "hits" were then confirmed in a scintillation proximity assay (SPA) and a DEAE membrane-based assay for [3H]AAG binding to Hsp90.  In addn., a surface plasmon resonance (SPR) assay that measures the direct interaction of Hsp90 with its inhibitors was developed and used to further characterize the identified inhibitors.  Several potent and reversible inhibitors of human Hsp90 with Kd values measured in the high nanomolar range were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB9HPTahQVyrVg90H21EOLACvtfcHk0ljF7ea3HDX21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVWjurk%253D&md5=93bbfc42bc8e7bd1a08a07706b9a687b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DS.%2BL.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DKlock%26aufirst%3DH.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.%2BJ.%26atitle%3DA%2520time-resolved%2520fluorescence%2520resonance%2520energy%2520transfer-based%2520hts%2520assay%2520and%2520a%2520surface%2520plasmon%2520resonance-based%2520binding%2520assay%2520for%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D331%26spage%3D349%26epage%3D357%26doi%3D10.1016%2Fj.ab.2004.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bussenius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcalas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowles, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhr, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFina, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lougheed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manalo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womble, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of xl888: a novel tropane-derived small molecule inhibitor of hsp90</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5396</span>– <span class="NLM_lpage">5404</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2012.07.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22877636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5396-5404&author=J.+Busseniusauthor=C.+M.+Blazeyauthor=N.+Aayauthor=N.+K.+Anandauthor=A.+Arcalasauthor=T.+Baikauthor=O.+J.+Bowlesauthor=C.+A.+Buhrauthor=S.+Costanzoauthor=J.+K.+Curtisauthor=S.+C.+DeFinaauthor=L.+Dubenkoauthor=T.+S.+Heuerauthor=P.+Huangauthor=C.+Jaegerauthor=A.+Joshiauthor=A.+R.+Kennedyauthor=A.+I.+Kimauthor=K.+Laraauthor=J.+Leeauthor=J.+Liauthor=J.+C.+Lougheedauthor=S.+Maauthor=S.+Malekauthor=J.+C.+Manaloauthor=J.+F.+Martiniauthor=G.+McGrathauthor=M.+Nicollauthor=J.+M.+Nussauthor=M.+Packauthor=C.+J.+Petoauthor=T.+H.+Tsangauthor=L.+Wangauthor=S.+W.+Wombleauthor=M.+Yakesauthor=W.+Zhangauthor=K.+D.+Rice&title=Discovery+of+xl888%3A+a+novel+tropane-derived+small+molecule+inhibitor+of+hsp90&doi=10.1016%2Fj.bmcl.2012.07.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90</span></div><div class="casAuthors">Bussenius, Joerg; Blazey, Charles M.; Aay, Naing; Anand, Neel K.; Arcalas, Arlyn; Baik, TaeGon; Bowles, Owen J.; Buhr, Chris A.; Costanzo, Simona; Curtis, Jeffrey K.; DeFina, Steven C.; Dubenko, Larisa; Heuer, Timothy S.; Huang, Ping; Jaeger, Christopher; Joshi, Anagha; Kennedy, Abigail R.; Kim, Angie I.; Lara, Katherine; Lee, Jae; Li, Jonathan; Lougheed, Julie C.; Ma, Sunghoon; Malek, Shiva; Manalo, Jean-Claire L.; Martini, Jean-Francois; McGrath, Garth; Nicoll, Monique; Nuss, John M.; Pack, Michael; Peto, Csaba J.; Tsang, Tsze H.; Wang, Longcheng; Womble, Scott W.; Yakes, Michael; Zhang, Wentao; Rice, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5396-5404</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With structural guidance, tropane-derived HTS hits were modified to optimize for HSP90 inhibition and a desirable in vivo profile.  Through an iterative SAR development process 12i [I; X = cyclopropyl, R1 = Me, R2 = (R)-sec-Bu, XL888] was discovered and shown to reduce HSP90 client protein content in PD studies.  Furthermore, efficacy expts. performed in a NCI-N87 mouse xenograft model demonstrated tumor regression in some dosing regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYT__qJeDg0rVg90H21EOLACvtfcHk0ljF7ea3HDX21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL&md5=d62d69690c1f80ae0489a6a1350f2abe</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DBussenius%26aufirst%3DJ.%26aulast%3DBlazey%26aufirst%3DC.%2BM.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DAnand%26aufirst%3DN.%2BK.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DBowles%26aufirst%3DO.%2BJ.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DCostanzo%26aufirst%3DS.%26aulast%3DCurtis%26aufirst%3DJ.%2BK.%26aulast%3DDeFina%26aufirst%3DS.%2BC.%26aulast%3DDubenko%26aufirst%3DL.%26aulast%3DHeuer%26aufirst%3DT.%2BS.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DA.%2BI.%26aulast%3DLara%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLougheed%26aufirst%3DJ.%2BC.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DManalo%26aufirst%3DJ.%2BC.%26aulast%3DMartini%26aufirst%3DJ.%2BF.%26aulast%3DMcGrath%26aufirst%3DG.%26aulast%3DNicoll%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DPack%26aufirst%3DM.%26aulast%3DPeto%26aufirst%3DC.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWomble%26aufirst%3DS.%2BW.%26aulast%3DYakes%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRice%26aufirst%3DK.%2BD.%26atitle%3DDiscovery%2520of%2520xl888%253A%2520a%2520novel%2520tropane-derived%2520small%2520molecule%2520inhibitor%2520of%2520hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5396%26epage%3D5404%26doi%3D10.1016%2Fj.bmcl.2012.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzamide tetrahydro-4h-carbazol-4-ones as novel small molecule inhibitors of hsp90</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3517</span>– <span class="NLM_lpage">3521</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2008.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18511277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3517-3521&author=T.+E.+Bartaauthor=J.+M.+Vealauthor=J.+W.+Riceauthor=J.+M.+Partridgeauthor=R.+P.+Faddenauthor=W.+Maauthor=M.+Jenksauthor=L.+Gengauthor=G.+J.+Hansonauthor=K.+H.+Huangauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=J.+Ottoauthor=S.+E.+Hall&title=Discovery+of+benzamide+tetrahydro-4h-carbazol-4-ones+as+novel+small+molecule+inhibitors+of+hsp90&doi=10.1016%2Fj.bmcl.2008.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90</span></div><div class="casAuthors">Barta, Thomas E.; Veal, James M.; Rice, John W.; Partridge, Jeffrey M.; Fadden, R. Patrick; Ma, Wei; Jenks, Matthew; Geng, Lifeng; Hanson, Gunnar J.; Huang, Kenneth H.; Barabasz, Amy F.; Foley, Briana E.; Otto, James; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3517-3521</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Hsp90 maintains the conformational stability of multiple proteins implicated in oncogenesis and has emerged as a target for chemotherapy.  We report here the discovery of a novel small mol. scaffold that inhibits Hsp90.  X-ray data show that the scaffold binds competitively at the ATP site on Hsp90.  Cellular proliferation and client assays demonstrate that members of the series are able to inhibit Hsp90 at nanomolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC-Wjx_IUjKbVg90H21EOLACvtfcHk0ljF7ea3HDX21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFSns74%253D&md5=f965e9a2cfd0d44a57bb1949cd87de63</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520benzamide%2520tetrahydro-4h-carbazol-4-ones%2520as%2520novel%2520small%2520molecule%2520inhibitors%2520of%2520hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3517%26epage%3D3521%26doi%3D10.1016%2Fj.bmcl.2008.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4288</span>– <span class="NLM_lpage">4305</span>, <span class="refDoi"> DOI: 10.1021/jm900230j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective+and+orally+active+antitumor+agents&doi=10.1021%2Fjm900230j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0ljfob2guPArhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305%26doi%3D10.1021%2Fjm900230j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulte, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins</span>. <i>J. Natl. Cancer. Inst.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1093/jnci/92.3.242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1093%2Fjnci%2F92.3.242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10655441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFShsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=242-248&author=M.+G.+Marcuauthor=T.+W.+Schulteauthor=L.+Neckers&title=Novobiocin+and+related+coumarins+and+depletion+of+heat+shock+protein+90-dependent+signaling+proteins&doi=10.1093%2Fjnci%2F92.3.242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins</span></div><div class="casAuthors">Marcu, Monica G.; Schulte, Theodore W.; Neckers, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">242-248</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) interacts with and stabilizes several oncogenic protein kinases (e.g., p185erbB2, p60v-src, and Raf-1) and is required for the stability and dominant-neg. function of mutated p53 protein.  Two unrelated antibiotics, geldanamycin and radicicol, bind specifically to an atypical nucleotide-binding pocket of Hsp90, a site that shares homol. with the ATP-binding domain of bacterial DNA gyrase B.  This interaction leads to destabilization of proteins that interact with Hsp90.  Since the nucleotide-binding site of gyrase B is targeted by coumarin antibiotics (e.g., novobiocin), we investigated whether these drugs can also interact with Hsp90 and affect its activity.  We used immobilized novobiocin, geldanamycin, or radicicol to isolate either endogenous Hsp90 from cell lysates or Hsp90 deletion fragments translated in vitro.  Effects of the coumarin antibiotics novobiocin, chlorobiocin, and coumermycin A1 on several proteins interacting with Hsp90 were assessed in vitro and in vivo.  Hsp90 binding to immobilized novobiocin was competed by sol. coumarins and ATP but not by geldanamycin or radicicol.  A carboxy-terminal Hsp90 fragment bound immobilized novobiocin but not immobilized geldanamycin, while a geldanamycin-binding amino-terminal fragment did not bind novobiocin.  All three coumarins markedly reduced cellular levels of p185erbB2, p60v-src, Raf-1, and mutated p53.  Furthermore, novobiocin reduced Raf-1 levels in the spleens of mice treated with the drug.  These coumarin antibiotics, particularly novobiocin, represent a first-generation alternative to other Hsp90-targeting drugs that are not as well tolerated.  Novobiocin's unique interaction with Hsp90 identifies an addnl. site on this protein amenable to pharmacol. interference with small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSMDAYykmhSbVg90H21EOLACvtfcHk0ljfob2guPArhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFShsbk%253D&md5=05873d976f0d6a3e721576732e580ff2</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.3.242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.3.242%26sid%3Dliteratum%253Aachs%26aulast%3DMarcu%26aufirst%3DM.%2BG.%26aulast%3DSchulte%26aufirst%3DT.%2BW.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DNovobiocin%2520and%2520related%2520coumarins%2520and%2520depletion%2520of%2520heat%2520shock%2520protein%252090-dependent%2520signaling%2520proteins%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D242%26epage%3D248%26doi%3D10.1093%2Fjnci%2F92.3.242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcu, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhouche, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L. M.</span></span> <span> </span><span class="NLM_article-title">The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized atp-binding domain in the carboxyl terminus of the chaperone</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">37181</span>– <span class="NLM_lpage">37186</span>, <span class="refDoi"> DOI: 10.1074/jbc.M003701200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M003701200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10945979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslWlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=37181-37186&author=M.+G.+Marcuauthor=A.+Chadliauthor=I.+Bouhoucheauthor=M.+Catelliauthor=L.+M.+Neckers&title=The+heat+shock+protein+90+antagonist+novobiocin+interacts+with+a+previously+unrecognized+atp-binding+domain+in+the+carboxyl+terminus+of+the+chaperone&doi=10.1074%2Fjbc.M003701200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone</span></div><div class="casAuthors">Marcu, Monica G.; Chadli, Ahmed; Bouhouche, Ilham; Catelli, Maria; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">37181-37186</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90), one of the most abundant chaperones in eukaryotes, participates in folding and stabilization of signal-transducing mols. including steroid hormone receptors and protein kinases.  The amino terminus of Hsp90 contains a non-conventional nucleotide-binding site, related to the ATP-binding motif of bacterial DNA gyrase.  The anti-tumor agents geldanamycin and radicicol bind specifically at this site and induce destabilization of Hsp90-dependent client proteins.  We recently demonstrated that the gyrase inhibitor novobiocin also interacts with Hsp90, altering the affinity of the chaperone for geldanamycin and radicicol and causing in vitro and in vivo depletion of key regulatory Hsp90-dependent kinases including v-Src, Raf-1, and p185ErbB2.  In the present study we used deletion/mutation anal. to identify the site of interaction of novobiocin with Hsp90, and we demonstrate that the novobiocin-binding site resides in the carboxyl terminus of the chaperone.  Surprisingly, this motif also recognizes ATP, and ATP and novobiocin efficiently compete with each other for binding to this region of Hsp90.  Novobiocin interferes with assocn. of the co-chaperones Hsc70 and p23 with Hsp90.  These results identify a second site on Hsp90 where the binding of small mol. inhibitors can significantly impact the function of this chaperone, and they support the hypothesis that both amino- and carboxyl-terminal domains of Hsp90 interact to modulate chaperone activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYmW6Q8h7j4LVg90H21EOLACvtfcHk0lhSFH4nicrx0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslWlt7s%253D&md5=837ade0878a635b98abd82a0bcf83cee</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003701200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003701200%26sid%3Dliteratum%253Aachs%26aulast%3DMarcu%26aufirst%3DM.%2BG.%26aulast%3DChadli%26aufirst%3DA.%26aulast%3DBouhouche%26aufirst%3DI.%26aulast%3DCatelli%26aufirst%3DM.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DThe%2520heat%2520shock%2520protein%252090%2520antagonist%2520novobiocin%2520interacts%2520with%2520a%2520previously%2520unrecognized%2520atp-binding%2520domain%2520in%2520the%2520carboxyl%2520terminus%2520of%2520the%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D37181%26epage%3D37186%26doi%3D10.1074%2Fjbc.M003701200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawgo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vielhauer, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajewski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. D.</span></span> <span> </span><span class="NLM_article-title">Ku135, a novel novobiocin-derived c-terminal inhibitor of the 90-kda heat shock protein, exerts potent antiproliferative effects in human leukemic cells</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1314</span>– <span class="NLM_lpage">1322</span>, <span class="refDoi"> DOI: 10.1124/mol.109.058545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1124%2Fmol.109.058545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19741006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFajtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=1314-1322&author=S.+N.+Sheltonauthor=M.+E.+Shawgoauthor=S.+B.+Matthewsauthor=Y.+M.+Luauthor=A.+C.+Donnellyauthor=K.+Szablaauthor=M.+Tanolauthor=G.+A.+Vielhauerauthor=R.+A.+Rajewskiauthor=R.+L.+Mattsauthor=B.+S.+J.+Blaggauthor=J.+D.+Robertson&title=Ku135%2C+a+novel+novobiocin-derived+c-terminal+inhibitor+of+the+90-kda+heat+shock+protein%2C+exerts+potent+antiproliferative+effects+in+human+leukemic+cells&doi=10.1124%2Fmol.109.058545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells</span></div><div class="casAuthors">Shelton, Shary N.; Shawgo, Mary E.; Matthews, Shawna B.; Lu, Yuanming; Donnelly, Alison C.; Szabla, Kristen; Tanol, Mehmet; Vielhauer, George A.; Rajewski, Roger A.; Matts, Robert L.; Blagg, Brian S. J.; Robertson, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1314-1322</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The 90-kDa heat shock protein (Hsp90) assists in the proper folding of numerous mutated or overexpressed signal transduction proteins that are involved in cancer.  Consequently, there is considerable interest in developing chemotherapeutic drugs that specifically disrupt the function of Hsp90.  Here, we investigated the extent to which a novel novobiocin-derived C-terminal Hsp90 inhibitor, designated KU135, induced antiproliferative effects in Jurkat T-lymphocytes.  The results indicated that KU135 bound directly to Hsp90, caused the degrdn. of known Hsp90 client proteins, and induced more potent antiproliferative effects than the established N-terminal Hsp90 inhibitor 17-allylamino-demethoxygeldanamycin (17-AAG).  Closer examn. of the cellular response to KU135 and 17-AAG revealed that only 17-AAG induced a strong up-regulation of Hsp70 and Hsp90.  In addn., KU135 caused wild-type cells to undergo G2/M arrest, whereas cells treated with 17-AAG accumulated in G1.  Furthermore, KU135 but not 17-AAG was found to be a potent inducer of mitochondria-mediated apoptosis as evidenced, in part, by the fact that cell death was inhibited to a similar extent by Bcl-2/Bcl-xL overexpression or the depletion of apoptotic protease-activating factor-1 (Apaf-1).  Together, these data suggest that KU135 inhibits cell proliferation by regulating signaling pathways that are mechanistically different from those targeted by 17-AAG and as such represents a novel opportunity for Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnRfCmPO43irVg90H21EOLACvtfcHk0lhSFH4nicrx0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFajtbzK&md5=03fe82110c457194b6a58a9222ffaeac</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.058545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.058545%26sid%3Dliteratum%253Aachs%26aulast%3DShelton%26aufirst%3DS.%2BN.%26aulast%3DShawgo%26aufirst%3DM.%2BE.%26aulast%3DMatthews%26aufirst%3DS.%2BB.%26aulast%3DLu%26aufirst%3DY.%2BM.%26aulast%3DDonnelly%26aufirst%3DA.%2BC.%26aulast%3DSzabla%26aufirst%3DK.%26aulast%3DTanol%26aufirst%3DM.%26aulast%3DVielhauer%26aufirst%3DG.%2BA.%26aulast%3DRajewski%26aufirst%3DR.%2BA.%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BD.%26atitle%3DKu135%252C%2520a%2520novel%2520novobiocin-derived%2520c-terminal%2520inhibitor%2520of%2520the%252090-kda%2520heat%2520shock%2520protein%252C%2520exerts%2520potent%2520antiproliferative%2520effects%2520in%2520human%2520leukemic%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D76%26spage%3D1314%26epage%3D1322%26doi%3D10.1124%2Fmol.109.058545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girgis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of biphenylamide derivatives as hsp90 c-terminal inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2014.10.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25462258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOjtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=442-466&author=H.+P.+Zhaoauthor=G.+Gargauthor=J.+B.+Zhaoauthor=E.+Moroniauthor=A.+Girgisauthor=L.+S.+Francoauthor=S.+Singhauthor=G.+Colomboauthor=B.+S.+J.+Blagg&title=Design%2C+synthesis+and+biological+evaluation+of+biphenylamide+derivatives+as+hsp90+c-terminal+inhibitors&doi=10.1016%2Fj.ejmech.2014.10.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors</span></div><div class="casAuthors">Zhao, Huiping; Garg, Gaurav; Zhao, Jinbo; Moroni, Elisabetta; Girgis, Antwan; Franco, Lucas S.; Singh, Swapnil; Colombo, Giorgio; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">442-466</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Modulation of Hsp90 C-terminal function represents a promising therapeutic approach for the treatment of cancer and neurodegenerative diseases.  Current drug discovery efforts toward Hsp90 C-terminal inhibition focus on novobiocin, an antibiotic that was transformed into an Hsp90 inhibitor.  Based on structural information obtained during the development of novobiocin derivs. and mol. docking studies, scaffolds contg. a biphenyl moiety in lieu of the coumarin ring present in novobiocin were identified as new Hsp90 C-terminal inhibitors.  Structure-activity relationship studies produced new derivs. that inhibit the proliferation of breast cancer cell lines at nanomolar concns., which corresponded directly with Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriNBiJ3-nN5bVg90H21EOLACvtfcHk0lhSFH4nicrx0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOjtr7P&md5=db84a45153f85cfce09c8c2a7487f93d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.034%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%2BP.%26aulast%3DGarg%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DJ.%2BB.%26aulast%3DMoroni%26aufirst%3DE.%26aulast%3DGirgis%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DL.%2BS.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DG.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520biphenylamide%2520derivatives%2520as%2520hsp90%2520c-terminal%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D442%26epage%3D466%26doi%3D10.1016%2Fj.ejmech.2014.10.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent hsp90 c-terminal inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2017.07.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29028527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=1-14&author=F.+Jiangauthor=A.+P.+Guoauthor=J.+C.+Xuauthor=H.+J.+Wangauthor=X.+F.+Moauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Identification+and+optimization+of+novel+6-acylamino-2-aminoquinolines+as+potent+hsp90+c-terminal+inhibitors&doi=10.1016%2Fj.ejmech.2017.07.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent Hsp90 C-terminal inhibitors</span></div><div class="casAuthors">Jiang, Fen; Guo, An-ping; Xu, Jia-cheng; Wang, Hui-Jie; Mo, Xiao-fei; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In order to discover novel Hsp90 inhibitors targeting the C-terminal ATP binding pocket, a novobiocin deriv. based ROCS model was constructed for virtual screening.  Compd. I was identified as the lead compd. and then a systematical structure activity relationship (SAR) study was conducted.  These efforts led to compd. II, which exhibited potent anti-proliferative activities against MCF7 and SKBr3 breast cancer cell lines.  In 4T1 mice breast cancer models, II exhibited potent tumor growth inhibition and anti-metastasis effect.  Compd. II as a potent antitumor agent targeting the Hsp90 C-terminal is worthy of further pre-clin. study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqd_QoafcBbVg90H21EOLACvtfcHk0liLDp3E_BVpvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvJ&md5=01389c6f8957dc81c124051127410ecb</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.080%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DA.%2BP.%26aulast%3DXu%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DMo%26aufirst%3DX.%2BF.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520novel%25206-acylamino-2-aminoquinolines%2520as%2520potent%2520hsp90%2520c-terminal%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D1%26epage%3D14%26doi%3D10.1016%2Fj.ejmech.2017.07.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazici, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for depletion of heat shock protein 90 client proteins by deguelin</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1093/jnci/djm007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1093%2Fjnci%2Fdjm007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17565155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVaqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2007&pages=949-961&author=S.+H.+Ohauthor=J.+K.+Wooauthor=Y.+D.+Yaziciauthor=J.+N.+Myersauthor=W.+Y.+Kimauthor=Q.+Jinauthor=S.+S.+Hongauthor=H.+J.+Parkauthor=Y.+G.+Suhauthor=K.+W.+Kimauthor=W.+K.+Hongauthor=H.+Y.+Lee&title=Structural+basis+for+depletion+of+heat+shock+protein+90+client+proteins+by+deguelin&doi=10.1093%2Fjnci%2Fdjm007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for depletion of heat shock protein 90 client proteins by deguelin</span></div><div class="casAuthors">Oh, Seung Hyun; Woo, Jong Kyu; Yazici, Yasemin Dakak; Myers, Jeffrey N.; Kim, Woo-Young; Jin, Quanri; Hong, Soon Sun; Park, Hyun-Ju; Suh, Young-Ger; Kim, Kyu-Won; Hong, Waun Ki; Lee, Ho-Young</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">949-961</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background The mol. chaperone heat shock protein 90 (Hsp90) participates in preserving the expression and activity of various oncoproteins, including hypoxia-inducible factor 1α (HIF-1α) and Akt.  Deguelin is a rotenoid with antitumor activities.  We investigated whether the antitumor activities of deguelin involve the functional inhibition of Hsp90.  Method Human xenograft tumors were generated in mice from H1299 (n = 6 per group) and A549 (n = 4 per group) non-small-cell lung cancer cells, UMSCC38 (n = 5 per group) head and neck cancer cells, MKN45 (n = 5 per group) stomach cancer cells, and PC-3 (n = 3 per group) prostate cancer cells.  Tumor-bearing mice were treated with deguelin at 4 or 8 mg/kg or with vehicle (as a control) twice a day by oral gavage for 15-28 days.  Protein expression was assessed by western blot anal.  Akt and Hsp90 were assessed by use of adenoviral vectors expressing constitutively active Akt or Hsp90.  Binding of deguelin to Hsp90 was examd. by docking anal. and by competition binding expts. with ATP-Sepharose beads.  The proteasome inhibitor MG132 was used to investigate deguelin's effect on the induction of ubiquitin-mediated proteasomal degrdn. of HIF-1α.  All statistical tests were two-sided.  Results Deguelin bound to the ATP-binding pocket of Hsp90 and disrupted Hsp90 function, leading to ubiquitin-mediated degrdn. of HIF-1α.  Administration of deguelin to xenograft-bearing mice statistically significantly decreased tumor growth by inducing apoptosis and decreasing the expression of Hsp90 client proteins, without detectable toxic effects.  For example, at 15 days after the start of deguelin treatment, the vol. of untreated control H1299 xenograft tumors was 798 mm3 and that of xenograft tumors treated with deguelin at 4 mg/kg was 115.9 mm3 (difference = 682.1 mm3, 95% confidence interval = 480.4 to 883.9 mm3; P<.001).  Conclusions The antitumor activities of deguelin appear to involve its binding to the ATP-binding pocket of Hsp90, which suppresses Hsp90 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq0Ge16pQ-y7Vg90H21EOLACvtfcHk0liLDp3E_BVpvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVaqtrY%253D&md5=4bd7e522dc30d92a136556d171a7dbf3</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjm007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjm007%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%2BH.%26aulast%3DWoo%26aufirst%3DJ.%2BK.%26aulast%3DYazici%26aufirst%3DY.%2BD.%26aulast%3DMyers%26aufirst%3DJ.%2BN.%26aulast%3DKim%26aufirst%3DW.%2BY.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DSuh%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DHong%26aufirst%3DW.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BY.%26atitle%3DStructural%2520basis%2520for%2520depletion%2520of%2520heat%2520shock%2520protein%252090%2520client%2520proteins%2520by%2520deguelin%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2007%26volume%3D99%26spage%3D949%26epage%3D961%26doi%3D10.1093%2Fjnci%2Fdjm007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (hsp90) inhibitors targeting proliferation and angiogenesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10863</span>– <span class="NLM_lpage">10884</span>, <span class="refDoi"> DOI: 10.1021/jm301488q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301488q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10863-10884&author=D.+J.+Changauthor=H.+Anauthor=K.+S.+Kimauthor=H.+H.+Kimauthor=J.+Jungauthor=J.+M.+Leeauthor=N.+J.+Kimauthor=Y.+T.+Hanauthor=H.+Yunauthor=S.+Leeauthor=G.+Leeauthor=S.+Leeauthor=J.+S.+Leeauthor=J.+H.+Chaauthor=J.+H.+Parkauthor=J.+W.+Parkauthor=S.+C.+Leeauthor=S.+G.+Kimauthor=J.+H.+Kimauthor=H.+Y.+Leeauthor=K.+W.+Kimauthor=Y.+G.+Suh&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+deguelin-based+heat+shock+protein+90+%28hsp90%29+inhibitors+targeting+proliferation+and+angiogenesis&doi=10.1021%2Fjm301488q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis</span></div><div class="casAuthors">Chang, Dong-Jo; An, Hongchan; Kim, Kyoung-suk; Kim, Hyun Ho; Jung, Jinkyung; Lee, Jung Min; Kim, Nam-Jung; Han, Young Taek; Yun, Hwayoung; Lee, Sujin; Lee, Geumwoo; Lee, Seungbeom; Lee, Ju Sung; Cha, Jong-Ho; Park, Ji-Hyeon; Park, Ji Won; Lee, Su-Chan; Kim, Sang Geon; Kim, Jeong Hun; Lee, Ho-Young; Kim, Kyu-Won; Suh, Young-Ger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10863-10884</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deguelin exhibits potent apoptotic and antiangiogenic activities in a variety of transformed cells and cancer cells.  Deguelin also exhibits potent tumor suppressive effects in xenograft tumor models for many human cancers.  Our initial studies confirmed that deguelin disrupts ATP binding to HSP90 and consequently induces destabilization of its client proteins such as HIF-1α.  Interestingly, a fluorescence probe assay revealed that deguelin and its analogs do not compete with ATP binding to the N-terminus of HSP90, unlike most HSP90 inhibitors.  To det. the key parts of deguelin that contribute to its potent HSP90 inhibition, as well as its antiproliferative and antiangiogenic activities, we have established a structure-activity relationship (SAR) of deguelin.  In the course of these studies, we identified a series of novel and potent HSP90 inhibitors.  In particular, analogs 54 and 69, the B- and C-ring-truncated compds., exhibited excellent antiproliferative activities with IC50 of 140 and 490 nM in the H1299 cell line, resp., and antiangiogenic activities in zebrafish embryos in a dose dependent manner (0.25-1.25 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonMGujwNaDpLVg90H21EOLACvtfcHk0liLDp3E_BVpvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgsbvF&md5=d997eea48c1301b19830f6f7c41f3747</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm301488q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301488q%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DD.%2BJ.%26aulast%3DAn%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BH.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DN.%2BJ.%26aulast%3DHan%26aufirst%3DY.%2BT.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DCha%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DSuh%26aufirst%3DY.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520deguelin-based%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520inhibitors%2520targeting%2520proliferation%2520and%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10863%26epage%3D10884%26doi%3D10.1021%2Fjm301488q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seong, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of a novel deguelin derivative, l80, which disrupts atp binding to the c-terminal domain of heat shock protein 90</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1124/mol.114.096883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1124%2Fmol.114.096883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25976766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaqsbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=245-255&author=S.+C.+Leeauthor=H.+Y.+Minauthor=H.+Choiauthor=H.+S.+Kimauthor=K.+C.+Kimauthor=S.+J.+Parkauthor=M.+A.+Seongauthor=J.+H.+Seoauthor=H.+J.+Parkauthor=Y.+G.+Suhauthor=K.+W.+Kimauthor=H.+S.+Hongauthor=H.+Kimauthor=M.+Y.+Leeauthor=J.+Leeauthor=H.+Y.+Lee&title=Synthesis+and+evaluation+of+a+novel+deguelin+derivative%2C+l80%2C+which+disrupts+atp+binding+to+the+c-terminal+domain+of+heat+shock+protein+90&doi=10.1124%2Fmol.114.096883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a novel deguelin derivative, L80, which disrupts ATP binding to the C-terminal domain of heat shock protein 90</span></div><div class="casAuthors">Lee, Su-Chan; Min, Hye-Young; Choi, Hoon; Kim, Ho Shin; Kim, Kyong-Cheol; Park, So-Jung; Seong, Myeong A.; Seo, Ji Hae; Park, Hyun-Ju; Suh, Young-Ger; Kim, Kyu-Won; Hong, Hyun-Seok; Kim, Hee; Lee, Min-Young; Lee, Jeewoo; Lee, Ho-Young</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-255</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The clin. benefit of current anticancer regimens for lung cancer therapy is still limited due to moderate efficacy, drug resistance, and recurrence.  Therefore, the development of effective anticancer drugs for first-line therapy and for optimal second-line treatment is necessary.  Because the 90-kDa mol. chaperone heat shock protein (Hsp90) contributes to the maturation of numerous mutated or overexpressed oncogenic proteins, targeting Hsp90 may offer an effective anticancer therapy.  Here, we investigated antitumor activities and toxicity of a novel deguelin-derived C-terminal Hsp90 inhibitor, designated L80.  L80 displayed significant inhibitory effects on the viability, colony formation, angiogenesis-stimulating activity, migration, and invasion of a panel of non-small cell lung cancer cell lines and their sublines with acquired resistance to paclitaxel with minimal toxicity to normal lung epithelial cells, hippocampal cells, vascular endothelial cells, and ocular cells.  Biochem. analyses and mol. docking simulation revealed that L80 disrupted Hsp90 function by binding to the C-terminal ATP-binding pocket of Hsp90, leading to the disruption of the interaction between hypoxia-inducible factor (HIF)-1α and Hsp90, downregulation of HIF-1α and its target genes, including vascular endothelial growth factor (VEGF) and insulin-like growth factor 2 (IGF2), and decreased the expression of various Hsp90 client proteins.  Consistent with these in vitro findings, L80 exhibited significant antitumor and antiangiogenic activities in H1299 xenograft tumors.  These results suggest that L80 represents a novel C-terminal Hsp90 inhibitor with effective anticancer activities with minimal toxicities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxzKLGllhTD7Vg90H21EOLACvtfcHk0lhorS2x_Xdn6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaqsbnO&md5=e7a2f4f64cce715e19ffd9393f88cd1a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.096883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.096883%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DMin%26aufirst%3DH.%2BY.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DSeong%26aufirst%3DM.%2BA.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DSuh%26aufirst%3DY.%2BG.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DM.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DH.%2BY.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520deguelin%2520derivative%252C%2520l80%252C%2520which%2520disrupts%2520atp%2520binding%2520to%2520the%2520c-terminal%2520domain%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D245%26epage%3D255%26doi%3D10.1124%2Fmol.114.096883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasiewicz, T. A.</span></span> <span> </span><span class="NLM_article-title">(−)-Epigallocatechin-3-gallate is a novel hsp90 inhibitor</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/bi801637q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801637q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVA%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=336-345&author=Z.+Y.+Yinauthor=E.+C.+Henryauthor=T.+A.+Gasiewicz&title=%28%E2%88%92%29-Epigallocatechin-3-gallate+is+a+novel+hsp90+inhibitor&doi=10.1021%2Fbi801637q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">(-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor</span></div><div class="casAuthors">Yin, Zhengyu; Henry, Ellen C.; Gasiewicz, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">336-345</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea, protects against certain types of cancers, although the mechanism has not yet been detd.  It was previously demonstrated that EGCG blocks aryl hydrocarbon receptor (AhR)-mediated transcription induced by the potent carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).  Unlike other AhR antagonists that directly bind to the AhR, EGCG inhibits AhR-mediated transcription by binding to hsp90.  We hypothesize that EGCG exerts anti-AhR and anticancer effects by acting as an hsp90 inhibitor.  Using proteolytic footprinting, immunopptn., and an ATP-agarose pull-down assay, EGCG was found to directly modulate the conformation of hsp90 and bind at or near to a C-terminal ATP binding site.  Hsp90 chaperone function, as assessed by its ability to mediate refolding of denatured luciferase, was inhibited by EGCG treatment.  Hsp90 dimerization, which occurs at the C-terminal end, was also inhibited by EGCG treatment.  Coimmunopptn. studies showed that EGCG stabilizes an AhR complex that includes hsp90 and XAP2 (hepatitis B virus X-assocd. protein 2), and decreases the assocn. of aryl hydrocarbon nuclear translocator (Arnt) with ligand-activated AhR.  Thus, EGCG, through its ability to bind to hsp90, blocks AhR response element (AhRE) recognition.  These studies indicate a novel mechanism whereby EGCG inhibits ligand-induced AhRE binding and AhR-mediated transcriptional activity.  In EGCG-treated human ovarian carcinoma SKOV3 cells, decreased levels of several cancer-related hsp90 client proteins, such as ErbB2, Raf-1 and phospho-AKT, were obsd.  EGCG also modified the assocn. of hsp90 with several cochaperones.  Overall, these data indicate that EGCG is a novel hsp90 inhibitor.  Further studies are needed to det. if this has a role in the antitumor actions of EGCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJtTASUyiNZLVg90H21EOLACvtfcHk0lhorS2x_Xdn6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVA%253D&md5=f68a174c84abfa0c7513e1d1125721dd</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fbi801637q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801637q%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DZ.%2BY.%26aulast%3DHenry%26aufirst%3DE.%2BC.%26aulast%3DGasiewicz%26aufirst%3DT.%2BA.%26atitle%3D%2528%25E2%2588%2592%2529-Epigallocatechin-3-gallate%2520is%2520a%2520novel%2520hsp90%2520inhibitor%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D336%26epage%3D345%26doi%3D10.1021%2Fbi801637q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasiewicz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotella, D. P.</span></span> <span> </span><span class="NLM_article-title">Towards the discovery of drug-like epigallocatechin gallate analogs as hsp90 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2263</span>– <span class="NLM_lpage">2266</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2014.03.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24745965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVWgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2263-2266&author=R.+Bhatauthor=A.+T.+Adamauthor=J.+J.+Leeauthor=T.+A.+Gasiewiczauthor=E.+C.+Henryauthor=D.+P.+Rotella&title=Towards+the+discovery+of+drug-like+epigallocatechin+gallate+analogs+as+hsp90+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Adam, Amna T.; Lee, Jungeun Jasmine; Gasiewicz, Thomas A.; Henry, Ellen C.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2263-2266</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">(-)-Epigallocatechin gallate (EGCG) is the major flavonoid of green tea and has been widely explored for a range of biol. activities including anti-infective, anti-inflammatory, anticancer, and neuroprotection.  Existing structure-activity data for EGCG has been largely limited to exploration of simple ethers and hydroxyl deletion.  EGCG has poor drug-like properties because of multiple phenolic hydroxyl moieties and a metabolically labile ester.  This work reports a substantial expansion of structure-activity understanding by exploring a range of semi-synthetic and synthetic derivs. with ester replacements and variously substituted arom. and alicyclic groups contg. more drug-like substituents.  Structure-activity relationships for these mols. were obtained for Hsp90 inhibition.  The results indicate that amide and sulfonamide linkers are suitable ester replacements.  Hydroxylated arom. rings and the cis-stereochem. in EGCG are not essential for Hsp90 inhibition.  Selected analogs in this series are more potent than EGCG in a luciferase refolding assay for Hsp90 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOuaPPZjVk-7Vg90H21EOLACvtfcHk0lhorS2x_Xdn6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVWgs7s%253D&md5=4398fa70ba76afc9c19e155259cf2cd6</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.088%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DAdam%26aufirst%3DA.%2BT.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DGasiewicz%26aufirst%3DT.%2BA.%26aulast%3DHenry%26aufirst%3DE.%2BC.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DTowards%2520the%2520discovery%2520of%2520drug-like%2520epigallocatechin%2520gallate%2520analogs%2520as%2520hsp90%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2263%26epage%3D2266%26doi%3D10.1016%2Fj.bmcl.2014.03.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of derrubone and select analogues</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1021/jo702366g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo702366g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOntb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=369-373&author=J.+M.+Hastingsauthor=M.+K.+Haddenauthor=B.+S.+J.+Blagg&title=Synthesis+and+evaluation+of+derrubone+and+select+analogues&doi=10.1021%2Fjo702366g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Derrubone and Select Analogues</span></div><div class="casAuthors">Hastings, Jedidiah M.; Hadden, M. Kyle; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-373</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, we reported that the natural product derrubone (I) exhibits Hsp90 inhibitory activity.  Due to its unique architectural scaffold and proposed rapid assembly, the synthesis of this natural product was pursued with the aim of identifying structure-activity relationships.  Synthesis of the natural product was accomplished in eight highly convergent steps, which led to a facile method for the construction of related compds.  Biol. evaluation of derrubone and its analogs identified several compds. that exhibit low micromolar inhibitory activity against breast and colon cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy5GrygGbgkbVg90H21EOLACvtfcHk0lhsFBo63OpHNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOntb3P&md5=5a121ce4c7369c2e7091373745ef4916</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjo702366g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo702366g%26sid%3Dliteratum%253Aachs%26aulast%3DHastings%26aufirst%3DJ.%2BM.%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520derrubone%2520and%2520select%2520analogues%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D369%26epage%3D373%26doi%3D10.1021%2Fjo702366g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Identification and initial sar of silybin: an hsp90 inhibitor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2659</span>– <span class="NLM_lpage">2664</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2010.12.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21273068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFKitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2659-2664&author=H.+Zhaoauthor=G.+E.+Brandtauthor=L.+Galamauthor=R.+L.+Mattsauthor=B.+S.+J.+Blagg&title=Identification+and+initial+sar+of+silybin%3A+an+hsp90+inhibitor&doi=10.1016%2Fj.bmcl.2010.12.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and initial SAR of silybin: An Hsp90 inhibitor</span></div><div class="casAuthors">Zhao, Huiping; Brandt, Gary E.; Galam, Lakshmi; Matts, Robert L.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2659-2664</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Through Hsp90-dependent firefly luciferase refolding and Hsp90-dependent heme-regulated eIF2α kinase (HRI) activation assays, silybin was identified as a novel Hsp90 inhibitor.  Subsequently, a library of silybin analogs was designed, synthesized and evaluated.  Initial SAR studies identified the essential, non-essential and detrimental functionalities on silybin that contribute to Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt94Ogk4uDwLVg90H21EOLACvtfcHk0lhsFBo63OpHNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFKitro%253D&md5=e4b5fe0694f91b55cb3d017a1c475d0f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.088%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DBrandt%26aufirst%3DG.%2BE.%26aulast%3DGalam%26aufirst%3DL.%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DIdentification%2520and%2520initial%2520sar%2520of%2520silybin%253A%2520an%2520hsp90%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2659%26epage%3D2664%26doi%3D10.1016%2Fj.bmcl.2010.12.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voruganti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhivker, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Elucidation of the hsp90 c-terminal inhibitor binding site</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.1021/cb200052x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200052x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=800-807&author=R.+L.+Mattsauthor=A.+Dixitauthor=L.+B.+Petersonauthor=L.+Sunauthor=S.+Vorugantiauthor=P.+Kalyanaramanauthor=S.+D.+Hartsonauthor=G.+M.+Verkhivkerauthor=B.+S.+J.+Blagg&title=Elucidation+of+the+hsp90+c-terminal+inhibitor+binding+site&doi=10.1021%2Fcb200052x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site</span></div><div class="casAuthors">Matts, Robert L.; Dixit, Anshuman; Peterson, Laura B.; Sun, Liang; Voruganti, Sudhakar; Kalyanaraman, Palgunan; Hartson, Steve D.; Verkhivker, Gennady M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">800-807</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Hsp90 chaperone machine is required for the folding, activation, and/or stabilization of more than 50 proteins directly related to malignant progression.  Hsp90 contains small mol. binding sites at both its N- and C-terminal domains; however, limited structural and biochem. data regarding the C-terminal binding site is available.  In this report, the small mol. binding site in the Hsp90 C-terminal domain was revealed by protease fingerprinting and photoaffinity labeling utilizing LC-MS/MS.  The identified site was characterized by generation of a homol. model for hHsp90α using the SAXS open structure of HtpG and docking the bioactive conformation of NB into the generated model.  The resulting model for the bioactive conformation of NB bound to Hsp90α is presented herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlggNNK43lbVg90H21EOLACvtfcHk0lhsFBo63OpHNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSgurc%253D&md5=04d10587dc95be898ec7e225cd0a7d4b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fcb200052x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200052x%26sid%3Dliteratum%253Aachs%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DVoruganti%26aufirst%3DS.%26aulast%3DKalyanaraman%26aufirst%3DP.%26aulast%3DHartson%26aufirst%3DS.%2BD.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DElucidation%2520of%2520the%2520hsp90%2520c-terminal%2520inhibitor%2520binding%2520site%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D800%26epage%3D807%26doi%3D10.1021%2Fcb200052x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratajczak, T.</span></span> <span> </span><span class="NLM_article-title">Modulation of chaperone function and cochaperone interaction by novobiocin in the C-Terminal domain of hsp90 - evidence that coumarin antibiotics disrupt hsp90 dimerization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">7161</span>– <span class="NLM_lpage">7171</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512406200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M512406200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=16421106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ygsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7161-7171&author=R.+K.+Allanauthor=D.+Mokauthor=B.+K.+Wardauthor=T.+Ratajczak&title=Modulation+of+chaperone+function+and+cochaperone+interaction+by+novobiocin+in+the+C-Terminal+domain+of+hsp90+-+evidence+that+coumarin+antibiotics+disrupt+hsp90+dimerization&doi=10.1074%2Fjbc.M512406200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90. Evidence that Coumarin Antibiotics Disrupt Hsp90 Dimerization</span></div><div class="casAuthors">Allan, Rudi K.; Mok, Danny; Ward, Bryan K.; Ratajczak, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7161-7171</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The C-terminal domain of Hsp90 displays independent chaperone activity, mediates dimerization, and contains the MEEVD motif essential for interaction with tetratricopeptide repeat-contg. immunophilin cochaperones assembled in mature steroid receptor complexes.  An α-helical region, upstream of the MEEVD peptide, helps form the dimerization interface and includes a hydrophobic microdomain that contributes to the Hsp90 interaction with the immunophilin cochaperones and corresponds to the binding site for novobiocin, a coumarin-related Hsp90 inhibitor.  Mutation of selected residues within the hydrophobic microdomain significantly impacted the chaperone function of a recombinant C-terminal Hsp90 fragment and novobiocin inhibited wild-type chaperone activity.  Prior incubation of the Hsp90 fragment with novobiocin led to a direct blockade of immunophilin cochaperone binding.  However, the drug had little influence on the pre-formed Hsp90-immunophilin complex, suggesting that bound cochaperones mask the novobiocin-binding site.  We obsd. a differential effect of the drug on Hsp90-immunophilin interaction, suggesting that the immunophilins make distinct contacts within the C-terminal domain to specifically modulate Hsp90 function.  Novobiocin also precluded the interaction of full-length Hsp90 with the p50cdc37 cochaperone, which targets the N-terminal nucleotide-binding domain, and is prevalent in Hsp90 complexes with protein kinase substrates.  Novobiocin therefore acts locally and allosterically to induce conformational changes within multiple regions of the Hsp90 protein.  We provide evidence that coumermycin A1, a coumarin structurally related to novobiocin, interferes with dimerization of the Hsp90 C-terminal domain.  Coumarin-based inhibitors then may antagonize Hsp90 function by inducing a conformation favoring sepn. of the C-terminal domains and release of substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqafkJcVZJK97Vg90H21EOLACvtfcHk0lhsFBo63OpHNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ygsLo%253D&md5=17eb0a30eb1e2cce9c803d8f52e3dccc</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512406200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512406200%26sid%3Dliteratum%253Aachs%26aulast%3DAllan%26aufirst%3DR.%2BK.%26aulast%3DMok%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DB.%2BK.%26aulast%3DRatajczak%26aufirst%3DT.%26atitle%3DModulation%2520of%2520chaperone%2520function%2520and%2520cochaperone%2520interaction%2520by%2520novobiocin%2520in%2520the%2520C-Terminal%2520domain%2520of%2520hsp90%2520-%2520evidence%2520that%2520coumarin%2520antibiotics%2520disrupt%2520hsp90%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7161%26epage%3D7171%26doi%3D10.1074%2Fjbc.M512406200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gray, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderwood, S. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the oncogene and kinome chaperone cdc37</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1038/nrc2420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnrc2420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18511936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFOkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=491-495&author=P.+J.+Grayauthor=T.+Princeauthor=J.+Chengauthor=M.+A.+Stevensonauthor=S.+K.+Calderwood&title=Targeting+the+oncogene+and+kinome+chaperone+cdc37&doi=10.1038%2Fnrc2420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the oncogene and kinome chaperone CDC37</span></div><div class="casAuthors">Gray, Phillip J., Jr.; Prince, Thomas; Cheng, Jinrong; Stevenson, Mary Ann; Calderwood, Stuart K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">491-495</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  CDC37 is oncogenic because it stabilizes the structures of mutated or overexpressed oncogenic kinases.  Targeting this chaperone activity, on which many tumors depend, is therefore an attractive option for broad-based therapy.  CDC37 is a mol. chaperone that phys. stabilizes the catalytic domains found in protein kinases and is therefore a wide-spectrum regulator of protein phosphorylation.  It is also an overexpressed oncoprotein that mediates carcinogenesis by stabilizing the compromised structures of mutant and/or overexpressed oncogenic kinases.  Recent work shows that such dependency of malignant cells on increased CDC37 expression is a vulnerability that can be targeted in cancer by agents that deplete or inhibit CDC37.  CDC37 is thus a candidate for broad-spectrum mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWFC_lNqASUbVg90H21EOLACvtfcHk0lhBF44Dl2ohVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFOkt7Y%253D&md5=4d58abe1731c3b24702e96c38b359a0f</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnrc2420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2420%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DP.%2BJ.%26aulast%3DPrince%26aufirst%3DT.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DStevenson%26aufirst%3DM.%2BA.%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26atitle%3DTargeting%2520the%2520oncogene%2520and%2520kinome%2520chaperone%2520cdc37%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D491%26epage%3D495%26doi%3D10.1038%2Fnrc2420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, D.</span></span> <span> </span><span class="NLM_article-title">Cdc37 goes beyond hsp90 and kinases</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14627196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=114-119&author=M.+MacLeanauthor=D.+Picard&title=Cdc37+goes+beyond+hsp90+and+kinases&doi=10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc37 goes beyond Hsp90 and kinases</span></div><div class="casAuthors">MacLean, Morag; Picard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">114-119</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Cell Stress Society International</span>)
        </div><div class="casAbstract">A review.  Cdc37 is a relatively poorly conserved and yet essential mol. chaperone.  It has long been thought to function primarily as an accessory factor for Hsp90, notably directing Hsp90 to kinases as substrates.  More recent discoveries challenge this simplistic view.  Cdc37 client proteins other than kinases have now been found, and Cdc37 displays a variety of Hsp90-independent activities both in vitro and in vivo.  It can function as a mol. chaperone by itself, interact with other Hsp90 cochaperones in the absence of Hsp90, and even support yeast growth and protein folding without its Hsp90-binding domain.  Thus, for many substrates, there may be many alternative chaperone pathways involving Cdc37, Hsp90, or both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMWmosbT89-rVg90H21EOLACvtfcHk0lhBF44Dl2ohVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlWkt7w%253D&md5=d411091b8924d2f909889c5d72ef7e5e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1379%252F1466-1268%25282003%2529008%253C0114%253ACGBHAK%253E2.0.CO%253B2%26sid%3Dliteratum%253Aachs%26aulast%3DMacLean%26aufirst%3DM.%26aulast%3DPicard%26aufirst%3DD.%26atitle%3DCdc37%2520goes%2520beyond%2520hsp90%2520and%2520kinases%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2003%26volume%3D8%26spage%3D114%26epage%3D119%26doi%3D10.1379%2F1466-1268%282003%29008%3C0114%3ACGBHAK%3E2.0.CO%3B2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMayo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finegold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span> <span> </span><span class="NLM_article-title">Induction of human cdc37 in prostate cancer correlates with the ability of targeted cdc37 expression to promote prostatic hyperplasia</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2186</span>– <span class="NLM_lpage">2193</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1203561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fsj.onc.1203561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10822368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslelsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2186-2193&author=L.+Stepanovaauthor=G.+Yangauthor=F.+DeMayoauthor=T.+M.+Wheelerauthor=M.+Finegoldauthor=T.+C.+Thompsonauthor=J.+W.+Harper&title=Induction+of+human+cdc37+in+prostate+cancer+correlates+with+the+ability+of+targeted+cdc37+expression+to+promote+prostatic+hyperplasia&doi=10.1038%2Fsj.onc.1203561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia</span></div><div class="casAuthors">Stepanova, Lilia; Yang, Guang; DeMayo, Franco; Wheeler, Thomas M.; Finegold, Milton; Thompson, Timothy C.; Harper, J. Wade</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2186-2193</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Cdc37 gene encodes a 50 kDa protein which targets intrinsically unstable oncoprotein kinases such as Cdk4, Raf-1, and src to the mol. chaperone Hsp90.  This activity is thought to play an important role in the establishment of signaling pathways controlling cell proliferation.  The budding yeast Cdc37 homolog is required for cell division and mammalian Cdc37 is expressed in proliferative zones during embryonic development and in adult tissues, consistent with a pos. role in proliferation.  Here the authors report that human prostatic tumors, neoplasias and certain pre-malignant lesions display increased Cdc37 expression, suggesting an important and early role for Cdc37 in prostatic transformation.  To test the consequences of increased Cdc37 levels, transgenic mice expressing Cdc37 in the prostate were generated.  These mice displayed a wide range of growth-related abnormalities including prostatic epithelial cell hyperplasia and dysplasia.  These data suggest that the expression of Cdc37 may promote inappropriate proliferation and may be an important early step in the development of human prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDstJD51g2NrVg90H21EOLACvtfcHk0lhBF44Dl2ohVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslelsbs%253D&md5=c513eda410627ed0fa71330f074d0202</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203561%26sid%3Dliteratum%253Aachs%26aulast%3DStepanova%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDeMayo%26aufirst%3DF.%26aulast%3DWheeler%26aufirst%3DT.%2BM.%26aulast%3DFinegold%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DT.%2BC.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26atitle%3DInduction%2520of%2520human%2520cdc37%2520in%2520prostate%2520cancer%2520correlates%2520with%2520the%2520ability%2520of%2520targeted%2520cdc37%2520expression%2520to%2520promote%2520prostatic%2520hyperplasia%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2186%26epage%3D2193%26doi%3D10.1038%2Fsj.onc.1203561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">The mechanism of hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37)</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)01027-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2803%2901027-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14718169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotF2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=87-98&author=S.+M.+Roeauthor=M.+M.+Aliauthor=P.+Meyerauthor=C.+K.+Vaughanauthor=B.+Panaretouauthor=P.+W.+Piperauthor=C.+Prodromouauthor=L.+H.+Pearl&title=The+mechanism+of+hsp90+regulation+by+the+protein+kinase-specific+cochaperone+p50%28cdc37%29&doi=10.1016%2FS0092-8674%2803%2901027-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50cdc37</span></div><div class="casAuthors">Roe, S. Mark; Ali, Maruf M. U.; Meyer, Philippe; Vaughan, Cara K.; Panaretou, Barry; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recruitment of protein kinase clients to the Hsp90 chaperone involves the cochaperone p50cdc37 acting as a scaffold, binding protein kinases via its N-terminal domain and Hsp90 via its C-terminal region.  P50cdc37 also has a regulatory activity, arresting Hsp90's ATP-ase cycle during client-protein loading.  We have localized the binding site for p50cdc37 to the N-terminal nucleotide binding domain of Hsp90 and detd. the crystal structure of the Hsp90-p50cdc37 core complex.  Dimeric p50cdc37 binds to surfaces of the Hsp90 N-domain implicated in ATP-dependent N-terminal dimerization and assocn. with the middle segment of the chaperone.  This interaction fixes the lid segment in an open conformation, inserts an arginine side chain into the ATP binding pocket to disable catalysis, and prevents trans-activating interaction of the N domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_fX2JWo9hA7Vg90H21EOLACvtfcHk0lg3Pm_ShzSI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotF2gsQ%253D%253D&md5=88bc0830eec565bac998b0c2e2e40c01</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2901027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252901027-4%26sid%3Dliteratum%253Aachs%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DAli%26aufirst%3DM.%2BM.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DThe%2520mechanism%2520of%2520hsp90%2520regulation%2520by%2520the%2520protein%2520kinase-specific%2520cochaperone%2520p50%2528cdc37%2529%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D87%26epage%3D98%26doi%3D10.1016%2FS0092-8674%2803%2901027-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">Hsp90 and cdc37 - a chaperone cancer conspiracy</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2004.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.gde.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15661534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=55-61&author=L.+H.+Pearl&title=Hsp90+and+cdc37+-+a+chaperone+cancer+conspiracy&doi=10.1016%2Fj.gde.2004.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 and Cdc37 - a chaperone cancer conspiracy</span></div><div class="casAuthors">Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol. chaperone system is involved in the activation of an important set of cell regulatory proteins, including many whose dysregulation drives cancer.  Recruitment of protein kinases to the Hsp90 system is mediated by the co-chaperone adaptor Cdc37 - an essential protein whose overexpression is itself, oncogenic.  Current structural, biochem. and biol. studies of Cdc37 are beginning to unravel the nature of its interactions with Hsp90 and protein kinase clients, and implicate it as a key permissive factor in cell transformation by dysregulated protein kinases.  The central role of the Hsp90-Cdc37 chaperone complex makes it an important target for future anti-cancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsaofLA0wLnrVg90H21EOLACvtfcHk0lg3Pm_ShzSI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFersw%253D%253D&md5=2795e3e44b6b0bbbe12dda55cb335769</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DHsp90%2520and%2520cdc37%2520-%2520a%2520chaperone%2520cancer%2520conspiracy%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2005%26volume%3D15%26spage%3D55%26epage%3D61%26doi%3D10.1016%2Fj.gde.2004.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samant, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span> <span> </span><span class="NLM_article-title">ATP-competitive inhibitors block protein kinase recruitment to the hsp90-cdc37 system</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">406</span>, <span class="refDoi"> DOI: 10.1038/nchembio0613-406d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnchembio0613-406d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2rsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=406&author=S.+Polierauthor=R.+S.+Samantauthor=P.+A.+Clarkeauthor=P.+Workmanauthor=C.+Prodromouauthor=L.+H.+Pearl&title=ATP-competitive+inhibitors+block+protein+kinase+recruitment+to+the+hsp90-cdc37+system&doi=10.1038%2Fnchembio0613-406d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system [Erratum to document cited in CA158:493078]</span></div><div class="casAuthors">Polier, Sigrun; Samant, Rahul S.; Clarke, Paul A.; Workman, Paul; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">406</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clarification is provided for ambiguous text on the displacement of Cdc37 and Hsp90 from ErbB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY4sMwGErB_LVg90H21EOLACvtfcHk0lg3Pm_ShzSI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2rsL4%253D&md5=1248426a4117c05b42b19aadde98ead8</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnchembio0613-406d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio0613-406d%26sid%3Dliteratum%253Aachs%26aulast%3DPolier%26aufirst%3DS.%26aulast%3DSamant%26aufirst%3DR.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DATP-competitive%2520inhibitors%2520block%2520protein%2520kinase%2520recruitment%2520to%2520the%2520hsp90-cdc37%2520system%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D406%26doi%3D10.1038%2Fnchembio0613-406d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">The human cdc37/hsp90 complex studied by heteronuclear nmr spectroscopy</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">3885</span>– <span class="NLM_lpage">3896</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806715200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M806715200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19073599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=3885-3896&author=S.+Sreeramuluauthor=H.+R.+Jonkerauthor=T.+Langerauthor=C.+Richterauthor=C.+R.+Lancasterauthor=H.+Schwalbe&title=The+human+cdc37%2Fhsp90+complex+studied+by+heteronuclear+nmr+spectroscopy&doi=10.1074%2Fjbc.M806715200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Cdc37·Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy</span></div><div class="casAuthors">Sreeramulu, Sridhar; Jonker, Hendrik R. A.; Langer, Thomas; Richter, Christian; Lancaster, C. Roy D.; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3885-3896</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are mol. chaperones, which are crucial elements in the protein signaling pathway.  The largest class of client proteins for Cdc37 and Hsp90 are protein kinases.  The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90.  Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 Å resoln. and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear soln. state NMR data and docking.  Our results demonstrate that the middle domain of Cdc37 exists as a monomer.  NMR and mutagenesis expts. reveal Leu-205 in Cdc37 as a key residue enabling complex formation.  These findings can be very useful in the development of small mol. inhibitors against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0h2OpThcpv7Vg90H21EOLACvtfcHk0lg3Pm_ShzSI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oru7g%253D&md5=aa7c4ab0d6585cd00dedca91c37372ea</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806715200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806715200%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DJonker%26aufirst%3DH.%2BR.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DRichter%26aufirst%3DC.%26aulast%3DLancaster%26aufirst%3DC.%2BR.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DThe%2520human%2520cdc37%252Fhsp90%2520complex%2520studied%2520by%2520heteronuclear%2520nmr%2520spectroscopy%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D3885%26epage%3D3896%26doi%3D10.1074%2Fjbc.M806715200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verba, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span> <span> </span><span class="NLM_article-title">Atomic structure of hsp90-cdc37-cdk4 reveals that hsp90 traps and stabilizes an unfolded kinase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1542</span>– <span class="NLM_lpage">1547</span>, <span class="refDoi"> DOI: 10.1126/science.aaf5023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1126%2Fscience.aaf5023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27339980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaitL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2016&pages=1542-1547&author=K.+A.+Verbaauthor=R.+Y.+R.+Wangauthor=A.+Arakawaauthor=Y.+X.+Liuauthor=M.+Shirouzuauthor=S.+Yokoyamaauthor=D.+A.+Agard&title=Atomic+structure+of+hsp90-cdc37-cdk4+reveals+that+hsp90+traps+and+stabilizes+an+unfolded+kinase&doi=10.1126%2Fscience.aaf5023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase</span></div><div class="casAuthors">Verba, Kliment A.; Wang, Ray Yu-Ruei; Arakawa, Akihiko; Liu, Yanxin; Shirouzu, Mikako; Yokoyama, Shigeyuki; Agard, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">6293</span>),
    <span class="NLM_cas:pages">1542-1547</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The Hsp90 mol. chaperone and its Cdc37 cochaperone help stabilize and activate more than half of the human kinome.  However, both the mechanism by which these chaperones assist their "client" kinases and the reason why some kinases are addicted to Hsp90 while closely related family members are independent are unknown.  A structural understanding of these interactions is lacking, as no full-length structures of human Hsp90, Cdc37, or either of these proteins with a kinase have been elucidated.  Here, the authors report a 3.9-Å cryo-electron microscopy structure of the Hsp90-Cdc37-Cdk4 kinase complex.  Surprisingly, the 2 lobes of Cdk4 were completely sepd. with the β4-β5 sheet unfolded.  Cdc37 mimicked part of the kinase N-lobe, stabilizing an open kinase conformation by wedging itself between the 2 lobes.  Finally, Hsp90 clamped around the unfolded kinase β5 strand and interacted with exposed N- and C-lobe interfaces, protecting the kinase in a trapped unfolded state.  On the basis of this structure and an extensive amt. of previously collected data, the authors propose unifying conceptual and mechanistic models of chaperone-kinase interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUbM1uvGsXbVg90H21EOLACvtfcHk0lgVV7kOQVWAIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaitL3O&md5=677703f45a5021d6f64b1811116816c4</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf5023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf5023%26sid%3Dliteratum%253Aachs%26aulast%3DVerba%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DR.%2BY.%2BR.%26aulast%3DArakawa%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%2BX.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DAtomic%2520structure%2520of%2520hsp90-cdc37-cdk4%2520reveals%2520that%2520hsp90%2520traps%2520and%2520stabilizes%2520an%2520unfolded%2520kinase%26jtitle%3DScience%26date%3D2016%26volume%3D352%26spage%3D1542%26epage%3D1547%26doi%3D10.1126%2Fscience.aaf5023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. A.</span></span> <span> </span><span class="NLM_article-title">Novel hsp90 inhibitor to disrupt hsp90/cdc37 complex against pancreatic cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-07-0484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1535-7163.MCT-07-0484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18202019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=162-170&author=T.+Zhangauthor=A.+Hamzaauthor=X.+Caoauthor=B.+Wangauthor=S.+Yuauthor=C.+G.+Zhanauthor=D.+A.+Sun&title=Novel+hsp90+inhibitor+to+disrupt+hsp90%2Fcdc37+complex+against+pancreatic+cancer+cells&doi=10.1158%2F1535-7163.MCT-07-0484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells</span></div><div class="casAuthors">Zhang, Tao; Hamza, Adel; Cao, Xianhua; Wang, Bing; Yu, Shuwen; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive disease with multiple biochem. and genetic alterations.  Thus, a single agent to hit one mol. target may not be sufficient to treat this disease.  The purpose of this study is to identify a novel Hsp90 inhibitor to disrupt protein-protein interactions of Hsp90 and its cochaperones for down-regulating many oncogenes simultaneously against pancreatic cancer cells.  Here, we reported that celastrol disrupted Hsp90-Cdc37 interaction in the superchaperone complex to exhibit antitumor activity in vitro and in vivo.  Mol. docking and mol. dynamic simulations showed that celastrol blocked the crit. interaction of Glu33 (Hsp90) and Arg167 (Cdc37).  Immunopptn. confirmed that celastrol (10 μmol/L) disrupted the Hsp90-Cdc37 interaction in the pancreatic cancer cell line Panc-1.  In contrast to classic Hsp90 inhibitor (geldanamycin), celastrol (0.1-100 μmol/L) did not interfere with ATP binding to Hsp90.  However, celastrol (1-5 μmol/L) induced Hsp90 client protein degrdn. (Cdk4 and Akt) by 70% to 80% and increased Hsp70 expression by 12-fold.  Celastrol induced apoptosis in vitro and significantly inhibited tumor growth in Panc-1 xenografts.  Moreover, celastrol (3 mg/kg) effectively suppressed tumor metastasis by more than 80% in RIP1-Tag2 transgenic mouse model with pancreatic islet cell carcinogenesis.  The data suggest that celastrol is a novel Hsp90 inhibitor to disrupt Hsp90-Cdc37 interaction against pancreatic cancer cells. [Mol Cancer Ther 2008;7(1):162-70].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYaUNr9Bi1cbVg90H21EOLACvtfcHk0lgVV7kOQVWAIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyhtQ%253D%253D&md5=2af27701d6ccd4397c7a7486d1335730</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0484%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26aulast%3DSun%26aufirst%3DD.%2BA.%26atitle%3DNovel%2520hsp90%2520inhibitor%2520to%2520disrupt%2520hsp90%252Fcdc37%2520complex%2520against%2520pancreatic%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D162%26epage%3D170%26doi%3D10.1158%2F1535-7163.MCT-07-0484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">Characterization of celastrol to inhibit hsp90 and cdc37 interaction</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">35381</span>– <span class="NLM_lpage">35389</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.051532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M109.051532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19858214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35381-35389&author=T.+Zhangauthor=Y.+Y.+Liauthor=Y.+K.+Yuauthor=P.+Zouauthor=Y.+Q.+Jiangauthor=D.+X.+Sun&title=Characterization+of+celastrol+to+inhibit+hsp90+and+cdc37+interaction&doi=10.1074%2Fjbc.M109.051532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction</span></div><div class="casAuthors">Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35381-35389</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer.  The loading of protein kinases to Hsp90 is actively mediated by the co-chaperone Cdc37.  The crucial role of the Hsp90-Cdc37 complex has made it an exciting target for cancer treatment.  In this study, the authors characterize Hsp90 and Cdc37 interaction and drug disruption using a reconstituted protein system.  The GST pull-down assay and ELISA assay show that Cdc37 binds to ADP-bound/nucleotide-free Hsp90 but not ATP-bound Hsp90.  Celastrol disrupts Hsp90-Cdc37 complex formation, whereas the classical Hsp90 inhibitors (e.g., geldanamycin) have no effect.  Celastrol inhibits Hsp90 ATPase activity without blocking ATP binding.  Proteolytic fingerprinting indicates celastrol binds to Hsp90 C-terminal domain to protect it from trypsin digestion.  These data suggest that celastrol may represent a new class of Hsp90 inhibitor by modifying Hsp90 C terminus to allosterically regulate its chaperone activity and disrupt Hsp90-Cdc37 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPbfNGpAapIrVg90H21EOLACvtfcHk0lgVV7kOQVWAIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurjN&md5=f8d15de4ecac58de8bb5274d9cf9cdcd</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.051532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.051532%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DYu%26aufirst%3DY.%2BK.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%2BQ.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DCharacterization%2520of%2520celastrol%2520to%2520inhibit%2520hsp90%2520and%2520cdc37%2520interaction%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D35381%26epage%3D35389%26doi%3D10.1074%2Fjbc.M109.051532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gande, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of inhibition of the human protein complex hsp90-cdc37, a kinome chaperone-cochaperone, by triterpene celastrol</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5853</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1002/anie.200900929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fanie.200900929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19585625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=5853-5855&author=S.+Sreeramuluauthor=S.+L.+Gandeauthor=M.+G%C3%B6belauthor=H.+Schwalbe&title=Molecular+mechanism+of+inhibition+of+the+human+protein+complex+hsp90-cdc37%2C+a+kinome+chaperone-cochaperone%2C+by+triterpene+celastrol&doi=10.1002%2Fanie.200900929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol</span></div><div class="casAuthors">Sreeramulu, Sridhar; Gande, Santosh Lakshmi; Goebel, Michael; Schwalbe, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5853-5855, S5853/1-S5853/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the kinome chaperone Hsp90 (kinome = set of all protein kinases in an organism) has long been known as mol. target for anticancer therapy.  Cdc37, a cochaperone of Hsp90 in mammalian cells, targets protein kinases and is upregulated in various cancers.  Gene-based expression studies have identified the triterpene celastrol, which represents a new class of non ATP-competitive inhibitors of Hsp90.  Herein, we describe in detail how celastrol disrupts the human Hsp90-Cdc37 complex.  We report that celastrol binds to Cdc37 but not to HSP90N as previously described.  This study is important as it will shift efforts in medicinal chem. towards the correct target within the protein-protein complex.  Our results indicates that the N-terminal kinase- binding and middle Hsp90N-binding domain of Cdc37 are the mol. target for the triterpene celastrol.  In light of the considerable potential of Cdc37 as a drug target and the binding of celastrol to it, these results can now be used to further understand the mol. basis for inhibiting this key Cdc37-Hsp90 complex in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWgmOS-yFB6rVg90H21EOLACvtfcHk0lgsd1j2jwnYyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFGltb4%253D&md5=d5264a2213c19a8b33ca56305ac2a29c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fanie.200900929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200900929%26sid%3Dliteratum%253Aachs%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DGande%26aufirst%3DS.%2BL.%26aulast%3DG%25C3%25B6bel%26aufirst%3DM.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DMolecular%2520mechanism%2520of%2520inhibition%2520of%2520the%2520human%2520protein%2520complex%2520hsp90-cdc37%252C%2520a%2520kinome%2520chaperone-cochaperone%252C%2520by%2520triterpene%2520celastrol%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D5853%26epage%3D5855%26doi%3D10.1002%2Fanie.200900929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Optimization and biological evaluation of celastrol derivatives as hsp90-cdc37 interaction disruptors with improved druglike properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5431</span>– <span class="NLM_lpage">5439</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2016.08.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27647369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5431-5439&author=F.+Jiangauthor=H.+J.+Wangauthor=Q.+C.+Baoauthor=L.+Wangauthor=Y.+H.+Jinauthor=Q.+Zhangauthor=D.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Optimization+and+biological+evaluation+of+celastrol+derivatives+as+hsp90-cdc37+interaction+disruptors+with+improved+druglike+properties&doi=10.1016%2Fj.bmc.2016.08.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties</span></div><div class="casAuthors">Jiang, Fen; Wang, Hui-Jie; Bao, Qi-Chao; Wang, Lei; Jin, Yu-Hui; Zhang, Qiong; Jiang, Di; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5431-5439</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) as a mol. target for oncol. therapeutics has attracted much attention in the last decade.  The Hsp90 multichaperone complex has important roles in the growth and/or survival of cancer cells.  Cdc37, as a cochaperone, assocs. kinase clients to Hsp90 and promotes the development of malignant tumors.  Disrupting the Hsp90-Cdc37 interaction provides an alternative strategy to inhibit the function of Hsp90 for cancer therapy.  Celastrol, as a natural product, can disrupt the Hsp90-Cdc37 interaction and induce degrdn. of kinase clients.  The study conducted here attempted to elucidate the structure-activity relationship of celastrol derivs. as Hsp90-Cdc37 disruptors and to improve the druglike properties.  23 Celastrol derivs. were designed, synthesized, and the biol. activities and physicochem. properties were detd.  The deriv. CEL20 showed improved Hsp90-Cdc37 disruption activity, anti-proliferative activities as well as druglike properties.  Addnl., CEL20 induced clients degrdn., cell cycle arrest and apoptosis in Panc-1 cells.  This study can provide ref. for the discovery of novel Hsp90-Cdc37 disruptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzu8IFI5qzR7Vg90H21EOLACvtfcHk0lgsd1j2jwnYyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFamurrL&md5=94fadc51317b113c4e79fdb1e338c6ab</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.070%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DOptimization%2520and%2520biological%2520evaluation%2520of%2520celastrol%2520derivatives%2520as%2520hsp90-cdc37%2520interaction%2520disruptors%2520with%2520improved%2520druglike%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5431%26epage%3D5439%26doi%3D10.1016%2Fj.bmc.2016.08.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunatilaka, A. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">Withaferin a targets heat shock protein 90 in pancreatic. Cancer Cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bcp.2009.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19769945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGgtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=542-551&author=Y.+K.+Yuauthor=A.+Hamzaauthor=T.+Zhangauthor=M.+C.+Guauthor=P.+Zouauthor=B.+Newmanauthor=Y.+Y.+Liauthor=A.+A.+L.+Gunatilakaauthor=C.+G.+Zhanauthor=D.+X.+Sun&title=Withaferin+a+targets+heat+shock+protein+90+in+pancreatic.+Cancer+Cells&doi=10.1016%2Fj.bcp.2009.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Withaferin A targets heat shock protein 90 in pancreatic cancer cells</span></div><div class="casAuthors">Yu, Yanke; Hamza, Adel; Zhang, Tao; Gu, Mancang; Zou, Peng; Newman, Bryan; Li, Yanyan; Gunatilaka, A. A. Leslie; Zhan, Chang-Guo; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-551</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of this study is to investigate the efficacy and the mechanism of Hsp90 inhibition of Withaferin A (WA), a steroidal lactone occurring in Withania somnifera, in pancreatic cancer in vitro and in vivo.  Withaferin A exhibited potent antiproliferative activity against pancreatic cancer cells in vitro (with IC50s of 1.24, 2.93 and 2.78 μM) in pancreatic cancer cell lines Panc-1, MiaPaCa2 and BxPc3, resp.  Annexin V staining showed that WA induced significant apoptosis in Panc-1 cells in a dose-dependent manner.  Western blotting demonstrated that WA inhibited Hsp90 chaperone activity to induce degrdn. of Hsp90 client proteins (Akt, Cdk4 and glucocorticoid receptor), which was reversed by the proteasomal inhibitor, MG132.  WA-biotin pull down assay of Hsp90 using Panc-1 cancer cell lyzates and purified Hsp90 showed that WA-biotin binds to C-terminus of Hsp90 which was competitively blocked by unlabeled WA.  Co-immunopptn. exhibited that WA (10 μM) disrupted Hsp90-Cdc37 complexes from 1 to 24 h post-treatment, while it neither blocked ATP binding to Hsp90, nor changed Hsp90-P23 assocn.  WA (3, 6 mg/kg) inhibited tumor growth in pancreatic Panc-1 xenografts by 30% and 58%, resp.  These data demonstrate that Withaferin A binds Hsp90, inhibits Hsp90 chaperone activity through an ATP-independent mechanism, results in Hsp90 client protein degrdn., and exhibits in vivo anticancer activity against pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriFWBOwGN6_rVg90H21EOLACvtfcHk0lgsd1j2jwnYyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGgtLzK&md5=98f0361915cd78d07965763f30afc392</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%2BK.%26aulast%3DHamza%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DGu%26aufirst%3DM.%2BC.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DGunatilaka%26aufirst%3DA.%2BA.%2BL.%26aulast%3DZhan%26aufirst%3DC.%2BG.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DWithaferin%2520a%2520targets%2520heat%2520shock%2520protein%252090%2520in%2520pancreatic.%2520Cancer%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D542%26epage%3D551%26doi%3D10.1016%2Fj.bcp.2009.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagoz, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, A. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudiger, S. G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">Sulforaphane inhibits pancreatic cancer through disrupting hsp90-p50(cdc37) complex and direct interactions with amino acids residues of hsp90</span>. <i>J. Nutr. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1617</span>– <span class="NLM_lpage">1626</span>, <span class="refDoi"> DOI: 10.1016/j.jnutbio.2011.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.jnutbio.2011.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22444872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XksFejtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=1617-1626&author=Y.+Y.+Liauthor=G.+E.+Karagozauthor=Y.+H.+Seoauthor=T.+Zhangauthor=Y.+Q.+Jiangauthor=Y.+K.+Yuauthor=A.+M.+S.+Duarteauthor=S.+J.+Schwartzauthor=R.+Boelensauthor=K.+Carrollauthor=S.+G.+D.+Rudigerauthor=D.+X.+Sun&title=Sulforaphane+inhibits+pancreatic+cancer+through+disrupting+hsp90-p50%28cdc37%29+complex+and+direct+interactions+with+amino+acids+residues+of+hsp90&doi=10.1016%2Fj.jnutbio.2011.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforaphane inhibits pancreatic cancer through disrupting Hsp90-p50Cdc37 complex and direct interactions with amino acids residues of Hsp90</span></div><div class="casAuthors">Li, Yanyan; Karagoz, G. Elif; Seo, Young Ho; Zhang, Tao; Jiang, Yiqun; Yu, Yanke; Duarte, Afonso M. S.; Schwartz, Steven J.; Boelens, Rolf; Carroll, Kate; Rudiger, Stefan G. D.; Sun, Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1617-1626</span>CODEN:
                <span class="NLM_cas:coden">JNBIEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-2863</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sulforaphane [1-isothiocyanato-4-((methyl-sulfinyl) butane)], an isothiocyanate derived from cruciferous vegetables, was shown to possess potent chemopreventive activity.  We analyzed the effect of sulforaphane on the proliferation of pancreatic cancer cells.  Sulforaphane inhibited pancreatic cancer cell growth in vitro with IC50s of around 10-15 μM and induced apoptosis.  In pancreatic cancer xenograft mouse model, administration of sulforaphane showed remarkable inhibition of tumor growth without apparent toxicity noticed.  We found that sulforaphane induced the degrdn. of heat shock protein 90 (Hsp90) client proteins and blocked the interaction of Hsp90 with its cochaperone p50Cdc37 in pancreatic cancer cells.  Using NMR spectroscopy (NMR) with an isoleucine-specific labeling strategy, we overcame the protein size limit of conventional NMR and studied the interaction of sulforaphane with full-length Hsp90 dimer (170 kDa) in soln.  NMR revealed multiple chem. shifts in sheet 2 and the adjacent loop in Hsp90 N-terminal domain after incubation of Hsp90 with sulforaphane.  Liq. chromatog. coupled to mass spectrometry further mapped a short peptide in this region that was tagged with sulforaphane.  These data suggest a new mechanism of sulforaphane that disrupts protein-protein interaction in Hsp90 complex for its chemopreventive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow4f3hTm6sKbVg90H21EOLACvtfcHk0lgEBcvDdKi0Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksFejtLg%253D&md5=56aa422e918b432dc6748f4a6009e547</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.jnutbio.2011.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jnutbio.2011.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DKaragoz%26aufirst%3DG.%2BE.%26aulast%3DSeo%26aufirst%3DY.%2BH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DY.%2BQ.%26aulast%3DYu%26aufirst%3DY.%2BK.%26aulast%3DDuarte%26aufirst%3DA.%2BM.%2BS.%26aulast%3DSchwartz%26aufirst%3DS.%2BJ.%26aulast%3DBoelens%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DRudiger%26aufirst%3DS.%2BG.%2BD.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DSulforaphane%2520inhibits%2520pancreatic%2520cancer%2520through%2520disrupting%2520hsp90-p50%2528cdc37%2529%2520complex%2520and%2520direct%2520interactions%2520with%2520amino%2520acids%2520residues%2520of%2520hsp90%26jtitle%3DJ.%2520Nutr.%2520Biochem.%26date%3D2012%26volume%3D23%26spage%3D1617%26epage%3D1626%26doi%3D10.1016%2Fj.jnutbio.2011.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z. R.</span></span> <span> </span><span class="NLM_article-title">Natural product kongensin a is a non-canonical hsp90 inhibitor that blocks rip3-dependent necroptosis</span>. <i>Cell. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.chembiol.2015.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27028885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=257-266&author=D.+R.+Liauthor=C.+Liauthor=L.+Liauthor=S.+Chenauthor=L.+Wangauthor=Q.+Liauthor=X.+D.+Wangauthor=X.+G.+Leiauthor=Z.+R.+Shen&title=Natural+product+kongensin+a+is+a+non-canonical+hsp90+inhibitor+that+blocks+rip3-dependent+necroptosis&doi=10.1016%2Fj.chembiol.2015.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis</span></div><div class="casAuthors">Li, Dianrong; Li, Chao; Li, Lin; Chen, She; Wang, Lei; Li, Qiang; Wang, Xiaodong; Lei, Xiaoguang; Shen, Zhirong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3-dependent necroptosis has recently garnered significant interest because of the unique signaling mechanisms and pathol. functions involved in this process.  Accordingly, a no. of chem. screens have identified several effective small-mol. inhibitors that specifically block necroptosis.  Here, we report the discovery that kongensin A (KA), a natural product isolated from Croton kongensis, is a potent inhibitor of necroptosis and an inducer of apoptosis.  Using a new bioorthogonal ligation method (TQ ligation), we reveal that the direct cellular target of KA is heat shock protein 90 (HSP90).  Further studies demonstrate that KA covalently binds to a previously uncharacterized cysteine 420 in the middle domain of HSP90 and dissocs. HSP90 from its cochaperone CDC37, which leads to inhibition of RIP3-dependent necroptosis and promotion of apoptosis in multiple cancer cell lines.  Collectively, our findings demonstrate that KA is an effective HSP90 inhibitor that has potential anti-necroptosis and anti-inflammation applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCEeQjx4di8rVg90H21EOLACvtfcHk0lgEBcvDdKi0Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqt78%253D&md5=0750612b811f8bd7379feca734ab6014</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%2BD.%26aulast%3DLei%26aufirst%3DX.%2BG.%26aulast%3DShen%26aufirst%3DZ.%2BR.%26atitle%3DNatural%2520product%2520kongensin%2520a%2520is%2520a%2520non-canonical%2520hsp90%2520inhibitor%2520that%2520blocks%2520rip3-dependent%2520necroptosis%26jtitle%3DCell.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D257%26epage%3D266%26doi%3D10.1016%2Fj.chembiol.2015.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span> <span> </span><span class="NLM_article-title">Fw-04–806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to n-terminus of hsp90 and disrupting hsp90-cdc37 complex formation</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">150</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-13-150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1186%2F1476-4598-13-150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24927996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=150&author=W.+Huangauthor=M.+Yeauthor=L.+R.+Zhangauthor=Q.+D.+Wuauthor=M.+Zhangauthor=J.+H.+Xuauthor=W.+Zheng&title=Fw-04%E2%80%93806+inhibits+proliferation+and+induces+apoptosis+in+human+breast+cancer+cells+by+binding+to+n-terminus+of+hsp90+and+disrupting+hsp90-cdc37+complex+formation&doi=10.1186%2F1476-4598-13-150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation</span></div><div class="casAuthors">Huang, Wei; Ye, Min; Zhang, Lian-Ru; Wu, Qun-Dan; Zhang, Min; Xu, Jian-Hua; Zheng, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">150/1-150/23, 23 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Heat shock protein 90 (Hsp90) is a promising therapeutic target and inhibition of Hsp90 will presumably result in suppression of multiple signaling pathways.  FW-04-806, a bis-oxazolyl macrolide compd. extd. from China-native Streptomyces FIM-04-806, was reported to be identical in structure to the polyketide Conglobatin.  Methods: We adopted the methods of chemproteomics, computational docking, immunopptn., siRNA gene knock down, Quant. Real-time PCR and xenograft models on the research of FW-04-806 antitumor mechanism, through the HER2-overexpressing breast cancer SKBR3 and HER2-underexpressing breast cancer MCF-7 cell line.  Results: We have verified the direct binding of FW-04-806 to the N-terminal domain of Hsp90 and found that FW-04-806 inhibits Hsp90/cell division cycle protein 37 (Cdc37) chaperone/co-chaperone interactions, but does not affect ATP-binding capability of Hsp90, thereby leading to the degrdn. of multiple Hsp90 client proteins via the proteasome pathway.  In breast cancer cell lines, FW-04-806 inhibits cell proliferation, caused G2/M cell cycle arrest, induced apoptosis, and downregulated Hsp90 client proteins HER2, Akt, Raf-1 and their phosphorylated forms (p-HER2, p-Akt) in a dose and time-dependent manner.  Importantly, FW-04-806 displays a better anti-tumor effect in HER2-overexpressed SKBR3 tumor xenograft model than in HER2-underexpressed MCF-7 model.  The result is consistent with cell proliferation assay and in vitro apoptosis assay applied for SKBR-3 and MCF-7.  Furthermore, FW-04-806 has a favorable toxicity profile.  Conclusions: As a novel Hsp90 inhibitor, FW-04-806 binds to the N-terminal of Hsp90 and inhibits Hsp90/Cdc37 interaction, resulting in the disassocn. of Hsp90/Cdc37/client complexes and the degrdn. of Hsp90 client proteins.  FW-04-806 displays promising antitumor activity against breast cancer cells both in vitro and in vivo, esp. for HER2-overexpressed breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI4HO_8pKpELVg90H21EOLACvtfcHk0lgEBcvDdKi0Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWns7o%253D&md5=bfa6127b46be0281667d296f020fde1b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-13-150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-13-150%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%2BR.%26aulast%3DWu%26aufirst%3DQ.%2BD.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%2BH.%26aulast%3DZheng%26aufirst%3DW.%26atitle%3DFw-04%25E2%2580%2593806%2520inhibits%2520proliferation%2520and%2520induces%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520binding%2520to%2520n-terminus%2520of%2520hsp90%2520and%2520disrupting%2520hsp90-cdc37%2520complex%2520formation%26jtitle%3DMol.%2520Cancer%26date%3D2014%26volume%3D13%26spage%3D150%26doi%3D10.1186%2F1476-4598-13-150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. J.</span></span> <span> </span><span class="NLM_article-title">Novel hsp90 inhibitor platycodin d disrupts hsp90/cdc37 complex and enhances the anticancer effect of mtor inhibitor</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2017.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.taap.2017.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28711525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Sjs77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2017&pages=65-73&author=T.+Liauthor=X.+Chenauthor=X.+Y.+Daiauthor=B.+Weiauthor=Q.+J.+Wengauthor=X.+P.+Chenauthor=D.+F.+Ouyangauthor=R.+Yanauthor=Z.+J.+Huangauthor=H.+L.+Jiangauthor=H.+Zhuauthor=J.+J.+Lu&title=Novel+hsp90+inhibitor+platycodin+d+disrupts+hsp90%2Fcdc37+complex+and+enhances+the+anticancer+effect+of+mtor+inhibitor&doi=10.1016%2Fj.taap.2017.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor</span></div><div class="casAuthors">Li, Ting; Chen, Xin; Dai, Xiao-Yang; Wei, Bin; Weng, Qin-Jie; Chen, Xiuping; Ouyang, De-Fang; Yan, Ru; Huang, Zhang-Jian; Jiang, Hu-Lin; Zhu, Hong; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-73</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a critically conserved mol. chaperone protein and promising therapeutic target for cancer treatment.  In this study, platycodin D (PD), a saponin isolated from traditional Chinese herb Platycodonis Radix, was identified as a novel Hsp90 inhibitor.  We verified that PD did not affect the ATPase activity of Hsp90.  However, PD disrupted the co-chaperone interaction of Hsp90/cell division cycle protein 37 (Cdc37) and subsequently degraded multiple Hsp90 client proteins without the feedback increase of Hsp70.  In different genotypes of non-small cell lung cancer cells, co-treatment with the mTOR inhibitor Everolimus and PD enhanced antiproliferation activity and apoptotic effect.  The feedback survival signal upon mTOR inhibition was fully terminated by the co-administration with PD through reduced epidermal growth factor receptor (EGFR) and insulin growth factor 1 receptor (IGF1R) expression, suppressed AKT activity, and reinforced 4E-BP1 inhibition.  Our results not only identified PD as a novel Hsp90 inhibitor by disrupting the protein-protein interaction of Hsp90/Cdc37 complex, but also provided mechanistic insights into the ineffectiveness of mTOR inhibitors and identified therapeutic strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqej7RTT1O-r7Vg90H21EOLACvtfcHk0lgWxef2R2Assw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sjs77P&md5=a75f51f4c0cf6bebe7cae977ee538848</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2017.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2017.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DX.%2BY.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DWeng%26aufirst%3DQ.%2BJ.%26aulast%3DChen%26aufirst%3DX.%2BP.%26aulast%3DOuyang%26aufirst%3DD.%2BF.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DZ.%2BJ.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26atitle%3DNovel%2520hsp90%2520inhibitor%2520platycodin%2520d%2520disrupts%2520hsp90%252Fcdc37%2520complex%2520and%2520enhances%2520the%2520anticancer%2520effect%2520of%2520mtor%2520inhibitor%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2017%26volume%3D330%26spage%3D65%26epage%3D73%26doi%3D10.1016%2Fj.taap.2017.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and identification of cdc37-derived peptides targeting the hsp90-cdc37 protein-protein interaction</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">96138</span>– <span class="NLM_lpage">96145</span>, <span class="refDoi"> DOI: 10.1039/C5RA20408A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1039%2FC5RA20408A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=96138-96145&author=L.+Wangauthor=Q.+C.+Baoauthor=X.+L.+Xuauthor=F.+Jiangauthor=K.+Guauthor=Z.+Y.+Jiangauthor=X.+J.+Zhangauthor=X.+K.+Guoauthor=Q.+D.+Youauthor=H.+P.+Sun&title=Discovery+and+identification+of+cdc37-derived+peptides+targeting+the+hsp90-cdc37+protein-protein+interaction&doi=10.1039%2FC5RA20408A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and identification of Cdc37-derived peptides targeting the Hsp90-Cdc37 protein-protein interaction</span></div><div class="casAuthors">Wang, Lei; Bao, Qi-Chao; Xu, Xiao-Li; Jiang, Fen; Gu, Kai; Jiang, Zheng-Yu; Zhang, Xiao-Jin; Guo, Xiao-Ke; You, Qi-Dong; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">116</span>),
    <span class="NLM_cas:pages">96138-96145</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As an attractive anticancer target, the Hsp90 chaperone machine regulates a wide range of oncoproteins.  Most of the Hsp90 inhibitors in clin. trials employ the same ATP blockage mechanism while little progress has been achieved with Hsp90-cochaperone complexes.  Numerous protein kinases assoc. with the Hsp90-Cdc37 PPI, a potential target for the treatment of cancers, to implement folding and maturation.  In order to explore the key residues of the Hsp90-Cdc37 binding interface for further design of peptide inhibitors, a combined strategy of mol. dynamics simulation and MM-PBSA anal. was performed.  Subsequent design and identification of an eleven-residue peptide (Pep-1) directly derived from the Cdc37 binding interface was achieved to exhibit a 6.9 μM binding capacity and 3.0 μM ATPase inhibitory rate.  This is the first evidence that a peptide inhibitor not only interferes with Hsp90 ATPase ability but also disrupts the Cdc37-Hsp90 PPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprJuH5_AXE6bVg90H21EOLACvtfcHk0lgWxef2R2Assw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7jI&md5=b7b3c57b5aa96ac8236adf5121c5aab8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1039%2FC5RA20408A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA20408A%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DGu%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DGuo%26aufirst%3DX.%2BK.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDiscovery%2520and%2520identification%2520of%2520cdc37-derived%2520peptides%2520targeting%2520the%2520hsp90-cdc37%2520protein-protein%2520interaction%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D96138%26epage%3D96145%26doi%3D10.1039%2FC5RA20408A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Optimization and bioevaluation of cdc37-derived peptides: an insight into hsp90-cdc37 protein-protein interaction modulators</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2016.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27818030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2iu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=233-240&author=L.+Wangauthor=L.+Liauthor=W.+T.+Fuauthor=Z.+Y.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Optimization+and+bioevaluation+of+cdc37-derived+peptides%3A+an+insight+into+hsp90-cdc37+protein-protein+interaction+modulators&doi=10.1016%2Fj.bmc.2016.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and bioevaluation of Cdc37-derived peptides: An insight into Hsp90-Cdc37 protein-protein interaction modulators</span></div><div class="casAuthors">Wang, Lei; Li, Li; Fu, Wei-Tao; Jiang, Zheng-Yu; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting Hsp90-Cdc37 protein-protein interaction (PPI) is becoming an alternative approach for future anti-cancer drug development.  We previously reported the discovery of an eleven-residue peptide (Pep-1) with micromolar activity for the disruption of Hsp90-Cdc37 PPI.  Efforts to improve upon the Pep-1 led to the discovery of more potent modulators for Hsp90-Cdc37 PPI.  Through the anal. of peptides binding patterns, more peptides were designed for further verification which resulted in Pep-5, the shortest peptide targeting Hsp90-Cdc37, exerting the optimal structure and the most efficient binding mode.  Subsequent MD simulation anal. also confirmed that Pep-5 could perform more stable binding ability and better ligand properties than Pep-1.  Under the premise of retentive binding capacity, Pep-5 exhibited lower mol. wt. and higher ligand efficiency with a Kd value of 5.99 μM (Pep-1 Kd = 6.90 μM) in both direct binding detn. and biol. evaluation.  The optimal and shortest Pep-5 might provide a breakthrough and a better model for the future design of small mol. inhibitors targeting Hsp90-Cdc37 PPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozt_piL7_yrbVg90H21EOLACvtfcHk0lgWxef2R2Assw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2iu73M&md5=a5e693af05109ebb1413198e4154ab53</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DW.%2BT.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DOptimization%2520and%2520bioevaluation%2520of%2520cdc37-derived%2520peptides%253A%2520an%2520insight%2520into%2520hsp90-cdc37%2520protein-protein%2520interaction%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D233%26epage%3D240%26doi%3D10.1016%2Fj.bmc.2016.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span> <span> </span><span class="NLM_article-title">Structure-based virtual screening and optimization of modulators targeting hsp90-cdc37 interaction</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2017.04.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28482218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvFGjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=63-73&author=L.+Wangauthor=L.+Liauthor=Z.+H.+Zhouauthor=Z.+Y.+Jiangauthor=Q.+D.+Youauthor=X.+L.+Xu&title=Structure-based+virtual+screening+and+optimization+of+modulators+targeting+hsp90-cdc37+interaction&doi=10.1016%2Fj.ejmech.2017.04.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction</span></div><div class="casAuthors">Wang, Lei; Li, Li; Zhou, Zi-Han; Jiang, Zheng-Yu; You, Qi-Dong; Xu, Xiao-Li</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Identification of novel Hsp90 inhibitors to disrupt Hsp90-Cdc37 protein-protein interaction (PPI) could be an alternative strategy to achieve Hsp90 inhibition.  In this paper, a series of small mols. targeting Hsp90-Cdc37 complex are addressed and characterized.  The mols.' key characters are detd. by utilizing a structure-based virtual screening workflow, derivs. synthesis, and biol. evaluation.  Structural optimization and structure-activity relationship (SAR) anal. were then carried out on the virtual hit of VS-8 with potent activity, which resulted in the discovery of compd. I as a more potent regulator of Hsp90-Cdc37 interaction with a promising inhibitory effect (IC50 = 27 μM), a moderate binding capacity (KD = 40 μM) and a preferable antiproliferative activity against several cancer lines including MCF-7, SKBR3 and A549 cell lines (IC50 = 26 μM, 15 μM and 38 μM resp.).  All the data suggest that compd. I exhibits moderate inhibitory effect on Hsp90-Cdc37 and could be regard as a first evidence of a nonnatural compd. targeting Hsp90-Cdc37 PPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4dkE1WfkLwLVg90H21EOLACvtfcHk0liMonEqaNSDlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvFGjt7c%253D&md5=4c4e51f6ccfc194f30d64b6310d2ac54</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.074%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DZ.%2BH.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DXu%26aufirst%3DX.%2BL.%26atitle%3DStructure-based%2520virtual%2520screening%2520and%2520optimization%2520of%2520modulators%2520targeting%2520hsp90-cdc37%2520interaction%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D63%26epage%3D73%26doi%3D10.1016%2Fj.ejmech.2017.04.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitor targeting the hsp90-cdc37 protein-protein interaction in colorectal cancer</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">eaax2277</span> <span class="refDoi"> DOI: 10.1126/sciadv.aax2277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1126%2Fsciadv.aax2277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=31555737" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&author=L.+Wangauthor=L.+X.+Zhangauthor=L.+Liauthor=J.+Jiangauthor=Z.+Zhengauthor=J.+Shangauthor=C.+Wangauthor=W.+L.+Chenauthor=Q.+C.+Baoauthor=X.+L.+Xuauthor=Z.+Y.+Jiangauthor=J.+Zhangauthor=Q.+D.+You&title=Small-molecule+inhibitor+targeting+the+hsp90-cdc37+protein-protein+interaction+in+colorectal+cancer&doi=10.1126%2Fsciadv.aax2277"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.aax2277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.aax2277%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%2BX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%2BL.%26aulast%3DBao%26aufirst%3DQ.%2BC.%26aulast%3DXu%26aufirst%3DX.%2BL.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26atitle%3DSmall-molecule%2520inhibitor%2520targeting%2520the%2520hsp90-cdc37%2520protein-protein%2520interaction%2520in%2520colorectal%2520cancer%26jtitle%3DSci.%2520Adv.%26date%3D2019%26volume%3D5%26doi%3D10.1126%2Fsciadv.aax2277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattanayak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nibbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valsecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergan, R.</span></span> <span> </span><span class="NLM_article-title">Precision therapeutic targeting of human cancer cell motility</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2454</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-04465-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs41467-018-04465-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29934502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FhtVSqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2454&author=L.+Xuauthor=R.+Gordonauthor=R.+Farmerauthor=A.+Pattanayakauthor=A.+Binkowskiauthor=X.+K.+Huangauthor=M.+Avramauthor=S.+Krishnaauthor=E.+Vollauthor=J.+Paveseauthor=J.+Chavezauthor=J.+Bruceauthor=A.+Mazarauthor=A.+Nibbsauthor=W.+Andersonauthor=L.+Liauthor=B.+Jovanovicauthor=S.+Pruellauthor=M.+Valsecchiauthor=G.+Franciaauthor=R.+Betoriauthor=K.+Scheidtauthor=R.+Bergan&title=Precision+therapeutic+targeting+of+human+cancer+cell+motility&doi=10.1038%2Fs41467-018-04465-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Precision therapeutic targeting of human cancer cell motility</span></div><div class="casAuthors">Xu Li; Huang Xiaoke; Krishna Sankar; Voll Eric; Pavese Janet; Pruell Sean; Valsecchi Matias; Xu Li; Gordon Ryan; Pattanayak Abhinandan; Bergan Raymond; Farmer Rebecca; Mazar Andrew; Nibbs Antoinette; Betori Rick; Scheidt Karl; Binkowski Andrew; Avram Michael; Chavez Juan; Bruce James; Anderson Wayne; Li Lin; Jovanovic Borko; Francia Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2454</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increased cancer cell motility constitutes a root cause of end organ destruction and mortality, but its complex regulation represents a barrier to precision targeting.  We use the unique characteristics of small molecules to probe and selectively modulate cell motility.  By coupling efficient chemical synthesis routes to multiple upfront in parallel phenotypic screens, we identify that KBU2046 inhibits cell motility and cell invasion in vitro.  Across three different murine models of human prostate and breast cancer, KBU2046 inhibits metastasis, decreases bone destruction, and prolongs survival at nanomolar blood concentrations after oral administration.  Comprehensive molecular, cellular and systemic-level assays all support a high level of selectivity.  KBU2046 binds chaperone heterocomplexes, selectively alters binding of client proteins that regulate motility, and lacks all the hallmarks of classical chaperone inhibitors, including toxicity.  We identify a unique cell motility regulatory mechanism and synthesize a targeted therapeutic, providing a platform to pursue studies in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTEhMxiVKBI9ysZ1x6zOs0vfW6udTcc2eZqus71FQFCo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FhtVSqsQ%253D%253D&md5=ddd8197485a52f20bc8bc406480f1c87</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-04465-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-04465-5%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DFarmer%26aufirst%3DR.%26aulast%3DPattanayak%26aufirst%3DA.%26aulast%3DBinkowski%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DX.%2BK.%26aulast%3DAvram%26aufirst%3DM.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DVoll%26aufirst%3DE.%26aulast%3DPavese%26aufirst%3DJ.%26aulast%3DChavez%26aufirst%3DJ.%26aulast%3DBruce%26aufirst%3DJ.%26aulast%3DMazar%26aufirst%3DA.%26aulast%3DNibbs%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DJovanovic%26aufirst%3DB.%26aulast%3DPruell%26aufirst%3DS.%26aulast%3DValsecchi%26aufirst%3DM.%26aulast%3DFrancia%26aufirst%3DG.%26aulast%3DBetori%26aufirst%3DR.%26aulast%3DScheidt%26aufirst%3DK.%26aulast%3DBergan%26aufirst%3DR.%26atitle%3DPrecision%2520therapeutic%2520targeting%2520of%2520human%2520cancer%2520cell%2520motility%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D2454%26doi%3D10.1038%2Fs41467-018-04465-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L. G.</span></span> <span> </span><span class="NLM_article-title">Dcz3112, a novel hsp90 inhibitor, exerts potent antitumor activity against her2-positive breast cancer through disruption of hsp90-cdc37 interaction</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.canlet.2018.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=30017966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKmur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2018&pages=70-80&author=X.+L.+Chenauthor=P.+Liuauthor=Q.+R.+Wangauthor=Y.+Liauthor=L.+Fuauthor=H.+Y.+Fuauthor=J.+M.+Zhuauthor=Z.+Q.+Chenauthor=W.+L.+Zhuauthor=C.+Y.+Xieauthor=L.+G.+Lou&title=Dcz3112%2C+a+novel+hsp90+inhibitor%2C+exerts+potent+antitumor+activity+against+her2-positive+breast+cancer+through+disruption+of+hsp90-cdc37+interaction&doi=10.1016%2Fj.canlet.2018.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction</span></div><div class="casAuthors">Chen, Xiangling; Liu, Peng; Wang, Quanren; Li, Yun; Fu, Li; Fu, Haoyu; Zhu, Jianming; Chen, Zhaoqiang; Zhu, Weiliang; Xie, Chengying; Lou, Liguang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-80</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hsp90 regulates the stability of oncoproteins important in tumor development and progression, and represents a potential therapeutic target.  However, all Hsp90 inhibitors currently in clin. trials target Hsp90 ATPase activity and exhibit low selectivity and high toxicity.  In this study, we discovered a new Hsp90 inhibitor, DCZ3112, with a novel mechanism of action.  DCZ3112 directly bound to the N-terminal domain of Hsp90 and inhibited Hsp90-Cdc37 interaction without inhibiting ATPase activity.  DCZ3112 inhibited the proliferation predominantly in HER2-pos. breast cancer cells, including those resistant to the classical Hsp90 inhibitor geldanamycin, which mainly targets ATPase.  DCZ3112 produced synergistic in vitro activity in inhibiting cell proliferation, inducing G1-phase arrest and apoptosis, and reducing AKT and ERK phosphorylation.  Consistent with this, DCZ3112 alone inhibited the growth of HER2-pos. BT-474 xenografts, and exhibited enhanced antitumor activity when combined with the anti-HER2 antibody trastuzumab.  Importantly, DCZ3112 also significantly inhibited the growth of trastuzumab-resistant BT-474 cells, and combined treatment retained synergistic antitumor activity.  Thus, our findings show that disrupting Hsp90-Cdc37 interaction may represent a promising strategy against HER2-pos. breast cancer, esp. those with acquired resistance to trastuzumab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq61vGUgD2y7LVg90H21EOLACvtfcHk0liMonEqaNSDlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKmur%252FP&md5=b1b995c35747c963804982f0e0700379</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DQ.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DH.%2BY.%26aulast%3DZhu%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DZ.%2BQ.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DXie%26aufirst%3DC.%2BY.%26aulast%3DLou%26aufirst%3DL.%2BG.%26atitle%3DDcz3112%252C%2520a%2520novel%2520hsp90%2520inhibitor%252C%2520exerts%2520potent%2520antitumor%2520activity%2520against%2520her2-positive%2520breast%2520cancer%2520through%2520disruption%2520of%2520hsp90-cdc37%2520interaction%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D434%26spage%3D70%26epage%3D80%26doi%3D10.1016%2Fj.canlet.2018.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, L.</span></span> <span> </span><span class="NLM_article-title">A novel class of small molecule inhibitors of hsp90</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1021/cb800162x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb800162x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=645-654&author=F.+Yiauthor=L.+Regan&title=A+novel+class+of+small+molecule+inhibitors+of+hsp90&doi=10.1021%2Fcb800162x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Class of Small Molecule Inhibitors of Hsp90</span></div><div class="casAuthors">Yi, Fang; Regan, Lynne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">645-654</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Unregulated cellular proliferation, caused by mutation or dysregulation of growth-promoting proteins, is an underlying cause of cancer.  Many such growth-promoting proteins exhibit an increased dependence on the activity of the chaperone heat-shock protein 90 (Hsp90) for correct folding and maturation in the cell.  One can therefore envision that inhibition of Hsp90 would be an effective and broadly applicable strategy for the development of anticancer agents.  Hsp90 functions in multichaperone complexes driven by the binding and hydrolysis of ATP.  Encouraging results have been obtained by inhibiting Hsp90 with 17-AAG, an active-site binding ATP analog.  Here we present the results of a different approach to inhibiting Hsp90 by disrupting its interaction with a cochaperone named Hsp organizing protein (HOP).  We have used an AlphaScreen technol. based high-throughput in vitro screen to identify compds. that inhibit this interaction.  In addn., we demonstrate that these compds. are active in vivo.  Treatment of human breast cancer cell lines BT474 and SKBR3 with these compds. decreases the levels of the Hsp90-dependent client protein HER2, with assocd. cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovstWzsi2PILVg90H21EOLACvtfcHk0liPYW-e-uZqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrsrjE&md5=ff2403160252e80306cca52c1e12db64</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fcb800162x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb800162x%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DF.%26aulast%3DRegan%26aufirst%3DL.%26atitle%3DA%2520novel%2520class%2520of%2520small%2520molecule%2520inhibitors%2520of%2520hsp90%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D645%26epage%3D654%26doi%3D10.1021%2Fcb800162x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L. G.</span></span> <span> </span><span class="NLM_article-title">Y-632 inhibits heat shock protein 90 (hsp90) function by disrupting the interaction between hsp90 and hsp70/hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo</span>. <i>Cancer. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1111/cas.12934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1111%2Fcas.12934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27002306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslOjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=782-790&author=W.+Q.+Wangauthor=Y.+Liuauthor=Z.+X.+Zhaoauthor=C.+Y.+Xieauthor=Y.+P.+Xuauthor=Y.+H.+Huauthor=H.+T.+Quanauthor=L.+G.+Lou&title=Y-632+inhibits+heat+shock+protein+90+%28hsp90%29+function+by+disrupting+the+interaction+between+hsp90+and+hsp70%2Fhsp90+organizing+protein%2C+and+exerts+antitumor+activity+in+vitro+and+in+vivo&doi=10.1111%2Fcas.12934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo</span></div><div class="casAuthors">Wang, Wenqian; Liu, Yang; Zhao, Zhixin; Xie, Chengying; Xu, Yongping; Hu, Youhong; Quan, Haitian; Lou, Liguang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">782-790</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) stabilizes a variety of proteins required for cancer cell survival and has been identified as a promising drug target for cancer treatment.  To date, several Hsp90 inhibitors have entered into clin. trials, but none has been approved for cancer therapy yet.  Thus, exploring new Hsp90 inhibitors with novel mechanisms of action is urgent.  In the present study, we show that Y-632, a novel pyrimidine deriv., inhibited Hsp90 in a different way from the conventional Hsp90 inhibitor geldanamycin.  Y-632 induced degrdn. of diverse Hsp90 client proteins through the ubiquitin-proteasome pathway, as geldanamycin did; however, it neither directly bound to Hsp90 nor inhibited Hsp90 ATPase activity.  Y-632 inhibited Hsp90 function mainly through inducing intracellular thiol oxidn., which led to disruption of the Hsp90-Hsp70/Hsp90 organizing protein complex and further induced cell adhesion inhibition, G0/G1 cell cycle arrest, and apoptosis.  Moreover, Y-632 efficiently overcame imatinib resistance mediated by Bcr-Abl point mutations both in vitro and in vivo.  We believe that Y-632, acting as a novel small-mol. inhibitor of the Hsp90-Hsp70/Hsp90 organizing protein complex, has great potential to be a promising Hsp90 inhibitor for cancer therapy, such as for imatinib-resistant leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb3SWb5XmEcrVg90H21EOLACvtfcHk0liPYW-e-uZqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslOjtL0%253D&md5=30bfc6b358cfb2e140434ff5b730b6c3</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1111%2Fcas.12934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12934%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%2BX.%26aulast%3DXie%26aufirst%3DC.%2BY.%26aulast%3DXu%26aufirst%3DY.%2BP.%26aulast%3DHu%26aufirst%3DY.%2BH.%26aulast%3DQuan%26aufirst%3DH.%2BT.%26aulast%3DLou%26aufirst%3DL.%2BG.%26atitle%3DY-632%2520inhibits%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520function%2520by%2520disrupting%2520the%2520interaction%2520between%2520hsp90%2520and%2520hsp70%252Fhsp90%2520organizing%2520protein%252C%2520and%2520exerts%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer.%2520Sci.%26date%3D2016%26volume%3D107%26spage%3D782%26epage%3D790%26doi%3D10.1111%2Fcas.12934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitt, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinkers, M.</span></span> <span> </span><span class="NLM_article-title">Overlapping sites of tetratricopeptide repeat protein binding and chaperone activity in heat shock protein 90</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">17857</span>– <span class="NLM_lpage">17862</span>, <span class="refDoi"> DOI: 10.1074/jbc.M001625200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M001625200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10751404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFakur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=17857-17862&author=A.+J.+Ramseyauthor=L.+C.+Russellauthor=S.+R.+Whittauthor=M.+Chinkers&title=Overlapping+sites+of+tetratricopeptide+repeat+protein+binding+and+chaperone+activity+in+heat+shock+protein+90&doi=10.1074%2Fjbc.M001625200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Overlapping sites of tetratricopeptide repeat protein binding and chaperone activity in heat shock protein 90</span></div><div class="casAuthors">Ramsey, Andrew J.; Russell, Lance C.; Whitt, Sherry R.; Chinkers, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">17857-17862</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The sequential binding of different tetratricopeptide repeat (TPR) proteins to heat shock protein 90 (hsp90) is essential to its chaperone function in vivo.  We have previously shown that three basic residues in the TPR domain of PP5 are required for binding to the acidic C-terminal domain of hsp90.  We have now tested which acidic residues in this C-terminal domain are required for binding to three different TPR proteins as follows: PP5, FKBP52, and Hop.  Mutation of Glu-279, Glu-730, and Asp-732 at the C terminus of hsp90 interfered with binding of all three TPR proteins.  Mutation of Glu-720, Asp-722, Asp-723, and Asp-724 inhibited binding of FKBP52 and PP5 but not of Hop.  Mutation of Glu-651 and Asp-653 did not affect binding of FKBP52 or PP5 but inhibited both Hop binding and hsp90 chaperone activity.  We also found that a conserved Lys residue required for PP5 binding to hsp90 was crit. for the binding of FKBP52 but not for the binding of Hop to hsp90.  These results suggest distinct but overlapping binding sites on hsp90 for different TPR proteins and indicate that the binding site for Hop, which is assocd. with hsp90 in intermediate stages of protein folding, overlaps with a site of chaperone activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjEclxxKhPLVg90H21EOLACvtfcHk0liPYW-e-uZqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFakur8%253D&md5=5bf7f5a12cd22debdb4104eb1beac0da</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001625200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001625200%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DA.%2BJ.%26aulast%3DRussell%26aufirst%3DL.%2BC.%26aulast%3DWhitt%26aufirst%3DS.%2BR.%26aulast%3DChinkers%26aufirst%3DM.%26atitle%3DOverlapping%2520sites%2520of%2520tetratricopeptide%2520repeat%2520protein%2520binding%2520and%2520chaperone%2520activity%2520in%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D17857%26epage%3D17862%26doi%3D10.1074%2Fjbc.M001625200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, S. R.</span></span> <span> </span><span class="NLM_article-title">A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2013.11.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24360559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOku73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=661-666&author=J.+R.+McConnellauthor=L.+A.+Alexanderauthor=S.+R.+McAlpine&title=A+heat+shock+protein+90+inhibitor+that+modulates+the+immunophilins+and+regulates+hormone+receptors+without+inducing+the+heat+shock+response&doi=10.1016%2Fj.bmcl.2013.11.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response</span></div><div class="casAuthors">McConnell, Jeanette R.; Alexander, Leslie A.; McAlpine, Shelli R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-666</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">When a cell encounters external stressors, such as lack of nutrients, elevated temps., changes in pH or other stressful environments, a key set of evolutionarily conserved proteins, the heat shock proteins (hsps), become overexpressed.  Hsps are classified into six major families with the hsp90 family being the best understood; an increase in cell stress leads to increased levels of hsp90, which leads to cellular protection.  A hallmark of hsp90 inhibitors is that they induce a cell rescue mechanism, the heat shock response.  The authors define the unique mol. profile of a compd. (SM145) that regulates hormone receptor protein levels through hsp90 inhibition without inducing the heat shock response.  Modulation of the binding event between heat shock protein 90 and the immunophilins/homologs using SM145, leads to a decrease in hormone receptor protein levels.  Unlike N-terminal hsp90 inhibitors, this hsp90 inhibitor does not induce a heat shock response.  This work is proof of principle that controlling hormone receptor expression can occur by inhibiting hsp90 without inducing pro-survival protein heat shock protein 70 (hsp70) or other proteins assocd. with the heat shock response.  Innovatively, the authors show that blocking the heat shock response, in addn. to hsp90, is key to regulating hsp90-assocd. pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-Jpd-Yb7brVg90H21EOLACvtfcHk0liH6iY4OoKPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOku73E&md5=a28c42be8b45e6e9525cf47096f3c2e8</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DMcConnell%26aufirst%3DJ.%2BR.%26aulast%3DAlexander%26aufirst%3DL.%2BA.%26aulast%3DMcAlpine%26aufirst%3DS.%2BR.%26atitle%3DA%2520heat%2520shock%2520protein%252090%2520inhibitor%2520that%2520modulates%2520the%2520immunophilins%2520and%2520regulates%2520hormone%2520receptors%2520without%2520inducing%2520the%2520heat%2520shock%2520response%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D661%26epage%3D666%26doi%3D10.1016%2Fj.bmcl.2013.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Retzlaff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitschke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">Asymmetric activation of the hsp90 dimer by its cochaperone aha1</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.molcel.2010.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20159554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=344-354&author=M.+Retzlaffauthor=F.+Hagnauthor=L.+Mitschkeauthor=M.+Hesslingauthor=F.+Gugelauthor=H.+Kesslerauthor=K.+Richterauthor=J.+Buchner&title=Asymmetric+activation+of+the+hsp90+dimer+by+its+cochaperone+aha1&doi=10.1016%2Fj.molcel.2010.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric activation of the Hsp90 dimer by its cochaperone Aha1</span></div><div class="casAuthors">Retzlaff, Marco; Hagn, Franz; Mitschke, Lars; Hessling, Martin; Gugel, Frederik; Kessler, Horst; Richter, Klaus; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-354</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The chaperone Hsp90 is an ATP-dependent, dimeric mol. machine regulated by several cochaperones, including inhibitors and the unique ATPase activator Aha1.  Here, we analyzed the mechanism of the Aha1-mediated acceleration of Hsp90 ATPase activity and identified the interaction surfaces of both proteins using multidimensional NMR techniques.  For max. activation of Hsp90, the two domains of Aha1 bind to sites in the middle and N-terminal domains of Hsp90 in a sequential manner.  This binding induces the kinetically unfavored N terminally dimerized state of Hsp90, which primes for the hydrolysis-competent conformation.  Surprisingly, this activation mechanism is asym.  The presence of one Aha1 mol. per Hsp90 dimer is sufficient to bridge the two subunits and to fully stimulate Hsp90 ATPase activity.  This seems to functionalize the two subunits of the Hsp90 dimer in different ways, in that one subunit can be used for conformational ATPase regulation and the other for substrate protein processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6haR106PYbVg90H21EOLACvtfcHk0liH6iY4OoKPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktbo%253D&md5=a57a2df1a7d29f1388d1e426fd3b8772</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DRetzlaff%26aufirst%3DM.%26aulast%3DHagn%26aufirst%3DF.%26aulast%3DMitschke%26aufirst%3DL.%26aulast%3DHessling%26aufirst%3DM.%26aulast%3DGugel%26aufirst%3DF.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DAsymmetric%2520activation%2520of%2520the%2520hsp90%2520dimer%2520by%2520its%2520cochaperone%2520aha1%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D37%26spage%3D344%26epage%3D354%26doi%3D10.1016%2Fj.molcel.2010.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koulov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPointe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razvi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, W. E.</span></span> <span> </span><span class="NLM_article-title">Biological and structural basis for aha1 regulation of hsp90 atpase activity in maintaining proteostasis in the human disease cystic fibrosis</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1091/mbc.e09-12-1017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1091%2Fmbc.e09-12-1017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20089831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1eqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=871-884&author=A.+V.+Koulovauthor=P.+LaPointeauthor=B.+W.+Luauthor=A.+Razviauthor=J.+Coppingerauthor=M.+Q.+Dongauthor=J.+Mattesonauthor=R.+Laisterauthor=C.+Arrowsmithauthor=J.+R.+Yatesauthor=W.+E.+Balch&title=Biological+and+structural+basis+for+aha1+regulation+of+hsp90+atpase+activity+in+maintaining+proteostasis+in+the+human+disease+cystic+fibrosis&doi=10.1091%2Fmbc.e09-12-1017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis</span></div><div class="casAuthors">Koulov, Atanas V.; La Pointe, Paul; Lu, Bingwen; Razvi, Abbas; Coppinger, Judith; Dong, Meng-Qiu; Matteson, Jeanne; Laister, Rob; Arrowsmith, Cheryl; Yates, John R., III; Balch, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">871-884</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The activator of Hsp90 ATPase 1, Aha1, has been shown to participate in the Hsp90 chaperone cycle by stimulating the low intrinsic ATPase activity of Hsp90.  To elucidate the structural basis for ATPase stimulation of human Hsp90 by human Aha1, the authors have developed novel mass spectrometry approaches that demonstrate that the N- and C-terminal domains of Aha1 cooperatively bind across the dimer interface of Hsp90 to modulate the ATP hydrolysis cycle and client activity in vivo.  Mutations in both the N- and C-terminal domains of Aha1 impair its ability to bind Hsp90 and stimulate its ATPase activity in vitro and impair in vivo the ability of the Hsp90 system to modulate the folding and trafficking of wild-type and variant (ΔF508) cystic fibrosis transmembrane conductance regulator (CFTR) responsible for the inherited disease cystic fibrosis (CF).  The authors now propose a general model for the role of Aha1 in the Hsp90 ATPase cycle in proteostasis whereby Aha1 regulates the dwell time of Hsp90 with client.  The authors suggest that Aha1 activity integrates chaperone function with client folding energetics by modulating ATPase sensitive N-terminal dimer structural transitions, thereby protecting transient folding intermediates in vivo that could contribute to protein misfolding systems disorders such as CF when destabilized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXgOZEiYJ7ELVg90H21EOLACvtfcHk0liH6iY4OoKPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1eqs7w%253D&md5=c4e6b806b8571f42253d9cece24d8011</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e09-12-1017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e09-12-1017%26sid%3Dliteratum%253Aachs%26aulast%3DKoulov%26aufirst%3DA.%2BV.%26aulast%3DLaPointe%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DB.%2BW.%26aulast%3DRazvi%26aufirst%3DA.%26aulast%3DCoppinger%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DM.%2BQ.%26aulast%3DMatteson%26aufirst%3DJ.%26aulast%3DLaister%26aufirst%3DR.%26aulast%3DArrowsmith%26aufirst%3DC.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DBalch%26aufirst%3DW.%2BE.%26atitle%3DBiological%2520and%2520structural%2520basis%2520for%2520aha1%2520regulation%2520of%2520hsp90%2520atpase%2520activity%2520in%2520maintaining%2520proteostasis%2520in%2520the%2520human%2520disease%2520cystic%2520fibrosis%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2010%26volume%3D21%26spage%3D871%26epage%3D884%26doi%3D10.1091%2Fmbc.e09-12-1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, C. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlasic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H</span></span> <span> </span><span class="NLM_article-title">Structural basis for recruitment of the atpase activator aha1 to the hsp90 chaperone machinery</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7600060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fsj.emboj.7600060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=14739935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtV2ru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=511-519&author=P.+Meyerauthor=C.+Prodromouauthor=C.+Liaoauthor=B.+Huauthor=S.+M.+Roeauthor=C.+K+Vaughanauthor=I.+Vlasicauthor=B.+Panaretouauthor=P.+W+Piperauthor=L.+H+Pearl&title=Structural+basis+for+recruitment+of+the+atpase+activator+aha1+to+the+hsp90+chaperone+machinery&doi=10.1038%2Fsj.emboj.7600060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery</span></div><div class="casAuthors">Meyer, Philippe; Prodromou, Chrisostomos; Liao, Chunyan; Hu, Bin; Roe, S. Mark; Vaughan, Cara K.; Vlasic, Ignacija; Panaretou, Barry; Piper, Peter W.; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-519</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hsp90 is a mol. chaperone essential for the activation and assembly of many key eukaryotic signaling and regulatory proteins.  Hsp90 is assisted and regulated by co-chaperones that participate in an ordered series of dynamic multiprotein complexes, linked to Hsp90s conformationally coupled ATPase cycle.  The co-chaperones Aha1 and Hch1 bind to Hsp90 and stimulate its ATPase activity.  Biochem. anal. shows that this activity is dependent on the N-terminal domain of Aha1, which interacts with the central segment of Hsp90.  The structural basis for this interaction is revealed by the crystal structure of the N-terminal domain (1-153) of Aha1 (equiv. to the whole of Hch1) in complex with the middle segment of Hsp90 (273-530).  Structural anal. and mutagenesis show that binding of N-Aha1 promotes a conformational switch in the middle-segment catalytic loop (370-390) of Hsp90 that releases the catalytic Arg-380 and enables its interaction with ATP in the N-terminal nucleotide-binding domain of the chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpiG2JApXabrVg90H21EOLACvtfcHk0lg165EHmA2yxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtV2ru7c%253D&md5=8e1699ec0804e3649a613710ba6e9001</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600060%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DVaughan%26aufirst%3DC.%2BK%26aulast%3DVlasic%26aufirst%3DI.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW%26aulast%3DPearl%26aufirst%3DL.%2BH%26atitle%3DStructural%2520basis%2520for%2520recruitment%2520of%2520the%2520atpase%2520activator%2520aha1%2520to%2520the%2520hsp90%2520chaperone%2520machinery%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D511%26epage%3D519%26doi%3D10.1038%2Fsj.emboj.7600060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiegler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbelke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korotkov, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">A chemical compound inhibiting the aha1-hsp90 chaperone complex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">17073</span>– <span class="NLM_lpage">17083</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.797829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M117.797829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28851842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Cqu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=17073-17083&author=S.+C.+Stieglerauthor=M.+Rubbelkeauthor=V.+S.+Korotkovauthor=M.+Weiwadauthor=C.+Johnauthor=G.+Fischerauthor=S.+A.+Sieberauthor=M.+Sattlerauthor=J.+Buchner&title=A+chemical+compound+inhibiting+the+aha1-hsp90+chaperone+complex&doi=10.1074%2Fjbc.M117.797829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical compound inhibiting the Aha1-Hsp90 chaperone complex</span></div><div class="casAuthors">Stiegler, Sandrine C.; Ruebbelke, Martin; Korotkov, Vadim S.; Weiwad, Matthias; John, Christine; Fischer, Gunter; Sieber, Stephan A.; Sattler, Michael; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">17073-17083</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The eukaryotic Hsp90 chaperone machinery comprises many co-chaperones and regulates the conformation of hundreds of cytosolic client proteins.  Therefore, it is not surprising that the Hsp90 machinery has become an attractive therapeutic target for diseases such as cancer.  The compds. used so far to target this machinery affect the entire Hsp90 system.  However, it would be desirable to achieve a more selective targeting of Hsp90-co-chaperone complexes.  To test this concept, in this-proof-of-principle study, the authors screened for modulators of the interaction between Hsp90 and its co-chaperone Aha1, which accelerates the ATPase activity of Hsp90.  A FRET-based assay that monitored Aha1 binding to Hsp90 enabled identification of several chem. compds. modulating the effect of Aha1 on Hsp90 activity.  The authors found that one of these inhibitors can abrogate the Aha1-induced ATPase stimulation of Hsp90 without significantly affecting Hsp90 ATPase activity in the absence of Aha1.  NMR spectroscopy revealed that this inhibitory compd. binds the N-terminal domain of Hsp90 close to its ATP-binding site and overlapping with a transient Aha1-interaction site.  The authors also noted that this inhibitor does not dissoc. the Aha1-Hsp90 complex but prevents the specific interaction with the N-terminal domain of Hsp90 required for catalysis.  In consequence, the inhibitor affected the activation and processing of Hsp90-Aha1-dependent client proteins in vivo.  The authors conclude that it is possible to abrogate a specific co-chaperone function of Hsp90 without inhibiting the entire Hsp90 machinery.  This concept may also hold true for other co-chaperones of Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWjWH-WJgm7Vg90H21EOLACvtfcHk0lg165EHmA2yxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Cqu7fF&md5=f1ea46c7c36e9b146f0efd3c91832d9c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.797829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.797829%26sid%3Dliteratum%253Aachs%26aulast%3DStiegler%26aufirst%3DS.%2BC.%26aulast%3DRubbelke%26aufirst%3DM.%26aulast%3DKorotkov%26aufirst%3DV.%2BS.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DJohn%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DA%2520chemical%2520compound%2520inhibiting%2520the%2520aha1-hsp90%2520chaperone%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D17073%26epage%3D17083%26doi%3D10.1074%2Fjbc.M117.797829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuniga-Pflucker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguila, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldschneider, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span> <span> </span><span class="NLM_article-title">Gp96, an endoplasmic reticulum master chaperone for integrins and toll-like receptors, selectively regulates early t and b lymphopoiesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2380</span>– <span class="NLM_lpage">2390</span>, <span class="refDoi"> DOI: 10.1182/blood-2009-07-233031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1182%2Fblood-2009-07-233031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19965672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2380-2390&author=M.+Staronauthor=Y.+Yangauthor=B.+Liuauthor=J.+Liauthor=Y.+K.+Shenauthor=J.+C.+Zuniga-Pfluckerauthor=H.+L.+Aguilaauthor=I.+Goldschneiderauthor=Z.+H.+Li&title=Gp96%2C+an+endoplasmic+reticulum+master+chaperone+for+integrins+and+toll-like+receptors%2C+selectively+regulates+early+t+and+b+lymphopoiesis&doi=10.1182%2Fblood-2009-07-233031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis</span></div><div class="casAuthors">Staron, Matthew; Yang, Yi; Liu, Bei; Li, Janet; Shen, Yuankai; Zuniga-Pflucker, Juan Carlos; Aguila, Hector L.; Goldschneider, Irving; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2380-2390</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Integrins contribute to lymphopoiesis, whereas Toll-like receptors (TLRs) facilitate the myeloid replenishment during inflammation.  The combined role of TLRs and integrin on hematopoiesis remains unclear.  Gp96 (grp94, HSP90b1) is an endoplasmic reticulum master chaperone for multiple TLRs.  We report herein that gp96 is also essential for expression of 14 hematopoietic system-specific integrins.  Genetic deletion of gp96 thus enables us to det. the collective roles of gp96, Integrins, and TLRs in hematopoiesis.  We found that gp96-null hematopoietic stem cells could support long-term myelopoiesis.  B- and T-cell development, however, was severely compromised with transitional block from pro-B to pre-B cells and the inability of thymocytes to develop beyond the CD4-CD8- stage.  These defects were cell-intrinsic and could be recapitulated on bone marrow stromal cell culture.  Furthermore, defective lymphopoiesis correlated strongly with failure of hematopoietic progenitors to form close contact with stromal cell niche and was not the result of the defect in the assembly of antigen receptor or interleukin-7 signaling.  These findings define gp96 as the only known mol. chaperone to specifically regulate T- and B-cell development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNk-bPWPJeWLVg90H21EOLACvtfcHk0lg165EHmA2yxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlOkurc%253D&md5=eef1c142b09de6d0856b121d25eaed54</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-233031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-233031%26sid%3Dliteratum%253Aachs%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DY.%2BK.%26aulast%3DZuniga-Pflucker%26aufirst%3DJ.%2BC.%26aulast%3DAguila%26aufirst%3DH.%2BL.%26aulast%3DGoldschneider%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26atitle%3DGp96%252C%2520an%2520endoplasmic%2520reticulum%2520master%2520chaperone%2520for%2520integrins%2520and%2520toll-like%2520receptors%252C%2520selectively%2520regulates%2520early%2520t%2520and%2520b%2520lymphopoiesis%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2380%26epage%3D2390%26doi%3D10.1182%2Fblood-2009-07-233031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Paralog specific hsp90 inhibitors - a brief history and a bright future</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F1568026616666160413141154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27072700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2779-2791&author=D.+T.+Gewirth&title=Paralog+specific+hsp90+inhibitors+-+a+brief+history+and+a+bright+future&doi=10.2174%2F1568026616666160413141154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future</span></div><div class="casAuthors">Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2779-2791</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background. The high sequence and structural homol. among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition.  Objective. This review surveys the state of developments in structural anal., compd. screening, and structure-based design that have been brought to bear on this problem.  Results. First generation compds. that selectively bind to Hsp90, Grp94, or Trap-1 have been identified.  Conclusion. With the proof of principle firmly established, the prospects for further progress are bright.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdyZyrXOyou7Vg90H21EOLACvtfcHk0lj_EfxINCk8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN&md5=208025ff36aa6e2d92d3ee107b20ab5f</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141154%26sid%3Dliteratum%253Aachs%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DParalog%2520specific%2520hsp90%2520inhibitors%2520-%2520a%2520brief%2520history%2520and%2520a%2520bright%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2779%26epage%3D2791%26doi%3D10.2174%2F1568026616666160413141154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baldo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paganetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span> <span> </span><span class="NLM_article-title">A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (hsp90) client protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">1406</span>– <span class="NLM_lpage">1414</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.294801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M111.294801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22123826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjslyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=1406-1414&author=B.+Baldoauthor=A.+Weissauthor=C.+N.+Parkerauthor=M.+Bibelauthor=P.+Paganettiauthor=K.+Kaupmann&title=A+screen+for+enhancers+of+clearance+identifies+huntingtin+as+a+heat+shock+protein+90+%28hsp90%29+client+protein&doi=10.1074%2Fjbc.M111.294801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein</span></div><div class="casAuthors">Baldo, Barbara; Weiss, Andreas; Parker, Christian N.; Bibel, Miriam; Paganetti, Paolo; Kaupmann, Klemens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1406-1414</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mechanisms to reduce the cellular levels of mutant huntingtin (mHtt) provide promising strategies for treating Huntington disease (HD).  To identify compds. enhancing the degrdn. of mHtt, we performed a high throughput screen using a hippocampal HN10 cell line expressing a 573-amino acid mHtt fragment.  Several hit structures were identified as heat shock protein 90 (Hsp90) inhibitors.  Cell treatment with these compds. reduced levels of mHtt without overt toxic effects as measured by time-resolved Foerster resonance energy transfer assays and Western blots.  To characterize the mechanism of mHtt degrdn., we used the potent and selective Hsp90 inhibitor NVP-AUY922.  In HdhQ150 embryonic stem (ES) cells and in ES cell-derived neurons, NVP-AUY922 treatment substantially reduced sol. full-length mHtt levels.  In HN10 cells, Hsp90 inhibition by NVP-AUY922 enhanced mHtt clearance in the absence of any detectable Hsp70 induction.  Furthermore, inhibition of protein synthesis with cycloheximide or overexpression of dominant neg. heat shock factor 1 (Hsf1) in HdhQ150 ES cells attenuated Hsp70 induction but did not affect NVP-AUY922-mediated mHtt clearance.  Together, these data provided evidence that direct inhibition of Hsp90 chaperone function was crucial for mHtt degrdn. rather than heat shock response induction and Hsp70 up-regulation.  Co-immunopptn. expts. revealed a phys. interaction of mutant and wild-type Htt with the Hsp90 chaperone.  Hsp90 inhibition disrupted the interaction and induced clearance of Htt through the ubiquitin-proteasome system.  These data suggest that Htt is an Hsp90 client protein and that Hsp90 inhibition may provide a means to reduce mHtt in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBzgxmFERTErVg90H21EOLACvtfcHk0lj_EfxINCk8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjslyksw%253D%253D&md5=b0cde124dc9c309851719560d6e44f28</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.294801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.294801%26sid%3Dliteratum%253Aachs%26aulast%3DBaldo%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DC.%2BN.%26aulast%3DBibel%26aufirst%3DM.%26aulast%3DPaganetti%26aufirst%3DP.%26aulast%3DKaupmann%26aufirst%3DK.%26atitle%3DA%2520screen%2520for%2520enhancers%2520of%2520clearance%2520identifies%2520huntingtin%2520as%2520a%2520heat%2520shock%2520protein%252090%2520%2528hsp90%2529%2520client%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D1406%26epage%3D1414%26doi%3D10.1074%2Fjbc.M111.294801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vought, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Correlation between chemotype-dependent binding conformations of hsp90α/β and isoform selectivity—implications for the structure-based design of hsp90α/β selective inhibitors for treating neurodegenerative diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2013.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24332488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=204-208&author=J.+T.+Ernstauthor=M.+Liuauthor=H.+Zuccolaauthor=T.+Neubertauthor=K.+Beaumontauthor=A.+Turnbullauthor=A.+Kallelauthor=B.+Voughtauthor=D.+Stamos&title=Correlation+between+chemotype-dependent+binding+conformations+of+hsp90%CE%B1%2F%CE%B2+and+isoform+selectivity%E2%80%94implications+for+the+structure-based+design+of+hsp90%CE%B1%2F%CE%B2+selective+inhibitors+for+treating+neurodegenerative+diseases&doi=10.1016%2Fj.bmcl.2013.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span></div><div class="casAuthors">Ernst, Justin T.; Liu, Michael; Zuccola, Harmon; Neubert, Timothy; Beaumont, Kevin; Turnbull, Amy; Kallel, Adam; Vought, Bryan; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-208</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HSP90 continues to be a target of interest for neurodegeneration indications.  Selective knockdown of the HSP90 cytosolic isoforms α and β is sufficient to reduce mutant huntingtin protein levels in vitro.  Chemotype-dependent binding conformations of HSP90α/β appear to strongly influence isoform selectivity.  The rational design of HSP90α/β inhibitors selective vs. the mitochondrial (TRAP1) and endoplasmic reticulum (GRP94) isoforms offers a potential mitigating strategy for mechanism-based toxicities.  Better tolerated HSP90 inhibitors would be attractive for targeting chronic neurodegenerative diseases such as Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64ZOr5JsRerVg90H21EOLACvtfcHk0lgbw5fFsMA9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO&md5=6799a46090ee297d70700f7c42b79f80</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DKallel%26aufirst%3DA.%26aulast%3DVought%26aufirst%3DB.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DCorrelation%2520between%2520chemotype-dependent%2520binding%2520conformations%2520of%2520hsp90%25CE%25B1%252F%25CE%25B2%2520and%2520isoform%2520selectivity%25E2%2580%2594implications%2520for%2520the%2520structure-based%2520design%2520of%2520hsp90%25CE%25B1%252F%25CE%25B2%2520selective%2520inhibitors%2520for%2520treating%2520neurodegenerative%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D204%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2013.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woody, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcacio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Identification of novel hsp90 alpha/beta isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating cns disorders such as huntington’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3400</span>, <span class="refDoi"> DOI: 10.1021/jm500042s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500042s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3382-3400&author=J.+T.+Ernstauthor=T.+Neubertauthor=M.+Liuauthor=S.+Sperryauthor=H.+Zuccolaauthor=A.+Turnbullauthor=B.+Fleckauthor=W.+Kargoauthor=L.+Woodyauthor=P.+Chiangauthor=D.+Tranauthor=W.+C.+Chenauthor=P.+Snyderauthor=T.+Alcacioauthor=A.+Nezamiauthor=J.+Reynoldsauthor=K.+Alviauthor=L.+Gouletauthor=D.+Stamos&title=Identification+of+novel+hsp90+alpha%2Fbeta+isoform+selective+inhibitors+using+structure-based+drug+design.+demonstration+of+potential+utility+in+treating+cns+disorders+such+as+huntington%E2%80%99s+disease&doi=10.1021%2Fjm500042s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease</span></div><div class="casAuthors">Ernst, Justin T.; Neubert, Timothy; Liu, Michael; Sperry, Samuel; Zuccola, Harmon; Turnbull, Amy; Fleck, Beth; Kargo, William; Woody, Lisa; Chiang, Peggy; Tran, Dao; Chen, Weichao; Snyder, Phillip; Alcacio, Timothy; Nezami, Azin; Reynolds, James; Alvi, Khisal; Goulet, Lance; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-based drug design strategy was used to optimize a novel benzolactam series of HSP90α/β inhibitors to achieve >1000-fold selectivity vs. the HSP90 endoplasmic reticulum and mitochondrial isoforms (GRP94 and TRAP1, resp.).  Selective HSP90α/β inhibitors were found to be equipotent to pan-HSP90 inhibitors in promoting the clearance of mutant huntington protein (mHtt) in vitro, however with less cellular toxicity.  Improved tolerability profiles may enable the use of HSP90α/β selective inhibitors in treating chronic neurodegenerative indications such as Huntington's disease (HD).  A potent, selective, orally available HSP90α/β inhibitor, 8-Cyclopentyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one, was identified that crosses the blood-brain barrier and demonstrated proof of concept by successfully reducing brain Htt levels following oral dosing in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKpHcuphxPXbVg90H21EOLACvtfcHk0lgbw5fFsMA9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D&md5=0d55fb738fc0f0615b5336b8dc17056a</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500042s%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DFleck%26aufirst%3DB.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DWoody%26aufirst%3DL.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DSnyder%26aufirst%3DP.%26aulast%3DAlcacio%26aufirst%3DT.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DAlvi%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520novel%2520hsp90%2520alpha%252Fbeta%2520isoform%2520selective%2520inhibitors%2520using%2520structure-based%2520drug%2520design.%2520demonstration%2520of%2520potential%2520utility%2520in%2520treating%2520cns%2520disorders%2520such%2520as%2520huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3382%26epage%3D3400%26doi%3D10.1021%2Fjm500042s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsumachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Tas-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1535-7163.MCT-14-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25416789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=14-22&author=S.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=H.+Hitotsumachiauthor=C.+Yoshimuraauthor=M.+Kitadeauthor=A.+Hashimotoauthor=K.+Itoauthor=A.+Gomoriauthor=K.+Takahashi&title=Tas-116%2C+a+highly+selective+inhibitor+of+heat+shock+protein+90%CE%B1+and+%CE%B2%2C+demonstrates+potent+antitumor+activity+and+minimal+ocular+toxicity+in+preclinical+models&doi=10.1158%2F1535-7163.MCT-14-0219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models</span></div><div class="casAuthors">Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins.  A no. of HSP90 inhibitors have been developed clin. for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic.  The 4-(1H-pyrazolo[3,4-b]pyridine-1-yl)benzamide TAS-116 is a selective inhibitor of cytosolic HSP90α and β that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1.  Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90α and β alone was sufficient to exert antitumor activity in certain tumor models.  One of the most notable HSP90-related adverse events universally obsd. to differing degrees in the clin. setting is visual disturbance.  A two-week administration of the isoxazole resorcinol NVP-AUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats.  In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue.  Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compd. in s.c. xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina.  Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors.  Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are obsd. with other compds. of this class.  Mol Cancer Ther; 14(1); 14-22. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB25Txc_IcKbVg90H21EOLACvtfcHk0lgbWU_b-faITg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D&md5=3ffdc26a7f0178d4e44413e22c003f77</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0219%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DHitotsumachi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DKitade%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DGomori%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26atitle%3DTas-116%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%25CE%25B1%2520and%2520%25CE%25B2%252C%2520demonstrates%2520potent%2520antitumor%2520activity%2520and%2520minimal%2520ocular%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D14%26epage%3D22%26doi%3D10.1158%2F1535-7163.MCT-14-0219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Structure-guided design of an hsp90β n-terminal isoform-selective inhibitor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">425</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs41467-017-02013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29382832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=425&author=A.+Khandelwalauthor=C.+N.+Kentauthor=M.+Balchauthor=S.+Pengauthor=S.+J.+Mishraauthor=J.+Dengauthor=V.+W.+Dayauthor=W.+Liuauthor=C.+Subramanianauthor=M.+Cohen&title=Structure-guided+design+of+an+hsp90%CE%B2+n-terminal+isoform-selective+inhibitor&doi=10.1038%2Fs41467-017-02013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span></div><div class="casAuthors">Khandelwal Anuj; Mishra Sanket J; Kent Caitlin N; Blagg Brian S J; Balch Maurie; Peng Shuxia; Deng Junpeng; Matts Robert; Day Victor W; Liu Weiya; Holzbeierlein Jeffery M; Subramanian Chitra; Cohen Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">425</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression.  Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways.  Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response.  The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments.  Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels.  Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmyRre9-yoQBpyrDyM_m9cfW6udTcc2eY6Ixop3fuqtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D&md5=cfa47e314c9bdbc1c38802108330cba7</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBalch%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DV.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26atitle%3DStructure-guided%2520design%2520of%2520an%2520hsp90%25CE%25B2%2520n-terminal%2520isoform-selective%2520inhibitor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D425%26doi%3D10.1038%2Fs41467-017-02013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span> <span> </span><span class="NLM_article-title">The chaperone activity of grp94 toward insulin-like growth factor ii is necessary for the stress response to serum deprivation</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1855</span>– <span class="NLM_lpage">1864</span>, <span class="refDoi"> DOI: 10.1091/mbc.e08-04-0346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1091%2Fmbc.e08-04-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19158397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1855-1864&author=O.+Ostrovskyauthor=N.+T.+Ahmedauthor=Y.+Argon&title=The+chaperone+activity+of+grp94+toward+insulin-like+growth+factor+ii+is+necessary+for+the+stress+response+to+serum+deprivation&doi=10.1091%2Fmbc.e08-04-0346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone activity of GRP94 toward insulin-like growth factor II is necessary for the stress response to serum deprivation</span></div><div class="casAuthors">Ostrovsky, Olga; Ahmed, Noreen T.; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1855-1864</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Insulin-like growth factor (IGF)-II is a hormone with mitogenic activity for many cell types and tissues.  We demonstrate that its intracellular processing and secretion strictly depend on the endoplasmic reticulum chaperone glucose-regulated protein (GRP) 94.  GRP94 interacts phys. and transiently with pro-IGF-II intermediates, and its activity is essential for secretion of active IGF-II, thus establishing IGF-II as a client of GRP94.  Embryonic stem (ES) cells that lack GRP94 are hypersensitive to stress conditions such as serum deprivation and die by apoptosis because they cannot respond to the stress by producing active IGF-II.  This chaperone-client interaction may explain the previously documented antiapoptotic activity of GRP94 in a no. of stress responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknJ115ssE_rVg90H21EOLACvtfcHk0lgbWU_b-faITg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D&md5=a38b8f235e33dd0e6c01fe3a04d3587e</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e08-04-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e08-04-0346%26sid%3Dliteratum%253Aachs%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DAhmed%26aufirst%3DN.%2BT.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DThe%2520chaperone%2520activity%2520of%2520grp94%2520toward%2520insulin-like%2520growth%2520factor%2520ii%2520is%2520necessary%2520for%2520the%2520stress%2520response%2520to%2520serum%2520deprivation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2009%26volume%3D20%26spage%3D1855%26epage%3D1864%26doi%3D10.1091%2Fmbc.e08-04-0346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, P. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. S</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Paralog-selective hsp90 inhibitors define tumor-specific regulation of her2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D+Patelauthor=P.+Yanauthor=P.+M+Seidlerauthor=H.+J+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+hsp90+inhibitors+define+tumor-specific+regulation+of+her2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0ljCSTZwJcYZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM%26aulast%3DPatel%26aufirst%3DH.%2BJ%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520her2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/jm9004708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.+C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials&doi=10.1021%2Fjm9004708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0ljCSTZwJcYZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17%26doi%3D10.1021%2Fjm9004708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Que, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Structure based design of a grp94-selective inhibitor: exploiting a key residue in grp94 to optimize paralog-selective binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2793</span>– <span class="NLM_lpage">2805</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2793-2805&author=N.+Queauthor=V.+M.+Crowleyauthor=A.+S.+Duerfeldtauthor=J.+Zhaoauthor=C.+N.+Kentauthor=B.+S.+J.+Blaggauthor=D.+T.+Gewirth&title=Structure+based+design+of+a+grp94-selective+inhibitor%3A+exploiting+a+key+residue+in+grp94+to+optimize+paralog-selective+binding&doi=10.1021%2Facs.jmedchem.7b01608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding</span></div><div class="casAuthors">Que, Nanette L. S.; Crowley, Vincent M.; Duerfeldt, Adam S.; Zhao, Jinbo; Kent, Caitlin N.; Blagg, Brian S. J.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2793-2805</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 and Hsp90, the ER and cytoplasmic hsp90 paralogs, share a conserved ATP-binding pocket that has been targeted for therapeutics.  Paralog-selective inhibitors may lead to drugs with fewer side effects.  Here, the authors analyzed 1 (BnIm), a benzyl imidazole resorcinylic inhibitor, for its mode of binding.  The structures of 1 bound to Hsp90 and Grp94 reveal large conformational changes in Grp94 but not Hsp90 that expose site 2, a binding pocket adjacent to the central ATP cavity that is ordinarily blocked.  The Grp94:1 structure reveals a flipped pose of the resorcinylic scaffold that inserts into the exposed site 2.  The authors exploited this flipped binding pose to develop a Grp94-selective deriv. of 1.  The authors' structural anal. shows that the ability of the ligand to insert its benzyl imidazole substituent into site 1, a different side pocket off the ATP binding cavity, is the key to exposing site 2 in Grp94.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhACqcGHClIrVg90H21EOLACvtfcHk0ljCSTZwJcYZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D&md5=a44f6bf0bd3df65cf20ca570a1ef37b8</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01608%26sid%3Dliteratum%253Aachs%26aulast%3DQue%26aufirst%3DN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520based%2520design%2520of%2520a%2520grp94-selective%2520inhibitor%253A%2520exploiting%2520a%2520key%2520residue%2520in%2520grp94%2520to%2520optimize%2520paralog-selective%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2793%26epage%3D2805%26doi%3D10.1021%2Facs.jmedchem.7b01608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Transformation of the non-selective aminocyclohexanol-based hsp90 inhibitor into a grp94-seletive scaffold</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=244-253&author=S.+J.+Mishraauthor=S.+Ghoshauthor=A.+R.+Stothertauthor=C.+A.+Dickeyauthor=B.+S.+J.+Blagg&title=Transformation+of+the+non-selective+aminocyclohexanol-based+hsp90+inhibitor+into+a+grp94-seletive+scaffold&doi=10.1021%2Facschembio.6b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold</span></div><div class="casAuthors">Mishra, Sanket J.; Ghosh, Suman; Stothert, Andrew R.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">244-253</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 kDa, Grp94, is the endoplasmic reticulum (ER) localized isoform of heat shock protein 90 (Hsp90) that is responsible for the trafficking and maturation of toll-like receptors, Igs, and integrins.  As a result, Grp94 has emerged as a therapeutic target to disrupt cellular communication, adhesion, and tumor proliferation, potentially with fewer side effects compared to pan-inhibitors of all Hsp90 isoforms.  Although, the N-terminal ATP binding site is highly conserved among all four Hsp90 isoforms, recent cocrystal structures of Grp94 have revealed subtle differences between Grp94 and other Hsp90 isoforms that has been exploited for the development of Grp94-selective inhibitors.  In the current study, a structure-based approach has been applied to a Grp94 nonselective compd., SNX 2112, which led to the development of 8j (ACO1), a Grp94-selective inhibitor that manifests ∼440 nM affinity and >200-fold selectivity against cytosolic Hsp90 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVr4w6ywqwLVg90H21EOLACvtfcHk0lhLs-jJQZ5XbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF&md5=5e9924483ab0c13f9a819a2d4bda55ee</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DTransformation%2520of%2520the%2520non-selective%2520aminocyclohexanol-based%2520hsp90%2520inhibitor%2520into%2520a%2520grp94-seletive%2520scaffold%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D244%26epage%3D253%26doi%3D10.1021%2Facschembio.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of a grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+J.+Blagg&title=Development+of+a+grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhLs-jJQZ5XbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Development of radamide analogs as grp94 inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4083</span>– <span class="NLM_lpage">4098</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmc.2014.05.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25027801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4083-4098&author=A.+Muthauthor=V.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=J.+B.+Zhaoauthor=J.+Hallauthor=B.+S.+J.+Blagg&title=Development+of+radamide+analogs+as+grp94+inhibitors&doi=10.1016%2Fj.bmc.2014.05.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radamide analogs as Grp94 inhibitors</span></div><div class="casAuthors">Muth, Aaron; Crowley, Vincent; Khandelwal, Anuj; Mishra, Sanket; Zhao, Jinbo; Hall, Jessica; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4083-4098</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hsp90 isoform-selective inhibition is highly desired as it can potentially avoid the toxic side-effects of pan-inhibition.  The current study developed selective inhibitors of one such isoform, Grp94, predicated on the chimeric and pan-Hsp90 inhibitor, radamide (RDA).  Replacement of the quinone moiety of RDA with a Ph ring (2) was found to be better suited for Grp94 inhibition as it can fully interact with a unique hydrophobic pocket present in Grp94.  An extensive SAR for this scaffold showed that substitutions at the 2- and 4-positions (8 and 27, resp.) manifested excellent Grp94 affinity and selectivity.  Introduction of heteroatoms into the ring also proved beneficial, with a 2-pyridine deriv. (38) exhibiting the highest Grp94 affinity (Kd = 820 nM).  Subsequent cell-based assays showed that these Grp94 inhibitors inhibit migration of the metastatic breast cancer cell line, MDA-MB-231, as well as exhibit an anti-proliferative affect against the multiple myeloma cell line, RPMI 8226.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdbHibsHh3rVg90H21EOLACvtfcHk0lhLs-jJQZ5XbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK&md5=6025c533f1c107eb5c54a559c679c8d2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.075%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%2BB.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDevelopment%2520of%2520radamide%2520analogs%2520as%2520grp94%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4083%26epage%3D4098%26doi%3D10.1016%2Fj.bmc.2014.05.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span> <span> </span><span class="NLM_article-title">Crystallization and preliminary x-ray diffraction analysis of trap1 complexed with hsp90 inhibitors</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1683</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1107/S2053230X14024959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1107%2FS2053230X14024959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=25484226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=1683-1687&author=H.+Jeongauthor=B.+H.+Kangauthor=C.+Lee&title=Crystallization+and+preliminary+x-ray+diffraction+analysis+of+trap1+complexed+with+hsp90+inhibitors&doi=10.1107%2FS2053230X14024959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallization and preliminary X-ray diffraction analysis of Trap1 complexed with Hsp90 inhibitors</span></div><div class="casAuthors">Jeong, Hanbin; Kang, Byoung Heon; Lee, Changwook</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1683-1687</span>CODEN:
                <span class="NLM_cas:coden">ACSFEN</span>;
        ISSN:<span class="NLM_cas:issn">2053-230X</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Hsp90 is a mol. chaperone responsible for the assembly and regulation of many cellular client proteins.  In particular, Trap1, a mitochondrial Hsp90 homolog, plays a pivotal role in maintaining mitochondrial integrity, protecting against apoptosis in cancer cells.  The N (N-terminal)-M (middle) domain of human Trap1 was crystd. in complex with Hsp90 inhibitors (PU-H71 and BIIB-021) by the hanging-drop vapor-diffusion method at pH 6.5 and 293 K using 15% PEG 8K as a precipitant.  Diffraction data were collected from crystals of the Trap1-PU-H71 (2.7 Å) and Trap1-BIIB-021 (3.1 Å) complexes to high resoln. at a synchrotron-radiation source.  Preliminary X-ray diffraction anal. revealed that both crystals belonged to space group P41212 or P43212, with unit-cell parameters a = b = 69.2, c = 252.5 Å, and contained one mol. per asym. unit according to Matthews coeff. calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGparb6NUaz8eLVg90H21EOLACvtfcHk0lhLs-jJQZ5XbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCls7bJ&md5=24ac12c18ae7c77a5f881f80959191b0</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1107%2FS2053230X14024959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053230X14024959%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DC.%26atitle%3DCrystallization%2520and%2520preliminary%2520x-ray%2520diffraction%2520analysis%2520of%2520trap1%2520complexed%2520with%2520hsp90%2520inhibitors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Commun.%26date%3D2014%26volume%3D70%26spage%3D1683%26epage%3D1687%26doi%3D10.1107%2FS2053230X14024959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheon, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Development of a mitochondria-targeted hsp90 inhibitor based on the crystal structures of human trap1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">4358</span>– <span class="NLM_lpage">4367</span>, <span class="refDoi"> DOI: 10.1021/ja511893n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja511893n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=4358-4367&author=C.+Leeauthor=H.+K.+Parkauthor=H.+Jeongauthor=J.+Limauthor=A.+J.+Leeauthor=K.+Y.+Cheonauthor=C.+S.+Kimauthor=A.+P.+Thomasauthor=B.+Baeauthor=N.+D.+Kim&title=Development+of+a+mitochondria-targeted+hsp90+inhibitor+based+on+the+crystal+structures+of+human+trap1&doi=10.1021%2Fja511893n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1</span></div><div class="casAuthors">Lee, Changwook; Park, Hye-Kyung; Jeong, Hanbin; Lim, Jaehwa; Lee, An-Jung; Cheon, Keun Young; Kim, Chul-Su; Thomas, Ajesh P.; Bae, Boram; Kim, Nam Doo; Kim, Seong Heon; Suh, Pann-Ghill; Ryu, Ja-Hyoung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4358-4367</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mitochondrial pool of Hsp90 and its mitochondrial paralog, TRAP1, suppresses cell death and reprograms energy metab. in cancer cells; therefore, Hsp90 and TRAP1 have been suggested as target proteins for anticancer drug development.  Here, the authors report that the actual target protein in cancer cell mitochondria is TRAP1, and current Hsp90 inhibitors cannot effectively inactivate TRAP1 because of their insufficient accumulation in the mitochondria.  To develop mitochondrial TRAP1 inhibitors, the authors detd. the crystal structures of human TRAP1 complexed with Hsp90 inhibitors.  The iso-Pr amine of the Hsp90 inhibitor PU-H71 was replaced with the mitochondria-targeting moiety triphenylphosphonium to produce SMTIN-P01.  SMTIN-P01 showed a different mode of action from the nontargeted PU-H71, as well as much improved cytotoxicity to cancer cells.  In addn., the authors detd. the structure of a TRAP1-adenylyl-imidodiphosphate (AMP-PNP) complex.  On the basis of comparative anal. of TRAP1 structures, the authors propose a mol. mechanism of ATP hydrolysis that is crucial for chaperone function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN-VB5CkPi2LVg90H21EOLACvtfcHk0lgKqg6zBf8mPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2htrs%253D&md5=c1142149eaa5f4157377ce64662fcfc1</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fja511893n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja511893n%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DCheon%26aufirst%3DK.%2BY.%26aulast%3DKim%26aufirst%3DC.%2BS.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DBae%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DN.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520mitochondria-targeted%2520hsp90%2520inhibitor%2520based%2520on%2520the%2520crystal%2520structures%2520of%2520human%2520trap1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D4358%26epage%3D4367%26doi%3D10.1021%2Fja511893n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Paralog specificity determines subcellular distribution, action mechanism, and anticancer activity of trap1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7569</span>– <span class="NLM_lpage">7578</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7569-7578&author=H.+K.+Parkauthor=H.+Jeongauthor=E.+Koauthor=G.+Leeauthor=J.+E.+Leeauthor=S.+K.+Leeauthor=A.+J.+Leeauthor=J.+Y.+Imauthor=S.+Huauthor=S.+H.+Kim&title=Paralog+specificity+determines+subcellular+distribution%2C+action+mechanism%2C+and+anticancer+activity+of+trap1+inhibitors&doi=10.1021%2Facs.jmedchem.7b00978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors</span></div><div class="casAuthors">Park, Hye-Kyung; Jeong, Hanbin; Ko, Eunhwa; Lee, Geumwoo; Lee, Ji-Eun; Lee, Sang Kwang; Lee, An-Jung; Im, Jin Young; Hu, Sung; Kim, Seong Heon; Lee, Ji Hoon; Lee, Changwook; Kang, Soosung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7569-7578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although Hsp90 inhibitors can inhibit multiple tumorigenic pathways in cancer cells, their anticancer activity has been disappointingly modest.  However, by forcing Hsp90 inhibitors into the mitochondria with mitochondrial delivery vehicles, they were converted into potent drugs targeting the mitochondrial Hsp90 paralog TRAP1.  Here, to improve mitochondrial drug accumulation without using the mitochondrial delivery vehicle, we increased freely available drug concns. in the cytoplasm by reducing the binding of the drugs to the abundant cytoplasmic Hsp90.  After analyzing X-ray cocrystal structures, the purine ring of the Hsp90 inhibitor 2 (BIIB021) was modified to pyrazolopyrimidine scaffolds.  One pyrazolopyrimidine, 12b (DN401), bound better to TRAP1 than to Hsp90, inactivated the mitochondrial TRAP1 in vivo, and it exhibited potent anticancer activity.  Therefore, the rationale and feasible guidelines for developing 12b can potentially be exploited to design a potent TRAP1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfck9jHWGc7Vg90H21EOLACvtfcHk0lgKqg6zBf8mPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM&md5=7cfcb60a5a2691eb7be6950ef7ede0ed</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00978%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DIm%26aufirst%3DJ.%2BY.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DParalog%2520specificity%2520determines%2520subcellular%2520distribution%252C%2520action%2520mechanism%252C%2520and%2520anticancer%2520activity%2520of%2520trap1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7569%26epage%3D7578%26doi%3D10.1021%2Facs.jmedchem.7b00978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lees-Miller, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, C. W.</span></span> <span> </span><span class="NLM_article-title">The human double-stranded dna-activated protein kinase phosphorylates the 90-kda heat-shock protein, hsp90 alpha at two nh2-terminal threonine residues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">17275</span>– <span class="NLM_lpage">17280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=2507541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADyaK3cXjtlCn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=17275-17280&author=S.+P.+Lees-Millerauthor=C.+W.+Anderson&title=The+human+double-stranded+dna-activated+protein+kinase+phosphorylates+the+90-kda+heat-shock+protein%2C+hsp90+alpha+at+two+nh2-terminal+threonine+residues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90α at two amino-terminal threonine residues</span></div><div class="casAuthors">Lees-Miller, Susan P.; Anderson, Carl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">17275-80</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The 90-kDa heat-shock protein, hsp90, is an abundant cytoplasmic protein that can be phosphorylated in vitro by a double-stranded (ds) DNA-activated protein kinase found in cells from several species.  The dsDNA-activated protein kinase from human HeLa cells phosphorylates 2 threonine residues in the sequence PEETQTQDQPME at the N-terminus of human hsp90α.  Hsp90β, which is 97% identical to hsp90α but lacks both N-terminal threonines, is not phosphorylated by the dsDNA-activated protein kinase.  Mouse hsp86 and rabbit hsp90α are homologous to human hsp90α; both heterologous proteins are phosphorylated at the same N-terminal threonines by the human dsDNA-activated protein kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNjFNhZV0j5rVg90H21EOLACvtfcHk0lgKqg6zBf8mPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjtlCn&md5=a00d1ed87ade6d7a1f8d824d4f4b8d28</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees-Miller%26aufirst%3DS.%2BP.%26aulast%3DAnderson%26aufirst%3DC.%2BW.%26atitle%3DThe%2520human%2520double-stranded%2520dna-activated%2520protein%2520kinase%2520phosphorylates%2520the%252090-kda%2520heat-shock%2520protein%252C%2520hsp90%2520alpha%2520at%2520two%2520nh2-terminal%2520threonine%2520residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D17275%26epage%3D17280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, Y.</span></span> <span> </span><span class="NLM_article-title">Protein kinase ck2 in health and disease: ck2: the kinase controlling the hsp90 chaperone machinery</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1840</span>– <span class="NLM_lpage">1849</span>, <span class="refDoi"> DOI: 10.1007/s00018-009-9152-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1007%2Fs00018-009-9152-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19387550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1840-1849&author=Y.+Miyata&title=Protein+kinase+ck2+in+health+and+disease%3A+ck2%3A+the+kinase+controlling+the+hsp90+chaperone+machinery&doi=10.1007%2Fs00018-009-9152-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">CK2: the kinase controlling the Hsp90 chaperone machinery</span></div><div class="casAuthors">Miyata, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1840-1849</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is a ubiquitous and essential protein kinase with pleiotropic substrates and function, but it remains unclear how, when, and where CK2 activity is regulated in cells.  Hsp90 is a major mol. chaperone that is required for the folding and function of its client proteins.  A complex contg. Hsp90 and its client protein includes co-chaperones such as steroid hormone receptor-specific FKBP52 and signaling kinase-specific Cdc37.  Co-chaperones work cooperatively with Hsp90 to stabilize client proteins and to keep them in a conformation amenable to activation under appropriate conditions.  Here, crit. roles of CK2 in the regulation of the Hsp90-mediated chaperone system are described.  CK2 phosphorylates and modulates Hsp90 and its co-chaperones, FKBP52 and Cdc37.  CK2-dependent phosphorylation of Cdc37 is essential for the chaperoning function of Hsp90-Cdc37 for multiple signaling protein kinases.  The tumor kinome appears to become addicted to the Hsp90-Cdc37 chaperone system, thus, targeting Hsp90, Cdc37, and CK2 is a promising strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW2ZhBoll7aLVg90H21EOLACvtfcHk0lisUuIHVce_ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D&md5=b4447a54564fde9c88ba6ab0b5b22e90</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9152-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9152-0%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26atitle%3DProtein%2520kinase%2520ck2%2520in%2520health%2520and%2520disease%253A%2520ck2%253A%2520the%2520kinase%2520controlling%2520the%2520hsp90%2520chaperone%2520machinery%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26spage%3D1840%26epage%3D1849%26doi%3D10.1007%2Fs00018-009-9152-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornbluth, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of apoptosome formation by suppression of hsp90beta phosphorylation in tyrosine kinase-induced leukemias</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">5494</span>– <span class="NLM_lpage">5506</span>, <span class="refDoi"> DOI: 10.1128/MCB.00265-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1128%2FMCB.00265-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18591256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVersLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=5494-5506&author=M.+Kurokawaauthor=C.+Zhaoauthor=T.+Reyaauthor=S.+Kornbluth&title=Inhibition+of+apoptosome+formation+by+suppression+of+hsp90beta+phosphorylation+in+tyrosine+kinase-induced+leukemias&doi=10.1128%2FMCB.00265-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of apoptosome formation by suppression of Hsp90β phosphorylation in tyrosine kinase-induced leukemias</span></div><div class="casAuthors">Kurokawa, Manabu; Zhao, Chen; Reya, Tannishtha; Kornbluth, Sally</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5494-5506</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Constitutively active tyrosine kinases promote leukemogenesis by increasing cell proliferation and inhibiting apoptosis.  However, mechanisms underlying apoptotic inhibition have not been fully elucidated.  In many settings, apoptosis occurs by mitochondrial cytochrome c release, which nucleates the Apaf-1/caspase-9 apoptosome.  Here the authors report that the leukemogenic kinases, Bcr-Abl, FLT3/D835Y, and Tel-PDGFRβ, all can inhibit apoptosome function.  In cells expressing these kinases, the previously reported apoptosome inhibitor, Hsp90β, bound strongly to Apaf-1, preventing cytochrome c-induced Apaf-1 oligomerization and caspase-9 recruitment.  Hsp90β interacted weakly with the apoptosome in untransformed cells.  While Hsp90β was phosphorylated at Ser 226/Ser 255 in untransformed cells, phosphorylation was absent in leukemic cells.  Expression of mutant Hsp90β (S226A/S255A), which mimics the hypophosphorylated form in leukemic cells, conferred resistance to cytochrome c-induced apoptosome activation in normal cells, reflecting enhanced binding of nonphosphorylatable Hsp90β to Apaf-1.  In Bcr-Abl-pos. mouse bone marrow cells, nonphosphorylatable Hsp90β expression conferred imatinib (Gleevec) resistance.  These data provide an explanation for apoptosome inhibition by activated leukemogenic tyrosine kinases and suggest that alterations in Hsp90β-apoptosome interactions may contribute to chemoresistance in leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVlqJSEyA3-rVg90H21EOLACvtfcHk0lisUuIHVce_ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVersLvF&md5=c55df706baaa7a54dc98a4289ce5ebf4</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1128%2FMCB.00265-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00265-08%26sid%3Dliteratum%253Aachs%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DReya%26aufirst%3DT.%26aulast%3DKornbluth%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520apoptosome%2520formation%2520by%2520suppression%2520of%2520hsp90beta%2520phosphorylation%2520in%2520tyrosine%2520kinase-induced%2520leukemias%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D5494%26epage%3D5506%26doi%3D10.1128%2FMCB.00265-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Old, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabb, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couts, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litman, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croy, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Arendt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witze, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweppe, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resing, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, N. G.</span></span> <span> </span><span class="NLM_article-title">Functional proteomics identifies targets of phosphorylation by b-raf signaling in melanoma</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.molcel.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19362540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1SrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=115-131&author=W.+M.+Oldauthor=J.+B.+Shabbauthor=S.+Houelauthor=H.+Wangauthor=K.+L.+Coutsauthor=C.+Y.+Yenauthor=E.+S.+Litmanauthor=C.+H.+Croyauthor=K.+Meyer-Arendtauthor=J.+G.+Mirandaauthor=R.+A.+Brownauthor=E.+S.+Witzeauthor=R.+E.+Schweppeauthor=K.+A.+Resingauthor=N.+G.+Ahn&title=Functional+proteomics+identifies+targets+of+phosphorylation+by+b-raf+signaling+in+melanoma&doi=10.1016%2Fj.molcel.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma</span></div><div class="casAuthors">Old, William M.; Shabb, John B.; Houel, Stephane; Wang, Hong; Couts, Kasey L.; Yen, Chia-yu; Litman, Elizabeth S.; Croy, Carrie H.; Meyer-Arendt, Karen; Miranda, Jose G.; Brown, Robert A.; Witze, Eric S.; Schweppe, Rebecca E.; Resing, Katheryn A.; Ahn, Natalie G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-131</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Melanoma and other cancers harbor oncogenic mutations in the protein kinase B-Raf, which leads to constitutive activation and dysregulation of MAP kinase signaling.  To elucidate mol. determinants responsible for B-Raf control of cancer phenotypes, the authors present a method for phosphoprotein profiling, using neg. ionization mass spectrometry to detect phosphopeptides based on their fragment ion signature caused by release of PO3-.  The method provides an alternative strategy for phosphoproteomics, circumventing affinity enrichment of phosphopeptides and isotopic labeling of samples.  Ninety phosphorylation events were regulated by oncogenic B-Raf signaling, based on their responses to treating melanoma cells with MKK1/2 inhibitor.  Regulated phosphoproteins included known signaling effectors and cytoskeletal regulators.  The authors investigated MINERVA/FAM129B, a target belonging to a protein family with unknown category and function, and established the importance of this protein and its MAP kinase-dependent phosphorylation in controlling melanoma cell invasion into three-dimensional collagen matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5p9Eyn9VIbbVg90H21EOLACvtfcHk0lisUuIHVce_ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1SrsLk%253D&md5=4e5e895c9a0f78097ad4fb418f4846d3</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DOld%26aufirst%3DW.%2BM.%26aulast%3DShabb%26aufirst%3DJ.%2BB.%26aulast%3DHouel%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCouts%26aufirst%3DK.%2BL.%26aulast%3DYen%26aufirst%3DC.%2BY.%26aulast%3DLitman%26aufirst%3DE.%2BS.%26aulast%3DCroy%26aufirst%3DC.%2BH.%26aulast%3DMeyer-Arendt%26aufirst%3DK.%26aulast%3DMiranda%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DR.%2BA.%26aulast%3DWitze%26aufirst%3DE.%2BS.%26aulast%3DSchweppe%26aufirst%3DR.%2BE.%26aulast%3DResing%26aufirst%3DK.%2BA.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26atitle%3DFunctional%2520proteomics%2520identifies%2520targets%2520of%2520phosphorylation%2520by%2520b-raf%2520signaling%2520in%2520melanoma%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D34%26spage%3D115%26epage%3D131%26doi%3D10.1016%2Fj.molcel.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barati, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rane, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeish, K. R.</span></span> <span> </span><span class="NLM_article-title">A proteomic screen identified stress-induced chaperone proteins as targets of akt phosphorylation in mesangial cells</span>. <i>J. Proteome. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1646</span>, <span class="refDoi"> DOI: 10.1021/pr0502469</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr0502469" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFShtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1636-1646&author=M.+T.+Baratiauthor=M.+J.+Raneauthor=J.+B.+Kleinauthor=K.+R.+McLeish&title=A+proteomic+screen+identified+stress-induced+chaperone+proteins+as+targets+of+akt+phosphorylation+in+mesangial+cells&doi=10.1021%2Fpr0502469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A Proteomic Screen Identified Stress-Induced Chaperone Proteins as Targets of Akt Phosphorylation in Mesangial Cells</span></div><div class="casAuthors">Barati, Michelle T.; Rane, Madhavi J.; Klein, Jon B.; McLeish, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1636-1646</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The serine-threonine kinase Akt regulates mesangial cell apoptosis, proliferation, and hypertrophy.  To define Akt signaling pathways in mesangial cells, we performed a functional proteomic screen for rat mesangial cell proteins phosphorylated by Akt.  A group of chaperone proteins, heat shock protein (Hsp) 70, Hsp90α, Hsp90β, Glucose-regulated protein (Grp) Grp78, Grp94, and protein disulfide isomerase (PDI) were identified as potential Akt substrates by two techniques: (a) in vitro phosphorylation of mesangial cell lysate by recombinant active Akt followed by protein sepn. by SDS-PAGE or 2-DE and phosphoprotein identification by peptide mass fingerprinting using MALDI-MS, or (b) immunoblot anal. of proteins from PDGF-stimulated mesangial cells using an anti-Akt phospho-motif antibody.  In vitro kinase reactions using recombinant proteins confirmed that Akt phosphorylates Hsp70, Hsp90α and β, Grp94, and PDI.  Immunopptn. of Akt from mesangial cell lysate copptd. Grp78 and Hsp70.  PDGF stimulation of mesangial cells caused an acidic shift in the isoelec. point of Hsp70, Hsp90, and PDI that was dependent on PI-3K activity for Hsp70 and Hsp90.  The data suggest that Akt-mediated phosphorylation of stress-induced chaperones represents a mechanism for regulation of chaperone function during mesangial cell responses to physiol. and pathol. stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG6MaU5uvP87Vg90H21EOLACvtfcHk0liVUkwOfIFWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFShtrs%253D&md5=4fcf7b7be5e8dae9b1b8bb135085f0b3</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fpr0502469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr0502469%26sid%3Dliteratum%253Aachs%26aulast%3DBarati%26aufirst%3DM.%2BT.%26aulast%3DRane%26aufirst%3DM.%2BJ.%26aulast%3DKlein%26aufirst%3DJ.%2BB.%26aulast%3DMcLeish%26aufirst%3DK.%2BR.%26atitle%3DA%2520proteomic%2520screen%2520identified%2520stress-induced%2520chaperone%2520proteins%2520as%2520targets%2520of%2520akt%2520phosphorylation%2520in%2520mesangial%2520cells%26jtitle%3DJ.%2520Proteome.%2520Res.%26date%3D2006%26volume%3D5%26spage%3D1636%26epage%3D1646%26doi%3D10.1021%2Fpr0502469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Boeuf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratton, J. P.</span></span> <span> </span><span class="NLM_article-title">Src-mediated phosphorylation of hsp90 in response to vascular endothelial growth factor (vegf) is required for vegf receptor-2 signaling to endothelial no synthase</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4659</span>– <span class="NLM_lpage">4668</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-05-0467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1091%2Fmbc.e07-05-0467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=17855507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12js7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=4659-4668&author=M.+Duvalauthor=F.+Le+Boeufauthor=J.+Huotauthor=J.+P.+Gratton&title=Src-mediated+phosphorylation+of+hsp90+in+response+to+vascular+endothelial+growth+factor+%28vegf%29+is+required+for+vegf+receptor-2+signaling+to+endothelial+no+synthase&doi=10.1091%2Fmbc.e07-05-0467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase</span></div><div class="casAuthors">Duval, Martine; Le Boeuf, Fabrice; Huot, Jacques; Gratton, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4659-4668</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Nitric oxide (NO) release from endothelial cells, via endothelial NO synthase (eNOS) activation, is central to the proangiogenic actions of vascular endothelial growth factor (VEGF).  VEGF signaling to eNOS is principally mediated by an Akt-dependent phosphorylation of eNOS and by increased assocn. of eNOS to the mol. chaperone, heat-shock protein 90 kDa (HSP 90).  Herein, the authors report that VEGFR-2 activation induces tyrosine phosphorylation of VEGF receptor 2 (VEGFR-2)-assocd. HSP 90β.  Tyrosine phosphorylation of HSP 90β in response to VEGF is dependent on internalization of the VEGFR-2 and on Src kinase activation.  Furthermore, the authors demonstrate that c-Src directly phosphorylates HSP 90 on tyrosine 300 residue and that this event is essential for VEGF-stimulated eNOS assocn. to HSP 90 and thus NO release from endothelial cells.  The authors' work identifies Y300 phosphorylation of HSP 90 as a novel regulated posttranslational modification of the chaperone and demonstrates its importance in the proangiogenic actions of VEGF, namely by regulating NO release from endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8mNvqIDcvcLVg90H21EOLACvtfcHk0liVUkwOfIFWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12js7nJ&md5=d769bb43d5186e3bc567b878d06b8d22</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-05-0467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-05-0467%26sid%3Dliteratum%253Aachs%26aulast%3DDuval%26aufirst%3DM.%26aulast%3DLe%2BBoeuf%26aufirst%3DF.%26aulast%3DHuot%26aufirst%3DJ.%26aulast%3DGratton%26aufirst%3DJ.%2BP.%26atitle%3DSrc-mediated%2520phosphorylation%2520of%2520hsp90%2520in%2520response%2520to%2520vascular%2520endothelial%2520growth%2520factor%2520%2528vegf%2529%2520is%2520required%2520for%2520vegf%2520receptor-2%2520signaling%2520to%2520endothelial%2520no%2520synthase%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2007%26volume%3D18%26spage%3D4659%26epage%3D4668%26doi%3D10.1091%2Fmbc.e07-05-0467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokita, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourboulia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B. T.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Swe1wee1-dependent tyrosine phosphorylation of hsp90 regulates distinct facets of chaperone function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.molcel.2010.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20159553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=333-343&author=M.+Mollapourauthor=S.+Tsutsumiauthor=A.+C.+Donnellyauthor=K.+Beebeauthor=M.+J.+Tokitaauthor=M.+J.+Leeauthor=S.+Leeauthor=G.+Morraauthor=D.+Bourbouliaauthor=B.+T.+Scroggins&title=Swe1wee1-dependent+tyrosine+phosphorylation+of+hsp90+regulates+distinct+facets+of+chaperone+function&doi=10.1016%2Fj.molcel.2010.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function</span></div><div class="casAuthors">Mollapour, Mehdi; Tsutsumi, Shinji; Donnelly, Alison C.; Beebe, Kristin; Tokita, Mari J.; Lee, Min-Jung; Lee, Sunmin; Morra, Giulia; Bourboulia, Dimitra; Scroggins, Bradley T.; Colombo, Giorgio; Blagg, Brian S.; Panaretou, Barry; Stetler-Stevenson, William G.; Trepel, Jane B.; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-343</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Saccharomyces WEE1 (Swe1), the only "true" tyrosine kinase in budding yeast, is an Hsp90 client protein.  Here we show that Swe1Wee1 phosphorylates a conserved tyrosine residue (Y24 in yeast Hsp90 and Y38 in human Hsp90α) in the N domain of Hsp90.  Phosphorylation is cell-cycle assocd. and modulates the ability of Hsp90 to chaperone a selected clientele, including v-Src and several other kinases.  Nonphosphorylatable mutants have normal ATPase activity, support yeast viability, and productively chaperone the Hsp90 client glucocorticoid receptor.  Deletion of SWE1 in yeast increases Hsp90 binding to its inhibitor geldanamycin, and pharmacol. inhibition/silencing of Wee1 sensitizes cancer cells to Hsp90 inhibitor-induced apoptosis.  These findings demonstrate that Hsp90 chaperoning of distinct client proteins is differentially regulated by specific posttranslational modification of a unique subcellular pool of the chaperone, and they provide a strategy to increase the cellular potency of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7UKPV6M9pnbVg90H21EOLACvtfcHk0liVUkwOfIFWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Kktb0%253D&md5=0c604b88a699ed15813e983cbf27bc29</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DA.%2BC.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DTokita%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DMorra%26aufirst%3DG.%26aulast%3DBourboulia%26aufirst%3DD.%26aulast%3DScroggins%26aufirst%3DB.%2BT.%26atitle%3DSwe1wee1-dependent%2520tyrosine%2520phosphorylation%2520of%2520hsp90%2520regulates%2520distinct%2520facets%2520of%2520chaperone%2520function%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D37%26spage%3D333%26epage%3D343%26doi%3D10.1016%2Fj.molcel.2010.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scroggins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zierer, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.18632%2Foncotarget.1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=23867252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1065-1074&author=K.+Beebeauthor=M.+Mollapourauthor=B.+Scrogginsauthor=C.+Prodromouauthor=W.+Xuauthor=M.+Tokitaauthor=T.+Taldoneauthor=L.+Pullenauthor=B.+K.+Ziererauthor=M.+J.+Leeauthor=J.+Trepelauthor=J.+Buchnerauthor=D.+Bolonauthor=G.+Chiosisauthor=L.+Neckers&title=Posttranslational+modification+and+conformational+state+of+heat+shock+protein+90+differentially+affect+binding+of+chemically+diverse+small+molecule+inhibitors&doi=10.18632%2Foncotarget.1099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span></div><div class="casAuthors">Beebe Kristin; Mollapour Mehdi; Scroggins Bradley; Prodromou Chrisostomos; Xu Wanping; Tokita Mari; Taldone Tony; Pullen Lester; Zierer Bettina K; Lee Min-Jung; Trepel Jane; Buchner Johannes; Bolon Daniel; Chiosis Gabriela; Neckers Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1065-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an essential molecular chaperone in eukaryotes that facilitates the conformational maturation and function of a diverse protein clientele, including aberrant and/or over-expressed proteins that are involved in cancer growth and survival.  A role for Hsp90 in supporting the protein homeostasis of cancer cells has buoyed interest in the utility of Hsp90 inhibitors as anti-cancer drugs.  Despite the fact that all clinically evaluated Hsp90 inhibitors target an identical nucleotide-binding pocket in the N domain of the chaperone, the precise determinants that affect drug binding in the cellular environment remain unclear, and it is possible that chemically distinct inhibitors may not share similar binding preferences.  Here we demonstrate that two chemically unrelated Hsp90 inhibitors, the benzoquinone ansamycin geldanamycin and the purine analog PU-H71, select for overlapping but not identical subpopulations of total cellular Hsp90, even though both inhibitors bind to an amino terminal nucleotide pocket and prevent N domain dimerization.  Our data also suggest that PU-H71 is able to access a broader range of N domain undimerized Hsp90 conformations than is geldanamycin and is less affected by Hsp90 phosphorylation, consistent with its broader and more potent anti-tumor activity.  A more complete understanding of the impact of the cellular milieu on small molecule inhibitor binding to Hsp90 should facilitate their more effective use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZ-jT50Ygfa91pGlMMoT5fW6udTcc2eZy6EiEG4F2Vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D&md5=1db8c9dca9517cd39a1b911107869582</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1099%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DScroggins%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DTokita%26aufirst%3DM.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPullen%26aufirst%3DL.%26aulast%3DZierer%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DBolon%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPosttranslational%2520modification%2520and%2520conformational%2520state%2520of%2520heat%2520shock%2520protein%252090%2520differentially%2520affect%2520binding%2520of%2520chemically%2520diverse%2520small%2520molecule%2520inhibitors%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D1065%26epage%3D1074%26doi%3D10.18632%2Foncotarget.1099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandawat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span> <span> </span><span class="NLM_article-title">Hdac6 inhibition enhances 17-aag-mediated abrogation of hsp90 chaperone function in human leukemia cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1893</span>, <span class="refDoi"> DOI: 10.1182/blood-2008-03-143644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1182%2Fblood-2008-03-143644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18591380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVylu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1886-1893&author=R.+Raoauthor=W.+Fiskusauthor=Y.+H.+Yangauthor=P.+Leeauthor=R.+Joshiauthor=P.+Fernandezauthor=A.+Mandawatauthor=P.+Atadjaauthor=J.+E.+Bradnerauthor=K.+Bhalla&title=Hdac6+inhibition+enhances+17-aag-mediated+abrogation+of+hsp90+chaperone+function+in+human+leukemia+cells&doi=10.1182%2Fblood-2008-03-143644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells</span></div><div class="casAuthors">Rao, Rekha; Fiskus, Warren; Yang, Yonghua; Lee, Pearl; Joshi, Rajeshree; Fernandez, Pravina; Mandawat, Aditya; Atadja, Peter; Bradner, James E.; Bhalla, Kapil</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1886-1893</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6) is a heat shock protein 90 (hsp90) deacetylase.  Treatment with pan-HDAC inhibitors or depletion of HDAC6 by siRNA induces hyperacetylation and inhibits ATP binding and chaperone function of hsp90.  Treatment with 17-allylamino-demothoxy geldanamycin (17-AAG) also inhibits ATP binding and chaperone function of hsp90, resulting in polyubiquitylation and proteasomal degrdn. of hsp90 client proteins.  In this study, we detd. the effect of hsp90 hyperacetylation on the anti-hsp90 and antileukemia activity of 17-AAG.  Hyperacetylation of hsp90 increased its binding to 17-AAG, as well as enhanced 17-AAG-mediated attenuation of ATP and the cochaperone p23 binding to hsp90.  Notably, treatment with 17-AAG alone also reduced HDAC6 binding to hsp90 and induced hyperacetylation of hsp90.  This promoted the proteasomal degrdn. of HDAC6.  Cotreatment with 17-AAG and siRNA to HDAC6 induced more inhibition of hsp90 chaperone function and depletion of BCR-ABL and c-Raf than treatment with either agent alone.  In addn., cotreatment with 17-AAG and tubacin augmented the loss of survival of K562 cells and viability of primary acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) samples.  These findings demonstrate that HDAC6 is an hsp90 client protein and hyperacetylation of hsp90 augments the anti-hsp90 and anti-leukemia effects of 17-AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRs9whnsH5-rVg90H21EOLACvtfcHk0lhbDVnZYEejUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVylu7jI&md5=146c22ba5b2fb605748f7afebe58878c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-03-143644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-03-143644%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DP.%26aulast%3DMandawat%26aufirst%3DA.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DHdac6%2520inhibition%2520enhances%252017-aag-mediated%2520abrogation%2520of%2520hsp90%2520chaperone%2520function%2520in%2520human%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1886%26epage%3D1893%26doi%3D10.1182%2Fblood-2008-03-143644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoston, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, N. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of dna methyltransferase 1 in human breast cancer cells</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-0330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1541-7786.MCR-07-0330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18505931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=873-883&author=Q.+Zhouauthor=A.+T.+Agostonauthor=P.+Atadjaauthor=W.+G.+Nelsonauthor=N.+E.+Davidson&title=Inhibition+of+histone+deacetylases+promotes+ubiquitin-dependent+proteasomal+degradation+of+dna+methyltransferase+1+in+human+breast+cancer+cells&doi=10.1158%2F1541-7786.MCR-07-0330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells</span></div><div class="casAuthors">Zhou, Qun; Agoston, Agoston T.; Atadja, Peter; Nelson, William G.; Davidson, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">873-883</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Histone deacetylases (HDAC) play a crit. role in chromatin modification and gene expression.  Recent evidence indicates that HDACs can also regulate functions of nonhistone proteins by catalyzing the removal of acetylated lysine residues.  Here, we show that the HDAC inhibitor LBH589 down-regulates DNA methyltransferase 1 (DNMT1) protein expression in the nucleus of human breast cancer cells.  Cotreatment with the proteasomal inhibitor MG-132 abolishes the ability of LBH589 to reduce DNMT1, suggesting that the proteasomal pathway mediates DNMT1 degrdn. on HDAC inhibition.  Deletion of the N-terminal 120 amino acids of DNMT1 diminishes LBH589-induced ubiquitination, indicating that this domain is essential for its proteasomal degrdn.  DNMT1 recruits the mol. chaperone heat shock protein 90 (Hsp90) to form a chaperone complex.  Treatment with LBH589 induces hyperacetylation of Hsp90, thereby inhibiting the assocn. of DNMT1 with Hsp90 and promoting ubiquitination of DNMT1.  In addn., inactivation of HDAC1 activity by small interfering RNA and MS-275 is assocd. with Hsp90 acetylation in conjunction with redn. of DNMT1 protein expression.  We conclude that the stability of DNMT1 is maintained in part through its assocn. with Hsp90.  Disruption of Hsp90 function by HDAC inhibition is a unique mechanism that mediates the ubiquitin-proteasome pathway for DNMT1 degrdn.  Our studies suggest a new role for HDAC1 and identify a novel mechanism of action for the HDAC inhibitors as down-regulators of DNMT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiWptPKR1-KLVg90H21EOLACvtfcHk0lhbDVnZYEejUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojsbo%253D&md5=3f4d1413990ed13ae6c54de161824191</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-0330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-0330%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DAgoston%26aufirst%3DA.%2BT.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DW.%2BG.%26aulast%3DDavidson%26aufirst%3DN.%2BE.%26atitle%3DInhibition%2520of%2520histone%2520deacetylases%2520promotes%2520ubiquitin-dependent%2520proteasomal%2520degradation%2520of%2520dna%2520methyltransferase%25201%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D873%26epage%3D883%26doi%3D10.1158%2F1541-7786.MCR-07-0330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nechtman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atadja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span> <span> </span><span class="NLM_article-title">Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">4833</span>– <span class="NLM_lpage">4842</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F0008-5472.CAN-08-0644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18559531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=4833-4842&author=Y.+Yangauthor=R.+Raoauthor=J.+Shenauthor=Y.+Tangauthor=W.+Fiskusauthor=J.+Nechtmanauthor=P.+Atadjaauthor=K.+Bhalla&title=Role+of+acetylation+and+extracellular+location+of+heat+shock+protein+90alpha+in+tumor+cell+invasion&doi=10.1158%2F0008-5472.CAN-08-0644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Role of acetylation and extracellular location of heat shock protein 90α in tumor cell invasion</span></div><div class="casAuthors">Yang, Yonghua; Rao, Rehka; Shen, Jie; Tang, Yun; Fiskus, Warren; Nechtman, John; Atadja, Peter; Bhalla, Kapil</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4833-4842</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Heat shock protein (hsp) 90 is an ATP-dependent mol. chaperone that maintains the active conformation of client oncoproteins in cancer cells.  An isoform, hsp90α, promotes extracellular maturation of matrix metalloproteinase (MMP)-2, involved in tumor invasion and metastasis.  Knockdown of histone deacetylase (HDAC) 6, which deacetylates lysine residues in hsp90, induces reversible hyperacetylation and attenuates ATP binding and chaperone function of hsp90.  Here, using mass spectrometry, we identified seven lysine residues in hsp90α that are hyperacetylated after treatment of eukaryotic cells with a pan-HDAC inhibitor that also inhibits HDAC6.  Depending on the specific lysine residue in the middle domain involved, although acetylation affects ATP, cochaperone, and client protein binding to hsp90α, acetylation of all seven lysines increased the binding of hsp90α to 17-allyl-amino-demethoxy geldanamycin.  Notably, after treatment with the pan-HDAC inhibitor panobinostat (LBH589), the extracellular hsp90α was hyperacetylated and it bound to MMP-2, which was assocd. with increased in vitro tumor cell invasiveness.  Treatment with antiacetylated hsp90α antibody inhibited in vitro invasion by tumor cells.  Thus, reversible hyperacetylation modulates the intracellular and extracellular chaperone function of hsp90, and targeting extracellular hyperacetylated hsp90α may undermine tumor invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKmXVX2VVP5rVg90H21EOLACvtfcHk0lhbDVnZYEejUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ejsLc%253D&md5=8bb95a83c6be8a48fe25a7c0ef64fc49</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0644%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DNechtman%26aufirst%3DJ.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DRole%2520of%2520acetylation%2520and%2520extracellular%2520location%2520of%2520heat%2520shock%2520protein%252090alpha%2520in%2520tumor%2520cell%2520invasion%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D4833%26epage%3D4842%26doi%3D10.1158%2F0008-5472.CAN-08-0644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Retzlaff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagleder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">Hsp90 is regulated by a switch point in the c-terminal domain</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1153</span>, <span class="refDoi"> DOI: 10.1038/embor.2009.153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fembor.2009.153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19696785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1147-1153&author=M.+Retzlaffauthor=M.+Stahlauthor=H.+C.+Eberlauthor=S.+Laglederauthor=J.+Beckauthor=H.+Kesslerauthor=J.+Buchner&title=Hsp90+is+regulated+by+a+switch+point+in+the+c-terminal+domain&doi=10.1038%2Fembor.2009.153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 is regulated by a switch point in the C-terminal domain</span></div><div class="casAuthors">Retzlaff, Marco; Stahl, Michael; Eberl, H. Christian; Lagleder, Stephan; Beck, Juergen; Kessler, Horst; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1147-1153</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an abundant, dimeric ATP-dependent mol. chaperone, and ATPase activity is essential for its in vivo functions.  S-nitrosylation of a residue located in the carboxy-terminal domain has been shown to affect Hsp90 activity in vivo.  To understand how variation of a specific amino acid far away from the amino-terminal ATP-binding site regulates Hsp90 functions, we mutated the corresponding residue and analyzed yeast and human Hsp90 variants both in vivo and in vitro.  Here, we show that this residue is a conserved, strong regulator of Hsp90 functions, including ATP hydrolysis and chaperone activity.  Unexpectedly, the variants alter both the C-terminal and N-terminal assocn. properties of Hsp90, and shift its conformational equil. within the ATPase cycle.  Thus, S-nitrosylation of this residue allows the fast and efficient fine regulation of Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsCS-4WbYkCbVg90H21EOLACvtfcHk0liHh329iWu4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVaksrrK&md5=bb8a17c9eac352e8aebaeff863f432e8</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fembor.2009.153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2009.153%26sid%3Dliteratum%253Aachs%26aulast%3DRetzlaff%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DEberl%26aufirst%3DH.%2BC.%26aulast%3DLagleder%26aufirst%3DS.%26aulast%3DBeck%26aufirst%3DJ.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DHsp90%2520is%2520regulated%2520by%2520a%2520switch%2520point%2520in%2520the%2520c-terminal%2520domain%26jtitle%3DEMBO%2520Rep.%26date%3D2009%26volume%3D10%26spage%3D1147%26epage%3D1153%26doi%3D10.1038%2Fembor.2009.153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span> <span> </span><span class="NLM_article-title">Tubocapsenolide a, a novel withanolide, inhibits proliferation and induces apoptosis in mda-mb-231 cells by thiol oxidation of heat shock proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">17184</span>– <span class="NLM_lpage">17193</span>, <span class="refDoi"> DOI: 10.1074/jbc.M709447200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M709447200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=18442981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFSnt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=17184-17193&author=W.+Y.+Chenauthor=F.+R.+Changauthor=Z.+Y.+Huangauthor=J.+H.+Chenauthor=Y.+C.+Wuauthor=C.+C.+Wu&title=Tubocapsenolide+a%2C+a+novel+withanolide%2C+inhibits+proliferation+and+induces+apoptosis+in+mda-mb-231+cells+by+thiol+oxidation+of+heat+shock+proteins&doi=10.1074%2Fjbc.M709447200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Tubocapsenolide A, a Novel Withanolide, Inhibits Proliferation and Induces Apoptosis in MDA-MB-231 Cells by Thiol Oxidation of Heat Shock Proteins</span></div><div class="casAuthors">Chen, Wen-Ying; Chang, Fang-Rong; Huang, Zih-You; Chen, Jyun-Hong; Wu, Yang-Chang; Wu, Chin-Chung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">17184-17193</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tubocapsenolide A (TA), a novel withanolide-type steroid, exhibits potent cytotoxicity against several human cancer cell lines.  In the present study, we obsd. that treatment of human breast cancer MDA-MB-231 cells with TA led to cell cycle arrest at G1 phase and apoptosis.  The actions of TA were correlated with proteasome-dependent degrdn. of Cdk4, cyclin D1, Raf-1, Akt, and mutant p53, which are heat shock protein 90 (Hsp90) client proteins.  TA treatment induced a transient increase in reactive oxygen species and a decrease in the intracellular glutathione contents.  Nonreducing SDS-PAGE revealed that TA rapidly and selectively induced thiol oxidn. and aggregation of Hsp90 and Hsp70, both in intact cells and in cell-free systems using purified recombinant proteins.  Furthermore, TA inhibited the chaperone activity of Hsp90-Hsp70 complex in the luciferase refolding assay.  N-Acetylcysteine, a thiol antioxidant, prevented all of the TA-induced effects, including oxidn. of heat shock proteins, degrdn. of Hsp90 client proteins, and apoptosis.  In contrast, non-thiol antioxidants (trolox and vitamin C) were ineffective to prevent Hsp90 inhibition and cell death.  Taken together, our results demonstrate that the TA inhibits the activity of Hsp90-Hsp70 chaperone complex, at least in part, by a direct thiol oxidn., which in turn leads to the destabilization and depletion of Hsp90 client proteins and thus causes cell cycle arrest and apoptosis in MDA-MB-231 cells.  Therefore, TA can be considered as a new type of inhibitor of Hsp90-Hsp70 chaperone complex, which has the potential to be developed as a novel strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6jKcM90BvAbVg90H21EOLACvtfcHk0liHh329iWu4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFSnt7c%253D&md5=1ea1deed86bc1ad05dc39b44313dda3e</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M709447200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M709447200%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BY.%26aulast%3DChang%26aufirst%3DF.%2BR.%26aulast%3DHuang%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DTubocapsenolide%2520a%252C%2520a%2520novel%2520withanolide%252C%2520inhibits%2520proliferation%2520and%2520induces%2520apoptosis%2520in%2520mda-mb-231%2520cells%2520by%2520thiol%2520oxidation%2520of%2520heat%2520shock%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D17184%26epage%3D17193%26doi%3D10.1074%2Fjbc.M709447200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samanta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative inhibition of hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1002/ijc.27687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fijc.27687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=22729780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVOmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=695-706&author=S.+Sarkarauthor=D.+Duttaauthor=S.+K.+Samantaauthor=K.+Bhattacharyaauthor=B.+C.+Palauthor=J.+P.+Liauthor=K.+Dattaauthor=C.+Mandalauthor=C.+Mandal&title=Oxidative+inhibition+of+hsp90+disrupts+the+super-chaperone+complex+and+attenuates+pancreatic+adenocarcinoma+in+vitro+and+in+vivo&doi=10.1002%2Fijc.27687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo</span></div><div class="casAuthors">Sarkar, Sayantani; Dutta, Devawati; Samanta, Suman Kumar; Bhattacharya, Kaushik; Pal, Bikas Chandra; Li, Jinping; Datta, Kaustubh; Mandal, Chhabinath; Mandal, Chitra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">695-706</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Pancreatic cancer is almost always fatal, in part because of its delayed diagnosis, poor prognosis, rapid progression and chemoresistance.  Oncogenic proteins are stabilized by the Hsp90, making it a potential therapeutic target.  We investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer.  Mahanine exhibited antiproliferative activity against several pancreatic cancer cell lines through apoptosis.  It induced early accumulation of reactive oxygen species (ROS) leading to thiol oxidn., aggregation and dysfunction of Hsp90 in MIAPaCa-2.  N-acetyl-L-cysteine prevented mahanine-induced ROS accumulation, aggregation of Hsp90, degrdn. of client proteins and cell death.  Mahanine disrupted Hsp90-Cdc37 complex in MIAPaCa-2 as a consequence of ROS generation.  Client proteins were restored by MG132, suggesting a possible role of ubiquitinylated protein degrdn. pathway.  Surface plasmon resonance study demonstrated that the rate of interaction of mahanine with recombinant Hsp90 is in the range of seconds.  Mol. dynamics simulation showed its weak interactions with Hsp90.  However, no disruption of the Hsp90-Cdc37 complex was obsd. at an early time point, thus ruling out that mahanine directly disrupts the complex.  It did not impede the ATP binding pocket of Hsp90.  Mahanine also reduced in vitro migration and tube formation in cancer cells.  Further, it inhibited orthotopic pancreatic tumor growth in nude mice.  Taken together, these results provide evidence for mahanine-induced ROS-mediated destabilization of Hsp90 chaperone activity resulting in Hsp90-Cdc37 disruption leading to apoptosis, suggesting its potential as a specific target in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2wjaaP-3orVg90H21EOLACvtfcHk0liHh329iWu4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVOmsrk%253D&md5=d78916f699b062c5d06f56338bf3526b</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1002%2Fijc.27687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27687%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DDutta%26aufirst%3DD.%26aulast%3DSamanta%26aufirst%3DS.%2BK.%26aulast%3DBhattacharya%26aufirst%3DK.%26aulast%3DPal%26aufirst%3DB.%2BC.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DDatta%26aufirst%3DK.%26aulast%3DMandal%26aufirst%3DC.%26aulast%3DMandal%26aufirst%3DC.%26atitle%3DOxidative%2520inhibition%2520of%2520hsp90%2520disrupts%2520the%2520super-chaperone%2520complex%2520and%2520attenuates%2520pancreatic%2520adenocarcinoma%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D695%26epage%3D706%26doi%3D10.1002%2Fijc.27687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcon, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crandon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zein, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannargudi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shnaidman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brega, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span> <span> </span><span class="NLM_article-title">A phase I study of pf-04929113 (snx-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6831</span>– <span class="NLM_lpage">6839</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-0821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1158%2F1078-0432.CCR-11-0821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=21908572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWlsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6831-6839&author=A.+Rajanauthor=R.+J.+Kellyauthor=J.+B.+Trepelauthor=Y.+S.+Kimauthor=S.+V.+Alarconauthor=S.+Kummarauthor=M.+Gutierrezauthor=S.+Crandonauthor=W.+M.+Zeinauthor=L.+Jainauthor=B.+Mannargudiauthor=W.+D.+Figgauthor=B.+E.+Houkauthor=M.+Shnaidmanauthor=N.+Bregaauthor=G.+Giaccone&title=A+phase+I+study+of+pf-04929113+%28snx-5422%29%2C+an+orally+bioavailable+heat+shock+protein+90+inhibitor%2C+in+patients+with+refractory+solid+tumor+malignancies+and+lymphomas&doi=10.1158%2F1078-0432.CCR-11-0821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas</span></div><div class="casAuthors">Rajan, Arun; Kelly, Ronan J.; Trepel, Jane B.; Kim, Yeong Sang; Alarcon, Sylvia V.; Kummar, Shivaani; Gutierrez, Martin; Crandon, Sonja; Zein, Wadih M.; Jain, Lokesh; Mannargudi, Baskar; Figg, William D.; Houk, Brett E.; Shnaidman, Michael; Brega, Nicoletta; Giaccone, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6831-6839</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: To det. the max. tolerated dose (MTD), toxicities, and pharmacokinetic/pharmacodynamic profile of the Hsp90 inhibitor PF-04929113 (SNX-5422) in patients with advanced solid tumors and lymphomas.  METHODS: This was a single-institution, phase I, dose-escalation study of PF-04929113 administered twice weekly.  Endpoints included detn. of dose-limiting toxicities (DLT), MTD, the safety profile of PF-04929113, pharmacodynamic assessment of PF-04929113 on Hsp70 induction, pharmacokinetic anal. of PF-04928473 (SNX-2112) and its prodrug PF-04929113, and assessment of response.  RESULTS: Thirty-three patients with advanced malignancies were treated.  Dose escalation was continued up to 177 mg/m2 administered orally twice a week.  One DLT (nonseptic arthritis) was noted.  No grade 4 drug-related adverse events were seen; grade 3 adverse events included diarrhea (9%), nonseptic arthritis (3%), aspartate aminotransferase elevation (3%), and thrombocytopenia (3%).  No objective responses were seen in 32 evaluable patients.  Fifteen patients (47%) had stable disease; 17 patients (53%) had progressive disease.  Pharmacokinetic data revealed rapid absorption, hepatic, and extrahepatic clearance, extensive tissue binding, and almost linear pharmacokinetics of the active drug PF-04928473.  Pharmacodynamic studies confirmed inhibition of Hsp90 and a linear correlation between pharmacokinetic parameters and Hsp70 induction.  CONCLUSIONS: PF-04929113 administered orally twice a week is well tolerated and inhibits its intended target Hsp90.  No objective responses were seen, but long-lasting stabilizations were obtained.  Although no clin. significant drug-related ocular toxicity was seen in this study, the development of PF-04929113 has been discontinued because of ocular toxicity seen in animal models and in a sep. phase I study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQzbnkoUJnibVg90H21EOLACvtfcHk0lgwar1SYSoXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWlsrzM&md5=2b10fada0eb9d1dc7e06826724edf21f</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0821%26sid%3Dliteratum%253Aachs%26aulast%3DRajan%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DR.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DAlarcon%26aufirst%3DS.%2BV.%26aulast%3DKummar%26aufirst%3DS.%26aulast%3DGutierrez%26aufirst%3DM.%26aulast%3DCrandon%26aufirst%3DS.%26aulast%3DZein%26aufirst%3DW.%2BM.%26aulast%3DJain%26aufirst%3DL.%26aulast%3DMannargudi%26aufirst%3DB.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DHouk%26aufirst%3DB.%2BE.%26aulast%3DShnaidman%26aufirst%3DM.%26aulast%3DBrega%26aufirst%3DN.%26aulast%3DGiaccone%26aufirst%3DG.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520pf-04929113%2520%2528snx-5422%2529%252C%2520an%2520orally%2520bioavailable%2520heat%2520shock%2520protein%252090%2520inhibitor%252C%2520in%2520patients%2520with%2520refractory%2520solid%2520tumor%2520malignancies%2520and%2520lymphomas%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D6831%26epage%3D6839%26doi%3D10.1158%2F1078-0432.CCR-11-0821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Hsp90 inhibition: elimination of shock and stress</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4983</span>– <span class="NLM_lpage">4987</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.bmcl.2010.06.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=20656483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4983-4987&author=A.+S.+Duerfeldtauthor=B.+S.+J.+Blagg&title=Hsp90+inhibition%3A+elimination+of+shock+and+stress&doi=10.1016%2Fj.bmcl.2010.06.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 inhibition: Elimination of shock and stress</span></div><div class="casAuthors">Duerfeldt, Adam S.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4983-4987</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The 90 kDa heat shock proteins (Hsp90) represent a class of mol. chaperones responsible for the maturation and stabilization of many oncogenic proteins.  Disrupting the ability of ATP to bind and facilitate the operation of Hsp90 has emerged as a promising approach toward cancer chemotherapeutic development.  While numerous Hsp90 inhibitory scaffolds have been identified, progress through the clinic has revealed many obstacles that should be addressed in future analog development.  Recent reports of the complications, pitfalls, and downstream effects assocd. with Hsp90 inhibition are discussed herein, in hopes of providing a ref. that can be used to guide the future design of Hsp90 inhibitory scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXsn3PYU8oqLVg90H21EOLACvtfcHk0lgwar1SYSoXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbjE&md5=d6f1ad3e632e69eb8d0df2ade911db69</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.108%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DHsp90%2520inhibition%253A%2520elimination%2520of%2520shock%2520and%2520stress%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4983%26epage%3D4987%26doi%3D10.1016%2Fj.bmcl.2010.06.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuttall, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, P. W.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the radicicol resistance displayed by a fungal hsp90</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1021/cb9000316</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb9000316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtl2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=289-297&author=C.+Prodromouauthor=J.+M.+Nuttallauthor=S.+H.+Millsonauthor=S.+M.+Roeauthor=T.+S.+Simauthor=D.+Tanauthor=P.+Workmanauthor=L.+H.+Pearlauthor=P.+W.+Piper&title=Structural+basis+of+the+radicicol+resistance+displayed+by+a+fungal+hsp90&doi=10.1021%2Fcb9000316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90</span></div><div class="casAuthors">Prodromou, Chrisostomos; Nuttall, James M.; Millson, Stefan H.; Roe, S. Mark; Sim, Tiow-Suan; Tan, Doreen; Workman, Paul; Pearl, Laurence H.; Piper, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-297</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a promising cancer drug target, as multiple oncogenic proteins are destabilized simultaneously when it loses its activity in tumor cells.  Highly selective Hsp90 inhibitors, including the natural antibiotics geldanamycin (GdA) and radicicol (RAD), inactivate this essential mol. chaperone by occupying its nucleotide binding site.  Often cancer drug therapy is compromised by the development of resistance, but a resistance to these Hsp90 inhibitors should not arise readily by mutation of those amino acids within Hsp90 that facilitate inhibitor binding, as these are required for the essential ATP binding/ATPase steps of the chaperone cycle and are tightly conserved.  Despite this, the Hsp90 of a RAD-producing fungus is shown to possess an unusually low binding affinity for RAD but not GdA.  Within its nucleotide binding site a normally conserved leucine is replaced by isoleucine, though the chaperone ATPase activity is not severely affected.  Inserted into the Hsp90 of yeast, this conservative leucine to isoleucine substitution recreated this lowered affinity for RAD in vitro.  It also generated a substantially enhanced resistance to RAD in vivo.  Co-crystal structures reveal that the change to isoleucine is assocd. with a localized increase in the hydration of an Hsp90-bound RAD but not GdA.  To the best of our knowledge, this is the first demonstration that it is possible for Hsp90 inhibitor resistance to arise by subtle alteration to the structure of Hsp90 itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqBiwlzDNYbVg90H21EOLACvtfcHk0lgwar1SYSoXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtl2qtbk%253D&md5=2498a51c8240132da8bfa3e88cbbc67e</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fcb9000316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9000316%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DNuttall%26aufirst%3DJ.%2BM.%26aulast%3DMillson%26aufirst%3DS.%2BH.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DSim%26aufirst%3DT.%2BS.%26aulast%3DTan%26aufirst%3DD.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26atitle%3DStructural%2520basis%2520of%2520the%2520radicicol%2520resistance%2520displayed%2520by%2520a%2520fungal%2520hsp90%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26spage%3D289%26epage%3D297%26doi%3D10.1021%2Fcb9000316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guettouche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voellmy, R.</span></span> <span> </span><span class="NLM_article-title">Repression of heat shock transcription factor hsf1 activation by hsp90 (hsp90 complex) that forms a stress-sensitive complex with hsf1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81588-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2FS0092-8674%2800%2981588-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=9727490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADyaK1cXlslOrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=471-480&author=J.+Zouauthor=Y.+Guoauthor=T.+Guettoucheauthor=D.+F.+Smithauthor=R.+Voellmy&title=Repression+of+heat+shock+transcription+factor+hsf1+activation+by+hsp90+%28hsp90+complex%29+that+forms+a+stress-sensitive+complex+with+hsf1&doi=10.1016%2FS0092-8674%2800%2981588-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1</span></div><div class="casAuthors">Zou, Jiangying; Guo, Yongle; Guettouche, Toumy; Smith, David F.; Voellmy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">471-480</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Heat shock and other proteotoxic stresses cause accumulation of nonnative proteins that trigger activation of heat shock protein (Hsp) genes.  A chaperone/Hsp functioning as repressor of heat shock transcription factor (HSF) could make activation of hsp genes dependent on protein unfolding.  In a novel in vitro system, in which human HSF1 can be activated by nonnative protein, heat, and geldanamycin, addn. of Hsp90 inhibits activation.  Redn. of the level of Hsp90 but not of Hsp/c70, Hop, Hip, p23, CyP40, or Hsp40 dramatically activates HSF1.  In vivo, geldanamycin activates HSF1 under conditions in which it is an Hsp90-specific reagent.  Hsp90-contg. HSF1 complex is present in the unstressed cell and dissocs. during stress.  We conclude that Hsp90, by itself and/or assocd. with multichaperone complexes, is a major repressor of HSF1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW_ZsrrM8VFrVg90H21EOLACvtfcHk0li8LdOJDx9gzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslOrsrY%253D&md5=26024c9d4e94c7f46986320fc667fd6f</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981588-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981588-3%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGuettouche%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DVoellmy%26aufirst%3DR.%26atitle%3DRepression%2520of%2520heat%2520shock%2520transcription%2520factor%2520hsf1%2520activation%2520by%2520hsp90%2520%2528hsp90%2520complex%2529%2520that%2520forms%2520a%2520stress-sensitive%2520complex%2520with%2520hsf1%26jtitle%3DCell%26date%3D1998%26volume%3D94%26spage%3D471%26epage%3D480%26doi%3D10.1016%2FS0092-8674%2800%2981588-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span> <span> </span><span class="NLM_article-title">New developments in hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2008.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.drup.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=19179103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=17-27&author=Y.+Y.+Liauthor=T.+Zhangauthor=S.+J.+Schwartzauthor=D.+X.+Sun&title=New+developments+in+hsp90+inhibitors+as+anti-cancer+therapeutics%3A+mechanisms%2C+clinical+perspective+and+more+potential&doi=10.1016%2Fj.drup.2008.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential</span></div><div class="casAuthors">Li Yanyan; Zhang Tao; Schwartz Steven J; Sun Duxin</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The molecular chaperone Hsp90 (heat shock protein 90) is a promising target in cancer therapy.  Preclinical and clinical evaluations of a variety of Hsp90 inhibitors have shown anti-tumor effect as a single agent and in combination with chemotherapy.  Current Hsp90 inhibitors are categorized into several classes based on distinct modes of inhibition, including (i) blockade of ATP binding, (ii) disruption of co-chaperone/Hsp90 interactions, (iii) antagonism of client/Hsp90 associations and (iv) interference with post-translational modifications of Hsp90.  The different functions of Hsp90 isoforms and the isoform selectivity of drugs need further investigation.  The correlation of cell surface Hsp90 with cancer metastasis and the emerging involvement of Hsp90 inhibition in cancer stem cells have become exciting areas that could be exploited.  Therefore, the aim of this review is (1) to summarize the up-to-date knowledge of mechanistic studies and clinical prospect of currently available Hsp90 inhibitors, (2) to enhance our perspectives for designing and discovering novel Hsp90 inhibitors, and (3) to provide an insight into less-understood potential of Hsp90 inhibition in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5kNKTb14uEhcr74wzj5o5fW6udTcc2eb_h4t9RkwjtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3jvV2mtg%253D%253D&md5=4d848faff412f714fb669add9d0cc4c7</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DS.%2BJ.%26aulast%3DSun%26aufirst%3DD.%2BX.%26atitle%3DNew%2520developments%2520in%2520hsp90%2520inhibitors%2520as%2520anti-cancer%2520therapeutics%253A%2520mechanisms%252C%2520clinical%2520perspective%2520and%2520more%2520potential%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2009%26volume%3D12%26spage%3D17%26epage%3D27%26doi%3D10.1016%2Fj.drup.2008.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein (p-gp)-mediated efflux limits intestinal absorption of the hsp90 inhibitor snx-2112 in rats</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.3109/00498254.2014.891781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.3109%2F00498254.2014.891781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=24555822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=763-768&author=H.+Liuauthor=H.+Sunauthor=Z.+Wuauthor=X.+Zhangauthor=B.+Wu&title=P-glycoprotein+%28p-gp%29-mediated+efflux+limits+intestinal+absorption+of+the+hsp90+inhibitor+snx-2112+in+rats&doi=10.3109%2F00498254.2014.891781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in rats</span></div><div class="casAuthors">Liu, Hongming; Sun, Hua; Wu, Zhufeng; Zhang, Xingwang; Wu, Baojian</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">763-768</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">1. The promising anticancer agent SNX-2112 (a novel Hsp90 inhibitor) is poorly bioavailable after oral administration.  Here, we aim to det. the role of P-glycoprotein (P-gp) in the intestinal absorption of SNX-2112.  2. We found that SNX-2112 significantly stimulated P-gp ATPase activity in in vitro ATPase assay with a small EC50 (the half-maximal effective concn.) value of 0.32 μM.  3. In the single-pass perfused rat intestine model, absorption of SNX-2112 was not favored in the small intestine with a (the wall permeability) value of 0.38-0.64.  By contrast, the compd. was well absorbed in the colon with a value of 1.19.  The P-gp inhibitors cyclosporine and elacridar (i.e. GF120918A) markedly enhanced SNX-2112 absorption in all four intestinal segments (i.e. duodenum, jejunum, ileum and colon) and the fold change ranged from 3.1 to 14.1.  Pharmacokinetic study revealed that cyclosporine increased the systemic exposure of SNX-2112 by a 2.5-fold after oral administration.  4. This is the first report that P-gp-mediated efflux is a limiting factor for intestinal absorption of SNX-2112 in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpkim7OEVzjbVg90H21EOLACvtfcHk0li8LdOJDx9gzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtLvJ&md5=8f1c1d5c849ab665be1bc94677cace42</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.891781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.891781%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DP-glycoprotein%2520%2528p-gp%2529-mediated%2520efflux%2520limits%2520intestinal%2520absorption%2520of%2520the%2520hsp90%2520inhibitor%2520snx-2112%2520in%2520rats%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26spage%3D763%26epage%3D768%26doi%3D10.3109%2F00498254.2014.891781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilaboa, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aller, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of multidrug resistance 1 (mdr1)/p-glycoprotein gene expression and activity by heat-shock transcription factor 1 (hsf1)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">24970</span>, <span class="refDoi"> DOI: 10.1074/jbc.M909136199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1074%2Fjbc.M909136199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10816597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsl2jtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=24970&author=N.+E.+Vilaboaauthor=A.+Galanauthor=A.+Troyanoauthor=E.+de+Blasauthor=P.+Aller&title=Regulation+of+multidrug+resistance+1+%28mdr1%29%2Fp-glycoprotein+gene+expression+and+activity+by+heat-shock+transcription+factor+1+%28hsf1%29&doi=10.1074%2Fjbc.M909136199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1)</span></div><div class="casAuthors">Vilaboa, Nuria E.; Galan, Alba; Troyano, Alfonso; De Blas, Elena; Aller, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">24970-24976</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Infection of HeLa cells with adenovirus-carrying HSF1+ cDNA, which encodes a mutated form of HSF1 with constitutive transactivation capacity, increased multidrug resistance 1 (MDR1) mRNA level and P-glycoprotein (P-gp) cell surface content and stimulated rhodamine 123 accumulation and vinblastine efflux activity.  On the other hand, infection with adenovirus-carrying HSP70 and HSP27 cDNAs did not increase MDR1/P-gp expression.  HSF1 regulates MDR1/P-gp expression at the transcriptional level, since HSF1+ bound the heat-shock consensus elements (HSEs) in the MDR1 gene promoter and also activated the expression of an MDR1 promoter-driven reporter plasmid (pMDR1(-1202)).  In addn., heat-shock increased pMDR1(-1202) promoter activity but not the activity of a similar reporter plasmid with point mutations at specific HSEs, and the heat-induced increase was totally inhibited by co-transfection with an expression plasmid carrying HSF1-, a dominant neg. mutant of HSF1.  The stress inducers arsenite, butyrate, and etoposide also increased pMDR1(-1202) promoter activity, but the increase was not inhibited (in the case of butyrate) or was only partially inhibited (in the case of arsenite and etoposide) by HSF1-.  These results demonstrate that HSF1 regulates MDR1 expression, and that the HSEs present in the -315 to -285 region mediate the heat-induced activation of the MDR1 promoter.  However, other factors may also participate in MDR1 induction by stressing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFTNvDebI3JLVg90H21EOLACvtfcHk0lgBIISFJT6IYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsl2jtb8%253D&md5=99fcd79dc175de14e75a9163e0a61e14</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M909136199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M909136199%26sid%3Dliteratum%253Aachs%26aulast%3DVilaboa%26aufirst%3DN.%2BE.%26aulast%3DGalan%26aufirst%3DA.%26aulast%3DTroyano%26aufirst%3DA.%26aulast%3Dde%2BBlas%26aufirst%3DE.%26aulast%3DAller%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520multidrug%2520resistance%25201%2520%2528mdr1%2529%252Fp-glycoprotein%2520gene%2520expression%2520and%2520activity%2520by%2520heat-shock%2520transcription%2520factor%25201%2520%2528hsf1%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D24970%26doi%3D10.1074%2Fjbc.M909136199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ojha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HuangFu, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J. P.</span></span> <span> </span><span class="NLM_article-title">1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of hsp90 and hdac</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2018.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29567459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlt1OhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=667-677&author=R.+Ojhaauthor=H.+L.+Huangauthor=W.+C.+HuangFuauthor=Y.+W.+Wuauthor=K.+Nepaliauthor=M.+J.+Laiauthor=C.+J.+Suauthor=T.+Y.+Sungauthor=Y.+L.+Chenauthor=S.+L.+Panauthor=J.+P.+Liou&title=1-Aroylindoline-hydroxamic+acids+as+anticancer+agents%2C+inhibitors+of+hsp90+and+hdac&doi=10.1016%2Fj.ejmech.2018.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC</span></div><div class="casAuthors">Ojha, Ritu; Huang, Han-Li; Huang Fu, Wei-Chun; Wu, Yi-Wen; Nepali, Kunal; Lai, Mei-Jung; Su, Chih-Jou; Sung, Ting-Yi; Chen, Yi-Lin; Pan, Shiow-Lin; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">667-677</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 1-aroylindoline-hydroxamic acids I [n = 2 - 8] and II were synthesized.  The results of the biol. evaluation led to the identification of compd. I [n = 6] as dual HDAC6/HSP90 inhibitor.  Compd. I [n = 6] displayed striking inhibitory effects towards the HDAC6 isoform and HSP90 protein with IC50 values of 1.15 nM (HDAC6) and 46.3 nM (HSP90).  Compd. I [n = 6] also exhibited 113, 139 and 246 fold higher selectivity for HDAC6 over HDAC 1, HDAC 3 and HDAC 8 isoforms and was endowed with significant cytotoxic effects with GI50 values ranging 1.04-1.61 μM against lung A549, colorectal HCT116, leukemia HL60 and EGFR T790M mutant lung H1975 cell lines.  Another interesting finding of the study was substantial cytotoxic effects of compd. I particularly against lung H1975 (NSCLC) cell lines with IC50 = 0.26 μM which was mediated through HSP90 inhibition.  Compd. I [n = 2] as such was devoid of HDAC inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgF2Cb1sTQY7Vg90H21EOLACvtfcHk0lgBIISFJT6IYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlt1OhtLk%253D&md5=7c6b877c774d207150bf49c45f9a9303</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DOjha%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DH.%2BL.%26aulast%3DHuangFu%26aufirst%3DW.%2BC.%26aulast%3DWu%26aufirst%3DY.%2BW.%26aulast%3DNepali%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.%2BJ.%26aulast%3DSu%26aufirst%3DC.%2BJ.%26aulast%3DSung%26aufirst%3DT.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DPan%26aufirst%3DS.%2BL.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26atitle%3D1-Aroylindoline-hydroxamic%2520acids%2520as%2520anticancer%2520agents%252C%2520inhibitors%2520of%2520hsp90%2520and%2520hdac%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D667%26epage%3D677%26doi%3D10.1016%2Fj.ejmech.2018.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Development of heat shock protein (hsp90) inhibitors to combat resistance to tyrosine kinase inhibitors through hsp90-kinase interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5563</span>– <span class="NLM_lpage">5586</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01106</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01106" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5563-5586&author=M.+Wangauthor=A.+Shenauthor=C.+Zhangauthor=Z.+Songauthor=J.+Aiauthor=H.+Liuauthor=L.+Sunauthor=J.+Dingauthor=M.+Gengauthor=A.+Zhang&title=Development+of+heat+shock+protein+%28hsp90%29+inhibitors+to+combat+resistance+to+tyrosine+kinase+inhibitors+through+hsp90-kinase+interactions&doi=10.1021%2Facs.jmedchem.5b01106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions</span></div><div class="casAuthors">Wang, Meining; Shen, Aijun; Zhang, Chi; Song, Zilan; Ai, Jing; Liu, Hongchun; Sun, Liping; Ding, Jian; Geng, Meiyu; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5563-5586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a ubiquitous chaperone of all of the oncogenic tyrosine kinases.  Many Hsp90 inhibitors, alone or in combination, have shown significant antitumor efficacy against the kinase-pos. na.ovrddot.ive and mutant models.  However, clin. trials of these inhibitors are unsuccessful due to insufficient clin. benefits and nonoptimal safety profiles.  Recently, much progress has been reported on the Hsp90-cochaperone-client complex, which will undoubtedly assist in the understanding of the interactions between Hsp90 and its clients.  Meanwhile, Hsp90 inhibitors have shown promise against patients' resistance caused by early generation tyrosine kinase inhibitors (TKIs), and at least 13 Hsp90 inhibitors are being reevaluated in the clinic.  In this regard, the objectives of the current perspective are to summarize the structure and function of the Hsp90-cochaperone-client complex, to analyze the structural and functional insights into the Hsp90-client interactions to address several existing unresolved problems with Hsp90 inhibitors, and to highlight the preclin. and clin. studies of Hsp90 inhibitors as an effective treatment against resistance to tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrgsVY9MSMrVg90H21EOLACvtfcHk0lgBIISFJT6IYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D&md5=2408b273b2a00136223ff21709c7ae2d</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520heat%2520shock%2520protein%2520%2528hsp90%2529%2520inhibitors%2520to%2520combat%2520resistance%2520to%2520tyrosine%2520kinase%2520inhibitors%2520through%2520hsp90-kinase%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5563%26epage%3D5586%26doi%3D10.1021%2Facs.jmedchem.5b01106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and pharmacological evaluation of alk and hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.ejmech.2018.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=29698859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVWmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=76-86&author=K.+Gengauthor=H.+Liuauthor=Z.+Songauthor=C.+Zhangauthor=M.+Zhangauthor=H.+Yangauthor=J.+Caoauthor=M.+Gengauthor=A.+Shenauthor=A.+Zhang&title=Design%2C+synthesis+and+pharmacological+evaluation+of+alk+and+hsp90+dual+inhibitors+bearing+resorcinol+and+2%2C4-diaminopyrimidine+motifs&doi=10.1016%2Fj.ejmech.2018.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs</span></div><div class="casAuthors">Geng, Kaijun; Liu, Hongchun; Song, Zilan; Zhang, Chi; Zhang, Minmin; Yang, Hong; Cao, Jingchen; Geng, Meiyu; Shen, Aijun; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-86</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Rather than by directly focusing on the ever-changing ALK mutants, here we report an alternative strategy to overcome the drug resistance caused by treatment of ALK inhibitors by developing ALK and Hsp90 dual targeting inhibitors.  Since Hsp90 is a mol. chaperone that regulates the maturation, activation and stability of numerous "client proteins" including ALK, dual targeting ALK and Hsp90 may bring more benefits and efficacy against drug resistance of ALK inhibitors.  By using our previously developed ALK inhibitor 6 and the clin. Hsp90 inhibitors AUY922 or AT13387 as the templates, we developed several series of resorcinol tethered 2,4-diaminopyrimidines as ALK/Hsp90 dual inhibitors bearing various linkers at different linking sites.  Compd. 10h and 10j showed high potency against ALK (17.3 vs 9.8 nM) and Hsp90α (100 vs 40 nM).  They also have high potency against ALK resistant mutants, esp. the gatekeeper mutation ALKL1196M.  Both compds. showed strong antiproliferative activity against the ALK-addictive H3122 cells (11 vs 13 nM).  The dual functioning mechanism is further confirmed by their down-regulation of the Hsp90 clients ALK and AKT, and up-regulation of the chaperone protein Hsp70 in H3122 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmqigxUQsz8bVg90H21EOLACvtfcHk0ljy6OVRzezw1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVWmsLY%253D&md5=a64e43ba5d725642af62313c1dbc8111</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%2520of%2520alk%2520and%2520hsp90%2520dual%2520inhibitors%2520bearing%2520resorcinol%2520and%25202%252C4-diaminopyrimidine%2520motifs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D152%26spage%3D76%26epage%3D86%26doi%3D10.1016%2Fj.ejmech.2018.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span> <span> </span><span class="NLM_article-title">The hsp90 inhibitor, nvp-auy922, attenuates intrinsic pi3k inhibitor resistance in kras-mutant non-small cell lung cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>406</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.canlet.2017.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28797845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2017&pages=47-53&author=K.+S.+Parkauthor=H.+Yangauthor=J.+Choiauthor=S.+Seoauthor=D.+Kimauthor=C.+H.+Leeauthor=H.+Jeonauthor=S.+W.+Kimauthor=D.+H.+Lee&title=The+hsp90+inhibitor%2C+nvp-auy922%2C+attenuates+intrinsic+pi3k+inhibitor+resistance+in+kras-mutant+non-small+cell+lung+cancer&doi=10.1016%2Fj.canlet.2017.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer</span></div><div class="casAuthors">Park, Kang-Seo; Yang, Hannah; Choi, Junyoung; Seo, Seyoung; Kim, Deokhoon; Lee, Chang Hoon; Jeon, Hanwool; Kim, Sang-We; Lee, Dae Ho</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">More than 25% of non-small cell lung cancers (NSCLCs) carry mutations in KRAS, one of the most common oncogenic drivers in this disease.  KRAS-mutant NSCLC responds poorly to currently available therapies; therefore, novel treatment strategies are needed.  Here, we describe a particularly promising targeted therapeutic strategy against KRAS mutation-harboring NSCLC intrinsically resistant to treatment by PI3K inhibition.  We found that intrinsic resistance to PI3K inhibition derived from RAF/MEK/ERK and RSK activation, bypassing blockage of the PI3K/AKT/mTOR pathway.  The HSP90 inhibitor AUY922 suppressed both PI3K/AKT/mTOR and RAF/MEK/ERK signaling, rendering cells sensitive to a PI3K inhibitor (omipalisib, GSK458).  Combining these two drugs achieved a synergistic effect, even using only sub-therapeutic concns.  Dual inhibition of the HSP90 and PI3K signaling pathways with sub-therapeutic doses of these combined anticancer drugs may represent a potent treatment strategy for KRAS-mutant NSCLC with intrinsic resistance to PI3K inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFsmXfZcBd8bVg90H21EOLACvtfcHk0lhj4Ypanoc7lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWks7%252FL&md5=751a305c9837aa4eb04b5a041aefdeba</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DD.%2BH.%26atitle%3DThe%2520hsp90%2520inhibitor%252C%2520nvp-auy922%252C%2520attenuates%2520intrinsic%2520pi3k%2520inhibitor%2520resistance%2520in%2520kras-mutant%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2017%26volume%3D406%26spage%3D47%26epage%3D53%26doi%3D10.1016%2Fj.canlet.2017.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaxton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugle, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riesenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. H.</span></span> <span> </span><span class="NLM_article-title">Clients and oncogenic roles of molecular chaperone gp96/grp94</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2765</span>– <span class="NLM_lpage">2778</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.2174%2F1568026616666160413141613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27072698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2765-2778&author=E.+A.+Ansa-Addoauthor=J.+Thaxtonauthor=F.+Hongauthor=B.+X.+Wuauthor=Y.+L.+Zhangauthor=C.+W.+Fugleauthor=A.+Metelliauthor=B.+Riesenbergauthor=K.+Williamsauthor=D.+T.+Gewirthauthor=G.+Chiosisauthor=B.+Liuauthor=Z.+H.+Li&title=Clients+and+oncogenic+roles+of+molecular+chaperone+gp96%2Fgrp94&doi=10.2174%2F1568026616666160413141613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94</span></div><div class="casAuthors">Ansa-Addo, Ephraim A.; Thaxton, Jessica; Hong, Feng; Wu, Bill X.; Zhang, Yongliang; Fugle, Caroline W.; Metelli, Alessandra; Riesenberg, Brian; Williams, Katelyn; Gewirth, Daniel T.; Chiosis, Gabriela; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2765-2778</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat shock protein (HSP) 90 paralogue, glycoprotein (gp) 96 possesses immunol. properties by chaperoning antigenic peptides for activation of T cells.  Genetic studies in the last decade have unveiled that gp96 is also an essential master chaperone for multiple receptors and secreting proteins including Toll-like receptors (TLRs), integrins, the Wnt coreceptor, Low D. Lipoprotein Receptor-Related Protein 6 (LRP6), the latent TGF docking receptor, Glycoprotein A Repetitions Predominant (GARP), Glycoprotein (GP) Ib and insulin-like growth factors (IGF).  Clin., elevated expression of gp96 in a variety of cancers correlates with the advanced stage and poor survival of cancer patients.  Recent preclin. studies have also uncovered that gp96 expression is closely linked to cancer progression in multiple myeloma, hepatocellular carcinoma, breast cancer and inflammation-assocd. colon cancer.  Thus, gp96 is an attractive therapeutic target for cancer treatment.  The chaperone function of gp96 depends on its ATPase domain, which is structurally distinct from other HSP90 members, and thus favors the design of highly selective gp96-targeted inhibitors against cancer.  We herein discuss the strategically important oncogenic clients of gp96 and their underlying biol.  The roles of cell-intrinsic gp96 in T cell biol. are also discussed, in part because it offers another opportunity of cancer therapy by manipulating levels of gp96 in T cells to enhance host immune defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTKDihIb-tPrVg90H21EOLACvtfcHk0lg88eLmLRHnzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK&md5=52930fd6506186a93a1a8decad51388c</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141613%26sid%3Dliteratum%253Aachs%26aulast%3DAnsa-Addo%26aufirst%3DE.%2BA.%26aulast%3DThaxton%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DFugle%26aufirst%3DC.%2BW.%26aulast%3DMetelli%26aufirst%3DA.%26aulast%3DRiesenberg%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26atitle%3DClients%2520and%2520oncogenic%2520roles%2520of%2520molecular%2520chaperone%2520gp96%252Fgrp94%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2765%26epage%3D2778%26doi%3D10.2174%2F1568026616666160413141613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Orduna, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ferrer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higueras, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Crespo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamas, S.</span></span> <span> </span><span class="NLM_article-title">S-nitrosylation of hsp90 promotes the inhibition of its atpase and endothelial nitric oxide synthase regulatory activities</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">8525</span>– <span class="NLM_lpage">8530</span>, <span class="refDoi"> DOI: 10.1073/pnas.0407294102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.0407294102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=15937123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFCgsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8525-8530&author=A.+Martinez-Ruizauthor=L.+Villanuevaauthor=C.+G.+de+Ordunaauthor=D.+Lopez-Ferrerauthor=M.+A.+Higuerasauthor=C.+Tarinauthor=I.+Rodriguez-Crespoauthor=J.+Vazquezauthor=S.+Lamas&title=S-nitrosylation+of+hsp90+promotes+the+inhibition+of+its+atpase+and+endothelial+nitric+oxide+synthase+regulatory+activities&doi=10.1073%2Fpnas.0407294102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities</span></div><div class="casAuthors">Martinez-Ruiz, Antonio; Villanueva, Laura; Gonzalez de Orduna, Cecilia; Lopez-Ferrer, Daniel; Higueras, Maria Angeles; Tarin, Carlos; Rodriguez-Crespo, Ignacio; Vazquez, Jesus; Lamas, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8525-8530</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Nitric oxide is implicated in a variety of signaling pathways in different systems, notably in endothelial cells.  Some of its effects can be exerted through covalent modifications of proteins and, among these modifications, increasing attention is being paid to S-nitrosylation as a signaling mechanism.  In this work, we show by a variety of methods (ozone chemiluminescence, biotin switch, and mass spectrometry) that the mol. chaperone Hsp90 is a target of S-nitrosylation and identify a susceptible cysteine residue in the region of the C-terminal domain that interacts with endothelial nitric oxide synthase (eNOS).  We also show that the modification occurs in endothelial cells when they are treated with S-nitroso-L-cysteine and when they are exposed to eNOS activators.  Hsp90 ATPase activity and its pos. effect on eNOS activity are both inhibited by S-nitrosylation.  Together, these data suggest that S-nitrosylation may functionally regulate the general activities of Hsp90 and provide a feedback mechanism for limiting eNOS activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndOSKWMybg7Vg90H21EOLACvtfcHk0lg88eLmLRHnzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFCgsbk%253D&md5=fd2103a67a370d38a64789148eeb7f58</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407294102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407294102%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Ruiz%26aufirst%3DA.%26aulast%3DVillanueva%26aufirst%3DL.%26aulast%3Dde%2BOrduna%26aufirst%3DC.%2BG.%26aulast%3DLopez-Ferrer%26aufirst%3DD.%26aulast%3DHigueras%26aufirst%3DM.%2BA.%26aulast%3DTarin%26aufirst%3DC.%26aulast%3DRodriguez-Crespo%26aufirst%3DI.%26aulast%3DVazquez%26aufirst%3DJ.%26aulast%3DLamas%26aufirst%3DS.%26atitle%3DS-nitrosylation%2520of%2520hsp90%2520promotes%2520the%2520inhibition%2520of%2520its%2520atpase%2520and%2520endothelial%2520nitric%2520oxide%2520synthase%2520regulatory%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D8525%26epage%3D8530%26doi%3D10.1073%2Fpnas.0407294102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burslem, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule modulation of protein homeostasis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">11269</span>– <span class="NLM_lpage">11301</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ohur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=11269-11301&author=G.+M.+Burslemauthor=C.+M.+Crews&title=Small-molecule+modulation+of+protein+homeostasis&doi=10.1021%2Facs.chemrev.7b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Modulation of Protein Homeostasis</span></div><div class="casAuthors">Burslem, George M.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11269-11301</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Control of protein levels by nucleic-acid-based technologies has proven to be a useful research tool but lacks the advantages of small mols. with respect to cell permeability, temporal control, and the potential generation of therapeutics.  In this Review, we discuss the technologies available for the control of intracellular protein levels with small mols. and compare the various systems available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcARydbgPK9bVg90H21EOLACvtfcHk0ljjzSMa6PNexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ohur3K&md5=f9f8dd98e2c71c7166d2d500b514d578</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00077%26sid%3Dliteratum%253Aachs%26aulast%3DBurslem%26aufirst%3DG.%2BM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520modulation%2520of%2520protein%2520homeostasis%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D11269%26epage%3D11301%26doi%3D10.1021%2Facs.chemrev.7b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Waste disposal-an attractive strategy for cancer therapy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1163</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1126/science.aam7340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1126%2Fscience.aam7340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28302825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1163-1167&author=J.+Salamiauthor=C.+M.+Crews&title=Waste+disposal-an+attractive+strategy+for+cancer+therapy&doi=10.1126%2Fscience.aam7340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Waste disposal-An attractive strategy for cancer therapy</span></div><div class="casAuthors">Salami, Jemilat; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6330</span>),
    <span class="NLM_cas:pages">1163-1167</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Targeted therapies for cancer are typically small mols. or monoclonal antibodies that act by inhibiting the activity of specific proteins that drive tumor growth.  Although many of these drugs are effective in cancer patients, the response is often not durable because tumor cells develop resistance to the drugs.  Another limitation of this strategy is that not all oncogenic driver proteins are "druggable" enzymes or receptors with activities that can be inhibited.  Here the authors describe an alternative approach to targeted therapy that is based on co-opting the cellular quality-control machinery-the ubiquitin-proteasome system-to remove specific cancer-causing proteins from the cell.  The authors first discuss examples of existing cancer drugs that work by degrading specific proteins and then review recent progress in the rational design and preclin. testing of small mols. that induce selective degrdn. of specific target proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVoZn-YpfXmbVg90H21EOLACvtfcHk0ljjzSMa6PNexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmt74%253D&md5=918621d50a82b7797aa0300537a4486e</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1126%2Fscience.aam7340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aam7340%26sid%3Dliteratum%253Aachs%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DWaste%2520disposal-an%2520attractive%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1163%26epage%3D1167%26doi%3D10.1126%2Fscience.aam7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Proteolysis-targeting chimeras: harnessing the ubiquitin-proteasome system to induce degradation of specific target proteins</span>. <i>Annu. Rev. Canc Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1146/annurev-cancerbio-030617-050430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1146%2Fannurev-cancerbio-030617-050430" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=41-58&author=K.+G.+Colemanauthor=C.+M.+Crews&title=Proteolysis-targeting+chimeras%3A+harnessing+the+ubiquitin-proteasome+system+to+induce+degradation+of+specific+target+proteins&doi=10.1146%2Fannurev-cancerbio-030617-050430"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1146%2Fannurev-cancerbio-030617-050430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-cancerbio-030617-050430%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DK.%2BG.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DProteolysis-targeting%2520chimeras%253A%2520harnessing%2520the%2520ubiquitin-proteasome%2520system%2520to%2520induce%2520degradation%2520of%2520specific%2520target%2520proteins%26jtitle%3DAnnu.%2520Rev.%2520Canc%2520Biol.%26date%3D2018%26volume%3D2%26spage%3D41%26epage%3D58%26doi%3D10.1146%2Fannurev-cancerbio-030617-050430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paiva, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Targeted protein degradation: elements of protac design</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2019.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.cbpa.2019.02.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=31004963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2019&pages=111-119&author=S.+L.+Paivaauthor=C.+M.+Crews&title=Targeted+protein+degradation%3A+elements+of+protac+design&doi=10.1016%2Fj.cbpa.2019.02.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted protein degradation: elements of PROTAC design</span></div><div class="casAuthors">Paiva, Stacey-Lynn; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111-119</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Targeted protein degrdn. using Proteolysis Targeting Chimeras (PROTACs) has emerged as a novel therapeutic modality in drug discovery.  PROTACs mediate the degrdn. of select proteins of interest (POIs) by hijacking the activity of E3 ubiquitin ligases for POI ubiquitination and subsequent degrdn. by the 26S proteasome.  This hijacking mechanism has been used to degrade various types of disease-relevant POIs.  In this review, we aim to highlight the recent advances in targeted protein degrdn. and describe the challenges that need to be addressed in order to efficiently develop potent PROTACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol6Nk0VkUdzLVg90H21EOLACvtfcHk0ljjzSMa6PNexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1yrt7s%253D&md5=5783311db47da378180c14d67526a398</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DPaiva%26aufirst%3DS.%2BL.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeted%2520protein%2520degradation%253A%2520elements%2520of%2520protac%2520design%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D50%26spage%3D111%26epage%3D119%26doi%3D10.1016%2Fj.cbpa.2019.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondeson, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mares, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, I. E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miah, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulholland, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelth-Savitski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casillas, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Besten, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Famm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruidenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harling, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Catalytic in vivo protein knockdown by small-molecule protacs</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fnchembio.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26075522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=611-617&author=D.+P.+Bondesonauthor=A.+Maresauthor=I.+E.+D.+Smithauthor=E.+Koauthor=S.+Camposauthor=A.+H.+Miahauthor=K.+E.+Mulhollandauthor=N.+Routlyauthor=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=N.+Zinnauthor=P.+Grandiauthor=S.+Shimamuraauthor=G.+Bergaminiauthor=M.+Faelth-Savitskiauthor=M.+Bantscheffauthor=C.+Coxauthor=D.+A.+Gordonauthor=R.+R.+Willardauthor=J.+J.+Flanaganauthor=L.+N.+Casillasauthor=B.+J.+Vottaauthor=W.+den+Bestenauthor=K.+Fammauthor=L.+Kruidenierauthor=P.+S.+Carterauthor=J.+D.+Harlingauthor=I.+Churcherauthor=C.+M.+Crews&title=Catalytic+in+vivo+protein+knockdown+by+small-molecule+protacs&doi=10.1038%2Fnchembio.1858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic in vivo protein knockdown by small-molecule PROTACs</span></div><div class="casAuthors">Bondeson, Daniel P.; Mares, Alina; Smith, Ian E. D.; Ko, Eunhwa; Campos, Sebastien; Miah, Afjal H.; Mulholland, Katie E.; Routly, Natasha; Buckley, Dennis L.; Gustafson, Jeffrey L.; Zinn, Nico; Grandi, Paola; Shimamura, Satoko; Bergamini, Giovanna; Faelth-Savitski, Maria; Bantscheff, Marcus; Cox, Carly; Gordon, Deborah A.; Willard, Ryan R.; Flanagan, John J.; Casillas, Linda N.; Votta, Bartholomew J.; den Besten, Willem; Famm, Kristoffer; Kruidenier, Laurens; Carter, Paul S.; Harling, John D.; Churcher, Ian; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The current predominant therapeutic paradigm is based on maximizing drug-receptor occupancy to achieve clin. benefit.  This strategy, however, generally requires excessive drug concns. to ensure sufficient occupancy, often leading to adverse side effects.  Here, we describe major improvements to the proteolysis targeting chimeras (PROTACs) method, a chem. knockdown strategy in which a heterobifunctional mol. recruits a specific protein target to an E3 ubiquitin ligase, resulting in the target's ubiquitination and degrdn.  These compds. behave catalytically in their ability to induce the ubiquitination of super-stoichiometric quantities of proteins, providing efficacy that is not limited by equil. occupancy.  We present two PROTACs that are capable of specifically reducing protein levels by >90% at nanomolar concns.  In addn., mouse studies indicate that they provide broad tissue distribution and knockdown of the targeted protein in tumor xenografts.  Together, these data demonstrate a protein knockdown system combining many of the favorable properties of small-mol. agents with the potent protein knockdown of RNAi and CRISPR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhnajD3CxS7Vg90H21EOLACvtfcHk0liqRFNMrxItDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP&md5=31eb8756c5661f78ab4527a50dc1e251</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1858%26sid%3Dliteratum%253Aachs%26aulast%3DBondeson%26aufirst%3DD.%2BP.%26aulast%3DMares%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DI.%2BE.%2BD.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DMulholland%26aufirst%3DK.%2BE.%26aulast%3DRoutly%26aufirst%3DN.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DFaelth-Savitski%26aufirst%3DM.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DWillard%26aufirst%3DR.%2BR.%26aulast%3DFlanagan%26aufirst%3DJ.%2BJ.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3Dden%2BBesten%26aufirst%3DW.%26aulast%3DFamm%26aufirst%3DK.%26aulast%3DKruidenier%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCatalytic%2520in%2520vivo%2520protein%2520knockdown%2520by%2520small-molecule%2520protacs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D611%26epage%3D617%26doi%3D10.1038%2Fnchembio.1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harbin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamman, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Differential protac substrate specificity dictated by orientation of recruited e3 ligase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">131</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-08027-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs41467-018-08027-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=30631068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BB3cjgt1Sksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=131&author=B.+E.+Smithauthor=S.+L.+Wangauthor=S.+Jaime-Figueroaauthor=A.+Harbinauthor=J.+Wangauthor=B.+D.+Hammanauthor=C.+M.+Crews&title=Differential+protac+substrate+specificity+dictated+by+orientation+of+recruited+e3+ligase&doi=10.1038%2Fs41467-018-08027-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase</span></div><div class="casAuthors">Smith Blake E; Wang Stephen L; Jaime-Figueroa Saul; Crews Craig M; Harbin Alicia; Wang Jing; Hamman Brian D; Crews Craig M; Crews Craig M</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PROteolysis-TArgeting Chimeras (PROTACs) are hetero-bifunctional molecules that recruit an E3 ubiquitin ligase to a given substrate protein resulting in its targeted degradation.  Many potent PROTACs with specificity for dissimilar targets have been developed; however, the factors governing degradation selectivity within closely-related protein families remain elusive.  Here, we generate isoform-selective PROTACs for the p38 MAPK family using a single warhead (foretinib) and recruited E3 ligase (von Hippel-Lindau).  Based on their distinct linker attachments and lengths, these two PROTACs differentially recruit VHL, resulting in degradation of p38α or p38δ.  We characterize the role of ternary complex formation in driving selectivity, showing that it is necessary, but insufficient, for PROTAC-induced substrate ubiquitination.  Lastly, we explore the p38δ:PROTAC:VHL complex to explain the different selectivity profiles of these PROTACs.  Our work attributes the selective degradation of two closely-related proteins using the same warhead and E3 ligase to heretofore underappreciated aspects of the ternary complex model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYPr3dBOGbeuR_TJajKxJDfW6udTcc2eY4Vq9kNaaDXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjgt1Sksg%253D%253D&md5=bd56c51f5966709ca5d1ff3dadb7cc79</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-08027-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-08027-7%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BE.%26aulast%3DWang%26aufirst%3DS.%2BL.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DHarbin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHamman%26aufirst%3DB.%2BD.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DDifferential%2520protac%2520substrate%2520specificity%2520dictated%2520by%2520orientation%2520of%2520recruited%2520e3%2520ligase%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D131%26doi%3D10.1038%2Fs41467-018-08027-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Hijacking the e3 ubiquitin ligase cereblon to efficiently target brd4</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+e3+ubiquitin+ligase+cereblon+to+efficiently+target+brd4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0liqRFNMrxItDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520e3%2520ubiquitin%2520ligase%2520cereblon%2520to%2520efficiently%2520target%2520brd4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, A. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span> <span> </span><span class="NLM_article-title">Protac-induced bet protein degradation as a therapy for castration-resistant prostate cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">7124</span>– <span class="NLM_lpage">7129</span>, <span class="refDoi"> DOI: 10.1073/pnas.1521738113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1073%2Fpnas.1521738113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=27274052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xptlyqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=7124-7129&author=K.+Rainaauthor=J.+Luauthor=Y.+M.+Qianauthor=M.+Altieriauthor=D.+Gordonauthor=A.+M.+K.+Rossiauthor=J.+Wangauthor=X.+Chenauthor=H.+Q.+Dongauthor=K.+Siuauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=C.+M.+Crewsauthor=K.+G.+Coleman&title=Protac-induced+bet+protein+degradation+as+a+therapy+for+castration-resistant+prostate+cancer&doi=10.1073%2Fpnas.1521738113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer</span></div><div class="casAuthors">Raina, Kanak; Lu, Jing; Qian, Yimin; Altieri, Martha; Gordon, Deborah; Rossi, Ann Marie K.; Wang, Jing; Chen, Xin; Dong, Hanqing; Siu, Kam; Winkler, James D.; Crew, Andrew P.; Crews, Craig M.; Coleman, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7124-7129</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostate cancer has the second highest incidence among cancers in men worldwide and is the second leading cause of cancer deaths of men in the United States.  Although androgen deprivation can initially lead to remission, the disease often progresses to castration-resistant prostate cancer (CRPC), which is still reliant on androgen receptor (AR) signaling and is assocd. with a poor prognosis.  Some success against CRPC has been achieved by drugs that target AR signaling, but secondary resistance invariably emerges, and new therapies are urgently needed.  Recently, inhibitors of bromodomain and extra-terminal (BET) family proteins have shown growth-inhibitory activity in preclin. models of CRPC.  Here, we demonstrate that ARV-771, a small-mol. pan-BET degrader based on proteolysis-targeting chimera (PROTAC) technol., demonstrates dramatically improved efficacy in cellular models of CRPC as compared with BET inhibition.  Unlike BET inhibitors, ARV-771 results in suppression of both AR signaling and AR levels and leads to tumor regression in a CRPC mouse xenograft model.  This study is, to our knowledge, the first to demonstrate efficacy with a small-mol. BET degrader in a solid-tumor malignancy and potentially represents an important therapeutic advance in the treatment of CRPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD7QtYgZVig7Vg90H21EOLACvtfcHk0liqEtGYxegjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xptlyqs7s%253D&md5=34218e685ad72950f3eb85586110c43d</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1521738113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1521738113%26sid%3Dliteratum%253Aachs%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%2BM.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DA.%2BM.%2BK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DH.%2BQ.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DColeman%26aufirst%3DK.%2BG.%26atitle%3DProtac-induced%2520bet%2520protein%2520degradation%2520as%2520a%2520therapy%2520for%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D7124%26epage%3D7129%26doi%3D10.1073%2Fpnas.1521738113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alabi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neklesa, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Androgen receptor degradation by the proteolysis-targeting chimera arcc-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">100</span>, <span class="refDoi"> DOI: 10.1038/s42003-018-0105-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fs42003-018-0105-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=30271980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A280%3ADC%252BB3czksVCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&pages=100&author=J.+Salamiauthor=S.+Alabiauthor=R.+R.+Willardauthor=N.+J.+Vitaleauthor=J.+Wangauthor=H.+Dongauthor=M.+Jinauthor=D.+P.+McDonnellauthor=A.+P.+Crewauthor=T.+K.+Neklesaauthor=C.+M.+Crews&title=Androgen+receptor+degradation+by+the+proteolysis-targeting+chimera+arcc-4+outperforms+enzalutamide+in+cellular+models+of+prostate+cancer+drug+resistance&doi=10.1038%2Fs42003-018-0105-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance</span></div><div class="casAuthors">Salami Jemilat; Crews Craig M; Alabi Shanique; Crews Craig M; Willard Ryan R; Vitale Nick J; Wang Jing; Dong Hanqing; Jin Meizhong; Crew Andrew P; Neklesa Taavi K; McDonnell Donald P; Crews Craig M</div><div class="citationInfo"><span class="NLM_cas:title">Communications biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The androgen receptor is a major driver of prostate cancer and inhibition of its transcriptional activity using competitive antagonists, such as enzalutamide remains a frontline therapy for prostate cancer management.  However, the majority of patients eventually develop drug resistance.  We propose that targeting the androgen receptor for degradation via Proteolysis Targeting Chimeras (PROTACs) will be a better therapeutic strategy for targeting androgen receptor signaling in prostate cancer cells.  Here we perform a head-to-head comparison between a currently approved androgen receptor antagonist enzalutamide, and its PROTAC derivative, ARCC-4, across different cellular models of prostate cancer drug resistance.  ARCC-4 is a low-nanomolar androgen receptor degrader able to degrade about 95% of cellular androgen receptors.  ARCC-4 inhibits prostate tumor cell proliferation, degrades clinically relevant androgen receptor point mutants and unlike enzalutamide, retains antiproliferative effect in a high androgen environment.  Thus, ARCC-4 exemplifies how protein degradation can address the drug resistance hurdles of enzalutamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQilKiHIro9_JI8NvIb08rbfW6udTcc2eYxWwoeY946BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czksVCksA%253D%253D&md5=b8b7a81226dcf37d9ff430244b21f952</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1038%2Fs42003-018-0105-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-018-0105-8%26sid%3Dliteratum%253Aachs%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DAlabi%26aufirst%3DS.%26aulast%3DWillard%26aufirst%3DR.%2BR.%26aulast%3DVitale%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DNeklesa%26aufirst%3DT.%2BK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DAndrogen%2520receptor%2520degradation%2520by%2520the%2520proteolysis-targeting%2520chimera%2520arcc-4%2520outperforms%2520enzalutamide%2520in%2520cellular%2520models%2520of%2520prostate%2520cancer%2520drug%2520resistance%26jtitle%3DCommun.%2520Biol.%26date%3D2018%26volume%3D1%26spage%3D100%26doi%3D10.1038%2Fs42003-018-0105-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerschmied, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Modular protac design for the degradation of oncogenic bcr-abl</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1002/anie.201507634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1002%2Fanie.201507634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=807-810&author=A.+C.+Laiauthor=M.+Toureauthor=D.+Hellerschmiedauthor=J.+Salamiauthor=S.+Jaime-Figueroaauthor=E.+Koauthor=J.+Hinesauthor=C.+M.+Crews&title=Modular+protac+design+for+the+degradation+of+oncogenic+bcr-abl&doi=10.1002%2Fanie.201507634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL</span></div><div class="casAuthors">Lai, Ashton C.; Toure, Momar; Hellerschmied, Doris; Salami, Jemilat; Jaime-Figueroa, Saul; Ko, Eunhwa; Hines, John; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">807-810</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteolysis Targeting Chimera (PROTAC) technol. is a rapidly emerging alternative therapeutic strategy with the potential to address many of the challenges currently faced in modern drug development programs.  PROTAC technol. employs small mols. that recruit target proteins for ubiquitination and removal by the proteasome.  The synthesis of PROTAC compds. that mediate the degrdn. of c-ABL and BCR-ABL by recruiting either Cereblon or Von Hippel Lindau E3 ligases is reported.  During the course of their development, the authors discovered that the capacity of a PROTAC to induce degrdn. involves more than just target binding: the identity of the inhibitor warhead and the recruited E3 ligase largely det. the degrdn. profiles of the compds.; thus, as a starting point for PROTAC development, both the target ligand and the recruited E3 ligase should be varied to rapidly generate a PROTAC with the desired degrdn. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdcSTHt5WfILVg90H21EOLACvtfcHk0liqEtGYxegjPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN&md5=58a5d78f32bc8a21fd1a6e0c38b8979c</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507634%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DToure%26aufirst%3DM.%26aulast%3DHellerschmied%26aufirst%3DD.%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DModular%2520protac%2520design%2520for%2520the%2520degradation%2520of%2520oncogenic%2520bcr-abl%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D807%26epage%3D810%26doi%3D10.1002%2Fanie.201507634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiskus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajapakshe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crew, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mill, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coarfa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K. N.</span></span> <span> </span><span class="NLM_article-title">Bet protein proteolysis targeting chimera (protac) exerts potent lethal activity against mantle cell lymphoma cells</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1038/leu.2017.207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=10.1038%2Fleu.2017.207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=28663582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eqt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=343-352&author=B.+Sunauthor=W.+Fiskusauthor=Y.+Qianauthor=K.+Rajapaksheauthor=K.+Rainaauthor=K.+G.+Colemanauthor=A.+P.+Crewauthor=A.+Shenauthor=D.+T.+Saenzauthor=C.+P.+Millauthor=A.+J.+Nowakauthor=N.+Jainauthor=L.+Zhangauthor=M.+Wangauthor=J.+D.+Khouryauthor=C.+Coarfaauthor=C.+M.+Crewsauthor=K.+N.+Bhalla&title=Bet+protein+proteolysis+targeting+chimera+%28protac%29+exerts+potent+lethal+activity+against+mantle+cell+lymphoma+cells&doi=10.1038%2Fleu.2017.207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Bet protein proteolysis targeting chimera (protac) exerts potent lethal activity against mantle cell lymphoma cells</span></div><div class="casAuthors">Sun, B.; Fiskus, W.; Qian, Y.; Rajapakshe, K.; Raina, K.; Coleman, K. G.; Crew, A. P.; Shen, A.; Saenz, D. T.; Mill, C. P.; Nowak, A. J.; Jain, N.; Zhang, L.; Wang, M.; Khoury, J. D.; Coarfa, C.; Crews, C. M.; Bhalla, K. N.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">343-352</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Bromodomain extraterminal protein (BETP) inhibitors transcriptionally repress oncoproteins and nuclear factor-κB (NF-κB) target genes that undermines the growth and survival of mantle cell lymphoma (MCL) cells.  However, BET bromodomain inhibitor (BETi) treatment causes accumulation of BETPs, assocd. with reversible binding and incomplete inhibition of BRD4 that potentially compromises the activity of BETi in MCL cells.  Unlike BETi, BET-PROTACs (proteolysis-targeting chimera) ARV-825 and ARV-771 (Arvinas, Inc.) recruit and utilize an E3-ubiquitin ligase to effectively degrade BETPs in MCL cells.  BET-PROTACs induce more apoptosis than BETi of MCL cells, including those resistant to ibrutinib.  BET-PROTAC treatment induced more perturbations in the mRNA and protein expressions than BETi, with depletion of c-Myc, CDK4, cyclin D1 and the NF-κB transcriptional targets Bcl-xL, XIAP and BTK, while inducing the levels of HEXIM1, NOXA and CDKN1A/p21.  Treatment with ARV-771, which possesses superior pharmacol. properties compared with ARV-825, inhibited the in vivo growth and induced greater survival improvement than the BETi OTX015 of immune-depleted mice engrafted with MCL cells.  Cotreatment of ARV-771 with ibrutinib or the BCL2 antagonist venetoclax or CDK4/6 inhibitor palbociclib synergistically induced apoptosis of MCL cells.  These studies highlight promising and superior preclin. activity of BET-PROTAC than BETi, requiring further in vivo evaluation of BET-PROTAC as a therapy for ibrutinib-sensitive or -resistant MCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAZxihoDZILrVg90H21EOLACvtfcHk0lh9m_MaxNnlBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eqt77J&md5=f771eee574daf11546b93866ea314381</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fleu.2017.207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2017.207%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DRajapakshe%26aufirst%3DK.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DColeman%26aufirst%3DK.%2BG.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DSaenz%26aufirst%3DD.%2BT.%26aulast%3DMill%26aufirst%3DC.%2BP.%26aulast%3DNowak%26aufirst%3DA.%2BJ.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DKhoury%26aufirst%3DJ.%2BD.%26aulast%3DCoarfa%26aufirst%3DC.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DBet%2520protein%2520proteolysis%2520targeting%2520chimera%2520%2528protac%2529%2520exerts%2520potent%2520lethal%2520activity%2520against%2520mantle%2520cell%2520lymphoma%2520cells%26jtitle%3DLeukemia%26date%3D2018%26volume%3D32%26spage%3D343%26epage%3D352%26doi%3D10.1038%2Fleu.2017.207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Salas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meagher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziazadeh, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of qca570 as an exceptionally potent and efficacious proteolysis targeting chimera (protac) degrader of the bromodomain and extra-terminal (bet) proteins capable of inducing complete and durable tumor regression</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6685</span>– <span class="NLM_lpage">6704</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00506</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00506" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlaqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6685-6704&author=C.+Qinauthor=Y.+Huauthor=B.+Zhouauthor=E.+Fernandez-Salasauthor=C.+Y.+Yangauthor=L.+Liuauthor=D.+McEachernauthor=S.+Przybranowskiauthor=M.+Wangauthor=J.+Stuckeyauthor=J.+Meagherauthor=L.+C.+Baiauthor=Z.+Chenauthor=M.+Linauthor=J.+L.+Yangauthor=D.+N.+Ziazadehauthor=F.+M.+Xuauthor=J.+T.+Huauthor=W.+G.+Xiangauthor=L.+Y.+Huangauthor=S.+W.+Liauthor=B.+Wenauthor=D.+X.+Sunauthor=S.+M.+Wang&title=Discovery+of+qca570+as+an+exceptionally+potent+and+efficacious+proteolysis+targeting+chimera+%28protac%29+degrader+of+the+bromodomain+and+extra-terminal+%28bet%29+proteins+capable+of+inducing+complete+and+durable+tumor+regression&doi=10.1021%2Facs.jmedchem.8b00506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression</span></div><div class="casAuthors">Qin, Chong; Hu, Yang; Zhou, Bing; Fernandez-Salas, Ester; Yang, Chao-Yie; Liu, Liu; McEachern, Donna; Przybranowski, Sally; Wang, Mi; Stuckey, Jeanne; Meagher, Jennifer; Bai, Longchuan; Chen, Zhuo; Lin, Mei; Yang, Jiuling; Ziazadeh, Danya N.; Xu, Fuming; Hu, Jiantao; Xing, Weiguo; Huang, Liyue; Li, Siwei; Wen, Bo; Sun, Duxin; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6685-6704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteins of the bromodomain and extra-terminal (BET) family are epigenetics "readers" and promising therapeutic targets for cancer and other human diseases.  We describe herein a structure-guided design of [1,4]oxazepines as a new class of BET inhibitors and our subsequent design, synthesis, and evaluation of proteolysis-targeting chimeric (PROTAC) small-mol. BET degraders.  Our efforts have led to the discovery of extremely potent BET degraders, exemplified by QCA570, which effectively induces degrdn. of BET proteins and inhibits cell growth in human acute leukemia cell lines even at low picomolar concns.  QCA570 achieves complete and durable tumor regression in leukemia xenograft models in mice at well-tolerated dose-schedules.  QCA570 is the most potent and efficacious BET degrader reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ZUIsfX3p6LVg90H21EOLACvtfcHk0lh9m_MaxNnlBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlaqsLrE&md5=2a731730641372f4526543e03d9ac76f</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00506%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DFernandez-Salas%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%2BC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%2BL.%26aulast%3DZiazadeh%26aufirst%3DD.%2BN.%26aulast%3DXu%26aufirst%3DF.%2BM.%26aulast%3DHu%26aufirst%3DJ.%2BT.%26aulast%3DXiang%26aufirst%3DW.%2BG.%26aulast%3DHuang%26aufirst%3DL.%2BY.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DWen%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DD.%2BX.%26aulast%3DWang%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520qca570%2520as%2520an%2520exceptionally%2520potent%2520and%2520efficacious%2520proteolysis%2520targeting%2520chimera%2520%2528protac%2529%2520degrader%2520of%2520the%2520bromodomain%2520and%2520extra-terminal%2520%2528bet%2529%2520proteins%2520capable%2520of%2520inducing%2520complete%2520and%2520durable%2520tumor%2520regression%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6685%26epage%3D6704%26doi%3D10.1021%2Facs.jmedchem.8b00506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1US7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1US7','PDB','1US7'); return false;">PDB: 1US7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2K5B','PDB','2K5B'); return false;">PDB: 2K5B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FWL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FWL','PDB','5FWL'); return false;">PDB: 5FWL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ELR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ELR','PDB','1ELR'); return false;">PDB: 1ELR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZ2','PDB','1QZ2'); return false;">PDB: 1QZ2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YER" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YER','PDB','1YER'); return false;">PDB: 1YER</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD','PDB','3QDD'); return false;">PDB: 3QDD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H8M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H8M','PDB','2H8M'); return false;">PDB: 2H8M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F','PDB','3O2F'); return false;">PDB: 3O2F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1F','PDB','4Z1F'); return false;">PDB: 4Z1F</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00940&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00940%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00940" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ad15f9d843d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
